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Title of the project no.: 
ROLE OF B LYMPHOCYTES IN CHRONIC RADIATION DAMAGE. 
Head(s) of project: 
Prof. H. BAZIN 
Scientific staff: 
Dr P. MANOUVRIEZ 
B. VANHOVE 
B. PLATTEAU 
I. Objectives of the project: 
Injuries of the immune system are a well known consequence of exposure to 
ionizing radiations. As an immune response is the result of a series of 
events which imply a number of cell populations, it is necessary to 
identify them and to analyse their respective radiosensitivities. The 
present program is focused on the humoral responses and especially on the 
B lymphocytes which can be divided in various subpopulations, depending 
on their membrane receptors, mobilities, localizations in the peripheral 
lymphoid organs, and evidently their respective physiological roles. The 
main objective of this program is to restore the normal function of the 
system in order to protect immunosuppressed patients against infections. 
11. Objectives for the reporting period: 
The reporting period was devoted to study: 
- B lymphocytes of rats after a chronic exposure of gamma rays given at a 
dose rate of 12, 20 and 30 cGy per day. 
- B lymphocytes of rats after a single exposure to a sublethal dose of 
irradiation given at a high dose rate. 
- Restoration of B lymphocyte cell populations in irradiated rats after 
intravenous injection of B lymphocytes from different origins. 
- Long term effects of prenatal or early postnatal irradiation on the 
immune system of rats. 
- Long term effects of prenatal or early postnatal irradiation on the 
circulating T lymphocytes of rats. 
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Ill. Progress achieved: 
3.1. Chronic exposure of gamma rays giyen at a low dose rate 
Irradiations to cobalt gamma rays were given to Sprague-Dawley male rats 
at a daily doses of 0, 0.07, 0.12, 0.20 or 0.30 Gy for a period of up to 
90 or 135 days. The observed effects increased with the daily dose and 
the duration of irradiation. However, at a daily dose of 0.07 Gy, as well 
as a daily dose of 0.12 Gy for 30 days, no clear effect was observed, in 
particular all rats showed visible follicles with germinal centres and 
well developed marginal zone cell populations. At all other doses and 
durations, there was a visible decrease of the B lymphocyte cell 
populations, with a much higher susceptibility of the marginal zone B 
population than of the follicular zone B population. 
3.2. Exposure to a single d9se given at a high dose rate 
Spleen IgM plasma cells (as seen in Fig.1) did not change in number 
during the months following 5 Gy whole body irradiation by comparison to 
the controls. Contrariwise, a large and significant increase of IgA 
plasma cells was detected in the same organ, reaching its maximum at day 
20 after irradiation (Fig.1). 
In the mesenteric lymph nodes, the number of IgM plasma cells fl~ctuated 
between 10 and 100 cells per section, whatever the time after·irradiation 
was. IgA plasma cells, in the same lymph nodes, were difficult to count. 
However, their number was constantly high, between 5 x 102 to 10 3 cells 
per section, whether in irradiated rats or in control rats. 
In the intestinal tract, there was a clear reduction in length of the 
villi associated with a size reduction of the Peyer's patches. An 
approximately equal number of IgA plasma cells could be seen in the 
lamina propria of the mucosae from day 1 to day 7 after irradiation. From 
day 10 to day 15 after irradiation, there was an enormous increase of IgA 
plasma cells which returned to normal at day 20 as well as the size of 
the villus. The number of IgA plasma cells in and around the Peyer's 
patches was always limited and not significantly different from those of 
the controls. 
The serum concentrations of the IgM and IgA are given in Fig.1. 
The IgM and IgG serum levels showed a rather similar pattern, both of 
these immunoglobulin isotypes slightly increased with time after 
irradiation. However, the control rats showed a similar increase of their 
IgM and IgG serum levels and so, no significant increase was detected in 
the irradiated rats by comparison to the control ones. 
On the contrary, the IgA serum level of the irradiated rats decreased in 
the days after irradiation and then, sharply increased up to day 25. This 
increase was followed by a decrease. Their IgA serum levels returned, 
after day 30, to the level of the control rats. 
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TIME (dayo) 
Number of IgM (top, left) and IgA (bottom, left) plasma cells and IgM 
(top, right) and IgA (bottom, right) serum levels in irradiated (5 Gy 
whole body irradiation) and control rats, as a function of time after 
irradiation. 
3.3. Restgration of B cell population in irra4iate4 rats 
The effects of lymphocyte transplantation on the restoration of the B 
lymphoid system after a 5 Gy whole body irradiation have been analysed in 
rats. Male and female 3 month-old Fisher rats have been irradiated with a 
gamma ray machine (137 caesium source). The standard radiation dose 
delivered was 5 Gy. 
In the first experiment, cells from histocompatible rats, either 3.5 x 
108 cells from spleen or 0.5 x 108 cells from mesenteric lymph node were 
intravenously inoculated, 4-hours after the irradiation. On days 1,3,7 
after irradiation and transplantation, irradiated or non-irradiated rats 
were sacrified. Serum immunoglobulins were measured and spleen, 
mesenteric lymph nodes and Peyer's patche~ were taken for 
immunohistologtcal studies. 
The immunoglobulin serum levels-of these animals are given in Fig.2. 
Tissue sections from spleen showed a clear appearance of follicular cells 
already at day 1 after irradiation, but the marginal zone cells appeared 
at day 3 in the spleen cell transplanted rats and at day 6 in irradiated 
rats in which mesenteric lymph node cells were inoculated. 
In another series of experiments, B lymphocytes have been transplanted in 
a congenic rat system that we have developed and in which, it is possible 
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to transfer B lymphoid cells and to follow these cells and their 
descendants. In rat species, a major immunoglobulin allotypy is located 
on the constant part of the kappa light chain. Moreover, kappa light 
chain represents the 95\ of the immunoglobulin light chain isotype in 
this species. Two allotypes have been described, the IgK-1a allotype 
being carried by the LOU strain and the IgK-1b allotype by, among others, 
the OKA strain (Backers et al. Immunochemistry 1974,!!,605). We have 
developed a congenic strain to the LOU/C rats having the kappa light 
chain of the OKA strain. Both strains, LOU/C with the IgK-1a locus and 
LOU/C.IgK-1b(OKA), are perfectly histocompatible as judged by reciprocal 
skin graft. We have also developed hybridomas synthetizing monoclonal 
antibodies which can react only with immunoglobulin molecule carrying the 
kappa light chain either of the IgK-1a allotype or the IgK-1b allotype. 
By transplanting lymphoid cells from rats of one strain in the other 
strain, it is possible to follow these cells and their secreted 
immunoglobulins but also their descendant cells and their products of 
secretion. 
Lymphoid cells of the LOU/C(IgK-1a) rats have been inoculated in 
LOU/C.IgK-1b(OKA) rats and the results given in table 1. 
'l'able 1: L~ transplaated f~ IJJU/C (IgK-1a) rats into irradiated LOO/C.IqK-1b(OIUt.) rata, 
u aeea by tbe IIARK-3 (-.use •U-rat kappa l:Lght cbaiD. of tbe lgK-1b allotype llUIIber 3). 
Time after 
tran&plantatl.on 
(1n days) 
Follicular zone* 
Marginal zone* 
IgM plaaaa ceua• 
10 15 20 25 30 40 50 60 
*The nuaber of cella per tiaaue ..Cuon is 9i ven in arbitrary unit by co.pariaon to the control non 
irradiated rata. 
•Thll n\Uiber of cella ia given per tiuue section: 0: no cells; ++: 25-50 cella; ... : >50 . 
• 3 
~ . 
Ill 
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.. . • > 
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Figure 2: 
IgG serum level of control 
(1) or irradiated (2)-
restored with spleen (3) 
or mesenteric lymph node 
cells (4) in function of 
time after irradiation. 
In conclusion, the follicular cell compartment (circulating B cells, mu 
positive and delta positive) can be , restored very quickly by spleen as 
well as lymph node cells. The marginal zone cells do not reach directly 
their normal localization but need two or· three days before being 
localized in their normal environment. When animals are restored with 
lymph node cells, they do not recover marginal zone cells before day 6 
after irradiation. We hope to understand the signification of this period 
of time. 
3.4. Long term effects of prgnatal or early post natal irradiation 
In collaboration with F. Vander Plaetse and R. Hooghe (Pathology Section, 
Biology Oept, Study Center for Nuclear Energy, B-2400 Mol, Belgium), we 
have looked for long term sequelae in the immune system of rat that had 
been irradiated on a single occasion (0-2 Gy, whole body irradiation, X-
rays) during prenatal or early postnatal life. At the age of 2 months, 
the histology of the spleen was normal, and so were the amounts and 
distribution of B and T lymphocytes. The serum immunoglobulin levels were 
not altered, even when the different isotypes were considered. At the age 
of 10 weeks, rats were immunized with a T-dependent or a T-independent 
dinitrophenylated-carrier antigen. Normal levels of specific antibodies 
were generated in all groups of animals. Thus no long term 
immunodeficiency could be documented in rats that had received up to 2 Gy 
before or early after birth. 
3.5. Lgng term effects of prenatal or early postnatal irradiation on 
circulating T lymphocyte subpopulations 
We have looked for long term sequelae in the immune system of rats that 
had been X-irradiated (0-2 Gy whole body irradiation) once or twice 
during prenatal or early postnatal life, in collaboration with R. Hooghe. 
At an age of 15 months, blood was taken for routine haematological 
analysis. In addition, T-cell subpopulations were analyzed at th~ FACScan 
with monoclonal antibodies W3-25, MRC OX-B and MRC OX-19, used 
respectively as C04, COB and pan-T reagents. In control males, 29% of 
blood lymphocytes expressed C04, 33% COB and 39 the pan-T marker. In 
females, the corresponding figures were 39, 34 and 53. These important 
differences between males and females were not affected by most 
irradiation protocols. However, females given 1 Gy 6 days after birth had 
only 31% C04, 26% COB and 39% lymphocytes expressing the pan-T marker. In 
contrast, females irradiated twice (1 or 2 Gy, 16 or 20 days after 
conception and 6 days after birth) often had a clear-cut increase of the 
COB positive population (46%) and a decrease of the C04 population (25-
32%) and of the OX-19 (pan-T) population (29-35%). In conclusion, a 
single irradiation (1 or 2 Gy) during prenatal or early postnatal life 
had little effect, except for a decrease of all T-cell populations in 
females irradiated 6 days after birth. Females irradiated twice showed an 
increase in COB and a decrease in C04 and "pan-T" populations. The fact 
that no effect was seen in males suggests a possible role for sex 
hormones in long term haematological effects of irradiation. 
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IV. Other research group(s) collaborating actively on this project [name(s) and 
address( es)]: 
Dr Jean MAAS and Ghislaine PINON-LATAILLADE 
Commissariat a l'Energie Atomique, Departement de Protection Sanitaire, 
Centre d'Etudes Nucleaires de Fontenay-aux-Roses NP n°6 F-92260 
Fontenay-aux-Roses, France. 
Drs Michel JANOWSKI and Robert HOOGHE 
CEN - Pathology Section - Biology Department Study Center for Nuclear 
Energy - B-2400 Mol, Belgium. 
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EURATOM FINAL REPORT. 
NON-STOCHASTIC EFFECTS OF ALPHA AND BETA RAPIATION ON MOUSE 
SKIN. 
Introduction. 
The problems arising in the nuclear power and related 
industries, from skin contamination with radioactive 
particles, continue to be a cause for concern. The acute 
effects (erythema, oedema, pigmentation, desquamation and 
ulceration) following penetrating irradiation from large 
uniform sources have been well documented, and the severity 
and duration of the reactions and the dose response 
relationships are known to be dependent on dose rate, dose 
protraction and the volume of tissue irradiated (Jarnrnet et al, 
1986). However, much less is known of the effects of less 
penetrating alpha and beta sources, although they play a major 
role in accidental exposures e.g. Goiania and Chernobyl, as 
well as in some occupational environments (UNSCEAR, 1988; 
Charles, 1986). 
The guidance from 1977-1984, offered by ICRP for skin 
exposure, has been widely criticised, especially its lack of 
clarity over dose averaging following exposure of areas of 
<<1~ of skin (Wells, 1986). There are very few human or 
animal data on the effect of varying the area of skin 
irradiated for different alpha and beta energies and the 
purpose of this study was to fill this experimental gap. The 
work has been collaborative with Drs.M.W.Charles and J.Wells 
of the CEGB Berkeley Nuclear Laboratories and with Dr.J. 
Hopewell of the CRC Laboratory at Oxford, the latter having 
studied early and late non-stochastic effects in pig skin. 
The precise aim of the work has been to attempt to 
provide quantitative answers to the following practical 
questions: Is there a minimum area that needs to be irradiated 
to induce moist desquamation?; What are the threshold doses 
for this effect, and how do these vary with the energy of the 
radiation and the area of skin exposed? To do this, we have 
generated dose response curves in mouse skin for three very 
- 1130 -
different energy beta emitters (promethium-147, thulium-170 
and strontium/yttrium-90r and for curium-244 alpha particles. 
Materials and Methodology. 
Experimental animals. 
Male, random-bred SAS/4 albino mice, 11 to 12 weeks old, 
were used in all experiments. They were obtained from a colony 
at the Medical College of St.Bartholomew's Hospital. Prior to 
irradiation, an area of dorsolateral skin was depilated with a 
depilatory agent, Veet (Reckitt Toiletries Ltd., Hull, U.K.). 
This procedure triggers resting (telogen) follicles into the 
active (anagen) cycle, thus ensuring that the epidermis and 
dermis were of a known thickness and that the hair follicles 
were at a known depth in the skin. The mice were irradiated 
immediately after depilation while the follicles were still in 
telogen. The average epidermal thickness at this time is 10.7 
± 1.6um (SE), dermal thickness 'is 441 ± 30um and the bases of 
the hair follicles are at 141 ± 15um (Hansen et al, 1984). 
These thicknesses take into account the natural elasticity of 
skin. Any mice showing hair regrowth before day 9 after 
depilation/irradiation were excluded from the experiments 
since such early regrowth implied that the follicles had been 
in anagen and not telogen at the time of irradiation. 
For each source and dose point, 12-18 mice were used and 
they were observed daily for 6 weeks for acute skin reaction 
with the unirradiated flank acting as control skin. 
Radioactive sources. 
The beta sources used were strontium-90/yttrium-90, 
thulium-170 and promethium-147 (E~ = 2.27, 0.97 and 0.23MeV 
respectively). The strontium sources were prqduced by Amersham 
International plc and were circular, with diameters between 1 
and 22.5mm. The thulium-170 sources were produced by Drs.M.W. 
Charles and J.Wells of the CEGB, by the neutron activation of 
pure thulium-169 in the form of a 0.1mm thick foil. The 
circular Tm-170 sources had diameters between 0.1 and 9mm and 
were mounted on pure aluminium rods. The 15mm circular 
promethium source was also produced by Amersham International 
plc. To enable the diameter of the source to be varied, 
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shields of aluminium and melinex (120:120um), with either 2, 5 
or 9mrn diameter circular holes punched in each, were fixed 
across the source, with the melinex in direct source contact 
to reduce scatter. 
The curium-244 alpha source (E•x = 5.8MeV) was made by 
UKAEA by neutron activation and was a large 2 x 4cm planar 
source. 
The dosimetry of all sources was carried out using an 
extrapolation ionisation chamber using ~ rar.ge of collector 
electrodes, from 1 to 10mm, and all beta dose measurements 
were central axis, made with a 16um tissue•equivalent window, 
and so the doses quoted in this paper actually refer to the 
doses at this depth in the skin. 
The dosimetry of the alpha sources was calculated at 
260Gy hr-1 (±10%) at the skin surface, 179Gy hr-1 at lOum and 
zero at 30um into the skin. 
Results. 
Figs.1, 2 and 3 show the dose response curves for the 
moist desquamative skin reaction following strontium, thulium 
and promethium exposures respectively. All of the dose 
response curves show a marked area effect, i.e. as the area 
irradiated increases, the dose required to produce moist 
desquamation decreases. Table I gives the approximate 
threshold doses for each of the sources and the doses required 
to produce moist desquamation in 50% of the mice (MD-50'~). 
A critical analysis of the temporal sequence of the acute 
responses for promethium, thulium and strontium was carried 
out using a comparison of three diameters (2mm, Smm and 9 or 
11mm) for each of the sources. Each of the tpulium and 
strontium sources demonstrated three distinct, dose dependent 
phases of response, and using the 11mm strontium data as 
examples, the details of the three phases are briefly 
described: 
1. At the lowest doses (~25Gy), no moist desquamation was seen 
and the mice exhibited only a low level dry desquamative 
reaction. 
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Table I. Threshold and.MD-50 Doses for Acute Skin Reactions. 
Source 
1nun Sr-90 
2nun Sr-90 
5nun Sr-90 
llnun Sr-90 
22.5nun sr-90 
0.1nun Tm-170 
o.5nun Tm-170 
1nun Tm-170 
2nun Tm-170 
5nun Tm-170 
9nun Tm-170 
2nun Pm-147 
5nun Pm-147 
9nun Pm-147 
15nun Pm-147 
Thresbold Qose 
140 
90 
30 
20 
10 
120 
75 
60 
45 
15 
10 
.:.. 
170 
140 
100 
Uz:tl tm-~Q !;!Oi!i! 
710 
250 
90 
48 
25 
610 
230 
130 
60 
30 
800 
400 
280 
{~:l!) 
~At intermediate doses (35-100Gy), there was little 
variation i~ the degree of moist desquamation, with some two 
third's of the mice showing a synchronised, short duration, 
moist desquamative response. The onset of this reaction at 12 
days and its duration of 8-9 days was independent of dose 
level in this range •. 
~At the highest doses (~125Gy), 100% of the mice showed 
moist desquamation, its onset being as early,as 6 to 8 days 
post-irradiation and the duration of the reaction was 6 weeks 
(@ 125Gy), and even longer for the higher doses. These 
persistant moist desquamative reactions were associated in 
many cases with an underlying ulceration. 
This sequence of dose dependent skin reactions was also 
observed with the other strontium sources, but as the area 
irradiated was reduced, the doses to produce phases 1, 2 and 3 
increased. 
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The results for the less penetrating betas from thulium 
produced the same three responses at dose levels similar to 
those for strontium, although the level of response in the 
intermediate phase was lower, i.e. following thulium 
irradiation, only 30% of the mice showed the synchronised, 
short duration moist desquamative response, in comparison with 
60% of the mice following strontium exposure. 
Finally, with promethi~, the least penetrating beta 
emitter, moist desquamation was not inducible at doses below 
100Gy and although the larger sources (see fig.3) produced an 
area- and dose dependent increase in reaction levels up to a 
100% response, there was no transition to the severe phase 3, 
the prolonged desquamative/ulcerative reaction. 
The acute reaction studies for the 8cm2 curium-244 source 
showed that even at the highest dose level used (180Gy), none 
of the animals exhibited moist desquamation. The acute 
response began as a mild·erythema on duy 2 pest-irradiation, 
and reached a peak response on day 6, when some 66% of the 
mice exhibited a number of dry flakes. Flaking was observed 
until approximately day 10, thereafter only mild erythema was 
seen persisting in only a few mice for two or three days. At 
lower dose levels (120 and 80Gy), there was a dose related 
increase in the time to reaction onset and a dose related 
reduction in the reaction duration, although the peak in 
response still appeared on days 6 and 7 respect.i. vely. 
At dose levels below 80Gy, the only discernible gross 
macroscopic reaction was a small degree of "mottling" in the 
skin coloration. At all dose levels, the acute reaction became 
difficult to score beyond 12 days post-irradiation since there 
was no disruption to the hair growth cycle b~yond a slight 
delay, so that at this time the hair regrowth obscured the 
irradiated field. 
This inability of curium alphas to elicit moist 
desquamation, even using large sources, meant that it was 
unnecessary to investigate smaller area alpha sources. The 
relative ineffectiveness of the alphas is presumably related 
to the lack of penetration of the particles - their maximum 
range being only H30um into the skin. Such a dose distribution 
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would leave >95% of the follicle basal cells unirradiated and 
available for rapid re-epithelialisation of the damaged 
superficial basal layer. 
Discussion. 
The data in this paper are comparable with some earlier 
published studies (Coggle et al, 1984) and confirm that 
strontium and thulium sources greater than 1mm in diameter are 
equally efficient at producing acute moist desquamation 
despite the greater penetration of the strontium betas. In 
contrast, the much less energetic betas of promethium-147 
required much higher doses to produce the same levels of acute 
skin reaction. But once again there was a pronounced area 
effect and with the smallest source (2mm-diameter), it was 
impossible to produce exudative epidermatitis in the mouse 
skin, even at doses as high as 1500Gy. A similar situation was 
found with the two smaller thulium-170 sources - 0.1 and 0.5mm 
in diameter - where the threshold dose, as fitted by eye for 
the 0.1mm source, is approximately 120Gy, whilst the MD-50 
value for the o.smm source is 610Gy, with a threshold of 75Gy. 
As was the case for the smaller promethium-147 sources (~Smm), 
the highest doses did not produce 100% moist desquamation, 
although the low dose rates of the small thulium sources 
prevented further investigation at higher doses. 
From Table I, it can be seen that the lmm Sr-90 MD-50 
value of 710Gy is much higher than the 1mm Tm-170 MD-50 value 
of 230Gy. This 'anomalous' result, with the more penetrating 
betas of the strontium source being less effective than those 
of the thulium, has still to be resolved, either physically, 
with a reassessment of the dosimetry of the .sources or 
biologically, using histology to check any degree of under-
scoring of the small lesions that might account for the 
result. 
To explain these area and energy effects, we propose that 
moist desquamative lesions heal principally by two processes: 
(a) by cell migration and division from basal cells at the 
periphery of the irradiated ~ield; 
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and/or (b) by cell migration and division from undamaged basal 
cells from within the field, from the epidermis and hair 
follicles. 
Cell migration from the periphery of the area has been 
shown by a number of authors, e.g. Franklin and Coultas (1984) 
and occurs in mice, pigs and guinea-pigs at rates of between 
0.1 and 0.4mm day-1 (Coggle et al, 1984; Devik, 1977; Osanov et 
al, 1976). Migration and division of cells within the field 
has similarly been demonstrated by other authors, e.g. Al-
Barwari and Potten using their micro-colony assay (1976). 
The working hypothesis also links the two repair 
mechanisms mentioned above to the energy of the radionuclides. 
No area effect is seen where the dose or energy of the beta 
particles is insufficient to damage the clonogenic basal 
cells, be they epidermal or follicular. As the energy of the 
electrons increases, gaps start to appear within the 
irradiated field; repair now occurs either from pockets of 
basal cells within the field or from the periphery and the 
relative roles of each mode of repair are dependent on both 
the energy of the radionuclide and the area of the field. The 
greatest area effect will be seen at the higher energies 
until, ultimately, repair is totally dependent on peripheral 
proliferation, when we will see the maximum area effect. This 
effect is also illustrated in the skin clonogen work of 
Withers (1967) who isolated areas of skin by lethally irrad-
iating an annulus around the field of study, so preventing 
cell migration. 
Our work has also produced a number of results that point 
to the involvement of dermal damage as contributing to the 
effects especially at the higher dose level,. 'pheee 3' 
reactions referred to previously. The depth dose distributions 
of both thulium and strontium do not stop at the basal layer 
and it seems plausible to suggest that the restorative 
capacity of the basal cells depends on the integrity of the 
dermal elements and that this is particularly important in 
producing the more persistent severe desquamative/u!cerative 
lesions at the higher doses and larger areas. Conversely, the 
inability of the weaker, less penetrating promethium betas to 
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elicit significant dermal damage may explain why severe phase 
3 damage was not inducible even with the highest doses and 
largest sources. Also, the lack of effect is pronounced due to 
the presence of surviving epithelial cells always available in 
the irradiated area from the hair follicles. 
From the mouse studies and the non-stochastic pig skin 
studies of our Oxford collaborates, it would not seem possible 
to choose a single area and depth dose over which to average 
dose which would then provide a single predictive indicator of 
skin damage for all source sizes and energies (see Charles et 
al, 1989). This is presumably due to the variety and 
complexity of the biological endpoints of the acute skin 
reactions. For the large area sources, the threshold doses of 
N 10-20Gy (see Table I) are in the region of the current life 
time ICRP skin dose limit of 20Gy. For chronic, occupational 
exposures, the sparing due to repair is expected to increase 
the thresholds somewhat: For small sources, weak radiations 
and where the exact skin area is unlikely to be persistently 
exposed, in practice the threshold doses are going to be 
orders of magnitude in excess of the current annual ICRP dose 
limits of O.SGy. These conclusions should be reassuring to 
those in the nuclear and other radiological industries who are 
currently concerned over potential health effects in skin of 
particulate irradiation. 
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EURATOM FINAL REPORT. 
STOCHASTIC EFFECTS OF ALPHA AND BETA RADIATION ON MOUSE SKIN. 
Introduction. 
Cancer induction is the most significant risk following 
irradiation in man. Human exposure to radiation is rarely 
uniform over the whole body or even over a whole tissue so 
that the epidemiological data used in cancer risk analysis are 
usually derived from non-uniform or partial body exposure. 
Consequently, it is important, for radiation protection 
purposes, to design experiments involving comparisons of 
uniform and non-uniform radiation exposure. This is especially 
relevant in assessing tumour induction in the skin, where 
possible sources of localised skin exposure include small 
radiotherapy sources, radiopharmaceuticals, collimated 
microbeams and both fission and activated products from 
nuclear reactors, neutron generators and associated 
facilities. For radioactive particulates emitting radiation 
with a very limited range, it is possible that high doses may 
be received by very small volumes of skin, while most of the 
skin will receive no dose. It has been suggested that such 
extremely inhomogeneous radiation would not have the same 
effect as a dose averaged over the whole skin surface. 
The carcinogenic effect of "hot particles" is not a new 
problem; it was considered by the International Commission on 
Radiological Protection in 1969 (ICRP, 1969) and has been a 
controversial issue ever since (Coggle et al, 1984). However, 
non-uniform irradiation of the skin is a hazard, commonly 
encountered in radiation protection, which has received very 
little attention (Wells, 1986), probably because of the 
current ICRP view that skin cancer is a negligible risk in 
comparison with such non-stochastic effects as ulceration and 
dermatitis. For skin exposed over areas of less than 1cm2, the 
current lack of guidance in ICRP (1977) reflects the lack of 
available information on non-uniform exposure. 
This lack of specific guidelines has meant that the 
nuclear industry and other authorities have based their 
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operational procedures and permitted levels of skin exposure 
on the assumption that the risk from radioactive particles is 
not affected by the spatial distribution of the resultant 
radiation. This view is, however, not universally accepted and 
has given rise to considerable debate (Wells, 1986). 
To investigate the problems posed by highly localised 
skin exposure, a collaborative project was set up between the 
Central Electricity Generating Board's Berkeley Nuclear 
Laboratories, the Radiation Biology Department at the Medical 
College of St.Bartholomew's Hospital and the CRC Normal Tissue 
Radiobiology Research Group at Oxford. The results of the 
study of non-stochastic effects in pig and mouse have recently 
been reported elsewhere (Hopewell, 1990; Williarns et al, 
1990). 
This paper presents data on the stochastic effects of 
thulium-170 beta irradiation on the skin of several different 
strains of mouse. The stochast'ic effects of alpha particles 
from a curium-244 source on a single mouse strain are also 
presented. Dose response curves are given for skin tumour 
induction following uniform and non-uniform modes of exposure. 
Materials and Methodology. 
Experimental animals. 
In most experiments, male random bred SAS/4 albino mice, 
10-12 weeks old, were used; male COl, male and female C57Bl/6 
and male CBA/Ca strains were used in the comparative study. 
Radiation sources. 
In the study to compare uniform with non-uniform 
irradiations, thulium-170 (E.x=0.97MeV) was used. The uniform 
rectangular 3.9 x 2.2cm sources were produced by wrapping 
lOOum thick thulium-169 metal foil in three layers of 15um 
thick aluminium. Ultrapure materials were used to avoid 
activation of trace elements. Non-uniform sources were 
produced as arrays of 8 or 32, 2rnrn diameter thulium foil discs 
mounted on an ultrapure lOOum thick aluminium sheet of area 4 
x 2cm. Source alignment was checked by x-radiography. 
Following neutron activation, the thuliurn-170 sources were 
allowed to cool to allow the 2BAl activation product to decay. 
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Depth doses and dose distributions of the beta sources 
were measured using an extrapolation ionisation chamber with 
collecting electrodes of diameters lmm up to lcm (minimum area 
of accuracy is l.lmm2) and with ultrathin (30um LiF/ Teflon) 
thermoluminescent dosimeters. Since the ionisation chamber has 
a 16um tissue-equivalent window, the measured "surface doses" 
actually refer to doses at this depth, whilst the beta doses 
at the base of the dermis are 50% of the skin surface doses. 
Using a lmm electrode, the minimum surface dose rate 
between individual sources in the 32-source array was measured 
at 40% of the peak dose and 90% of the mean dose over the 
whole array. In the case of the 8-source array, each source 
was independent; peak doses measured with the lmm electrode 
were an order of magnitude greater than the mean dose over the 
whole area. The initial dose rates were 17.3Gy min-1 for the 
uniform source, 18.1 and 4.9Gy min-1 for the 32- and a-source 
non-uniform arrays respectively. Following calibration, the 
sources were mounted in lead and aluminium irradiation jigs 
with interlock and failsafe chambers. 
For the alpha particle irradiations, similar Bcm2 
rectangular curium-244 (lOOuCi) sources were made and covered 
with a 4um melinex film. The skin surface dose rate was 
calculated at 260Gy hr-1 (±10%), 179Gy hr-1 at lOum and the dose 
at 30um was zero. These sources were mounted in identical 
failsafe mouse irradiation jigs, 
Irradiation procedure. 
Mice were anaesthetised using 62.5mg k~1 body weight 
intraperitoneal sodium pentobarbitone and an area 5 x 3cm of 
the right or left flank was depilated using Veet (Reckitt 
Toiletries Ltd., Hull). The mice were secured to an aluminium 
tray and placed in the jigs. Control mice were sham 
irradiated. In the first thulium-170 experiment, involving 
1200 SAS/4 mice in groups of 100, doses between 20 and lOOOGy 
(uniform), 20 to SOOGy (32-array) and 20 to 450Gy (8-array) 
were given. In the second thulium-170 SAS/4 experiment, doses 
of 2, 5, 10 and 20Gy were used. In the study of strain 
differences, groups of 55-65 albino (SAS/4, COl), brown 
(CBA/Ca) and black (C57Bl/6) mice were given uniform thulium-
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170 beta doses between 12.5 and 100Gy. Finally, SAS/4 mice 
were used in the curium-244 alpha carcinogenesis experiment 
where eight dose groups of 75-100 mice were given uniform 
doses between 2 and 180Gy. 
Mice were observed daily for 6 weeks through the acute 
skin reaction period and then weekly throughout their lifespan 
for signs of morbidity and for the appearance of a skin tumour 
in or adjacent to the irradiated area. Post-mortem examination 
was performed on all animals and all tumours were kept for 
histopathological classification. 
Results. 
I. Uniform versus non-uniform thulium-170 data. 
None of the 152 control mice developed skin tumours on 
their irradiated flank skin. However, a total of 389 skin 
tumours developed in the irradiated mice and Table I shows the 
spectrum of pathologies induced by the uniform and non-uniform 
thulium-170 sources. 
Fig.1 shows the cumulative skin tumour incidence in the 
first experimental series at 120-129 weeks post-irradiation as 
a function of mean skin surface (16um) dose for the uniform, 
32- and 8-arrays of thulium-170. These data show that there is 
no significant reduction in tumour incidence above 300Gy, and 
so the whole range of uniform data cannot be fitted to any 
simple single radiobiologically acceptable model. 
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Table I. Pathology of Skin Tumours Induced by Thuliurn-170 Beta 
Particles <expressed as %'s>. 
Tumour type 
Squamous cell 
carcinoma 
Uniform source 
(n=286) 
1.7 
Squamous papilloma 2.8 
Basal cell 
carcinoma 
1.0 
Sub-Total 5.6% 
Rhabdomyosarcoma 62.6 
Leiomyosarcoma 5.6 
Fibrosarcoma 3.1 
Undifferentiated 3.1 
sarcoma 
Other malignant 1.7 
tumours of dermal origin 
Fibroma 7.3 
Leiomyoma 
Other benign 
1.7 
2.8 
tumours of dermal origin 
Sub-Total 88.1% 
Unknown pathology 6.3% 
Non-uniform 
(32-array) 
(n=75) 
4.0 
1.3 
5.3% 
52.0 
5.3 
6.7 
4.0 
2.7 
9.3 
4.0 
4.0 
88.0% 
6.7% 
Non-uniform 
(8-array) 
(n=28) 
7.1 
7.1% 
42.9 
7.1 
7.1 
3.6 
10.7 
3.6 
75.0% 
17.9% 
The data on the cumulative incidence of skin tumours as a 
function of time after uniform irradiation showed that the 
latent period was a function of dose up to 100Gy, but that at 
doses above 100Gy, up to 1000Gy, tumours appeared 20-40 weeks 
post-irradiation, irrespective of dose level. 
Data below 300Gy are best fitted by a linear induction 
and simple sterilisation function: oe-D/Do and the high 
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incidence at the lowest (20Gy) dose precludes any threshold 
model. This lack of a threshold in the response is underlined 
by the results of the second series of e~~eriments with doses 
of 2, 5, 10 and 20Gy and figure 2 shows the combined uniform 
dose response relationship. This has a p value of 0.1 and a 
turnover dose point of 220 ± 60Gy. 
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A linear regression analysis of the data below 150Gy, 
constrained to pass through the origin by the method of la~st 
squares, fitted well and explained 97% of its variability, the 
goodness of fit confirming the lack of threshold. 
The data in fig.l clearly indicate a reduced tumour 
incidence, at all doses, for the non-uniform irradiation, with 
the most marked reductions seen with the more inhornoger.oua, a-
point source. 
II. Thulium-170 beta carcinogenesis in different mouse 
strains. 
The strain difference experiment is almost completed, 
however, the analysis of the data is still preliminary, 
although nevertheless interesting. 
The two albino strains, COl and SAS/4, both show a firm 
dose response rela~ionship in their cumulative tumour 
incidence. The COl strain has a higher response at all dose 
levels, but also has a 17.5% tumour incidence in the control 
group, in eontrast with the SAS/4's zero control incidence. 
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The C57Bl/6 black strain show an interesting response 
with a possible threshold effect. None of the control mice 
produced a tumour on the irradiated area and at the lowest 
dose level of 12.5Gy, one animal produced at t~~our at 124 
weeks post-irradiation; the remaining dose groups appear to 
have identical dose response curves with a peak cumulative 
tumour incidence at 120 weeks post-irradiation of 30-40%. 
The CBA brown strain produced no tumours in the control 
group and a single tumour at the lowest 12.5Gy dose level. 
There was a strong dose response relationship in the 
cumulative tumour incidence at the higher doses. 
A full pathological analysis is still to be completed. To 
date, the majority of the tumours have now been classified as 
malignant fibrous histiocytomas (Y~H's). Also, it appears that 
the pigmented mice appear to be less susceptible to the 
induction of malignant epidermal tumours than are the albino 
strains, but these conclusion~ are still preliminary. 
III.Curium-244 alpha carcinogenesis data. 
To date, after 12 to 24 months post-alpha irradiation, 
with doses between 2Gy and 180Gy, no skin tumours have been 
recorded in the 760 SAS/4 mice in the study. 
Discussion. 
The literature on experimental radiogenic skin cancer 
studies has recently been reviewed (Coggle end Williame, 
1990). Albert, Burns and their colleagues have carried out a 
large number of experiments in CD strain rate using X rays, 
monoenergetic electrons, protons and alpha and beta particles 
(see Burns and Albert, 1986). The dose effect relationship for 
electrons was curvilinear and tended to approach linearity for 
high LET radiations and at high doses, the incidence of 
tumours gradually declined. 
A similar dose response pattern, of a curvilinear 
increase with dose for both epidermal and dermal tumours with 
a considerable fall-off at the highest doses, was reported by 
Hulse (1967) in CBA mice following thallium-204 beta 
irradiation. In more recent papers, using the same beta 
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sources, the incidence curves for both types of tumour showed 
little tendency to fall in mice for doses as high as 260Gy 
(Hulse et al, 1983). Finally, Tanooka (personal communication, 
1984) found no skin tumours in the dorsal skin of female CD 
mice given single doses of strontiurn-90 beta irradiation up to 
175Gy, and more recently, Ootsuyama and Tanooka (1988) have 
reported threshold doses for tumour induction following 
chronic or promoted ~Sr irradiation. 
In humans, there appears to be a racial variation in the 
incidence of amelanotic skin cancers induced by ior.ising 
radiation. About a dozen studies of irradiated human 
populations have been reviewed by Shore (1990) and it is of 
note that they provide no evidence for a dose threshold and 
are compatible with a linear dose response relationship. A 
figure of approximately 10-4-1o-s cm-2 Gy-1 is obtained from these 
epidemiological studies and if these skin cancer risks are 
applicable to the wnole body skin area then the skin cancer 
risk for the whole body could be as high as 10-100% Gy-1. 
The studies reported in this paper add to the sparse 
literature on experimental skin cancer induction. The uniform/ 
non-uniform thulium-170 experiments (fig.1) clearly offer no 
evidence for any mechanism giving rise to a 'hot particle 
effect'; the data refute any such hypothesis. These thulium 
experiments confirm the work of Albert and Burns who showed 
that sieve and grid patterns of exposure afforded a degree of 
protection against skin tumour induction. 
The detailed pathological analysis of approxim~tely 400 
radiogenic skin cancers in our mice showed 4% of epidermal 
origin, 96% of dermal origin and this is comparable with 
results in CBA mice as found by Hulse et al (1983) and in 
contrast with 95% epidermal : 5% dermal in the rat (Burns and 
Albert, 1986). However, in contrast to Hulse's CBA mouse data, 
the SAS/4 dose responses (fig.1 and 2) do not indicate any 
evidence for a thresQold and this is in-agreement with the 
totality of the human radiogenic skin cancer data currently 
being reviewed by the ICRP Skin Task Group. The dose response 
(fig.1) shows no tendency to decline at high doses indicating 
that any cell-killing component must be minimal., 
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Our failure so far to induce any skin tumours using the 
8cm2 curium alpha source is not surprising since its depth dose 
characteristics preclude any significant alpha penetration of 
the critical dermal structures that give rise to 96% of the 
radiation induced tumours in the beta experiments described 
above. 
The intercomparison of the carcinogenic response in 
different strains of mice following between 12.5 and lOOGy 
showed some wide variations in incidence, latency and tumour 
spectrum. For example, the minimum latent period appears to be 
not only dose related but also related to the longevity of the 
particular strain, such that despite producing the same 
overall numbers of tumours, the minimum latent periods for the 
CBA strain were much longer than those of the SAS/4, the 
latter being the shorter-lived. This may throw an interesting 
light on the problems of extrapolating data from the short-
lived rodent to the human. These data also support the theory 
that even within a single species, variations in the target 
cell populations will be critical in determining ~ancer 
proneness. 
Despite the differences between experimental results, 
useful inferences about the temporal and dose responses can be 
drawn by comparing the number of tumours per cm2 of skin 
induced in mice and rats with the human data. This comparison 
is discussed in full in our recent paper (Coggle and Williams, 
1990). Suffice to report here that the human skin cancer 
incidence is some two orders of magnitude lower than the 
totality of the rodent data, the latter showing a surprising 
degree of convergence. This discrepancy may be because human 
tumours are almost wholly epidermal, of extremely long latency 
and are widely under-reported, whereas in our experience of 
experimental systems, epidermal tumours form only a small 
percentage of the radiation induced tumours. 
The most important message of this longterm study of non-
uniform beta exposure of mouse skin is that the results are in 
direct contradiction to the 'hot particle hypothesis' and 
indicate that non-uniform exposure produces far fewer tumours 
than uniform exposure. This should be reassuring to those in 
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radiation protection who are currently concerned about the 
biological effectiveness of such particulates. 
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I. Objectives of the project: 
Diagnosis, prognosis and treatment of acute localized irradiations in pigs. Dosimetric 
assays by non invasive biophysical methods to evaluate the size and intensity of the 
radiolesions as an aid for surgery. Pathogenic studies of irradiated tissues by histological, 
immunocytochemical and histoenzymological methods. Pharmacological treatment screening in 
pigs and rabbits. Surgical treatment in pigs. Post-irradiation fibrosis studies in pigs : this 
healing process is investigated with respect to extracellular matrix synthesis, cellular 
proliferation abilities and molecular biology aspects. 
11. Objectives for the reporting period: 
-Improvement of non invasive biophysical methods for the diagnosis of the location 
and the intensity of the radiolesions. As far as prognosis is concerned it is important to 
determine, as early as possible, the limits for tissue which will undergo necrosis and delayed 
fibrosis. 
-Treatment assays with different classes of pharmaceutics: steroidal and non 
steroidal anti-inflammatory drugs; vasotropic substances, haemorheological agents (anti-
ischemic), platelet anti-agregants and anti-histaminic drugs. 
-Persistance of the fibrotic activity beyond normal healing time suggested that 
fibroblasts involved in this process would present some peculiar properties which were to be 
investigated: on one hand biochemical and cellular culture characteristics of the fibrotic 
fibroblasts were studied, as were in the other hand, their kariotypes and their molecular 
biology patterns. 
Experimental models for localized irradiation studies (all doses are given at 2 cm 
depth i.e. 4 times higher at the skin basal layer): 
Large White pigs, 40-60 Kg, were irradiated on the external side of the right thigh 
(m. biceps femoralis) with a collimated source of 1921r at doses between 30 and 84 Gy. 
New Zealand rabbits were irradiated with the same device on the back (m. iliospinalis) 
at doses between 10 and 40 Gy. 
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Ill. Progress achieved: 
111-1. Diagnosis 
a) Thermography: 6 pigs (3-30 Gy, 3-64 Gy). Combined thermographic 
measurements carried out with superficial probes (1 0 GHz microwave probe or thermistor) 
and a 3 GHz microwave probe for deeper measurements were able to discriminate between 
superficial and deep tissue injuries after local irradiation. Although the superficial thermic 
reactions (observed for the first ten days) ware similar in both cases, the deeper thermic 
reaction was significantly higher (60-100%)in the case of deep radiolesions. 
b) X Bays Computed TomographyiXBCTl and Nyclear Magnetic Besonnance lmaging 
(NMBI): 10 pigs (4-84 Gy, 6-64 Gy), 36 rabbits (between 10 and 40 Gy). 
The early oedematous reaction following local irradiation was visualized either by 
XCBTorNMBI. 
Oedema made the oedematous tissues less dense for X-rays absorption and involved a 
higher proton density conspicuous with NMB imaging. 
In these conditions it was possible, as soon as 3-4 days after irradiation to delimit 
tissue areas exposed to doses above 40-50 Gy in pigs and in rabbits. Blind NMB image 
analysis, pixel by pixel, for signal intensity and heterogeneity allowed a discrimination 
between rabbits exposed on the back at 1 0, 20, 30 and 40 Gy within 8 days. 
c) Gamma scintigraphy· 12 pigs (3-30 Gy, 9-60 Gy). 
Local scintigraphies were performed in pigs with 201 Tl chloride and a ggm Tc 
labelled glycolipidopeptide. After local irradiation (60 Gy) 201 Tl made obvious the early 
inflammatory reaction, followed by a latent period before a second wave of uptake by the 
radiolesion, which began towards the 30th day and plateaued from the 70th until the 200th 
day after irradiation (latest experimental data). 
Using a g9m Tc labeled glycolipidopeptide, supposed to reveal activated 
macrophages, made obvious a significant uptake of the radiolesion which began towards the 
50th day, reached a maximum between 70-90 days and decreased rapidly beyond. 
This kinetic aspect of the radiolesion labeling suggested two hypothesis according to 
the pathological evolution previously studied: 201 Tl might label the fibroblasts and 99m Tc 
labeled glycolipidopeptide the macrophages. Then it might be possible to follow with these two 
markers the early hyperemic reaction, the inflammatory reaction with migrating 
macrophages around tissues proceeding to necrosis process and finally the replacement of 
necrotized tissues by fibroblasts, 201 Tl chloride being possibly the marker of fibrosis. 
d) Biochemistry 
Histochemistry : 10 pigs (64-84 Gy). 
Extemporaneous histological observations (for instance during surgery) were able to 
characterize as soon as on day 6 tissues exposed above 20 Gy where fibrinogen 
extravasation is obvious; by the 15th day deposit of fibronectin on the one hand and changes 
in energy··matabolism enzymes on the other were evident in tissues irradiated above 30-35 
Gy (threshold dose for muscular necrosis in our hands). At that time and for these doses not 
any modification could be seen by classical histological methods. 
Serum biochemistry : 40 pigs (30-40-64-84 Gy). 
Changes in acute phase proteins and muscular enzymes were studied in serum of 
irradiated and control pigs; some of the 30-40-64 Gy irradiated pigs were treated with anti-
inflammatory or/and platelet inhibitor drugs. 
Daily analysis of the evolution of serum albumin and globulins levels made it possible 
to discriminate between pigs irradiated at 84-64 Gy and those irradiated at 40-30 Gy. In the 
first group a close relation was observed between clinical, thermal and biochemical evolution 
of the pathological process. In the second group, change in the serum biochemistry was 
significant during the silent phase (from the clinical and thermal point of view). In both 
groups, rises of C.K., L.D.H. and myoglobin level were consistent with an important muscular 
necrosis development. 
As we observed it previously for the thermal reaction, treatments acted in any case 
like a factor reducing irradiation doses with regard to biochemical profiles in serum. 
Three peaks of serum interferon were found in the 84 Gy irradiated group (1 o pigs), 
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corresponding to three inflammatory periods: first (24-48 h) during early 
erythema; second (1 0·14th day) during the epidermolysis and sloughing phase where a local 
inflammatory reaction was obvious at the periphery of the lesion; the last period correspond 
to massive necrosis with local inflammatory reaction and oedema (35-60th day). 
111-2. Treatment. 
a) Syrgjcal treatment: 8 pigs, 64 Gy. 
We pointed out previously the benefit of early removal (before day 1 O) of tissues 
given more than 30 Gy after local irradiation, on the extent of the radiolesions . 
Removal of the irradiated skin only, in the first days after exposition, decreased 
largely the local inflammatory reaction and limited the spreading of fibrosis. 
b) Medjcal treatment: 200 rabbits, 10-40 Gy. 
A clinical long term study (40 weeks) was performed in 60 rabbits irradiated on the 
back with doses from 1 0 to 40 Gy; the dose of 20 Gy was choose for drug screening, 
considering both clinical and histological results. 
In a second experiment 7 pharmacological treatments were given for 8 weeks to 140 
rabbits exposed to 20 Gy on the back: steroidal (SAl) and non steroidal (NSAI) anti-
inflammatory agents, 2 vasodilatators (VD), 1 platelet anti-agregant (PAG), 1 
haemorheological agent (anti-ischemic) (HA) and a combination of NSAI + HA. 
··Results: 
-Anti-inflammatory agents (SAl and NSAI) had a !imitating effect on the clinical 
evolution of the lesions, especially the cutaneous necrosis. 
-Vasotropic substances (HA, VD, PAG) had no effect on the clinical evolution of the 
radiolesions and might exibit a rebound effect after the end of the treatment. 
-Platelet inhibitor and haemorheological agent had no effect on the clinical evolution 
of the skin lesions but limited the deep muscular necrosis. 
-Combination of HA and NSAI involved a dose reduction factor of about 2 with regard 
to the clinical evolution of the skin injuries and the muscle radionecrosis. 
111-3. Conclusion on diagnosis and treatments. 
- Qlagnosjs. 
In our experimental model, the different methods described above made possible the 
discrimination between irradiation doses involving either a spontaneous healing process (30-
40 Gy) or a permanent ulcer (64-84 Gy). Furthermore a threshold could be assessed for a 
muscular exposition between 20 and 30 Gy. 
A major interest of these biophysical, biochemical 'and biological methods was to 
make obvious , and to a certain extent to quantify, the effects of different treatments as dose 
reducing factors. 
- Treatments. 
Surgical treatments trials in pigs led us to define two threshold for muscle 
radiosensitivity: about 30:40 Gy for direct necrosis and 10-20 Gy for the limits of delayed 
fibrosis extent in spontaneously healing radiolesions. After early removal of irradiated skin 
the fibrosis extent is limited to tissue given above 25-30 Gy. 
As far as medical treatment is concerned, the combination of non steroidal anti-
inflammatory and haemorheological agents, given for 8 weeks after exposition to 20 Gy 
irradiated rabbits, involved a dose reduction factor of 2. 
111-4. Fibrosis stu-dies. 
- Objectjves. 
Post-irradiation fibrosis exhibited, particularly in non spontaneously healing lesions, 
a tendency to spread out in surrouding tissues, weakly or not irradiated; fibroblasts isolated 
from radiation-induced fibrotic tissues exhibited in culture an abnormal and activated 
phenotype. The first question about that cellular activation was related to the initial events 
of fibrogenesis : have the cells involved in the healing process been irradiated and 
subsequently retained cytogenetic anomalies ? 
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The second question was related to the late stages : which were the stimulatory 
factors responsible for the chronic inflammation in the fibrotic tissues ? Those factors could 
be of two types : either the products of degradation of the extracellular matrix, which are 
known to be stimulatory factors for fibroblasts; or different cytokines involved in 
inflammatory reactions, such as TNF (tumor necrosis factor) and IL-2 (interleukine 2). 
Furthermore other growth factors such as FGF (fibroblast growth factor P) and TGF 
(transformmg growth factor ) are known to regulate fibroblast proliferation and matrix 
synthesis. 
- Methodology. 
Fibrotic tissues were removed from the pig thigh lesion between 1 and 24 months 
after irradiation and fibroblasts were isolated and put into culture medium. Total RNA was 
extracted both from the tissues and from fibroblasts culture. 
- .s.uw.m. 
In fibrosis tissue samples taken off after 3-5 months total protein synthesis 
(assessed with labeled precursor) was about ten times higher than in normal muscle : the 
collagen percentage was respectively 54 and 7 % . 
Collagen synthesis was 20 times higher than in muscular tissue : ARNm levels were 
8 times higher for type I collagen and 5 times higher for type Ill. Nevertheless, probably due 
to transcription ratio and ARNm half-lives, collagen Ill was more abundant in fibrotic tissues. 
In fibrosis extracted fibroblasts (FEF) cultures fibronectin synthesis was 3-6 times 
higher than in normal dermal fibroblasts (OF); glycosaminoglycanes synthesis was 1.25 
(dermatane sulfate, chondroitine) and 2.2 (hyaluronic acid) times higher. Collagen synthesis 
was 2 times higher in FEF with an ARNm transcription ratio increased for type Ill collagen and 
decreased for type I : the isotypes ratio (VIII) was 3 times lower than in OF. 
As far as FEF proliferation in culture was 10 times higher than OF (even in 20 
months post-irradiation samples) the possible role of growth factors was to be investigated 
in radiation induced fibrosis processes : 
-the response of FEF to EGF (epidermal growth factor) assessed by increasing the 
cells number in culture was 2 times higher than for OF. 
-a fragment of heparin degradation products (CY 222, Lab. Choay, France) was added 
to the cultures medium. That fragment modulated the abnormal collagen phenotype of the FEF, 
and particularly decreased the type Ill and V collagen synthesis. 
-the number of cell receptors for the FGF was high on FEF cell membrane : 70,000 
high affinity and 140,000 low affinity receptors. 
-the expression of TGF p , TNFaand IL-2 were investigated at the mRNA level in both 
tissue and cell cultures. Preliminary data showed a high level expression of IL-2 receptors in 
the FEF. 
- Conclusion. 
The first results in cytogenetic studies suggested that FEF derived from irradiated 
cells. The high level of chromosome damages might be responsible for the pretransformed 
state of those fibroblasts and perhaps might lead to secondary radio-induced cancers. A 
consistent observation about this hypothesis was the spontaneous perennisation of FEF cell 
lines (at the present time more than 50 subcultures) when normal OF cultures died after 
1 0-15 subcultures. 
In vitro modulation of the collagen phenotype by the heparin fragments showed that 
the degradation products of the extracellular matnx might be regulatory factors of the 
fibrotic processes. As regards growth factors, their expression was stud1ed as a function of 
time after irradiation, in order to understand the initial reactions in fibrosis genesis and the 
pers1stance of chronic inflammation in later stages; preliminary data showed that IL-2 and 
FGF could be involved in those processes. 
- 1157-
IV. Other research group(s) collaborating actively on this project [name(s) and 
address(es)]: 
-Laboratoire Central de Pathologie, HOpital Saint-Louis, 2 Place du Docteur Fournier, 75010 
Paris : Prof. C. Brocheriou, Or 0. Verola. 
-Laboratoire de Biochimie du Tissu Conjonctif, G.R. C.N.R.S. 40, lnstitut Universitaire de 
Recherche sur les Maladies Vasculaires. Faculte de Medecine, 8 rue du Gal Sarrail, 94010 
Creteil : Prof. L. Robert. 
V. Publications: 
1 
- 1985 
- Daburon F., Lefaix J.L., Remy J., Fayart G, Tricaud V. 
lntenrlt et llmites des mesures thermographiques microondes pour le diagnostic et le 
pronostic des Irradiations aigues localisees chez le pore. Radioprotection, 1985, 20, 3, 207-
225 
- Lefaix J.L., Verola 0., Daburon F., Brocheriou C. 
Les lesions cutanees et musculaires apres irradiation aigOe chez le pore. Etude histologique et 
histoenzymologique. Ann. Pathol., 1985, 5, N°4-5, 249-258. 
- 1986 
- Br~heriou C., Verola 0., Lefaix J.L., Daburon F. 
Histopathology of cutaneous and subcutaneous irradiation-induced injuries. 
Proceedings of a Workshop Held in Saclay 1985. 
British Journal of Radiology, 1986, suppl. W19, 101-104 
- Daburon F., Lefaix J.L., Laval J.L., Martin M., Le Bas J.F., Waksmann B. 
lnterAt de la tomographie X et RMN pour le diagnostic precoce des irradiations localisees. 
Etude experimental& chez le pore. 
Journal de Blophysique et Biomecanique, 1986, 1 0, 89-92 
- Daburon F. 
Biophysical methods for assessing the radiation dose causing lesions in the skin and 
subcutaneous tissues. 
Proceedings of a Workshop Held in Saclay 1985, 
British journal of Radiology, 1986, Suppi.N°19, 75-82. 
- Daburon F., Lefaix J.L., Remy J., Bolnot D., Guilbaud J. 
Development of lesions resulting from acute localised irradiation in the pig : trials for 
medical and surgical management. 
Proceedings of a Workshop held in Saclay 1985 
British Journal of Radiology, 1986, Suppi.N°19, 128-131 
- 1158 -
- Lefaix J.L., Verola 0., Brocheriou C., Daburon F. 
Early changes in irradiated skeletal muscle : a histoenzymological and immunocytochemical 
study. 
Proceedings of a Workshop Held in Saclay 1985, 
British Journal of Radiology, 1986, suppi.N"19, 109-113 
- Martin M., Remy J., Daburon F. 
In vitro growth potential of pig fibroblasts isolated from radiation induced fibrosis. 
International Journal of Radiation Biology 1986, 49, 5, 821-828. 
- Martin M., Remy J., Daburon F. 
In vitro growth potential of fibroblasts isolated from pigs with radiation induced fibrosis. 
Proceedings of a Workshop held in Saclay 1985, 
British Journal of Radiology, 1986, Suppi.N"19, 99-100 
- Remy J., Martin M., Lefaix J.L., Daburon F. 
Radiation-induced fibrosis in pig muscle : pathological and cellular observations. Br. J. 
Cancer, 1986, 53, suppi.VII, 232-233 
- Remy J., Martin M. 
Radiosensitivity of pig fibroblasts in vitro clonal growth assay. 
Proceedings of a Workshop Held in Saclay 1985, 
British Journal of Radiology, 1986, Suppl. N"19, 95-99 
- Rhodes-Feuillette A., Verola 0., Lefaix J.L., Ogunkolade W., Daburon F;, Brocheriou C., 
MahouyG. 
The correlation of the interferon response with pathology and thermography studies in a pig 
model for the evaluation of local irradiation lesions. 
Proceedings of a Workshop Held in Saclay 1985, 
British journal of Radiology, 1986, Suppi.N"19, 117-121 
- Verola 0., Lefaix J.L., Daburon F., Brocheriou C. 
Vascular damage after acute local irradiation : a light and electron microscope study. 
Proceedings of a Workshop Held in Saclay 1985, 
British Journal of Radiology, 1986,Suppi.N"19, 104-108 
- Wegrowski J., Lafuma C., Lefaix J.L., Robert L., Daburon F. 
Modifications of collagen, fibronectin and glysaminoglycans of the pig thigh muscle after 
acute local gamma irradiation. 
Proceedings of a Workshop Held in Saclay 1985,. 
British Journal of Radiolology, 1986, Sup pi. N"19, 113-116 
1987 
- Bignon J., Daburon F., Lambre C., Herbage D., Begin R. 
Mechanisms and early detection of fibrosis induced by various exogenous agents. 
Round table in "Tissue fibrosis : immune cells and mediators, local immunity", vol.3, J.P. 
Revillard and N. Wierzbicki Eds., Fondation Franco-AIIemande, Suresnes, France, 1987, 191-
202. 
- Daburon F., Lefaix J.L., Remy J., Fayart G., Tricaud Y. 
Mesures thermographiques microondes apres irradiation localises chez le pore : methodes 
d'acquisition et de traitement. ITBM, 1987, 8, 367-383. 
- 1159 -
- Wegrowski J., El Nabout, Lafuma C., Martin M., Daburon F. 
Collagen and fibronectin modifications in radiation-induced muscular fibrosis of the pig. In 
vivo and in vitro studies. 
The Arthritis and Rheumatism-Council for Research. Conf. Proceedings N•2, 1987, 39-41 
- 1988 
- Lefaix J.L., Daburon F., Martin J.L., Jeandey C. 
lnterllt de l'analyse en composantes principales appliquee a l'imagerie RMN pour le diagnostic 
precoce de !'irradiation aigue localisee, etude experimentale chez le lapin. I.T.B.M., 1988, 
Vol.9, N•4, 429-445 
- Wegrowski J., Lafuma CH., lefaix J.L., Daburon F., Robert L. 
Modification of collagen and noncollagenous proteins in radiation-induced 'muscular fibrosis. 
Experimental and Molecular Pathology, 1988, 48, 273-285. 
- 1989 
- Daburon F., Lefaix J.L., Hoffschir D. 
Dosimetrie biologique des irradiations aigOes localisees. Revue Generale Nucleaire, 1989, 
N•4, 304-308. 
- El Nabout R.,Martin M., Remy J.,Robert L., Lafuma C. 
Heparin fragments modulate the collagen phenotype of fibroblasts from radiation-induced 
subcutaneousfibrosis. 
Experimental and Molecular Pathology, 1989, 51, 111-122 
- El Nabout R.,Martin M., Remy J.,Robert L., Lafuma C. 
Modifications of collagen biosynthesis and deposition in cultured dermal.tibroblasts isolated 
from pigs with radiation-induced fibrosis. 
Cutaneous Development Aging and Repair, G. Abatangelo., J.M. Davidson Eds. fidia Research 
Series, vol.18, section IV,293--297, Liviana Press, Padova, 1989 
- Hoffschir D., Toubeau M., Fayart G., Daburon F. 
Utilisation potentielle du 201 Tl pour !'evaluation scintigraphique des lesions d'irradiation. 
Etude experimentale sur le pore. Journal de Medecine Nucleaire et de Biophysique, 1989, 13, 
3, 157-165. 
- Martin M., Remy J., Daburon F. 
Abnormal proliferation and ageing of cultured fibroblasts from pigs with subcutaneous 
fibrosis induced by gamma irradiation. The Journal of Investigative Dermatology, 1989, 93, 
497-500. 
2 I 
- 1985 
- Dabuton F., Lefaix J.L., Remy J., Martin M., Bolnot D., Guilbaud J., Verola 0. 
Evolution des lesions apres irradiation aigiie localisee chez le pore. Essais de traitement 
medical et chirurgicai.Rapport CEA-IPSN-DPS-84-05-SPE, 1985. 
- 1160 -
- 1986 
- Lefaix J.L., Daburon F. 
Modifications precoces du muscle squelettique apres una irradiation aigue : correlation entre 
l'histologie et les tomographies RX et RMN 
2eme Colloque National sur les Maladies Neuromusculaires, Tours, 1986. 
- Remy J.,Wegrowski J., Martin M., Daburon F., Robert L. 
Radiation induced fibrosis : fibroblastic proliferation and biosynthesis in v1tro. 
Xth Meeting of the Federation of European Connective Tissue Societies, 1986. 
- 1987 
- Daburon F., Lefaix J.L., Remy J., Hoffschir D., Fayart G. 
Biophysical methods for the diagnosis of acute localized irradiation experimental studies in 
pigs. Congress Radiation Research, Edinburgh, 1987, Abs. E41-8V. 
- Lafuma C., El Nabout R., Martin M., Remy J., Robert L. 
Modulation in fonction of aging, of synthesis, content and types ratio of collagen in cultured 
fibroblasts from radiation in duced subcutaneous fibrosis compared to normal porcine dermis 
fibroblasts 
International Symposium on Cutaneous Development, Aging and Repair, University of Padova, 
octobre 1987, Abs.40 
- Lefaix J.L., Daburon F., Creche! F., Tricaud Y. 
Consequences plasmatiques et thermographiques d'une irradiation aigue localisee. Analyse 
qualitative et quantitative chez le pore. 
Rapport CEA-R-5395, 1987. 
- Lefaix J.L., Daburon F., Hartmann D., Creche! F., Tricaud Y. 
La sclerose musculaire apres irradiation aigue 
Local Immunity International Symposium Series Vol.3, Tissue Fibrosis : Immune Cells and 
Mediators, Editors JP Revillard, N.Wierzbicki, 1987, Abs.de poster, p 248-249 
- Martin M., Remy J., Wegrowski J., Daburon F. 
Muscular fibrosis : kinetic and biochemical studies on primary and long-term cultures 
Fondation Franco-AIIemande. Local Immunity, International Symposium Series.Vol.3, 1987, 
Abs. de poster p247 
- Remy J., Martin M., Wegrowski J., Daburon F. 
Fibrosis : late effect of local radiation damage, in vitro studie 
Congress Radiation Research, Edinburgh, 1987, Abs. E22-22P 
- Wegrowski J., Remy J., Lafuma C. 
Noncollagenous proteins of radiation-induced subcutaneous fibrosis 
Glycoconjugates (IX th lnt. Symposium), Lille, 6-11 juillet 1987, Abs. 
- 1988 
El Nabout R., Martin M., Remy J., Robert L., Lafuma C. 
Collagen synthesis and deposition in cultured fibroblasts from subcutaneous radiation-induced 
fibrosis. Modification in function of cell ageing. 
Xlth Meeting FECTS, Amsterdam, 1988, Abs.W176 
- 1161 -
- El Nabout R., Martin M., Re my J., Petitou M., Choay J., Robert L;, Lafuma C. 
Heparin fragments modulate the collagen phenotype of fibroblasts from radiation induced 
subcutaneous fibrosis. 
Xlth Meeting FECTS, Amsterdam, 1988,Abs.N"9 
-Martin M., El Nabou R., Remy J., Lafuma C., Daburon F. 
Ageing and collagen synthesis in normal and fibrotic pig fibroblasts in culture 
Xlth Meeting FECTS, Amsterdam, 1988, Abs. N"178 
- Martin M., Remy J., Daburon F. 
Abnormal growth potential and ageing of cultured fibroblasts from pigs with radiation-
induced fibrosis. Biologie et Pathologie Moteculaire de la Matrice Extracellulaire, Colloque du 
25eme anniversaire de la Societe Franc;aise du Tissu Conjonctif, 1988. 
- Remy J., W8growski J., Crechet F., Martin M., Daburon F. 
Collagen in post-radiation fibrosis. biochemical and molecular studies. 
Xlth Meeting FECTS, Amsterdam, 1988, Abs. N"22 
- 1989 
- Lefaix J.L., Daburon F., Remy J. 
Irradiation aigOe et fibrose musculaire developpement et caracteristiques chez le pore. 
Rapport CEA-R-5479, 1989, 45p 
- Lefaix J. L. 
Contrib'ution A !'etude physiopathologique de !'irradiation aigOe localisee. These de Docteur de 
I'Universite Paris VI, 19 Juin 1989.0 
- 1162 -
RADIATION PROTECTION PROGRAMME 
Final Report 
Contractor: 
Com. Naz. per la Ricerca e lo 
Sviluppo dell'Energia Nucleare e 
delle Entot·gie Alternative, ENEA 
Viale Regina Hargherita, 125 
I-00198 Roma 
Contract no.: BI6-C-059-I 
Head(s) of research team(s) [name(s) and address(es)]: 
Prof. G. Doria 
Laboratorio di Patoloeia 
ENEA-CRE Casaccia 
C.P. 2400 
I-00100 Roma A.D. 
Telephone number: 06-30483619 
Title of the research contract: 
Radiation damage and recovery of the immune system. 
List of projects: 
1. Age-related changes in immunological functions in relation to 
radiation exposure. 
- 1163 -
Title of the project no.: 1 
Changes in immunological functions in relation to radiation exposure. 
Head(s) of project: 
Prof. Gi no Dori a 
Laboratorio di Patologia, ENEA C.R.E. Casaccia 
C.P. 2400, 00100 Roma A.D., Italia 
Scientific staff: 
Dr. L. Adori ni 
Dr. D. Frasca 
I. Objectives of the project: 
1. Recovery ofT cell functions in irradiated mice by immunoregulatory 
molecules. 
2. Characterization of the interactions between the T cell receptor, 
antigenic epitopes and MHC class II molecules. 
11. Objectives for the reporting period: 
1. Restoration ofT helper cell activity and IL-2 production in 
irradiated mice by injection of synthetic molecules: 
1.1. thymosin alpha-1 
1.2. hu r IL-1 beta 
1.3. 163-171 nonapeptide of hu IL-1 beta 
2. Mapping of antigenic epitopes that interact with MHC class II 
molecules and the T cell receptor 
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Ill. Progress achieved: 
Expression of effector immune functions is modulated by cellular 
and molecular interactions in a complex immunoregulatory network. The 
antibody response of B cells to immunogens is induced by the 
stimulation of antigen-presenting cells (APC) and modulated by T cells 
and factors which regulate antibody quality (isotype, allotype and 
idiotype) as well as intensity and duration of the response. Following 
immunization antigen is phagocytized and processed by APC 
(macrophages, B cells, dendritic cells), and the resulting peptides 
are presented in association with MHC class II molecules to activate 
T helper (Th) cells. Activated Th cells express cytokine-specific 
receptors, including IL-2 receptors (IL-2R), produce and secrete 
several lymphokines (IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IFN-gamma), 
and trigger the activation of antigen-stimulated B cells to antibody 
production. Cytokines play a major role in amplification of the immune 
response. Thus, antigen-stimulated macrophages synthesize and release 
IL-l that amplifies IL-2 production by antigen-activated Th cells. IL-
2 promotes proliferation of activated T and B cells and modulates IL-
2R expression, while other lymphokines regulate T and B cell 
differentiation. 
Our studies in BDFl mice on the radiosensitivity and recovery of 
unprimed Th cells have indicated that these immunoregulatory cells are 
very radiosensitive and recover slowly, as some functional defects are 
still detectable 3 months after 200 cGy and complete recovery is 
reached 6 months after 400 cGy. Recovery of Th cell activity from 
radiation damage is accelerated by injecting mice with synthetic 
thymosin alpha-1, a peptide of 28 aminoacid residues identified in 
bovine thymus extracts and very effective in the induction ofT cell 
markers and functions. We found that a single injection of 10 ug 
of thymosin alpha-1 in 3 month old mice, 4 days after 200 cGy 
completely restores Th cell activity. Th cells were induced by 
carrier-priming 7 days after irradiation and titrated 4 days later by 
the ability of spleen cells from the carrier-primed mice to induce a 
hapten-specific antibody response of spleen cells from unprimed mice 
upon in vitro stimulation with the hapten-carrier conjugate. 
Since irradiation is known to impair not only Th cell activity 
but also IL-2 production, experiments were performed to determine 
whether the injection of thymosin alpha-1 in irradiated mice could 
restore IL-2 production. Three month old mice were total-body exposed 
to 100, 200, 300, or 400 cGy of X rays and given a single injection of 
10 ug thymosin alpha-1 1 hour, 4, 7, or 14 days after irradiation. 
Spleen cells were harvested 3 days after thymosin alpha-1 injection 
and assayed for IL-2 production upon in vitro stimulation by 
Concanavalin A and Phorbol Myristic Acetate. Results from this series 
of experiments show that IL-2 production is reduced by irradiation and 
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may be restored to some extent by a single injection of thymosin 
alpha-1, the recovery being more pronounced when thymosin alpha-1 is 
given early after small radiation doses. In a subsequent series of 
experiments mice exposed to 100, 200, 300, or 400 cGy were given 3 
injections of 1, 10, or 100 ug thymosin alpha-1 1 hour, 1 and 2 days 
after irradiation. Spleen cells were harvested the day after the last 
thymosin alpha-1 injection and assayed for IL-2 production. Results 
from two experiments indicate that maximum recovery of IL-2 production 
is attained by 3 injections of 10-100 ug thymosin alpha-1 after 100-
300 cGy (100%) or 400 cGy (55-70%). Furthermore, the proliferative 
response of mitogen-stimulated spleen cells from irradiated mice to 
exogeneous IL-2 added to culture is increased by thymosin alpha-1 
injection, implying enhanced expression of IL-2R. 
The results of these experiments altogether indicate that 
thymosin alpha-1-induced enhancement of Th cell activity in 
irradiated mice may be mediated by increased Il-2 production and 
expression of Il-2R. The effect of thymosin alpha-1 in irradiated mice 
may result from acceleration of T cell precursor maturation and/or 
expansion of the mature T cell population. These findings on the 
recovery of Th cells, IL-2 production and Il-2R expression are very 
promising as they clearly indicate that thymosin alpha-1 is a powerful 
immunoregulatory molecule that may be successfully used for treatment 
of T cell immunodeficiencies in accidentally or therapeutically 
irradiated persons. Such a conclusion might also be extended to other 
thymic hormones. 
Immunogerontology has clearly demonstrated in animals and humans 
that the immune system undergoes profound changes with aging which 
favour infections, autoimmune diseases, and tumour development. Not 
only the proportion of the various cell populations changes with 
advancing age but also the radiosensitivity of these cells may 
increase as a result of the decreased level of enzymes that neutralize 
free radicals. It is therefore very relevant to radiation protection 
to study changes in immune functions of aging animals for precise 
evaluation of radiation-induced dysfunctions which cannot be readily 
extrapolated from radiobiological studies carried out in young-adult 
animals. 
At variance with previous studies, the radiosensitivity of the 
immune system has been investigated on mouse populations exposed to 
sublethal doses of X-rays in adulthood or much later in aging. In our 
study the radiosensitivity of Th cells has been assessed in BDF1 mice 
exposed to 50-400 cGy at 3 or 18-22 months of age. Th cells were 
induced by carrier-priming 7 days after irradiation and titrated 4 
days later. In each experiment Th cell activity of spleen cells from 
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irradiated mice was expressed as percent of the activity of spleen 
cells from unirradiated controls. The log residual Th cell activity as 
a function of radiation dose was fitted by a straight line forced 
through the origin and the 037 ± S.E. were calculated from each 
linear regression. Preliminary experiments indicate the following 
037 ± S.E.: 225 ± 25, 241 ± 35, 557 ± 118 for young mice and 115 ± 12 
for old mice. Thus, the radiosensitivity of Th cell activity appears 
2-3 fold increased in old mice. These findings suggest the need for 
extensive studies of the immunological effects of irradiation in 
aging animals since the mean life span of the human population in 
Europe is continuously increasing and a progressively larger number of 
old individuals is exposed to the risk of accidental (non-
professional) or medical irradiation. 
In spite of its potent immunostimulatory effects, the possible 
use of IL-l as immunomodulator in humans is hampered by its 
inflammatory effects. IL-l, indeed, induces a series of typical 
inflammation-associated metabolic responses, such as fever and 
prostaglandin G release from cells of hypothalamic thermoregulatory 
centers, neutrophilia, synthesis of hepatic acute phase proteins, and 
alteration of glucose homeostasis as well as of the blood levels of 
divalent cations and corticosterone. 
In studies directed at defining possible functional domains 
within the IL-l molecule, a synthetic nonapeptide of human IL-l beta 
(VQGEESNOK, position 163-171) was identified which could mimic several 
of the in vitro and in vivo immunostimulatory activities of the entire 
protein but devoid of IL-l like inflammatory effects. 
In our studies the immunorestorative capacities of human 
recombinant (hu r) IL-l beta and of its synthetic 163-171 fragment 
were compared in mice immunodepressed by aging, sublethal irradiation, 
or both. Injection of hu r IL-l beta into immunodepressed mice 
immediately after carrier-priming could restore to normal level Th 
cell activity. The ability of spleen cells from hu r IL-l beta-treated 
immunodepressed mice to produce IL-2 upon in vitro mitogen stimulation 
was also increased significantly as compared to that of untreated 
mice and approached that of immunocompetent controls. The 
immunorestorative activity of hu r IL-l beta on Th cell activity and 
IL-2 production could be mimicked by the synthetic 163-171 nonapeptide 
which, at the doses used, produced in most instances even greater 
effects than the whole protein. Although the optimal immunorestorative 
doses of the 163-171 peptide were several orders of magnitude higher 
than those of hu r IL-l beta, the complete lack of IL-l like 
inflammatory effects suggests that the synthetic fragment may be 
successfully used as immunomodulating agent in the therapy of T cell 
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immunodeficiencies. 
Based on these findings we investigated the radioprotective 
effects of hu r IL-l beta and of the synthetic 163-171 nonapeptide on 
the survival of lethally irradiated mice. BDFl mice were injected 
with 2 ug of the nonapeptide or the whole protein and total-body 
X-irradiated with 850 cGy (LD 100/ 20), 20 hrs later. Both molecules 
were found to protect mice from radiation death, although the 
nonapeptide is half as effective as hu r IL-l beta which yields 
about 80% survival. These preliminary observations suggest the 
possible use of the nonapeptide to prevent radiation injury with no 
toxic effects. 
As soon as the central role of T cells in immunoregulation has 
been established, the molecular characterization of the antigen-
specific T cell receptor (TCR) has become a major issue of 
investigation. In our laboratory the TCR was firstly studied on a 
cloned T cell lymphoma line, LH8-105, obtained by radiation leukemia 
virus-induced transformation of hen egg-white lysozyme (HEL)-specific 
mouse suppressor T cells. 
The LH8-105 cell clone constitutively releases in culture 
supernatant products that specifically suppress the T cell-dependent 
proliferation, antibody response, and delayed-type hypersensitivity to 
HEL. LH8-105 cells were found to express on the cell surface dimers of 
84 Kd composed of two 42 Kd subunits immunoprecipitated by rabbit 
antibodies directed against TCR constant region structures of helper 
and cytotoxic T lymphocytes. Thus, the overall structure of the TCR 
expressed by LH8-105 cells is similar to that described for helper and 
cytotoxic T cells. These studies have been extended to examine the 
rearrangement and expression of genes encoding the alpha and beta 
chains of the TCR. These suppressor T cells were found to exhibit 
alpha chain gene rearrangement, deletion of both alleles of the 
constant region (C) gene segment C beta 1 and rearrangement of the two 
alleles of C beta 2 when analysed by Southern blot hybridization. 
Restriction analysis suggested that the DNA rearrangement is beyond 
the second joining-region (J) minigene of the J beta 2 cluster. These 
results establish that at least some mouse suppressor T cell clones, 
like helper and cytotoxic T lymphocytes, rearrange and transcribe the 
genes coding for the alpha and beta chains of the TCR. 
Subsequent studies in our laboratory were addressed to functional 
aspects of the TCR by analysing how Th cells recognize protein 
antigens as peptide-MHC complexes espressed on the surface of APC. 
Synthetic peptides of HEL have been used to analyse an immunodominant 
epitope forTh cells of the H-2d haplotype, which is contained in 
- 1168 -
the HEL sequence 107-116 and is recognized in association with l-Ed 
molecules. The immunodominance of this epitope in HEL-primed H-2d mice 
was demonstrated by the analysis of the T cell proliferative response 
induced by synthetic peptides covering the entire HEL sequence. Single 
residue substitutions at position 113, 114 or 115 were found to 
abrogate the ability of peptide 105-120 to activate Th cells. 
Substitutions at residues 113 and 115 affect T cell recognition but 
not the binding to l-Ed molecules whereas a substitution at position 
114 profoundly impairs the capacity of the peptide to interact with l-
Ed molecules. Thus, a strict correlation exists between binding of a 
peptide to MHC class II molecules and its immunogenicity, since a 
single substitution drastically reduces binding capacity and 
abolishes immunogenicity. This indicates that the MHC molecules are 
able to discriminate between very similar structures and may, in part, 
explain how the limited diversity of the I~HC class II molecules 
expressed by any given individual could select relevant epitopes from 
among the almost endless variety of protein and peptide antigens. 
Analysis of the structural characteristics of peptide ligands 
interacting with l-Ed molecules lead to the conclusion that 
interactions between peptides and MHC class II molecules are usually 
very permissive since about 80-90% of single residue substitutions in 
the peptide molecule are acceptable. The specificity of the immune 
response, however, is maintained by T cell recognition which accepts 
only 10-20% of substitutions in a given peptide. 
Since the formation of peptide-MHC complexes is very permissive, 
peptides with unrelated sequences are expected to compete for binding 
to the same MHC molecule, and this, indeed, has been shown to occur in 
vitro. We, therefore, examined whether such a competition could also 
regulate T cell responses in vivo. We found that a synthetic peptide 
corresponding to residues 46-62 of mouse lysozyme, although not 
immunogenic itself, effectively inhibits the priming for T cell 
responses when injected into mice together with immunogenic protein or 
peptide antigens. The inhibition observed strictly correlates with the 
capacity of the competitor to bind to the particular MHC molecule 
presenting the foreign antigen, and its extent depends on the molar 
ratio between antigen and competitor. Thus, the mouse peptide 46-62, 
which binds to I-Ak molecules, prevented priming forTh cell responses 
by foreign peptides such as HEL 46-61 or HEL 112-129, which also binds 
to I-Ak molecules. These and other observations from our laboratory on 
the immunodominance ofT cell epitopes demonstrate the exquisite MHC 
specificity of in vivo competition between peptides generated during 
antigen processing in APC. It is, therefore, conceivable to modulate 
Th cell activation by interfering with the binding of antigenic 
peptides to MHC class II molecules. This could open the way to a 
rational treatment of autoimmune diseases and allograft rejection. 
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Title of the project no.: 
Mechanisms governing the response of the hemopoietic- system and defining its tolerance to par-
tial body and inhomogenous irradiation 
Head(s) of project: 
Prof. Dr.rer.nat. W. Nothdurft and Prof. Dr. med. T.H.Fliedner 
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Dr.K.Baltschukat (1985-1988), Prof. Dr.W.Ealvo (1985-1987), Dr.L. Kreja (1985-1989), Prof. 
Dr.W. Nothdurft (1985-1989), Dr.I.Seitz (1985-1986), Dr.K.-H. Steinbach (1985-1988), Dr.C. 
Wemer (1985) 
I. Objectives of the project: 
It was the objective of this project to investigate in which way the tolerance of the hemopoie-
tic system to an exposure of the body to ionizing radiation, i.e. its canpensatory capacity and 
the regenerative potential is dependent on the fraction of the bone marrow surviving the irra-
diation and its localization within the body. The events that had to be' investigated in detail 
were (a) the compensatory response of the hemopoietic cells in the non-irradiated marrow, (b) 
the seeding of circulating stem cells to the damaged bone marrow sites, and (c) the recovery 
processes in the latter. 
11. Objectives for the reporting period: 
The specific aims were to study the local events and the systemic control of the hemopoietlc 
response and the regeneration after partial body irradiation and after exposures to a unifom 
as well as an Inhomogeneous total body irradiation on the level of the progenitor ce)l compart-
ments using canine experimental models. Based on deteminations of the progenitor cells of the 
granulocyte-macrophage and the erythroid lineage, GM-CFC and BFU-E, respectively, the acute 
changes in the hemopoietic tissue and the functional status in a long tem were detemined and 
related to the blood cell concentration. As a prerequisite of these In vivo studies progenitor 
cell analyses had to be performed characterizing the normal state with respect to their concen-
tration in various bones of the total skeleton and their cycling state. In addition, it was of 
particular interest to study their radiation response characteristics. 
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Ill. Progress achieved: 
1. Methodology 
{a) The irradiations of the dogs (beagles) were perfonned with 300 KVp X-rays (HVL = 4 nm Cu) 
at a dose rate of 0.065 Gy/min on the middle axis of their body. Homogeneous total body 
irradiation (TB!) was achieved by bilateral exposure. The dogs (n • 3) received a dose of 2.4 
Gy (on the middle axis in tissue). Measurements of the bone marrow doses performed in different 
bone cavities by means of thermoluminescent dosimeters (TLD-100, 1 nm x 6 nm) resulted in 
values ranging from 1.5 Gy to 2.0 Gy depending on the location. In contrast, an inhomogeneous 
TB! was performed in other dogs (n = 6) by unilateral exposure only, i.e. they were irradiated 
with their left side directed to the radiation source. Under there conditions the values of the 
doses in the different bone marrow sites showed considerable differences, ranging from 0.9 Gy 
(right iliac crest) to 3.1 Gy (head of the left humerus) at the extreme. Calculations of the 
mean marrow doses resulted in values of 1.7 Gy respectively 1.8 Gy for the bilateral and the 
uni latera 1 exposure. For the fract iona 1 surviva 1 of the GM-CFC in percent of the tota 1 GM-CFC 
numbers in the whole body rather similar values were detennined for either exposure, i.e. 6.7% 
for homogeneous TB! and 7.7% for the unilateral exposure. Lower body irradiation (LBI) was 
employed as an approppriate model of partial body irradiation. For LBI the lower part of the 
body including the last lumbar vertebrae, the lower extremities and the tai 1 was exposed 
bilaterally to 11.7 Gy, while the upper part of the body including the fourth lumbar vertebra, 
the upper extremities and the head, was shielded in a lead box. LBI involved the abrogation of 
approximately 28% of the tota 1 bone marrow mass. The dose generated in the shielded part of the 
body was found two orders of magnitude lower than the delivered dose. In all the irradiated 
dogs sequential detenninations of several hematological parameters were performed within a 
period up to one year after the exposure. These included detenninations of the blood cell 
counts, of GM-CFC in peripheral blood and different bone marrow sites, and BFU-E at certain 
occasions. 
{b) The GM-CFc were assayed by means of a standardized agar culture-technique using serum from 
irradiated dogs (0.3 ml/ml) as a source of colony stimulating activity, {CSA) and irradiated 
blood leukocytes from a normal dog for enhancement of colony growth. For the detenninations of 
BFU-E appropriate methods of collecting the bone marrow and suitable culture conditions had to 
be established. Bone marrow samples were obtained from up to 18 different bones using different 
methods. In some cases the bone marrow was scraped out from a resected piece of the humerus or 
a rib. Erythrocyte-poor cell suspensions were obtained from the bone marrow samples by either 
sedimentaton in the presence of dextran (1.5%) or by density gradient separation over 
lymphoprep (density 1.077 g/ml or 1.070 g/ml). Initially, a culture system was employed 
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consisting of methylcellulose and 20% to 30% fetal calf serum, additives such as transferrin 
and a - thioglycerol, erythropoietin (Epo) at 2-2.5 JU/ml and canine leukocyte-conditioned 
medium as a source of burst-promoting activity (BPA). In the course of the research work some 
methodological studies were performed in which several modifications were applied to improve 
BFU-E growth, or eventually to simplify the culture system. In addition, culture techniques 
were established allowing the growth of multipotential progenitor cells (Mix-CFC) from canine 
bone marrow. 
(c) The radiation response characteristics of different types of progenitor cells from canine 
bone marrow were determined under conditions of in vitro irradiations with 280 kVp X-rays (HVl 
c 2 nm Cu) at a dose rate of 0.72 Gy/min. Values of D and n were calculated from the linear 
parts of the survival vs. dose plots on a semi-logarithmic graph by means of linear regression 
analysis. 
2. Results 
(a) Progenitor cell concentrations in the bone marrow under normal conditions. 
In most bone marrow sites in the bones of the trunk-skeleton containing red marrow the GM-CFC 
concentration was found in the range from 180 to 350 per 10 mononuclear cells (HNC). The red 
marrow in the spongeous structures of the proximal part (epiphysis) of the humerus. contains 
GM-CFC at concentration falling in the upper range of the values. On the other hand, 
significantly lower concentrations were obtained for the marrow in the vertebrae. Rather low 
GM-CFC concentrations of approximately 70 per 10 MNC and 50 per 10 HNC were present in the 
proximal part of the fen~.~r and the distal part of the humerus, respectively. However, 
considerable differences could be detected between the GH-CFC levels in individual dogs of the 
groups under study. 
Only small differences were observed between the BFU-E growth for HNC suspensions that were 
obtained from the marrow samples by sedimentation in the presence of dextran or by density 
separation using lymphoprep of a density of 1.070 g/ml. However, colony formation could be 
increased by a factor of 1.5 if instead of 20% FCS a mixture of 20% FCS and 10% serum col-
lected from total body irradiated (3.9 Gy) dogs at day 10 after the exposure was added to the 
cultures. Obviously, the acts as a source of BPA more effective than leukocyte conditioned 
medium. In any case, the 8FU-E values determined in bone marrow samples from different sites 
were significantly lower than the GM-CFC numbers, i.e. between 43 and 118 per 10 HNC in 
comparison to between 180 and 350 for the latter in the same sites. Again there was the, 
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tendency for the humeral marrow to have higher BFU-E concentrations than the bone marrow of the 
iliac crest and the sternum. The BFU-E concentration in the peripheral blood was found to be in 
the range from 30 to 100 per ml and thus only slightly lower than the GM-CFC concentration. 
On the other hand, the cloning efficiency of BFU-E in bone marrow cell suspensions could be 
increased by a factor of 2-4 if the cell separations were perfonned with Lymphoprep of a 
density of 1.070 g/ml instead of 1.077/g/ml. Furthermore, the colony growth of BFU-E in cul-
tures containing fetal calf serum (FCS) or without FCS was much better when recombinant human 
Epo (rh-Epo) instead of the natural Epo from anemic sheep was used as a specific stimulator. 
Similar results were obtained for the canine multipotent progenitor cell Mix-CFC. All the other 
recombinant factors of human origin ( rh-GM-CSf, rh-G-CSF, rh-M-CSF, rh-! 1-3) exhibited no 
canine BFU-E stimulating activity. The factor rh-IGF-1 was found, potentiate the effect of BPA 
on BFU-E in suboptimally stimulated cultures. 
(b) Radiation response of erythroid progenitor cells (BFU-E) 
For the determinations of the radiation response characteristics of the BFU-E suspensions of 
bone marrow MNC were irradiated as indicated with increasing radiation doses. Thereafter, the 
ce 11 s were cultured in me thy lee llu lose. The surviva 1 fractions obtained for BFU-E after 
irradiation under steady state conditions could be optimally fitted by a simple exponential 
curveS = exp with a value of Do= 0.15 Gy. Thus, the BFU-E were found extremely radiosensitive 
when compared to the GM-CFC, for which under similar conditions values of Do in the range from 
0.55 Gy to 0.61 Gy were obtained. 
Additional experiments were performed to test whether the radiosensitivity of the BFU-E could 
be influenced under conditions of enhanced proliferation. However, it was found difficult to 
establish appropriate culture conditions that would allow the BFU-E to proliferate in parallel 
to their differentiation. The best results with a recovery factor of 70% after 24 hs were 
obtained when the BFU-E were cultured in the presence of FCS and 1-2 IU Epo/ml. The results 
obtained with this method indicate that the radiosensitivity may decrease when the cells are 
proliferating in suspension cultures under optimal growth conditions. 
(c) Irradiations of dogs under different exposure conditions 
(a) Homogeneous total body irradiation by bilateral exposure (BLE) 
The most important hematological effects of the acute TBI with a midline-in-tissue dose of 2.4 
Gy can be summarized as follows: the lymphocytes had dropped to approximately 20 % of the 
initial average value within 24 hs after the exposure. The recovery was slow as expected and 
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at day 125 the lymphocyte concentration had just recovered to approximately 50 % of the nomal 
values. The granulocyte concentration had reached its nadir at day 8 after TB!, when it had 
droppped to approximately 25% of the pre-irradiation value. The definite granulocyte recovery 
c011111enced ~t day 20 and at day 40 the values were back in the pre-irradiation range. The GM-CFC 
in the different bone marrow. sites had decreased to between 3% and 7 %of their initial 
concentration. In all the bone marrow sites the recovery of the GM-CFC concentration was quite 
fast in the period between day 14 and day 28 .. However thereafter the GM-CFC values remained at 
a subnormal level, i.e. between 50% and 86% of the pre-irradiation values, up to day 125.The 
BFU-E concentration in the different bones was found extremely reduced 24 hs. after the exposure 
to between 0.2% and 3% of the inital values depending on the site. These in vivo data are 
compatible with the high radiosensitibity of the BFU-E to in vitro irradiation, as compared to 
the GM-CFC. The BFU-E in the different bones showed a steady increase in the period between day 
1 and day 28 after the exposure. However, the BFU-E values in all the bones remained subnormal 
up to 1 year after the exposure, and clearly these residual deviations from the pre-irradiation 
state were more pronounced than for the GM-CFC. 
(~) Inhomogeneous total body irradiation by unilateral exposure (ULE) 
The inhomogeneous TB! was characterized by the following radiation doses: entrance dose = 3.8 
Gy, midline-in-tissue dose • 2.7 Gy, and exit dose· 0.9 Gy. As indicated under 1. Methodology, 
part (a), the extreme values of the bone marrow doses were 3.1 Gy for the cavity in the head of 
the left humerus and 0.9 Gy for the marrow cavity in the right iliac crest. However, the 
hematological effects of these irradiations conditions as observed in the blood leukocytes and 
the thombocytes were concruent with those as reflected in the dogs which had received the 
homogeneous TB! by bilateral exposure. Thus, with respect to the overall hematological 
consequences both BLE and ULE were isoeffective. Nevertheless, the Inhomogeneous dose 
distribution in the various !Jone marrow sites was quite well reflected by the degree of 
reduction in their GM-CFC concentration at day 1 after the exposure with values ranging from 
0.44 % to 16 % of the inital concentration, depending on the location in the body. At the same 
time the S-phase fraction of the GM-CFC was found significantly increased in different bone 
marrow sites. 
The fast regeneration of the GM-CFC in the period up to day 28 was strictly dependent on the 
initial degree of the damage. On the other hand, the GM-CFC values remained clearly subnormal 
up to day 60 after the exposure; at day 125 they were rather normal again. 
In the un i latera 1. ly exposed dogs the BFU-E concentration was determined in the bone marrow of 
the head of the humerus that was directed away from the source, i.e. was protected by the body 
and thus received less irradiation, i.e. 1.1 Gy and consequently less damage than most of the 
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other bone marrow sites. On the first day after the exposure the BFU-E had dropped to values 
between 1 %and 8% of the initial concentration as predicted on the basis of their extremely 
low Do value. However, in the interval between day 1 and day 14 after irradiation the BFU-E 
concentration showed a rapid increase to between 150 % and 250 of the pre-irradiation value in 
contrast to the GM-CFC that within the same period had % reached only approximately 16 % of the 
pre-irradlaiton values. Thereafter the BFU-E remained In the normal range or remained slightly 
above up to 1 year after irradiation. In contrast, the GH-CFC values in the same bone marrow 
sites were found still subnormal at day 48 and day 60, but had normalized at day 125 at least. 
( ) Partial body irradiation 
The intensive irradiation with a dose of 11.7 Gy of the bone marrow in the lower part of the 
body corresponding to 30% of the total bone marrow mass resulted in rather moderate transient 
changes of the blood cell concentration. The granulocyte values showed a transient fall to 
approximately 75% of the pre-irradiation values and a complete recovery within the first 30 
days after the exposure. The platelet concentration decreased to approximately 80 % of the 
average pre-irradiation level with the nadir at day 21. Thereafter it increased rapidly and was 
virtually back in the normal range at day 30. In contrast the lymphocytes showed a llllCh 
stronger response insofar that they had decreased to 40% of the pre-irradiation level already 
within the first 24 hs after the exposure. It took about 130 days before they had reached their 
norma 1 pre- i rrad i at ion 1 eve 1. 
The GH-CFC concentration in the protected bone marrow (humerus, scapula) showed an inmediate 
decrease to approximately 40 % of the pre-irradiation values within 24 hs after the irradiation 
of the lower part of the body (LBI). This was followed by an increase in the following 30 days 
that led to normal values for the GM-CFC in the humerus but still clearly subnormal values for 
the GM-CFC in the scapula. The .S-phase cells in the protected marrow increased by more than 
100% within 1 day after the exposure and remained elevated until day 36. 
In the irradiated bone marrow sites of the iliac crest no progenitor cells could be detected at 
the first day after the exposure. However, there was a rapid increase in the bone marrow GH-CFC 
concentration to 50 % of the pre-irradiation level by day 21. On the other hand, there was no 
further increase in the period up to day 60 after the exposure. Slightly higher values were 
found at day 140, but there was no complete recovery in the irradiated sites one year after 
irradiation. The GH-CFC in the blood showed a severe depresssion within the first 24 hs after 
the exposure. The subsequent course of events was characterized by a transient increase between 
day 10 and 25 with a second decrease in the period from day 30 to 45. At least at day 130 the 
GH-CFC in the blood had returned to the preirradiation levels. 
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Ill. Discussion 
The survival of persons exposed to irradiation in the lower range of possibly fatal doses 
depends mainly on the functional status of the hemopoietic tissue and its regenerative 
capacity. This has been clearly shown during the recent accidents in nuclear power stations and 
industry. However, the anatomical distribution over the different bones of the hemopoietic stem 
cells and progenitor cells surviving an exposure may be quite different depending on the 
conditions of the exposure, i.e. whether it was total body irradiation with a homogeneous bone 
marrow dose distribution or a more or less inhomogeneous dose distribution. Under extreme 
conditions partial body irradiation may arise with certain fractions of the whole bone marrow 
organ being completely or nearly absolutely protected against the incident beam. 
Under the fanner conditions the regeneration events may be mainly local originating from 
resident surviving stem cells. However, it has to be asked whether after an inhomogeneous total 
body irradiation the local regeneration of the different bone marrow sites (receiving different 
degrees of dcunage) is associated with systemic equilibration processes due to exchanges of 
hemopoietic cell migration via the circulation. Clearly, after partial body irradiation where 
large doses in the range of 10 Gy had been received by a certain fraction of the marrow seeding 
of stem cells from the protected marrow could be the most essential prerequisite for any early 
repopulation. On the other hand in the early phase of regeneration the protected marrow may 
compensate in an essential way for the damage in the early phase of regeneration. 
The research work perfonned in the present project was addressed to all these afonnent ioned 
aspects of hemopoietic regeneration and tolerance due to compensatory mechanisms. 
The results obtained in our normal dogs from the quantitative determinations of the GM-CFC and 
BFU-£ tndicate that the concentration of each of these prOgenitor cells in different bone 
marrow spaces containing active red marrow is not uniform. On the other hand, there is 
obviously a close correlation between the concentration of the GH-CFC and BFU-E in the various 
bone marrow sites. In either case the differences may become important under conditions of 
inhomogeneous or partial body irradiations and at least have an influence on the early response 
of the granu locyte renewa 1 system. 
Both types of canine progenitor cells the GM-CFC as well as the BFU-E are inactivated by 
irradiation in vitro in a strictly or quasi-exponential fashion: and the same holds true for 
the n~~ltipotential progenitor cell Mix-CFC. This is in general accordance with most data 
obtained for progenitor cells from human bone marrow, when the colony growth is sti1111lated by 
conditioned media from different sources. However, to our knowledge the canine BFU-E seems to 
be the most radiosensitive cell among all the hemopoietic elements from the different species. 
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Nevertheless, the results obtained from the BFU-E detenninations in the dogs which received a 
homogeneous TB! indicate that the BFU-E and the GM-CFC in identical bone marrow sites may have 
rather different repopulation kinetics after certain exposure conditions. The BFU-E showed a 
steady sharp increase in the period from day 1 to day 28. However, up to 1 year after TB! with 
a dose of 2.4 Gy they remained clearly more suppressed in relation to the pre-irradiation 
leve 1 s than the GM-CFC. 
The data obtained on the first day after the inhomogenous TB! from the comprehensive GM-CFC 
detenninat ions in 7 different bone marrow sites are in accordance with the response predicted 
on the basis of the bone marrow dose distribution. Consequently, the actual surviving fractions 
may be a valuable indicator of the radiation damage received by a certain amount of bone 
marrow. In this context it is of special interest to notice that the GM-CFC survival fractions 
in different bones of the unilateral by irradiated animals at the extreme varied by a factor of 
approximately 36. Nevertheless, it could clearly be shown that despite the inhomogeneous dose 
distribution the integral (or systemic) damage to the bone marrow of these dogs was similar to 
that obtained in the dogs which received the homogeneous TB! by bilateral exposure. Namely, 
that both exposures were hematologically isoeffective became evident from the congruencies in 
the changes of the blood cell concentrations of all lineages. Thus, using this canine model it 
could clearly be demonstrated, that the degree of the blood cell depression and its temporal 
pattern of changes is detennind by the total fraction of surviving clonogenic hemopoietic cells 
independent of the pattern of their distribution within the skeleton. 
Sever a 1 cone lus ions of theoret ica 1 as well as of pract ica 1 interest can be drawn from the data 
obtained using the canine model of partial body irradiation. First of all it could be 
demonstrated that the exposure of 30% of the tota 1 bone marrow mass resulted in a severe 
lymphocyte depression within 24 hs after the exposure, whereas the blood granulocyte and 
platelet values showed only minor changes within the first 3 weeks following the exposure. 
Therefore, an initial lymphocyte depression after irradiation may well be a monitor per se that 
in fact certain damage has been caused; however, the lymphocyte changes cannot be applied as a 
prognostic indicator of hemopoietic recovery. The reason for this is that in the case of 
partial body irradiation the protected bone marrow whether 70% or 30 %of the total mass is 
able to compensate effectively for the damage in the exposed sites by rapid cell proliferation 
and differention within 24 hs after irradiation. On the other hand, it could be shown that in 
the highly irradiated bone marrow sites there was a significant degree of repopulation by 
hemopoietic elements already at day 7 after the exposure. This fact is clearly due to the 
seeding of stem cells from the protected marrow sites since in dogs receiVing homogeneous TB! 
with a much lower dose of 3.9 Gy progenitor cells could be detected at much lower numbers if 
any at day 7 or 9 after the exposure. 
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I. Objectives of the project: 
The various cell types forming the cellular stroma (reticulum cells, endothelial cells, 
fibroblasts/fibrocytes, macrophages, nerve fibres) and its extra-cellular matrix are considered 
rather resistant to radiation with respect to acute destruction. However, due to their long 
lifespan late disintegration of the stroma is of importance resulting in functional and 
structural alterations that again may lead to bone marrow hypoplasia or even aplasia. 
Therefore, the sensitivity of the stroma in situ and certain cell types to ionizing radiation 
and its impact on the hemopoietic supportive function was studied using in vivo and in vitro 
assay systems. 
11. Objectives for the reporting period: 
The specific aims were to define and characterize the stroma 1 elements with respect to their 
biological and biophysical properties and their capacity to support hemopoietic function under 
normal conditions and after irradiation. For this purpose both in vitro and in vivo studies 
were performed using mainly canine models. In vitro certain stromal cells were studied with 
respect to their clonal growth characteristics and proliferative capacity and their radiation 
response characteristics. Suspension cultures prepared from fetal organs with their unique 
hemopoietic activity were employed to eventually produce specific hemopoietic growth factors 
for further characterization. At least long-term eo-cultures had to be established with the aid 
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to analyze short-range interactions between the stroma and hemopoietic elements. In vivo the 
association between the different types of stroma cells and the different helllopoietic cell 
lineages was studied in specimens from different tissues of the fetus and the adult. The models 
of partial body irradiation and inhomogeneous total body irradiation were ~loyed to study 
hemopoietic reconstitution in relation to irradiation-induced stromal changes. At least as 
another approach to the same problem transplantations of hemopoiet le cells from feta 1 liver 
were performed into recipients which before had been treated with high dose TB!. 
' -' 
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Ill. Progress achieved: 
1. Methodo 1 ogy 
(a) For in vitro studies of different stromal functions and analyses of certain cell types cell 
cultures were prepared from bone marrow aspirates or biopsy material from different bones of 
normal adult dogs or from different fetal organs showing hemopoietic activity. The 
fibroblast/fibroblastoid colony forming cell (CFU-F) was taken as representative of clonogenic 
progenitor cells of the hemopoietic supportive stroma. Their biological and radiobiological 
properties were determined under different conditions. This included systematic studies to be 
performed to find out the optimum sampling techniques, separation methods and cell culture 
conditions. Various approaches to establish long-term canince bone marrow cultures were based 
on the culture system according to Dexter. First, different bone marrow preparations were used 
to establish an adherent cell layer in the culture flasks as a hemopoietic supportive 
microenvironment. Second, different culture conditions especially with respect to the serum 
components in the medium were tested for their influence on the maintenance of hemopoietic 
activity. In addition, the influence of several growth factors was tested by means of 
progenitor cell determinations. 
(b) The radiation response characteristics of the CFU-F were determined under conditions of in 
vitro irradiations with 280 kVp x-rays (HVL = 2 nm Cu) at a dose rate of 0.72 Gy/min. Values of 
0 and n were derived from the 1 inear parts of the survival vs. radiation dose plots on a 
semi-logarithmic graph by means of a linear regression analysis. Colony scoring was performed 
at day 14 after the exposure. 
(c) Different types of radiation exposures using moderate to high radiation doses were employed 
to study the in situ effect of irradiation on the stroma in general and its progenitor cell 
compartment CFU-F in particular. Bone marrow specimens including pieces obtained from the ribs 
were used for determinations of the total cell nwnber and of the CFU-F and the 
granulocyte-macrophage progenitor cell (GM-CFC). In addition, qualitative and quantitative 
histological and electronmicroscopical techniques including histochemical approaches were 
applied to the exminations of the microenvironment and the associated hemopoietic elements. 
The irradiations of the dogs (beagles) were performed with 300 kVp X-rays (HVL • 4 nm Cu) at a 
dose rate of 0.065 Gy/min on the middle axis of their body. Homogeneous total body irradiation 
(TB!) was given as a conditioning regimen to dogs which thereafter received transplantations of 
fetal liver cells for hemopoietic reconstitution. The dogs were irradiated by bilateral 
exposure with a total dose of 17.5 Gy given in 3 fractions of 5.85 Gy each within 5 days. An 
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inhomogeneous TB! in a llllch lower dose range was given to other dogs and was achieved by 
unilateral exposure (ULE), i.e. the dogs were irradiated with their left side directed to the 
radiation source. Accordingly the values of the doses in different bone marrow sites showed 
considerable differences ranging from 0.9 Gy (right iliac crest) to 3.1 Gy (head of the left 
humerus) at the extreme. Partial body irradiation was performed as upper body irradiation 
(UBI). The upper part of the body including the head and the fourth lumbar vertebra was exposed 
bilaterally to a single dose of 11.7 Gy, while the lower part of the body including the lower 
extremities and the tail was shielded in a lead box. Sequential partial body irradiation was 
given to other dogs to study the regeneration of the hemopoietic tissue in a highly irradiated 
stroma and its compensatory response to a second challenge. In this case the animals first 
received bilateral upper body irradiation (UBI) with a dose of 11.7 Gy and after 56 days they 
received lower body irradiation (LBI) with the same dose. 
2. Results 
(a) Stroma progenitor cells CFU-F 
Bone marrow was collected from normal dogs using different methods and several cell separation 
techniques were applied to find out the optirum sampling conditions for CFU-F. Bone marrow 
aspirates from which the cell suspensions for culturing were prepared by sedimentation in the 
presence of dextran (1.5%) or by density separation over Lymphoprep (density 1.077 g/ml) 
yielded extremely low numbers of CFU-F. In contrast, if the cell suspensions were separated 
using the buffy coat method by simple centrifugation a cloning efficiency of 40 to 90 CFU-F per 
10 bone marrow cells was obtained for aspirates from different bones. Similar values were 
obtained for marrow samples that were scraped out from resected bones and cultured without 
further separation. Interestingly, using the same methods between 3 and 5 CFU-F per 10 bone 
marrow cells only were found in the fatty marrow in the head of the tibia. The low numbers 
correlated quite well with the low incidence of hemopoietic progenitor cells in the same site. 
The cells defined as CFU-F were found to be rather heterogeneous with respect to cell size (as 
determined by velocity sedimentation) and did not show the capability of phagocytosis. 
Reproducible survival data for canine bone marrow CFU-F were obtained in all of the experiments 
performed. Obviously survival was related to the radiation dose not in a simple exponential 
fashion. An appropriate fit to the empirical data was obtained by means of a llllltitarget-model 
S • 1-[1-exp(-0/0 )]n. However, the survival fractions showed a clear negative slope in the 
range of doses be low 1 Gy. The values of the survival curve parameters obtained for CFU-F from 
the humerus were 0 = 2.61 • 0.40 Gy, n = 1.04 • 0.42, and from the iliac crest 0 = 2.41 • 0.38 
Gy, n = 1.38 • 0.62. 
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The capacity of CFU-F for repair of sublethal damage after in vitro irradiation was tested 
in the following way using the split-dose technique: The cells were kept in suspensions at 
appropriate concentrations and irradiated at room temperature with increasing doses in the 
range from 0.36 Gy to 9 Gy. Cell suspensions that had received a dose of 2.9 Gy were kept at 
either room temperature or 37°C for 2 hs to allow possible recovery from the first dose and 
then were again exposed to incremental doses to establish a survival curve. The survival 
data obtained for the CFU-F after the second irradiations were characterized by the follo-
wing features: Generally the CFU-F number had decreased 2 hs after the first dose to approxi-
mately 60% of the original survival fraction independent of the incubation temperature in the 
interval between the two tract ions. However, the slopes of of the survival curves obtained 
after the second irradiations were rather different from the single-dose data. Thus, there is 
in principle some recovery from sublethal damage of the CFU-F. However, in the test system 
employed it was macked by interfering effects perhaps due to suboptimal holding conditions in 
the interva 1 between the exposures. 
(b) Liquid cultures of cell suspensions from fetal tissues 
Experiments were performed in which cell suspensions prepared from different fetal organs were 
kept in liquid cultures in order to investigate, whether or not, and if, under which 
circumstances the cells would be able to produce factors stimulating hemopiesis. It could be 
shown that fetal liver cells (2 x 10 cells/ml) taken from a 35 old canine fetus were able to 
produce factors that were stimulating megakaryocyte formation in vitro. Interestingly, in the 
primary cultures osteoblasts and osteoclasts were found among the adherent cell layers. 
(c) Long- term bone marrow cu 1 tures 
Different bone marrow preparations were tested for their suitability to establish adherent cell 
layers. The best results with a maintenance of the layer over more than 10 weeks were obtained 
when bone marrow was scraped out from the bones and cultured directly without any further 
preparation, or when bufty coat cells were used collected from bone marrow cell suspensions 
after centrifugation at 400 g for 10 min. On the other hand, nucleated cell suspensions 
obtained from bone marrow aspirates by means of sedimentation in the presence of dextran or by 
density gradient centrifugation (Lymphoprep) produced poor layers if any. The maintenance of 
hemopoietic activity in the cultures as assessed by the presence of GM-CFC was clearly 
dependent on the serum constituents of the culture medium and further supplementation. At least 
GM-CFC could be found up to 8 weeks after preparation of the cultures, when the culture medium 
was supplemented with dog and horse serum (10% each) and 10 mol hydrocortisone. No further 
improvement could be achieved with culture flasks that were prepared with an extracellular 
matrix. 
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In contrast to bone marrow cultures of canine cells long-term cultures with hemopoietic 
activity for approximately 13 weeks could be established for llllrine cells on the basis of the 
Dexter system. Up to this time the presence of GM-CFC as well as pluripotent stem cells (CFU-S) 
could be demonstrated. It was interesting to notice that In the lll.lrlne bone marrow cultures 
adlpocytes (fat cells) were quite frequent in contrast to the canine bone marrow cultures. Some 
Improvement In the hemopoletlc activity in the latter could be achieved when dog serum 
containing colony stilllllating activity or conditioned medium from allogeneic bone marrow cell 
suspensions was tdded to the long term tultures. 
(d) Effects of Irradiations under different exposure conditions 
(a) Fractioned total body Irradiation followed by fetal liver transplantation The CFU-F numbers 
in pieces of the ribs of a defined length of 1 aa were determined in dogs which had received 
fractionated TBI with a total dose of 17.5 Gy and transplants of fetal liver cells thereafter. 
The CFU-F nwdlers remained clearly subnormal up to 2 years after treatment. On the other hand, 
hemopoietic recovery was quite fast when compared to transplants of canine bone marrow cells, 
and no significant hemopoietic defects could be observed. This raises the question as to the 
significance of detenninations of CFU-F nwdlers as a monitor of the hemopoletlc supportive 
capacity of an irradiated stroma. 
(Ill Inhomogeneous total body irradiation 
Under the conditions of the unilateral exposure employed quite different radiation doses were 
obtained In the bone marrow of the ribs on the left side of the body or the right side, i.e. 
2.7 Gy and 1.1 Gy. The most essential findings obtained 1 year after the exposure were as 
follows: The number of the CFU-F obtained for the bone marrow of the left rib was by a factor 
of x 0.71 lower than that obtained for the right side. Yet, this difference was insignificant. 
In contrast, the total flwdler of hemopoietic cells determined as mononuclear cells (HNC) in 
total or as GII-CFC was significantly lower In the bone marrow of the left ribs that had 
received 2.7 Gy when compared to the contralateral ribs that had received 1.1 Gy. 
( •) Upper body irradiation 
It was of Interest to notice that in the-'dogs which had received a single dose of 11.7 Gy given 
to their upper body the numbers of CFU-F in the ribs had decreased to less than 20% of the 
pre- irradIation value in the period up to day 80 after the exposure. At least one year after 
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the treatment there was a gradua 1 return toward norma 1 of the CFU-F numbers in the bone marrow 
of the ribs. Using histological techniques and cytological criteria it could be shown that the 
cellularity in the irradiated bone marrow sites was clearly reduced up to day 120 at least and 
was nearly normal again at day 380. The stroma showed an increase in the number of connective 
tissue fibres, especially in areas attached to the bone trabeculae. In areas in which fibrosis 
was marked there was little or no hemopoietic activity. 
(S) Sequential hemibody irradiation 
To study whether an irradiated stroma is able to support a compensatory response of the 
hemopoietic tissue to an extraordinary challenge the hematologic changes were studied in dogs 
which received first a single myeloablative dose of 11.7 Gy to their upper body and, after an 
interval of 56 days were given the same dose to their lower body. The bone marrow volumes 
irradited during the first and the second exposure were equivalent to approximately 70% and 
30%, repectively, of the total bone marrow mass. At day 56 after the exposure of the upper 
body, when the second irradiation (lower body) was performed the granulocyte values were still 
s 1 ight ly subnorma 1. At the same time the GM-CFC concentration in the different irradiated bone 
marrow sites, i.e. the humeri, the sternum, the scapulae and the ribs, had recovered to between 
27% and 40% of the normal values. In all the pre-irradiated bone marrow sites in the forepart 
of the body a slight compensatory increas in the GM-CFC was already observed at the first day 
after the exposure of the lower body. The increase in the GM-CFC concentration continued up to 
day 21. It was related to a significant rise in the Sphase fraction within the same period of 
time. The maximum GM-CFC values were followed by a second decrease and a levelling-off within 
the lower range of the inital values or at quite normal levels beyond day 120 after the last 
exposure. 
3. Discussion 
The structural integrity of the bone marrow stroma and its functional status is the essential 
prerequisite for the maintenance of hemopoiesis and its regenerative and compensatory capacity 
under disturbed conditions. Thus, it is of importance to study the biology of the stroma and 
its elements under normal circumstances and the effects of different types of exposures to 
ionizing radiation on the stroma itself. 
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One approach in the present programne was to study the fibroblastoid colony fonning unit 
(CFU-F). These cells are considered to be representative of the progenitor cell population of 
the hemopoiet ic microenvironment. Consequently, they might be of importance in a longtenn for 
the replacement of the long-lived differentiated elements of the stroma, such as fibrocytes, 
reticulum cells etc. 
The results obtained indicate that the concentration of the CFU-F in different bones is closely 
related to the hemopoietic activity in the respective bone marrow sites as measured by the 
incidence of hemopoietic progenitor cells, i.e. GM-CFC and BFU-E. With respect to their 
radiobiological properties it is of interest that the clonogenic CFU-F are relatively 
radioresistant when compared to hemopoietic progenitor cells. The D values of 2.4 Gy of the 
canine bone marrow CFU-F are by a factor of 4 higher than those for the GM-CFC, and they are 
obviously by a factor of approximately 2 higher than the D values reported for human bone 
marrow CFIU-F. The presence of a shoulder, though quite small, on the survival curve is 
Indicative of some capacity for accumulation of sublethal damage. Therefore, some capacity of 
sublethal damage repair could also be expected. However, when split-dose irradiations were 
perfonned a significant loss of CFU-F after the first dose could be noted. Perhaps this loss 
was due to the fact that the CFU-F were irradiated in suspension and not in an adherent state. 
Nevertheless, when the survival data were corrected for the loss a clear split-dose recovery 
became evident if the two doses were separated by an interval of 2 hs. 
In the dogs which had received inhomogeneous TBI by an unilateral exposure the differences 
that could be detected between the CFU-F numbers in the ribs at least 1 year after the expo-
sure were rather small. These findings show that the initial cell loss and the differences 
in the CFU-F numbers must have been nearly compensated within the 1 years period. 
On the other hand, there was clearly some late damage present in the hemopoietic tissue in 
the bone marrow that had received a dose of 2.7 Gy. This was obviously not directly related 
to the CFU-F. 
The data obtained from the partial-body irradiated dogs clearly indicate that certain types of 
damage to the stroma are responsible for the delayed regeneration of hemopoiesis as reflected 
in the subnormal GM-CH: values in bone marrow sites that had received a single dose of 11.7 Gy. 
It could be shown that the CFU-F numbers In the irradiated sites also remained clearly 
subnormal for severa~ months after the exposure. On the other hand, in this model microscopical 
examination revealed structural alterations In the stroma evident as an increased number of 
connective tissue fibres. Clearly, in areas in which fibrosis was marked there was 1 ittle or no 
hemopoietic activity. However, despite such local defects the hemopoietlc function in a given 
site was nearly normal after 1 year as became evident from the GM-CFC detenninatlons in 
aspirates. 
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Sequential half body irradiation was employed to test whether a pre-irradiated stroma is able 
to allow a compensatory response of the hemopoietic tissue similar to that in an unirradiated 
state. It could be demonstrated that bone marrow sites that had partially recovered from a 
radiation dose of 11.7 Gy were able to compensate effectively for the damage that was produced 
in other parts of the skeleton by a second irradiation with the same dose, if this second 
irradiation was performed 56 days after the first one. The compensation was achieved in the 
same way as observed in a previously unirradiated bone marrow, namely by a strongly increased 
prol iteration within the following 3 weeks. Thus it can be concluded that the stroma that had 
received a dose of 11.7 Gy is able to supply the microenvironmental conditions required for 
such an extraordinary response of hemopoiesis. 
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Title of the project no.: 
Pathogenesis of late hemopoietic failure and proliferative disorders in hemopoietic/lymphopoie-
tic cell systems as a consequence of protracted low level radiation exposure. 
Head(s) of project: 
Prof. Dr. T.M. Fliedner and Prof. Dr. H.J. Seidel 
Scientific staff: 
Prof. Dr. w. Calvo (1985-89), Dr. M. Gulich (1989), Dr. A. Ingendaay (1987-88), Dr. L. Kreja 
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I. Objectives of the project: 
It was the objective of this project to analyse the pathogenetic mechanisms that eventually 
lead to the development of myelogenous leukemia or to aplastic anemia when mamnals are being 
exposed to ionizing radiation or cytotoxic drugs. In addition, it was of interest to study the 
effects arising from the combined action of radiation and certain cytotoxic chemicals. 
11. Objectives for the reporting period: 
Several experimental models and modes of treatment were employed depending on the specific 
aspects to be studied. 
In mice, the problem was studied in what way the total body irradiation as a eo-carcinogen 
could enhance the leukemogenic effect of the drug methylnitrosourea, that specifically causes T 
ce 11 leukemias. The leukemogenic effect of benzene after inhalation as a consequence of chronic 
exposure to low concentrations of the compound was also studied in mice. In these experiments 
certain analyses of early stem cell changes were performed. However, they were mainly directed 
to long-term effects with respect to the induction of malignancies. 
In dogs the progenitor cell changes and other hematological parameters were examined during and 
after continuous treatment with low doses of intravenously injected cyclophosphamide as a model 
of chronic damage to the hemopoietic cell compartments. With respect to hematological radiation 
effects in man retrospective analyses of peripheral blood cell changes in persons as a conse-
quence of (accidental) protracted radiation exposure were performed. 
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Ill. Progress achieved: 
1. Methoilo logy 
a) In the studies of the leukemogenic effects of methylnltrosourea (MNU) and total body ir-
radiation female BDFl mice, 4 or 10 weeks old, were used. MNU was dissolved In saline and admi-
nistered Intravenously. Total body Irradiation was performed with 280 kV X-rays (filter 1.5 mm 
Cu and 1 mm Al) at a dose rate of approximately 0.3 Gy/min. The Irradiation was given in 
various doses in single sessions or fractlonated, and at different intervals before or after 
MNU. The bone marrow and the spleens of mice were used to prepare cell suspensions for hemo-
poietic stem cell and for natural killer cell assays. 
In the past 2 years the methodology used in these murine leukemogenesls studies was further de-
veloped by establishing molecular biology techniques such as transfection, Southern and Nor-
thern blotting in close collaboration with the European Late Effects Project Group. 
b) The studies on the leukemogenic effect of benzene were performed using an tnhalatton chlllllber 
that allowed chronic exposure of the mice to defined low concentrations of gaseous benzene. The 
mice were exposed to different concentrations of benzene for periods up to 8 to 16 weeks. 
c) In beagle!, the studies on the hematological effects of protracted treatment with cyclophos-
phamide were !Jerformed as follows: cyclophosphamide (Cy) was given at a dose of 3 mg/kg body 
weight per day for 23 days. Several hematologlcal parameters were determined, but special 
eq~hasis was given to the determinations of the granulocyte/macrophage progenitor cells 
(GM-CFC) In the bone marrow and the blood. A biomathematlcal model developed to simulate canine 
granulopoiesis was employed for these data also. 
d) As far as the human hematological data from radiation accidents is concerned, detailed In-
formation aboUt tbe Algerian accident became available (and later, a continuously updated data 
bank on radiation accidents was established). In the Algeria~ accident 4 persons were Involved 
receiving total body Irradiations at doses In the range from 8.62 to 10.15 Gy during 38 days. 
Thus the daily dose amounted up to 0.23 - 0.27 Gy. This exposure resulted from a 192-radlum 
source. In all these patients a severe granulocytopenia was observed at the end of the expo-
sure. The patients received Intensive medical treatment, and spontaneous hemopoletic recovery 
commenced around 35 days after the end of the exposure. 
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2. Results 
a) Leukemogenes is in mice 
The major question was whether there is a synergistic action of the sequential treatment of the 
mice with tota 1 body irradiation and the drug MNU. Furthermore, it had to be asked whether an 
impaired NK cell function was involved. With a given dose of 50 mg/kg of MNU an "optimal" leu-
kemia (T cell-lymphoma) induction with various mouse strains and also mice in various ages was 
found, the median induction time varied around 18-20 weeks, more than 95% of the animals died 
from malignancy. Additional external radiation in doses of 12 x 0,1.25 Gy (in weekly intervals 
during the first period of the latency period) to 12 x 0.75 Gy had no influence on these end-
points. There was however, as expected, a significant influence on hemopoietic stem cells. With 
50 mg/kg of MNU also single doses of radiation either before or after the chemical were not 
effective with respect to leukemia development. There were, however, two experimental condi-
tions, that reveal a synergistic effect. When the NMU dose was reduced, with the consequence of 
a prolonged latency period, repeated doses of radiation did reduce the latency period to the 
above mentioned 18-20 weeks. Single doses of radiation between 1.5 and 4.5 Gy 2-5 weeks before 
lower doses of MNU (40 mg/kg) did also enhance the leukemia development. Natural killer cell 
activity could not be correlated to the leukemogenesis. Effects on the NK cells like injection 
of corynebacterium parvum, use of various mouse strains with other background activities, and 
also use of endotoxin or antithetaglobulin were without influence. 
The model was then used for molecular analysis. DNA preparations were obtained from bone marrow 
and thymus during the latency period and used for transfection. Some active preparations were 
found rather early (after 3-5 weeks), but so far the responsible one-genes have not been 
identified. Since mutated N-ras genes are found in MNU induced leukemias, a series has been 
begun to look for these mutations using the polymerase-chain-reaction (in collaboration with 
Janowsk i/ Mol). 
b) With benzene 30% malignancies of the lymphoid systems were observed in a longterm experi-
ment. The hemopoiet ic stem cell system was carefully ana lysed during a benzene exposure period 
up to 16 weeks. The late erythroid stem cells (CFU-E) turned out to be the most sensitive para-
meter for the toxic action of this solvent. Adaptation of the erythroid system to this stress 
condition could be analysed - there is an enhanced turnover of erythroid precursors. 
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c) In cyclophosphamide-treated beagles the effects in the hemopoietic cell system as seen after 
low dose irradiation could be induced. The biomathematical model, developed for radiation, 
could also be used for an analysis of these changes, which occurred on the level of stem cells, 
cells in the peripheral blood and also regulatory factors (CSA). 
d) The hematological data from this radiation accident were used to compare the kinetics of 
depression and recovery with the results of experimental protocols in dogs in order to improve 
the model. After this it was decided to build up a data base for observations in human beings 
after radiation exposure. This has led to a new large research project which evolved from this 
contract (Post-Chernobyl-studies). 
Discussion 
Hemopoietic failure (aplasia) and malignancy as a consequence of radiation exposure are diffi-
cult to analyse in their stages of development. Even in mice no clear indication for the most 
critical decision between the two endpoints aplasia or neoplasia could be found. Stem cell de-
pression may and may not be involved, the NK cell system had no influence. In a given leukemo-
genic protocol a synergism of a chemical agent and external radiation was seen, when each agent 
alone was in a suboptimal dose. The enhancement of leukemogenesis in such protocols by precee-
ding radiation is thought to be a target cell phenomenon. During the recovery from a median 
dose of radiation more target cells seem to be present than under steady state conditions. - If 
mutations in the N-ras gene are a critical event, the more recently established methods of 
molecular biology should be able to detect mutated genes in various hemopoietic organs during 
the latency period. This will contribute to the question of the target cell system. 
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IV. Other research group(s) collaborating actively on this project [name(s) and 
address(es)]: 
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E.P. Cronkite/Brookhaven. The molecular analysis is being done in a joint effort with the De-
partment of Radiobiology in Mol. 
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Title of the project no.: 
A cooperative study to establish radiation protection criteria for non-
uniform skin exposure based on experiments on pig and mouse skin. 
Head(s) of project: 
M W Charles 
Scientific staff: 
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J Wells 
I. Objectives of the project: 
A collaborative programme will investigate non-stochastic effects in mouse 
and pig skin and stochastic effects in mouse skin, following uniform and 
non-uniform alpha and beta irradiation. This should enable radiological 
protection criteria to be developed for limiting non-uniform skin exposure 
and will provide the design parameters for personal skin dosemeters. In 
particular the aim is to identify the nature and depth of cells at risk in 
the skin and to identify an appropriate area over which dose should be 
averaged. 
11. Objectives for the reporting period: 
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Ill. Progress achieved: 
1. Introduction 
The current recommendations of the International Commission on 
Radiological Protection (ICRP 1977) regarding limitation of skin exposure 
are on the basis of non-stochastic effects. An annual dose limit of 
0.5 Gy is recommended on the basis of a life-time exposure limit of 20 Gy 
and a target cell depth of between 50-100 micrometers (~) or 5-10 mg cm- 2 
mass thickness in tissue. Because of the paucity of human and animal data 
the ICRP have been unable to provide definitive advice regarding the 
appropriate area and depth over which this dose should be averaged, 
particularly for small areas and highly non-uniform exposures such as 
those from small radioactive sources ('hot particles'). Recently, 
however, considerable information on non-stochastic and stochastic effects 
following radiation exposure of the skin has become available from animal 
studies and recent epidemiological studies in man also provide new 
information on the risk of radiation induced skin cancer. In this paper 
this new information, with associated dosimetry data, will be combined in 
order to suggest how an improved, coherent and defensible system of skin 
dose limitation may be achieved. 
2. Stochastic effects 
The risk of skin cancer mortality given by the ICRP in 1977 was considered 
to be much less than that for other organs, and on this basis non-
stochastic effects were considered to be the limiting biological end-
point. The ICRP (publication 28) subsequently gave a mortality risk 
figure of 10- 4 sv- 1 for a whole body skin exposure. 
The recent data of Shore (1989) which are based on an exhaustive review of 
all the available human data, give a whole body radiation induced skin 
cancer risk figure. This amalgamates risks for those parts of the body 
subjected to UV exposure together with the significantly lower risk for 
the remaining parts of the body normally shielded by clothing from UV 
exposure. The average whole-body skin cancer risk figures, for both 
sexes combined, are given in Table 1 and support current ICRP risk 
figures. On the absolute model the risk is about half that given 
previously by the ICRP while on the relative risk model the risk is 
perhaps twice that previously given by the ICRP. 
TABLE 1 
RADIATION INDUCED SKIN CANCER RISK FIGURES FOR MAN 
Incidence/10-4 Sv- 1 Mortality*/10-4 sv- 1 
Absolute risk model 233 0.47 
Relative risk model 971 1.94 
*Using 0.2% mortality (data from Shore, 1989). 
For comparison the 1978 ICRP risk figure for skin cancer mortality 
is 10-4 sv- 1 • 
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The choice of skin depth which is appropriate for evaluating skin dos~ 
relevant to skin cancer induction is a matter of some controversy. The 
observation of excess basal cell carcinomas in uranium miners subjected to 
alpha irradiation of the skin would seem to support epidermal involvement 
but some questions remain regarding the veracity of this particular study. 
On the basis of equivocal evidence it would be prudent to assume the ' 
potentially pessimistic use of the basal layer of the epidermis as the 
target cells for skin cancer induction. 
2.1 Non-fatal cancers 
Since the clinical treatment of skin cancer is relatively inexpensive and 
generally involves little trauma and only a few days of lost work, the 
question arises as to whether any detriment should be associated with 
successfully treated skin cancers. 
A recent NRPB review of radiation risk philosophy (Clarke 1989) indicated 
that in the future it was likely that non-fatal cancers would receive a 
weighting in order to evaluate health detriment. The NRPB have in fact 
given whole body exposure risk figures based on an assumed detriment 
weighting (let us call this W0 ) of 0.1-0.2 for non-fatal cancers. A high 
W0 value could over-ride the difficult choice of a figure for the 
proportion of skin cancers which prove to be fatal, which forms the basis 
of a skin cancer mortality risk figure (assumed to be 0.2% in Table 1). 
2.2 Skin cancer following spatially non-uniform skin exposure. 
In the case of highly non-uniform exposures, where some cells may be 
subjected to high doses, it is possible that the mean dose may 
underestimate the stochastic risk due to a supralinear dose response 
relationship, or over-estimate due to cell sterilisation. Some models 
have postulated that localised gross tissue damage may produce a dramatic 
increase in tumour incidence by several orders of magnitude compared to 
uniform exposures (the so called 'hot particle·effect'). Evidence against 
this hypOthesis has been found in studies of skin cancer induction in 
rodents following non-uniform exposures. In one such study (Charles et al 
1988) mouse skin was subjected to a wide range of beta doses, down to 
2 Gy (skin surface dose) using a plane uniform source of 170Tm (Emax 
0.97 MeV) or arrays of 8 and 32 small (2 mm diameter) sources distributed 
over the same area of 8 cm2 • For all doses (averaged over the total area 
of 8 cm2 ) the highest tumour incidence occurred following uniform 
exposures. These data refute the 'hot particle' hypothesis and support the 
use of mean dose as a conservative measure of carcinogenic risk following 
spatially non-uniform skin exposure. 
3. Non-stochastic effects 
Non-stochastic effects were considered by the ICRP in 1977 to be more 
important than' stochastic effects for skin dose limitation and they 
recommended an annual skin dose limit of 0.5 Sv (20 Gy life-time). In 
fact, few relevant data were available to the ICRP at the time to support 
this dose limit. More·recent results have become available from this 
collaborative radiobiology study of the effects of beta irradiation on pig 
and mouse skin. The late dermal response in the two species differs due 
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to the difference in blood supply to the skin. Since the blood supply in 
pigs is similar to that in man these results have been used primarily as 
the basis for considerations relevant to radiological protection. 
3.1 Acute tissue breakdown. 
Dose effect curves have been obtained for acute tissue breakdown of pig 
skin for a variety of beta radiation source sizes. For these studies the 
skin surface doses were measured with an extrapolation chamber with an 
effective window thickness of 16 ~ and an electrode area of 1.1 mm2 
(Wells 1988). The ED50 and ED~o values were calculated using probit 
analysis and are given in table 2. The pronounced dependence of effect on 
beta energy (90Sr/Y, ~70Tm and ~47Pm: Emax:2.27; 0.97 and 0.225 MeV) and 
the influence of the radiation source size (0.1 - 40 mm diameter) in 3-4 
month old female Large White pigs are clearly seen. The early epithelial 
responses were consistent with repopulation of the irradiated epidermis by 
surviving epithelial cells from around the hair follicle and from the 
periphery of the irradiated area. For 90Sr/Y and ~70Tm larger sources 
produced moist desquamation which occurred within 4-5 weeks of exposure, 
following the mitotic death of basal epidermal stem cells. For smaller 
sources, after higher local doses, the tissue breakdown is due to 
interphase death of dermal cells, resulting in ulceration which occurs at 
about 1-2 weeks. For the lower energy ~47Pm sources an acute epidermal 
breakdown occurred at 1-2 weeks. This early and transient response to 
~47Pm was due to interphase death of suprabasal epithelial cells subjected 
to very high doses. For the larger sources the doses required to produce 
epidermal breakdown in 50% of the irradiated fields (ED50 ) are about 28, 
73 and 360 Gy (measured at a depth of 16~) for 90Sr/Y, ~ 70Tm and ~47Pm 
respectively. 
It does not appear to be possible to choose a unique single area and depth 
over which to average dose which will provide a single predictive 
indicator for all source sizes and beta energies. This is presumably due 
to the various complex end-points actually involved in the acute responses 
of the skin. However, the use of an average dose over an area in the 
vicinity of 1 cmz does lead to considerable accord in the dependence of ED 
values on source size for the range of beta emitters used in these 
studies. Some limited extrapolation chamber measurements have been made, 
using various sizes of collector electrode, which enables some guidance to 
be given on the relationship between the doses from these sources when 
averaged over different areas (Wells et al 1982; Wells 1986, 1988). 
Table 3 provides information which indicates the ratio between the 
measured dose at 16 ~ averaged over an area of 1.1 mm2 and the estimated 
dose at 16 ~ ~veraged over an area of 1 cm2 • The average doses over an 
area of 1 cmz are based on measurements using an extrapolation chamber 
electrode of area 1.1 mmz together with subsidiary data from Wells (1986, 
1988) and Wells et al (1982) and subsidiary beta dosimetry calculations 
using the computer codes BETA (Bailey 1973) and VARSKIN (Traub et al 
1987); see table 3. These ratios (table 3) have been used in figure 1 to 
indicate how the ED10 values (doses for a 10% incidence of the acute skin 
response) for pig skin (Hopewell 1989) averaged over 1 cm~ at depths of 
16 ~, depend upon the source size. Since the acute effect for large area 
sources arises due to the response of cells near the dermal/epidermal 
junction (and the suprabasal cells in the case of ~ 4 .,Pm) the dose limit 
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should be related to the depth of these cells (in the vicinity of lOO~). 
If a depth range of 100-150 ~ is used then, for the larger sources, the 
ED10 values are reduced compared to the values at 16 ~ by ~2, ~2 and ~10 
for 90Sr/Y, 170Tm and 147 Pm respectively , and are all then in good 
agreement (see also figure 1; Table 3 and footnote c) 
For small sources the ED10 doses (averaged over an area of 1 cm2 at a 
depth of 16 ~, 1.6 mg cm- 2 in tissue) are about 3 Gy (figure 3). 
Threshold doses are, for practical purposes, considered to be perhaps 2/3 
of the ED10 values. For consistency with the procedure recommended for 
large area exposures it would appear to be appropriate to define a dose 
limit for small area exposures (including 'hot particles') at a depth in 
the vicinity of lOO ~· This choice of depth does however have an 
important impact on the appropriate value of a dose limit for poorly 
penetrating, low energy beta radiations for which the depth doses vary 
considerably over depths of even a few tens of ~· To date however there 
are no published data on the acute effects of radioactive particle 
exposures (source diameter < 1mm) for low energy beta emitters. When such 
data are available it may be necessary to revise the choice of depth to 
which the dose limit is related. With this reservation, and in view of 
philosophical as well as practical uncertainties involved in determining 
the threshold, a dose limit of 1 Gy (averaged over 1 cm2 at a depth of 
100-150 ~) appears to be satisfactory for the practical prevention of 
transient acute ulceration following 'hot particle' exposures. Although 
knowledge of hot particle effects has increased substantially, more 
information is required to relate the measured doses in these studies to 
other possible dose parameters and to provide a bridge between measured 
and calculated beta doses, particularly for small radioactive sources. 
Work is in progress to provide these data and to extend animal studies to 
source sizes below 1 mm for a range of beta radiation energies, including 
60Co (~ax 0.3 MeV). 
3.2 Late effects. 
Late dermal atrophy, which has been observed in pig and man following X-
irradiation has also been observed following acute beta exposure studies 
for the two higher energy sources but not in the case of 147Pm (Hamlet et 
al 1986). The dose-related changes in late skin effects indicates that 
dermal atrophy (visible as an induration) can occur at doses below the 
threshold for acute epidermal breakdown and may thus be a more limiting 
detrimental end-point following acute exposures. For similar magnitudes 
of slight dermal atrophy there is a factor of about 2-3 difference in the 
surface dose for 90Sr/Y and 170Tm which can be reconciled if a dose 
measurement is made in the mid to upper dermis at a depth in the region of 
0.5 mm. For late telangiectasia in human skin the ED50 value for a 
moderate severity at S years was about 65 Gy for total doses given at 2 Gy 
per fraction (Tureson and Notter 1986). The threshold dose was about 
40 Gy (equivalent single dose about 12.5 Gy). Clinically evident late 
atrophy in large fields given 30 fractions that were associated with a 50% 
incidence of a visible effect was about 69 Gy (Reinhold et al 1989) with a 
threshold dose of about 40 Gy and an equivalent single dose of about 
10 Gy. Since these observed detrimental clinical effects are of dermal 
or1g1n a dose measurement in the dermis rather than the epidermis would 
again appear to be appropriate. 
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4. Stochastic versus non-stochastic effects 
It is necessary to bring together the discussions of stochastic and non-
stochastic effects and to consider which of these effects is likely to be 
limiting in practice. A schematic amalgamation of the dependence of 
stochastic and non-stochastic dose limits on the area irradiated is 
indicated in figure 2. The non stochastic dose limits have been taken 
from radiotherapy data. The stochastic dose limit is based on an assumed 
upper limit of acceptable life-time mortality risk of 2x10- 2 • This was 
derived using a current ICRP risk figure for whole body exposure of 
10-2 SV- 1 and an upper limit of life-time exposure of 50 msv x 40 years. 
The skin cancer risk has been assumed to be proportional to the area of 
skin exposed. Skin cancer induction may be the limiting biological 
response for large area exposures, particularly if a mortality risk figure 
at the higher end of the indicated range is chosen by including a 
weighting W0 for non-fatal cancers in excess of 1%. If a relative risk 
model is used to predict life-time radiation induced skin cancer 
incidence, and if a detriment weighting factor W0 of 10% were to be 
applied, then an effective risk factor of 10-2 sv- 1 would apply for 
detrimental stochastic skin effects. An intermediate situation is the 
most plausible. In situations where cancer is considered limiting the 
relevant monitoring depth will be that of the epidermal basal layer and a 
conservative depth range would be between 20-100 ~ (2-10 mg cm2 ). 
Depending upon the choice of the value of the stochastic risk figure, 
there is an area of exposed skin below which there is a transition to dose 
limitation on the basis of non-stochastic effects. For any reasonable 
value of stochastic risk it is apparent that for those relatively small 
body areas normally exposed to the highest skin doses, such as the fingers 
or hands, the limiting end point will be non-stochastic, and the relevant 
monitoring depth will be deeper, at some point in the dermis. 
The risk of cancer from a 'hot particle' can be readily evaluated using 
the dose limit criteria of 1 Sv averaged over an area of 1 cm2 and the 
skin cancer risk figures per cm2 derived from Table 1 using a value for 
total skin area of about 2 x 104 cm2 • This leads to a mortality risk of 
10-a for a hot particle exposure in the region of the non stochastic 
effect threshold dose (using a relative risk model). The mortality risk 
for a single hot particle exposure therefore is negligible and limitation 
of such skin exposures should be on the basis of prevention of acute 
tissue breakdown. 
5. Conclusions 
On the basis of the data discussed here it is possible to suggest some 
guidance for the limitation of radiation exposure of the skin. 
5.1 Whole body skin exposures 
5.1.1 Non stochastic effects. 
In order to prevent late detrimental cosmetic effects due to chronic 
dermal exposure a life time dose limit (based on clinical data and 
supported by animal studies) should be less than 40 Gy. The current ICRP 
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life-time dose limit of 20 Gy (0.5 Gy per year) if maintained, would 
represent a margin of safety. The dose should be evaluated in the upper 
dermis at a depth in the region of 500 ~· A suitable depth range to 
facilitate practical measurements would be between 300-500 ~ (30-50 mg 
cm-2) 
5.1.2 Stochastic Effects (skin cancer). 
On the basis of a mortality risk figure of 2 x 10-4 sv- 1 and an upper 
limit of acceptable risk of 5 x 10-4 per year, an occupational life time 
dose limit would be 100 Sv (2.5 Sv per year). The dose should be 
evaluated to the basal cells of the epidermis which can conservatively be 
taken to~be at a depth between 20 -100 ~ (2-10 mg cm- 2 ). 
5.2 Partial body skin exposures 
5.2.1. Non stochastic effects. 
The discussion of a non-stochastic dose limit, given in 5.1.1 should 
be considered to be independent of the area exposed, subject to 
comments in 5.3. 
5.2.2. Stochastic effects (skin cancer). 
The discussion of a dose limit for stochastic effects given in 5.1.2 
should also apply to exposures involving all of the areas of the body 
normally subject to UV exposure (face hands and arms) since the skin 
cancer risk figure, on which the dose limit is based, is dominated by 
exces.s skin cancers reported in these skin areas. For smaller areas of 
skin the dose limit, on the basis of skin cancer mortality, will be 
proportionally higher. 
5. 3 'Hot particle' exposures. 
'Hot particle' exposures are spatially non-uniform exposures from discrete 
radioactive·sources with dimensions of the order of less than or about 
1 mm. Highly localised re-irradiation of the same skin site is normally 
considered~ to be highly unlikely. Early acute ulceration is considered to 
be the ~nd-point of concern because of the possibility of infection. 
Early acute ulceration should be pr~vented if the'average dose over an· 
area of 1 cm2 , measured between depths of 100-150 ~ (10-15 mg cm-2) 
delivered within a few hours, is restricted to 1 Sv. Alternative exposure 
limitation criteria, such as total number of beta particles emitted, couLd 
be used. Revision of this recommendation should be considered when 
further data on 'hot particle' skin exposures for low energy beta emitters 
become available. 
5.4 General comments on skin dosemeter design. 
In order to comply with both the stochastic and non-stochastic dose 
limits, for routine chronic exposures, personal skin dosemeters may need 
to provide measurements of dose at 2 depths relevant to dermal (300-
500 ~) and epidermal (20-100 ~) biological effects. An alternative 
conservative proeedure could involve only one measurement at the 
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superficial depth (20-100 ~) with the application of the lower dose limit 
relevant to the dermal response (say 0.5 Sv per year). Such a procedure 
would be essentially the same as that currently adopted in several 
countries using the recently available thin dosemeters designed to measure 
dose between 50 and 100 ~ in accord with ICRP publication 26. In 
situations where depth dose information is available it may be possible to 
justify the evaluation of the dermal dose alone using an appropriate 
dosemeter with a thicker and deeper detector element, such as one of the 
many thermoluminescence dosemeter (TLD) designs which have been available 
for some years 
If a skin dosemeter is required to provide clinical prognostic information 
in the event of an accidental over-exposure then the use of a device with 
at least 2 detection elements will be required. 
The thickness of a routine personal skin dosemeter is clearly of 
imPortance in providing the necessary energy response of the detector. 
The area of the dosemeter, for exposures other than those due to 'hot 
particles', is not a particularly imPortant parameter from a biological 
standpoint but may be relevant to questions related to the radiation 
sensitivity of the device. Most currently used TLD dosemeters, such as 
those of the sachet type with areas of about 1 cm2 , for example, would be 
appropriate and could also be used to provide 'hot particle' dose 
assessments using the criterion of average dose. 
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over an area of 1 cm2 at a depth of 16 ~, is indicated as a function of 
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to relate the dose averaged over 1 cm2 to the directly measured dose 
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TABLE 2. 
ACUTE BREAKDOWN OF PIG SKIN FOLLOWING BETA RADIATION EXPOSURE. 
VALUES OF ED50 AND ED10 
DOSES AVERAGED OVER AN AREA OF 1.1 mm• AT A DEPTH OF 16 f.llll 
ISOTOPE SOURCE EDso (a) ED10 (a) TYPE OF 
DIAMETER LESION 
/mm /Gy /Gy 
90Sr/Y 40 28.6+1.4 20.1+1.4 MD 
22.5 27.3+0.7 21.1+1.2 MD 
15 42.3+4.8 21.0+3.4 MD 
11 44.8+4.5 22.0+3.2 MD 
5 70.3+5.0 34.4+4.0 MD 
2 119 +9 82 +10 AU 
1 253 +31 104 +25 AU 
170Tm 19 71.9+5. 7 47.5+4.2 MD 
9 73.9+2.6 48.8+2.8 MD 
5 85.8+4.6 56.7+3.9 MD 
2 179 +15 77.7+9.4 AU 
1 202 +24 87.7+12.6 AU 
0.5 339 +36 147 +20 AU 
0.1 197 +25 85.7+13.1 AU 
147Pm 1 341 +22 203 +27 AEN 
(b) 9 381 +23 244 +30 AEN 
5 410 +22 272 +27 AEN 
2 478 +26 340 +27 AEN 
(a) Measured dose at a depth of 16f.llll, averaged over an electrode 
area of 1.1 mm· 
(b) Surface doses for 147Pm are about 50% higher than at 16 f.llll· 
MD - moist desquamation 
AU - acute ulceration 
AEN - acute epidermal necrosis 
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TABLE 3 
ACUTE BREAKDOWN OF PIG SKIN FOLLOWING BETA RADIATION EXPOSURE. 
THE RATIO BETWEEN 
MEASURED DOSEs<a> AND DOSES AVERAGED OVER AN AREA OF 1 cma 
ISOTOPE SOURCE 
DIAMETER 
/mm 
90Sr/Y 40 
22.5 
15 
11 
5 
2 
1 
170Tm 19 
9 
5 
2 
1 
0.5 
0.1 
147Pm. 15 
9 
5 
2 
<a>AVERAGE DOSE OVER 1.1 mm2 AT 16 1.1m 
AVERAGE DOSE OVER 1cm2 
RATIO BASED ON 
<b>measurement <c>calculation 
of average dose over 1 cm2 
1 
1 
18 
1 
8.7 
25 
1 
1.6 
5 
32 
1 
1 
1.03 
1.1 
5 
28 
69 
1 
1.6 
5 
28.7 
70 
75 
75 
1 
1.6 
5 
32 
<"'>RATIO USED IN 
FIGURE 1 
1 
1 
1 
1 
2 
7 
18 
1 
1.2 
2.4 
8.7 
25 
27 
27 
1 
1.6 
5 
32 
(a) The majority of dose measurements were made using an extrapolation 
chamber with an electrode of area 1.1 mm2 at a depth of 16 \.lm· 
(b) This ratio is based on extrapolation chamber measurements at an 
equivalent tissue depth of 16 \.lm, using several different sized electrodes 
(Wells et al ,1982; Wells, 1988). 
(c) The ratio is based on a simplified calculation of doses at a depth of 
16 ~.~m, using a plane source geometry, neglecting self absorption (Bailey, 
1973; Traub et al, 1987). Based on such calculations the ratio is 
increased by factors of about <2, <2 and <10 for 90Sr/Y, 170Tm and 147Pm 
respectively, when the average-dose over an area of 1cm2 is calculated at 
a depth of 100-150 \.lm· 
(d) Measured values are used where available. The ratio of calculated 
values for various source sizes has been used to guide interpolation of 
measured values. 
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I. Objectives of the project: 
'Ib investigate residual haemopoietic injw:y in tenns of deficiencies in 
various progenitor and maturing cell populations, after irradiation 
delivered acutely, at low dose rate, or using various fractionation 
reg.imens. 
11. Objectives for the reporting period: 
1) 'Ib study acute responses of haeoopoietic progenitor cells (e.g. 
cru-s, Q1-c:FC) and stranal progenitor cells (c:ro-F, ossicle-fanning 
cells), variously in murine, canine and human marrow. 
2) To assess recovery and residual injw:y in the various cell 
populations, using also long-tenn marrow cultures, and to interpret 
dose-response relationships in tenns of deficiencies in particular 
subpopulations of cells and in the interactions between them. 
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Ill. Progress achieved: 
1. METHOOOI.OGY 
1.1 Bone marrow sources Murine, canine, and human marrow were used 
variously in these studies. Fenoral marrow was used fran 10-12 week old 
B6D2F1 mice. Cell suspensions were made using Fischer's or Iscove's 
rrediUI'fi. 
A semi-purified population of primitive celi:s (FACS-BM) was obtained by 
using a metrizamide density cut (1.089 ml ) followed by sorting twice 
on a FACS machine. The population collected contained 95% CFU-S and 
MIX-cFC (a 20-fold enrichment). Bi-potential CFC 'Y!_Efe obtained fran 
marrow 3 days after injection of mice with 200 rng kg CP. The marrow 
cells were subjected to a metrizamide de.!Jfity cut, followed by 
collection of fractions at 24-36 ml min using a counterflow 
centrifugal elutriator. CCE-BM was highly enriched for CCM-cFC. 
Rib marrow was used fran adult Beagle dogs. Sternal or iliac crest 
marrow was used fran haematologically nonnal male and female patients 
undergoing diagnostic procedures, or fran rib segments renoved for 
access during surgery. canine and human marrow samples were layered on 
to_f.ID equal volume of lyrrphocyte separation rneditnn (density 1.077 g 
ml , Flow Labs) at roan teng;Jerature. The cells were centrifuged, and 
the interface aspirated and washed twice with 
Iscove' s-Modified-Dulbecco '·s rneditnn. 
1. 2 Irradiations These were variousl:E' (a) 13;
0eo gamna-rays at 
dose-r'!yes between 0. 0005 and 0. 05 Gy min , (b) Cs ganma-rays at 4 
~ !!ljn , and (c) 300 kVp X-rays (10 mA, hvl=2.3 rnn Cu) at 0.6-0. 7 Gy 
rru.n 
1.3_1CFU-S Recipient mice received 15.5 Gy 
60eo ganma-rays at 0.016 Gy 
min Colonies were counted at day 9 and 11. CFU-S per 11-day colony 
were assessed by secondary transplantation. CFU-S in axial and marginal 
fenoral-marrow samples were renoved using different sized syringe 
needles. Progenitor cell cycling was measured using thymidine sui~fde 
(7. 4 MBq 3Hl'dR in 0. 2 ml rreditnn, specific activity 555 GBq mrole ) • 
CFU-S stimulator was prepared as conditioned medium after short or long 
incubation times. Stimulating activity was assessed using 3h or 18h 
incubations with 'responder' cells followed by thymidine suicide 
measurements. . 
1.4 In vitro CFC For mouse marrow, Iscove's rneditnn was used with 20% 
horse sertnn, 0.3% agar and one or IIDre of the following factors at 
optimal concentrations: IL-l, recanbinant IL-3 (a gift fran Amgen), 
recombinant human (rh) GM-csF (a gift fran Biogen), partially purified 
murine M-cSF, (rh) G-CSF (Angen) • For canine marrow, 20% foetal calf 
sertnn or 10% irradiated-dog sertnn (a gift fran Dr. w. Nothdurft, Ulm 
University) was used together w~ 1% ~e sertnn albtnnin, end one or 
IIDre of the above factors or 10 WBC ml , 15% PHA-conditioned rreditnn, 
or 20% 5637-Gl. For human marrow, 20% foetal calf sertnn was used 
together \'lith the above purified or recombinant growth factors. 
CUltures were incubated in htnnidified 5% Co2 , 5% 0;;: and 90% N:. at 37°C 
for 7-12 days. 
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1.5 c:ro-F 
calf serum. 
CUltures were set up using Iscove's nedium, and 5% foetal 
They were incubated in 5% C02 , 95% N2 at 37°C for 7 days. 
1. 6 Ossicles A plug of fenural marrow was inserted under the kidney 
capsule of recipient mice, and the ossicle produced was assayed for 
CFU-S after 8 weeks. 
1. 7 Long-tenn cultures CUltures were established using 1 femur in ±g 
ml Fischer's medium supplE!Ileilted with 20% pretested horse serum and 10 
M hydrocortisone. The cultures were fed weekly by demipopulation. 
Total sulphated GAGS were detected by eo-precipitation using chondroitin 
sulphate as carrier in an excess of CPC. 
2. RESULTS AND DISCUSSIOO 
2.1 Acute Responses 
2.1.1 Haemopoietic cells 
Cultures of y-irradiated murine bone""illaaTTW cells were grown using 
different mlony-stim.tlating factors (CSF) to analyse in detail the 
radiosensitivity of the mlony-fo.tming cells (CFC) in the haemopoietic 
hierarchy (Baird 1988). With unfractionated bone-marrow the Do values 
ranged fran 1.3 Gy (Gt-cSF) to 1.0 Gy (M-cSF), all with n = 1. However, 
'Nhen IL-3 was used the Do was 1.2 Gy and the survival curve had a 
shoulder (n = 1.9). A canbination of IL-3 with IL-l resulted in a Do of 
1. 2 Gy with n = 1, hence the IL-l may S01ehcM reduce the repair capacity 
of the CFC responsive to IL-3. When the cells were m-treated with 
M-CSF and IL-l the Do was again 1.2 Gy with n = 1, indicating that the 
population stinnUated may be the same population recruited by IL-3 with 
IL-l. '!he canbination of IL-3 with M-cSF and with IL-l produced a 
biphasic survival curve with a Do of 1. 7 Gy for the resistant population 
(60%), suggesting that these CSF-s may have stim.tlated a sub-population 
of resistant progenitors. These data indicate that the use of different 
CSF-s can influence the shape of the survival curve for Gt-cFC and that 
the progenitor cells beccme increasingly nore radiosensitive as they 
progress through developrent. 
With semi-purified populations of primitive (FACS-.BM) or bipotential CFC 
(CCE-BM), Do values were generally larer with respect to the equivalent 
values for unpurified bone marrow (range 62 ± 7 cGy to 135 ± cGy) • This 
suggested that factors produced by stim.tlated accessory cells may 
influence the subpopulation selection and hence the neasured 
radiosensitivity of the CFC. 
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Cultures of y-irradiated canine bone marrow cells were grown for 10 days 
using different colony-stimulating factors (CSF) at optimal 
concentrations. These included 10% serum (OS) fran dogs irradiated 9 
days previously with 3.9 Gy (kindly provided by Dr W. Nothdurft, Ulm 
University) together \·lith 106 white blood cells (WBC) per ml, 15% 
PHA-conditioned medium (CM) , 20% 5637-cM, 3000 U/ml human rGM-cSF, and 
5000 U/ml human rG-CSF. Sensitivity parameters are shown in Table 1. 
There was no significant shoulder on the survival curve using DS + WBC or 
5637-<J.1, but there was with PHA-CM, measured as the mean of values in 
several experbrents. The curves detennined using rGM-cSF and rG-CSF 
showed significant shoulders but the latter was assessed in only one 
experbrent. Average values of colony-fonning efficiency (CFE) were 
similar when using different factors, and Do values were about 50 cGy (up 
to 70 cGy) or less. There was no clear relationship between CFE and Do 
over an extrene range of about 7 in values of CFE. Cluster (2 to 49 
cells) : colony (~ 50 cells) ratios increased fran about 1 in controls to 
about 5 after 1 GJ. These studies confirm other data in the literature 
using irradiated dog serum as a source of stimulator which show that 
progenitor cells in the dog are 100re radiosensitive than in mouse or in 
man (see below). 
Table 1. Radiosensitivity of haeiOOpoietic progenitor cells 
CSF CFE% Do± sern (cGy) n 
~ DS+~ 0.05 50 ± 5 1.9± 0.4a (71 ± 7 1.0) 
PHA-CM 0.08 41 ± 4 2.0 ± 0.3 
(64 ± 3 1.0) 
5637-cM 0.06 40 ± 5 1.5± 0.3a 
(50 ± 2 1.0) 
rhGM 0.05 33 ± 6 2.2 ± 0.7 
rhcf 
(52 ± 4 1.0) 
0.06 21 ± 5 6.2 ± 3.8 
(52 ± 11 1.0) 
IV! .an h5637-CM 0.09 138 ± 12 1.0± 0.1a 
(130 ± 4 1.0) 
rhiL-3 0.14 124 ± 16 1.0 ± 0.1a 
rhG>f 
(122 ± 6 1.0) 
0.14 115 ± 15 1.4± 0.2a 
rhcf 
(138 ± 7 1.0) 
0.08 100 ± 21 1.0± 0.3a 
(100 ± 8 1.0) 
~ = not significantly different fran 1.0 
= 1 experiment only 
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Human haerropoietic a:ns were obtained fran rib samples or aspirates 
(Baird et al 1989) • Optimal concentrations of the human CSF were lower 
for human CFC than for dog CFC, being 1000 U/ml rhG1-csF or G<SF, 500 
ng/ml rhiL-3, and 10% h5637-cM. The colonies were COWlted between days 
9 and 12 of growth. All the survival curves were exponential, and there 
was no significant correlations between radiosensitivity and 
colony-fanning efficiency (CFE) arrong dif£erent experiments. Mean 
values of the survival parameters anong several exper:irnents are quoted 
in Table 1, although there was a significant difference between 
experiments in the case of IL-3 and G-CSF. The use of rhG-CSF gave the 
lowest Do value of 100 cGy. 
A CC~~pa.rison of these data for dog and man with those for ITPUse shCMS 
the following features: 
(a) The human CSF had a higher activity on human than on dog CFC, 
(b) A higher degree of biological variation was evident in human 
samples than in ItDuse or dog samples, 
(c) Different proportions of CFC are stimulated by the same CSF in 
different species, and sare take , longer to produce colonies, 
(d) The CFC stimulated in dog bone marrow are ItDre radiosensitive 
CCIIpaied to human and ItDuse, and the latter show sare similarities 
in radiosensitivity, 
(e) G<SF recruits the ItDst radiosensitive subpopulation in all 3 
species, and in general radiosensitivity increases with 
differentiation status. 
(f) Aroong the different experiments with a given CSF, the 
radiosensitivity was not related to the CFE, 
(g) The increase in cluster:colony ratio with increasing dose was ItDre 
marked in the case of the dog than the ItDuse, and this may reflect 
or be the cause of the higher apparent sensitivity of haenopoietic 
cells in the dog. 
The analysis of 68 published sets of dose-incidence data (Hendry and 
Roberts, 1989) for marrow failure in different species, using a 
double-log ItDrtality function, has indicated: 
1) There is ItDre heterogeneity, i.e. greater sums-of-squares per 
degree of freedan, within the data sets for llDUse than for larger 
species (ItDnkey, dog, sheep, goat, pig). 
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2) For mice the curves for acute doses are characterized by a D
0 
of 
qbout lOO cGy for tissue-rescuing units (or target cells), which 
-4 
are depleted at most to about 3 x 10 at 1050 . 
3) Larger species are I!Blch less tolerant to target-cell depletion, the 
. -2 -3 
corresponding level being consistently in the range of 10 - 10 
at uo50• Also, the D0 is often lower (-v55cGy), which is canpatible 
in the dog with such a value for hemopoietic progenitor cells. 
4) With larger species there is an unexpected reduction in 
heterogeneity when the dose rate is lower, which gives a D
0 
lower 
than expected and a higher extrapolate. 
It is concluded that the position and slope of the dose-incidence curves 
are compatible with interpretations based primarily on target-cell 
number and survival characteristics, modified by additional 
heterogeneity factors. 
2.1.2 Stromal cells 
Mice were irradiated to the whole-body with cobalt-60 gamna-rays at a 
dose-rate of 0. 7 Gy per day for 30 days (Wang et al, 1987). The number 
of fibroblastic colony fanning units (CFU-F) was assessed in ferroral 
marrow taken fran mice killed at various days during and after 
irradiation. Colonies canprising mainly fibroblasts but also 
endothelial cells and macrophages were grown in agar and counted at day 
7 of growth. The number of CFU-F declined at a rate which was nearly 
exponential, and there was little evidence for a threshold. The decline 
was characterised by a Do value of about 2.5 Gy down to a surviving 
fraction of 0.1 (total dose about 7 Gy). After higher doses the 
resolution of the assay decreased, but the exponential decline appeared 
to continue with a somewhat lesser slope. After an accumulated dose of 
9 Gy, recovery was seen after a lag period of about 10 days. The 
recover./ reached a plateau at about 40% of control by 25 days, and this 
was followed by a further recovery phase between 2 and 5 months taking 
the CFU-F content back to near normal. After 20 Gy, the lag period 
before recovery was less, and the plateau was reached early at about 18 
days. The later period of recovery was absent. The rate of decline in 
CFU-F content during irradiation was similar to that found previously 
using higher dose-rates of 0.045 or 0.014 Gy per minute, and this 
suggests that the limiting initial slope of the survival curve was 
reached using all these dose-rates. Also, the sensitivity was less than 
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that found for haenopoietic stan cells (CFU-S) by a factor of about 2.5. 
The near-plateau in CFU-S at about 1 % of control during extended 
continuous irradiation was not seen clearly for the CFU-F, suggesting 
that there was no increased cycling and proliferation of CFU-F during 
irradiation. RecoveJ:y of the CFU-F population after 9 Gy accumulated 
doses was slower than for CFU-S, but after 20 Gy the levels of CFU-F and 
CFU-S were within a factor of 2 during the recovery period. 
The kidney implant was made fran the whole ferroral marrow plug taken 
fran control or irradiated mice and transplanted into untreated 
recipient mice either immediately or at 8 to 22 weeks after irradiation 
of the donor. The CFU-S content of the ossicles declined approx:imately 
exponentially with increasing dose at 4.2 Gy/rninute, and the D value 
0 
was about 1.5 Gy (M:>lineux et al, 1987) • This was similar to that found 
for CFU-F in the irradiated ferrora. There was a sparing effect of the 
low dose-rate of 0.016 Gy per minute, particularly after high doses. 
After 10 Gy delivered at high dose-rate, no ossicles fonned, in contrast 
to after the low dose-rate where ossicles were fonned containing 10% of 
the number of CFU-S in control ossicles. 
The similarity of the sensitivity of CFU-F and the cells fonning the 
ossicle is expected if the CFU-F are the primary progenitor cells of the 
ossicle, possibly requiring secondary associated (radioresistant) cell 
populations for develoJ;m.!Dt. Other studies have suggested that the 
CFU-F fonn an important part of the haeroopoietic microenvironment, 
recently for example by the similarities between cells in colonies 
derived fran CFU-F and in the stranal canponent of long-tenn cultures. 
Also of note is the marked sparing of low dose-rate irradiation. en 
average over the dose range used of 0-10 Gy the sparing was similar in 
magnitude for CFU-F and for the ossicle-fonning cells, although for the 
latter the curve tended to be biphasic with rn::>re sparing than for CFU-F 
after high doses (7 .5 and 10 Gy) than for low doses (2.5 and 5 Gy). 
2. 2 Late responses 
2.2.1 Progenitor cells 
Following irradiation given at 4.2 Gy per minute, recovery of CFU-S in 
the fEmlr had reached 70% by 3 weeks after doses up to 4.5 Gy, and 40% 
after 6.5 Gy (Gallini et al, 1988). These values increased to 100% and 
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70% by 3 m:mths. G'l-cFC showed less recovery at 3 weeks, but showed an 
overshoot at 3 m::mths. Thereafter, both CFU-S and G'l-cFC numbers 
declined to reach 30-50% of control at 9 months after 6.5 Gy, with 
higher levels after lower doses. The numbers of CFU-F recovered much 
more slowly, and at 6 months after 6.5 Gy they had reached only 20% of 
control (again with higher levels after lower doses). 
After irradiation at 0.0005 Gy/minute, there was little change in the 
CFU-S content of the femur between 3 weeks and 9 months, when recovery 
had reached about 70% after all doses between 1.5 and 12.5 Gy. GM-cFC 
were also at about 70% of control at 9 months. The long-term levels of 
CFU-F were higher at all times of assay from 3 weeks after high doses 
given using the low instead of the high dose-rate, reaching 40-70% of 
control at 9 months after doses from 1.5-12.5 Gy. 
long-term recovery of CFU-S and GM-cFC in the femora of irradiated mice 
was incomplete up to 9 months after doses up to 6.5 Gy given at either 
high or low dose-rate. After 6. 5 Gy at high dose-rates, the levels of 
CFU-F at 6 months were lower than those for the haemopoietic 
progenitors, but this difference was less marked when low dose-rate was 
used. This indicates that the greater recovered levels of CFU-F 
following low dose-rate irradiation did not help restore the full 
complerrent of haemopoietic progenitors. Either there is no apparent 
need for full regeneration - increased cycling and/or amplification 
coping adequately - or the micro-environment is more suboptimal in the 
long-term than indicated solely by CFU-F numbers. 
The correlation between the acute response of CFU-F and the 
ossicle-forming cells was not borne out by the subsequent recovery in 
the irradiated donor mouse. When a delay of 8 or 22 weeks was 
introduced between the irradiation and the removal of the marrow plug 
for irrplantation, there was recovery by a maximum factor of 2-3 in terms 
of numbers of CFU-S in the ossicles, after both dose-rates and at both 
times of assay (Holineux et al, 1988). The recovery was much greater 
for numbers of CFU-F in the femur, being a factor of 10-20 after 
7.5-lOGy. This suggests that CFU-F may be only one ccmponent of the 
stromal elements required for ossicle formation, with other components 
developing injury slowly and requiring longer times for recovery. 
- 1229 -
Groups of mice were given 15 · fractions (5 per week) whole-body garmia-
irradiation (0.064 Gy per minute) using equal doses per fraction, and 
the dose per fraction ranged fran 0. 7 down to 0.1 Gy per fraction. 
other groups received one course of 15 fractions, followed after a 
recovery interval of 3 weeks, by a second course of 15 fractions 
(Gallini et al, 1989). At day 3 after the last of 15 fractions, there 
was a dose-dependent reduction in the number of CFU-S per fanur, 
characterised by a Do value of about 3 Gy. 'Ihere was marked' recovery by 
3 weeks to about 50% of the age-matched controls, with little dose-
dependence being deoonstrated. ~e was little further 'recovery, and 
by 9-12 mnths numbers of cru-s were' still subnonnal (60-80%) even after 
the smallest total doses used of 1. 5 Gy. 
GM-CFC were less affected than CFU-S at day 3 after the last dose. 
Recovery :improved to 6 mnths and then later declined, and by 12 mnths 
the levels of CFU-S and Gi-CFC were similar. Values of CFU-S per colony 
were reduced at 3 days and at 3 weeks after the last dose. Later there 
was recovery but by 6-12 mnths after the highest· total dose· of 10.5 Gy 
the values were about half nonnal. CFU-F were less affected 'than the 
CFU-S and G1-CFC at day 3 after the last dose, · arid there was good 
recovery in the longtemt after the lower doSes. The data for 
CFU-S/ossicle were mre scattered, but overall they showed a similar 
pattern to that seen for CFU-F. In the long-texm the levels· of CFU-S 
after the higher accumulated doses were slightly lower suggesting 
greater injury by higher accumulated doses. Stem-cell quality, assessed 
by CFU-S per colony, showed a consistent reduction after the highest 
accunulated dose of 21 Gy delivered in 30 fractions. 
The rate of cycling of stem cells (CFU-S) and gramilocyte-macrophage 
colony-fonning cells (GM-CFC) was measured in the fem:>ral marrow of mice 
at various ti.nes after whole-J:xxiy irradiation with 1.5-10 ·Gy or 4 doses 
of 4.5 Gy (each separated by 3 weeks) (Tejero et al, 1988). A 
dose-dependent increase in the cycling rate of both CFU-S and Gi-cFC was 
observed which was similar at all times of assay between 3 weeks and 36 
months. This invariance with ti.ne was in contrast to in oontrOls·, where 
for Gi-CFC the cycling rate declined unexpectedly with increasing age of 
the mice. This latter obserVation is of in'p:>rtance in the use of 
cycle-specific cytotoxic drugs where less effect on this in'p:>rtant cell 
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po:pulation may be found in older animals, and possibly in man. The 
cycling of CFU-S and GH::F'C was also increased at 6-10 rronths after 4 
doses of 4.5 Gy, and the femoral content of these precursor cells was 
reduced rrore than after single doses. In addition, when assessing 
separately the central core of marrow and the peripheral cylinder inside 
the bone shaft, it was found that the concentration of CFU-S was similar 
in both regions. This is in contrast with the higher concentration 
found in marginal than in axial marrow in controls. Assessment of the 
level and production of a stimulator of CFU-S cycling showed that the 
level was elevated in both axial and marginal marrow fractions, but the 
rate of production of stimulator was much reduced. 
The acute recovery of populations of day 11 CFU-S, iv-cFC and CFU-F in 
rrouse bone marrow, following a test dose of X-rays, cyclophosphamide 
(CP) or busulphan given to mice previously treated with repeated priming 
doses, was in general predictable fran the arrount of residual injury 
after the priming doses. A marked exception was iv-c:FC after X-rays, 
which although amplified to near normal levels during the residual 
injury phase, recovered after the test irradiation fran low levels of 
CFU-S. The arrount of residual injury after sequential treatments of 
different agents was in general less than expected on the basis of the 
product of the effects of the individual agents. This was rrost marked 
for CP priming treatments, where the long-teilll recovery of day 11 CFU-S 
after the test dose remained persistently above control levels. Also, 
sare correlation was found between :i.nproved stranal recovery (CFU-F) and 
the CFU-S cont:P..nt following the sequential treatment protocols. 
2. 2 . 2 I.ong-teilll cultures 
Injury inflicted upon the marrow strana following whole-body irradiation 
and its repair over a one year period has been assessed in primary 
long-teilll bone marrow cultures established at increasing time intervals 
post irradiation (Bierkens et al, 1989). Different doses (4.5, 10, 
4x4.5 Gy) at different dose-rates (1.6 cGy/min and 0.05 cGy/min) were 
chosen so as to maximise the sparing effect in the strana. The stranal 
cellularity in long-term cultures established shortly after irradiation 
was reduced by 40 to 90% depending on the applied dose and dose-rate. 
As a consequence of the poor repopulation ability of the strana the 
etmtulative CFU-S and Gvl-cFC production dropped sharply by 70 to 100% of 
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the levels in control cultures. The sparing which occurred in the 
stroma at low dose-rate was reflected at the hemopoietic precursor cell 
level as a higher incidence of CFU-S and GM-cFC progenitors. A slow 
recovery of the strana to generate an adherent layer was paralleled by 
increasing ntmlbers of CFU-S and GM-c:FC. Whereas the stranal 
regeneration was near CX'.Ilplete 1 year after irradiation, the CFU-S and 
GM-c:FC levels reached only between 50 and 80% of the levels in control 
cultures. CUltures established fran 4x4.5 Gy mice perfonned poorly over 
the entire 1 year period. SUlphated GAGs which have been implicated in 
the establishment of the functional integrity of the stroma, did not 
constitute an aspect of the radiation damage to the marrow stroma at any 
tine after irradiation. 
A parallel set of experim:mts was perfonned to assess the ability of 
stromal layers established fran irradiated mice over a one year period 
(as above) to 'hcme' a fresh innoculum of haemopoietic cells. The 
resunption of ability of the stroma to induce active haemopoiesis was 
shown to be dependent on its ability to generate a fully established 
layer. As for primary cultures, one year after irradiation the stromal 
layers had regained their ability to support prolonged proliferation and 
differentiation of a fresh marrow innoculum. Both these results suggest 
that the proliferative regeneration of the stroma is paralleled by the 
resunption of its ability to support active henopoiesis. No evidence 
was provided for persistent defects in the functioning of the stroma 
following doses up to 10 Gy to the whole body at low dose-rate. In 
contrast, non-adherent cells produced in primary cultures established at 
increasing intervals after irradiation perfonned poorly when 
reinoculated on 'nonnal' stromal layers. Their ability to repopulate a 
stranal. environrrent was dependent on both the dose and the dose-rate 
initially delivered to the donor mice. 
3. crncr.usrrns 
These studies have greatly extended our knowledge of the radiation 
response of the haemopoietic system in different species, in particular 
concerning long-term responses and the effects of changing dose-rate or 
fractionation patterns. A correlation is drawn between haemopoietic and 
stranal recovery, the latter being responsible for slow but extensive 
haemopoietic recovery after very low dose-rate irradiation. 
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I. Objectives of the project: 
The accidental exposure of the skin to ionising radiation can result in 
the development of a spectrum of early and late non stochastic changes. At 
present, there is confusion and a lack of understanding of the pathogenesis 
of these various effects and although a complex nomenclature has evolved to 
describe them, in some instances this has proved to be erroneous and/or 
misleading. A clear understanding of the effects of radiation on the skin 
and knowledge of the underlying pathogenesis of lesions, with the 
identification of target cells, is essential if accidental overexposures 
are to be treated successfully or effects due to occupational exposure are 
to be avoided by the setting of realistic dose-limits. 
11. Objectives for the reporting period: 
The pathogenesis of early and late radiation-induced changes to thE! 
skin have been evaluated extensively in the pig, since the skin of this 
species ls both grossly and hlstologically similar to that of man. Early 
effects have been examined after irradiation with X-rays and 13-rays from 
sources emitting a range of 13 -energies. The effects of chang.!.ng source 
size has also been evaluated. Late radiation effects, represented largely 
by tissue atrophy, have been examined for per.!.ods up to two years after 
irradiation. 
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Ill. Progress achieved: 
The results of extensive studies carried out. on pig skin, over the 
period covered by t.he present. research contract, have indicated t.hat. t.he 
t.ype of radiation responses observed depend bot.h on the area of skin 
exposed and on t.he energy of t.he radiation. Exposures result.lng from 
contact. with discreet. radioactive part.lcles ( 1 hot.' particles) or 
radioactive source of low energy, which are poorly penet.rat.ed int.o tissue, 
produce effects t.hat. are different. mechanist.ically from those seen after 
more generalised exposure. This has not. been recognised until recently and 
t.he usage of t.he same terminology t.o describe both sets of lesions has, in 
t.he past., caused considerable confusion. 
EFFECTS OF GENERALISED EXPOSURE 
Following more generalised exposure of t.he skin t.o ionising radiation 
several distinct. phases of response have been ldent.lfled and t.he possible 
underlying pat.hogenesls lnvest.igat.ed. These phases of response include:-
a) a very early t.ranslent. erythema 
b) the maln eryt.hemat.ous reaction, reflecting indirectly a varylng 
severlt.y of loss of basal cells; eit.her a dry or a moist. 
desquamatory response may be seen after 3-6 weeks, depending on the 
exposure dose 
c) a lat.e phase of erythema associated wlth dermal lschaemla and t.he 
possible development. of necrosis after 8-16 weeks 
d) t.he appearance of late skin atrophy after >26 weeks. 
a) Early transient. erythema 
This was seen wit.hin a few hours of lrradlat.ion wlt.h doses ~15Gy. It. 
subsided after 24-48 hours. The underlying mechanisms responsible for this 
effect have not. been investigated. 
b) The main erythematous reaction 
The results of investigations indlcat.e t.hat the target. cell population, 
damage to which cause t.his response, ls the basal cell populat.lon of the 
epidermis. The reddenlng of t.he skin ls thought. to represent. a secondary 
inflammatory reaction. Wlt.hln a few days of irradlat.ion with X-rays a 
marked fall was found ln the 3H-t.hymidlne labelllng lndex of basal cells 
(Fig. 1). The mit.otlc index was also decreased and the number of 
degenerating cells slightly Increased after single doses of 15 and 20Gy. 
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However, the process of cell death at mitosis may not. be the major 
contributory factor, for if basal cells that are not. reproduct.lvely vlable 
simply dlfferentlate and migrate ln the usual way this would, even in the 
absence of any cell divlslon, lead t.o the denudation the epidermis within a 
t.lme scale approximately equivalent. t.o that. of lts normal turnover. The 
loss of cells from the basal layer was found to occur at. a rate of 
~2.6~/day after single dose of 15 or 20Gy of X-rays (Flg. 2), Thls was 
close to the natural turnover rate ln the epidermis. This rate of cell 
loss was Independent of the radiation dose and would suggest, after hlgher 
doses, that. total denudation of the epldermls would occur after a latent 
interval of 30-35 days. The t.lme of appearance of spotting moist. 
desquamation was 33.2 ± 1.1 days after single doses of >25Gy~ 
The repopulation of the basal layer of the epidermis aft.er'irradlat.lon, 
with doses just. above or just. below the threshold for moist. desquamation, 
is predominantly due to the proliferation of surviving clonogenlc cells 
' from within the irradiated area, however, wlth increasingly smaller areas 
of skln the mlgratlon of cells from the field edge may make a larger 
cont.rlbut.ion. Such clusters ·.of viable cells (colonles) are flrst. seen just 
prior to the appearance of the peak skin reaction and can be identified as 
groups of cells with a near normal denslt.y (Fig. 2) and with a 3H-t.hymldine 
labelling index as high as 40-50~ (Flg. 1). A hlgh proportion of these 
groups of labelied cells were associated with the canal of hair follicles. 
Flgure 1: 
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Tome after lrrodlatoonldaysl 
Time-course of the changes in. the 3a-thymldlne labelling 
index (±SE) of basal cells ln the epidermis of Large White 
pigs ·after. irradiation with single doses of 15Gy ( "') · and 
20Gy (•) of X-rays, The open symbols indiated the labelling 
lndex ln the cell colonles and the hatched area the value 
(±SE) in unirradlat.ed skin. 
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Figure 2: 
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Time-course of the changes ln the density of the basal cells 
(±SE) in the epidermis of Large WhHe pigs after irradiation 
with single doses of 15Gy ( •) and 20Gy ( •) of X-rays. The 
open symbols represent the values for the regenerating cell 
colonies and the hatched area the density of cells (±SE) in 
unirradiated skin. 
Th.!.s ftnding has lmportant lmpllcaUons for non-uniform exposure, since 
irradiation with intermediate energy s-emitters will leave a high 
proportion of reproduct.:.vely viable eplthellal cells wUhln the canal of 
hair follicles, even after relatively high skin surface doses. 
The maln erythematous reaction and the associated epithelial response 
in areas exposed to ~rays for strontium-90 (Emax 2.2MeV) and thulium-170 
(Emax 0.97MeV) are compared in Fig. 3. The responses of two representative 
areas are compared, irradiation was with sources of comparable s.!.ze and 
with skin surface doses at the ~ED 100 for moist desquamation, i.e. 40Gy and 
130Gy for strontium-90 and thulium-170 1 respectively. In each instance the· 
maximum level of erythema was seen at 3-6 weeks after irradiation and was 
classified as moderate to bright red (score B-C). Moist desquamation 
(score S or T) developed after 4-6 weeks, this was transient and a dry, 
scaly, desquamation was reported after 5-6 weeks (score R). Moist 
desquamation was more prolonged after strontium-90 irradiation despite the 
fact that these sites received a lower skin surface dose. The more rapid 
resolution of moist desquamation after thullum-170 irradiation, and the 
higher skin surface doses required to produce the same effect as for 
strontium-90, can be explained by the presence of a large number of 
surviving epithelial cells within the canal of hair follicles. 
At doses above the En 100 for moLst desquamation the basal layer of the 
epidermis was frequently found to be completely denuded of clonogenic 
cells; secondary ulceration, involving the loss of dermal tissue, tended to 
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Figure 3: Time-course of changes in the severity of erythema and an 
indication of the presence or absence of desquamation and 
dermal necrosis after the irradiation of pig skin with 
surface doses representing the ED 0 for moist. desquamation from st.ront.ium-90 (a) or t.hulium-17% (b) i.e. 40Gy and 130Gy, 
respectively. Responses for individual fields from two pigs 
are illustrated which were assessed at. weekly intervals 
(Erythema: A - minimal; B - moderate; C - bright. red; 
D - dusky; E - mauve. Desquamation: R - dry; S - <! and 
T - >! the irradiated area showing moist. desquamation. 
Necrosis: U- <! and W- >! the irradiated field). 
develop in such situations as a consequence of both infection and trauma. 
Healing was by invasive fibrosis leadlng t.o scar tissue formation. 
c) Late erythema 
The late phase of erythema varies in its severity but. at its maximum is 
characterised by skin with a dusky or mauve appearance. The incidence of 
these changes increases with dose after a threshold dose of -15.4Gy of 
X-rays. The react.lon is associated with the presence of oedema and studies 
of lymphatic clearance, after a single X-ray dose of 18Gy, have provided 
evidence for impaired lymph flow at. 9 and 12 weeks after irradiation. 
Necrosis was found t.o develop in -50% of sites after a dose of 20.70Gy, a 
dose at. which all fields showed the distinct. dusky/mauve erythema which is 
taken t.o be representative of vascular insufficiency. A comparison of the 
severity of this late phase of erythema (Fig. 3) and the assoclat.ed depth 
dose curves for the two S-emit.t.ers st.ront.lum-90 and t.hullum-170 have 
ldent.lfied the vessels of the deep dermal plexus as an important. target. 
cell population. This suggestion is supported by the histological 
appearance of the vessels in this region; occlused or partly occluded 
art.erioles were a frequent. finding. 
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d) Late skin atrophy 
After irradiation with single doses from a 22.5mm diameter strontium-90 
plaque dermal atrophy in pig skin has been shown to develop in two distinct 
phases (Fig. 4). The first phase developed between 14-20 weeks and the 
later phase >52 weeks after irradiation. 
The mechanisms leading to these two phases of tnjury are still 
uncertain. n is probable that the pathogenesis of the first phase is 
similar to that proposed for the development of dermal necrosis over a 
similar time scale after higher doses. An alternative suggestion, that it 
might represent the loss of parenchyma! flbroblasts, would not appear to be 
the case since any loss of fibroblasts follows the vascular changes. This 
suggests that flbroblasts are not a primary target cell population. The 
pathogenesls of the second phase of dermal thinning is even more obscure. 
However, degeneration of the smooth muscle cells of the tunica med ~a of 
small arterioles and their replacement by hyaline material is seen, along 
wlth the presence of dilated telangiectatic capillaries, petechial 
haemorrhages and foci of necrosis. 
Figure 4: 
j '"' 
i~~~~ 
, ..~ ""h "" 
r: ·-~-[~~ 
Tme otter Irrodobon(weeksJ 
Time-related changes in the relative thickness (±sE) of the 
dermis of pig skin after irradiation with single doses of 10, 
21, 27 and 33Gy from a 22.5mm diameter strontium-90 plaque. 
EFFECTS OF HIGHLY NON-UNIFORM LOCALISED EXPOSURE 
Localised non-uniform exposure of the skin may result from contact with 
highly radioactive particles, 'hot' particles, with a diameter of ~2mm or 
from irradiation with very low energy s-emitters. 
a) 'Hot• particle irradiation 
The primary lesion resulting from irradiation with 'hot particles' of 
strontium-90 or thulium-170 is acute ulceration. The depth and size of the 
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ulcer wlll depend on the dose and the energy of the emissions from the 
particle. The full lesion develops within two weeks, well in advance of 
the time scale associated with the development. of moist. desquamation. This 
lesion was not. found to be associated with 'hot.' particle irradiation 
because the cell depletion caused by a loss of the reproductive capacity of 
basal cells was replaced rapidly by the migration of viable cells from 
outside the high-dose area. Prior to the development. of ulcers, after 
doses of >100Gy (the dose averaged over 1.1mm2), a small pale circular area 
wlt.h a slight. bluish tinge can be detected; this is frequently surrounded 
by a halo of erythema. Within a few days of irradiation hist.ologlcal 
st.udles have shown pyknosis of the nuclei of endothellal cells and 
flbroblast.s in the papillary dermls and by 5-7 days after irradiation the 
pa,plllary dermis . is largely devoid of cell nuclei beneath the source 
although a paley s~ainlng epidermis remains intact.. Ulceration is evident. 
when the overlying epidermis separates from the necrotic dermis and is 
lost.. Doses that. are usually associated with producing the death of cells 
in 1nt.erphase will produce acute ulceration. Shallow ulcers may be covered 
by a dry serum exudate, but. this should not. be confused with dry 
desquamation which, anyway, occurs over a longer time scale. 
lesions leave a scar with the appearance of a smail dimple. 
b) Low energy 8-lrradiat.ion 
Healed 
These investigations have been carried out. using promet.hium-147 
(Emax 0.22MeV) the depth dose profile of which is such that. there is an 
-so~ reduction ln dose across the layers of the epidermis. Histological 
studies carried out. after promet.hium-147 irradiated have shown that. for 
very hlgh skin surface doses (>200Gy) the earliest detectable lesion is 
pyknosis of the cells of the upper viable layers of the epidermis after 
3 days. Cell death wit.hln these layers initiates an inflammatory reaction 
with the subsequent. total disruption of tbe . epidermis after 7-10 days. 
This has the gross appearance of moist. or dry desquamation (i.e. a dried 
serum exudate) which fully heals within 3-7 days, i.e. within -20 days of 
irradiation. Thls is well before the normal t.lme of appearance of 
classical moist. desquamation which has a totally different underlying 
pathogenesls. 
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These investigations provide, for t.he first. time, a detailed 
understanding of t.he types of reactions that. may be encountered in t.he skln 
after exposures that. are of relevance t.o radiation protection. This is of 
considerable benefit. t.o this area of t.he European Communities Radiat.lon 
Protection Programme, providing a better sclent.ific basis for future 
investigations related t.o radiological protection and skin exposure. 
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I. Objectives of the project: 
Dr. M. Rezvani 
Dr. V. Sieber 
Considerable concern has been expressed as to the adequacy of the 
existing radlolog.!.cal protectlon guidelines as they apply to the exposure 
of the skin. Occupational exposures involving the skin are frequently 
non-uniform and can Involve the Irradiation of either a significant area of 
skin or a very small region, as .!.n the case of contact with a h.!.ghly 
radioactive particle ('hot particle'). To improve the existing 
radiological protection guidelines information is needed on the 
dose-related changes ln both the early and late effects of radiation from 
sources of differing slze, energy of em.!.ssion, and dose-rate. 
11. Objectives for the reporting period: 
Studies have been carried out on the skin of pigs to determine the 
dose-related changes ~n the acute response from three f3 -emitterS, 
strontlum-90 (hlgh energy), thulium-170 (Intermediate energy) and 
promethlum-147 (low energy). Irradiation has been wlth sources which 
varied .!.n size from 0.1-40mm in diameter. Exposures from these sources 
were considered to be acute exposures, in that they had a maximum duration 
of ~2 hours. For a 22.5mm diameter source of stronttum-90 the effects of 
radiation dose-rate have been examined. 
The effects of the area of tlssue irradiated on the severity of late 
dermal atrophy has also studied at 2 years after irradiation from 
strontium-90 and thulium-170 sources. 
- 1247 -
Ill. Progress achieved: 
In an extensive series of studies, dose-effect relationships have been 
established for the endpoints of early molst desquamation and late dermal 
atrophy after the lrradiatlon of areas of skin of ?;19.5mm2 and for acute 
ulceration and late dermal atrophy after 'hot particle' exposure. A 'hot 
partlcle' refers to a source of ~2mm diameter. For irradiations involving 
the very low energy f3-emltter, promethium-147, the dose-related incidence 
of acute epidermal necrosis was investigated for sources of differing size. 
a) Moist desquamation 
The dose-related changes in the incidence of moist desquamation, which 
develops after 4-6 weeks, were determined after the irradiation of pig skin 
with strontium-90 sources of 5·40mm in diameter. After an Initial 
threshold dose the proportion of fields irradiated that developed moist 
desquamation increased wlth dose (Fig. 1). The ED50 values (±SE) for moist 
desquamation were derived from these curves and are listed in Table 1. In 
this table are also listed the associated ED 10 ( ±SE) and estimated 
threshold doses obtained following irradiat;l.on with this range of source 
size. The ED50 declined markedly from ~ 70Gy from a 5mm diameter 
strontium-90 source to ~27Gy for a ~22.5mm diameter source. 
Perhaps of significance, from the vlew point of mechanlslDS, is the 
observation that the dose-effect curves for the 5, 11 and 15mm diameter 
sources were significantly shallower than those for the two larger sources. 
This implies a greater inhomogenicity in the cell populations irradl.ated 
with the smaller sources. This may reflect an increase in the stimulus for 
cell migration after higher doses from these sources. This would also 
help to explain the reduction in the source-size effect at the ED 10 and at 
the estimated threshold doses for moist desquamation. 
The irradlatlon of skin wlth a B -emitter of a significantly lower 
energy than strontium-90, thulium-170 (Emax 0.97MeV), would leave many 
reproductively vlable basal cells within the irradiated area 
basal cells situated in .the canal of the hair follicle. 
i.e. those 
In such a 
situation the mlgration of cells from the edges of an irradiated area would 
be expected to be of less importance in determining the response of skin to 
increasing areas to Irradiation. The findlng of a significantly reduced 
source-size effect and higher skin-surface..:.doses for both the ED50 , ED 10 , 
and estimated threshold doses in pig skin after Irradiation with 
thulium-170 sources of 5-19mm diameter (Fig. 2) provides major evidence · 
- 1248 -
for the presence and lmportance of these viable clonogenic cells from 
within the canal of the hair follicles. 
For strontium-90 sources of 22.5mm diameter the ED50 for molst 
desquamation was also found to vary markedly with dose-rate. This ranged 
from 27.3 ± 0.7Gy for doses given from the high dose-rate source to >100Gy 
for doses given at 0.01Gy/min (Table 2). 
Figure 1: 
Figure 2: 
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Dose-related changes ln the percentage of skin sltes 
developing moist desquamation after irradiation from 5-40mm 
diameter strontlum-90 plaques and acute ulceration after 
irradiation from 1 or 2mm diameter 'hot particles•. The data 
are those of Hopewell et al. ( 1986) replotted by probit 
analysis. Error bars indicate ±SE on the ED~q values 
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Dose-related changes in the percentage of skin sites 
developing moist desquamation after irradiation from 5-19mm 
diameter thulium-170 plaques and acute ulceration after 
irradiation from 0.1-2.0mm diameter 'hot particles•. The 
data are those of Hopewell et al. (1986) replotted by problt 
analysis and including a dosimetry correction for the 
0.1-1.0mm diameter sources. Error bars indicate ±SE on the 
ED50 values. ( o - 19mm; o - 9mm; o - 5mm; A - 2mm; •- 1mm; 
•-0.5mm; •-0.1mm). 
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Table 1 Var1at.1on 1n ED50 values (:!SE), ED10 and estimated threshold 
doses for acute breakdown of t.he skln or plgs after 6-irradia tion 
Isotope Sources ED50 ED10 Estimated Type of 
dlamet.er (Gy) (Gy) threshold lesion 
(mm) dose (Gy) 
90Sr/60y 40 28.6 ± 1.4a 20.1 ± 1.4 N17 o5 
22.5 27.3 ± 0.7 21.1 ± 1.2 N17o5 
15 42.3 ± 4.8 21.0 ± 3.4 N17 o5 MD 
11 44.8 ± 4.5 22.0 ± 3.2 N19.0 
5 70.3 ± 5.0 34.4 ± 4.0 N25.0 
2 119.3 ± 9.0 82.0 ± 10.1 ... 50.0 AU 
253.7 ± 31.0 104.2 ± 24.6 N70.0 
170Tm 19 71.9 ± 5.7a 47.5 ± 4.2 N35o0 
9 73.9 ± 2.6 48.8 ± 2.8 N35.0 MD 
5 85.8 ± 4.6 56.7 ± 3.9 N39o0 
2 178.7 ± 14.9 77-5 ± 9.4 N5o .• o 
1 201.9 ± 23.7 87.7 ± 12.6 N65.0 
0.5 338.6 ± 35.6 147.1 ± 19.5 N85.0 AU 
0.1 197.4 ± 24.9 85.7 ± 13.1 N6o.o 
246.0 :t 37.8 106.8 ± 16.4 N70.0 
147Pm 15 512 ± 33b 305 ± 41 N200 
9 572 ± 35 ·366 ± 45 N200 
5 615 ± 33 408 ± 40 N250 AEN 
2 717 ± 39 510 ± 40 N350 
aDose at. a 16~ depth, averaged over 1.1mm 2 
bOose at the skln surface • averaged over 1. 1mm2 
MD - moist desquamation; AU -
1
aout.e ulceration; 
AEN ·- acute epldermal necrosis 
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Table 2. Variation in the ED50 (±SE) for moist desquamation in pig skin 
after irradiation with s-rays from 22.5mm diameter strontium-90 
plaques of differing dose-rate 
Dose Rate ED50 ±SE 
(Gy/min) (Gy) 
3.0 27.3 ± 0.7 
0.102 36.8 ± 3.2 
0.048 42.2 ± 2.0 
0.023 66.6 ± 3.7 
0.01 >100 
b) Highly non-uniform irradiation 
- Irradiation with poorly penetrating B-emitters 
A comparison of the acute radiation responses of the skin to a low 
energy emitter source, such as promethium-147, wlth that of strontium-90 
and thullum-170 ls not mean1ngful because of the different biological 
responses they produce. The dose-effect curves for acute epithelial 
necrosls after promethlum-147 Irradiation are shown in Fig. 3. A small 
source-slze effect was seen. However, this ls of doubtful significance 
given the dlfflcultles associated with the recognition of mlnor skin 
changes in very small areas after irradiation with the smaller sources. 
Figure 3: 
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Dose-related changes in the percentage of skln sites 
developing acute epithelial necrosls (±SE) after irradiation 
from 2-15mm diameter promethium-147 plaques. ( "'- 15mm; 
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- 1251 -
The skin surface doses required to produce any effect after promethium-147 
irradiation i.e. >200Gy would suggest that persons likely to be exposed to 
low energy 6-rays of -o.225MeV may warrant special consideration when 
setting dose limits. 
- Irradiation with 'hot' particles 
The dose-response curves showing the proportion of areas of skin that 
were exposed to 6-irradiation from 'hot• particles of either strontium-90 
or thulium-170 that developed acute ulceration are also illustrated in 
Figs. 1 and 2. The majority of these dose-effects were much shallower than 
those associated with the development of moist desquamation. This 
indlcated that a six-fold increase in dose was associated with the change 
from a 10~ incidence of acute ulceration (ED 10 > to a 90~ incidence. The 
doses quoted for these studles were measured with an extrapolation chamber 
with an equivalent window thickness of 16\lm wlth a collecting electrode 
with an area of 1.1mm2• The ED50 for acute ulceration from 'hot• particles 
of ~mm diameter was -250Gy. Slightly lower ED50 values of -120Gy and 
-180Gy were obtained from 2mm diameter particles of strontium-90 and 
thulium-170, respectively (Table 1). 
c) Late skln damage 
For irradiations wlth ,intermediate and higher energy 6 -emitters late 
skin changes, which include dermal atrophy, may prove to be cosmetically 
the most unacceptable late normal tissue changes that could determine the 
dose-limit for radiological protection. Meas~rements of dermal thickness 
at 2 years after the lrradlatlon of pig skln showed that significant dermal 
thinning was observed at doses that dld not produce an early epithelial 
desquamation or acute ulceration (Figs. 4 and 5). However, threshold doses 
for atrophy of skin have still to be established for a severity of dermal 
thinning that might be considered to be cosmetically unacceptable. 
Extrapolation from data showing the severity of dermal thinning after 
irradiation from strontium-90 and thulium-170 would suggest a threshold-
dose of -10 and -15Gy for the prevention of dermal thinning for thls energy 
of 6 -emU ters for sources of 5-22. 5mm diameter (Figs. 4 and 5) • These 
exposures were given at a high dose-rate. 
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Flgure 4: 
Figure 5: 
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Relative reduct.lon ln dermal thickness ( ±SE) ln plg skin 
104 weeks aft.er lrradlat.lon with st.rontium-90 S -rays from a 
22.5mm (+), 15 (e), 11 (o), 5 (o), 2. (.&) or 1 (V} mm diameter 
source. 
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Relative reduction in dermal thickness ( ±SE) in pig skin 
104 weeks aft.er Irradiation wlt.h t.hulium-170 S-rays from a 
0.1 (•); 0.5 (.&); 1.0 (•) and 2.0mm (D) dlamet.er source. The 
data for 5-19mm diameter source were equally well flt.t.ed by 
the llne fitted through the 2.0mm diameter data points. 
These data provlde, for the first. time, a rat.lonal guide for the 
development. of improved radiological protection criteria for the skln. The 
lnformat.lon has provided a major contribution to both ICRP and NRCP task 
group reports relating to the problems of skin exposure. This prov ldes 
perhaps the best. evldence and of the relevance of the studies to the 
European Communities Radiological Protection Programme. 
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Title of the project no: 
Rapid techniques for graft assessment following bone marrow 
transplaMtion designed for large scale use following accidental 
lethal exposure to radiation. 
Head(s) of project: 
Dr. Peter Humphries 
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I. Objectiues of the project: 
Our objectives have been to develop a most highly sensitive and 
r12pid process for 8nalysis of donor 12nd recipient cells for use in 
the monitoring of bone marrow transplantations. Our process is 
based upon 11 series of high information-content DNA markers 
and the polymerase chain reliction. The process has been 
developed with the objective of 12ssessing conditioning 
therapies (' total body irradi8tion) 8nd the role of mixed 
chimerism in long-term surviv8J, 8nd 8S 8 me11ns of npid 
engrt'lftment monitoring in on envtronment81 crisis situation. 
11. Objectiues for the reporting period: 
As I. above. 
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I I!. Progress Bthieued: 
1. Introduction: 
The occurrence of o mojor nucleor occident ot the nucleor power 
stotion in Chernobyl on 26th April 1986 ottrocted mojor media 
coveroge, particularly concerning the effect of such on occident 
on the heolth of the human population. Discussion of the 
incident olso focussed on the types of therapy ovoilabJe to 
victims of such on occident. Severol orticles hove been written 
on the pros ~tnd cons of using bone morrow tr~tnsplont~ttion (BMT) 
os 11 modolity of therapy for victims exposed to rodi~ttion doses 
such os those experienced ot Chernobyl ( 1,2}. Hemopoietic stem 
cells ore highly sensitive to the cytotoxic effect of ionizing 
rodiotion end et levels of >8Gy, toxicity to these marrow cells 
mey be lethol. At present BMT is e successful treetment for a 
wide range of hoemotologicel mollgnencies, including leukoemie 
ond oplostic oneemie (3), end is e logical treatment for victims 
of occidentel totol bod!t irrediotion who receive e sufficiently 
high dose thet they ore likely to die from marrow failure. While 
there would be problems ossocioted with BMT in the Chernobyl 
situation (other n~diotion injuries, Jack of donors, lack of 
previous experience) it moy still benefit certain subsets of 
occident survivors. However, os in oll BMT situations, it is 
important to be oble to monitor the outcome of o tronsplant. 
This could be of particular importance in o crisis situotion 
where decisions concerning therapy or o second . tronsplont 
open:~tion may hove to be t~tken quickly to ensure survivol of the 
potient. 
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In order to monitor a transphmt successfully, 1t is necessary to 
have 8 m8rker which 8llows discrimination between donor 8nd 
host cells. (1) To 8ssess engntftment or rejection 8nd (2) tts 
en index of mixed chimerism (the coexistence of donor 8nd host 
cells in· e stable chimera following BMT). Classica11y, this has 
been achieved by the use of protein polymorphtsms (red cell 
antigens, isoenzymes, immunoe11otypes) or by karyotyp'tc 
analysis (4-6). Recently the increasing use of DNA technology 
has allowed the sensitive monitoring of engr8ftment post BMT 
(7 ,B). This has been achieved by using DNA probes which detect 
neutr81 variation in the DNA of the donor and the host. This 
V8ri8tion can be of two main types: 
(8) Restriction fragment length polymorphisms (RFlPs). Here 
mutations in DNA create or destroy restriction enzyme 
sites.· 
(b) Minisate11ites t~nd vt~riable number tandem repeats 
(VNTRs). Here the variation is in the length of tandemly 
repeated blocks of DNA. 
Wh11e judicious use of such probes 8Hows vtrtu81Jy 811 
tnmsp18nts to be monitored, the time for 8n8lysis, l8ck: of 
sensitivity at Yery low levels of mixed chimerism end possible 
problems in the routlne analysis in time ltmiling situGtions has 
prompted us to investigate new, more reptd and sensitive assays 
for assessment of chimerism post BMT. 
lnitiaJJy we developed a dot blot 8ssay for assessment of sex 
mismatched tr8nspl8nts (9). ·This 8SS8Y W8S based on the use of 
8 DNA sequence thttt W8S present on the V chromosome ttt 11 copy 
number appro8ching 2000. An assay was devised which 
permitted V specificity to be 8chieved in a dot blot format. The 
highly repetitive n8ture of the probe aJJowed 8 high level of 
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sensitivity to be ftChieved. In the period of the present project 
we have been engaged in the development of rapid engraftment 
essays bcsed on a recently developed technique, the polymerase 
choin reaction (PCR). This technique permits the rapid 
exponentl~t1 ~tccumulation of specific t~trget DNA from a defined 
DNA template by an in vitro amp1ification reaction ( 1 0). We 
hove adopated this technique initially to the analysis of sex 
mismatched transplants ( 11, 12) but more recently the technique 
has been extended to the analysis of n11 transplant situations 
( 13, Lnw1er et al., manuscript in prepnration). 
2. Methodology: 
PCR is achieved by the use of synthetic oligonucleotides to 
prime a region of DNA for subsequent copying by c DNA 
synthesising enzyme called DNA polymerase. These synthetic 
sequences (cal1ed primers or amp1imers) are chosen to 
compliment flanking regions of the target DNA. Under 
appropriate annea 1 i ng conditions these primers bind to 
denatured DNA and act as t1 storting site for DNA polymerose. 
provided the necessory building blocks (nucleoside 
triphosphotes) are present. Repeated cycles of DNA 
denaturation. primer annealing and DNA synthesis (extension) 
ollows for exponent1n1 increase of the target DNA, ns D~A 
synthesised in one cycle of amplificntion nets as o templ.ate for 
the next cycle. 
(o) Sea mismatched analysis~ 
We have odapted this technique to the nmplificntion of Y 
specific sequences. Primers which specify Y specific frt~gments 
ht1ve been synthesised on nn Applied Biosystems DNA synthesiser 
(Model 391 A ·peR MATE.) (See T8ble 1). Bone mnrrow ospirtltes. 
peripheral blood stlmples or stored slide mtlterial is then 
preptlred for an~tlysis as follows. White cells are pelleted, 
resuspended in dH20 tlnd boiled for five minutes to lyse cells and 
relec!;e the DNA. (For stored sHdes. material is scr~tped off 
directly into dH20 for subsequent lysis using 8 sterile sc~tlpel 
blade}. Cell debris is pelleted ~tnd an 81iquot of the supernotant 
{containing the crude extract of DNA) is token for PCR analysts. 
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Following PCR (deta11ed conditions are outlined in 11) the 
amplified material is assayed by electrophoresis through a 21 
agarose geL Fidelity of amplification is confirmed by digestion 
of the amplified fragment with a restriction enzyme and 
subsequent analysis on an ~tgarose gel with known DNA molecular 
weight markers. 
(b) Sea matched transplants: 
Recently it has been discovered that the tandem repetitive block 
(dC-dA)n : {dG-dT)n is a source of natural variation in human DNA 
which can be accessed using PCR ( 14, 15). These blocks are 
called microsatellites and they show variation in the number of 
repeat blocks between individuals. Since there are 50,000 of 
these so-called ·eA repeats· scattered throughout the genome, 
they represent a new source of natural polymorphism in human 
populations. PCR can be used to amplify and type the different 
v8ri8nts (811eles) at vftrious microsatellite loci throughout the 
genome, a11owing markers to be generated which can be used to 
assess all tr~tnsplant situ~ttlons, regardless of sex. Primers are 
synthesised to bind to stngle copy sequences fl~tnktng th~se 
mirosa'tellites. ·peR 'is performed 88 before, except th8t 32P 
labelled dCTP is encorponted into the PCR product. The product 
is then electrophoresed on an 81 polyacryl8mide den8turing gel 
and differences between individua-ls 8f"these polymorphic loci 
are reflected in 8 different mob11ity after electrophoresis. This 
can by visualised by drying down the gel and exposing it ~o 
autoradiography for a short period of time. Several 
microsatellites m~ty be typed simult~tneously aiJowing many 
transplant situations to be assessed rapidly. 
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3. Results and discussion: 
(o) Sea mismatched analysis: 
Using the techniques fiS outllned flboYe. chimerism WfiS t~ssessed 
in fiYe p8tients fo11owing sex matched 8l1ogeneic BMT to assess 
the Yfllidity of the fiSSfly. As we11 t~s using PCR, 611 st~mples 
were olso tested by kt~ryotyping of bone marrow cells find dot 
blot t~nalysis of blood and bone m8rrow. While the results of 
Karyotypic onolysis suggested a complete chimerism in four 
patients and the presence of a mixed chimera in one patient. PCR 
also detected a mixed chimeric state in a second patient which 
has now persisted to Day 925 post tr8nsplant and which is still 
undetected by k8ryotypic ant~lysis. The patient in which mixed 
chimerism W8S detected by PCR 8nd k8ryotyping subsequently 
rel8psed and the incidence of mixed chimerism 8nd its 
subsequent effect (if t~ny) on re18pse or surYiYfll is currently 
being addressed in 6 long term study on 33 petients, sex 
mismatched and sex mGtched (LGwler et ol. mttnuscript in 
prepGration). The sensitiYity of the 8SS6Y of sex mism8tched 
situ8tions W8S such thflt 8 positiYe m81e sign81 could be 
obtGined from 500-5000 mt~le cells by direct gel Gn8lysis and 
this could be reduced to 5-50 cells by the use of 
autoradiogr8phy following primer labelhng or encorporation of 
label into the PCR product. While DNA extraction for Southern 
analysis c~tn be time consuming and laborious we have reported 
ttere a rapid lysis method and direct PCR which allows sttmples 
to be annlysed in < 24 hours. PCR allows rapid enrichment of 
source materi~tl providing adequate ~tmounts of high quollty 
material for analysis. 
(b) Sen matched analysis: 
Recently we have extended this technique to the onalysis of sex 
matched material by amplifying microsatellites 8S described in 
the section on Methodology. We h8ve demonstr8ted the 
usefullness of this technique by showing thot all of 33 donor 
recipient pairs moy be monitored successfully using o penel of 
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oligonucleotides as outlined in Table 1 ( 13). This technique is 
quite easy to perform and does not require purification of high 
quality DNA. This combined with the Jack of need for time 
consuming Southern Dnt:~1ysis ond e6se of reoding 
autoradiographs (which could be 6Utomoted to computer gel 
reading) m6kes us feel that this method is even superior to 
minisate11ite anolysis in the ossessment of chimerism post 
tronsplant. 
The application of the techniques outllned in this report to 
stored slide material meens thet retrospectlve as well as 
prospective studies con be performed. Recently we hove 
estoblished a co11aboretion with the Universtty of Minnesota to 
look at chimerism in a large number of patients ot thftt 
transplant centre. -sotety by the analysts of stored sltde 
materiel. To d8te 20 patients heve been essessed end we ere 
submitting the -data accrued in this study to the Amencen 
Society ·of Haemetology Meeting in Boston in December 1990. 
Also a collaboration will begin in Spring 1990 in a prospective 
study on the assessment of chimerism in severe aplostic 
onaemia. This wi11 be done in collaborotion with the EBMT 
Working Party on Aplastic Anaemio. 
The sensitivity and ropidity of the techniques described obove 
wm ollow mony somples to be analysed simultaneously and with 
great accuracy, parameters Which could be of major significance 
in the management of transplanted victims in a crisis situation 
following an accidental releose of ionizing rodiation into the 
environment. The techniques also allow a thorough investigation 
of the natural progression of a bone marrow transplant and 
allow us to enswer questions concerning the incidence of mixed 
chimerism and its subsequent effect on graft relapse rejection 
or overall engraftment and survival. 
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I. Objectives of the project: 
In vitro culture of embryos represents a simple model system to analyse 
very precisely the modifications of radiosensitivity occurring during the 
preimplantation period. The one-cell embryo has been little studied and 
results obtained so far showed that this stage is particularly 
radiosensitive. However, the techniques utilized for these investigations 
were very different and implied, for example, in vitro or in vivo 
fertilization and irradiation, use of natural or hormone-stimulated 
ovulation. In addition, hybrid or inbred strains of varying 
radiosensitivities were used. Such variations in the experimental 
conditions could explain, at least partially, important discrepancies 
reported between laboratories. In this project, we intended to study the 
influence of these factors, and the mechanisms by which they can modify 
the response of the embryo to X-irradi~tion. 
11. Objectives for the reporting period: 
This report is a summary of the main results obtained during the period 
1985-1989. A!' underlined in the discussion, some studies are st.ill in 
progress. In order to spare space, the methodology has been restricted to 
the strict mininlUIIl necessary to the comprehension of the experiments. 
Detailed data on the techniques used and on the results will be found in 
the publications of which the referE-nces are mentioned at due places. 
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Ill. Progress achieved: 
Methodology 
1. Influence of the strain on the radiosensitivity of the mouse zygote 
studies on the "one-cell block" 
1.1. The "one-cell block", as an unusual radiat)on-induced G2-arrest. 
Time-dependence, dose-dependence, and its specificity (refs. 1-2). 
It is generally believed that embryonic rnort.al ity induced by irradj at ion 
of the preimplantation stages occurs mainly near the timt> of implantation. 
However, results obtained in our lol:K>ratory suggested a high loss before 
the first cleavage, when BALB/c zygotes were irradiated at the pronuclear 
stage. To clarify these observotions, BALB/c females were induced to 
superovulate by i.p. of 5 i.u. PMS and 5 i.u. hCG 48 hours apart. Such 
hormonal treatment induces superovulation about 12 hours after hCG 
injection. Females were caged overnight with males o:t the same strain and 
irradiations with 1 Gy of X-rays were performed each hour during the 12 
hours following fertilization. Females were killed on the following 
morning and the proportion of eggs which had cleaved were noted. 2-cell 
embryos were cultured for 4 clays, at the end of which the proportion of 
those which had reached the blastocyst stage were also noted. Development 
to the 2-cell stage and to the blastocyst stage were combined to colculate 
the LDSO value for the time of maximal radiosensitivity, after application 
of different doses of X-rays. 
Our studies were devoted to the characterizaHon of the block effect found 
in a number of eggs irradiated at the pronuclear st.age. This effect will 
be referred to as the "one-cell block". The eventual existence of the 
"one-cell block" was investigated in four other strains (T-stock, CFl, AKR 
and C57Bl). In addition, investigations on the importance of the maternal 
genotype for t.his effect were performed by irradiation of pregnant females 
from different crosses involving the BALB/c strain (~ BALB/c x tf Fl (~ 
BALB/c J< <! C57Bl) ; ~ Fl x tf BALB/c ; !i' Fl x <! Fl). Tbe fact that the 
"one-cell block" is a particular form of G2-arrest was verified by 
c:etennination of the DNA cont.ent in a number of pronuclei. For this 
purpose, irradiation was performed at 20 hours after hCG (time of maximal 
sensitivity for the "one-cell block") , and BALB/ c eggs were collected and 
fixed between 30 ho\Jrs (i.e. just before the presumed first cl e•ovage) and 
50 hours after hCG, before being analyzed by cytofluorometry. 
1.2. Analysis of polypeptide synthesis and phosphorylation in blocked eggs 
(refs. 3,4,6) 
The "one-cell block" could possibly result from an action of radiatim> on 
some critical protein (s) needed for division. A :o:tudy of polypeptide 
synthesis and phosphorylation during the first 40-45 hours of development 
was therefore undertaken in control and irradiated eggs. Details on the 
techniques used for these studies may be found in refs. 3, 4 and 6. For 
these studies, BALB/ c eggs were either used as controls, or in vivo 
irradiated with 2.5 Gy at 20 hours after hCG (with that dose, all embryos 
are blocked) . In addition, a con•pl ementary study was per forroed on Fl eggs, 
either untreateed or irradiated in vivo with 2.5 Gy (no block effect in 
th"t strain) or 8 Gy (aln•ost all blocked) at 20 hour!> ofter hCG. 
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1. 3. Influence of caffeine on the "one-cell block" (ref. 5 + results to be 
published) 
Since caffeine is known to reverse G2-arrest in many cell types, we also 
tested its action on irradiated, blocked eggs. Those were incubated at 
different times after irradiation of the mothers, in a medium containing 
various concentrations of caffeine. The influence of caffeine on G2-arrest 
and embryonic development was determined. 
The question of the necessity of protein synthesis for the action of 
caffeine was tested by incubating eggs with caffeine and cycloheximide 
according to various schemes. For this purpose, synchronous populations of 
eggs were used (mating possibility reduced to 2 hours) since, even in 
control eggs, protein synthesis is necessary for the progression to 
mitosis until one or two hours before it. 
1.4. Relationship between the "one-cell block" and chromosome damage 
(ref. 5) 
According to .some authors, chromosome damage is, directly or indirectly, 
the cause of G2-arrest. Thus, we studied chromosome damage in zygotes able 
to escape G2-arrest after irradiation at different times of the cell 
cycle, and we compared it with the chromosome damage found in zygotes 
cleaving after G2-arrest or which would be blocked but were forced to 
cleave at the right time by incubation with caffeine. 
1.5. Irradiation and adaptive response in the mouse zygote (to be 
published) 
Human lymphocytes exposed to very low doses of radiation (1 cGy) in Gl, S 
or G2, are less susceptible to the induction of cytogenetic damage by 
subsequent high doses of X-rays. This has been attributed to the induction 
of a repair mechanism that causes the restitution of X-ray induced 
chromosome breaks. The possibility of an adaptive response was also 
investigated in the BALB/c zygote for two important reasons : 
1) if. chromosome damage is partially implied in the radiation-induced 
G2-arrest, improvement of its repair could diminish the proportion of 
blocked zygotes, or the duration of the block ; 
2) Embryos escaping the "one-cell block" undergo at least 4 divisions 
before dying from the morula stage. We and others clearly showed that this 
non-specific preimplantation mortality is the consequence of chromosomal 
injury, leading to an elimination of genetic material during the 
successive divisions. 
If doses as low as 1 cGy or even less can protect the zygote from a 
second, normally lethal dose, and allow its survival although a number of 
radiation events have taken place in the genome of the cell which 
functions as stem cell, the long-term consequences of this may be very 
important and require extensive investigations. 
For these experiments, very synchronous populations of embryos were used. 
Three groups of pregnant females were constituted 1) controls 2) 
females receiving 1 cGy 0.5 hours after fertilization and 1.5 Gy 7.5 hours 
later ; 3) females receiving only 1.5 Gy 8 hours after fertilization. 
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Influence of the treatment on the "one-cell block" and on the development 
of the embryos escaping it were examined. 
1.6. One-cell block and irradiation with low doses (to be published) 
Embryos given low doses of X-rays were collected a few hours before the 
presumed division, and transferred in culture medium. At each control, 
cleaved embryos were separated from the other ones, and their development 
was followed to the blastocyst stage. 
2. Influence of various methodological factors on the radiosensitivity of 
the mouse zygote (ref.B) 
These experiments were undertaken to investigate the influence of some 
methodological factors on the radiosensitivity of the mouse zygote. The 
factors studied were 1) the use of natural or hormone-stimulated ovulation 
(5 i.u. or 1 i.u. gonadotropins), 2) the procedure followed for 
fertilization : mating overnight, or only during a short period in the 
morning after all oocytes have been ovulated, in vitro fertilization, 3) 
the type of irradiation, i.e. in vivo or in vitro irradiation. The 
radiosensitivity of the BALB/c zygote~s estimated under the different 
experimental conditions by measuring their ability to cleave and to 
further develop to the blastocyst stage, after irradiation with different 
doses of X-rays at the pronuclear stage. Development to the 2-cell stage 
and to the blastocyst stage were combined to obtain the surviving 
fractions and these values were used to calculate the LD50 values. These 
were graphically estimated from the best fitting dose-response curves. 
Results 
1. Influence of the strain on the radiosensitivity of the mouse zygote 
studies on the "one-cell block" 
1.1. The "one-cell block", as an unusual radiation-induced G2-arrest. 
Time-dependence, dose-dependence, and its specificity. 
Two types of effect were found in BALB/c embryos, depending on the time of 
irradiation during the first cell cycle. When irradiation with 1 Gy was 
delivered between 14 and 21 hours after hCG injection, eggs which had 
cleaved at the right time developed normally in culture up to the morula 
stage, where a high mortality occurred. On the other hand, when 
irradiation was performed between 17 and 24 hours after hCG, a high 
proportion of the eggs did not cleave at the right time, remaining blocked 
at the one-cell stage ("one-cell block"). The time of maximal sensitivity 
for this effect was found to be 20 hours after hCG, i.e. 8 hours after 
superovulation and fertilization. After different doses of X-rays applied 
at that time, the proportion of eggs which remained blocked at the 
one-cell stage increased linearly with the dose administered, from 0.25 to 
2 Gy, at which dose more than 90 percent of the eggs were blocked. The 
block effect was not irreversible after 1 Gy, about 30-40% of the 
blocked eggs recovered partially, cleaved with a delay of about 20 hours, 
but died soon thereafter. 
When both types of effect of radiation (block at the one-cell stage and 
mortality at later stages) were combined, the time of maximal 
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radiosensitivity during the first cell cycle was also found to be 20 hours 
after hCG, with an LD50 value of 95 cGy fer development to the blastocyst 
stage. 
Although BALB/c zygotes were particularly sensitive for the "one-cell 
block", it was also found in CFl zygotes, but the doses of X-rays needed 
were very high. Other strains tested were not sensitive for the "one-cell 
block". Furthermore, different crosses between BALB/c and Fl (~ BALB/c x d 
C57Bl) mice showed that the "one-cell block" is determined by the maternal 
genotype, resulting DKJSt probably from a primary action on a 
radiosensitive factor appearing 5 hours after sup(•rcvulation, and 
synthesized from components accumulated in the cytoplasm during oogenesis. 
Cytofluorometric analysis of the pronuclear DNA content of uncleaved eggs 
showed t.hat DNA synthesis was unaffected by X-irradiat ion, and that they 
were blocked in G2 phase of the first eel] cycle. Consequently, the 
"one-cell block" constitutes a particular fonn of the so-called 
"G2-arrest". 
1.2. Analysis of polypeptide synthesis and phosphorylation in blocked eggs 
Results of detailed studies on protein synthesis during the first and 
second e~nryonic cell cycles showed that blocked BALB/c eggs underwent the 
same modifications ill protein synthesis as control eggs of the same age, 
except during first mit.osis, for three polypeptide sets of 30, 35 and 45 
kilodaltons molecular weight. The most remarkable differer.ce between them 
was the appearance in cleaving controls,of 3 spots at 35 kilodaltons that 
were absent in blocked irradiated eggs. The same difference was observed 
in Fl eggs which received 8 Gy of X-rays, a dose leading to a block 
similar to that observed in BALB/c eggs given 2.5 Gy, whereas in Fl eggs 
irradiated with 2.5 Gy, a dose insufficient to block them, these 35 kd 
polypeptides were indeed present. After presun1ed division, biochemical 
modifications typical ot the 2-cell stage (activation of the embryonic 
genome, synthesis of new polypeptides, disappearance of maternal proteins) 
occurred in blocked eggs, as they did j n control 2-cell embryo!'. In 
additjon, results of incubation with (3 2 P) showed that the first mitosis 
specific polypeptides which were lacking in blocked eggs resul t.ed from 
post-translational modifications, involving phosphorylations. This 
suggests a link between the inability to progress to mitosis and an 
absence of specific phosphorylation. 
1.3. Influence of caffeine on the "one-cell block" 
Eggs were incubated immediately after ir:t<>diation of the mothers, in 
medium containing various concentrations of caffeine. With 2 mM caffeine, 
the G2-arrest induced by X-rays was almost completely suppressed. However, 
most eggs which had been induced to cleave without delay died during the 
subsequent stages, only a small proportion of them being able to reach the 
blastocyst stage. Eggs were incubated in 2 mM caffeine during different 
per~oas following irradiation. Results showed that caffeine must be 
present during the period of normal first cleavage (i.e. after 30 hours 
after hCG) to suppress the G2-arrest. Thus, caffeine clearly restores a 
process which immediately precedes division, but does not occur in embryos 
h·radiated 10 houzs earlier, with sufficient. doses of X-rays. Incubations 
of very synchronous populations of eggs (possibility of mating limited to 
2 hours) with caffeine and cycloheximide showed that 1) synthesis of 
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proteins occurs after the CH-TP in irradiated eggs (CH-TP : cycloheximide 
transition point, i.e. the time at which all proteiP syn1:hesis normally 
needed for mitosis has been completed in control embryos, incubation with 
cycloheximide being then without effect on division) ; 2) wheP sufficient 
time is allowed for such synthesis to occur, addition of caffeine can 
allo~1 to some extent recovery from the "one-cell block", even in the 
presence of cycloheximide. 
Since the action of caffeine is restricted to the period of no~al first 
cleavage, we concluded that caffeiPe could act by restoring, directly or 
indirectly, the post-translatioPi:'.l modifications of polypeptides which, 
apparently, play an im1x)rtant role in the procE'sses leading to division, 
an hypothesis which was also supported by the results from two-dimensional 
electrophoresis. 
1.4. Relationship between the one-cell block and chromosome damage 
Results from our cytogenetic studies performed on eggs cleaving at the 
right time showed that in such eggs, the proportions ot chromosome 
aberrations varied in function of the time of irradiation, showing clear 
relations with the varying rates of lethality occurring from the morula 
stage. On the other hand, eggs undergoing a G2-arrest and analyzed in late 
cleavage, showed more chrC>Inosome damage than thost> escaping it, and 
similar results wen' obtained in eggs forced to cleave at the right ~ime 
by caffeine. However, different elements also suggest that chromosome 
aberrations are surely not the only cause of C2-arrest and this assumption 
was still indirectly reinforced by the studied reported hereunder. 
1.5. Irradiation and adaptive response in the mouse zygote 
Preliminary results indicated that 1) irradiation of the zygotes by 1 cGy 
followed by 1.5 Gy 7.5 hours later influences neither the pn1portion of 
blocked eggs nor the duration of the one-cell block ; 2) in contrabt, such 
treatment could confer a relative prot~ction to those embryos escaping the 
one-cell block which showed a development quite similar to that of control 
embryos up to the blastocyst stage. This observation, which could be very 
important, must however be taken with caution, due to the still 
insufficient number of embryos observed. 
1.6. One-cell block and irradiation with low doses 
Results of these t•xperiments showed that 10 cGy constitutes apparently the 
limit. for induction of the one-cell block. rn contrast with the results 
obtained after doses of 1 Gy or more, where the delay was always 
equivalent to one entire cell cycle, large individual differences were 
found after application of lower dobes of radiation. Interestingly, eggs 
suffering even a slight delay were unable to survive up to the blastocyst 
stage, whatever the dose administered. 
2. Influence of various methodological factors on the radiosensitivity of 
the mouse zygote 
The results of our studies suggested that the protocols used for mating 
and fertilization probably hav~ a greater influence on embryonic survival 
following irradiation than the use of gonadotropins to stimulate 
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ovulation. Highest degree of synchronism in the development of the embryos 
is achieved by restricting mating possibility to a short period or by 
using in vitro fertilization. Very low values of LD50 were obtained under 
such ~ynchronous conditions (50-80 cGy), confirming the high 
radiosensitivity of the mouse zygote at the early pronuclear stage. 
Comparison between the effects of in vivo and in vitro irradiation did not 
permit the unequivocal conclusion-o~ greater radiosensitivity of the 
embryo in vitro than in vivo. 
Discussion 
The aim of the present project was to investigate the influence of various 
factors (strain, methodological factors) on the response of the 
preimplantation embryos to X-irradiation. 
The BALB/c zygote has been found to be a very useful model to study the 
mechanisms of the radiation-induced "one-cell block". This constitutes a 
particular and very pronounced form of the so-called "G2-arrest" which, 
although described and investigated in cultured cells since more than 30 
years, is still not clearly understood. A lot of work remains to be done 
on the BALB/c zygote as well as on other cells, before the mechanisms of 
G2-arrest become completely clarified. However, some conclusions may 
already be drawn from the work performed to date. 
The radiation-induced G2 arrest has been considered by some authors as a 
passive consequence of a damage to a proteinaceous target whose integrity 
would be a prerequisite for progression to mitosis. Recent results 
suggest, however, that the restitution of such a division protein, or more 
broadly, repair of the lesion (s) responsible for G2-arrest is not an 
absolute requirement for G2 cell progression. This conclusion is based on 
the fact that, in the presence of caffeine, the requirement of irradiated 
CHO cells for protein synthesis is alleviated, suggesting that the 
mechanisms responsible for G2 cell progression actually remain intact in 
these cells (Rowley, Int. J. Radiat. Biol. 48, 811-820, 1985). According 
to Rowley, G2-arrest could then be an active response to irradiation, 
triggered by defects not directly concerned with progression, but 
presumably highly advantageous for the cell to repair before mitosis. 
Other elements support the hypothesis of an active response. Indeed, 
recent studies on CHO cells strongly suggest that the primary target for 
G2-arrest should be located in the nuclear membrane (Schneidermann and 
Hofer, Radiat. Res. 84, 462-476, 1980) and in our experiments, the 
"one-cell block" cannot be induced, before 17 hours after hCG, a time 
corresponding to the formation of the pronuclei in the zygotes. If the 
primary target is located in the nuclear membrane, G2-arrest or, at least, 
the "one-cell block", should constitute an active response to irradiation. 
Indeed, it has been clearly shown that early development of the mouse egg 
occurs independently of the embryonic genome until the 2-cell stage, and 
neither physical nor chemical enucleation affects any of the molecular 
changes that have been detected before the early 2-cell stage. Experiments 
involving irradiation and replacement of the pronuclei by others from 
unirradiated zygotes will help to resolve conclusively this important 
point. If such zygotes suffer no "one-cell block", the target should be in 
the pronuclei and the one-cell block (and probably, more broadly, the 
G2-arrest) should be an active response to irradiation. 
It must be noted that some results from our studies also support the 
hypothesis of a passive consequence. Indeed : 
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1) Synthesis of critical (?) proteins was found to occur after the CH-TP 
in irradiated embryos. Such protein synthesis is insufficient, per se, 
to induce the division of blocked embryos, but is necessary to allow 
the recovery from G2-arrest in the presence of caffeine. 
2) Studies performed with doses of 1 or 2 Gy of X-rays showed that zygotes 
cleaving after G2-arrest carry multiple chromosome aberrations and die 
after a few more divisions. 
3) Studies realized with much lower doses showed that zygotes undergoing 
even a slight division delay are also unable to reach the blastocyst 
stage. 
Whatever the response, active or passive, we think that the absence of 
division, at least in the mouse zygote, could be indirectly linked to an 
absence of modifications of critical polypeptides, occurring at a 
post-translational level during the mitosis. This is supported by the 
absence of specific phosphorylations which was evidenced in the blocked 
zygotes at the normal time of mitosis and which, with the absence of the 
second round of replication, constituted the only visible qualitative 
difference with control embryos, up to the end of the second cell cycle. 
One may imagine that the phosphorylation of specific polypeptides, 
occurring after a chain of reactions, should require a certain treshold of 
critical protein(s), a condition not satisfied in blocked zygotes despite 
the additional synthesis occurring after the CH-TP. Caffeine could act by 
forcing the process of phosphorylation of mitotic polypeptides, at the end 
of the chain of reactions. 
The particular sensitivity of the BALB/c strain to the "one-cell block" 
could result form a deficiency or a lack of expression of components 
accumulated in the cytoplasm of the oocyte during oogenesis and which are 
required to repair radiation damage to the cell. 
Taking into account all results obtained to date, we think that the 
"one-cell block" and more broadly, the radiation-induced G2-arrest, are 
certainly not a simple consequence of chromosome damage. 
Among the methodological factors possibly affecting the response of the 
embryo to irradiation, the use of superovulating hormones has often been 
evoked. Our studies clearly showed that, in fact, these hormones do not 
increase the radiosensitivity of the mouse zygote. On the other hand, our 
results also suggest similar radiosensitivities of the zygote in vitro and 
in vivo. 
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1. Objectives of the project: 
Le contrat de recherche 816065-F portait sur les effets non 
stochastiques de l'irradiation de l'homme: diagnostic, pronostic et 
traitement des irradiations aigües accidentelles 
Le projet n°1 concernait le diagnostic et le traitement des 
radiolésions cutanées: évaluation biophysique, biochimique et 
biologique des dommages à la peau et aux tissus sous-jacents après 
irradiation accidentelle; amélioration des protocoles 
thérapeutiques 
Il. Objectives for the reporting period: 
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Ill. Progress achieved: 
Les irradiations partielles a1gues ont en règle générale une origine 
accidentelle; aussi sont-elles relativement rares. 
Chaque accident relève de circonstances exceptionnelles, qui lui 
sont propres. Aussi les paramètres d'exposition diffèrent d'un 
accident à l'autre. 
Il s'ensuit que les manifestations cliniques sont multiples et 
variées. 
Dans ces conditions, il s'avère difficile de recueillir les données 
suffisantes pour effectuer une étude systématique de la sémiologie 
clinique et des formes évolutives de la maladie et elles sont 
souvent mal connues. Cette étude toutefois a pu être entreprise à 
l'Institut Curie, où un grand nombre de sujets ont été examinés et 
traités. 
Une des caractéristiques de l'évolution des irradiations partielles 
aigües est de comporter dans la plupart des cas une phase de 
latence clinique qui peut induire en erreur le médecin non averti. 
D'autre part, l'évolution clinique est étroitement dépendante de la 
quantité d'énergie délivrée; aussi est-il indispensable de disposer 
d'examens paracliniques susceptibles de fournir des 
renseignements dosimétriques pendant la phase infraclinique. 
Enfin, sur le plan thérapeutique, d'une part il y a carence de 
traitement étiologique, d'autre part le traitement symptomatique 
n'est pas parfaitement codifié; il souffre en particulier de la 
méconnaissance fréquente de la pathologie potentielle au moment 
où le médecin examine le sujet et prend les décisions 
thérapeutiques, chirurgicales notamment. 
Systématisation des manifestations cliniques, mise au point 
d'investigations paracliniques, recherche de traitement étiologique 
et codification de la thérapeutique systématique constituent les 
trois principaux axes de recherche. 
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A. METHODOLOGIE 
Les études ont porté, sur des patients ayant subi des irradiations 
partielles uniques accidentelles, sur certains malades traités 
localement par radiothérapie ainsi que pour certains investigations 
non dommageables sur des sujets normaux. 
Les modalités d'irradiation partielle accidentelle offre un spectre 
particulièrement intéressant compte tenu de la diversité des 
sources et de la variété des paramètres spatiaux-temporels. On 
peut en particulier classer les rayonnements incidents en: photons 
x de faible énergie (2 à 30 Kev, 20 à 50 Kev); photons y d'Ir 192 (== 
300 Kev), photons y de Co 137 (== 600 Kev) et de Co 60 (== 1, 2 Mev). 
Les investigations diagnostiques ont fait appel aux méthodes 
cliniques et paracliniques suivantes: 
Sémiologie clinique 
Thermographie à caméra infrarouge 
à caméra microondes 
Scintigraphie vasculaire 
osseuse (traceur MDP-TC 99m) 
Capillaroscopie: microscope + système vidéo 
Les procédés thérapeutiques ont fait appel à des méthodologies 
médicales et chirurgicales concernant: 
L'inflammation 
Les infections 
Les donneurs 
Les nécroses 
B. RESULTATS 
Ils portent sur les diagnostic et le traitement des irradiations 
partielles accidentelles compte tenu des modalités de 
surexposition. 
1. SYSTEMATISATION DE LA SEMIOLOGIE CLINIQUE · 
La sémiologie clinique des irradiations partielles a1gues est 
extrèmement riche; de nombreux paramètres conditionnent sa 
diversité; ce sont essentiellement le niveau de dose , la 
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distribution chronologique et topographique de la dose, mais aussi 
les caractères physiques de la source (nature et énergie des 
rayonnements). L'évolution aussi est influencée par ces 
paramètres. On peut ainsi décrire un certain nombre de formes 
cliniques: 
- des formes évolutives: 
- forme limitée, une épithéliite exsudative 
- forme avec endothéliite vasculaire 
- formes contractées 
- formes liées aux caractères physiques de la source 
- formes liées aux modalités chronologiques d'exposition 
- formes liées au volume et à la topographie 
- formes associées à une irradiation globale 
- formes avec induction de cancer 
Il. THERMOGRAPHIE 
2.1. Sujets normaux: 
Les investigations ont porté essentiellement 
vu la fréquence des irradiations palmaires. 
informations sur: 
- la température de base 
la carte thermique de la main 
- l'influence du sexe 
- les variations physiologiques 
- le rôle du tabagisme 
- les pathologies associées 
2.2. Sujets irradiés accidentellement 
sur la main normale, 
Elles ont fourni des 
Les résultats essentiels ont été obtenus concernant les niveaux 
thermiques, les caractères topographiques, la chronologie des 
réponses, les relations avec la dose, les conséquences cliniques et 
le bilan préchirurgical. 
2.2.1 Niveaux thermiques 
- seuil 
- gradient minimal 
- gradient maximal 
- incidence du stress en fonction de la topographie 
- effet écran des phlyctènes 
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2.2.2 Caractères topographiques 
- corrélations avec la clinique 
- évaluation de l'étendue potentielle des lésions 
- gradient de dose étalé (source nue) 
- gradient de dose étroit (collimation) 
- effet d'écran des phlyctènes 
- phénomènes d'accompagnement 
2.2.3 Chronologie des réponses 
- introduction 
- précocité infraclinique 
- fugaces 
- tardives 
- poussée 
- long terme: - normalisation 
- hyperthermie 
- hypothermie 
- physiopathologie 
Relations avec la dose 
- similitude de présentation 
- apport à la dosimétrie physique relative 
- gradient thermique - correspondance. dosimétrique 
Conséquences cliniques 
Bilan préchirurgical 
Ill. SCINTIGRAPHIE VASCULAIRE DES MAINS 
Les paramètres étudiés sont: 
- les rapports de concentration du traceur côté irradié/côté 
sain aux différents temps indiqués ci-dessus, 
- les rapports de pentes des pics du premier passage 
vasculaire, 
- les index de volume vasculaire, calculés pour chaque doigt, 
les profils longitudinaux montrant la répartition 
topographique du traceur au niveau des doigts 
Un groupe témoin a été examiné, comprenant des patients pour 
lesquels, à l'occasion de scintigraphies osseuses demandées dans le 
cadre de leur bilan, le passage vasculaire du traceur au niveau des 
mains est enregistré. 
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Les résultats montrent des différences très significatives entre 
mains irradiées et mains non irradiées, ainsr qu'entre mains 
irradiées et les mains du groupe témoin. Ils mettent en évidence 
des augmentations importantes du débit vasculaire au niveau des 
territoires irradiés. 
IV. CAPILLAROSCOPIE 
Les sujets ont été examinés au niveau des doigts. On a obtenu, dans 
le cas de surexposition des doigts, une réponse directement liée à 
l'exposition; dans le cas d'exposition des mains, une réponse 
indirectement liée à l'irradiation mais cependant intéressante. 
On a notamment observé: 
- une rarefaction ou une disparition des anses capillaires 
- des modifications morphologiques des anses 
V. THERAPEUTIQUES MEDICALES 
5.1 Face à l'inflammation, les essais thérapeutiques ont été 
effectués avec la superoxydismutase (SOD): on a observé une nette 
réduction des phénomènes inflammatoires entraînant une réduction 
notable de la phase de restauration. 
5.2 L'infection a fait l'objet de traitements préventifs et curatifs: 
- la prévention a été obtenue par mise en œuvre de prototypes 
d'isolement segmentaire: notamment des isolateurs plastiques 
adaptés aux extrémités des membres 
- les traitements curatifs antibiotiques ont été entrepris sur 
la base des dorinées fournies par l'antibiogramme. 
5.3 La douleur est présente à tous les stades de l'évolution, et peut 
même se manifester ·après traitement et guérison. Elle est 
complexe et pose de difficiles problèmes thérapeutiques 
nécessitant souvent la coopération de spécialistes. Les résultats 
ont été obtenus par des moyens médicaux, physiques et 
chirurgicaux. En plus des traitements classiques faisant appel aux 
anti-inflammatoires, aux analgésiques, aux sédatifs, aux 
anxiolytiques, aux hypnogènes et aux anti-dépresseurs, on a obtenu 
les résultats intéressants qui suivent: 
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- vasodilateurs utilisés localement selon la technique dite de 
"bloc chirurgical", en particulier pour les douleurs du membre 
supérieur 
- médicaments à impact cortical pour les douleurs fantômes: 
agents physiques telles que la neurostimulation transcutanée 
métamérique, libérant des endorphines 
l'excision en cas d'ulcération nécrotique. 
VI. THERAeEUTIOUES CHIRURGICALES 
Le traitement chirurgical intervient pour les ulcérations profondes 
et les nécroses potentielles ou constituées. Il est essentiellement 
à visée conservatrice, mais certains cas exigent l'amputation. 
Les résultats obtenus portent sur les indications thérapeutiques et 
sur les modalités techniques. 
6.1 Indications thérapeutigues 
Les résultats indiquent que les indications thérapeutiques doivent 
être posées très rapidement en vue d'une intervention unique si 
possible, ce qui ne peut être obtenue qu'n disposant d'un faisceau 
d'informations diagnostiques fourni par le dosimétrie physique, les 
examens cliniques et paracliniques thérmiques et vasculaires. 
6.2 Modalités techniques 
Les résultats chirurgicaux ont permis de préciser une stratégie 
rationnelle, notamment pour les brûlures radiologiques profonde~. 
D'une part, l'excision doit n'être ni insuffisante ni excessive. 
D'autre part, s~lon l'état favorable ou non des tissus conjonctivo-
v.asculaire sous-jacents, _ le recouvrement peut faire appel à des 
techniquQs de greffes ou à des lambeaux pédiculés ou libres. 
VIl.. CONCLUSIONS 
Les conclusions essentielles que l'on peut tirer des résultats 
concernant les irradiations partielles accidentelles sont les 
suivantes: 
1. La distribution superficielle ou profonde de l'irradiation est une 
donnée capitale pour le pronostic et le traitement. 
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2. Cette information ne peut être obtenue par la seule sémiologie 
clinique; la dosimétrie physique fournit des données intéressantes 
mais relatives; la thermographie et la scintigraphie fournissent 
des éléments complémentaires. Seule une synthèse de l'ensemble 
des donnnées diagnostiques permet de poser des indications 
thérapeutiques rationnelles. 
3. Les irradiations partielles accidentelles et superficielles 
guérissent normalement grâce à l'isolement et avec des 
traitements médicaux. 
4. Les irradiations partielles accidentelles profondes ne peuvent 
actuellement être traitées de façon optimale que par l'association 
d'isolement, de traitement médicaux et de techniques chirurgicales 
conservatrices. 
5. En cas d'accident impliquant un grand nombre de victimes 
potentielles, un triage est nécessaire. Dès le premier jour, en 
l'absence de manifestation clinique, les examens thermographique 
et scintigraphique permettent d'affirmer ou d'infirmer une 
surexposition partielle accidentelle. 
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1. Objectives of the project: 
Le projet n°2 concernait le diagnostic et le traitement de 
l'irradiation globale: indicateurs biologiques de l'irradiation 
globale. En fait, le deuxième projet a porté non seulement sur les 
indicateurs biologiques, mais également sur les facteurs 
biologiques et pharmacologiques aidant à la restauration des tissus 
hématopoïétiques. 
Il Objectives for the reportmg period 
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Ill. Progress achieved: 
A. METHODOLOGIE 
1. MODALITES EXPERIMENTALES ET CLINIQUES: 
Les études ont été effectuées soit in vitro, soit sur le singe 
"Macacus fascicularis", soit sur des patients irradiés 
thérapeutiquement ou accidentellement. 
Il. PROTOCOLES D'IRRADIATION 
Les modalités d'irradiation ont été les suivantes: 
1. Des protocoles d'irradiation in vitro ont porté sur des 
lymphocytes humains du sang circulant soumis à l'irradiation 
unique de 1 à 10 Gy (essentiellement à 4 Gy). 
2. Pour les singes: 3 protocoles d'irradiation: 
2.1 Irradiation globale unique à 2 Gy 
2.2. Irradiation globale de 8 à 10 Gy, étalée sur 4 à 5 semaines et 
fractionnée à 0,4 Gy par jour. 
2.3 Irradiation globale continue de 5 à 8 Gy 
3. Pour les patients: 5 protocoles d'irradiation: 
3.1 Irradiation globale unique de 10 Gy (avec protection pulmonaire 
à 8 Gy). 
3.2 Irradiation globale de 12 Gy étalée sur 3 jours et fractionnée 
sur 6 séances. 
3.3 Irradiation globale de 13,2 Gy étalée sur 4 jours et 
hyperfractionnée sur 11 séances. 
3.4 Irradiation thoraco-abdominale unique à 1 Gy et à 6 Gy avec 
protection des poumons et du foie. 
3.5 Irradiation localisée à la glande mammaire (60 Gy) et au 
sternum (45 Gy), étalée sur 6 semaines et fractionnée sur 30 
séances. 
- et, en cas d'irradiation accidentelle: évaluation de la dose par 
dosimétrie physique après reconstitution d'accident. 
REMARQUE: Pour un certain nombre de patients, le traitement était 
mixte (chimiothérapie + radiothérapie ou radiothérapie + 
chimiothérapie). 
- 1288-
Ill. METHODES D'INVESTIGATION 
Les méthodes d'investigation utilisées ont fait appel à la clinique, 
à l'hématologie, à la biochimie, à la cytogénétique, à la biologie 
moléculaire, à la physiopathologie et à la thérapeutique. 
1. Clinique· 
1.1 Etude du syndrome GVH (réaction du greffon contre l'hôte), aigu 
ou chronique. 
1.2. Etude de la toxicité à court terme (maladie reina-occlusive du 
foie, troubles fonctionnels respiratoires, inhibition des sécrétions 
salivaires et lacrymales). 
1.3. Etude de la toxicité à long terme (échocardiogramme, études 
endocriniennes, troubles de croissance). 
2. Hématologie 
2.1 Etude de la dépression hématologique immédiate post-radique 
(granulocytes et lymphocytes et typage HLA) 
2.2 Etude de la restauration hématologique 
3. Biochimie 
3.1 Etude des indicateurs hormonaux de l'irradiation (cortisol 
plasmatique, ACTH, adrénaline et nosadrénaline, hormone 
thyroïdienne et TSH). 
3.2 Etude des indicateurs métaboliques: gaz expirés: éthane -
penthane. ~-.• 
4. Cytogénétique 
4.1 Etude des aberrations chromosomiques instables: dicentriques 
et acentriques 
4.2 Etude de la distribution statistique (Poissonnienne), liée à 
l'hétérogénéité de l'irradiation 
4.3 Etude des variations de la radiosensibilité chromosomique 
4.4 Etude du chimêrisme hématopoïétique après allogreffe 
5. Biologie moléculaire 
5.1 Etude des ruptures d'ADN et des systèmes de réparation dans 
les lymphocytes humains 
5.2 Etude de la capacité de réparation des lésions d'ADN 
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6. Physiopathologie 
6.1 Etude de la myélofibrose (PDGF, TGFI3, TGFa) 
6.2 Rôle des fact.eurs fibrosants plaquettaires 
6.3 Etude du stroma médullaire et de la. myélofibrose 
7. ThérapeutiQue 
7.1 Traitement des insuffisances médullaires secondaires à une 
allograffe par le GMCSF 
7.2 Traitement des aplasies médullaires par transplantation à 
partir de sang de cordon; ombilical. 
B. RESULTATS 
Ils portent sur certains effets pathologiques post-radiques, sur les 
indicateurs biologiques des effets de l'irradiation et sur la 
restauration hématopoïétique. 
1. EFFETS PATHOLOGIQUES POST-RADIOUES. 
1 Pathologie hépatiQue: mise en évidence de l'induction de maladie 
veina-occlusive du foie chez des patients soumis à des traitements 
chimio-radiothérapiques. 
2 Pathologie pulmonaire: modifications des épreuves fonctionnelles 
respiratoires che,z des patients soumis à une irradiation 
pulmonaire de 8 Gy. 
3 Pathologie des glandes salivaires et lacrymales: constatation. 
d'une inhibition des sécrétions salivaires et lacrymales chez des 
malades ayant subi une allogreffe après irradiation. 
4 Effets cytogénétiQues: 
- irradiation partielle: une irradiation partielle étalée et 
fractionnée sur 6 semaines, mammaire et sternale, de l'ordre de 55. 
Gy, correspond pour les aberrations chromosomiques 
lymphocytaires à une irradiation globale unique de 2 Gy. 
- l'étude, sur un nombre de cas limités chez l'homme, de la 
distribution poisonnienne des altérations chromosomiques 
lymphocytaires, n'a permis qu'une appréciation qualitative de 
l'hétérogénéité de dstribution spatiale des doses. 
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- l'étude de la radiosensibilité chromosomique lymphocytaire 
par irradiation in vitro surajoutée à une irradiation thérapeutique 
in vivo, a montré: 
- des modifications de la réparation des aberrations 
dicentriques et acentriques, ainsi 
- qu'une altération de la capacité de réparation des 
lésions de l'ADN. 
5. Fibrose 
Parmi les facteurs fibrosants plaquettaires (EGFR ou TGFa, PDGF, 
TGFB), le rôle du facteur TGFB est apparu prépondérant dans un 
modèle de fibrose médullaire. 
li. INDICATEURS BIOLOGIQUES DES EFFETS DE L'IRRADIATION 
1 Indicateurs hématologiques: 
1.1 Le pic granulocytaire constant entre 4 et 8h après une 
irradiation globale unique de 10 Gy, n'est plus significatif au-
dessous de 2 Gy. 
1.2 La chute lymphocytaire après une irradiation globale unique de 
10 Gy a été confirmée égale à 50% en 8h et à 75% en 24h. 
1.3 Le typage HLA a été impossible à réaliser dans un cas sur cinq 
après 18h et dans 2 cas sur 5 après 24h, dans le cas d'une 
irradiation globale unique de 10 Gy. 
2 Indicateurs hormonaux 
2.1 Après une irradiation globale unique de 10 Gy, on a constaté 
pour le cortisol et I'ACTH, dans les 4 premières heures, un pic 
constant compris entre 4,5 pour le cortisol et 6,5 pour I'ACTH. 
Les taux d'adrénaline et d'hormones thyroïdiennes n'ont montré 
aucune modification significative 
3. Indicateurs enzymatiques 
Après irradiation globale, un pic d'amylasémie est constant. Il est 
dose-dependant. Le seuil de réponse se situe entre 0,5 et 1 Gy et 
on a montré qu'il n'existait pas, si les glandes salivaires n'étaient 
pas irradiées. 
4. Indicateurs métaboliques 
Des différentes techniques ont rendu impossible l'obtention de 
résultats concluants chez l'homme de la mesure de l'éthane et du 
penthane expirés. 
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Ill. RESTAURATION HEMATOPOIETIOUE 
1. Les premières transplantations à partir de sang de cordon 
ombilical permettent d'entretenir la possibilité de succès dans des 
situations qui ne seraient pas strictement HLA identique. 
2. L'utilisation de facteurs de croissance GMCSF a permis une 
reconstitution médullaire totale chez des malades atteints d'une 
insuffisance médullaire secondaire à une allogreffe dans un 
pourcentage important de cas. 
DISCUSSION 
1. EFFETS PATHOLOGIQUES POST-RADIOUES 
1. Pathologie hépatique: les maladies veina-occlusives du foie chez 
les patients traités par chimio-radiothérapie, semblent dues à la 
chimiothérapie ou à l'existence d'une sérologie positive à 
cytomégalovirus avant greffe. 
2, Pathologie pulmonaire: les modifications des épreuves 
fonctionnelles respiratoires apparaissent majorées en cas de 
réaction du greffon contre l'hôte et en cas de pneumonie 
infectieuse, en particulier à cytomégalovirus. 
3. Pathologies des glandes salivaires et lacrymales: on a pu 
differencier les troubles salivaires dûs à l'irradiation des lésions 
liées à une réaction GVH chronique. 
4. Effets cytogénétiques 
- Il convient d'être prudent dans l'interprétation des 
aberrations chromosomiques après irradiation accidentelle du fait 
de distribution spatio-temporelle différente de doses qu'une 
analyse statistique poissonnienne peut dans certains cas, aider à 
élucider. 
- L'irradiation lymphocytaire surajoutée in vitro, après 
irradiation in vivo, permet de mettre en évidence des modifications 
de la radiosensibilité chromosomique et de la capacité de 
réparation des lésions de l'ADN. 
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li. INDICATEURS BIOLOGIQUES 
1. Indicateurs hématologiques 
En cas d'irradiation accidentelle, il apparaît capital d'effectuer des 
examens hématologiques toutes les 2h dès le 1er jour en de cerner 
le pic granulocytaire et la chute lymphocytaire. Par ailleurs, le 
typage HLA doit, dans toute la mesure du possible être effectué 
dans les premières douze heures. 
2. Indicateurs hormonaux 
Parmi les indicateurs hormonaux, les pics d'ACTH et le cortisol 
sont caractéristiques, à condition d'effectuer le dosage dans les 4 
premières heures de l'irradiation. 
3. Indicateurs enzymatiques 
L'amylasémie à 24h apparaît comme un indicateur sensible avec un 
seuil inférieur à 1 Gy à condition que les glandes salivaires aient 
été irradiées. 
Ill. RESTAURATION HEMATOLOGIQUE 
1. En cas d'insuffisances médullaires secondaires à des allogreffes, 
qu'elles soient liées à une GVH aigüe ou à une infection à CMV, 
l'utilisation de GMCSF permet dans un fort pourcentage de cas, une 
reconstitution médu !laire totale. 
2. Dans des situations qui ne seraient pas strictement HLA 
identique, des espoirs de succès paraissent permis en utilisant des 
transplantations à partir du sang de cordon ombilical. 
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I. Objectives of the project: 
Our aim is to reveal and study the mechanisms of 
sensitivity of the central nervous systen1 using 
morphological and biochemical approach. We also intend 
the dependence on dose and radiation quality using a 
irradiation protocols. 
11. Objectives for the reporting period: 
A. Morpholog_i_c?;t_ assays : 
fetal radio-
a combined 
to determine 
spect:rum of 
-For X-ray doses of 1 to 15 cGy and' 600 keV and 2.5 MeV neutron 
doses of 1 to 15 cGy administered at different ages, changes in body 
and brain weight, and in ultrastuctural brain parameters; 
- Comparison between low dose rates of gamma rays and high dose 
rates of X-rays administ&rPd at day 15 post Conception; 
- Relative biological effectiveness of X-rays versus neutrons. 
B. Biochemical studies : 
- For X-ray doses of 0.5 to 2 Gy at different fetal stages, changes 
in body and brain weight, biogenic and nes, amino acids, and receptors. 
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Progress achieved: 
The observations made at Hiroshima and Nagasaki have drawn attention to the risk of mental 
retardation after exposure in utero during the early period of pregnancy. The data do not 
allow to decide whether a threshold dose exists for this effect. Indeed, a linear non-threshold 
dose effect relationship for mental retardation, if demonstrated, would have important 
consequences for radiation protection regulations and practices. 
It is unlikely that human data will become available which can resolve the problem; therefore, 
one must search for animal models to study evolution and mechanisms of radiation-induced 
changes in utero. Obviously, no animal model, except perhaps primates, can give a fully 
satisfactory answer although they can give useful indications. The present studies concentrate 
on two important aspects, morphological and biochemical changes in the adult rat after 
exposure in utero at different times of pregnancy. 
I. Morphological Studies. 
Introduction. 
Little attention has been devoted up to now to the hazards of very low doses of irradiation 
( <20 cGy) on the development of CNS. However, in close relationship with the present 
exponential development in microelectronics and in quantitative image analysis, numerous 
developmental abnormalities can now be detected at much lower dose levels than foreseeable 
just a few years ago. 
It is also our conviction that the relatively important anatomical alterations which were found 
by such methods and are described below, must be the consequences of numerous transient 
and/or chronical changes occurring at the deeper ultrastructural, macromolecular and molecular 
levels; the biochemical part of this report deals in considerable detail with a selection of these 
latter alterations. We assume that the present studies will provide unvaluable clues leading 
towards the discovery in the near future of more subtle abnormalities present even after lower 
doses of irradiation ( <1 cGy ?) and eventually close enough to the exposure range found in 
everyday life. 
Material and methods. 
The methods involved in this research largely belong to general morphology. However, a few 
peculiar aspects must be pointed out here: 
1. The use of standardized animal litters. The major goal of the present investigations is to 
reveal brain alterations after the lowest possible doses of irradiation. However, biological 
variability is in general so high that very faint effects could get lost. In an attempt to 
control at least a part of the variations, only animals born in litters of 8 to 10 pups were 
considered. Moreover, these selected litters were reduced to 8 pubs one day after birth. We 
are convinced that such protocole enabled us to detect tissular involutions at the very low 
dose levels described below. 
2. All irradiations are performed on day 15 post conception (pc). This date corresponds to a 
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particularly active period of cerebral organogenesis, and consequently also to a stage Df 
major radiosensitivity. 
3. Quantitative image analysis. Among the various brain parameters considered as indicators of 
abnormalities, the most sensitive are those integrating a large number of tissue components; 
namely, measurements of tissular areas or volumes. The quantitation of these parameters 
was performed using a digitizing graphic tablet interfaclld to a PC. Such data proved to be 
more sensitive to radiation injury than the brain weight since they pinpoint selected tissular 
areas which are specifically proliferating on day -15 pc and are consequently exposed to a 
major risk. 
Results ~nd Discussion. 
1. X-ray exposure. 
a) Major changes in body weight and brain weight. 
Body weight and brain weight still range among the best available indicators of general brain 
damage induced during its organogenesis. Hamilton . .et al. (1989) used this simple measurement 
but were only able to recognize a significant decrease in brain weight after doses >= 80 cGy 
gamma rays given at day 28 pc in the beagle. In the WIStar R/cnb rat used in Mol, X-
irradiation given at day 15 pc causes much more severe effects. A tendency to brain atrophy 
can be noted after doses as low as 5 cGy. Actually, a significant microcephaly is found after 10 
cGy if one exclusively uses animals born in standardized litters of 8 +/-1 pups. Stich eiituatioh 
will even deteriorate using 600 KeV neutrons as shown in Table I. 
b) Minor ch~ges in the glial distribution of the cerebral cortex. 
In the adult rat CNS, the glial tissue is the cellular component at major risk after an 
irradiation. It was indeed shown by us in the recent past (1982,1986a,1989), that a total 
eradi~tion of a specific glial cell type characterizes the first _effects of an irradiation. This 
radiosensitive glial cell displays many characteristics of immature cells. and could be considered 
as a residual multipotential embryonary cell still persisting in the adult brain. A long time 
after irradiation, these _cells come back but other alterations develop: the so-called late effects 
of ionizing radiations. These degenerative changes consist in the development of fibrosis in 
astroglia, a depletion of oligodendroglia but also an hypertrophy of certain capillary blood 
vessels (telangiectasia). 
Since glial changes were prominent after irradiation of the adult brain, it was initially thought 
that a modified glial radiobehaviour could also be recognized after prenatal irradiation. P. 
Rakic work in the eighties highlighted the primordial role of a prenatal glial component, the 
radial glia, during the setup of the various brain substructures anc;l in particular, of the 
cerebral cortex. According to his views, radial glia multiplies prior to the cortical development, 
in order to provide a ,scaffolding along which the different neuronal cell types will Jl!,igrate and 
ultimately settle up. It could thus be assumed that the effects of radiation injury bearing on 
radial glia would become largely amplified due to this leading architectonic role. 
However, a study of 15 month old adult rats which had undergone prenatal irradiation with 
45 cGy at day 15 pc does not reveal major variations of the glial populations (Reyners, in 
Kriegel et al., 1986b). In fact, the glial cell densities significantly increased but cell sizes were 
significantly smaller than in the controls. Computation revealed that the total cell amounts 
were actually not modified. On the other hand and possibly in relation with this cellular 
atrophy, a grey and white matter atrophy were clearly evident. 
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c) Decrease of the thickness of grey and white matter. 
Grey matter: the thickness of the cerebral cortex has significantly decreased by 16.7% in the 
15 month old brain after in utero irradiation with 45 cGy at day 15 pc. However, here also 
the total amount of nerve cells has not decreased although cell size is significantly diminished. 
According to Schneider and Norton (1981) and lumermann (1987), the neural cell processes 
have reduced and degenerated. 
Atrophy of the cingulum: The latter observations also valuably explain why the cingulum 
bundle (a corpus callosum subsidiary which is made of numerous myelinated axons arising 
from the neurons of the surrounding cerebral cortex) is deeply diminished (up to 35.2%) after 
45 cGy X-irradiation at day 15 pc (Table Il). Due to the sensitivity of this criterion, it was 
attempted to evaluate this structure as exactly as possible. 
It was found that its cross-sectional area normally decreases nearly linearly along the antero-
posterior axis of the brain. In such conditions, it was decided to measure cingulum areas at 
various levels along the brain axis (which were estimated thanks to an examination of the 
complex morphology of the subjacent hippocampus). On the resulting plot, the area located 
below the line joining all the measurements and between 2 arbitrarily chosen reference 
positions (anterior and posterior) was called the cingulum volume. This parameter was found 
to represent the best morphological indicator of radiation injury actually known (Table ill); 
this is also valid for all the other irradiation shedules analysed in this report. As far as X 
irradiation is concerned, significant atrophy of the cingulum was observed in 3 month old 
female rats after as low as 10 cGy X-rays at day 15 pc. Of course, larger effects are observed 
after neutron irradiation. 
2. Neutron exposure (600 KeV and 2.5 MeV>. 
a) Major changes in brain weight. 
A most comprehensive study deals with the 600 KeV neutrons. The data are given in table I. 
TABLE I. BRAIN WEIGHTS after 600Kev NEUTRON IRRADIATION in UTERO at day 15 
pc. (Mean weights in mg +/- s.e.m, ': significantly different from controls; n= number of rats 
per experimental point.) 
AGE DOSE (cGy) 
0 1 2.5 5 10 15 
3mo 1369±8 1319±14 1307±8 1292±8 1191±8" 1072±8" 
(n=30) (n=15) (n=20) (n=18) (n=14) (n=11) 
15mo 1519±11 1498±18 1469±11* 1421±19* 1303±13" 
(n=15) (n=10) (n=14) (n=9) (n=10) 
24mo 1543±9 1541±10 1513±10" 1461±9" 1346±20" 1243±21" 
(n=23) (n=15) (n=18) (n=16) (n=10) (n=9) 
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Brain weight is an excellent indicator of CNS alteration. However, some of the data are to be 
considered with caution: in 3 month old rats, a Bignificant difference (p<0.005, not indicated) 
was detected between the 30 controls and the 15 brains treated with 1 cGy. It appears -that 
uncontrolled factors have certainly played an important role in BUCh observations. lftdeed, NO 
significant difference in brain weight was found between the groups treated with 1, 2.5 and as 
much as 5 cGy. The significant difference which exists between the 5 and 10 cGy· brains is 
certainly more meaningful. 
In rats of 15 and 24 months of age, the difference between ·the controls and the 1 cGy brains 
is clearly unsignificant. In these conditions, the significant difference which appears between 
the previous 2 groups and the 2.5 cGy rats, could really be considered as real. It also appears 
that the effects are more severe in the old adults than in the younger 3 month old animals. A 
similar trend was observed for the X-irradiated cingulum volume and so is in favour of the 
latter observation (Table m. 
b) Severe atrophy of the cingulum. 
Neutrons provoke an atrophy of the cingular white matter as shown in Table m. 
TABLE ll. The effect of TIME after 45 cGy of in utero X-irradiation (at. day 15 pc) on the 
CINGULUM VOLUME. (Figures give the percentage QC atrophy with respect to matching 
controls; n=5; the effect of TREATMENT increases signiticantJy with AGE (p interact. <0.02) 
in a 2-way ANOVA). 
AGE lmo 3mo 6mo 15mo 24mo 
Effect -20.6% -21.8% -34.1% -24.3% -35.2% 
TABLE m. CINGULUM VOLUME of 3mo rats after IRRADIATION in UTERO at day 15 pc. 
(Mean volumes in arbitrary units +/- s.e.m; *: P<0.05; TMT :treatment; NTN :neutron) 
TMT DOSES (cGy) 
0 2.5 5 10 15 20 100 
NTN 40.9±1.8 39.5±2.1 27.9±3.7° 19.5±3.5' 
2.5 Jl4ev (n=5) (n=5) (n=5) (n=5) 
NTN 44.4±1.51 42.5±1.8 40.1±1.8 36.8±1.8• 12.4±3.6' 
0.6 MeV (n=20) (n=15) (n=16) (n=15) (n=7) 
x . .....,. 44.7:tUI! 41.5±3.4 33.7±1.8• 30.4±3.4° 27.3±1.5° 
250Kvp (n=4) (n=4) (n=4) (n=4) (n=4) 
GAMMA 39.6±2 26.7±2.3° 5±4' 
Co60 (n=8) (n=8) (n=7) 
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3. Gamma ray exposure versus X-ravs. 
Low dose rates of gamma ray exposures were utilized in order to compare with the effects of high dose rates (of X-
rays) at day 15 pc. As shown in Table m, there is no difference between these 2 kinds of irradiation (for 20 cGy 
exposures). 
Other studies now in progress will bear on the effect of very low dose rates of gamma rays administered during the 
last week of pregnancy or the whole of it: they will deal with the problems of the possible threshold after low dose 
exposure. 
4. Relative Biological Efficiency <RBEl. 
RBE values can be derived from table m for the cingulum atrophy. The values were computed with respect to X-rays 
and are relatively modeat for this endpoint since they range from 2.78 for the 600 KeV neutrons to a low 1.57 for the 
less efficient 2.5 Me V ones. 
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II. Biochemical Studies. 
Introduction: 
The study aimed to elucidate the mechanism of action of radiation on the developing brain 
and its consequences by using an experimental model which could give information on brain 
activity in the adult. For this· purpose, we have investigated the level of biogenic amines and 
their receptors in different structures of the adult rat brain at different ages after exposure of 
the pregnant mother. 
Material and Methods 
Rats were gposed at day 10, 12 or 15 of pregnancy to 0.5, 1 or 2 Gy of X rays (200 KVvp, 
filter 1mm Cu, about 1 Gy/min). Timing of pregnancy was ascertained from the vaginal plug 
after overnight mating. 
At different ages, the offspring was sacrificed, the brain was dissected and the following 
structures were isolated by dissection: cortex, hippocampus, striatum, thalamus, hypothalamus, 
cerebellum, medulla. The tissues were frozen until assay and pooled where needed. 
For the determination of Biogenic amines and amino acids, the tissues were homogenized in 
perchloric acid to which a small amount of ascorbic acid had been added, and the supernatant 
was used for column chromatography after neutralisation. Biogenic amines were determined by 
HPLC followed by electrochemical detection. 
Amino acids and related biogenic amines were reacted with o-phthalaldehyde, separated by 
HPLC chromatography and determined by fluorimetry. The most important and most 
consistently found substances were: epinephrine, norepinephrine, dopamine, dopa, serotonin, 
glutamic acid, glutamin, GABA, aspartic acid and taurine. However, some data are also 
available for DOPAC, 5-hydroxyindolacetic acid, glycine, histidine, thyrosine, ethanolamine and 
some unidentified compounds. 
For the determination of receptors, the membrane fraction was isolated by centrifugation and 
incubated with a range of concentrations of radioactive ligands in the presence and absence of 
competitors in order to distinguish between specific and non-specific binding. The data were 
evaluted for the maximal binding capacity (Bmax in femtomoles/mg tissue) and the dissociation 
constant (Kd, nanomoles) by non-linear analysis of the Michaelis-Menten type hyperbolic 
function and, after linearisation, by the Scatchard procedure. Usually, the direct non-linear 
regression yielded more reliable values. It should be pointed out that many receptors can be 
determined only with a relatively high error (15-20%) since the results are obtained as the 
difference between total and non-specific binding where the latter often can be as much as 
50% of the total binding of a lignand. Autoradiography of the receptors was performed on 
tissue blocks sectioned in 20 p, sections. The sections were incubated with the radioactive 
ligand at 25"C for 60 minutesin the presence and absence of the specific competitor, briefly 
washed 4 times with Tris buffer and exposed to an "H LKB film for 20 days at -80"C. 
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The following receptors were determined with the mdioactive ligand and the oompetitor shown 
in parenthesis: 82-serotonin receptors ("H-ketanserin, methysergide); cholinergic {muscarinic} 
receptors (8H-quinuclidinyl benzilate, atropin or pirenzepine); Hl-histamin receptors) ("H-
Pyrilamine, triprolidine); opiate receptors ("H-fentanyl, dextromommide); benzodiazepine 
receptors ("H-flunitmzepam, clonazepam); D2-dopamin ("H-spiperone, domperidone). 
Results 
Data on different reoeptors are shown in the following tables N. It should be noted that data 
from only one bmin structure is shown, ie, that with the highest content of receptor. Data on 
other structures, where obtained, are summarized in the legend of the tables. Note statistically 
significant differences (p 0.05) are indicated as '· 
Benzodiazepine Receptors in Cortex 
(percent of controls) 
(with 'H-flunitrazepam and clonazepam) 
Age B ma:r Kd 
lrrad. 10 days 
1 month old 89 71' 
3 months old 102 60' 
6 months old 83 78' 
lrrad. 12 days 
1 month old 101 78' 
3 months old 97 77' 
6 months old 91 82 
lrrad. 15 days 
1 month old 91 58' 
3 months old 97 78' 
6 months old 98 87 
Note: Both Kd and B ma:r diminish from 3 to 6 
months in controls. No changes found in 
cerebellum after irradiation or with age 
S2-Serotonin Receptors in Cortex 
(percent of controls) 
(with 'H-ketanserin and methysergide) 
Age B ma:r Kd 
lrrad. 10 days 
20 days old 106 144' 
1 month old 102 99 
2 months old 92 168' 
lrrad. 12 days 
20 days old 105 58' 
1 month old 104 61' 
2 months old 90 63' 
lrrad. 15 days 
20 days old 90 78 
1 month old 121 86 
2 months old 134' 146' 
Note: Both Kd and B ma:r increase slightly with 
age. 
D2-Dopamin Receptors in Striatum 
(percent of controls) 
(with 'H11piperone and domperidone) 
Age B ma:r Kd 
lrrad. 10 days 
1 month old 110 111 
3 months old 108 92 
Irrad. 12 days 
1 month old 118 92 
3 months old 113 100 
lrrad. 15 days 
1 month old 111 78' 
3 months old 121 115 
Note: no significant change with age is observed 
S2-Serotonin Receptors in Striatum 
(percent of controls) 
(with 'H-ketanserin and methysergide) 
Age B ma:r 
lrrad. 10 days 
20 days old 71' 
1 month old 112 
2 months old 116 
lrrad. 12 days 
20 days old 98 
1 month old 112 
2 months old 116 
lrrad. 15 days 
20 days old 84 
1 month old 80 
2 months old 74' 
Kd 
72' 
95 
195' 
91 
81 
148' 
70' 
76' 
180' 
Note: Both Kd and B ma:r do not change much 
with age 
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Opiate Receptors in Cortex 
(in percent of controls) 
(with 'H·Fentanyl and dextromoramide) 
Age B max Kd 
lr~ad. 10 days 
3 months old 151" 153' 
6 months old 152. 125. 
lrrad. 15 days 
3 months old 98 141" 
6 months old 128. 74. 
Note: no significant changes with age (3/6 months). 
1n the hippocampus a slight reduction of both B 
max and Kd after 3 and 6 months. 
' . 
HI-Histamine Receptors 
(in percent of controls) 
(,.;ith 'H-Pyrilamine and tripolidine) 
Age B max Kd 
lrrad. 10 days 
1 month old 126 110 
3 months old 105 62. 
6 months old 102 78. 
rrad. 12 days 
1 month old 103 95 
3 months old 121 . 89 
6 months old 103 70. 
lrrad. 15 days 
1 month old 94 82 
3 months old ss· 78. 
6 months old 13s· 136. 
Note: Both Kd and B max increase with age in 
controls. No significant changes found in 
hippocampus after irradiation or with age 
Table V Changes in weight of the total anlmal, total brain and the striatum after exposure in utero to 1 Gy at 
different times of pregnancy 
Animal weight g Brain weight mg Striatum weight mg 
1 month 3 months 1 month 3 months 1 month 3 months 
Control 140 245 1385 1772 59 63 
day 10 143 212 1270 1612 53 63 
day 12 126 210 1073 1326 40 51 
day 15 137 ~33 1002 1354 36 50 
Figure VI Autoradiographic display of specific and nonspecific opiate receptors in normal and 
irradiated brain at an age of 3 months. No significant differences are observed. Similar 
observations have been made on diazepine receptors. 
Control 
Total Specific 
" . ' 
I 
. le 
Opiate Receptors 
Irradiated 
Total Specific 
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Data on total brain weight, animal weight, and the weight of the striatum are shown in table 
V. Similar observations were made on other brain structures with hippocampus showing the 
most marked alterations after radia~on. 
The data demonstrate that most receptors display an increase rather than a decrease in 
activity per g tissue after an in utero exposure to 1 Gy, and, for the receptors so far studied 
by autoradiography, show no marked change in distribution. It should be noted that the error 
of the determination of some receptors is relatively large (15-20%) since the data are obtained 
as the difference between total and nonspecific binding where non-specific binding can 
represent as much as 50% of total ligand bound. 
Data on biogenic amines and amino acids in different brain areas from rats exposed at 10, 12 
or 15 days of pregnancy to 1 Gy at an age of 1 month are shown in the table VII. Data, not 
shown, have been obtained also for 18 days (2 experiments), 1 months (2 experiments), 2 
months, 3 months (2 experiments), 4 months and 6 months after 1 Gy and for 1 months and 
3 months after 1.5 Gy. Marked and reproducible changes were found in several 
neurotransmitters but again these reflect as often increases as decreases. In a general way 
however, increases seem to be more frequent indicating a tendency to compensate for cell loss 
by an increase in neurotransmitter content. 
Conclusions 
The changes found in receptors or neurotransmitters although significant dfound are not very 
pronounced and represent increases as well as decreases. However, method is subject to a 
relatively large error (15-20 %) since results are obtained by subtracting a relatively large 
amount of non-specific from total binding. 
Preliminary autoradiographic data while showing clearly different binding in the various brain 
structures do not indicate so far an important difference between irradiatied and non-irradiated 
brain areas except where major tissue defects occur. 
Biogenic amines and amino acids (not presented in detail) show often an increase in amount 
when related to tissue mass or no changes when related to total brain structure. 
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Table VII. Biogenic amines and amino acids in 1 months old rats exposed to 1 Gy on day 10, 
12 or 15 of pregnancy 
Cortex Hippocampus Striatum Thalamus HypothalamusCerebellum Medulla 
Dopamin 
Day 10 128 79 103 128 99 60 
Day 12 78 119 60 24 
Day 15 101 141 140 70 52 
DOPA 
Day 10 91 71 69 
Day 12 83 101 82 
Day 15 122 107 39 
Norepinephrine 
Day 10 53 92 90 113 106 140 
Day 12 75 140 102 89 
Day 15 195 135 183 149 106 141 
Epinephrine 
Day 10 114 92 81 76 118 43 153 
Day 12 73 98 106 103 134 75 
Day 15 129 117 189 176 135 142 
Aspart.Ae. 
Day 10 155' 96 129 115 119 107 
Day 12 191 109 95 117 103 124 96 
Day 15 143 78 42 86 113 95 
Glutamic~. 
Day 10 51 127 84 96 106 113 107 
Day 12 187' 90 92 124 87 128' 80 
Day 15 169' 105 107 75 125" 114 130" 
Glutamine 
Day 10 85 131 109 123 111 86 99 
Day 12 117 88 77 77 133" 113 104 
Day 15 185" 91 99 35" 71 88 70" 
GABA 
Day 10 111 133 79 91 128" 94 112 
Day 12 205" 85 84 112 113 103 90 
Day 15 255" 105 104 107 96 112 100 
Taurine 
Day 10 59" 110 59* 88 106 99 112 
Day 12 174" 116 78 102 81 121" 86 
Day 15 140" 88 146" 72 64" 91 84 
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Title of the project no.: 2 
Early and late radiation damage to the hematopoietic and immune systems 
of newborn animals 
Head(s) of project: 
L. de Saint-Georges 
Scientific staff: 
G.B. Gerber 1 R. Hooghe 1 M. Janowski 1 L. de Saint-Georges 
I. Objectives of the project: 
The working hypothesis is that the radiosensitivity of the haemopoietic 
system (and immune system in particular) is different in adult and in 
developing animals. Short- and long-term consequences of prenatal and 
neonatal irradiation are therefore studied. 
11. Objectives for the reporting period: 
The work under the reported period of investigation aimed to test the 
ability of the irradiated hemopoietic system of neonate and adult mice 
of different strains to adapt to an increased demand either immediately 
after the irradiation or after a recovery period of 14 1 30 1 90 days 
following the irradiation. The reticulocyte reaction following hypoxic 
exposure was used as test system. 
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Ill. Progress achieved: 
1. CAPACITY OF . IRRADIATE[) HEMOPOIETIC SYSTEM OF THE NEONATE AND ADULT 
MOUSE TO }IJ)APT TO AN INCREASED DEMAND 
Introductjon 
Fractionation of a dose result.s j n most instances in less damage 
compared to a single exposure. 'l'here exist however several exceptions to 
this rule one notably being the greater radiosensibility of infant mice 
to fractionated X-ray exposure. 
~!ice exposed at day 6 of life seem incapable of repajring radiation 
damage as do adults and display a greater mortality when dose is split 
between day 6 and day 9. Maximal sensitization occurs when the 
conditioning dose is smaller than the· test dose. 
Mice surviving the acute phase of the radiation syndrome after 
fractionated exposure also die more frequently from aplastic anemia and 
thymic lymphoma during the first half year of life than those exposed to 
a single dose. Th~· difference in the survival after irradiation 
disappears in juvenile mice. 
Material and methods 
a) Protocol of irradiation 
Animals were whole body X rays irradiated under a Philips RT 250 tube at 
photon energy 250 KV, 15 mA using a 1 mm Cu filter (HVL 1. 9 mm) • 'l'he 
dose rate was 0.95 Gy and total doses were 3.1 Gy in a single exposure 
or 3 .1 Gy fractionated in 1.1 and 2. 0 Gy at a 3 days interval. Doses 
were monitored with a Farmer Baldwin 2570 dosimeter placed in the middle 
of the field. 
b) Hypoxic stimulation 
Erythropoiesis was stimulat.ed by keeping the mice at low pressure in the 
device described in figure 1. It consjsted in an air-tight cage 
connected to a rotary pump. Pressure jn the cage was maintajned constand 
at 350 mbar by means of a periodically switched electromagnetic valve 
connected to outside air. Pressure in the cage was measured by means of 
a STATHAM pressure transducer. The signal was amplifj ed, fed into a 
comparator and the resulting signal was used to activate the valve via 
an optocoupler. ' 
A 3 days hypoxic stimulation was experimentally determined to be the 
optimal tjme for recording the maximal reticulocyte ccunte. 
~later and food were given ad libitum. 
Immediately after low pressure stimulation, mice were killed and the 
percentage of reticulocytes was determined on smears after staining wit~ 
methylen blue. 
c) Experimental animals : 
6 days and 3 months old BALB/c and C57BL mice from the CEN, Mol, animal 
facility were used in the experiments. 
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Results 
Reticulocyte reacth>n varies profoundly according to the strain of mice 
considered and only BALB/c mice were giving good reproducible results 
and were further considered as our experimental model (Tabel I). 
Table I 
% reticulocytes for each stimulated period 
0 days 14 days 30 days 90 days 
----··· 
BALB/c 6 da::rs 
Control 21.90+4.36 5.09+2.37 4.91+1.65 2.61+0. 71 
3.1 Gy 7.63+"3.07 6.86+"1.88 2.86+0.88 2.95+"0.88 
1.1 Gy + 2 Gy 8.29+2.74 6.41+2.03 3.80+0.88 4.14+1.47 
BALB[_c __ 3 months 
Control 3.39+1.32 2.31+0.55 2.88+0.76 2.74+2.04 
3,1 Gy o.o7+0.o9 5. 96+"1.43 1. 11+1.oo 0.83+"0.43 
1.1 Gy + 2 Gy 1.34+"2.68 4.94+0.89 3.28+0.64 2.45+o. 71 
BALB/c 1 month non exposed non stimulated mice 1.81+0. 73 
3 months 1.51+0.28 
-----
Differences in the percentages of reticulocytes released in the 
circulation are recorded for neonate and adult mice all along the 
experimental time up to 90 days post irradiation. 
Non-irradiated, non-stimulated adult BALB/c mice have a reticulocyte 
count of 1.81% ~ 0.73. 
In the non-irradiated hypoxy stimulated mice (Control mice), the 
reticulocyte count was decreasing from 5.6% (9 days old mjce) to reach 
90 days after a plateau at 2.61 ~ 0.71 %. 
In the irradiated stim\1lated mice, three phases should be considered 
separately : the acute phase, from 0 to about 14 day e. after hypoxic 
stimulation, the "repair" phase, from 14 to 30 days and the chronic 
phase front 30 to 90 days and over. 
In adult mice a typical behaviour with immediate damage followed by a 
repair phase is seen during the first 30 days. 
In neonate mice, irradiation results in an immediate high reticulocyte 
response that gradually decreases with time after irradition. 
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As seen after 14 days, in either young or adult mice, a single 
irradiation has a more long-lasting depressing effect that a 
fractionated one. In juvenile mice however, the values are higher and 
recovery appears to have rather place after single exposure whereas an 
increased reaction is maintained after fractionated dose. 
One remarquable feature after day 14 is that in both the neonate and 
adult mice, the roughly similar parallel evolution of the reticulocye 
counts for the single and fractionated dose. The main difference between 
young and adult mice residing essentially in a rather constant shift 
downward of about 2 % of all the count from irradiated mice. 
Discussion 
The results demonstrate that reticulocyte reaction and hence hemopoietic 
marrow behaviour differs profoundsly between adult and neonate mice for 
the period considered. 
In both cases a single irradiation leads to lower reticulocyte counts 
.than a fractionated exposure and compared to the control mice, the 
depletion is more marked in adult than juvenile mice. 
The more significant differences are observed during the first 14 days 
following irradiation where exposure results in a depletion of the 
reticulocyte count in adult but in an amplified response in young mice. 
These results on regeneration of the erythropoietic marrow in neonates 
·could be explained by a preferential stimulation of erythropoiesis in 
irradiated neonates compared to irradiated adults. Indeed it has been 
observed earlier that the ratio erythroid to granulocytic type of spleen 
colonies increases in irradiated neonate mice up to day 30. 
Another aspect which play an important role in the difference between 
adults and neonates response to stimulation is the reaction of the 
stromal cells needed to maintain normal marrow function, and the 
incomplete marrow functional characteristics in the young mouse. Indeed 
in juvenile mice, the stromal cells are still undergoing cellular 
·divisions and are therefore much more radio-sensitive tha~ the quiescent 
adult ones. An indirect stimulating effect on hemopoietic stem cells via 
a damage to stromal cells and the resulting marrow disfunction could 
better explain the opposite erythrocyte reaction between adult and 
neonates. 
It is also known that the marrow blood flow rate is under the 
sympathetic nerves control. This control was shown active in the rat 
only two weeks after birth. Bone marrow blood flow, stromal cells, and 
the integrity of endothelium are important for the release capacity of 
newly produced blood cells from marrow precursors into the systemic 
circulation. It is therefore evident than a greater radiosensitivity of 
neonate stromal system and a still uncont~oled marrow blood flow could 
also explain the early differences observed in the reticulocyte response 
between juvenile and adult mice by an immediate ·release· of reticulocytes 
into the marrow circulation through the damaged reticulo-endothelium of 
the medullar system. 
The results presented emphasize the importance of stromal cell 
consideration in the study of the stem cell radiosensitivity in vivo. 
Erythrocyte response analysis after hypoxic stimulation is a good model 
for the study of the functional integrity of the marrow after 
irradiation. 
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2. HOST STEM CELL BEHAVIOUR AFTER WHOLE BODY IRRADIATION FOLLOWED BY 
BONE MARROW GRAFT 
Introduction 
Hemopoietic pluripotent stem cells first appear in the primitive yolk 
sac, subsequently reach the embryonic liver and hence migrate to the 
marrow cavity during a period of several days starting before birth to 
become exclusively medular a few days after birth. 
The bone marrow stromal system constitution is a prerequisite to the 
appearance of hemopoiesis in the bone cavity. 
The current view is that stromal cells and hemopoietic stem cells belong 
to different cell population with their own specific progenitor cells. 
However several authors suggest that some stromal cells could be at the 
origin of the hemopoiesis. Islam (1985), from histopathological evidence 
of human bone marrow biopsies, suggest that endosteal lining cells could 
be the true stem cells giving rise to osteoprogenitor cells and to 
hemopoietic stem cells. The problem is thus far from elucidated. 
The present experiment investigated the possibility of awakening some 
quiescent stem cells remaining after letal whole body irradiation by 
analysing the leukocyte karyotype of hypoxia stimulated recipient mice 
at different time after marrow graft from mouse cells with a different 
karyotype. 
Material and methods 
Normal C57BL/Cnb (40 chromosomes) and C57BL/Cnb with 38 chromosomes 
(36+2 acrocentrics) obtained by Robertsonian translocation (Leonard et 
al.) produced and bred in the CEN-Mol animal facility, were used 
respectively as recipient and donor mice in the bone graft experiment. 
At 10 days, 1,2,3,4 and 5 months after the bone marrow graft, 8 mice 
were stimulated by a 3 day hypoxia at 350 mBar as described in the above 
part of the report. 
Blood was then collected and smears were analysed for the presence of 
the different karyotypes. 
Bone marrow graft : 
Mice of the 40 chromosome karyotype were irradiated whole body with 8.5 
Gy at a dose rate of 0.95 Gy/min (1 mm Cy filter, HVL 1.9 mm) then 
injected ( i. v.) with 500,000 marrow cells from donor mice with the 38 
chromosome karyotype. 
Group A, was exposed to hypoxia stimulation while the other, groupe B, 
not. 
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Results 
----
Re~ults are displayed for each group. 
Group A 
10 days 
1 mollth 
2 months 
3 months 
4 months 
5 months 
Control 
Discussion 
36+2 chr. 
(Donor) 
94.97 
100.0 
98.17 
93.19 
90.07 
C57BL/Cnb 
C57BL/Cnb 
40 chr. 
(Host) 
5.03 
o.o 
1.83 
6.81 
9.93 
(38 chr.), 
(40 chr.), 
4 months 
4 months 
Group B 
36+2 chr. 40 chr. 
(Donor) (Host) 
71.4 ' 29.26 
' 97.51 2.49 
96.70 3.30 
96.41 3.59 
95.77 4.23 
93.20 6.80 
lOO 
' 
36+2 chr. 
lOO 
' 
40 chr. 
Results shown no significant differences between groups A and B. Jn the 
letaJJy irradia,ted mice, aft.er bone marrow graft, cells with the donor 
karyotype charact.eristics (38 chr.) are largely predominant and are 
responsible of the mouse survival. 
The remaining host type cells (40 chr.) survive in important amount till 
10 days after in·adjation then decrease dramatically thereafter bnt 
never completely disappear. 
Even after a letal X-irradiation dose, the marrow steru cells pool is not 
completely destroyed. The host cell karyotype population, after a 10 day 
period of reduction due to direct radiation damages, is stabilized. This 
population thereafter does not increase with time and therefore does not 
suggest any activation of some quiescent host earlier precursors but 
rather suggest a simple survival and activity of a few of the ·host stem 
cells. 
Those results determine the basement line of further expedmellts in 
whjch intensive stimulcot.ions of the hemopoietjc cell pool will be 
checked for their possible effect on the karyotype ratio between host 
and donor type. A predominant stimulated reapparition of the host cell 
karyotype would strongly support the existence of an earlier progeni t.or 
than the Hemopoietic Stem Cell as defined by the CFUs assay. 
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Title of the project no.3: EFFECT OF FRACTIONATION OF GAMMA 
RAYS AND NEUTRONS ON CANCER INDUCTION AND PROMOTION IN MOUSE 
LIVER. 
Head of project: J.R. Maisin 
Scientific staff: J.R. Maisin*, G. Gerber**, M. Janowski***, 
M. Lambiet-Collier***, G. Mattelin*** 
* UCL, Brussels, ** CEC, Brussels, *** CEN, Mol. 
I. Objectives of the project: 
I. to study the effects of X-rays alone or combined with 
carbon tetrachloride (CC1 4 ) on induction and promotion 
of cancer in adult mouse liver ; 
II. to carry on the analysis of the final results of the 
study performed during the period 1980-1984 on the 
relative effectiveness of a single or fractionated whole 
body gamma or 50 MeV neutron exposure with respect to 
survival and cancer induction in C57BL mice. 
II Objectives for the reporting period: 
1. to determine the lifespan of mice exposed locally on the 
upper part of the abdomen, with increasing doses of 
X-rays, treated with a single subcutaneous injection of 
CC1 4 or exposed to X-irradiation following or preceeding 
eel. treatment; to perform autopsy and histological 
analysis of tissue samples of dead mice ; 
2. to finalize the analysis of the results of the study 
performed during the period 1980-1984 on the relative 
effectiveness of a single or fractionated whole-body 
gamma or 50 MeV neutron exposure with respect to 
survival and cancer induction in and C57BL mice. 
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Ill. Progress achieved: 
I. Effects of X--rays alone or COIT1bined with eel.. on 
induction and promotion of cancer in adult mouse liver 
Male e57BL enb mice (DL50/30 days 5.75 Gy) 
weighi 119 25 to 30 g were used throughout. 
12 weeks old and 
All mice treated with carbon tetrachloride (eel,.) (Merck T 
pur) 1eceived a dose of 0.1 ml of a 40% solution of eel. in 
MLglyol 812 administered subcutaneously in the neck region. 
All eel. injections were administered between 11 and 12 am. 
The conditions of X-irradiation were 250 kV 12.5 mA, dose 
rate 0.096 Gy/min, 1 mm Cu filter giv1ng a HVL of 1.88 mm Cu. 
Focus distance 125 cm. During each exposure, the X-ray dose 
was measured in air using a 2750 A Nuclear Enterprise 
dosimeter. Mice were fixed on a plastic plate and irradiated 
in groups of 4 on the upper part of the abdomen. The rest of 
the body was shielded w1th 2 plates of lead (5 mm thick). 
All irradiation were carried out during the morning hours. 
The control mice were divided in three groups: normal 
controls (67 ~ice), r~~trol mice exposed to 0.5 (57 mice), 1 
{5~ mice), 2 {54 mice), 4 {58 mice) or 6 Gy {57 mice) (Total 
number of mice: 286 mice) and normal control mice treated 
with eel. (19 mice). 
The treated mice were divided in two groups: 
1) X-irradiated mice following eel. treatment. After eel. 
treatment mice were exposed 69 hours later to 0.5 (60 m1ce), 
2 {56 mice), 4 {57 mice), 6 Gy {57 mice) (Total number of 
mice: 285 mice) 
2) X-irradiated mice preceding eel. treatment. Mice were 
exposed to 0.5 (56 mice), 1 (58 mice), 2 (113 m1ce} and 6 Gy 
(59 mice) and treated three months later with eel. (Total 
number of mice: 396 mice). 
The mice were housed two per cage and kept unti·l death. 
Autopsies were performed and tissue samples ·were taken for 
histological analysis. The following diseases were 
classified: liver adenoma and carcinoma, liver sarcoma, 
liver angioma, liver angioma + liver sarcoma, liver adenoma 
+ sarcoma + carcinoma. ~hymic lymphoma, myeloid leukaemia, 
adenocarcinoma of other organs, sarcoma of other organs. 
'rhe data were evaluated by the Kaplan-Meier procedure using 
as criteria cause of death and possible cause of death. 
No significant differences exist in survival time between 
the non irradiated mice treated or not with eel., the 
irradiated mice without eel. treatment and the irradiated 
mice following or preceding eel. treatment. 
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The causes of death in our normal control C57BL male mice 
~re in the following decreasing order of frequency: non 
~anc~rous late degenerative changes in lung (56.7 %) ~5 per 
~ent of the control ~1ce died from any types of leukaemias. 
Tl1e inci::lence of 1 iver adenoma + adenocan::inoma and sarcoma 
(in r.ormal conb·e>l mice} was 11.9 per cent (Table I). In 
control mice treated with eel. the incidence of adenoma + 
adenocal'C1noma + sarcoma is twice as large as in normal 
controls (Table II). 
Table I. 
-------
Treat 
-ment 
ccntr. 
0 .. 'i Gy 
1 Gy 
2 Gy 
4 Gy 
6 Gy 
Incidence of liver tumours 1n control mice and 
in mice exposed to increasing doses of X 
radiation 
Number Liver tumour incidence in % 
of mice 
( 1} (:!} ( 3) (4) 
adenoc. sarc. angio. all 
+ aden. malig 
turn. 
68 1C.5 1 . 4 1.4 11 . 9 
57 17.5 1. 75 5.3 19.25 
'57 1C.5 I . 75 3.5 12.3 
54 24 5.5 5.5 29.5 
58 27.6 8.6 1 c. 3 36 . .:2 
"' 
57 21 0 7 21 
The Kaplan-Meier estimates show a low significance 
(0.05 P•0.08) for all malignant liver tumours 
between normal control and m1ce exposed to 4 Gy. 
(1) adenoma+ adenocarcinoma 
(2) sarcoma 
(3) a.ngioma 
(4) all mal tgna.nt tumc .. urs 
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Table II. Incidence of liver tumours in mice receiving 
a single injection of carbon tetrachloride 
before increasing doses of X radiation 
Treat Number Liver tumour incidence in % 
-ment of mice 
( 1 } ( 2} { 3} {4} 
adenoc. sarc. angio. all 
+ aden. malig 
tum. 
contr. 68 10.5 1.4 1.4 11.7 
contr. +eel. 19 26.31 0 0 26.31 
cel.+O. 5 Gy 60 21.6 1 . 6 1.6 23.3 
eel. + 1 Gy 56 17.8 0 5.3 17.8 
eel. + 2 Gy 56 19.6 7. 1 8.9 26.7 
eel. + 4 Gy 57 24.6 0 8.8 24.6 
eel. + 6 Gy 56 30.3 
* 
3.6 10.7 33.9 
* 
* The Kaplan-Meier estimates shoK a high significance 
{P<0.01} for adenoma+ adenocarcinomasand all malignant 
liver tumours betKeen normal control and mice treated 
Kith eel. + 6 Gy. 
{1} adenoma+ adenocarcinoma 
{2) sarcoma 
{3) angioma 
{4) all malignant tumours 
The incidence of the different types of 
irradiated mice Kithout eel 4 treatment, 
treated Kith eel 4 and in mice treated 
irradiation Kith eel. is given in tables II 
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liver tumours in 
in control mice 
before or after 
and III. 
Table III. Incidence of liver tumours in mice receiving 
a single injection of carbon tetrachloride 
after increasing doses of X radiation 
Treat Number Liver tumour incidence in % 
-ment of mice 
{ 1 ) { 2) { 3) {4) 
adenoc. sarc. angio. all 
+ aden. malig 
turn. 
contr. 68 10.5 1 .4 1.4 11 . 7 
contr. +eel 4 19 26.31 0 0 26.31 
0.5 Gy+eel. 56 26.8 * 1. 8 1 0. 7 28.6 * 
1 Gy + eel. 58 18.9 * 6.9 5.2 25.8 * 
2 Gy + eel. 113 19.5 * 5.2 3.5 24.8 * 
4 Gy + eel. 113 31.8 6.2 6.2 38 
6 Gy + eel. 59 44. 0°* 10.2 10.2 54. 2°* 
The Kaplan-Meier estimates show a high significance 
{P<0.01) for adenoma+ adenocarcinoma and all malignant 
liver tumours between normal control and mice treated 
with 6 Gy + eel •. 
* The Kaplan-Meier estimates show a high significance 
{P<0.01) for adenoma+ adenocarcinoma and all malignant 
liver tumours between most of the group of mice 
irradiated before eel. treatment and the groups of mice 
irradiated with 6 Gy before eel. treatment. 
{1) adenoma+ adenocarcinoma 
{2) sarcoma 
{3) angioma 
{4) all malignant tumours 
When compared to normal controls only the data on adenoma + 
adenocarcinoma and on all malignant tumours in mice exposed 
to 6 Gy preceding or following eel. treatment present 
significant statistical differences {P<0.01). 
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The same observation was made when the data of the groups of 
mice irradiated before CC1 4 treatment were compared with 
control X-irradiated mice exposed to the same doses of X-
rays. 
When the data of the different groups of mice irradiated 
before eel. treatment were compared to the data of the mice 
of the same group irradiated with 6 Gy, very significant 
results were observed for adenoma + carcinoma of the liver 
and for all malignant liver tumours for most of the group of 
mice (Table III). 
3. Discussion 
The experimental data show that administration of eel. three 
days prior to X-irradiation result after high dose of X-
irradiation (6 Gy) in an increase in the number of adenoma + 
adenocarcinoma + sarcoma though not to the same extent as 
when CC1 4 was given three months after exposure to X-rays. 
These results demonstrate that a combined treatment of a 
promotor given before or after an X-rays exposure seems to 
increase, after high irradiation doses, the incidence of 
liver cancers in C57BL mice. The result obtained for groups 
of mice promoted with eel. three months after irradiation 
seems to show that no time lag is needed for promotion. 
Following CC1 4 treatment liver tissue is severely damaged: 
from 1/4 to 1/2 of the central region of each lobule is 
necrotic and eosinophilic. Mitotic figures are scattered at. 
random throughout the intact parenchyma. Abnormalities are 
rare in mice receiving X-irradiation preceding eel. 
treatment. There is a marked increase in the number of 
mitotic abnormalities compared to eel. treated controls. The 
percentage of abnormal mitotic figures increased with X-rays 
doses. 
4. Conclusions 
The administration of eel. three days prior to irradiation 
results after high doses of X-irradiation (6 Gy) in an 
increase in the number of adenoma+ adenocarcinoma +·sarcoma 
of the liver though not to the same extent as when eCl 4 was 
given three months after exposure to X-rays. The results 
obtained for the group of mice promoted with eel. three 
months after irradiation seems to show that no time lag is 
needed for promotion 
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II. Relative effectiveness of a single or fractionated 
whole-body gamma or 50 MeV neutron exposure with respect 
to survival and cancer induction 
1. Methodology 
Male C57BL Cnb(F58) mice, 12 weeks old and weighing 25 to 30 
g were used. Gamma irradiations were performed with a ' 37Cs 
unit at doses of 0.25, 0.5, 1, 2, 4 or 6 Gy at a dose rate of 
0.3 Gy/rnin. Irradiation was delivered in a single session, 
in 10 equal doses delivered 24 h apart, or in 8 equal doses 3 
h apart. 
Neutron irradiation was performed at the UCL-cyclotron of 
Louvain-la-Neuve. Neutrons were produced bombarding a thick 
beryllium target with deuterons (d(50)+Be). The indicated 
doses are the total absorbed doses D"~' including the gamma 
contribution Dy which was about 7% at the level of the 
animals. As far as fractionation is concerned, single 
neutron doses were compared to eight equal fractions 3 h 
apart. 
The mice were housed two per cage and kept until death. An 
autopsy was performed, and tissue samples were taken for 
histological analysis. Fewer than 1% of the mice were lost 
due to decomposition, cannibalism, etc. The following 
diseases were classified: thymic lymphoma, nonthyrnic 
lymphoma, myeloid leukaemia, lung carcinoma, liver carcinoma, 
thyroid carcinoma, adrenal carcinoma, various sarcomas, 
thyroid adenoma, adrenal adenoma, spleen adenoma, and 
noncancerous late degenerative changes in lung and kidney. 
For statistical purposes the following groups were also 
pooled: all leukaernias, all carcinomas and sarcomas, all 
malignant tumors, and all benign turners. 
The data were evaluated by the Kaplan-Meier procedure using 
criteria cause of death and possible cause of death. 
Comparison between individual groups was carried out by a 
modified Wilcoxon procedure according to Heel and Walburg; 
an entire set of different doses from one radiation schedule 
was evaluated by the procedure of Peto using a program kindly 
supplied by Dr Wahrendorf and translated by us into Basic for 
use in a Model IV TRS-80 microcomputer. The data were 
evaluated for trend, heterogenity, and linearity with respect 
to cause of death and incidental disease. Calculation of the 
Cox proportional hazard model was carried out using a Basic 
program given to us by Chmelevsky and Kellerer. 
No significant difference exists in survival time of C57BL 
mice in function of dose between a single gamma or a single 
neutron exposure. Both gamma fractionation schedules are 
clearly less effective than a single gamma exposure in 
reducing survival. On the contrary, a fractionation of 
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neutrons seems to be slightly although not significantly more 
effective in reducing life span than a single exposure, 
whereas neutron exposure of the thorax does not affect life 
span. Survival time appears to be a linear function of dose 
in all the experimental groups studied (Fig. 1). 
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Fig. 1. Dependence of survival time of C57BL mice on dose. 
Data are shown for single or fractionated (10 
fractions 10 days apart and 8 fractions 3 h apart) 
exposure to gamma rays as well as for single or 
fractionated (8 fractions 8 h apart) exposure to 
neutrons. 
Life-shortening, calculated by linear weighted regression on 
dose of the values obtained by the Kaplan-Meier calculation 
for survival time, amounts to 31.1 ± 2.6 days/Gy for a 
single exposure, 19.6 ± 2.9 days /Gy for a 10-fraction gamma 
exposure, and 16.5 ± 3.4 days/Gy for an 8-fraction gamma 
exposure. For a single neutron exposure, life-shortening is 
32.5 ± 5.9 days/Gy; for fractionated neutrons it is 44.8 z 
13.2 days/Gy. 
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Causes of death 
Causes of death in control mice are in the following 
decreasing order of frequency: noncancerous late degenerative 
changes in lung and kidney (glomerulosclerosis); 18t of the 
controls die from any type of leukaemias; and 16% from 
carcinomas and sarcomas among which liver adenomacarcinoma is 
most frequent. 
The data and the statistical evaluation demonstrate that 
malignant turners (particularly leukaemias, including thymoma) 
as well as noncancerous late degenerative changes in lung are 
the principal causes of life-shortening after a single high 
gamma irradiation. A comparison of the crude percentage 
incidences in function of dose suggests that fractionated 
exposure, in particular that delivered in 8 fractions 3 h 
apart, is more efficient in causing malignant turners and all 
leukaemias. No difference is noticeable with respect to 
thymoma. This impression is strengthened by Kaplan-Meier 
plots: all carcinomas and sarcomas appear to occur somewhat 
earlier after 1 Gy at a schedule of 8 fractions than after 10 
fractions or a single exposure. The same fractionation 
schedule also is more efficient in causing leukaemias after a 
dose of 2 Gy which, given as a single dose or in 10 
fractions, does not cause earlier leukaemias compared to the 
other groups (Fig. 2). 
Similar observations also pertain to all malignant turners 
after 2 Gy. At a dose of 4 Gy, the fractions are less 
rather than more efficient in causing leukaemias or all 
malignant tumors than 10 fractions or a single exposure. 
Following a single neutron exposure, the crude percentages 
of leukaemias and thymoma appear to increase somewhat more 
rapidly with dose than after gamma exposure. There is no 
clear difference discernable in crude incidences between 
single and fractionated neutron exposure for all malignant 
turners. Because a much larger effect of neutrons had been 
expected when the experiment was designed, the doses have 
unfortunately not been chosen in such a way that neutron and 
gamma exposure could be compared directly for all individual 
doses. The Kaplan-Meier presentations indicate, however, 
that after fractionated neutron exposure all malignant turners 
occur earlier after a single 1.65 Gy neutron exposure and 
perhaps still earlier after a fractionated one than after a 
single 2 Gy gamma exposure. The differences with respect to 
all leukaemias are less marked for single exposure of 
neutrons and gamma rays, but fractionated neutrons appear to 
result in an earlier appearance of leukaemias than a single 
neutron exposure. Exposure of the thorax only to low doses 
of neutrons causes a significant increase in leukaemias, all 
carcinomas and sarcomas, and all malignant turners, although 
it does not affect survival time. 
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C57BL mice following a 2 Gy gamma ray d0se given in 
a single exposure, in 8 fractions at intervals of 
24 h. Controls are also shown. 
At equal dose, life-shortening in C57BL mice was slightly 
less pronounced after a f1actionated gamma irradiation than 
after a single exposure. These observations thus agree with 
earlier findings on BALB/c mice. Fractionation also 
appears, however, to result in an earlier and more frequent 
appearance of tumors after doses in the range of 1-2 Gy 
(Kaplan-Meier plots) although this difference is not 
statistically significant. This also confirms the earlier 
observations on BALB/c mice, a strain which has a much higher 
spontaneous incidence of tumors than the C57BL and in which 
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fractionation was Also found to be more effective in_causing 
tumors except for thymic lymphoma. Since the average life 
span is longer after fractionation, it appears that earlier 
death after single exposure occurs from noncancerous late 
degenerative lesions. 
The differences found in the present study between induction 
of radiation-induced cancer by fractionated and single gamma 
exposure are small and not yet well enough established from a 
statistical point of view. They show, nevertheless, that 
fractionation of gamma rays would not necessarily be less 
effective than single exposure in the dose range of about 1-2 
Gy. 
Single and fractionated neutro~ exposure 
Fractionation of d(50)+Be neutrons appears to cause a more 
marked life-shortening and an earlier appearance of tumors 
than single neutron exposure although the statistical 
significance of the results is not established. No 
statistically significant difference between single and 
fractionated neutron exposure could however be observed for 
all carcinomas and sarcomas and for all leukaemias. 
Information on the effects of fractionation on tumor 
induction by d(50)+Be neutrons is not available, but some 
observations have been made on fission neutrons: in general, 
fractionation. either has. no ~ffect or. provokes an 
enhancement. Enha.n_cements are particularly noticeable a.t 
higher neutron doses. 
Local neutron exposure of the thorax had been carried out in 
the expectation of an increased incidence of lung tumors, but 
this was not the case. 
The RBE for life-shortening of C57BL mice for d(50)+Be 
neutrons compared to gamma rays was. not significantly 
different.from unity. This agrees with our previous data on 
BALB/c mice. The uncertainty concerning the shape of the 
dose-effect curve for induction of all . malignant tumors 
precludes a calculation of the RBE; a very rough estimate 
obtained from the proportional hazard parameter at doses 
between 2 and 6 Gy for gamma rays and between 0.54 and 3 Gy-
of neutrons suggests an RBE betweep 1 and 1.5 for single 
exposure to gamma rays. The RBE of d(50)+Be neutrons for 
life-shortening appears to be lower than for other end 
points. D(50)+Be neutrons are, of cour~e, expected to have 
much lower RBE than fission neutrons; nevertheless, the RBE 
values in the present study for life-shortening seem 
surprisingly low. 
Neutron irradiation caused 
irradiation and the RBE 
higher, probably between 2 
although the present data 
assessment. 
somewhat more cancers than gamma 
for cancer induction might be 
and 3 in the range of 1 to 3 Gy, 
do not allow a more. precise 
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Title of the project no.4: THE EFFECT OF AGE ON LIVER TUMOUR 
INDUCTION BY RADIATION ALONE OR COMBINED WITH A CHEMICAL 
CARCINOGEN 
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I. Objectives of the project: 
I. to study the influence of age on tumour induction in mice 
by X- and neutron irradiation 
II. to study to which extent small dose of X- and neutron 
effects of irradiation could potentiate the 
diethylnitrosamine 
II. Objectives of the reporting period: 
1. to study to which extent small 
irradiation could potentlate 
diethylnitrosamine (DEN) on the 
tumours 
dose of X- and neutron 
the effects of 
induction of liver 
2. to study the influence of age on tumour induction in 
mouse by X- and neutron irradiation 
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Ill. Progress achieved: 
1. Methodology 
Female C57BL/Cnb mice 8 to 10 weeks old were bread with one 
male of the same age. Pregnant female were housed singly in 
plastic cages. Checks for delivery were made twice daily. 
At an age of 14 or 21 days, the male offspring was given an 
~i.p. injection of 0, 0.31, 0.62, 1.25 and 5.0 ~ of DEN in 
0.9% NaCl solution per~ body weight. The mice were fed ad 
libitum with standard laboratory chow and water. Animals 
were kept in a temperature controlled room with a 12 hour 
light-dark cycle. 
The conditions of X-irradiation were 250 kV, 15 mA, exposure 
rate 0.95 Gy/min, 1 mm Cu filter giving a HVL of 1.85 mm Cu. 
During each exposure the X-ray dose was measured in air using 
a 2750-A Nuclear Enterprise dosimeter. Mice were exposed in 
groups of ten in partitioned plastic cages. 
The neutron irradiations were performed at the new thick-
target Be(d,n)-field at Ed 6.3 MeV using a distance of 
about 55 cm for the source and a pyramidial collimator (2.2 x 
2.2 cm at the source and 14.1 x 14.1 cm at the sample 
position). The neutron spectrum extends to a maximum of 10.7 
MeV, the average neutron energy being 3.1 MeV. The doses 
have been determined for each irradiation as usual with a 
0.53 cm0 thimble ionisation chamber operated in continous TE-
gas flow by total charge determination using <W> = (31.9 ± 
1.5) eV. Small temperature and pressure corrections were 
applied. 
The 5020 mice used for this experiment were distributed in 
the following 7 groups : 
1. mice treated with DEN alone 
Treatment at an age of 14 days with 0.31, 0.62, 1.25 and 2.5 
fg/g of DEN (320 mice) 
2. mice treated with X-rays alone 
Treatment at an age of 7 and 21 with a single dose of 0.50, 1 
and 3 Gy of X-rays (480 mice) 
3. mice treated with neutrons alone 
Treatment at an age of 7 and 21 days with a single dose of 
0.25, 0.50 and 1 Gy of 3.1 MeV neutrons (480 mice) 
4. mice treated with DEN + X-rays 
Treatment at an age of 14 days with 0.31, 0.62, 1.25 or 2.5 
~gfg of DEN followed by a s1ngle dose of 0.5, 1 or 3 Gy of X-
rays 7 days later (960 mice) 
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5. mice treated with X-rays + DEN 
Treatment at an age of 7 days with a single dose of 
and 3 Gy followed 0.31, 0.62, 1.25 or 2.5 ~g/g of DEN 
later (960 mice) 
0. 50' 1 
7 days 
6. mice treated with DEN + neutrons 
Treatment at an age of 14 days with 0.31, 0.62, 
~/g of DEN followed by a single dose of 0.12, 
Gy of 3.1 MeV neutron 7 days later (460 mice) 
1.25 and 2.5 
0.25 and 0.5 
7. mice 
Treatment at 
0.25 and 0.5 
1.25 and 2.5 
treated with neutrons + DEN 
an age of 7 days with a single dose of 
Gy of 3.1 MeV neutron followed by 0.31, 
fg/g of DEN 7 days later (960 mice) 
0. 1 2' 
0.62, 
Autopsies were performed and the livers were removed in 
toto, weighed and inspected for the presence of grossly 
visible discoloration and for the number and size of nodular 
lesions. Sections of liver, 2 to 4 mm thick, were made 
through the longest axis of each lobe, fixed in buffered 
formalin and embedded in paraffin. Three tm thick sections 
were cut 200 ~m apart and stained with haematoxylin and 
eosin. Four types of focal and nodular lesions were 
distinguished and recorded: foci, hyperplastic nodules, 
hepatocellular adenomas and hepatocellular carcinomas. 
The focal lesions in 3-dimensional space were evaluated 
quantitatively from 2-dimensional liver intersections 
utilizing a MOP-VIDEOPLAN (KONTROL) image analyser. This 
computer was corrected to a transluscent digitizing table 
used either with a light cursor and a "Camera lucida" 
equiped Zeiss IM-35 microscope for direct measurement at 
microscopic resolution or as a screen for the projection of 
the whole section and macroscopic measurements. Calibration 
of the operating system was done using a calibration Zeiss 
Test-lines. 
Choice of radiation doses: The choice of the X-ray doses to 
be used for the experiments on combined effects was based on 
a previous study on whole body irradiated adult C57BL male 
mice. The LD50 at 30 days was determined for mice exposed at 
7 or 14 days of age and was respectively 5.87 and 5.78 Gy. 
The causes of death in our normal control C57BL male mice 
are in the following decreasing order of frequency: 66% of 
non stochastic lung diseases and kidney diseases (glomerulo-
sclerosis); 18% of the controls died from various types of 
leukaemias (e.g. thymoma 1.87%); 16% from carcinoma and 
sarcoma among which liver adenoma + adenocarcinoma (11%) 
were the most frequent. 
- 1333 -
Among the X-irrad1ated mice surviving longer than 30 days 
after increasing doses of X-rays, thymic lymphoma was most 
often (85.3%) responsible for death within 197 days. The 
optimal doses required to induce thymic lymphoma in the mice 
irradiated at 7 and 14 days of age were 6.5 and 5 Gy 
respectively. Thymic lymphoma was however rare in mice 
exposed to the doses of 0.5, 1 and 3 Gy used in the present 
experiment. 
Diethylnitrosamine h~~tocarcinogenesis in the infant mo~~~: 
It was important to know to what extent our substrain of 
C57BL mice was susceptible to the induction of liver 
hepatomas by diethylnitrosamine. Since some strains and 
substrains are particularly prone to development of 
hepatomas, others are less susceptible. Genetic studies 
showed that the lethal genes Ay increase susceptibility to 
the extent that all male AyAF hybrid mice surviving for 16 
months develop hepatomas. The susceptibility of a given 
species or strain of mice also varies with the particular 
carcinogen. 
The results show that the C57BL/Cnb strain used is 
susceptible to the induction of liver cancer by DEN (Fig.1). 
The mice treated with the highest doses of DEN suffered from 
the most invasive lesions. The average number of liver 
lesions increased with doses of DEN. The latency period for 
the appearance of foci depends essentially on the dose of 
DEN. With the highest doses of DEN (2.5 ~g/g) at 10 weeks 
after the beginning of the treatment each treated mouse 
presents lesions, their number increasing with time. For the 
lowest doses of DEN (0.3 ~g/g) the latency period for the 
appearance of liver lesions is longer and waiting a period of 
50 or 60 weeks, some mice among the 10 treated mice do not 
present any lesions. 
Effects of X-r~combined with DEN on lesions induction in 
mou~_U_y_~z:. 
Combined treatment of DEN + X-rays: 
Combined treatment of 0.31, 0.62, 1.25 or 2.5 ~g/g given 7 
days before increasing doses of X-rays showed that the 
development of liver lesions depends essentially on the dose 
of DEN and not on the dose of X-rays (Fig. 1 and 2). When 
the results obtained for a same dose of DEN and increasing 
doses of X-rays are compared, the results are not 
statistically different. 
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~_1_. Development of liver lesions (foci, nodules, 
adenomas and carcinomas) in C57BL mice expressed in 
mm2 of damaged liver tissue following a combined 
treatment of a given dose of DEN given 7 days before 
increasing doses of X-rays. 
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Combined treatment of X-rays + DEN: 
Combined treatment of X-rays given 7 days before increasing 
doses of DEN showed that the development of liver lesions 
behaved in the same way as the comparable group of mice 
receiving DEN before X-rays exposure (Fig. 3 and 4) 
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Fig. 3. Microscopic liver lesions (foci, nodules, adenomas 
and carcinomas) following a combined treatment of a 
given dose of DEN 7 days before increasing doses of 
X-rays. 
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f~. Microscopic liver lesions (foci, nodules, adenomas 
and carcinomas) following a combined treatment of 
increasing doses of X-rays 7 days before increasing 
doses of DEN. 
Mice treated with DEN + neutrons or with neutrons + DEN: 
Unfortunately due to repair work at the Van Der Graef of the 
BCMN during the first part of the year 1988, the neutron 
irradiation had to be postponed until the end of the year 
1988 and the first part of the year 1989. The preliminary 
results obtained show that neutron irradiation given 7 days 
before or .after the administration of DEN does not have any 
additive or synergistic effects compared with the data 
obtained with DEN or neutron irradiated alone. 
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There is a great scarcity of systematic data in which an 
analysis of combined effects can be based in spite of the 
large number of reports, where combined actions were tested 
and interactions claimed. There are at least three types of 
combined actions: 
- additivity: (when the end-effect of the combined action 
equals the sum of the effects of the two agents acting 
independentely). 
- synergism: (when the effects of the combined action exceed 
the sum of the effects produced separately by the agents). 
- antagonism: (when the combined action results in an effect 
which is less than expected from the sum of the actions of 
the interacting agents). 
In spite of the advantage of the liver system it has not 
been used very much for the study of the possible 
interactions of irradiations and chemicals. A synergistic 
action of fission neutrons with N,N-2-7-
fluorenylenebisacetamide (2,7-FAA) was reported for 
irradiation of liver and gastric carcinoma but not for the 
intestinal tumours. Localized X-irradiation in association 
with 2,7-FAA administered in the diet accelerated the 
induction of hepatomas and similar effects were reported when 
X-rays were given with 0-aminoazotoluene and of radioactive 
144Cs and dimethylaminoazobenzene (DBA}. The infant mouse 
liver is much more easily transformed by chemical carcinogens 
than the adult liver. This may be due to the particular 
characteristics of infant liver which differ in several 
respects from the adult. 
In a preliminary experiment we demonstrated that X-rays 
administered several days days before a single injection of 
DEN was more effective in inducing microscopic liver nodules 
than when administered 7 days after DEN administration 
(Maisin et al, 1986). Similarily in rats treated neonataly 
it was demonstrated that combining the DEN and radiation 
treatment, total focus yield was significantely increased 
although the response declined with the increasing radiation 
dosage. The author suggested that quantitatively different 
types of genetic damage {carcinogen-induced point mutation) 
and radiation induced rearrangements may interact 
synergistically in the induction of phenotypically altered 
cells. Our results show that the incidence of liver lesions 
after combined treatment of increasing dose of DEN for X-rays 
depends essentially on the dose of DEN, that the combined 
treatment of DEN and X-rays is not more effective than DEN 
given alone and that the dose of X-rays administered 7 days 
before a single injection of DEN is not more effective than 
when administered 7 days after DEN. Preliminary data on the 
induction of liver tumours after combined treatment of 
increasing doses of DEN or neutrons show similar results. 
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The incidence of liver lesions after combined treatment with 
increasing doses of DEN and X-rays depends essentially on 
the dose of DEN. The combined treatment of DEN and X-rays or 
of X-rays + DEN is not more effective than DEN given alone. 
Preliminary results obtained with neutron irradiation given 7 
days before or after the administration of DEN seem not to 
present any additive or synergetic effects compared with the 
data obtained with DEN or neutron irradiation alone. 
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I. Objectives of the project: 
The evaluation of ionizing radiation overexposure has been made, until now, by measuring 
chromosomal aberrations in the mitotic lymphocytes of irradiated individuals. more 
recently, a method taking into account the radio-induced membrane modifications of 
different sub-populations of blood cells has been described. 
Our aim is to adapt these valuable methods, but heavy and tedious, for flow cytometry 
analysis with the expected following benefits: rapidity, analysis of large number of 
biological objects, multi-parametric analysis, immediarte statistical analysis, correlations 
between different parameters. 
The purpose of the project is to evaluate the potenciality of flow cytometry towards three 
main goals: heterogenous chromosomal aberration detection on flow karyotypes, use of 
anti-centromeric antibodies for detection of a- and dicentric chromosomes, and 
measurement of membrane modifications by fluorescent probes (lectins, monoclonal 
antibodies). 
11. Objectives for the reporting period: 
Work for the reporting period concentrated mainly on the labeling of chromosomal 
kinetochores. Different techniques were used in order to make it homogeneously staining 
chromosomes and to reduce background due to non specific staining by fluorescent 
antibodies. 
Staining and detection of reticulocytes was performed using Thiazole Orange. 
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Ill PROGRESS ACHIEVED 
The proposal involved three aspects: 
1-Direct estimate of dose related damages to the irradiated chromosomes after 
exposure of lymphocytes in vitro. 
2-Analysis of chromosomal aberrations by means of monoclonal antibodies. 
3-Studies of radiation induced changes in the cell membranes. 
1- DIRECT DETECTION OF CHROMOSOMES CHANGES USING FLOW 
CYTOME1RY. 
The first two years have been devoted to technical investigations mainly dealing 
with improving cell culture and mitotic preparations. Computerized analysis of 
monoparametric signals related to DNA content (ethydium bromide) of each chromosome 
group has been proposed for three species: man, non human primates and pigs. High 
resolution biparametric scans of chromosomes have been tested by simultaneous 
recording of DNA content and relative concentration of AT/GC bases using Hoechst and 
Chromomycine A3. This last improvement allowed to separate 16-17 different peaks 
instead of 12 in the previous experiments for Macacafascicularis, with the ATC 3000 
flow cytometer. 
The smallest chromosome of Macaca fascicularis was well separated from the 
background of cellular debris in a monovariate flow karyotype. It was thus possible to 
define a value of the background (BF) in this area normally free of chromosomes in 
relation to the number of analysed chromosomes. In 4 irradiation experiments on blood of 
2 individuals, each experiment as well as the mean of the experiments showed a 
dose-effect relationship. However, if one wants to determine the value of the received 
dose from an isolated BF value through the mean standard curve, one can easily see some 
discrepancy in the results. This variability has certainly several causes: variability among 
the individuals and variability of the history of each individual (opposed to the stability of 
an in vitro cell culture), but certainly also the extreme dependance on the way 
chromosome suspensions are prepared. 
These results, from blood isolated from two different individuals, are not very 
optimistic about the possibility of obtaining biological dosimetry when using such a 
method, contrary to the conclusions of the literature. However this method remains of 
some value for the detection of clastogenic agents in in vitro genetic toxicology tests. This 
general approach to study DNA damage generated by ionizing radiation does not seem to 
be promessfull for human biological dosimetry and so, we decided to analyse 
chromosomal abnormalities by a molecular approach involving flow sorting. 
A recurrent t( 11 ;22) breakpoint was mapped by chromosome flow sorting and 
spot-blot hybridization. 
The breakpoint of the recurrent t(11;22) translocation, one of the most frequent 
chromosome anomalies encountered in human population, always involves bands 
11q23.2 and 22q 11.2. The involvement of the Cl locus of the immunoglobulin I gene 
cluster on chromosome 22 has been suggested: however, in situ hybridization 
experiments have yielded conflicting results. In order to solve these dicrepancies by 
another aproach, we have used bivariate flow sorting to separate the chromosomes of 
interest and to map the specific breakpoints by direct spot-blot hybridization with the 
gene-specific radiolabelled DNA probes Alu, VA, ets. The results showed 
unambiguously that in the t(11;22) patient analysed a set of CA, and VA, genes was 
tranlocated to the der(11) chromosome. Since VA, genes are situated proximally to CA, 
genes, we demonstrated that, in the case studied here, the chromosome 22 breakpoint in 
now located within or even immediately close to the CA, region. 
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The transmission of a chromosome translocation has been followed in an 
experimental pig family 
Again, the involved methodology was spot-blot hybridization after flow sorting. 
The efficiency of this method prompted us to determine if it was applicable to porcine 
gene localisation. The availability of individuals carrying a t(3;7)(p 1.3; 12.1) translocation 
favored this approch to confmn the assignment of MHC to porcine chromosome 7. 
Oncogene detection by enzymatic amplification on flow sorted chromosomes 
Direct spot blot hybridization on flow sorted chromosomes has allowed gene 
mapping and characterization of chromosomal reammgements. But this thechnique still 
requires a relatively high number of sorted chromosomes and several concentrations in 
order to get an unambiguous positive signal especially when probing a single copy gene. 
The Polymerase Chain Reaction (PCR) was used to amplify directly on a few flow sorted 
chromosomes a specific sequence which can be then reliably identified. The results show 
that PCR reduces dramaticaly the requirement of flow sorted materialfor the detection of 
unique DNA sequence on specific chromosomes. So the combination of PCR and flow 
cytometry should enable the rapid and precise characterization of chromosomal 
reammgements and oppens potential diagnostic applications. 
2- ANALYSIS OF CHROMOSOMAL ABERRATIONS BY MEANS OF 
MON()(l.()NAL ANTIBODIES. 
The feasibility of Kinetochore identification by imunostaining with autoantibodies 
secreted by scleroderma patients with CREST syndrome was evaluated during the first 
year of the contract. During the 2nd year, we demonstrated that a slight modification of 
labelling technique made it possible to stain chromosomes in suspension by indirect 
immunofluorescence with anti-centromere sera. However, we observed that a non 
specific fluorescence was revealed by the FITC-conjugated antibody and made the 
quantitative development of the method difficult 
Two human lymphoblastoid cell lines ICB 100 and 101 were used. Purified IgG 
and sera from patients with the CREST syndrome of scleroderma were the source of 
antikinetochore antibodies. The second FITC-labelled antibodies were anti-human IgG. 
All labelling was made on chromosomal suspensions. The flow cytometric analyses were 
carried out with dual-laser configuration for the detection of Hoechst-bound DNA 
fluorescence and the FITC-bound centromere fluorescence. Controls were only incubated 
with FITC labelled anti-human IgG. 
Thanks to the possibility of analysing FITC fluorescence of the chromosome 
only, it was possible to detect the binding of antikinetochore antibodies to the 
chromosomes. Although we found no clear fluorescence intensity increase for a dicentric 
chromosome population obtained after cell culture irradiation, the existence of a tail on the 
FITC histogram precluded the detection of these dicentrics by flow analysis. Control 
experiments showed that the contaminent fluorescence seemed to be centromere non 
specific but chromosome specific. The presence of some chromosomes with higher level 
of FITC fluorescence may be due either to antibodies recognizing antigens other than the 
kinetochore or to kinetochores with different sizes varying with the chromosome lengths. 
The analy~ by immurtoblotting of the antigens recognized by the sera seemed to indicate 
the existence of some minor IgG able to recognize determinants other than the· 
kinetochores .. 
Futher development were made during 1988 and 1989. Thanks to the courtesy of 
Dr. Earnshaw (Johns Hopkins University, Baltimore, Maryland, USA), 2 ·mouse 
monoclonal antibodies directed against CENP-B (one of the proteins of the kinetochore) 
were used for the centromere labelling of chromosomal suspensions from the two human 
lymphoblastoid cell lines ICB 100 and 101 previously employed (see "Euratom Progress 
Report 1987", p. 705-710). 
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These antibodies recognized different epitopes of a fusion protein obtained 
through the expression of a cDNA containing part of the gene CENP-B and part of the 
bacterial ~galactosidase gene (Earnshaw W.C. et al., I Cell Bioi, 1987, 104: 817-829). 
The second fluorescent FITC-labelled antibodies were sheep anti-mouse IgG. Indirect 
immunofluorescence was also performed on HeLa cells grown on coverslips as described 
for the characterization of new nucleus specific autoantibodies (Guilly M.N. et al., Eur I 
Cell Bioi, 1987,43: 266-272). Various dilutions of these mouse monoclonal antibodies 
were tested on HeLa cells by indirect immunofluorescence microscopic analysis. A 
positive staining of kinetochores was only observed at low dilutions (1:10) contrary to 
human antiserum which still gave positive results at high dilution (1:10 000). Presently, 
none of these mouse monoclonal antibodies gave centromeric labelling on chromosomes 
in suspension with the method already used with human sera from patients with the 
CREST syndrome of scleroderma. · 
The negative results obtained on chromosomal suspension with these mouse 
monoclonal antibodies anti-CENP-B are understandable when comparing the difference 
in affinity observed on HeLa cells between them and human serum. The apparent low 
affinity of these mouse monoclonal antibodies may originate from trivial reasons such as 
lyophylisation/rehydratation difficulties. But as for the same human sera affinity 
differencies were observed between in situ and in suspension labelling techniques, it is 
very likely that the epitopes recognized on the fusion protein or on the cells grown on 
coverslips are more or less either hidden or modified when the chromosomes are released 
from the cells into the flow analysis buffer. 
These results raise questions about the best biological reagents suitable for 
specific, high affinity, labelling of chromosome centromeres in suspension. It was thus 
decided, before searching for human monoclonal antibodies, to come back to human 
anti-kinetochore sera with 3 objectives: improvement of chromosomal suspension 
labelling method with new human antisera; characterization of human kinetochore 
proteins by immunoblotting and immunoprecipitation; purification of these proteins in 
order to produce new monoclonal antibodies and/or polyclonal sera. 
Through collaboration with Dr F. Danon (Laboratoire -d'lmmunochimie et 
d'Immunopathologie, Hopital St Louis, Paris), 59 human sera from patients with the 
CREST syndrome of scleroderma were available. Indirect immunofluorescence was 
performed, as described in the preceeding section, on HeLa cells grown on coverslips, 
except that the second fluorescent FITC-labelled antibodies were sheep anti-human IgG. 
For biochemical characterization of the sera, immunoblotting and immunoprecipitation of 
nuclear proteins from KE37 cells were performed as reported for lamins (Guilly et al., 
1987, see above). 
All of the 59 sera were tested at various dilutions on HeLa cells. Though all were 
characterized as antikinetochore-specific by immunofluorescence analysis, the FITC 
background differed from one serum to another. Biochemical characterization of 17 sera 
was undertaken by performing immunoblotting and immunoprecipitation of the 
recognized nuclear antigens from a human T lymphoblastoid cell line (KE37). On 
immunoblots, most of the sera ( 11/17) detected the 80 kD nuclear protein (CENP-B). The 
antibodies eluted from this nitrocellulose-immobilized antigen labelled the kinetochores on 
cultured cells. However an important background level and a strong non-specific staining 
of the histones were often observed with this technique. Immunoprecipitation of 
biosynthetically labelled nuclear proteins was carried out to overcome the problem· of 
non-specific binding. This method allowed the identification of 8 other proteins having 
the following molecular weights: 21, 51, 65, 70, 75, 110, 150 and 200 kD, which were 
also recognized by some of the 17 CREST patients' sera. 
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The variation of FITC background between sera reinforces the need to select the 
best one and to detennine accurately the optimal concentrations for autoimmune sera and 
FITC-labelled second antibodies. The results from immunoblotting and 
immunoprecipitation experiments show that antigens other than the 80 kD protein may be 
recognized by the patients' sera. As the mercury arc lamp used in fluorescence 
microscopy has a poor exciting capacity for FITC, the human eye cannot distinguish very 
low fluorecence level which can be revealed by laser illumination. For example, the 
detection limit of the flow cytometer used (A TC 3000) is 700 true FITC molecules 
(Gaucher et al.,1988, this study). Therefore it is important to characterize biochemically 
the antigens recognized by the CREST sera before looking for monoclonal or polyclonal 
antibodies. In this respect the immunoprecipitation of biosynthetically labelled nuclear 
proteins seems to be a good technique. The obtention of pure antigens from chromosomal 
centromeric regions may solve the necessity of a choice between monoclonal antibodies 
(specific, low affmity) and polyclonal antibodies (less specific, high affinity). Another 
approach could be the use of a slit-scan flow cytometer which allows the recognition of 
the fluorescence profile of each chromosome. The possibilty of setting a fluorescence 
intensity threshold should permit the unambiguous detection of dicentric chromosomes. 
During the last year of the contract, a cooperative research has been developed 
with Barbara Trask at Lawrence Livermore National Laboratory on the DBC Flow 
cytometer prototype in order to optimize the discrimination of these low intensity 
fluorescence signals. Sera were selected on the basis of the lowest background and a 
method for separating labeled chromosomes from unbound antibodies, debris and nuclei 
was developed: centrifugation on a Ficoll 400 discontinuous 12-25% gradient. Flow 
analysis of centromere labeled chromosomes stained for AT/GC bases content, showed 
that: 
1- Flow karyotype resolution was maintained after staining procedure. 
2-The centromeres specific-FITC fluorescence intensity, was estimated to be 8 
times higher than the background fluorescence in the case of human,. and even higher for 
hamster. 
3· There is no pll>PQrtionality between ~e FiTC signal and the DNA content. 
Thus, the FITC signal can be considered as strongly centromere related. 
These last results showed unambiguously that human anti-kinetochore antibodies 
should allow quantitative detection of centromeric material. 
3- RADIATION INDUCED CHANGES IN CELL MEMBRANES 
Samples taken from human donnors and from Sprague Dawley rats were used 
and prepared for binding with concanavalin A (ConA) labeled with Fluorescein 
isothyocyanate (FITC), after a slight -fixation with paraformaldehyde. Fluorescence 
intensity was recorded after excitation at 488nm on a ATC 3000 flow cytometer. The 
detection was found feasible despite some variability, partially reduced in fixed cells, as 
shown by introduction of an internal· control made of florescent beads. Fluorescence 
intensity plateaued for concentration of FITC between 100 and 150mg of ConA per 
million of cells. 
, . Rats were exPQsed to a cobalt source in vivo to 0, 0.5, 1, 2 Gy at a dose rate of 
0.25 Gy per minute. Resulting fluorescence was analysed 2 hours after exposure in the 
different blood cell s.ubtypes. 
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Results were constantly negative in that sense that radio-induced changes were 
not discernable from inter-individual variability. Moreover, changes were unpredictable, 
receptor sites being increased or decreased in number for similar exposure conditions. 
In conclusion, as observed by other authors, and notely by Dehos, Radiation 
Protection Programme progress report 1987, we can not recommend the use of recptors 
for ConA lectin as an indicator for over-exposure to ionizing radiation. 
GENERAL REMARKS 
Despite flow cytometer is a very powerful tool, there are still progress to be made 
before it can be used under operational conditions for sorting irradiated people. 
It would be unexpected if a direct recording of the karyotype in flux could reveal, 
in individuals, a reliable dose dependant relationship due to clastogenic effects. Despite 
this limit, the feasibility of translocation detection was shown and gene amplification with 
PCR should become a powerfull tool to detect radiation induced genetic damages. 
Membrane receptors to lectins have not been validated in flux up to now. 
The most promissing method remains centromere identification by human 
antibodies which will probably allow to detect dicentric chromosomes. Production and 
purification of the reagent are still needed and validation of the process still calls for slit 
scan devices. 
Some implementations are already known as feasible like mutation at the 
glycophorin locus for red blood cells, other may be of great interest like reticulocyte 
counting that we develop for simpler devices in the laboratory. Attention should also be 
paid to telomeric fraction of the chromosome. It is known as a region of DNA required 
for replication and stability of the chromosome; it may be involved in assymetrical 
exchanges as dicentrics and arguments (Chadwick and Leenhouts) have been given that 
telomere can rejoin a broken end of another chromosome. Preliminary results in our 
hands have shown that telomeres and centromeres are involved in large scale 
chromosome rearrangements as shown by a repetitive sequence of DNA specific for 
hamster telomere and centromere. 
The centric regions of human chromosomes contain a heterogeneous mixture of 
highly repetitive DNA sequences families, one of which is present in the centromere of 
all human chromosomes (alpha satellite DNA). This sequence can be used as a probe for 
further development of the technique. 
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Title of the project no.: 
816-C-31 0-F _ 
Fetal dosimetry : measurement of the effects induced after in utero 
chronic irradiation as a function of dose rate and gestation age. 
Head(s) of project: 
Or H. Metivier 
SPEISTCEIL TT, BP 12 91680 Bruyeres le Chatel, France. 
Scientific staff: 
H. Coffigny, P. Fritsch and M. Beauvallet. 
I. Objectives of the project: 
The aim of this project is to estimate irradiation doses delivered to 
the embryo or the fetus after internal contamination by radionuclides. For 
that purpose, we determine a dose-effect relationship between the 
irradiation doses delivered by protracted external irradiation during the 
whole intra-uterine life or part of it, and biologicals effects measured on 
different radiosensitive target organs. Thus, irradiation doses delivered 
after internal contamination could be estimated from the measurement of 
the induced biological effects. 
11. Objectives for the reporting period: 
In order to estimate the irradiation doses delivered to the embryo and 
the fetus after internal contamination, the effects of protracted gamma 
whole body irradiation during the whole intra-uterine life of rodents or 
part of it were studied . For a given dose rate delivered during the whole 
intra-uterine life, different early or late effects induced by the external 
irradiations were analysed to determine the effects for which a clear 
~ose-effect relationship could be observed as a function of the delivered 
dose. For these effects, we have studied the influence of dose rates and 
we have estimated the intra-uterine periods of their induction. 
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Ill. Progress achieved: 
Methodology 
Rats and mice were irradiated by 60Co gamma rays (>23 hours per 
day) during the whole intra-uterine life and two groups of mice were 
irradiated during the last 213 or last 1/3 of gestation. Dose rates were 3, 
1 0, 25 and 37 cGy /day in rats and 20, 40 and 60 cGy/day in mice. Four 
groups of rat fetuses received a 1 Gy acute irradiation on day 15 p.c. at 
doses rates of 0.86, 4.75, 23.9 and 239 Gy/day. 
Early effects were studied the last day of gestation and late 
effects at 3 months of age. Intra-uterine and post-partum mortality, body 
and brain weights were measured. Brain histology was analysed. 
Results 
Except for a dose rate at 60 cGy/day delivered during the entire 
gestation, the irradiations did not increase intra-uterine lethality as 
compared with controls. In mice irradiated at 40 cGy/day during the whole 
gestation or at 60 cGy/day during the last 213 of gestation, all pups died 
during the neonatal period whereas no lethality was observed for lower 
dose rates. In rats and mice, the fetal weight measured on the last day of 
gestation decreased as a linear function of the delivered dose or dose rate. 
Relative brain weight also showed a significant decrease for the largest 
delivered doses. 
In adults, body weight of irradiated rats and mice was similar to 
controls. On the contrary, the relative brain weight decrease was larger in 
the adults than in the fetuses. Brain weights decreased as a linear 
function of doses or dose rate. The rest of the brain (mesencephalum and 
cerebellum) was poorly altered by the irradiations. In mice, the brain 
weight drop was similar when irradiation was delivered during the whole 
gestation or during the last 1/3 of gestation. 
The brain weight decrease induced by 1 Gy acute irradiation varied 
as a function of dose rate for rates larger than 4.75 Gy/day. Gros 
malformations were only observed for these largest dose rates. 
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Discussion 
Fetal body weight and adult brain weight are good parameters to 
estimate the dose delivered during the protracted irradiation of rats and 
mice during their intra-uterine lites but are restricted to unlethal doses . 
In the range of dose rates up to 60 cGy/day these weight alterations are 
not dose rate dependant. 
By contrast, after a1 Gy acute irradiation delivered on day 15 p.c., a 
specific dose rate effect was observed in adults as concerned brain 
weight for dose rates larger than 4,75 Gy/day. Further studied are needed 
to characterize this dose rate effect on brain and to determine if this dose 
rate effect could be induced in other target organ . 
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IV. Objectives for the next reporting period: 
The objectives for the next reporting period are: 
-to complete the histologic studies on brain for a better 
characterization of the dose rate effect 
-to study other target organs such as gonads . 
V. Other research group(s) collaborating actively on this project [name(s) and 
address( es)]: 
VI. Publications: 
* Coffigny H., Fritsch P., Vernois Y., Beauvallet M., Court L., Metivier H. and 
Masse R. 
Influence of dose rate on the biological effects of protracted gamma 
irradiation during the whole gestation of rats. EULEP Newsletter, 1988, 
50, 28-29. 
* Fritsch P., Coffigny H., Vernois Y., Beauvallet M., Court L., Metivier H. and 
Masse R. 
Early and late effects of protracted gamma irradiation during 
intra-uterine life. EULEP Newletter, 1989, 52, 26-27. 
* Coffigny H., Fritsch P., Beauvallet M., Court 1., Metivier H. and Masse R. 
Dose-rate effect of gamma irradiation during the intra-uterine life on 
brain development. 22nd Annual Meeting of the European Society for 
Radiation Biology. Brussels, Belgium, September 11-16, 1989. 
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Title of the project no.: 
Macrophage involvement in actinide-induced lung disease 
Head(s) of project: 
Dr A Morgan 
Scientific staff: Dr ND Priest, Dr A Taya, Hr RJ Talbot, Hr JP Kelllngton. 
I. Objectives of the project: 
To study the effects of alpha-emitting transuranic nucl ides on 
the alveolar macrophage and the use of this cell as a marker for 
investigating early radiation effects on the lung. To extend 
this work to lung epithelial cells. 
11. Objectives for the reporting period: 
1} To study the effects of inhaled a emitters on macrophage 
kinetics. 
2} To assess functional changes in the alveolar macrophage 
induced by inhaled a-emitters. 
3} To study the induction of nuclear aberrations in alveolar 
macrophages, particularly at low radiation doses. 
4} To initiate work on the effect of a emitters on alveolar Type 
II pneumocytes and Clara cells. 
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Ill. Progress achieved: 
1. Effects of inhaled g emitters on alveolar macrophage kinetics 
1. 1 Methodo 1 ogy 
The use of 3H-labelled thymidine and autoradiography to detect AM in 
S-phase is not possible following the inhalation of a emitters because the 
silver grains produced in the photographic emulsion by 3H are obscured by 
a tracks. We have therefore developed an alternative technique which 
i nvo 1 ves the incorporation of bromodeoxyur id i ne {BrdU) , an ana 1 ogue of 
thymidine, into the DNA of dividing AM. The BrdU-substituted DNA is 
visualised by an immunocytochemical technique using a fluorescent labelled 
monoclonal antibody against BrdU. 
1.2 Results 
Using the BrdU technique, it was established that in normal CBA mice, 
approximately 1.7% of AM recovered by broncho-alveolar lavage are 
undergoing DNA synthesis. In addition, it has been shown that less than 1 
in 1000 AM are in mitosis. Additional studies in normal CBA mice showed 
that there was no significant change in the DNA labelling of AM over a 
period of 24 hours, indicating that there is no diurnal variation. 
To investigate the effect of a emitters on DNA synthesis in AM, mice 
were exposed to 239Puo2 to give initial alveolar deposits {!ADs) of 60 and 
400 Bq. The proportion of AM in S-phase at various times after exposure 
are shown in Fig. 1.1. 
JO 
i ~ . , -~-----------------I ,. ' ;:;, --. ---------..J _.. '-,, ,'-'p -
..__.. SJIAM-EXI'OSEIJ 
o--· ---o -60 ll11 2391•uoz 
o-·-o -4UU ll<J Z.IYJ•uuz 
o+-~--~.--.--.--------------. 
0 7 " ll ~ ~ TI 
TIME Ai.~rER EXPOSURE (DAYS) 
Fig. 1.1 Pro~~~tion of alveolar macrophages in S-phase following exposure 
to Pu02. 
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1.3 Discussion 
The pre l i m i nary work with control CBA m lce showed that the alveolar 
macrophage is not a terminally-differentiated cell incapable of further 
division and that, under normal conditions, approximately 1.7% of AM 
recovered by lavage are umlergoing DNA synthesis. This value compares 
well with the results of other studies using 3H-labelled thymidine. 
Studies of AM kinetics following exposure to 239puo2 {see Fig. 1.1) 
showed that the number of AM in S-phase is depressed for a period of about 
2 weeks following exposure to 239puo2 to give an IAD of 400 Bq. This 
inhib.ltion of the normal cell cycle accounts, at least in part, for the 
reduction tn the number of AM which occurs over this period. The 
subsequent increase in the number of AM eo i ne ides with the increase of 
ce 11 s in S-phase. The resu 1 ts of this study are consistent with the 
theory of an intrapulmonary pool of proliferating AM, or AM precursors. 
2. Functjonal changes in pulmonary alveolar macrophages following 
exposure to 239puo2 
2.1 Methodology 
The c 1 earance of i nso 1 ub 1 e part i c 1 es from. 1 ung is mediated by the 
alveolar macrophage {AM). Previous studies have shown that the mobt 1 i ty 
of AM which had taken up 239puo2 In vitro was impaired. The objective of 
the present study was to investigate the effect of inhaled 239puo2 on the 
phagocytic competence of AM using fluorescent polystyrene microspheres 
{FP). Initial studies were carried out to determine the relationship 
between the conditions of exposure {concentration of FP and exposure time) 
and the distribution of FP in AM. Mice were exposed to a constant 
concentration of FP and groups were withdrawn from the exposure chamber 
after 5, 20, 75 and 165 min. Animals from each group were killed at 1 and 
8 d after exposure and AM recovered by broncho-alveolar lavage in situ. 
Using cytocentrifuge slides, measurements were made of the labelling index 
{LI - proportion of AM which contain FP) and the mean number of FP per 
labelled AM {LAM). From this information, the mean number of FP per AM 
was calculated. 
In the study with 239puo2, mice were exposed by inhalation to give an 
IAD of 250 Bq. At subsequent time points {5, 19, 33 and 96 d 
post-exposure) groups of mice were exposed to FP by inhalation and killed 
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2 d later when the lungs were lavaged. Lis for AM recovered from control 
and 239pu-exposed mice were compared. 
2.2 Results 
The Lis for AM recovered from mice exposed to FP for varying periods 
are shown in Fig. 2.1 and the numbers of FP per AM in Fig. 2.2. 
Day 1 Day 8 
Exposure time, minutes 
Fig. 2.1 Labelling indices of AM recovered by lavage at 1 I and 8 ~ d 
after exposure. 
Day 1 Day 8 
Fig. 2.2 Mean number of FP per AM at 1 I d and 8 ~ d post-exposure. 
(Some of the AM recovered in washes 1 and 2 contained too many FP (>50) to 
assess accurate I y and in these groups measurements were restricted to 
washes 3-10). 
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The Lis of AM recovered from mice which had been exposed to 239Puo2, 
and killed following exposure to FP, are shown in Table 2.1. 
Time Control 239puo2 
{d) 
7 49.1±10.1 55.4±4.1 
22 49.9± 2.4 51. 3±8. 7 
35 46.3±26.6 50.4±9.6 
98 47.6± 4.7 46.7±0.8 
Table 2.1 Percent of reco2e9ed macrophages containing fluorescent 
particles following exposure to 3 Pu02. Mean ± SEM. 
Mice from thi~ group, and from a sham-exposed control group, were 
killed at 7, 21, 35 and 98 days·following exposure to 239puo2 to give an 
!AD of 250 Bq. Two days before sacrifice, mice were exposed to airborne 
FP. The lungs were lavaged with physiological saline to recover AM and 
the recovered cells were analysed by flow cytometry {FACS). In addition, 
cytospins of AM were prepared so that the results obtained by FACS could 
be compared with those obtained by manual scoring of cells using a 
conventional microscope equipped with epifluorescence. 
2.3 Discussion 
Fig. 2.1 shows that, at 1 d post-exposure, Lis were significantly 
greater for washes 1 and 2 than for washes 3-10, but at 8 d these 
differences had largely disappeared. Fig. 2.2 shows that mean numbers 
of FP/LAM at 1 d were much greater in cells recovered in washes 1 and 2 
than in washes 3-10, The differences between 1 and 8 d are due to the 
presence of a relatively few heavily-loaded LAM which were recovered in 
the in it i a I washes. The preferent i a I recovery of these heav i 1 y-1 oaded 
ce 11 s, and the fact that most had been removed from the I ungs by 8 d, 
suggest that they are situated either in the smaller conducting airways or 
in alveoli adjacent to the terminal bronchioles and have picked up 
particles deposited preferentially at these sites. The mean numbers of FP 
per AM were 1 inearly-related to exposure time which indicates that there 
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was no saturation of the phagocytic capacity of AM. We conclude from this 
study that, in terms of particle distribution, AM recovered in washes 3-10 
are more representative of the general AM pool than cells recovered in 
washes 1 and 2. The relationship between LI and FP/AM for washes 3-10 at 
8 d is shown in Fig. 2.3 from which it can be deduced that, if the AM 
pool contains immature non-phagocytic cells, the proportion of such cells 
is small. 
100 ,-------------------; 
FP/ AM 
Figure 2.3 Relationship between LI and number of FP/AM in mice exposed 
for 5-165 min. Results for combined washes 3-10 at 8 d after exposure. 
In mice exposed to 239puo2 followed by FP, the differences in 
labelling index between experimental and control mice were not significant 
at any time point (Table 2.1). Indeed, the LI in experimental mice at 7 d 
appeared to be greater than in controls, possibly because of the reduction 
in AM numbers at this time. Examination of cytocentr i fuge preparations 
showed that, in 239Pu-exposed mice, more macrophages contained >30 FP than 
in controls. Subsequent autoradiography showed that cells which contained 
many FP also contained a relatively large 239Pu activity. Thus it 
appears either that AM containing 239Puo2 have an enhanced phagocytic 
activity, or that both 239puo2 and FP are deposited preferentially at 
favoured sites within the lung and are taken up by AM at these sites. 
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3. Induction of nuclear aberrations at low doses 
3.1 Methodology 
Previous studies {Morgan .et...M. 1989) showed that the induction of 
nuclear aberrations in alveolar macrophages is a sensitive indication of 
radiation damage. In that study, !ADs of 21-1660 Bq were used and the 
incidence of nuclear aberrations scored on cytocentrifuge preparations. 
Recently, this investigation was extended using lADs down to <1 Bq. 
3.2 Resylts 
All the measurements were made on AM recovered by lavage at 35 days 
after exposure to 239Puo2. Estimates of the total yield of AM with 
micronuclei (MiAH} are shown in Fig. 3.1. 
Yield MIAM Bq•1 
::::r' +-------------~ 
2500H--------------i ~ 2000H-'r--------------j 1\ 15001---'-+-------------j 
>,""' 
10001-----..:...,.~----------j 
5001--------L~=---~--;~·--1 
0~-~-~-~-~--~~ 
0 2 4 e a ~ 12 
Initial Alveolar Deposit 
MEAN- SEM 
Fig. 3.1 Total numbers of HiAM per Bq !AD of 239Puo2 at 35 d post-exposure 
3.3 Qjscyssjon 
The incidence of AM with micronuclei recovered from sham-exposed 
control mice was less than 0.1%. Even at the lowest !AD (0.76 Bq) both 
the incidence and estimated total number of MiAM were greater than in 
control mice and demonstrates the sensitivity of this test as an index of 
cytogenetic damage to AM. 
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Fig. 3:1 shows how the yield of MiAM per unit dose increases rapidly 
wih decreasing dose. In a previous study the yield of MiAM per unit dose 
at the lowest IAD (21 Bq) was approximately 370. This value compares well 
to a yield of 480 MiAM per Bq at the highest IAD (10.8 Bq) in the recent 
study. 
Micronuclei are not expressed until a cell has divided at least once. 
The results of this study probably indicate the increased death of AM with 
cytogenetic damage, and an inhibition of AM division after exposure to 
higher doses of 239Pu. 
4. Effects of alpha emitters on lung epithelial cells 
Our i ng the period under review, the focus of work has shifted from 
the alveolar macrophage to lung epithelial cells (Type II pneumocytes and 
Clara cells) which, unlike the highly differentiated alveolar macrophage, 
are thought to be tumour progenitor cells. The main objective has been to 
develop techniques for studying changes in epithelial cells following the 
inhalation of insoluble alpha emitters and radon/radon daughters. The 
techniques which have been developed include the following:-
• Gross morphology using plastic lung sections including methods 
for quantifying subtle morphological changes at the light microscope 
level. 
• Ultrastructural changes using TEM. 
• B i oche m iea I de terminations i ne 1 ud i ng enzymes, protein and cytok i nes 
(interleukin) levels in lavage fluid. 
• Expression of oncogenes, cytokeratins and lectins during the 
development of lung tumours. 
Preliminary results of a short-term study, which involved exposure of 
mice to 239puo2 to give an initial deposit of 500 Bq, showed that there 
was an increase in the proliferation of epithelial cells, particularly 
Type II cells, between 4 and 8 weeks after exposure. Hyperplastic changes 
in Type I I ce 11 s were a 1 so observed. These studies w i 11 be extended to 
lower levels of alpha emitters in long-term studies. The results will 
contribute to better understanding of the mechanisms by which alpha 
emitters cause pre-neoplastic damage to the lungs. 
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IV. Other research group(s) collaborating actively on this project [name(s) and 
address( es) 1: 
None. 
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Title of the project no.: 1 
Morphological and immunological characterization of cells from typical 
focal CNS lesions in the rat following prenatal X-irradiation and their 
relationships to ethylnitrosourea neurocarcinogenesis. 
Head(s) of project: 
Dr. W. Schmahl 
Scientific staff: 
Dr. J. Plendl 
I. Objectives of the project: 
This project is concerned with the post-irradiational membrane properties of the 
neuroglioblasts in the rat fetus. These cells represent the stem cell population 
for the development of the central nervous system. An ordered sequence of cell 
division, neuron migration and settlement depends largely on functional 
membrane constitution, thus influencing intercellular contacts, cell communi-
cation and pattern recognition. Alterations of these membrane properties by 
prenatal irradiation are suggested to modify the response of single cells or of 
the tissue as a whole to a potential carcinogenic agent, like ethylnitrosourea 
(ENU). 
11. Objectives for the reporting period: 
One important factor for inducing late effects following either X-irradiation of the 
fetus or in response to ethylnitrosourea (ENU) treatment is the magnitude of 
DNA repair. In the present experiments we analyzed the DNA repair capability 
of the fetal brain and liver simultaneously with long-term observations of rats 
which were treated in utero either by X-irradiation, ENU, or both in combination. 
This should reveal any relationship between the influence on Q6-alkylguanine-
DNA alkyltransferase activity, which is the specific acceptor protein in DNA 
repair process, and the incidence of tumours in the offspring. 
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Ill. Progress achieved: 
1 I METHODOLOGY 
1.1. Prenatal tissue sampling 
14 pregnant rats were divided into 6 groups and treatment schedules as 
shown in Table 1. The dams were killed under C02-inhalation on day 17 of 
gestation between 10 a. m. and 12 a. m. The fetal brains and livers were 
rapidly removed, as well as the maternal brains and a part of the liver. The 
pooled organs were homogenized at 4°C, sonicated and centrifuged at 
28000 g for 30 min. for tissue extraction. The transfer of 3H-Iabelled 
methyl groups from the oS-position of guanine in DNA to the acceptor 
protein was determined from the appearance of tritium in an insoluble 
protein fraction (procedure as described by Myrnes et al., Carcinogenesis 
5, 1061-1064, 1984). 
1 .2. Postnatal long-term observation 
18 pregnant rats were treated as described in Table 1. The offspring were 
observed until 26 months of age. In addition to macroscopical observation 
all brains were observed histologically by serial sections of the forebrains. 
2. RESULTS 
2.1. In the brain of the rat fetuses the content of the transferred oG-methyl-
guanine of the controls was 6.4 ± 2.3 fmol/2501lg extract protein. This 
represents 100.0 ± 35.9% alkyltransferase (AT) activity as shown in 
Table 2. The AT activity dropped to 60.9 ± 23.0% of untreated controls 
after ENU treatment (group 4). A dose of 1 Gy induced a slight increase in 
AT activity compared to controls (131 .3 ± 23.8 %, group 2) and a dose of 
2 Gy induced a clear induction of AT (201 .6 ± 21.7 %, group 3). The 
combination of X-irradiation pretreatment and ENU injection reduced this 
increase to 103.1 ± 34.8 % at a dose of 1 Gy and to 157.8 ± 25.7% at a 
dose of 2 Gy. By contrast, the AT in the liver of the rat fetuses did not react 
in such a clear manner. Only a single dose of 2 Gy resulted in an increase 
to 142.3 ± 13.4 % of controls. 
2.2. There were no brain tumours either in controls or in X-irradiated offspring. 
ENU (50 mg/kg) induced gliomas in 15 of 34 offspring (= 44.1 %) with a 
mean multiplicity of 2.13 per affected animal. Pre-irradiation with 1 .0 Gy 
dropped the glioma frequency to 26.8% (multiplicity 2. 18). In those 
offspring which were X-irradiated with 2.0 Gy before ENU application, we 
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Table 1: Pattern of treatment and numbers of the treated rats 
Group No. 1 2 3 4 5 6 
Treatment Controls X-irrad. X-irrad. ENU X-irrad. plus ENU 
(gestation day 16) 1.0Gy 2.0Gy (50 mg/kg) 1.0 Gy 2.0Gy 
Prenatal tissue 
sampling 
No. of dams 2 3 3 2 2 2 
No. of fetuses 23 37 35 24 25' 22 
11 Postnatal tissue 
sampling 
No. of dams 2 3 3 3 4 3 
No. of fetuses 22 32 25 34 41 24 
Table 2: AT activity In brain and liver after application of ~NU 
alone or in combination with X-lrradlatlon on gestation day 16 
of the rat 
Group No. AT activity(%) in the in the in the 
in the fetal brain dam's brain fetal liver dam's liver 
1 (Controls) 100.0 ± 35.9 100.0 ± 3.6 100.0 ± 1.8 100.0 ± 11.6 
2 X-irrad. 131.3 ± 23.8 b 146.4 ± 19.5 c . 97.7 ± 16.7 127.7 ± 16.7 
1.0Gy 
3 X-irrad. 201.6 ± 21.7 c 171.4 ± 16.7 c 142.3 ± 13.4 157.4± 11.5 
2.0Gy 
4 ENU, 60.9 j: 23.0. 69.6± 7.7 95.5 ± 18.5 112.9± 4.0 
5 X-irrad. 103.1 ± 34.8 8 116.1 ± 10.7c 113.6 ± 12.4 149.0 ± 3.0 
1.0 Gy plus ENU 
6 X-irrad. 157.8 ± 25.7 c 142.9 ± 7.5 c 110.5 ± 11.1 156.0 ± 2.1 
2.0 Gy plus ENU 
Significance evaluated against group 4: a: p < 0.05; b : p < 0.01; c : p < 0.001 
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·observed only 2 brain tumours (2124 = 8.3 %). The latency times were 
uniformely within a rather small range between 335 days and 369 days. 
3. DISCUSSION 
The AT activity of controls is higher in the liver than in the brain. However, 
AT activity is higher in the rat fetuses than in the adults: in the fetal brains 
2.3-fold, in the fetal liver 1.4-fold. Application of either treatment alone or in 
combined treatments affected AT activity in the brain of both the dams and 
fetuses in a similar manner. The major finding was a clear decrease in the 
AT activity after ENU treatment. This correlates with a significant increase in 
the incidence of brain tumours. The inductive effect of X-irradiation on AT 
activity corresponds in turn with a reduction of this tumour incidence after 
the combined treatments. 
4. SURVEY 
about the complete period of the contract 
The aim of the present research field developed from the observation of a 
reduced response of prenatally X-irradiated brain of rats to a single dose of 
the carcinogen ethylnitrosourea (ENU) which mainly induces tumours of 
the brain in the offspring of treated dams. When ENU was applicated alone 
during the early fetal period (gestation day 13-15), this resulted in about 
60-70% glioma frequency in the offspring within 30 months. X-irradiation 
(0.5 - 1.5 Gy) before ENU application reduced the brain tumour frequency 
in a dose-dependent manner. 
Our first studies concentrated to the early effects of X-irradiation at the fetal 
rat forebrain. Even after a short interval of 2 hours the first alterations of the 
neuroglioblast cell population were observable. They consisted of a 
change of the glycoprotein compounds of the cytoplasmatic membranes, 
which was detectable by a newly arising affinity to Dolichos biflorus lectin 
which specifically binds to N-acetylgalactosamine residues. 
4.1. If the early membrane alterations of brain cells are detectable by lectins, 
why should not be there endolectins within the damaged brains which are 
binding to the altered cells and thereby initiate reparation processes? This 
suggestion led us to our studies about growth control by lectins of glial 
cells, initiated to carcinogenic transformation by ENU, as well as of glioma 
cells. These studies were done both in vivo by early treatment of the rat 
offspring with lectins, and in vitro. 
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The following results were compiled until now: 
a. In vivo studies 
Daily applications for 5 days of 10 mg/kg Wheat germ agglutinin (WGA) 
increases brain tumour response after prenatal application of ENU 
(50 mg/kg) on gestation day 14 (83.6 % versus 56.2 %, respectively; 
p < 0.05). lt was suggested that WGA is an antagonist of nerve growth 
factor (NGF) at its receptor site. NGF ist known for its inhibitory effects upon 
ENU-induced trigeminal tumours. Thus, the tumour-promoting effects of 
WGA may be explained. Conversely, the presence of a WGA-Iike endo-
lectin within prenatally in X-irradiated brains may be not responsible for the 
combined effects of X-irradiation and ENU, although an increased WGA 
affinity of X-irradiated cells was described by others. 
b. In vjtro studies 
Glioma cells were grown in culture flasks. Addition of Concanavalin A 
(10 J.Lg/ml), a mannoside-specific lectin resulted in a long-lasting growth 
depression of the glioma cells. This was evident both by mitotic rate, 
reduced 3H-thymidine labelling, shape alterations of th~ cells, and by an 
increased intracellular content of intermediary filaments (GFAP-immuno-
cytochemistry). 
4.2. As we hypothesized the presence of a growth-depressing, soluble and 
diffusible (lectin-like) mediator acting upon ENU-transformed glioblasts 
arising in fetal brains subsequent to X-irradiation, we initiated trans-
plantation experiments for its proof. 
Mice were X-irradiated on gestation day 14 with a dose of 1.0 Gy. This 
animal model was chosen, because of a well known pattern of lesions 
induced by X-irradiation. Newborn were grafted intracerebrally with cells of 
the CS glioma line. This procedure resulted in a poor acceptahce of the 
grafts by the pren~tally X-irradiated offspring. In contrast, sham-irradiated 
controls revealed a rapid take of the C6-grafts, getting moribund within 
6 days. These differences were markedly and si~nificant. Also by histology 
a wide spread infiltration of the C6-grafts in X-irracfiated brains with 
leucocytes was a prominent finding. From this, severe necrosis of tumour 
areas resulted which are correlated with the longer survival time of these 
animals. 
4.3. As an additional growth-modulating mediator in prenatally X-irradiated 
brains we suggested alterations in the opioid system. We tried to correlate 
the changes of opioid receptor status of forebrain ne.uroglioblasts with the 
well known deficits in histological detectable repair capabilities in 
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prenatally X-irradiated brains. These experiments were performed upon 
the hypothesis that enhanced opioid-/and/or opioid receptor density 
results in suppression of perinatal cell proliferation within the brains, thus 
preventing reparation processes from any overshooting effect. 
Consequently we studied the reparation processes of prenatally 
X-irradiated rats (1.0 Gy on gestation day 14) in response to postnatal 
daily applications of naltrexone (50 mg/kg) which is a specific endorphin 
recaptor antagonist. This chronic suppression resulted in a two-fold pattern 
of late effects in the forebrain. The first effect, an early appearing inter-
mittent hyperplasia of the subependymal layer seemed to be beneficial for 
cell renewal and reparation of the radiation-induced lesions. The second 
finding was a long-lasting proliferation capacity even of those glioblast 
cells which are heterotopically dispersed to more peripheral cortical sites. 
However, the latter proliferation capacity did not look beneficial for the 
animal, as it showed symptoms of a dysplastic growth, not contributing to 
efficient reparation or regeneration of the brain. 
5. SYNOPSIS 
We described both genetic (DNA-related) effects and epigenetic effects 
after X-irradiation which are directly correlated with the reduced carcino-
genic efficacy of a subsequent ENU treatment upon glial cells: 
5.1. The DNA-related effects are reduction of alkyltransferase activity after ENU 
alone, but an augmentation after combined treatments of rat fetuses with 
X-irradiation and ENU. This corresponds with a decreased tumour re-
sponse after combined treatments. 
5.2. The epigenetic effects which we have studied are an upregulation of the 
cellular opioid system due to prenatal X-irradiation. This system is 
represented by various opioid receptors on the cell surface which are part 
of a communication system, engaged in perinatal growth modulation. 
Upregulation of the opioid receptors is connected to fetal growth sup-
pression. The cellular proliferation rate, however, is positively linked to the 
carcinogenic effects of ENU. Therefore the upregulation of the opioid 
system in fetal brain after X-irradiation stands in direct connection to a 
reduced tumour frequency after additional ENU treatment. 
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I. Objectives of the project: 
Exposure of different cell cycle stages of one cell mouse embryos in 
vivo and in vitro to different radiation qualities (neutrons, X-rays, 
beta-rays) and determination of: 
1. chromosomal aberrations in the first, second, and third mitosis 
after irradiation 
2. number,of micronuclei in the first, second, and third interphase 
after irradiation 
3. teratogenic effects. 
Emphasis is laid on the effects of low doses. 
11. Objectives for the reporting period: 
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Ill. Progress achieved: 
INTRODUCTION 
Virtually nothing is known on radiation risk of human embryos during 
preimplantation stage. This is a problem, because women are not aware 
of a possible pregnancy as long as the embryo did not implant, so that 
radiation exposure may take place during this time, and nobody has a 
chance to assess the risk involved in this exposure. Fortunately, 
development during preimplantation stage is similar in almost all 
mammals (including man), so that extrapolation from mouse to man will 
be easier in this case than in many other animal experiments. 
In particular, the one-cell stage (zygote) turned out to be very 
radiosensitive in previous experiments. Studies of one-cell embryos do 
not only provide us with informations on radiation risk, but in 
addition offer the chance to look for basic mechanisms of radiation 
effects. This is made possible mainly by the synchronous development 
of embryos up to the eight-cell stage, by the high number of different 
endpoints that can be determined, and by the possibility to carry out 
in vivo and in vitro experiments. 
This report summarizes the results on cytogenetic and teratogenic 
effects after radiation exposure (X-rays, neutrons, or B-rays) of 
one-cell mouse embryos in various cell cycle stages. 
METHODOLOGY 
All the methods have been described in detail elsewhere. Thus, only a 
brief outline will be given here. The mouse strain used was "Heiligen-
berger Stamm" (a strain similar to NMRI mice). 
a) In vitro culture techniques 
(Detailed description in: MUller et al. 1985) Three females and one 
male were mated for 2 hours in the morning (6 to 8 a.m.). After 
checking for a vaginal plug, pregnant mice were killed by cervical 
dislocation and one-cell embryos released from the oviduct by cutting 
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the ampulla. Cumulus cells were removed by a 5 min incubation in 
hyaluronidase. Embryos were transferred to Kasai's medium (Kasai et 
al. 1978), supplemented with bovine serum albumin and EDTA. Culture 
conditions were 37 degrees centigrade, 10% carbon dioxide and 95% 
humidity. 
b) Cytogenetic damage 
(Detailed description in: WeiBenborn and Streffer 1988a,b) Micronuclei 
were determined after fixation of the embryos using the technique of 
Tarkowski (1966). All particles with the following characteristics 
were counted as micronuclei: a) Stainable with ethidium bromide; b) 
round-shaped with distinct boundaries; c) diameter between 5 and 20% 
that of the main nucleus. Chromosome aberrations: Shortly before the 
mitosis under study, colchicine was injected intraperitoneally (in 
vivo experiments) or added to the medium (in vitro experiments) and 
after arresting mitosis in metaphase, embryos were flushed from the 
oviducts (in vivo studies) or taken out of the medium (in vitro 
studies). Chromosomes were fixed using the tecnnique of Tarkowski 
(1966; in vivo studies) or of Mikamo and Kamuguchi (1983; in vitro 
studies). 
c) Teratogenic effects 
(Detailed description in: Pampfer and Streffer 1988, MUller et al. 
1989) Embryos were irradiated in vivo on day 1 of gestation and the 
uterus content was checked on day 19 for early and late resorptions, 
fetal death, living normal or malformed fetuses. Skeletal 
abnormalities were determined after clearing of the fetuses with 
potassium hydroxide and staining with alizarin sulfonic acid. 
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RESULTS AND DISCUSSION 
1. Cytogenetic damage 
1.1 Exposure to X-rays or neutrons 
Table 1 shows the number of structural chromosome aberrations in the 
first, second, and third mitosis after X-irradiation at different 
t~mes after conception. In all cases a significant increase was 
observed in comparison to the control. However, the different times of 
irradiation revealed different sensitivities: the time of completion 
Table 1: Chromosome aberrations in 1st, 2nd, and 3rd mitosis after 
X-irradiation (0.94 Gy) 
Mitosis 
1 to 2 
2 to 4 
4 to 8 
Time of 
irrad. 
(h p.c.) 
Contr. 
1 
3 
6 
9 
12 
Contr. 
1 
3 
6 
9 
12 
Contr. 
1 
3 
6 
9 
12 
Chromosome type 
aberrations 
0.023 
0.167 
0.249 
0.124 
0.180 
0.129 
0.006 
0.049 
0.139 
0.125 
0.047 
0.176 
0.015 
0.086 
0.136 
0.171 
0.106 
0.186 
Chromatid type 
aberrations 
0 
0.034 
0.184 
0.188 
0.140 
0.519 
0.036 
0.114 
0.169 
0.145 
0.172 
0.196 
0.062 
0.100 
0.269 
0.181 
0.182 
0.228 
Total 
0.023 
0.210 
0.433 
0.312 
0.320 
0.648 
0.042 
0.163 
0.308 
0.270 
0.219 
0.372 
0.077 
0.186 
0.405 
0.352 
0.288 
0.414 
No. of 
metaphases 
132 
60 
60 
64 
50 
54 
168 
61 
65 
96 
64 
51 
194 
70 
74 
88 
66 
70 
of the second meiotic division (1 h p.c.) was the least sensitive 
period, and sensitivity increased in the order early G2 (9 h p.c.), S 
(6 h p.c.), Gl (3 h p.c.), and late G2 (12 h p.c.). The comparatively 
low sensitivity during completion of the second meiotic division may 
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be due to the peculiar chromatin structure at this stage. The 
unusually low sensitivity during early G2-phase may depend either on 
some cells that were still in S-phase 9 h p.c. or on an effective 
proof-reading by repair systems shortly after DNA-replication. The 
high frequency of aberrations after exposure in late G2 (12 h p.c.) 
can be explained by the short time interval available for repair 
processes before mitosis is starting. 
Examination of neutron exposure revealed RBE values between 
approximately 5 and 7. The best fit for structural chromosome 
aberrations was a linear plot of the dose response 
irrespective of radiation quality (X-rays or neutrons). 
relations 
In the second and third mitosis after radiation exposure, a very 
prominent loss of complete chromosomes was observed. The extent of 
hypoploidy was independent of the cell cycle stage irradiated, but 
dependent of radiation dose and quality. 
Micronucleus formation (Table 2) shows a radiation sensitivity similar 
to that one of chromosome aberrations. The frequency of micronuclei 
Table 2: Micronucleus formation ~fter X-irradiation (0.94 Gy) 
Time 
(24 h p.c.: 2-cell stage; 48 h p.c.: mainly 4-cell stage; 
54 h p.c.: mainly 8-cell stage). 
of irradiation Micronuclei per cell at 
(h p.c.) 24 h p.c. 48 h p.c. 54 h p.c. 
Control 0.013 0.008 0.006 
1 0.158 0.066 0.062 
3 0.265 0.138 0.079 
6 0.209 0.102 0.080 
9 0.068 0.048 0.026 
12 0.290 0.179 0.169 
All the results of exposed embryos (with the exception of the 9 h 
exposure and 24 h micronucleus determination) were significantly 
different (P smaller than 0.05) from the control. 
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was higher than the frequency expected from the sum of acentric 
fragments and polycentric chromosomes in the corresponding metaphase. 
After consideration also of the number of lost chromosomes, 
micronucleus frequency was lower than expected, so that one has to 
assume, that micronuclei may be the result of the fusion of several 
chromatin particles (acentric fragments, complete chromosomes). 
1.2 Exposure to B-rays 
Table 3 shows the number of chromosome aberrations in the first, 
second, and third mitosis after a 2hour exposure to 3 H-thymidine in 
Gl-, S- or G2-phase. Not unexpectedly, only exposure during S-phase 
Table 3: Chromosome aberrations in 1st, 2nd, and 3rd mitosis after 
exposure to 3 H-thymidine for 2 hours in Gl , S or G2 
Mitosis 
1 to 2 
2 to 4 
4 to 8 
Activity 
(kBq/ml) 
Control 
50 
100 
100 
Control 
100 
100 
100 
Control 
100 
100 
200 
100 
Cell 
cycle 
phase 
Gl 
Gl 
s 
Gl 
s 
G2 
Gl 
s 
s 
G2 
Chromosome 
type 
aberrations 
2 
0 
1 
0 
7 
2 
7 
1 
2 
1 
15 
16 
1 
Chromatid 
type 
aberrations 
0 
0 
0 
1 
1 
2 
14 
0 
1 
1 
22 
13 
0 
No. of 
meta-
phases 
72 
15 
34 
27 
248 
97 
86 
48 
103 
63 
73 
24 
37 
Aberr. 
per 
metaphase 
0.03 
0 
0.03 
0.04 
0.03 
0.04 
0.24 
0.02 
0.03 
0.03 
0.51 
1.21 
0.03 
increased the number of chromosome aberrations. Somewhat unexpected, 
however, is the result that no increase was observed in the first 
mitosis after exposure. The amount of activity, that was necessary for 
the induction of aberrations, was much higher compared to 3 H-arginine 
(Table 4). 
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Table 4: Chromosome aberrations in 1st, 2nd, and 3rd mitosis after 
exposure to 3 H-aq~inine for 2 hours in Gl, S or G2 
Mitosis Activity Cell Chromosome Chromatid No. of Aberr. 
(kBq/ml) cycle type type meta- per 
phase aberrations aberrations phases metaphase 
1 to 2 Control 2 0 72 0.03 
12.5 Gl 2 0 65 0.03 
50 Gl 0 0 24 0 
2 to 4 Control 7 1 248 0.03 
2.5 G1 28 13 86 0.48 
2.5 s 5 13 48 0.38 
2.5 G2 8 6 43 0.33 
12.5 G1 85 31 96 1.21 
12.5 s 16 39 53 1.04 
12.5 G2 23 24 52 0.90 
4 to 8 Control 2 1 103 0.03 
2.5 G1 9 6 45 0.33 
2.5 s 9 8 65 0.26 
2.5 G2 11 10 61 0.34 
12.5 G1 13 9 41 0.54 
12.5 s 20 19 58 0.67 
12.5 G2 19 23 59 0.71 
Exposure to 3 H-arginine showed additional peculiarities. Irrespective 
of the cell cycle phase exposed, an increase in the frequency of 
aberrations was observed. This is in line with the fact that histone 
synthesis in early embryonic development is not restricted to a single 
cell cycle phase. The ratio of chromosome type to chromatid type 
aberrations is clearly dependent on the cell cycle phase exposed. This 
ratio is correlated with the number of disintegrations occurring 
before or after DNA replication. Again, however, no increase in the 
frequency of aberrations was observed for the first mitosis after 
exposure. 
These results underline previous results (MUller et al. 1987), in 
which the high potential of exerting deleterious effects on early 
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embryonic development has been shown for 3 H-thymidine and, in 
particular, for 3 H-arginine. 
2. Teratogenic effects 
The major radiation risk during the preimplantation period is prenatal 
death. However, there are some reports in the literature pointing also 
to an enhanced teratogenic risk for the surviving fetuses. Our results 
(Table 5) support this conclusion: there was a marked dose-dependent 
increase in the frequency of gross abnormalities after irradiation of 
Table 5: Prenatal death and malformations after irradiation of 1-cell 
mouse embryos 1 h p.c. 
Treatment Number of Number of live Number of malformed 
live fetuses fetuses per mouse fetuses (percentage) 
Controls 216 8.1 2 ( 0.9) 
Neutrons 
0.12 Gy 245 6.6 6 2.5) 
0.25 160 5.7 12* 7.5) 
0.50 220 4.2 19* ( 8.6) 
0.75 119 2.4 28* (23.5) 
X-rays 
0.25 Gy 133 6.7 3 2.3) 
0.50 197 5.5 6 3.1) 
1.00 147 4.3 10* ( 6.8) 
2.00 178 2.2 35* (19.7) 
* S~gnificantly different from control at P smaller than 0.01 
1-cell mouse embryos 1 h p.c. with either neutrons or X-rays. The most 
prominent malformation was gastroschisis, whereas exencephaly was 
observed at much lower frequency. The number of malformed fetuses 
increased with a quadratic function of neutron or X-ray dose, whereas 
fetal death was compatible with a simple exponential function. RBEs 
were in the range of 2 to 3. 
Malformations were not only inducible 1 h p.c. (Table 5), but 
throughout the first day of gestation (Table 6) and the entire 
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Table 6: Prenatal death and malformations after X-irradiation of 
1-cell embryos. 
Treatment Number of Number of live Number of malformed 
live fetuses fetuses per mouse fetuses (percentage) 
Control 216 8.1 2 (0.9) 
1 Gy/ 1 h p.c. 147 4.3 10* (6.8) 
Control 527 8.0 6 (1.1) 
1 Gy/ 3 h p.c. 343 2.9 22* (6.4) 
Control 204 7.9 4 (2.0) 
1 Gy/ 6 h p.c. 247 4.5 13 (5.3) 
Control 200 7.7 6 (3.0) 
1 Gy/12 h p.c. 251 5.3 10 (4.0) 
* Significantly different from control at P smaller than 0.01 
preimplantation period (data not shown). Radiation sensitivity, 
however, varied considerably, with the early times after conception (1 
h p.c., 3 h p.c.) being the most sensitive. It is particularly 
important, that there was no indication of a threshold dose after 
exposure of 1-cell embryos. 
The study of skeletal malformations revealed that there was no general 
increase in the number of skeletal abnormalities after X-ray exposure 
on day 1 of gestation, but that those fetuses that already showed a 
gastroschisis had more skeletal defects than either the controls or 
the irradiated fetuses without a gastroschisis. 
The results of the teratogenic experiments emphasize that one should 
not look at the preimplantation period only as a period of either 
embryonic death or unimpaired development after irradiation. 
Obviously, there exist conditions under which those embryos that 
survive irradiation are at an increased teratogenic risk. 
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Project I 
I. In vitro multiplication of purified rhesus monkey and human 
pluripotent hemopoietic stem cells. 
Head(s) of project: 
G. Wagemaker 
Scientific staff: 
J.J. Wielenga, F. van Gils, H. Burger, V. Smit 
I. Objectives of the project: 
The project is directed at purification of rhesus monkey and human stem 
cells and their subsequent in vitro multiplication to achieve suffi-
cient numbers of stem cells for sustained engraftment using partially 
or completely mismatched donors. 
If. Objectives for the reporting period: 
The objectives of the project can be summarized as follows: 
1. The development of a method allowing for rapid and large-scale 
purification of rhesus monkey and human hemopoietic stem cells 
by positive identification. 
2. The identification of hemopoietic growth factors which stimu-
late proliferation of hemopoietic stem cells. 
3. The development of a culture method that supports the prolife-
ration of pluripotential hemopoietic stem cells. 
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Ill. Progress achieved: 
PROGRESS REPORT 1985 - 1989 
1. The development of a method allowing for rapid and large-scale 
purification of rhesus monkey and human hemopoietic stem cells by 
positive identification. 
The purification of rhesus monkey and human bone marrow hemopoietic 
stem cells was pursued by a combination of phsyical methods (density 
gradient centrifugation as a pre-enrichment step and E-rosette sedi-
mentation or cytotoxic lysis using the monoclonal antibody Campath-1 as 
methods to remove T lymphocytes) followed by positive selection of stem 
cells either on the basis of expression of class II (DR) MHC-antigens 
or expression of HPCA-1 (CD34) antigens. 
The presence of DR-antigens on the rhesus monkey hemopoietic stem cell 
was shown by measuring the repopulating capacity in an autologous 
regeneration assay of BM grafts depleted well as enriched for DR-posi-
tive cells progenitor cells. The latter were pre-enriched by disconti-
nuous albumin density centrifugation and complement mediated lysis 
using CAMPATH-1. In the grafts depleted of DR-positive cells, the 
repopulating capacity was at least 20-fold depleted. In the grafts 
enriched for DR-positive cells, an at least 40-fold enrichment of the 
repopulating capacity was measured. Thus, by these two criteria, the 
repopulating stem cells of the rhesus monkey are DR-posi ti ve cells. 
Unfortunately, the DR-antigen density of the repopulating stem cells 
appeared to be heterogenous, also DR-dull cells being highly enriched 
for stem cells. This heterogeneity of OR-expression renders selection 
of DR-positive cells insufficiently suitable for transplantation 
procedures, since high yields can only be obtained at the expense of 
considerable contamination with DR-negative cells. 
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Figure 1. CD34-expression on Rhesus monkey CFU-C, histogram of pre-
enriched Rhesus monkey BM cells. The shaded area represents 
the window set for sorting positive cells. The double-
shaded area represents the window set for sorting the 3% 
most bright cells. 
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An advance was made when a similar technology was used to assess the 
potential of the anti-CD34 monoclonal ICH3 (collaboration with Prof. 
R. J. Levinsky, London) , which cross-reacts with rhesus monkey cells 
(Figure 1). Using fluorescence-activated cell sorting, very high 
frequencies of hemopoietic progenitor cells, as detected by in vitro 
assay for colony-forming cells, could be achieved by selecting for CD34 
positive cells. Furthermore, using a quantitative regeneration assay 
involving transplantation of standardized numbers of autologous BM 
cells in lethally irradiated monkeys, the repopulating capacity of the 
CD34 positive cells appeared to be enriched to a similar degree as the 
enrichment obtained for .progenitor cells. These results demonstrated 
that the procedure involving labelling with ICH3 did select for cells 
capable to reconstitute a hemopoietic system in vivo and also implied 
that the procedure did not change the engraftment properties of the 
isolated stem cells. 
Since the autologous transplantation procedure in 3 kg rhesus monkeys 
already stretched the capacity of the cell sorter to prepare BM grafts 
to its limits, it was decided to develop a method that was more rapid 
and applicable to the scale suitable for the preparation of stem cell 
concentrates for BMT in adult human patients. ICH3 was coupled to mono-
sized polystyrene particles (Dynal, Norway}, which are smooth surfaced, 
slightly hydpophilic beads with a uniform magnetic core and a diameter 
of 4.5 micrometer. Various pilot experiments. demonstrated, that this 
procedure did not enable elution ·of the bound cells from the beads 
without unacceptable cell loss. To circumvent this problem, we bound 
Protein A covalently to the magnetic beads and conjugated the ICH3 to 
Protein A; cells bound to the antibody can be eluted from the Protein A 
beads by competitive elution using excess soluble IgG, for which bovine 
plasma was used. Using this method, approximately 1% of the original 
nucleated cell count was recovered as rhesus monkey ICH3+ cells and 
contained on the average 70% of the HPC responding to recombinant GM-
CSF, using T cell depleted cryopreserved stem cell concentrates as well 
as unfractionated fresh BM obtained from rhesus monkeys. Progenitor 
cell enrichment was about 60- to 100-fold, the fraction of residual T 
lymphocytes 2-3 logs less than the original BM. Autologous as well as 
allogeneic transplantation experiments in lethally irradiated monkeys 
revealed rapid regeneration originating from the enriched cell popu-
lations as well as sustained chimerism. It was concluded that ·selection 
of HSC by means of ICH3/Protein A beads is a safe, rapid and reliable 
large-scale method to enrich for stem cells and to remove undesired 
cells from a BM graft. Its large-scale application for human use is 
being further developed. 
2. The identification of hemopoietic growth factors which stimulate 
proliferation of hemopoietic stem cells. 
In mice, the hemopoietic growth factor interleukin-3 (IL-3) has been 
strongly implicated in proliferation of hemopoietic stem cells. IL-3 
stimulates stem cells to proliferate and to produce committed proge-
nitor cells along all bone marrow derived blood cell lineages. It 
synergizes in this property with IL-1, IL-6 and GM-CSF, the synergizing 
mechanisms still subject of further investigations. Of pivotal impor-
tance to the develppment of human stem cell multiplication in vitro, 
therefore, was the isolation, characterization and production of human 
IL-3. 
We cloned the gene encoding human IL-3 in 1986 by hybridization of 
radiolabelled mouse IL-3 cDNA with a cDNA library obtained from mRNA of 
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stimulated human lymphocytes. The human gene was identified by sequence 
homology with the mouse gene in the 3 ' -noncoding region, based on 
highly conserved ATITA repeat units. The gene, that has five exons, 
codes for an IL-3 protein of 133 amino acids with two cystein residues 
which are of importance for its biological activity and two potential 
N-linked glycosylation sites. The overall homology with mouse IL-3 is 
very low and, hence, cross-reactivity of biological activity between 
the two species was not observed. Expression of the human gene in pro-
karyotic as well as eukaryotic cells yielded a functional protein, that 
stimulates human multipotential bone marrow cells to produce committed 
progenitor along a variety of bone marrow blood cell production linea-
ges. The biological activity of human IL-3 on human bone marrow cells 
is completely analogous to that of mouse IL-3 on mouse bone marrow 
cells. The lack of protein sequence homology between mouse and human 
IL-3 was more extreme than that for any of the other known hemopoietic 
growth factors, which predicted a higher than usual rate of evolutio-
nary divergence for IL-3. The pharmaceutical development of human IL-3 
is in progress. 
When we tested human IL-3 for its biological activity on rhesus monkey 
bone marrow cells, we noted a considerably lower effectiveness than 
observed for human bone marrow cells. We recognized that preclinical 
studies with rhesus monkeys required identification, characterization 
and production of rhesus monkey IL-3. Hence, the molecular cloning of 
the gene encoding rhesus monkey IL-3 was accomplished in 1988 by scree-
ning a Lambda Charon 40 library containing Rhesus monkey genomic DNA 
with human IL-3 cDNA. The nucleotide sequence of the rhesus monkey IL-3 
gene compared with the human IL-3 gene displays more than 90% homology 
and is, similar to the human gene, divided into five small exons; the 
mature protein comprises 124 amino acids, which is 9 residues shorter 
than the human counterpart. Overall protein homology is about 80%. The 
two cystein residues that play an essential role in protein folding in 
the murine as well as the human IL-3 are also conserved in rhesus IL-3. 
The rhesus IL-3 gene expressed in COS-cells yielded a product that was 
biologically active using rhesus as well as human BM cells as targets, 
although the human IL-3 so far was found to be considerably less active 
on rhesus monkey BM cells. Expression of the rhesus IL-3 gene in a bac-
terial species resulted in a highly efficient production, which enabled 
purification of rhesus IL-3 and its further characterization. Rhesus 
monkey IL-3 was approximately lOO-fold more active than human IL-3 in 
stimulating rhesus monkey multipotential progenitor cells, but there 
was no difference in biological activity betwen the two IL-3 species 
when human bone marrow cells were used as targets. Hence, the encoun-
tered species barrier of human IL-3 in rhesus monkeys is unidirectio-
nal. Pairwise comparisons of the IL-3 of the coding sequences for 
mouse, rat, gibbon, rhesus monkey and human IL-3 revealed that IL-3 in 
general is a rapidly evolving protein, especially human IL-3 evolving 
from the common ancestral node from which gibbons and humans diverg~~ 
some 12 million years ago, with the unusual high rate of 2.5 x 10 
nonsynonymous (i.e. amino acid changing) nucleotide substitutions per 
site per year. Thus, the unidirectional species specificity of human 
IL-3 as encountered in rhesus monkeys has been caused by its rapid 
evolutionary divergence. Although beyond the scope of this report, it 
is noted that rhesus monkey IL-3 administered to rhesus monkeys stimu-
lated the production of all bone marrow derived blood cell lineages 
without the need for additional growth factors, thus contrasting 
results published so far for human IL-3 administered to Macaca species. 
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3. The development of a culture method that supports the proliferation 
of pluripotential hemopoietic stem cells. 
The recent development of large-scale positive selection of human and 
rhesus monkey hemopoietic stem cells and the availibility of human and 
rhesus monkey IL-3 now sets the stage for attempts to multiply purified 
hemopoietic stem cells in vitro. For mouse stem cells a serum free, 
chemically defined culture system has been developed, that has been 
adapted for human and rhesus monkey stem cells. It has been recognized 
that proliferation of mouse hemopoetic stem cells in vitro is dependent 
on IL-3 and eo-dependent on other hemopoietic growth factors, such as 
IL-l, IL-6 and GM-CSF, as well as on more generally acting agents, such 
as hydrocotisone and adrenergic agonists; in addition, stem cells have 
histamine receptors. As yet, stimulation of proliferation of stem cells 
results after a few cell divisions in cell differentiation, leading to 
the production of pathway-restricted progenitor cells and loss of stem 
cell capacity as tested in transplantation experiments. Thus, although 
IL-3 has been identified as a primary proliferative stimulus for stem 
cells, stem cell replication is probably dependent on a complex inter-
play of stimuli. Our current efforts are directed at testing conditions 
under which differentiation can be restricted and replication with 
maintenance of stem cell capacities will be promoted. This fundamental 
work is performed for human, rhesus monkey and mouse bone marrow. 
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II. Nonlethal multimodality conditioning for transplantation of T 
lymphocyte depleted stem cell fractions 
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D. W. van Bekkum 
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G. Wagemaker, J.J. Wielenga, F. van Gils, P.J. Heidt, J. Zoetelief 
I. Objectives of the project: 
This project is devoted to the development of nontoxic (nonlethal) 
conditioning regimens as an adjuvant to a moderately high doses of 
total body irradiation, including isolation, chracterization and 
production of a lymphokine that suppresses the action of T lymphocytes. 
11. Objectives for the reporting period: 
1. Tests with immunosuppressive monoclonal antibodies as adjuvants 
to total body irradiation for bone marrow transplantation in 
mice. 
2. Development of a method to purify and produce the lymphokine 
that suppresses the action of T-lymphocytes. 
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Ill. Progress achieved: 
1. Tests with immunosuppressive monoclonal antibodies as adjuvants to 
total body irradiation for bone marrow transplantation in mice. 
This project was initiated because it was recognized that acceptance of 
a MHC mismatched, T-lymphocyte depleted bone marrow graft in primates 
required a total dose of 12-14 Gy X-rays TBI, which is unacceptable due 
to lethal side-effects. Therefore, the acceptance of mismat~hed, T-
lymphocyte depleted bone marrow by a recipient requires the development 
of an immunosuppressive regimen to prevent rejection that lacks the 
toxicity of such a high dose of TBI. For this purpose, we set out to 
test possible synergism between TBI and other immunosuppressive agents 
in mice. A take failure model was developed in F --> P mice to eli-
minate any influence of immunosuppression caused ~Y graft-versus-host 
reaction. Initially, agents such as deoxycoformicin, goe 1734, cyclo-
sporin-A and mitoxanthrone were included, but none of these proved to 
be sufficiently suitable, either due to toxicity additive to that of 
TBI, or by lack of effectiveness. We therefore shifted to monoclonal 
antibodies directed against T-lymphocytes. 
Monoclonal antibodies directed against T-lymphocytes are thought to be 
the most promising nontoxic immunosuppressive agents for conditioning 
for bone marrow transplantation in victims of radiation accidents. The 
monoclonal antibodies currently tested in mice include rat-anti-mouse 
L3T4/Lyt-2 {CD4/CD8) monoclonal antibodies of IgG2b isotype {Department 
of Pathology, Cambridge University, UK) IUld rat-anti-mouse Thy-1 of 
IgG2b isotype {Department of Immunology, Institute of Hematology, GSF, 
Munich, FRG) • Currently, we are testing. these monoclonals in sel!li-
allogeneic and allogeneic mouse models for partial chimerism, notably 
alpha-thalassemic mice and W/Wv mice. The former {Wagemaker et al., 
Transplantation 42, 1986, 248 -251) are an optimal model to test the 
immunosuppressive potential of monoclonal antibodies, since engraftment 
can be longitudinally followed in single mice by means of the red cell 
size marker. Using these mice, it was shown that the anti L3T4/Lyt2 
combination of monoclonal antibodies have an immunosuppressive capacity 
equivalent tot 3 to 4 Gy TB!, while that of anti-Thy-1 is comparable to 
2 to 3 Gy TBI. An example of the efficacy of these monoclonal anti-
bodies using mice carrying the thalassemia marker to detect chimerism 
is shown in Figure 1. It is expected that a further improvement of such 
a regimen can be achieved by combining these ·cytotoxic liiOnoclonal··anti-
bodies with leukocyte function-blocking antibodies, such as anti-LFA-1. 
Anti-human LFA-1 was found to cross-react wit.h rhesus .monkey cells. 
Based on the .. hypothesis that graft rejection has similar effector cells 
as graft-versus-host reactions, the immunosuppressive effectiveness of 
anti-LFA-1 was tested in rhesus monkeys in a graft-versus-host model {a 
fully mismatched donor-recipient combination) as well·as a host-versus-
graft model {8.5 Gy X-rays as conditioning, using a 3-4 log T lympho-
cyte depleted, fully mismatched bone marrow graft). Anti-LFA-1 appeared 
to be incapable to prevent lethal graft-versus-host disease or graft 
rejection, respectively, and it is concluded that its immunosuppressive 
action as a single agent is weak. Therefore, the efficacy of such a 
function-blocking antibody is probably eo-dependent on other immuno-
suppressive agents. 
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Efficacy of monoclonal antibodies against T-lymphocytes 
{L3T4. Lyt-2) in preventing rejection of semi-allogeneic 
bone marrow, using cure from thalassemia as a marker of 
chimerism. 
2. Development of a method to purify and produce the lymphokine that 
suppresses the action of GvH-inducing T-lymphocytes. 
The role of suppressor cells in the establishment of transplantation 
tolerance has been demonstrated by several investigators. It has also 
been demonstrated that natural suppressor cells, exerting nonspecific 
suppression are involved in abrogation of T-lymphocyte responses in 
vitro and in vivo. The presence of such natural suppressor cells was 
demonstrated in neonatal spleen and thymus. The natural suppressor 
cells exert their activity by means of a soluble factor. The culture 
supernatants of fused mouse neonatal spleen cells and a T cell lymphoma 
contain a soluble suppressor factor {SUF) that suppresses T-lymphocyte 
responses both in vivo and in vitro. In vitro incubation of spleen and 
bone marrow cells with SUF prior to transfer to lethally irradiated 
mice, prevents the acute GvHD reaction without affecting the hemo-
poietic stem cells. Fractionation of the crude supernatant revealed the 
presence of two suppressive moieties, one of high {>lOOkD) and one of 
low {<3kD) molecular weight. These two moieties exert suppression inde-
pendently and by distinct mechanisms. Only the high molecular weight 
moiety interferes both with the GvH reaction in vivo and with in vitro 
T-lymphocyte proliferation induced by various stimulation signals such 
as alloantigen, mitogen or OKT3. By studying the kinetics of the high 
molecular weight SUF moiety mediated suppression it became evident that 
it interferes at an early stage of T lymphocyte activation. The factor 
is not specie.s-specific. Its further characterization and production 
awaits the development of a large-scale purification method followed by 
molecular approaches. 
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Title of the project no.: 
Comparison of damage from internal alpha-irradjation on the hemopoietjc 
and stromal system in adult and pre- and postnatal mice 
Head(s) of project: 
Greet E.R. Schoeters 
Scientific staff: 
R. Van Den Heuvel 
G. Schoeters 
o. Vanderborght 
I. Objectives of the project: 
This study aims to &earch for cells at risk with respect to the induction 
of long-term effects like bone tumors and myeloproliferative disorders. 
During the latency period before long-term effects appear, effects on 
stromal and hemopoietic ste'4rells of hemopoietic organs are studied after 
contamination of mice with Am. The investigation includes different age 
groups : foetal, neonatal and adult mice. Their sensitivity to internal 
alpha-emitters will be compared. 
11. Objectives for the reporting period: 
1 Radiation damage to haemopoietic and stromal stem cell concentration 
and to long-term bone marrow cultures in which stromal ~~:p s maintain 
haemopoiesis in vitro, is investigated after exposure to Am in utero 
or injection of adults. The persistence and nature of this damage is 
analyzed. 
2 After contamination of pregnant mice, the transfer of Am to the foetus, 
its distribution and retention in different organs is analyzed. The 
absorbed radiat-ion dose is calculated. 
3 Study of the stroma J cells in haemopoietic li ve>r, spleen and bone 
marrow during foetal and postnatal development impoztance in 
regulation of haemopoiesis. 
4 Initiation of a survival experiment using fostered offspring of Am 
contaminated pregnant mice : the occurrence of late radiation effects 
is checked. 
5 Development of an ir: vitro assay for osteogenic differentiation of 
adult bone marrow cells. 
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Ill. Progress achieved: 
1) Methodology 
l.A. Long-term bone IDEr~o~ cultures are initiated from 
a. mice injected with 11 Am at adult age (0, 33, 70, 146, 300, 1200 
kBq/kg) ; 241 
b. offspring of Am contaminated pregnant mice (0, 102, 430, 485 and 
1500 kBq/kg) and fost.e>red with a non-contaminated mice ; 
c. not-fostered offspring of contaminated pregnant mice (0,480 kBq/kg). 
The CFU-GM proliferation is checked in these cultures. 
l.B. CFU-s, CFU-GM and CFU-f stem cell assays were performed from the 
bone marrow of offspring contaminated in utero. 
l.C. Cc-cultures were performed to analyse which component in the LTC is 
radiosensitive, either the stromal adherent layer or the haen>opoietic 
cells. Bone marrow cultures depleated from haemopoietic stem cells were 
obtained via 1) X-irradiation of the LTC or 2) culture conditions in 25% 
foetal calf sert~. Stromal layers were reseeded with haemopoietic cells 
from control or Am contaminated offspring. CFU-GM numbers in the LTC 
were followed. 
2. Pregnant BALB/c mice were injected with 500 kBq 241Am/kg at the 14 d. 
of gestation. The Am retention was measured in the offspring between one 
day after injection until 3 months after birth in liver, skeleton, 
(femur, calvarium, mandibula, ribs) and gastro-intestinal tract. Ca and 
Fe content of the selected organs were measured, using an I.C.A.P. 
emission spectrophotometer. 
3. Short-term (CFU-f), long-term stromal (LTC) cultures and eo-cultures 
(between stromal and haemopoietic cell populations of different origin) 
were establighed from liver, spleen and bone marrow at different 
developmental ages. 
4. Pregnant BALB/~4rice at 14 d of gestation were injected with o, lOO, 500 and 1500 kBq Am/kg. At birth, newborn mice were transferred to a 
fostermother. At 3 weeks of age, mice were separated and housed 
indidivually. 
5. Marrow from femurs of adult mice were collected as a marrow plug and 
cultured under sped fie conditions. This c>steogenic model is 
characterized. 
2) Resul~~ 
l.A.a) After 241Am injection of adult mice LTC were less able to support 
CFU-GM proliferation. The radiation effect lasted at least until 17 
weeks after contamination. Damage was observed at the lowest level of 
injected radioactivity (33.2 kBq/kg). The cumulative dose in the 
skeleton was then 0.33 gray at. 4 w after Am injection. 
b) In offspring exposed to Am in utero and reared by a 
non-contaminated fostermother, stromal bone marrow cells showed no 
change in their ability to maintain haemopoiesis in LTC. 10 w 
post-contamination the cumulative dose in the femur reached 0.0098 Gy 
and 20 w post-contamination the accumulated dose amounted to 0.0125 Gy. 
c) LTC from offspring contaminated in utero and reared by their own 
contaminated mother, were less able to support CFU-GM proliferation than 
LTC from non-contaminated offsprings. This radiation damage persisted 71 
weeks after contamination. The cumulative dose to the femur was as low 
as 0.011 Gy. 
Although the accumulated doses to the femur were comparable (with 
l.A.b.) radiation effects were only seen when Am contamination was a 
result from the placental transfer and the intake during lactation. 
l.B. The haemopoietic stem cell concentrations (CFU-s, CFU-GM) and the 
stromal stem cell concentrations (CFU-f) in the bone marrow, were not 
impaired after Am contamination in utero. A diminished stem cell 
concentration in the initial cell suspension from which LTC were derived 
can thus not account for the effects seen in the LTC. 
l.C. Haemopoietic cells derived from 241Am contaminated offspring had a 
reduced proliferation capacity on stromal adherent layers which were 
cultured in 25% FCS. However, when comparing the stroma, the stromal 
adherent cells derived from contaminated mice supported better the 
production of CFU-GM. 
2. After contamination of pregnant mice with 241Am, 0.02% of the Am is 
trar.sferred through the placenta to the foetus. In the foetus, Am 
concentrated in the liver and skeleton. The Am concentration in the 
skeleton varied considerably between various parts e.g. mandible and 
calvarium showed a 4 fold higher Am concentration compared t.o the femur. 
The amount of Ani which initially deposited in a bone depended en the Ca 
concentration of the bone at that time. The Am retention pattern was 
different among the considered fetal bones the Am concentration 
decreased rapidly in bones with high growth rates. 
The fractional retention in the liver remained constant till one rrcnth 
of age. The subsequent decrease occurred simultaneously with a decrease 
of the Fe content. 
Am transfer through lactation resulted in a final.increase in Am content 
by a factor of 3. The incorporation occurred in the skeleton. 
The retention data were used to calculate initial dose rates and 
absorbed radiation doses in function of time in the organs. 
3. Studying the changing haemopoietic system during development is 
useful for the analysis of the role of stromal cells in haemopoiesis 
which in turn may be important to understand disturbances in radiation 
induced deregulation of haemopoietic cell proliferation (leukemia). 
During yolk sac, liver, spleen and bone marrow haemopoiesis in mice, at 
ages ranging between 11 d of gestation and adult life, important changes 
in the stromal stem cell population (CFU-f) occur which are correlated 
with haemopoiesis. 
Studies with 3 H-thymidine incorporation indicated that stromal stem 
cells in developing haemopoietic organs have a high proliferation 
activity (up to 70%) in contrast with adult stromal cells. 
In LTC from developing liver, spleen and bone marrow, the proliferation 
of CFU-GM was supported. The CFU-GM concentrations in the LTC reflected 
the haemopoietic activity of the organ of origin at the time the culture 
was initiated. In the stromal layer of the LTC, the presence of 
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macrophages and glycosaminoglycans (sulphated and non-sulphated) showed 
a positive correlation with the haemopoietic activity. This correlation 
did not exist for fibronectin and alkaline phosphatase positive cells. 
Their presence was inversely related with the proliferation capacity of 
the stromal stem cells which suggested that these components are a 
differentiation product of more mature stromal cells. 
eo-cultures revealed that the stromal cell compartment in the LTC 
determined the haemopoietic activity. 
4. Results are not completely analyzed yet. Up to now, 403 of 579 
offpsring died. 
5. Murine adult bone marrow cells exhibit mjneralizing capacity in vitro 
as shown via 85-Sr uptake and morphological studies. The production of 
extracellular bone matrix molecules was observed in function of 
incubation time alkaline phosphatase, osteonectin, osteocalcin and 
collagen type I. Matrix vesicles and needles of hydroxy-apatite crystals 
were observed. 
3) Discussion 
1. Perinatal haemopoietic and stromal cells are radiosensitive and can 
be considered as target cells for early changes and late effects after 
contamination in utero. The LTC culture system is a sensitive system to 
examine radiation damage. Our results indicated that the age of the 
animals at exposure determined the radiation-induced effects. 
Supplementary intake of 241-Am via lactation seems important. Using LTC, 
damage was observed at lower radiation doses if Am contamination 
occurred at foetal than at adult ages. These observations are important 
for risk estimation during pregnancy and for neonates. 
2. The Am distribution and retention in the foetus (after contamination 
of the dam) differs from the Am distribution in the adult (after 
contamination at adult age). This has implications for absorbed dose and 
risk calculations. 
3. The study of changes in the stromal system of haemopoietic organs 
during development is useful to determine the factors important in the 
interactions between stromal and haemopoietic cells in regulation of 
haemopoiesis. Understanding of the mechanisms underlying haemopoiesis 
can help us to understand the nature of radiation effects. 
The large proportion of cycling stromal stem cells in fetal haemopoetic 
organs, implies that these stromal cells may be very radiosensitive. 
4. The in vitro bone formation assay may provide the opportunity to 
identify~h~row cells with an osteogenic potential (target cells for 
bone tumor development ?) and to investigate the mechanisms triggering 
differentiation towards osteogenesis. 
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IV. Other research group(s) collaborating actively on this project [name(s) and 
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V. Publications: 
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(CFU-f) from adult bone marrow. British Journal of Cancer" 53, suppl. 
VII, 169-170 (1986). 
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Biol. 97, p. 376, 1986. 
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Radiation Research 111, 185-191 (1987). 
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G.B. Gerber, H. J.l.1etivier, H. Smith, Martinus Nijhoff Publishers, 
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Dordrecht, Nederland, pp. 201-208 (1987). 
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Haemopoiesis in long-term cultures of liver, spleen and bone marrow 
of pre- and postnatal mice : CFU-GM production. 
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shows a deficient in vitro haemopoiesis. 
Int. J. Rad. Biol.-caccepted July 1989). 
G. Schoeters, R. Van Den Heuvel, H. Leppens, F. Vander Plaetse, 0. 
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metabolism and comparison with distribution of l>.m after injection 
of adults. 
Int. J. Rad. Biol. (submitted October 1989). 
2. Theses, abstracts 
S. VerseJe 
Pre- and postnatal investigation of the stromal system from murine 
haemopoietic organs. 
Master's Degree Theses (1989). Biology Department, University of 
Antwerp. 
E. Mathieu 
Extracellula~ matrix and celltypes in bloodforming organs in vitro. 
Master's Degree Theses (1987). Biology Department, University of 
Antwerp. 
B. Rubbrecht 
Correlation between ea, Fe and 241Am content in the liver and 
skeleton from pre- and postnatal mice. Industrial Engineer Degree 
Theses (1987), Denayer High-School, Mechelen. 
I. Le~·oy 
In vitro mineralisation of bone marrow derived from the femur of 
adult mice. 
Ind. Eng. Degree Theses (1987), Denayer High School, Mechelen. 
R. Van Den Heuvel, G. Schoeters, 0. Vanderborght 
Morphological changes in the stromal stera cell assay (CFU-f) 
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Europeau Journal of Cell Biology, Suppl. 20, Vol. 44, p. 54 (1987). 
E. Hathieu, R. Van Den Heuvel, G. Schoeters, 0. Vanderborght 
Relation between hemopoietic activity and the presence of 
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and postnatal) . (abstract) . 
European Journal of Cell Biology, Suppl. 20, Vol. 44, p. 45 (1987). 
G. Schoeters 
Adult mouse bone marrow cells mineralize in vitro. 
Calcif. Tissue Int. V41, 52, pp 47 (1987) (abstract). 
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G. Schoeters, R. Van Den Heuvel 
The distribution of 241-Am in the mouse fetus and its effects. 
EULEP Newsletter SO, 22-23 (1988). 
G. Schoeters, R. Van Den Heuvel, o. Vanderborght 
Am-241 uptake and distribution in offspring from BALB/c mice 
contaminated in utero : relation to calcium and iron metabolism. 
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Offspring of ~241 contaminated mice : late effects on the marrow. 
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Title of the project oo.: 1 -
., 
Ratios of yields of myelo1d leukaemia and osteosarcoma induced 1n m1ce by 
224Ra. 
Head(s) of project: 
E.R.Humphreys 
Scientific staff: 
E.R.Humphreys 
I. Objectives of the project: 
To show. in CBA/H mice, that the yield of myeloid leukaemia is 
greater than that of osteosarcoma follow1ng the 1nJection of amounts of 
224Ra which are less than optimum for induc1ng osteosarcoma. 
11. Objectives for the reporting period: 
1. To continue the 1nvestigation of a single injection of different 
amounts of 224Ra into male CBA/H mice and the identificat1on of subtypes 
of the induced myeloid leukaemias by cell morphology. 
2. To continue the long-term investigation of the effects in male 
CBA/H mice of the protraction in time of the administrat1on of 22 4Ra 
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Ill. Progress achieved: 
INTRODUCTION 
The potential contam1nation of the environment bv a-partlcle em1tt1ng 
radionuclldes 1s a cont1nu1ng spur to the experimental invest1gat1on of 
their toxicity. Animal exper1ments (Vaughan 1973, Muller et al 1978) and 
human exper1ence (Rowland et al 1983, Mays et al 1986) have shown 
osteosarcoma to be the maJor late effect. More recently 1t has been shown 
that myelo1d leukaem1a, as well as osteosarccma, 1s induced by 224Ra in 
CBA/H mice and that there may be a range of injected amounts of 224Ra in 
which more myeloid leukaemia than osteosarcoma 1s induced (Humphreys et al 
1985a, Humphreys et al 1985b). 
In most exper1ments the results from an1mals have been obtained from 
s1ngle administrations of activity. This contrasts with the cont1nuous 
contamination which would be likely from a contaminated env1ronment. In a 
series of long-term exper1mi:mts carr1ed out c1t Neuherberg, however, 22 4Ra 
was administered to NMRI mice in multiple in:ections over a period 
extending up to several months as well as in single adminlstrations. It 
was shown that 224Ra exerts a much more osteo:>arcomagen1:: effect when 
protracted in time than when given 1n a single amount (Muller et al 1978). 
It became clear subsequently, however, that the effect of protract1ng the 
administration was reduced when smaller total amounts of Z2 4Ra were 
administered and at 148Bq g-1 and less, the effect was not seen (Muller et 
al 1983; Muller· et al 1989). 
In a more recent series of experiments (MUller et al 1988) it has now 
been show11 that s1gn1ficant changes 1n the y·1eld of lymphoma can be caused 
by protract 1 ng a very much smaller tot a 1 amount of 18. 5Bq g-1 224Ra glVen 
to m1ce over a period of 36 weeks. The mice used in these experiments 
suffer a spontaneous incidence of lymphoma late in life but the effect of 
the protracted administration of 224Ra, compared w1th s1ngle 1njection, 1s 
to induce a ma 1 i gnant 1 ymphob 1 ast i c 1 ymphoma after a very cons 1 derab 1 :-' 
reduced latent period. 
The effect of protracting the admimstration of a-particle act1v1ty 
has not been comprehens1vely explored in the CBA/H mouse. In a small 
exper1ment in which zaspu was admin1stered in s1ngle or div1ded affiounts 1t 
was seen that, for the same total amount adm1n1stered, more cases of 
myeloid leukaemia were seen in the animals given 2aspu in divided amcunts 
than were seen in those animals given the same activ1ty 1n a s1ngle amount 
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tHumphreys et al 1987). The total numbers of leukaem1as were small 
however. The present reports describes exper1ments which a1m to 
1nvestigate the effect of protracting the administration of 2 Z4Ra 1n CBA/H 
m1ce. 
The a1ms of the present ongo1ng exper1ments are therefore: 
1. To confirm that myeloid leukaem1a is 1nduced by 
s1ngle 1njected amounts of 224Ra which are less 
than opt1mum for inducing osteosarcoma. 
2. To determ1ne whether, 1n th1s range of 
administered amounts of 224Ra, the yield of 
myeloid leukaemia 1s greater than that of 
osteosarcoma. 
3. To determine whether the yield of myeloid 
leukaemia 1s 1ncreased by injecting the same 
overall amounts of zz•Ra in multiple al1quots 
over a period of time. 
MATERIALS AND METHODS 
224Ra was obtained from Amersham Buchler, Braunschwe1g, GFR v1a 
Amersham International, Amersham, Un1ted Kingdom as a solut1on of the 
chloride in sterile pnysiological sal1ne. This was diluted with sterile 
physiological saline containing 100~gcm-3 Ca2+ (diluting solution- OS) 
for the single inJection experiments to give inject1on solutions 
containing 4, 8, 16 or 32kBqg-1 and, for the multiple lnJectlon 
experiments, to give injection solutions conta1ning 200, 400 or 800Bq g-1. 
Duplicate standards were prepared from each inJect;on solution and their 
gamma-activities determ1ned !using an LKB Cempugamma sc1nt1llat1on 
counter) 1n a closely-defined reg1on of the gamma energy spectrum which 
included the 240keV gamma rays from 212Pb. 
All of the m1ce whicn were used were male CBA/H, 84_±5 days old at 
first or only inJection. In the s1ngle 1nject1on exper1ment each mouse was 
injected intraper1toneally w1th 0.5cm3 of the appropr1ate inJeCtlon 
solution; control mice were lnJected with 0.5cm3 diluting solution. 1he 
mice 1n the multiple lnJeCtlon experiment were inJected intraperitoneally 
tw1ce each week for e1ght weeks; they were we1ghed at the time of 
injection and injected lntraperitoneally with suffic1ent of the 
appropr1ate inject1on solution to g1ve 32, 64 or 128Bq g-1 body mass 224Ra 
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1 n tot a 1 over the e1 ght weeKs of the experiment. The cont ro ., m1 ce 1 n the 
mult1ple 1nJect1on experiment were treated 1n the same way as the 
experimental animals except that the 1nject1on solut1on conta1ned no 
radium. 
The an1mals were not assigned from their l1tters to the1r 
experimental groups 1n a predetermined order but, because they were 
assigned at intervals and not all groups were represented at eacn 
assignment, the d1stribut1on of l1tters among groups was not entirely 
random. The ammals were housed no more than four to a box 1meas·Jnng 
305mm X 125mm X 120mml 1n open accommodation and were allowec unrestr1cted 
access to food <D1et 801 157 RM No.1E from Special Diet Services Ltd. J and 
water. The food was generally in the form of compressed pellets but those 
mice wh1ch developed faulty dentition with increasing age (Humohreys et al 
1985b) were given add1tional powdered diet mixed in a soft paste w1th 
water. All animals were 1nspected at least once each day and a l1st 
prepared each week of m1ce wh1ch needed more deta1led exam1nat1on. 
The presence of anaemia is the most reliable ind1cator of leukaem•a 
and was detected most eas1ly in the living an1mal by pa:lor of the feet. 
If anaemia was accompanied by a palpable spleen then leukaemia was more 
pos1tively indicated. In these animals a tail vein blood sample was ta~en 
and blood smears prepared and treated w1th Leishman's stain. The presence 
of atyp1cal or immature white cells was most often the s1gnal t~r the 
an;mal to be killed even if the number of wh1te cells seen 1n the smear 
did not appear to be increased above the normal range. The mice with 
suspected leukaemia were weighed and killed under deep chlorcform 
anaesthesia by opening the chest and taking a ma>imum blood sample from 
the heart. Further blood smears were prepared and treated w1th Le~shman's 
stain as above and red and wh1te ~ells counted in a haemocytometer. 
The organs and t1ssues of the an1mals were then exam1ned by a 
standard routine and a record kept of the observation~. The spleen was 
weighed, approximately 100mg homogen1sed 1n 5ml Earle's med1um and 0.5ml 
aliquots of the suspension 1njected intraperitoneally into three 10- 14 
week old female CBA/H mice. Samples of liver, spleen, kidney, at least cne 
lymph node, sternum and lumbar vertebrae were taken from all leukaemic 
an1mals and fixed in formal sal1ne before sect1oning and sta1ning wlth 
haematoxylin and eosin. Samples of other tissues were taken if their 
appearance warranted closer exam1nation. 
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Paralysis, particularly of the hind limbs, was sometimes a s1gn of 
osteosarcoma in the living animal. These an1mals and those with palpable 
masses apparently associated with the skeleton were radiographed under 
Halothane anaesthesia. Radiographs were taken routinely in two pos1tions -
one prone with limbs splayed and the other. right side down w1th limbs in 
"running" pos1tions. Osteosarcoma was generally inferred from the presence 
of opacities in the skeleton or less frequently, from the presence of 
apparent osteolysis. If osteosarcoma was suspected the mouse was killed 
and given a post-mortem examination as described above but Wlthout blood 
cell counts or transplantat1on if leukaemia was not also suspected. In 
these animals samples of the relevant bones were taken for histology in 
addition to the standard samples from sternum, lumbar vertebrae and soft 
tissues. 
The remaining animals in the exper1ment were allowed to live until 
they died or were humanely killed (as above) when they were judged to be 
able to live for no more than one or two days more or appeared to have a 
condition which might cause pain or distress. All· of these animals were 
weighed immediately prior to death or,. if they were found dead, 
immediately before the post-mortem examination; they were all X-rayed. 
Smears were prepared from cardiac blood samples taken from all animals 
which were killed and samples of organs and tissues were taken from all 
an1mals for histolog~ as described above. 
Diagnoses of myeloid leukaemia and of osteosarcoma were based on 
exam1nation of tissues under the microscope. 
Myeloid leukaemia does not occur spontaneously in these mice. Any 
occurrence of myeloid leukaemia, therefore, in mice given 224Ra, was 
assumed to have been radiation-induced. Similarly, spontaneous 
osteosarcoma occurs very infrequently and, in 224Ra-treated animals, was 
assumed to have been induced by the radium. 
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RESULTS 
Tables 1 and 2 show the status of both experiments in January 1990. 
Table 
Occurrence of myeloid leukaemia and osteosarcoma 
Status January 1990 
Single injection experiment 
224Ra injected ( Bq g-1) 0 69 138 
No. of mice entered 400 400 400 
No. of mice dead 234 281 397 
Mean days inj.-death 620 631 665 
Mice diagnosed as having: 
Myeloid leukaemia 0 4 11 
Osteosarcoma 0 3 
Table 2 
Occurence of myeloid leukaemia and osteosarcoma 
Status January 1990 
Multiple injection experiment 
224Ra inJected (Bq g-1) 32 64 128 
No. of mice entered 200 200 200 
No. of mice dead 52 45 107 
Mean days 1nj.-death 389 358 511 
Mice diagnosed as having: 
Myeloid leukaemia 0 0 4 
Osteosarcoma 0 0 
280 550 
400 400 
395 231 
669 570 
15 11 
6 
From table 1 it is clear that, in this range of injected amount of 
224Ra, more myeloid leukaemia than osteosarcoma is induced. As the 
experiment nears completion, however, it is likely that more osteosarcoma 
than myeloid leukaemia will be diagnosed and that the present ratio of 
myeloid leukaemia:osteosarcoma of 41:11 will decrease. 
The investigation of the effect of protraction is at a much earlier 
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stage and table 2 shows that only four myeloid leukaemias and one 
osteosarcoma have been diagnosed to date. 
DISCUSSION 
Mice were not introduced 1nto e1ther expenment at the same ;·ate 1n 
all groups. The unequal rates of death and apparent d1fferences 1n mean 
period between inJection to death are to some extent a reflection of th1s. 
The mean periods between injection and death for the 1nduct1on of 
myelo1d leukaemia from a single inJeCtlon of 224Ra were (513 ± 24J days 
and (485 ± 43) days and for the induction of osteosarcoma (553 ± 64) days 
and (633 ± 49) days for the present and previous experiments (~~mphreys et 
al 1985a) respectively. 
The present experiments suggest that mor~ myeloid leukaemia than 
osteosarcoma is induced in the range ~~ administered amounts of 224Ra 
between 70 and 600Bqg-1. It is unlikely, however, that the ratio myeloid 
leukaemia : ost~osarcoma will remain as high as 41:11 as the experiment 
continues t~ completion. 
I~ these results are accepted as relevant to humans then persons 
exposed to amounts of a-particle emitter less than optimum for induc1ng 
osteosarcoma may be at risk instead from myelold leukaemia. There are 
several features of the myeloid leukaemia seen in these mice which are 
similar to those seen in human acute myeloid leukaemla and recent 
(unpublished) observations have shown that of the seven possible subtypes 
of myeloid leukaemia seen 1n humans (FAB classification) five have been 
provisionally identified by blood cell morphology in the mice used in the 
present experiments. Finally, however, it is only 1n the eluc1dat1on of 
the mechanisms of leukaemogenesis 1n both mice and humans that the nature 
of the this response to radiation can be fully ldentified and true value 
of the mouse model understood. Epidemiological evidence from patients 
treated with 224Ra in the German Federal Republic before 1950 showed 
conclusively that osteosarcoma was the major late effect (Mays et al 
1986). In these studies, although there were 53 cases of osteosarcoma 
(compared with 0.2 cases expected) there was a stated inc1dence of only "0 
- 3 excess cases of myeloid leukaemia attributable to radium". This 
evidence appears to show therefore that the sens1tiv1ty of humans to 
J-particle-induced osteosarcoma is at least an order of magn1tude greater 
than 1s the1r sensitivity to myeloid leukaemia. The present experiment 
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snows, however. that 1n m1ce there 1s a region of exposure to Z< 4Ra below 
that which caused a max1mum yield of osteosarcoma in which the yield of 
myelo1d leukaem1a 1s greater than that of osteosarcoma. If these results 
can be used as a model for man then it might be expected that there 1s a 
s1mi lar reg1on in human exposure to 22 4Ra where the 1nc1dence ot leu~,aemia 
may become greater than that of bone tumour. In an ep1dem1olog1cal study 
of pat 1 ents given smaller amounts of 22•Ra than 1 n the earl1 er study the 
three bone tumours which have been diagnosed 1n the exposed populat1on 
(fibrosarcoma, reticulum cell sarcoma of the bone marrow and general1zed 
plasmocytoma - Wick et al 1986) contrast with the types of bone tumours 
(mostly osteosarcomas) which were diagnosed 1n the populat1on exposed to 
larger amounts of 2 24Ra (Mays et al 1986). Leukaemia has also been 
diagnosed in the pat1ents g1ven the smaller amounts of 224Ra although 
the1r induction by radiation has not so far been cla1med. The ultimate 
findings of these stud1es w1ll have an important bear1ng on the quest1on 
cf human sensit1vity to the 1nduct1on of leukaemia by bone-seek1ng 
:-particle-emitting radionucl1des. 
To date the multiple 1nject1on experiment has not confirmed a general 
shorten1ng of latent period s1m1lar to that seen at Neuherberg 1n those 
cases of myeloid leukaemia wh1ch have been induced or that a s1gnif1cant 
1ncrease m the y1eld of myeloid leukaem1a has been caused by protract10n. 
These exper1ments, however, are still at an early stage. 
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Title of the project no.: 2 
The role of oncogene activation in 224 Ra-induced myeloid 
leukaemia 
Head(s) of project: 
Dr R Cox and Prof G E Adams 
Scientific staff: 
Dr E R Humphreys 
I. Objectives of the project: 
To determine the involvement of specific oncogene activation 
events in the induction of murine myeloid leukaemia (AML) by 
the bone-seeking radionuclide 224 Ra and whether such 
activation events are linked with radiation-induced chromosomal 
changes in target bone marrow cells. 
11. Objectives for the reporting period: 
1. To use karyotypic analyses to search for consistent 
chromosomal changes in AMLs 2. To study the status of 
chromosomal changes in the induction of AML 3. To develop an 
automated karyotyping system 4. To cytogenetically study the 
relative leukaemogenic effectiveness of X-rays and a-particles 
5. To analyse the structure and expression of proto-oncogenes 
and growth factor genes in AMLs. 
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Ill. Progress achieved: 
METHODOLOGY 
1.1 Karyotypic analysis: The G-banded karyotypes of CBA/H AMLs 
induced either by 224 Ra or X-rays were analysed both directly 
(in leukaemic tissues) and indirectly (in short term cultures 
+or- mitogen stimulation (1,7)). In situ chromosome 
hybridization of 3 H labelled gene probes to metaphase 
preparations was performed using published techniques (8). The 
development of a computer-assisted image processing system for 
the analysis of G-banded murine chromosomes was achieved 
through close collaboration with the MRC Human Genetics Unit 
(6, 7' 9). 
1.2 In vitro cellular irradiation and transplantation: Bone-
marrow cells were prepared by lavage of the long bone-marrow 
cavities of male donor mice. Marrow cells were irradiated in 
Yit£Q with 3 Gy 250 Kvp X-rays (cells contained in a medium 
suspension) or with 1.3 Gy a-particles from a Pu source (cells 
held as a monolayer on a thin Mylar window) . Irradiated and 
mock-irradiated male donor cells (106-1o7) were transplanted by 
tail vein injection into female recipient mice previously 
irradiated with 10 Gy X-rays for the purposes of bone-marrow 
ablation. The clonal proliferation of the irradiated male 
donor cells was investigated at various post-transplantation 
intervals by karyotic analyses of bone-marrow, spleen and blood 
cell preparations of transplanted animals (1). 
1.3 Molecular analysis of genes in AMLs: Leukaemic cells were 
isolated from bone-marrow and spleen of recipient CBA/H mice. 
High M.Wt. DNA, total RNA and mRNA were purified from cells 
using standard preparative techniques (12). DNA was digested 
with restriction endonucleases, electrophoresed on agarose 
gels, Southern blotted and hybridized to 32P radiolabelled gene 
probes. RNA analyses were performed by either dot blot or 
Northern blot techniques. Hybridizing sequences on DNA and RNA 
blots were detected by autoradiography. For pulsed field gel 
electrophoresis very high M.Wt. DNA was prepared and 
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restriction enzyme-digested in agarose plugs. Electrophoresis 
was performed in a rotating gel apparatus varying voltage and 
pulse time in order to achieve separation of restriction 
fragments of M.Wt. 50 kb to 1Mb. 
2 RESULTS AND DISCUSSION 
2.1 Karyotypic analysis of induced AMLS: A total of 53 
leukaemic clones (both primary and passaged neoplasms) were 
karyotyped; 7 induced by a-particles from 224 Ra, 47 induced by 
X-rays. Of these, 52 showed some form of chromosome (eh) 2 
rearrangement; 36 were scored as deletions, 26 as 
translocations but unambiguously distinguishing such events in 
aneuploid neoplasms containing marker chromosomes was not 
always possible. Since the highest frequency of ch2 
translocation was observed in early studies of passaged AMLs 
that had not been available as primary·neoplasms it is also 
possible that some of these represent clonal selection of 
further ch2 changes. However, there was no evidence of specific 
differences between ch2 rearrangement in a-particle and X-ray 
induced AMLs and sequential karyotypic analysis of passaged 
AMLs indicated that ch2 change was generally stable. Ch2 
translocation in AMLs was in most cases accompanied by loss of 
chromosomal material. However, although loss of ch2 material 
between the C and F regions was frequently observed in AMLs 
this was not invariable and consistent loss of a single ch2 G 
band could not be determined from these analyses (1,3). 
Similarly, unlike the situation in human leukaemias that show 
gene activation events associated with chromosomal change, ch2 
breakpoints.(BPs) in murine AMLs were not restricted to a 
single chromosomal sub-region. While the C region (23 BPs) and 
the E4-F region (26 BPs) were most frequently involved, 6BPs 
were scored in the centromere - C1 region, 2 BPs in the E1 
region and 6 BPs in the G region. Consequently, while it 
appears that preferential ch2 breakage in radiation-induced 
AMLs is a feature of the leukaemogenic process, these data do 
not clearly point towards the consistent involvement of 
specific chromosomal sites associated with gene activation 
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events. It is possible, however, that the resolution of G 
banding techniques are in some cases failing to resolve complex 
multi-site rearrangements in AMLs (12). 
2.2 In vitro cellular irradiation and bone marrow 
transplantation These studies were initiated in order to 
determine whether prior 3 Gy X-irradiation of transplanted 
marrow led to the subsequent repopulation of recipient animals 
by haemopoietic cell clones carrying specific radiation-induced 
chromosomal rearrangements. The findings of these studies may 
be summarised as follows: a) Proliferating donor diploid cell 
clones carrying stable chromosomal abnormalities were observed 
in recipient marrow(- 5 days), in spleen (9-11 days) and 
subsequently in T-lymphocytes (33-35 days) b) Between 0.3 and 
0.5 of such clones carried ch2 rearrangements c) The frequency 
of such ch2 events (1-1.5 per recipient) exceeded that expected 
of randomly induced chromosomal damage d) Many ch2 rearranged 
clones appeared to exhibit some form of preferential 
recruitment and/or proliferative advantage e) Transplantation 
of unirradiated cells failed to yield any chromosomally 
abnormal clones (1). Overall, it was concluded that ch2 events 
similar to those seen in AMLs were induced directly by X-rays 
in multipotential haemopoietic cells and appeared to confer 
phenotypic changes to some carrier cells. Consequently some 
ch2 rearrangements in AMLs may represent initiating events for 
this radiogenic neoplasm. 
From a total 88 ch2-rearranged haemopoietic cell clones, 54 
were scored as deletions, 34 as translocations (usually without 
losses). However, while as in the case of AMLs, there was clear 
evidence of ch2 BP clusters in the C and E4-F regions, other 
regions (B, E1 and G) were also over-represented. Despite 
their likely relevance to murine leukaemogenesis, no ch2-
rearranged transplantation clones have yet been shown to 
progress to frank AML. The induction by X-rays of ch2 
rearrangement in multipotential haemopoietic cells may there-
fore represent the manifestation of multiple site ch2 fragility 
following radiation damage thus providing a substantial post-
-1~1-
irradiation pool of genotypically altered cells from which 
clonal AML only rarely develops. 
2.3 Chromosomal rearrangement; Relative effectiveness of X-rays 
and a-particles; Both human epidemiological and experimental 
animal studies indicate that a-particles from bone-seeking 
actinides are only weakly leukaemogenic. This could arise 
either through intrinsic hypersensitivity of haemopoietic 
target cells to the lethal effects of a-particles or because 
the short range of a-particles from bone surface failed to 
result in the irradiation of a large proportion of these cells. 
In order to approach this problem experimentally, lavaged 
marrow cells were irradiated in vitro with a-particles from 238 
Pu (1.3 Gy) or X-rays (3 Gy) to give CFU-S surviving fractions 
of~ 0.1. Semi-quantitative estimates of the induction of 
stable chromosomal changes in multipotential haemopoietic cells 
were obtained by sequential karyotypic analysis of recipient 
animals receiving a and X-irradiated donor marrow. These 
analyses showed that whereas X-irradiation induced 3.2 stable 
chromosomal rearrangements per recipient (~ 50% of which 
involved ch2) the corresponding figure for a-particles was only 
0.25. This result is precisely that which would be expected if 
target multipotential cells were extremely sensitive to the 
lethal effects of a-particle traversal and that the majority of 
cells surviving a-irradiation carry no stable chromosomal 
damage because they received no a dose to the cell nucleus. 
Current studies using a partial marrow ablationjself-
repopulation experimental strategy for the analysis of in vivo 
haemopoietic irradiation by X-rays (3 Gy) or a-particles from 
224 Ra (16 kBq/mouse) are providing further evidence on the 
relative inefficiency of a-particles in inducing stable 
chromosomal changes in surviving multipotential haemopoietic 
cells. It was provisionally concluded that the weak 
leukaemogenicity of a-particles from bone-seeking radionuclides 
may be more strongly influenced by intrinsic target cell radio-
sensitivity than by a combination of inhomogeneous a dose and 
target cell distribution. 
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2.4 Computer-assisted karyotyping: An image processing system 
developed for automated analysis of human chromosomes (Piper J 
and Lundsteen C. Trends. Genet l 309 1987) was retrained for 
murine metaphase chromosomes. Initially, 15 CBA/H splenocyte 
metaphases previously analysed manually were used to train the 
classifier to identify the centromeric region and the G band 
pattern of each chromosome. Subsequently, the system was tested 
for classification accuracy against two independent observers 
scoring 47 manually selected and 51 automatically selected 
metaphases. The algorithm for centromeric determination was 
found to have an error of - 9%. Total agreement between the 
system and the two observers was achieved in - 70% of all 
mitoses. Disagreement between observers on ambiguously banded 
chromosomes was no less than that between the system and each 
of the observers. The principal source of system error was 
distinguishing chromosomes 8 and 12 (7). The mean time for 
image processing and analysis of a single metaphase was - 4 min 
and since training, - 4250 murine metaphase preparations have 
been successfully analysed. The system has subsequently been 
trained to analyse Chinese hamster metaphase preparations. 
2.5 Molecular analysis of AMLs: Molecular analyses have been 
principally focussed on the structure and expression of ch2 
encoded genes in ch2 rearranged passaged AMLs (2,10,11,12). In 
these studies normal bone marrow cells were used as controls. 
No evidence for consistent intragenic rearrangement nor 
substantial gene expression changes was obtained from analyses 
of the c-ab!, c-src nor ~2m loci. Similarly, DNA analyses also 
failed to show any rearrangements centred on the EMV-15 
proviral locus. Negative data on these loci were obtained with 
up to seven AMLs and it was provisionally concluded that none 
were specifically associated with ch2 rearrangement. Attention 
was also paid to an AML (N122) that was characterised by a ch11 
- 2 translocation. Murine ch11 contains a conserved chromosomal 
segment which includes the haemopoietic growth factor (HGF) 
genes Il-3 and Csfgm; the c-erb proto-oncogene is also encoded 
on this chromosome. However, DNA and mRNA analyses failed to 
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provide evidence for rearrangement·or changes in the expression 
of these genes that might be associated with chromosomal 
translocation. AML N122 did however show significant up-
regulation of the normal Skb c-abl mRNA transcript in the 
absence of intragenic rearrangement but, to date, N122 is the 
only AML to show this. HGF genes were also analysed in AMLs 
N36 (t2:2) and N452 (del 2). With the exception of an 
intragenic rearrangement and mRNA transcript change in the 
Csfgm gene of N36, negative results were obtained. In 
addition, analysis of the proto-oncogenes c-mos (ch10), c-fos 
(ch12), c-myc (ch15), c-sis (ch15) and c-pim-1 (ch17) also 
failed to reveal consistent structural or activational changes 
in up-to 7 AMLs. The Csfm (ch3) gene and its receptor encoding 
gene, c-fms (ch18) were also studied but, again, yielded 
negative results. 
During the course of these analyses the cytokine genes 
interleukin (Il)-1 a and ~were assigned to murine ch2 
(D'Eustachio ~ Immunogenetics ~' 339, 1987). Using in situ 
chromosome hybridization techniques Il-1a and ~ genes were 
located to the F region of ch2, cytogenetically close to a 
frequent ch2 breakpoint in AMLs (8). Subsequent in situ 
analyses revealed that, in the complex t2:2 AML N36, one copy 
of Il-1~ was translocated to the C2 region and appeared to be 
close to a C2/F translocation junction on the long derivative 
chromosome. Analysis of mRNA showed-evidence of Il-1~ but not a 
gene deregulation in N36 and two other ch2-rearranged AMLs 
(N122 and N452) but not in a fourth AML {N42A) that carried two 
cytogenetically normal ch2 copies (12). Conventional Southern 
analyses showed that Il-1~ deregulation in these AMLs was not 
associated with intragenic rearrangement but that in N36, site-
specific demethylation had occurred within the ~ gene. In 
order to explore a possible relationship between some forms of 
ch2 rearrangement and Il-1~ deregulation pulsed field gel 
electrophoresis was used to search for possible rearrangement 
of Il-1~ flanking sequences. These analyses established a 
preliminary long-range (~ 700 kb) restriction map of the murine 
Il-1 gene region and showed a) that the a and ~ sequences are 
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very closely linked (25-35 kb) within this region and b) that 
the N36 AML contains a structural rearrangement between 50 and 
300 kb from the ~ gene. The possibility exists therefore that 
this rearrangement in ~ gene flanking sequence represents the 
C2/F translocation junction in AML N36 and that Il-1~ 
deregulation might be directly associated with some forms of 
radiation-induced ch2 rearrangement in AMLs. This latter 
possibility was recently shown to be less likely by the absence 
of Il-1~ gene flanking sequence rearrangement in AML N452 which 
also contains a putative C2/F junction on ch2. Consequently, 
considerable uncertainty remains on the significance of the 
Il-1~ gene deregulation in the AMLs described here and the 
flanking sequence rearrangement demonstrated in AML N36. 
2.6 Conclusions: Cytogenetic studies have revealed that the ch2 
rearrangements and deletions that characterise radiation-
induced murine AMLs may have their origins in directly induced 
chromosomal damage in multipotential haemopoietic cells. 
Molecular studies have so far failed to unambiguously identify 
specific ch2 encoded genes involved with ch2 rearrangement but 
Il-1~ appears to be close to a ch2 translocation junction in 
one AML and may be deregulated as a consequence of a flanking 
sequence rearrangement. Cytogenetic analysis has been used to 
show that a-particles are inefficient at inducing stable 
chromosomal change in multipotential haemopoietic cells and it 
is suggested that these cells are hypersensitive to the lethal 
effects of a-irradiation. This may account for the weakly 
leukaemogenic effects of bone-seeking a-emitting radionuclides. 
The cytogenetic studies outlined here point towards multi-site 
fragility of murine ch2 in haemopoietic cells to X-irradiation. 
The molecular basis of this remains unexplained but some ch2 
breakpoint clusters in AMLs and irradiated haemopoietic cells 
cytogenetically correspond to constitutive chromosomal 'fragile 
sites' recently identified in the mouse (Djaladi M et al Hum . 
.G.!ill.tl. ll, 157, 1987). 
Current cytogenetic studies with X-irradiated CBA/H embryo 
fibroblast cultures suggest that perhaps one copy of ch2 in 
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this mouse strain is uniquely sensitive to radiation induced 
breakage and that this unexpected feature is determined by germ 
line DNA sequences encoding regions of instability possibly 
imprinted during gametogenesis. If correct, this hypothesis 
predicts that the high frequency of ch2 rearrangement observed 
in irradiated haemopoietic cells repopulating marrow-ablated 
recipients may not reflect any immediate phenotypic effect of 
ch2 rearrangement (i.e. through gene activation and selective 
clonal advantage) but is simply a consequence of the extremely 
high post-irradiation frequency of these events in certain 
somatic tissues of this mouse strain. This explanation would 
account for the high sensitivity of a mouse strain, showing a 
low spontaneous incidence, to radiation myeloid 
leukaemogenesis. The hypothesis may also imply the requirement 
for a second genetic event, probably on the other ch2 homologue 
of a ch2 rearranged/deleted haemopoietic clone, in order to 
fully initiate leukaemogenesis. Experiments are in progress to 
further establish these tentative associations between ch2 
instability, genetic imprinting and radiation myeloid 
leukaemogenesis in the CBA/H mouse. 
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I. Objectives of the project: 
The objective of this project is to obtain insight in shapes of dose-response relationships and 
mechanisms by which various types of effects are induced in mammalian cells by ionizing 
radiations of different linear energy transfer. An analysis with respect to similarities and 
differences in various parameters of the dose-effect relationships and of RBE values will be 
performed to assess implications for hypotheses about mechanisms involving the induction of 
effects by single tracks of particles and by accumulation of damage from different tracks. 
Possible differences in characteristic parameters are presumably related to differences in repair 
of damage in cells. Chromosome damage is at least in part the cause of cell reproductive death, 
but can also cause other changes expressed in surviving cells. A better understanding of these 
effects will contribute to a basis for assessment of Q-values for radiation protection. 
11. Objectives for the reporting period: 
Studies were performed to analyze dose-effect relationships for the induction of chromosome 
damage and cell reproductive death in mammalian cells irradiated with photons and neutrons. 
To apply modern flow cytometry to the study of radiation induced cellular damage, a high 
resolution apparatus for flow karyometry has been built, which has been optimalized for the 
detection of chromosome aberrations. 
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Ill. Progress achieved: 
Analysis of chromosome damage 
In order to obtain insight in the relationships between the induction of chromosome damage 
and cell reproductive death, experiments have been performed on the scoring of acentric frag-
ments. The ratio's of acentric fragments to dicentrics and centric rings obtained in addition 
studies were for R-l,M cells: 4.0; for V-79 Chinese hamster cells: 1.8; and for RUC-2 cells: 
1.4. The ratio's of cell reproductive death and chromosome aberrations, taking also acentric 
fragments into account, are equal to 1.3 for R-1,M cells, 1.2 for V -79 Chinese hamster cells 
and 1.6 for RUC-2 cells. These results indicate that cell reproductive death is associated in a 
large fraction of the cases with gross chromosome aberrations. 
Because of the variable size of acentric fragments and the large amount of labour involved in 
the scoring of dicentrics, centric rings and fragments, an automated detection method is 
required to make more rapid progress in this field. For this purpose, a chromosome flow 
cytometry system has been build which is capable of measuring the DNA contents of in-
dividual chromosomes at rates in excess of 1000 chromosomes per second. This system 
incorporates two high power lasers and a dedicated fast data processing facility. Univariate and 
bivariate flow karyograms can be measured to assess the frequency of aberrant chromosomes. 
For these studies chromosome staining with Hoechst 3358 and Chromomicin A3 are employed 
to detect differences in Adenine-Thymine and Guanine-Cytosine base pair ratio's, respectively. 
Hoechst 33258 is excited by UV-light and Chromomycin A3 by photons at 458 nm wave 
length. 
V79 Chinese hamster cells were irradiated in Go phase with 200 keV X rays and with 14 Me V 
neutrons. Dose-response curves were determined for three endpoints: I. chromosome aber-
rations; 11. events causing reproductive death and Ill. chromosome damage detected by flow 
cytometric analysis of chromosomes isolated from metaphase cells in irradiated cultures. The 
changes observed in the flow karyotypes from irradiated cultures were quantitatively evaluated 
by computer analysis. 
Cultures were irradiated in plateau-phase containing more than 90 per cent Go+G 1 cells in 
order to induce only chromosome type aberrations in metaphase. After irradiation cultures were 
incubated for 30 min at 37·c, trypsinized, replated in appropriate dilutions, and allowed to 
start progression through the intermitotic cycle for 16 h. 
Measurement of chromosome damage by FCM was performed by methods developed earlier. 
The technique involves accumulation of cells in mitosis by vinblastine during 5 h, their disrup-
tion to prepare a chromosome suspension, measurement of DNA histograms of chromosomes 
stained with Propidium Iodide and analysis of these histograms by a computer program 
developed to derive dose-effect relationships. 
Cultures used for measurements of visible chromosome aberrations at mitosis were also treated 
with vinblastine for 5 h. After hypotonic treatment, the cells were fixed on slides and stained 
with Giemsa. Well spread metaphases were scored for dicentrics, tricentrics, and centric rings. 
Cells employed for measurements of clonogenic capacity were cultured for 8 days, fixed, 
stained with Giemsa and clones containing 50 or more cells were scored. 
In the flow karyograms from irradiated cells the heights of the peaks representing intact 
chromosomes, are reduced and their widths are increased. In addition, the areas between the 
peaks are partly filled with signals from damaged chromosomes. The extent of the changes 
observed in the flow karyotypes provides a measure of the radiation effect which at first sight 
is difficult to evaluate quantitatively. · 
We employed a method using Fourier analysis to derive a quantitative measure of the radiation 
damage. The information concerning the shape of the chromosome peaks in the histograms is 
represented by their Fourier spectrum. Histograms of partly damaged chromosomes show a 
reduction of the high frequency components of the Fourier spectrum. The decrease in the 
square root of the sum of the high frequency components of the power spectrum is taken as a 
measure of the radiation effect observed in the flow karyotypes. By this procedure the increase 
in background, reduction of peak size and peak broadening all contribute to the final measure 
of damage. 
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The frequency of chromosomal lesions registered by changes in the flow karyotype was 
derived using a computer model. We simulated the effect of breaks in chromosomes, which 
can cause di- and tri-centrics, a-centric fragments, rings, breaks an~ deletions. The probability 
of induction of lesions in each chromosome was assumed to be proportional to its DNA con-
tent. Starting from flow karyotypes of unirradiated cultures, series of histograms have been 
generated demonstrating through this computer simulation the effect of an increasing number 
of chromosome aberrations per cell on flow karyotypes (Aten et al., 1984). The simulated data 
were then analyzed by calculating the changes in the Fourier power spectra in the same way as 
with the flow karYotypes from irradiated cell cultures. By comparing the results of the analysis 
of the experimental and simulated histograms, we estimated the frequencies of chromosomal 
lesion~ in the flow karyotypes from the irradiated cultures. 
Compari~n cif the RBE's for the three endpoints suggests that the FCM technique measures 
damage: which is induced with a similar relative biological effectiveness in dependence on the 
dose as obtained for impairment of cell reproduc'tive capacity. For the directly visible 
chromosome aberrations scored, the RBE values in the low dose range are larger. 
Analysis of cell reproductive death 
Studies of reproductive death of cells cultured in vitro have been performed with different cell 
lines and with neutrons and alpha particles of different energies. In an analysis of these data it 
was calculated that for cells which had attached to dishes and had spread out to a flat shape, the 
actual cross section of the cell nuclei perpendicular to the beam of alpha particles can vary, for 
T-1 human cells used in older experiments as well as for C3H 10 Tl/2 mouse cells and NBCH-
3 Chinese hamster cells, from values of about 70 Jlm2 to values in excess of 300 Jlm2. Never-
theless, for irradiations with alpha particles using the tract segment method the cross section 
for inactivation, derived from own data on published results did not vary greatly. For T-1 
human cells the maximum cross section with LET values in excess of 100 keV/Jlm was 35 
Jlm2, while for V79 cells and C3HlOT1/2 cells values between 30 and 50 Jlm2 and for HF 
human diploid cells a value of about 60 Jlm2 have been published. It could be concluded that 
the pro~ability of inactivation for an alpha particle at the most effecpve energy of about 2-3 
Me V can be described by an effectiveness per unit particle trac~ length throng~ the cell nucleus 
of betweeri which are all within a relatively narrow range of 0.05 to 0.08 pet j.J.in. This would 
imply that if an alpha particle of this energy passes through a spherical cell with a nuclear 
volmrte of 500 Jlm3 and a diameter of about 10 Jl1ll, the mean track length in the nucleus is 6.3 
Jlm and the probability by ll_single particle of inactivation could be as large as 0.5, while for a 
flat shaped cell with a thickness of 2 Jlm this probability may be as· low as 0.1. It can be 
concluded that no discrepancy exists between data published in the literattite about the number 
of alpha particle tracks through the nuclei required to inactivate mammalian cells, because the 
observed differences can ·be ascribed to the time intervli'I between plating and irradiation of 
cells, which is associated with' attachment and spreading of cells on the bottom of culture 
dishes. In early experiments with T-1 human cells this time interVal was only 4 hours and cells 
had not spread out at the time of irradiation, while in many later studies time intervals of 24 hr 
between plating and ~ation were used. For an extrapolation to cells irradiated in the human 
body, e;g; ·limg cells jttadiat~ by alpha particles from ra~on daughters, a spherical shape of 
the nucleus is probably more relevant than a flattened shape. 
Composite interaction 
From an analysis of data on the relative biological effectiveness of niany types of radiation, 
inclu~g heavy particles aild neu,tl;uns, the suggestion has been derived earlier that for the type 
of damage causing the single track component, a composite interaction mechanism must be 
responsible, invol$g several primary changes. The steep increase of the cross-section versus 
LET curve between 20 and 100 keV/Jlm of tissue and the large RBE-values observed, indicate 
that for the induction of this damage several hundred eV of energy niust be deposited in sites 
with dimensions of the order of 10 nm. · 
In order to explain what is implied by the suggestion of a composite interaction, it is of interest 
to hypothesize about the mechanism responsible for the single track type of damage. On the 
basis of many experimental results concerning the induction of DNA double strand breaks 
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(DSB), it appears attractive to assume that these breaks are involved in the induction of re-
productive death. A DSB is generally assumed to result from two single strand breaks (SSB) 
close together in the DNA, and therefore constitutes an effect which requires more than an 
amount of energy equivalent to a single ionization. i.e. more than about 30 eV. However, the 
most simple hypothesis that a single DSB is responsible for the induction of mammalian cell 
reproductive death appears to be incorrect. Firstly, a dose of 1 Gy of low- or high-LET 
radiation causes per cell20-40 DSB's which evidently are not all lethal, because this dose will 
cause less than 50 per cent lethality in cells of average sensitivity. It must be concluded that 
most DSB's do not lead to cell reproductive death but are repaired. 
It was concluded (Barendsen, 1988) that an alpha-particle with an LET of 100-200 keV/Jlm, 
which impinges on a spherical nucleus of a mammalian cell with 10 pg of DNA, will traverse 
50-100 times through a DNA double strand of 2 nm diameter, 20-50 times through a 
nucleosome of 11 nm diameter or 3-10 times through a chromatin fiber of packed nucleosomes 
of 30 nm diameter. During such a traversal a large amount of energy is deposited, adequate to 
induce a composite type of damage. This is consistent with the observation that between 100 
and 200 ke V /Jlffi the cross section for cell death is constant. 
Based on the two types of conclusions from experimental data, i.e., the requirement of a large 
amount of energy deposited in a small volume with dimensions of the order of 10 nm and the 
suggestion that high-LET radiations produce unrepairable DNA lesions more effectively, it 
might be hypothesized that one single DSB is not sufficient for the induction of cell re-
productive death but that two DSB's, if produced close together within a distance of the order 
of 10 nm, constitute the composite effective lesions responsible for cell reproductive death. 
This would imply that a structure with dimensions larger than the DNA helix of 2 nm diameter 
is the critical target. Candidates are the nucleosomes with a diameter of 11 nm and the 
chromatin fibers of packed nucleosomes, with a diameter of about 30 nm. 
The hypothesis that lethal lesions induced by single tracks are the result of two DSB's 
produced sufficiently close together in chromatin fibres, may be extended to suggestions about 
potentially lethal lesions which might be associated with somewhat larger distances between 
two DSB's. The distance within which two DSB's have to be produced to cause cell death 
might be variable and part of the composite lesions might only be potentially lethal, depending 
on various factors, e.g., on the degree of super-coiling of the DNA and on the metabolic state 
of the cell. On the basis of this assumption it is possible to interpret differences in radiosen-
sitivity among cells with respect to the initial slope of the survival curve. Only a small fraction 
of the total number of DSB's is known to be effective, i.e., the number of 20 to 40 DSB's pro-
duced by a dose of 1 Gy induces only an average of less than one lethal event. It is well es-
tablished that almost all of the single strand DNA breaks and a large majority of the DSB's 
induced in mammalian cells by ionizing radiations are repaired. The composite interaction of 
two DSB's produced sufficiently close together in the critical structure might prevent their 
accurate repair and might subsequently result in loss of part of the DNA information. The 
distance between the two DSB's might be critical, however, with respect to probability that 
repair mechanisms can eliminate the lesions. Consequently, if this hypothesis is correct, it 
must be assumed that the initial slope of a survival curve depends strongly on the capacity of 
cells to repair DSB's. 
The hypothesis of a composite DSB interaction would also be consistent with the observation 
that the RBE values for cell lethality by single events are larger than RBE-values for DSB 
induction. It is evident that the probability of causing two DSB's close together by a single 
particle must depend more strongly on the LET than the induction of a single DSB. 
A hypothesis about lethal and potentially lethal damage 
The hypothesis that lethal lesions induced by single tracks are the result of two DSB's produ-
ced sufficiently close together, i.e. within 10 nm, in a chromatin fiber or in two neighbouring 
fibers, may be extended by suggesting that potentially lethal lesions might be associated with 
somewhat larger distances between two DSB's produced by single particle tracks. The distance 
within which two DSB's have to be produced to initiate cell death might be variable and part of 
these composite DNA lesions might only be potentially lethal, depending on various factors, 
e.g., on the degree of super-coiling of the DNA, and on the metabolic condition of the cell as 
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well as its stage in the cell cycle, which may be associated with differences in conformation of 
the DNA. On the basis of this assumption it is possible to interpret differences in radiosen-
sitivity among cells with respect to the initial slope of the survival curve. These differences 
might be associated with the degree of packing of DNA in the cell nucleus. This degree of 
supercoiling may depend on the cell cycle stage and cell conditions. In this way, the paired 
DSB hypothesis thus provides also the possibility to explain differences in radiosensitivity as a 
function of cell cycle stage. 
The mechanism suggested by the paired DSB hypothesis for cell reproductive death may 
involve several subsequent pathways. The composite interaction of two DSB's produced 
sufficiently close together in the critical structure might inhibit repair and could subsequently 
result in loss of part of the genome. The distance between the two DSB's might be critical, 
however, with respect to probability that repair mechanisms can eliminate the lesions. Poten-
tially lethal lesions might be assumed to be repairable if culture conditions are favorable, 
because for these lesions the distance between two DSB's might be larger than for lethal 
lesions. Consequently, if this hypothesis is correct, it must be assumed that the initial slope of 
a survival curve, and not only the accumulative type of damage, depends strongly on the 
capacity of cells to repair DSB's in dependence on their interaction distance. 
The hypothesis of a composite interaction of paired DSB 's would also be consistent with the 
observation that the RBE values for celllethality by single events, as represented by a ~-values 
in the linear quadratic equation F(D) = a1D + a2D2 with D is the dose, are larger than RBE 
values for DSB induction (Prise et al., 1987). It is evident that the probability of causing two 
DSB's close together by a single particle must depend more strongly on the LET than the 
induction of a single DSB. This suggestion would be consistent with the observation by 
Blocher (1988) and by Frankenberg-Schwager et al. (1984), that the RBE of a-particles for 
unrejoined DSB's is increased as compared to the RBE for the total initial double strand 
breaks. 
The hypothesis of a composite DSB interaction can also lead to a suggestion about the depen-
dence of potentially lethal damage on LET. With low-LET particles it is expected that the 
induction of two DSB's at distances of approximately 10- 30 nm is a relatively rare event For 
most DSB's the distances will be larger and repair is expected to be efficient, preventing lethal 
damage. Therefore, the effectiveness of a given dose of low-LET particles may be expected to 
depend strongly on the capacity of cells to repair lesions from two DSB's which are produced 
at slightly larger distances than required for lethal lesions. Thus, potentially lethal lesions are 
expected to constitute a relatively large part of the lethal lesions. With increasing LET, PLD is 
expected to be somewhat more effectively produced, i.e._ the RBE increases. But, at very high 
LET, Pill is expected to be reduced, because the average distance between DSB's becomes 
smaller than the critical distance of about 10 nm. . 
It may be concluded that in the context of the hypothesis described, the damage which causes 
the linear term in the linear quadratic equation, is for low-LET radiation not "unrepairable" 
damage in the sense that the magnitude of the linear term is independent of the repair capacity 
of the cell, but rather that it may be strongly dependent on this capacity and, as a consequence, 
it may vary from cell type to cell type, it may depend on the cell stage in the intermitotic cycle 
and on cellular conditions during and after exposure. For radiations of very high-LET, these 
factors are of less importance. · 
The influence of /.El' on reproductive death through accumulation of sublethal damage 
The damage represented by the quadratic term in the linear quadratic equation, is the type of 
damage caused by accumulation of lesions. It is known that this damage depends strongly on 
dose fractionation and dose rate, with repair times in the range of 0.5 - 2 h. Little attention has 
been given to the analysis of the dependence of this type of damage on the LET. Some infor-
mation can be obtained from an analysis of the survival curves obtained with a-particles and 
deuterons (Barendsen, 1967). However, the derivation of a2-values from these data is as-
sociated with considerable uncertainties. Estimates of a2-values from these curves may have 
uncertainties as large as 50 per cent. Notwithstanding these large errors, it is evident from the 
derived data that the cumulative type of damage shows only a small dependence on LET 
between 5 and 25 ke V /J.Un of tissue (Barendsen, 1989). 
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This result is consistent with information on the interaction of sublethal damage from doses of 
high-LET radiation with sublethal damage from X-rays, published by Ngo et al. using fast 
neutrons, and Bird et al. using a-particles as high-LET radiation (Ngo et al., 1977; Bird et al., 
1983). They deduced that at larger doses of high-LET radiation, an interaction was observable, 
but the amount of sublethal damage produced by high-LET radiation is approximately equal to 
that produced by the same dose of X-rays. From these results it can be deduced that the RBE 
for induction of sublethal damage by high-LET radiation is in the range of 1 to 2 and certainly 
does not increase to a value of 5 - 10 in the range of 20- 100 keV/jlm. It may be concluded 
that the dependence of sublethal damage on LET is significantly different from the relation 
obtained for the component of damage which increases linearly with the dose. Nevertheless, 
sublethal damage does not decrease with LET in the range of 10 - 100 keV/jlm and this 
indicates that it is not associated with simple chemical reactions or SSB's. The differences in 
RBE-LET relations are consistent with the published data mentiond. 
For the induction of sublethal lesions, energy deposition events of the range of 100-150 eV 
might be sufficient, consistent with the observation mentioned earlier that about 300 eV is 
effective for inducing lethal lesions, hypothesized to consist of two DSB 's. However, whether 
single DSB's constitute sublethal lesions or whether some other type of DNA damage can 
interact with DSB's to produce the cumulative type of damage which causes mammalian cell 
reproductive death, remains to be elucidated. Ward has made the suggestion that locally 
multiple damaged sites, LMDS, on both strands in a small region of DNA might cause effec-
tive lesions (Ward, 1985). 
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- G.W. Barendsen. Dose-effect relationships for various responses of mammalian cells to 
irradiations of different linear energy transfer. J. Soc. Radiol. Prot. 4, 143, 1984. 
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Title of the project no.: 
Transformation of cells in culture by ionizing radiations of different linear energy tranfer 
Head{s) of project: 
Prof.dr. G.W. Barendsen 
Scientific staff: 
Prof.dr. G.W. Barendsen, Dr.ir. H.B. Kal, and Mr. J.F. Gaiser 
I. Objectives of the project: 
The research is aimed at obtaining quantitative information and insights in the cellular proces-
ses occurring after irradiation which determine the development of malignant tumours. In par-
ticular, studies were performed on the relative biological effectiveness of various types of 
radiations, which differ in the pattern of energy deposition in volumes of sub-cellular dimen-
sions, e.g. chromosomes, because the results can provide information on the mechanisms by 
which cells are transformed, acquiring malignant characteristics, or are affected with respect to 
their proliferation and as a consequence have lost the capacity to express altered properties in 
their progeny. Differences between dose-effect relations obtained with radiations of different 
linear energy transfer can thus be used to test various hypotheses about carcinogenesis. 
Studies on transformation of cells in culture are relevant to carcinogenesis because the clones 
with altered morphological characteristics can develop into tumours upon inoculation in 
syngeneic hosts. 
11. Objectives for the reporting period: 
For the induction of cell transformation it is evident that similarities in dose-effect relationships 
and the dependence on radiation quality in comparison with the induction of chromosome 
aberrations and cell reproductive death are observed. But these cannot be considered as proof 
of a hypothesis that similar primary mechanisms are involved. Cell transformation, which is 
induced with a relatively low frequency compared to cell reproductive death or gross 
chromosome aberrations, could in principle be caused by a type of DNA damage which does 
not represent breakage of a DNA molecule. Therefore, studies on chromosomal aberrations in 
clones of transformed cells were performed. 
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Ill. Progress achieved: 
Studies have been carried out on cell transformation in vitro by 300 kV X-rays and fast 
neutrons of 0.5 Me V, 4.2 Me V and 15 Me V energy, using three different cell lines of rodent 
origin. The aim of these investigations is to compare the dependence of the relative biological 
effectiveness (RBE) on the linear energy transfer (LET) or linear energy (Y) for cell transfor-
mation with similar data for other cellular effects. Such a comparison can yield insights in 
similarities or differences in the primary stages of the induction of these various types of 
responses. The comparison of data for three different cell lines is of interest because com-
parison of data for three different cell lines is of interest because differences in numbers of 
chromosomes of their DNA content might influence the frequency of the induction of 
transformation. The cell lines used in our studies differ significantly: C3H/10Tl/2 mouse cells 
with 90 chromosomes, WAG/R-2 rat cells with 42 chromosomes, and NBCH-3 hamster cells 
with 22 chromosomes. 
With the C3H/10Tl/2 cells survival curves and dose-effect curves for transformation have 
been obtained for fast neutrons of 0.5 Me V, 4.2 Me V and 15 Me V energy and for 300 kV X-
rays. These curves have been analyzed with respect to values of t1, t2, a 1 and a2 in the 
representations F(D) = t 1D+t2D2 for transformation and S(D)/S(O) = exp-(a1D+a2D2) for 
survival. The values of the parameters were derived as averages from at least three separate 
experiments. 
The cell survival curves obtained with neutrons of different energies over the range of doses 
employed, 0-0.4 Gy of 0.5 Me V neutrons and equivalent doses of neutrons of other energies, 
are not significantly different from exponential curves. For X-rays, doses ranged from 0 to 4 
Gy. The curves for cell transformation by fast neutrons are not significantly different from 
linear curves. 
Data for cell reproductive death and transformation of the WAGR-2 and NBCH-3 cell lines 
have only been measured for 300 kV X-rays and 0.5 Me V neutrons. 
The results show that RBE values obtained as ratio's of a 1 values and of tt values for neutrons 
relative to corresponding at or t1 values for X-rays are very similar for the induction of 
reproductive death and transformation, respectively. This applies to all three cell lines. 
The values of at and t1 for the different cell lines are presented in Figu,re lA as a function of 
Y p. The values of Y p pertain to a sphere of 1 Jlm diameter. Corresponding data for 
chromosome aberrations, dicentrics and centric rings, induced in other lines, published by 
Zoetelief and Barendsen (lnt. J. Radiat. Bioi., Vol. 43, 1983, p. 319-362), are presented in 
Figure lB. 
In the present discussion the parameters of the linear terms derived for X-rays will be con-
sidered for a comparison with corresponding values for neutrons. The contribution of the 
quadratic terms for low-LET radiations introduces an increased uncertainty in the estimation of 
values of the linear terms. As a consequence, the RBE values of neutrons relative to X-rays 
vary more among different cell types than the dependence of the effectiveness per unit dose on 
neutron energy. Notwithstanding these uncertainties, the results presented in Figure lA show 
that the dependence of the effectiveness for the induction of cell transformation on Y p is very 
similar to the corresponding relations for cell reproductive death. A similar conclusion about 
equal RBE-Y p relations has been drawn by Zoetelief and Barendsen from a comparison of 
dicentric and centric ring aberrations with the induction of cell reproductive death in three other 
cell lines. This is illustrated in Figure lB. 
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Figure 1: Effectiveness per unit dose as a function of Y F, the frequency mean of the lineal energy for fast 
neutrons, derived for effects induced in various typeS of mammalian cells in culture. 
A. Loss of clonogenic capacity (solid symbols) and cell transformation (open symbols), derived from survival 
curves and dose-effect relations, respectively, for three cell lines. Values of the effectiveness per unit of dose 
for loss of clonogenic capacity were derived as parameters of linear terms, by analysis of survival curves 
with the formula: S(D}/S(O) = exp-(a 1 D+a2Dl). Values of the effectiveness per unit dose for cell transforma-
tion were derived as parameters t 1 of linear terms, by analysis of the experimental data with the formula 
F(D)=t1D+t2D2. 
B. Loss of clonogenic capacity (solid symbols) and induction of dicentrics and centric rings (open symbols), 
derived from survival ciirves and dose-effect relations, respectively, for three cell lines. ValueS of tile effec-
tiveness per unit of dose for loss of clonogenic capacity were derived as parameters a 1 Qf linear terms by 
analysis of survival curves with the formula: S(D}/S(O)=exp-(a 1D+a2D2). Values of the effectiveness per 
unit dose for chromosomal aberrations were derived as parameters b1 of linear terms by analysis of the 
experimental data with the formula A(D}=b1D+~D2. 
On the basis of similarities in RBE-LET relations the hypothesis can be advanced that cell 
transformation, chromosome structural changes and cell lethality are induced by similar 
primary biophysical events involving large energy deposition events of a few hundred e V in 
small volumes with dimensions of 10-20 nm causing chromosome structural alterations. 
However, target regions are larger by a factor of 103 for lethal lesions as compared to 
transforming lesions. Support for this hypothesis was derived form experiments in which in 
ciones from individual transformed cells structural changes of chromosomes were detected by 
flow karyometry. The NBCH-3 cell lines used for these studies was derived from a newborn 
Chinese hamster. Between passages 7 and 25 these cells are diploid, contain 22 chromosomes 
and they can be transformed by radiation. This small number of chromosomes provides an 
advantage in flow karyotyping as well as in the application of binding techniques. By contrast 
the lOTl/2 mouse fibroblasts and the 3T3 mouse fibroblasts contain approximately 80 
chromosomes. 
In previous communications analysis have been presented of karyotypes measured by flow 
cytometry of cells of an established diploid line of new born Chinese hamster origin, desig-
nated NBCH-3. A comparison was made of karyotypes of clones transformed after irradiation 
of the normal cells, which contain 22 chromosomes. In a bivariate flow karyotype all 
chromosome numbers 1 to 7 and X and Y can be distinguished, while 8 and 9 coincide. 
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Clones are scored as phenotypically transformed if the cultures show multilayers and criss-
crossing. 
Univariate and bivariate flow karyograms showed that the large majority of these clones of 
transformed cells contained numerical alterations and/or marker chromosomes. The detection 
of these abnormalities by flow karyometry requires that they are present in the majority of the 
cells and therefore must have been initiated in the primary irradiated cell or in an early genera-
tion of the cells in a clone developing from an irradiated cell. As an initial hypothesis it was 
assumed that the observed chromosomal changes were correlated with the transformed charac-
teristics of the cells. Inoculation of 106 cells of a transformed clone subcutaneously in nude 
mice yield in 80-90 per cent of the cases sarcomas and the cells are able to grow in 5 per cent 
agar medium. 
Analysis of 25 separate clones did not yield a specific pattern among the chromosomal chan-
ges. Alterations occurred in chromosomes number 1, 2, 3, 4, 6, 8 and Y, while in addition 
marker chromosomes were detected in several clones. 
In view of this diversity of karyotypic changes in the clones of transformed cells the 
hypothesis of a causal relation with the transformed characteristics was questioned. Therefore, 
it was decided to analyze karyotypes of cells in clones, which developed after irradiation, but 
which did not exhibit the transformed phenotype. Cells of NBCH-3 passage 19 were plated in 
five T-25 flasks and irradiated with 4 Gy of gamma rays (137 Caesium). After clone for-
mation, one morphologically transformed and on non-transformed clone was isolated out of 
each flask and subcultured. 
As can be seen in Table 1, both transformed and non-transformed clones contain structural 
and/or numerical changes of the chromosomes. Extra peaks in the bivariate plots are designated 
as marker chromosomes (M) without further characterization by G-banding. One clone 1C 
appears to be normal. However, there are no changes specifically related to the malignant 
phenotype or to the tumorigenicity. For instance, four clones have lost the Y chromosome. 
Three clones with malignant phenotype and one with normal phenotype. Out of the three 
transformed clones, two gave rise to a tumour upon inoculation and one was negative. Clone 
1B and clone 2D, though they have a different phenotype, both give rise to a tumour. No other 
commonly shared aberrations can be detected. From this and previous work, it can be con-
cluded that there is no association of tumorigenicity with a specific chromosomal aberration, as 
can be detected by flow cytometry. Neither is there an association of transformed phenotype 
with a specific chromosomal aberration. 
Table 1: Summary of characteristics and chromosomal aberrations in irradiated transformed and non-
transformed cells. 
Clone 
lA 
2A 
lB 
2B 
lC 
2C 
ID 
20 
lE 
2E 
Phenotype 
malignant 
loss ofY 
normal 
num. aberr. chrom. 2 
malignant 
num. aberr. chrom. 4 
loss ofY 
normal 
malignant 
normal 
malignant 
normal 
malignant 
normal 
Chromosome aberration Tumour/inoculations 
M between chrom. 1 and 2 0/2 
M between chrom. 2 and X 0.4 
M between chrom. 2 and 3 4/4 
M between chrom. 7 and 8 0/4 
loss ofY n.d. 
no aberrations 0.2 
numb. aberr. chrom. Y 0.4 
M between chrom. 2 and 3 3/4 
M clones to chrom. 3 n.d. 
loss ofY 0/4 
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Data on the influence of the dose rate of fast neutrons have been obtained for the NBCH-3 cell 
line. Dose-effect relationships for transformation frequency per surviving cells were measured 
for 1 Me V neutrons. It could be concluded that no enhancement of cell transformation is 
observed for a dose rate of 3 mGy.min-1 compared to 150 mGy.min-1 with frequencies of 0.8 
x; 1Q-3 and 1.5 x 10-3, respectively. It should be noted that the uncertainties in these values are 
about a factor of 2 and the observed difference is not significant. 
IV. Other research group(s) collaborating actively on this project [name(s) and 
address( es)]: 
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1987 (E.M. Fielden, J.F. Fowler, J.H. Hendry and D. Scott, eds.). Published by Taylor 
and Francis, London. 
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Title of the project no.: 
Experimental studies on lung tumour induction by inhalation of radon in combination with 
some promoting agents, present in cigarette smoke. 
Head(s) of project: 
Prof.dr. G.W. Barendsen. 
Scientific staff: 
Prof.dr. G.W. Barendsen, Dr. B. Hogeweg, Drs. Meijnders, Mr. J.S. Groen. 
I. Objectives of the project: 
The lung tumour risk for the general public, associated with the inhalation of radon daughters, 
is generally estimated on the basis of a risk factor, derived from epidemiological data on 
various exposed groups (e.g. uranium miners, A-bomb survivors and irradiated patients). The 
value of this risk factor is strongly determined by the data for miners, a group consisting of 
heavy smokers. From these data, conflicting conclusions, involving protective as well as 
synergistic action, have been inferred with respect to the risk of the combined exposure to 
radon and to tobacco smoke. Consequently, no definite risk for a non-smoking population can 
be estimated. 
It is the aim of this study to analyze such interaction mechanisms of combined exposure to 
radon with other inhaled toxic agents, in order to improve insights in the values of estimates of 
the radon daughter risk. 
11. Objectives for the reporting period: 
For the study rats. will be exposed to a mixture of radon and formaldehyde and acetaldehyde, 
respectively. For the last year of the program plans were: 
measurements of the radon daughter concentration levels; 
exposures of WAG/Rij rats to two radon daughter levels of 200 and 800 WLM. 
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Ill. Progress achieved: 
It is generally assumed that the inhalation of radon at natural background leveJs, in accordance 
with the linear dose-effect hypothesis, is associated with a contribution to the lung tumour 
incidence. On the basis of the current mean radon concentration in Dutch houses of 29 Bqlm3 
and a risk factor for lung tumour induction of 1.10-3 cases per Sv lung dose equivalent, it can 
be estimated that for the Dutch population (during an at risk age between 40 and 80 year) the 
mean yearly lung tumour incidence associated with this level is approximately 2.1 per 
100,000. This corresponds to a contribution to the mean annual death rate from lung tumours 
for the Dutch population of approximately 8 per cent. 
According to Doll (1981), 85 per cent of the lung tumours results from smoking, in particular 
of cigarettes. Since the risk factor is derived mainly from the epidemiological data on uranium 
miners, it is relevant for a mixed population consisting of a relatively large percentage (of circa 
70%) of generally heavily smoking men. Therefore, it is most likely that the actual contribution 
form radon inhalation in a general population is much lower than estimated. Consequently, it 
can be concluded that approximately 10 per cent of the lung tumour incidence must be at-
tributed to exposure to other agents and might result from interactions of combined exposures 
to radon and the various other indoor agents. 
It is the aim of this experimental study on lung tumour induction by inhalation of radon com-
bined with other toxic indoor agents, to analyze these possible synergistic effects. From the 
epidemiological data of the uranium miners it can be concluded that the lung tumours, as-
sociated with the radon daughter inhalation, are mainly of bronchogenic origin. Furthermore, 
these tumours result from the exposure.ofthe basal bronchial cells to the alpha particles, which 
are emitted during decay of the radon daughters. Therefore, interactions between this alpha 
particle radiation and other indoor agents may be expected to occur in this bronchial region. It 
has been demonstrated (Sterling, 1985), that formaldehyde is a major toxic agent of the indoor 
air. Since a continuous inhalation of air with a low concentration of formaldehyde may result in 
irritation and edema of the upper respiratory tract, interactions in the bronchial regions are to 
be expected from a combined exposure of radon and formaldehyde. 
In order to study such interactions in an experimental system, rats will be exposed by inhala-
tion to radon daughters combined with formaldehyde and with acetaldehyde, respectively. 
Acetaldehyde was selected as second agent on the basis of its occurrence in relatively large 
concentrations in cigarette smoke. Furthermore, acetaldehyde was selected, in order to dif-
ferentiate between a cilia toxic and cocarcinogenic action of formaldehyde, since the two agents 
act differently on the bronchial epithelial cells. On the basis of the lung tumour induction, 
results in rats derived by Chameaud et al (Chameaud, 1981), it was evaluated that a relatively 
high level of about 1000 a 2000 Working Level Month (WLM) is required for an optimal 
detection of a synergistic effect. This is due to the incidence dose curve which demonstrates a 
linear increase of the incidence up to 3000 WLM and, after reaching a maximum at a level of 
about 4000 WLM, a decrease with increasing exposure. Such a shape can be explained on the 
basis of a competition between tumour inducing and cell killing effect of the ionizing radiation. 
Consequently, above the level of 1000 a 2000 WLM an interference of a synergistic interaction 
and the cell killing effect can not be excluded. On the other hand, since induction is a stochastic 
effect and therefore subjected to variations, selection of an exposure level lower than 1000 
WLM will decrease the statistical significance. 
For the exposure of the rats to this radon level in the mentioned combinations, an inhalation 
chamber was developed which is based on a "nose only" system. This "nose only" system was 
selected, since in this system the production of ammonia in the exposure chamber from the 
action of urea-positive bacteria on urine and faeces can be prevented. The lung tumour induc-
tion of radon inhalation, as mentioned, is associated with the exposure of the basal bronchial 
cells to alpha particles emitted by the various short living radon daughters. Due to their decay 
properties, concentrations of these daughters are only developed about one hour after the decay 
of the radon. In order to achieve the required daughter concentrations with a limited amount of 
radium in the generator, a system as presented in Figure 1 was developed. The total volume of 
the inhalation chamber is approximately 5 dm3. 
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The respired air is, after the passage through a C02 absorber via a feedback loop, recirculated 
in the chamber; the oxygen consumption of the animals is replenished by fresh oxygen, which 
passes through the radon generator. Detectors and circuits for the monitoring and the regulation 
of the differential pressures of the various gases (such as radon, 0 2 and C02) will be con-
nected to the inhalation chamber. As a result of this construction, the activity of the radium in 
the generator source can be restricted to about 7.5 MBq. 
References: 
Chameaud, J. et al. Proc. Intern. Conf. on Radiation Hazards in Mining: Control, 
Measurements and Medical Aspects. ed. M. Gomez (1981) 222. 
Doll, R. et al. Nat. Cancer 66, 1191, 1981. 
Sterling, T.D. et al. J. Environ. Sci. Health c2(2), 185, 1984. 
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Figure l: Scheme of "nose only" inhalation system for the exposure of rat lungs to a mixture of radon and 
aldehydes. 
The measurements were performed with the current radon generator, having a radium activity 
of about 5 MBq. . 
The efficiency of the radon mixture increases with increasing build-up period, but this cor-
responds with a low ventilation rate. However, due to the enhanced C~ concentration in the 
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expired air, a low ventilation rate can result in hyperventilation to the animals. Measurements 
showed that for the constructed "nose only" chamber an air flow of about 11 dm3 per minis 
required in order to prevent this hyperventilation. This corresponds to a mean residence time of 
the radon in the chamber of about 0.5 min. Since the radon daughter concentration is strongly 
dependent on the residence time, the concentration measurement have been performed for the 
air flow of 11 dm3 per min. 
For the determination of the radon concentration, a single filter method was selected. After 
sampling of the air during 5 min with a sampling capacity of 2 dm3 per min, the activities of 
the nuclides Po214 and Po218 collected on the filter were measured at different time intervals, 
using a germanium alpha spectrometer. From these activities, the effective concentration of the 
daughter mixture can be calculated with the application of the characteristic equations for the 
decay. Calibration of this spectrometer arrangement with a flat Arn241 source, resulted in a 
counting efficiency of 8.49 per cent for the emitted alpha particles. This value is in good 
agreement with the calculated efficiency of 8 per cent. 
In order to compare the effects of the various delay systems with a system having a continuous 
air supply, a series of three concentration measurements was performed for this latter con-
dition. This resulted in effective concentrations of 0.05, 0.02 and 0.04 WL. 
For the arrangement with the 2m3 chamber as delay system, measurements were performed 
after a build up period of 1 and 16 h, respectively. The effective concentrations were 0.04 and 
0.09 WL, respectively. This demonstrates that in comparison to the direct method, even after a 
build-up period of 16 h, the increase in the concentrations is small. Since radon daughter 
products will attach to aerosols, smoke was introduced in the air flow of the radon generator in 
order to measure a potential enhancement. This resulted in an enhancement of the effective 
concentration by a factor of about 8. 
The measurements performed on a system with a small vessel and with no additional smoke 
aerosols resulted in values for the effective concentration of0.05 WL and 0.06 WL. The extra 
addition of smoke aerosols resulted for this system in an enhancement by a factor of about 2 to 
3. 
Since the application of the smoke aerosols will be unacceptable for the planned inhalation 
experiments with rats, the effect of water vapour aerosols on the concentration was studied on 
the system with the small vessels. From these measurements it was concluded that the effec-
tiveness of this vapour is equal to that of the smoke aerosols. 
It can be concluded that the resulting effective concentrations with the applied delay systems 
will be too low in comparison to the required concentration. This is most likely the result of the 
short periods for build-up of the daughter products. On the basis of the value of about 100 for 
the ratio of the effectivities for a build-up of 3 h and 30 s, respectively, the more complex 
recycling system may be expected to approach required concentrations. 
The system was completed and tested for the radon concentration at a number of flow rates. A 
water vapour-aerosol generator was installed in order to increase the probability of attachment 
of radon daughters to particles in the inhaled air. The efficiency of the radon mixture increases 
with increasing build-up period, but this is associated with a low ventilation rate. However, 
due tot he enhanced C(h concentration in the expired air, a low ventilation rate did result in 
hyperventilation of the animals. Measurements showed that for the constructed "nose only" 
chamber an air flow of about 11 dm3 per min is required in order to prevent this hyperven-
tilation. This corresponds to a mean residence time of the radon in the chamber of about 0.5 
min. Since the radon daughter concentration is strongly dependent on the residence time, the 
concentration measurement have been performed for the air flow of 11 dm3 per min. 
Radon concentrations were expressed as working levels (WL). The highest level of about 
12000 WL at an RaA/RaC ratio of 0.57 was measured for conditions where no rats were 
present. For other flow rates WL levels were in the range of 4000-10000. However, when rats 
were placed in the exposure system the concentration decreased greatly to levels of 200-400 
WL. It is evident that the inhalation and retention of Radon daughters in the rats greatly 
influenced the exposure conditions and caused decreases by factors of 10 to 20. Levels 
between 1000 and 2000 WL were aimed at for further studies. 
In order to attain higher exposure levels, collaboration was sought with the lnstitut de Protec-
tion et de Surete Nationale, France (Dr. Lafuma). 
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The experiments in Razes, France, and Rijswijk were carried out in 1988 and in 1989 with Rn-
222. The WL value can be measured by air sampling, i.e. letting a certain amount of air pass 
through a membrane filter. the daughters will deposit on the filter and their original concentra-
tions may be derived from measurements of the alpha activity collected on the filter. A well-
known method, for measurement of these concentrations has been developed by Tzivoglou et 
al. (1953) and modified by Thomas (1972). A very rapid determination of the WL number has 
been developed by Kusnetz (1956), and modified by Rolle (1972). 
Ten different concentrations of Rn-daughters the WL value have been determined with both the 
Rolle and the Thomas method. The results can be found in Table 1. The agreement between the 
two methods is rather poor. Taking into account their maximum error of 20 per cent (Rolle) 
and 10 per cent (Thomas), they are allowed to differ up to 25 per cent at the most. Among the 
six comparisons that can be made, however, only half of them differ between 20 and 25 per 
cent, while the other three show even greater differences, up to 160 per cent. 
Lung burdens have been determined directly by killing rats immediately after a period of 6 
hours of Radon inhalation, and measuring the gamma-activity from Pb-214 in the lung as a 
function of time. The extrapolated activity at t=O (end of inhalation) is thought to be a reliable 
measure for the actual dose rate to the lungs. These measurements have been carried out in 
Razes with the Rijswijk equipment at three different WL values as determined wit the Thomas 
method. 
It was concluded that concentrations of 834 WL in Rijswijk and 3861 WL in Razes result in 
practically the same deposition of radioactivity in the lung. The same is true for 445 WL in 
Rijswijk and 1485 WL and 2964 WL in Razes. 
The WL values giving the same lung dose are different by a factor of 2 up to 7, the largest 
discrepancies occurring between WL values determined by different methods. Even if one 
takes into account the poor agreement between the Rolle and Thomas method, the differences 
are still large. 
We have found that simultaneous measurements of WL values, using the Rolle and the 
Thomas method, may yield very different results. This leads s to believe that at least one of the 
two methods should be thoroughly investigated for its accuracy and its applicability in WL 
measurements. 
Furthermore, we found that the WL value as such might be a rather poor measure for purposes 
of estimating the lung dose. If this can be confirmed, it may have important consequences for 
the calculations of risk from exposure to Radon and its daughters, both in mining practice and 
in the field of public health. 
We therefore propose that a research project is to be started aimed at clarifying the problems 
related to WL measurements and the validity of the WL value as a measure for lung dose rates. 
Table 1: WL values measured in the Razes inhalation facility 
date Rolle method Thomas method 
morning afternoon morning afternoon 
11-04-1988 652 665 1455 
12-04-1988 1747 1858 1435 1485 
13-04-1988 1500 1796 3866 
14-04-1988 2272 2285 2841 2964 
The radon chamber for exposure of rats has been completed and exposures of groups of rats to 
various radon concentrations have been started. Based on the newest data from the scientific 
research at Razes, France (Dr. Chameaud) it was concluded that the initially proposed ex-
posures to 1000 and 2000 WLM would be too large to study synergism between Radon and 
acetaldehyde. Consequently, selected levels were 200 and 800 WLM, at which the expected 
lung cancer incidence would be about 10 and 30 per cent, respectively. 
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Exposures at these levels have started with 40 rats per group, either radon alone, acetaldehyde 
alone, and combined exposures to both agents, as well as appropriate sham treated controls. 
These exposures are still continuing, 50 per cent being completed by December 1988. Results 
on lung tumour development can be expected to be obtained in 1990. 
IV. Other research group(s) collaborating actively on this project [name(s) and 
address( es)]: 
V. Publications: 
- L.W. Put, R.J. de Meijer and B. Hogeweg. Survey of radon concentrations in Dutch 
dwellings. Proc. of Exposure to Enhanced Natural Radiation and its Regulatory 
Implications, Maastricht, 25-27 March, 1985. 
- B. Hogeweg. Een analyse van de risicofactoren voor blootstelling van de long aan lage 
stralingsdoses. RBI-rappon no. 3375, 1986. 
- B. Hogeweg. Eindrapponage en evaluatie van het SA WORA-onderzoekprogramma naar het 
achtergrondniveau van de natuurlijke straling in Nederland. Rapponnr. 3477. 
Radiobiologisch Instituut TNO, Rijswijk, 1986. 
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Title of the project no.: BI 6 D 010 l 
Radiation Carcinogenesis: Follow up of cancer patients treated by radiotherapy for the 
appearance of a second independent tumor 
Head(s) of project: Prof. Aldo Becciolini 
Scientific staff: Cellai E.; Balzi M.; Pacini P.; Santoni R.; Cionini L.; Porciani s.; Olmi 
P.; Chiavacci A.; Biti G.P.; Zanieri E.; De Maria D. (MO); Falchi A.M. (MO); Giach~ V.; 
Lanini A.; Mungai V.; Mungai R.; Pupi A.; Cintolesi V.; Magrini S.; Fallai C. 
I. Objectives of the project: 
The aim of the study was to evaluate the carcinogenic effect of ionizing radiation in pa-
tients with neoplasia in different sites and treated by radiotherapy. The incidence of sec-
ond primary tumors, histologically proven, was analyzed according to the time elapsed from 
irradiation and to the appearance in the irradiated volume. The research ne~ds to be com-
pleted in order to have a higher number of cases and a larger follow-up. In this part of the 
study we organized and examined the clinical records of patients treated by radiotherapy in 
the past 15-20 years or more. The study was carried out in Florence at the University and 
Hospital Radiotherapy Sections and at the Nuclear Medicine Section for the 131J treatment 
in the thyroid carcinomas. Also the Radiotherapy Section of the University of Modena par-
ticipated in the study. The study also examined biochemical, morphological, and cell ki-
netics parameters that can be used as markers of the radiation damage. These elements could 
point out correlations with the possible appearance of a second tumor and contribute to the 
explanation of radioinduced carcinogenesis mechanisms. 
11. Objectives for the reporting period: 
The study of the past year mainly concerned the analysis of patients with breast carcinoma 
and treated by ionizing radiations. The incidence of second primary tumors was compared 
with that of patients undergoing chemotherapy alone. The analysis of patients affected by 
gynecologic and head neck tumors is still in progress and includes also the cases of the 
University of Modena. 
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III. Progress achieved 
The possibility that ionizing radiations produce turners is 
well documented, but the mechanisms producing the process are 
not yet known. Radiation carcinogenesis is a stochastic 
process and its probability increases as the dose increases. 
However, following very high doses, turner incidence in the 
irradiated volume appears to decrease because cell death is 
more probable than cell transformation induced by the ionizing 
radiations. 
Doses received during radiodiagnostic or nuclear medicine 
examinations are too low to produce a significant increase in 
the cancer incidence when compared to the natural incidence. 
Instead, during radiotherapy an elevated dose is absorbed in 
the directly irradiated volume while a slightly elevated dose, 
yet one capable of increasing the incidence of a second 
primary turner, is absorbed in the surrounding zone and in the 
other parts of the body. 
In those patients treated with radiotherapy, it is difficult 
to attribute a second primary turner to ionizing radiations 
since it could be the result of a certain spontaneous 
predisposition to malignant transformations. However, this 
type of relationship has not been pL-oven. 
According to warren and Gates, all second we considered tumors 
have a malignant histologic pattern, are not metastases of the 
first tumor, and must be clearly distinguishable without 
reasonable doubt from the first tumor. 
A continuous, accurate follow up is essential for this type of 
study. For many years in the Radiotherapy center (University 
and Hospital) of Florence many thousands of patients affected 
by tumors in different organs and tissues were treated with 
ionizing radiation while others underwent chemotherapy. 
Most of this study examined patients with primary tumors 
treated solely with curative radiation therapy. All cases 
were histologically proven to be cancer. Patients with 
metastases previously treated with radiotherapy were excluded. 
About 2500 patients per year were followed for many years with 
periodic evaluations of the disease and of possible late 
radiation damage. About 1800 new patients undeL-went 
radiotherapy each year in the Center. 
Different radiation sources (2 telecobalt units, Betatron, 2 
linear accelerators, after-loading sources) were used for 
external and endocavity radiotherapy. Moreover, 
radiometabolic treatments with 131J for thyroid carcinoma, 
hyperthyroidism and toxic adenoma were performed. 
Conventional fractionation (2 Gy/die, 5 days/week) was used 
for external radiotherapy with gamma rays, X rays or 
accelerated electron beams. More recently, different 
fractionation regimens (1 Gy x 3/dle, 2Gy x 2/die, 2 Gy x 
3/die) were introduced for treatment of head and neck cancers. 
The use of these d1fferent radiation sources and treatment 
schedules allowed evaluation of the different acute and mainly 
late effects of ionizing radiations. 
The aim of the research was to continue the study of patients 
during follow up to evaluate the incidence of a second primary 
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turner in the irradiated area or outside of it. Most subjects 
were affected by breast cancer, gynecologic turner, Hodgkin's 
lymphoma, head and neck (ENT) turner or thyroid carcinoma. 
During treatment and follow up, besides clinical and 
radiological examinations, the concentration of some molecules 
considered to be important biochemical indicators of radiation 
injury or turner markers were assayed to evaluate the 
correlation of these parameters with the condition of the 
patient, prognosis, recurrence and the appearance of a second 
independent turner. 
Particular attention was paid to those patients affected by 
Hodgk1n's disease since there has been increased recovery and 
a prolonged survival time over the past decades due to 
improved therapeutic treatment. A total of 918 patients were 
treated from 1955 to 1985. In two cases (0.2%) the second 
turner preceded Hodgkin's disease whereas in 0.4% of patients a 
synchronous second turner appeared. In 35 cases (3.8%) the 
second primary tumor was metachronous. The mean latent period 
between the first and the second primary tumor was 8.4 years 
(range 1-21). 
The treatment modalities were determined according to the 
clinical characteristics and the hystopathology of the 
disease. The second neoplasia was classified in two groups: 
a) acute leukemia and non Hodgkin's lymphoma; 
b) solid turner. 
To analyze the incidence of a second primary turner patients 
were divided into the following three groups according to the 
type of treatment: 
a) 347 radiotherapy only (RT); 
b) 482 radio- and chemotherapy (RT+CT); 
c) 89 chemotherapy only (CT}. 
The incidence of a second primary tumor was 5.4%, 2.6% and 
3.3% respectively for groups a, b, and c. 
Solid tumor in the irradiated volume appeared in 13 cases 
treated with RT and in 5 cases treated with RT+CT. Six 
patients treated with RT and 2 treated with RT+CT showed a 
second turner outside the irradiated volume. Two second turners 
occurred in patients treated with CT. Seven patients 
contracted leukemia; six of them after RT+CT. 
In the 1311 cases of ENT turners treated with RT there was an 
incidence of 52 metachronous second turners. The distribution 
of the second neoplasia ~s a function of the location of the 
first turner was: nasopharynx 10/223, oropharynx 11/282, 
hypopharynx 2/80, oral cavity 7/229, larynx 22/368, salivary 
glands 0/60 and paranasal sinuses 0/69. Most of the second 
tumors (41) appeared outside· the ENT sites. Eight of 11 cases 
in the ENT region occurred in the irradiated volume. The 
mean latent period between the first and second tumor was 4.5 
years (range 1-12). 
Our most recent study primarily examined the incidence of 
breast turners. only the patients treated with postoperatory 
RT after radical surgery of the primary tumor were included; 
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radiotherapy has been assoc1ated with chemotherapy only in a 
small number of cases in recent years. Conventional 
fractionation (2 Gy/die, 5 daysjwk for a total dose of 44-50 
Gy) was used in all cases. The survey was divided into three 
periods of observation: 
a) 447 cases treated from 1971 to 1975. One patient had 
already been affected with a tumor and three others had 
synchronous turners. Second turners appeared in 19 patients: 3 
cases of leukemia were reported from 4 to 7 years after 
treatment whereas the others were solid turners of the stomach 
(4), lungs (2), K corporis (2), colon (2), ovary (2) and in 
other places (4). 
b) 238 cases treated from 1976 to 1983. One patient had a 
synchronous tumor and two had a second turner 5 years after 
treatment. 
c) 706 cases treated from 1984 to 1988. 3 turners preceded 
treatment, 2 were synchronous and 2 metasynchronous. Of these 
1 case of leukemia appeared after 3.5 years and 1 case of K 
corporis after 4.5 years. 
Out of a total of ~391 cases treated from 1971 
second turners were observed in the period 
(1.64%). However, for many of these the follow 
to 1988, 23 
following RT 
up period was 
short, espec1ally for the appearance of solid turners, and 
other clinical records must still be analyzed. 
The patients who had relapses or metastases during the follow 
up were later treated with CT. 
The study compared the incidence of patients undergoing RT 
with a homogeneous group according to age, clinical state, 
histotype, etc. of patients with breast turners treated with 
CT. out of a total of 2032 patients 3 turners before breast 
cancer and 4 synchronous turners were observed. 
In the group of 229 patients treated with CT between 1971-1975 
7 second tumors appeared, 4 within 3 years after treatment. 
In the 1976-1983 period, out of 1250 patients 25 second turners 
were observed; of these 1 was leukemia, 13 stomach or colon 
turners and 8 ovaric or K corporis turners. In the 553 patients 
treated most recently (1984-1988) 3 second turners have been 
observed till now. 
The overall incidence of second tumors was 1.72%, similar to 
that found in cases treated with RT. The incidence of 
leukemia in the 2 groups was different: 4 cases (0.29%) were 
observed in the group treated with RT compared to 1 case 
( 0. 05%) in the group treat_ed with CT. However, too few cases 
have been observed to make this datum meaningful. Another 
difference between the two groups concerned the incidence of 
second turners found in the gastrointestinal tract: 0.57% in 
the group treated with RT and 0.84% in that treated with CT. 
No significant d1fferences were found in the incidence of 
gynecological turners (0.43% and 0.49%). It should be noted 
that in the group treated with RT the second turner generally 
had a longer period of latency. 
The results of the study of patients with cervical carcinomas 
concerned primarily cases 1n advanced clinical stages. 
According to the clinical stage, patients were treated with RT 
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and surgery or only RT for the more advanced forms. Patients 
in stage IIb and with small sized turners were treated with 
intracavity RT; the others 111ere treated with external RT. The 
patients in this latter group received over the pelvis 2 
Gy/die, 5 days/week a total dose ranging from 50 to 70 Gy. 
The clinical records of 577 patients were analyzed, and 12 
second turners were observed. Five of these occurred before 
cervical carcinoma and 2 were synchronous. In 5 patients 
metachronous second turners were observed outside the 
irradiated volume. The follow up period for this pathology 
was and is, however, too short. 
Part of the study focused on 457 patients affected by thyroid 
carcinoma and treated with 131J (2.8-7.4 GBq) from 1977 to 
1987. Of these patients, 39 were lost during follow up and 25 
died of thyroid carcinoma or non neoplastic disease. Four 
second tumors, located in the breast, kidney, bladder or 
prostate, were observed during the 2-6 year period after 
radiometabolic therapy. one case of A.L.L. was observed in a 
patient who had received 2 doses of 131J (2.8 and 5.5 GBq 
respectively) with ~ 19 month interval between doses. The 
A.L.L. appeared 7.5 years after the second administration. 
The Institute of Radioq1erapy of the University of Modena 
recently joined the study on Radiation carcinogenesis in 
patients undergoing radiotherapy. A preliminary analysis of 
the incidence gathered between 1972 and 1987 demonstrated that 
out of 25000 patients examined 383 had multiple primary 
turners: 86 were synchronous and 297 metachronous. A total of 
8385 patients who underwent RT were analyzed: all were treated 
with conventional fractionation (total dose 45-55 Gy) over 
different parts of the body. During follow up 217 cases of 
second primary tumor were observed; of these 16 patients 
(0.19%} had developed the second tumor in the irradiated 
volume, with an average latent period of 17.7 years (range 8-
30). The subdivision of these patients according to the 
irradiated zone showed that out of 2127 patients irradiated 
on the pelvis for turners of the uterus, of the rectum or of 
the bladder, 4 (0.19%) developed a second turner of the rectum, 
3 (0.14%) of the endometrium and 1 (0.05%) of the ovary. Of 
the 2255 patients treated in the ENT region 3 (0.13%) deve-
loped a second tumor of the larynx or at the base of the 
tongue. Three second turners (breast, skin and lung), equal to 
0.25%, were observed in i169 patients treated on the thoracic 
region; 2 other second turners of the skin (0.67%) were 
observed in 2834 patients treated regionally for surgically 
removed breast cancers. 
Simultaneously with the epidemiologic studies other studies 
were conducted on the patients during treatment and follow up 
in order to find molecules or biochemical indicators of acute 
and late damage in the tissues of the irradiated volume; 
changes in these molecules during radiotherapy could be used 
to evaluate the effects of increasing doses of ionizing 
radiations on specific parts of the body. The information 
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obtained would also be able to be used in the quantitative 
evaluation of damage after accidental exposure. 
The presence of a close correlation between the cell 
proliferation and differentiation processes and the 
concentration of the polyamines spermidine (spd) and spermine 
(spm) persuaded us to study the behavior of these molecules in 
different tissues and in some body liquids following 
irradiation. 
Preliminary experimental results were obtained from tissues 
with different proliferative activity (small intestine, 
spleen, kidneys) from rats exposed to whole body irradiation 
with 3 Gy (gamma rays from 60Co) and sacrificed between a few 
hours and 2 months after irradiation. 
Verification of the proliferative activity, evaluated by 
administration of 3H-thymidine 1 hour before sacrifice, 
demonstrated an optimum correlation between the reduction of 
the tissue polyamines and the block of the proliferative 
activity in the days following irradiation. Even the 
following phase of repair was well represented by an increase 
of the polyamines in correspondance with the increase of 3H-
thymidine uptake. 
In the clinical studies, notable modifications of the 
extracellular polyamines were observed in their urine 
excretions during the radiotherapy of patients affected by 
head and neck tumors or uterine cervix tumors. However, the 
results were highly variable, probably because of both the 
sample collection and preservation methods and the enzymatic 
reactions that partially change the meaning of the urine 
concentrations. For these reasons a study of the polyamines 
in the red blood cells was begun; this also gave more reliable 
information because kidney catabolism of the polyamines is 
avoided. Preliminary results on patients irradiated in the 
pelvic area showed a significantly reduction of the polya-
mines; its compatibility with radiation injury is now being 
verified. 
Among the biochemical indicators of damage on specific 
tissues, the serum tissue polypeptide antigen (TPA) and a-
amylase had an optimal correlation with the amount of damage 
induced in the salivary glands after the first day of 
treatment in patients with head and neck turners treated with 
different fractionation regimens (2 Gy x 1/die, 1 Gy x 3 
/die, 2 Gy x 2/die, 2 Gy x 3/die, with a total dose of 60-66 
Gy in the first three and 52 Gy in the last regimen). The 
results showed that a-amylase activity and TPA increased as a 
function of the total daily dose and that the higher the dose 
the less the length of the increase: on the first day the 
values of serum TPA and a-amylase activity showed a 
correlation coefficient of 0.971 and 0.999 respectively with 
the total dose. This relationship was still present the 
second day of treatment but afterwards the increase 
disappeared. 
These results demonstrated that the two molecules were valid 
indicators of the amount of radiation damage; they were 
proposed as biochemical dosimeters of exposure, even 
accidental, for the head and neck region. 
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Besides the preceding molecules, other parameters were studied 
during our research. Among these some serum oligoelements 
(Cu, zn and Mg) and the acute phase reactant proteins were 
assayed. During therapy large changes were observed in the 
concentration of both the olygoelements and the proteins. 
These changes were only slightly correlated with the effects 
of therapy and a clear dose-effect relationship did not 
emerge. 
A study is currently being performed on patients irradiated in 
the pelvic region for treatment of prostate carcinomas. The 
red blood cells polyamines and prostatic acid phosphatase 
(PAP), prostatic-specific antigen (PSA) and serum TPA were 
determined at preestablished intervals during treatment and 
follow up. Preliminary results seem to indicate dependency 
between the variations of the concentration of these molecules 
and the effect of the ionizing radiations. 
CONCLUSIONS 
The results of the-study appear interesting and increase the 
previously available informations. Since the observation 
period is still short, especially with regards to the 
appearance of solid turners, the study has continued with the 
characterization of available control groups from the tumor 
registries. The organization and collection of clinical 
records performed during this period makes periodic data 
revision easier for follow up updating. Analysis of the data 
related to the single neoplastic pathologies must still be 
completed in the various centers collected in the research. 
In the near future, besides updating the follo~ up and 
completion of the study of other clinical records, an 
epidemiological analysis will be performed in order to 
evaluate the incidence of second turners in patients treated 
with RT as compared to those treated with CT. Furthermore, 
based on the analysis of the tumor registries, the signifi-
cance of the increase in the incidence of second turners in pa-
tients treated with RT will be determined. 
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Contract no.: B16-D-072-NL 
Role of oncogenes in malignant transformation of mouse cells. 
P.A.J. Bentvelzen 
Radiobiological Institute TNO 
Lange Kleiweg 151 
NL- 2280 HV Rijswijk 
V. Krump-Konvalinkova, P. van Klaveren, J. Dijk, A.G.M. Haaksma 
To test the hypothesis that radiation carcinogenesis involves the separation of a proto-oncogene 
from a neighbouring cis-acting negative control element and subsequent translocation into the 
vicinity of a strong positive control element. 
To characterize an oncogene rescued from a tumour cell line which has arisen after exposure of 
the murine fibroblast line NIH/3T3 to irradiated mouse DNA and plasmids containing the 
selectable marker neoR confirming resistance to the neomycine analogue 0418 as well as 
plasmids containing the long terminal repeat of a murine leukaemia virus. To establish whether 
this oncogene was also involved in the oncogenic transformation of other cell lines induced by 
fragmented mouse DNA. · 
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Ill. Progress achieved: 
MATERIALS AND METHODS 
Cell culture. NIH/3T3 cells and its transfectants were cultured in Dulbecco's Modification 
of Eagle's Medium (DMEM) with glutamine, supplemented with 10% heat inactivated newborn 
calf serum (NCS). For Re208F cells fetal calf serum (FCS) was used. 
Generation ofT -neo 1. T-neo 1 is a morphological transformant obtained by transfection 
via calcium phosphate precipitation of NIH/3T3 cells with a mixture of DNAs. This mixture 
consisted of BALB/c liver DNA which was sheared by forcing 1 ml of a 500 Jlg/ml solution 20 
times through a 0.5 mm syringe as well as the plasmids pKO-neo and pM1sp. As judged by gel 
electrophoresis, the actual size of the fragments ranged from 5-25 kbp. pM1sp consists of a 
Mo-MLV LTR with flanking mink sequences cloned into the Eco R1 site ofpBR 322. pKO-neo 
contains the Tn5 neomycin resistance gene in a SV40 transcription unit (courtesy of Dr. D 
Hanahan, Harvard University, Massachusetts), which can confer resistance to the toxic 
compound G418. One day after transfection cultures were split 1:9 and subjected to G418 
selection (1 mg/ml}. After two weeks of selection the T-neo 1 clone was picked and expanded in 
culture. The resulting cell line has a stable G418 resistant phenotype. 
Plasmid Rescue. Two Jlg of restriction endonuclease digested T-neo 1 DNA was ligated 
(16 hours, 15 Oq using 24 units T4 ligase in 400 Jll of the appropriate buffer according to 
instructions of the manufacturer. These conditions favor the formation of circular molecules. E. 
Coli strain JA221 was transformed with the ligated DNA. Ampicillin resistant colonies were 
selected for the criteria described in the text. 
Oncogenicity assay. NIH/3T3 cells were transfected with cesium chloride purified 
plasmid (0.5 Jlg per 3.105 cells, seeded one day prior to transfection) and 15 Jlg sheared 
salmon sperm DNA as carrier. In the case of pT24 (positive control containing activated ras 
oncogene) 0.1 Jlg plasmid was used. Two weeks after transfection 106 cells were injected 
subcutaneously into a single nude mouse less than 20 weeks old. On average 5 mice were used 
per assay. Tumors developed within 4 weeks. Mice that did not show any tumors after 10 
weeks were considered negative. Parallel cultures of transfected cells were kept for observation 
of morphological transformation. 
Other methods. Propagation of plasmids in E. Coli strain JA221, selection using 
antibiotics, plasmid isolation, endonuclease treatment as well as DNA/RNA isolation and 
blotting experiments were all performed using standard molecular biological protocols. For 
RNA isolation we used the Guanidinium/Cesium Chloride protocol. Southern blots were 
routinely performed at 370c (50% formamide) and washed at 680C, 0.2xSSC. Northern blot 
hybridization was at 450c, wash at 520c, 0.15xSSC. 
RESULTS 
The T -neo 1 cell line. T -neo 1 is the result of transfection of NIH/3T3 cells with a mixture 
containing irradiated fragmented BALB/c mouse DNA, the plasmid pM1sp which harbors a 
Mo-MLV LTR and pKO-neo, a plasmid which can confer G 418 resistance as a selectable 
marker. These experiments yielded many G 418 resistant cells (3-5 clones per ng plasmid) 
almost all of which were not morphologically transformed. One clone gave rise to the T-neo 1 
line, which has a transformed phenotype presumably caused by the action of a cellular oncogene 
associated with an acquired copy of the Mo-ML V L TR. 
Numerous copies of integrated plasmid DNA were found in the genome of T-neo 1 cells. 
Southern blot hybridization with a probe that can discriminate between endogenous and 
exogenous Mo-ML V L TRs also revealed the presence of at least six copies of newly inserted 
LTR. 
Plasmid Rescue. In order to isolate the sequences responsible for the oncogenic 
transformation, DNA isolated from this T-neo 1 cell line was digested with six different 
restriction enzymes and religated to form circular molecules. Transformation of bacteria yielded 
50 ampicillin resistant colonies (Table I}. The majority of these colonies were sensitive to 
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tetracycline, indicating that part of the original plasmid sequences had been lost. None of the 
clones was resistant to kanamycin and therefore presumably not derived from pKO-neo. 
DNA was isolated from these clones and hybridized on nitrocellulose to a Mo-MLV LTR 
specific probe. Nineteen clones proved to contain sequences homologous to the probe. Four of 
these clones were analyzed in more detail. The plasmids were subjected to digestion with 
combinations of restriction enzymes to detennine the relative position of their recognition sites. 
Taking the Pvu I site in the ampicillin resistance gene as a reference we were able to con$truct 
restriction maps of the plasmids. We estimate that the reScued plasmids may have lost 2.5-3 kb 
as compared to pMlsp, but three ofthem have gained.t.S-~.5 kb of unidentified DNA. We 
chose to examine the plasmid pSa9, which contains the Jarges(stretch of unidentified DNA, in 
more detail. Its restriction map is shown in Figure 1. For companson the map of the Mo-ML V 
LTR carrying plasmid pMlsp is also shown. 
Occurrence and expression of the Sa9 sequence. When the Sa9 sequence originated 
from the transfected BALB/c DNA, one or more extra copieS of the sequence would have to be 
present in the genome ofT-neo 1. We therefore isolated the 2.5 kb Sph I fragment containing 
the major part of the sequence and used it as a probe in a' Southern blot. ~IH/3T3 contains 
several endogenous sequences closely related to the Sa9 sequences. The sequence has been 
amplified in T -neo 1. · 
Northern blot analysis of total cellular RNA revealed an RNA molecule of about 2 kb not 
present in NIHI3T3 cells which hybridized to the Sph I fragment probe. An RNA of similar size 
reacted with the Mo-MLV LTR probe suggesting that both sequences are present in the same 
transcript. 
These data are consistent with the idea that Sa9 might contain (part ot) an oncogene from the 
fragmented BALB/c DNA transcriptionally stimulated by the Mo-MLV LTR. In addition, the 
Sa9 Sph I fragment probe did not hybridize with the DNA of the oncogenes abl, erb-B, fes, 
fms,fos, int-1, myb, myc,pim-1, H-ras, K-ras, N-ras, raj, rei, ros, sis, src or yes and never 
found any hybridization, indicating that the putative oncogene is not homologous to any of these 
known genes. 
Conservation of the Sa9 sequence in unrelated animal species. Extended 
exposure of films from Southern blots showed that sequences related to the Sa9 sequence were 
present in the DNA of various animal species. The sequences -were most prominent in mouse 
and rat DNA, but were also observed in human, bovine, chicken and trout DNA, although the 
blot was washed at low salt (0.2xSSC). However, the required length of exposure indicates that 
there are few stretches of substantial homology. It appears that the putative gene from which the 
Sa9 sequence stems is present in quite different vertebrate species, indicating at best partial 
conservation. 
Oncogenicity of Sa9. To test for transforming capacities we transfected the plasmid to 
NIH/3T3 as well as RE 208 F cells and screened for morphological transformation. Table IT 
shows that Sa9 has at best a minimal transforming capacity. However, when cells were 
inoculated into nude mice two weeks after transfection, tumors appeared at the site of 
inoculation within four weeks. The occurrence of tumors cannot be explained by the action of 
the Mo-ML V LTR, since pMlsp did not have similar oncogenic potential. Involvement of the 
pSa9 oncogene was found at the DNA and at the RNA level. This result proves the oncogenic 
capacity of Sa9. 
Sa9 harbors the MMTV L TR. In view of the Southern blot patterns of two mouse DNAs 
(BALB/c and NIHI3T3) with the pSa9 sequence as a probe compared to an MMTV LTR probe 
(Koornstra and Bentvelzen, unpublished results) and the occurrence of a weakly homologous 
sequence in other animal species, we have examined whether a relation exists between the Sa9 
sequence and MMTV. Sequences related to this virus are·found not only in mice, but also in 
humans, rats, tree shrews and several other animal species. We have compared the pSa9 
sequence to the MMTV genome by hybridization with probes which represent the three most 
important transcription units of the virus: gaglpol, env and the LTR containing the 3' long open 
reading frame (orf). Spot blot analysis shows that the plasmid hybridizes to a probe from the 
L TR, but only slightly to a probe from the gaglpol region and not at all to a probe from the etW 
region. In order to determine the exact location of the L TR in the plasmid we digested it with a 
combination of the restriction enzymes A va I and Sph I and performed Southern blot analysis 
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with the MMTV LTR as a probe. There is a strong hybridization with the 1.4 kb fragment 
which is of sufficient size to contain an entire MMTV LTR. The 1.0 kb fragment probably 
contains a short stretch homologous to the MMTV LTR. Substitution of Ava I by Pst I showed 
the same. Figure 2 gives our interpretation of these results. The L TR is situated in the lower 
right quadrant. Sa9 is not unique in containing the MMTV LTR. Upon reinvestigation using 
spot blot hybridization with an MMTV LTR probe, 39 of the 50 rescued plasmids were found to 
be positive. 
If the 3.5 kb acquired DNA found in the rescued plasmid stems from the sheared BALB/c 
mouse DNA, it must also contain MMTV LTR flanking sequences. Since neither env nor gag 
sequences could be detected in pSa9, we reasoned that the mouse DNA flanking the MMTV 
LTR must be present in at least one extra copy in T-neo 1 DNA as compared to NIH/3T3. Taq I 
digestion of the 2.5 kb Sph I fragment of Sa9 gives rise to two major fragments. Hybridization 
with an MMTV LTR specific probe shows that only the 1150 basepair fragment contains 
MMTV LTR sequences whereas the 850 basepair fragment does not We have used this latter 
fragment as a probe on Southern blots of T-neo 1 DNA and compared it to an MMTV-LTR 
specific probe (table Ill). Several extra bands are seen in T-neo 1 DNA with the non-LTR probe 
indicating that the sequence is an acquired MMTV-LTR flanking sequence. 
In order to assess whether the transforming activity of the Sa9 could indeed be due to the 
MMTV -orf sequence contained in the L TR, we have constructed several expression vectors 
containing MMTV -orf. These were transfected to NIH/3T3 cells. Two weeks later the cells 
were inoculated into BALB/c nude mice. In three separate experiments it was found that 80-
100% of the inoculated mice produced fibrosarcomas within four weeks. As was the case in 
pSa9-induced tumours these tumours contained plasmid sequences in their cellular DNA on 
additional MMTV -orf sequences. 
In three other tumour lines induced by irradiated fragmented BALB/c mouse DNA we 
observed additional MMTV -orf sequences. 
DISCUSSION 
We have undertaken experiments in order to gain insight into the molecular background of the 
transformed phenotype of cell line T-neo 1. This cell line was originated by transfection of 
NIH/3T3 cells with fragmented normal BALB/c DNA in conjunction with an Mo-MLV LTR 
and 0418 resistance as a selection marker. We have used plasmid rescue as a technique to select 
for sequences closely associated to the Mo-MLV LTR and its flanking plasmid sequences. This 
approach has resulted in several clones containing various amounts of DNA not present in the 
original plasmids used for transfection. One of these clones, Sa9, has been studied in more 
detail. 
The acquired sequence in Sa9 is present in T-neo 1 in several extra copies in addition to the 
ones endogenous to NIH/3T3. This indicates that the fragmented BALB/c DNA has served as 
its source. The analysis of the RNA of T-neo 1 indicates that this particular sequence is 
transcribed, and that the Mo-ML V L TR presumably directs this expression. 
The sequence can be found in different mouse strains and various vertebrate species not 
closely related to the mouse, as is the case for the oncogenes studied to date. 
The observed amplification and expression of the Sa9 sequence suggests its responsibility for 
the oncogenic phenotype of the T-neo 1 line. Amplification and overexpression have been 
demonstrated for several oncogenes like myc and ab/. We have failed to observe substantial 
morphological transformation of NIH/3T3 or RE 208F cells after transfection with Sa9. 
Apparently this test system is not adequate, since nude mice did develop tumors after 
inoculation with NIH/3T3 cells two weeks after transfection with Sa9. In view of this, Sa9 
must contain an oncogene. We found no homology to the oncogenes ab/, erb-B,fes,fms,fos, 
int-1, myb, myc, pim-1, H-ras, K-ras, N-ras, raj, re/, ros, sis, src or yes, although we can not 
exclude the possibility that Sa9 contains a part of, or a sequence related to one of these 
oncogenes. 
We did find hybridization to a probe from the MMTV LTR. This L TR contains a large open 
reading frame of which we have demonstrated the involvement in in trans regulation. It is easy 
to envisage how such a mechanism could provoke oncogenic deregulation of cellular 
metabolism. A similar mechanism has been proposed for the HTL V I tax gene. At present the 
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question remains unsolved whether the oncogenic capacities of the Sa9 sequences are brought 
about by expression of the L TR trans activator or whether alteration (perhaps mutation as is the 
case for the ras oncogene or rearrangement of the MMTV L TR sequences for instance like the 
ones seen in mouse T -cellleukemia underlies these phenomena. 
The oncogenic capacity of exogenous MMTV -orf sequences, which are part of the MMTV-
L TR, supports the view that the transactivating potential of this sequence per se contributes to 
the oncogenic transformation. We have recently found that the tax genes of HTLV and BLV 
also produce tumours in this NIH/3T3 transfection nude mouse assay. 
Since we have found amplification of MMTV-orf sequence in a few other transformed 
Nlli/3T3 lines produced after inoculation with irradiated BALB/c mouse DNA we tentatively 
conclude that indeed the separation of this transactivating proviral gene from inhibiting 
sequences under the influence of irradiation may play a role in some cases of radiation 
carcinogenesis. 
Table I. Plasmid rescue from the T-neo 1 cell line 
restriction8 No. Ampf No. Tetr No. L TR positive 
enzyme clones clones clones 
Bglll 9 0 3 
Clal 0 0 0 
Hind ill 4 1 1 
Kpnl 3 0 1 
Sac nb 32 2 13 
Smal 2 1 1 
IIEnzyme used to digest T-neo 1 DNA which after ligation and transformation 
to E. Coli was checked for resistance to ampicillin and tetracycline. The 
resulting plasmids were spotted on nitrocellulose, hybridized with a Mo-ML V 
U3 specific probe and washed at 0.2xSSC. 
bpSa9 stems from this series. 
Table 11: Transforming capacity of rescued plasmid 
Recipient 
Cell Line 
Plasmid Morpholog:tcally 
transformed clones 
(#/Jlg plasmid) 
Tumors m nude mice 
three weeks after inoculation 
NIH/3T3 
RE208F 
none 
pT24a 
pM1spb 
pSa9 
none 
pT24 
pM1sp 
pSa9 
0.2 
473 
12 
19 
0 
250 
8 
10 
a: plasmid carrying an activated ras oncogene. 
b: cloned Mo-MLV LTR. 
c: ND=Not done. 
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#inoculated # with tumor 
5 
5 
6 
7 
NDC 
ND 
ND 
ND 
0 
5 
1 
6 
Table ill: Compilation of Southern blots ofT-neo 1 DNA a using the MMTV LTR and 
the non-MMTV L TR part of pSa9 as probes. 
Pst I EcoRI Hind Ill 
MMTV-LTR non-LTRb MMTV-LTR non-LTR MMTV-LTR non-LTR 
8.8 -20 >10 
8.1 11.2 9.0 >9 
6.8 8.8 9.0 8.4 
6.4 6.4 7.2 7.6 7.8 
5.6 
.2.1 5.9 D. 6.1 
5.0 4.9 .u 4.9 
~ 4.0 4.2 4.0 4.5 4.6 
3.8 3.7 3.9 3.8 4.2 4.0 
3.4 3.5 3.7 3.8 3.6 
.12 3.2 3.3 3.3 M 3.4 
2.6 2.6 3.1 3.1 3.0 3.1 
2.3 2.8 2.9 
.1...8 2.3 2.6 2.7 
1.2 1.2 .1...2 2.5 
1.7 2.2 2.2 
1.5 1.6 2.0 
1.4 1.8 
1.1 
a: Endogenous copies as determined by Southern blot analysis of NIH/3T3 DNA are underlined. 
b: 850 bp Taq I fragment of 2.5 kb Sph I pSa9 fragment. 
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Figure I: Reslriction maps of pM I sp (cloned Mo-ML VL TR) compared to the plasmid pSa!l 
wbich was rescued from T-nco I. Thiclc lines indica10 unidentified DNA. 
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Figure 2: Presumed Joc:alizalion of the MMlV-cxfrdatcd scqucnc:c in pSaq. 
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Title of the project no.: -
Incidence of cancer and non-stochastic diseases in an irradiated population of rhesus monkeys. 
Head(s) of project: 
Prof.dr. J.J. Broerse 
Scientific staff: 
Prof.dr. J.J. Broerse and Dr. C. Zurcher 
I. Objectives of the project: 
Specific information related to the risk of radiation induced tumours or other late effects in man 
is limited. Data obtained from studies with larger animals and especially subhuman primates 
may be extremely valuable to assess the risk in man and also to estimate the RBE for tumour 
induction by neutron irradiation of human patients. In addition, the induction of non-stochastic 
effects in various tissues and the RBE of neutrons for these effects are of increasing impor-
tance for radiation protection problems. The present study on longevity, tumour induction and 
other late effects of total body irradiation of rhesus monkeys with fission neutrons and X rays 
has been in progress for about 25 years. 
11. Objectives for the reporting period: 
At this moment at about 4/5 of the estimated duration of the study, approximately 90 per cent 
of the irradiated monkeys have died compared with 50 per cent of the control group. All 
remaining monkeys receive a physical examination each month by a veterinarian with extensive 
experience with non-human primates for the clinical presence of tumours, cataract formation 
and changes in general condition. 
The necropsy results over the total contract period are reported and the diagrams for malignant 
tumour development are updated. Risk factors and RBE values are derived from the tumour 
incidence results. 
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Ill. Progress achieved: 
Introduction 
The two groups of long-tenn surviving irradiated monkeys are part of a study on the effective-· 
ness of bone marrow transplantation to prevent death due to the haemopoietic syndrome 
(Broerse et al., 1978). One group of long-tenn survivors consisted of nine macaques irradiated 
with fission neutrons with doses ranging from 2.3 to 4.4 Gy (average dose 3.4 Gy) and the 
other of 20 X-irradiated macaques which received doses between 3.0 and 8.6 Gy (average 
dose 6.7 Gy). A third group of 21 untreated rhesus monkeys of comparable age distribution 
was maintained under identical husbandry conditions to serve as a control group. 
The tumour incidence and post-irradiation observation periods for rhesus monkeys are shown 
in Figures 1 and 2. Time of irradiation and time of occurrence of tumours are indicated. Lines 
ending in cross bars signify death and arrow heads denote that the monkeys are still alive. 
observation 
period 
1960 
I 965 
1 970 
1 975 
1 980 
1985 
1990 i 
number 
dead/ number 
at risk 
number with I 
malignant 
tumours / total 
observation 
per.od ( y l 
FISSION 
NEUTRONS 
T 
T 
X RAYS 
: 1 1 • = time of irrad1at10n 
1
1 
: : ! : T = malignant tumour 
. ' 
T 
17/ 
20 
10/ 
237 
Figure 1: Tumour incidence in long-term surviving rhesus monkeys after irradiation and bone marrow 
transplantation. 
Necropsy results 
Rhesus monkey no. 730, an untreated control, born in 1961, died after a two-month period of 
increasing anorexia and weight loss on December 21, 1984. A necropsy and complete his-
tological examination was perfonned. The clinical findings and the emaciation at death could be 
explained by an extensive saucerlike ulcerative carcinomatous process (diameter 7 cm) in the 
cardia of the stomach, extending into the lower esophagus, pancreas and spleen. A large 
metastasis (diameter 6 cm) with central necrosis was found in the liver. Other tissues did not 
show significant changes and no other metastases were observed. 
In the monkey no. 646, irradiated with 2.6 Gy fission neutrons in 1965, a glomus tumour of 
the right scrotum and 2 subcutaneous nodules, one neurofibroma and the other neurofibro-
matosis, were removed in 1979 and 1982, respectively. The general condition of this animal 
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gradually deteriorated after Mantoux testing in November 1984. 
At that time, in association with stretching of the hind legs during anesthesia, subcutaneous 
hemorrhages occurred in both inguinal regions. Thereafter, the hemorrhagic area got infected 
with focal ulceration. The local inflammatory process appeared to be resistant to any therapy 
and the animal died, presumably due to sepsis, on January 24, 1984. The gross necropsy 
revealed large hemorrhagic areas in both inguinal regions with discoloration and softening of 
the underlying adductor muscles and focal ulceration of the covering skin, status after extirpa-
tion of the right testicle and scrotal glomus tumour and a number of other lesions in lungs, 
kidneys, liver, adrenal gland, thyroid, pituitary and ischiadic nerve. In addition, many tissues 
(muscle of left thigh, skin of left foot, meninges, thyroid, mucosa of intestinal tract) showed 
small, well circumscribed hemorrhagic areas ranging from 1.0-0.3 cm diameter. Between the 
first and second finger of the left foot an hemorrhagic area with ulceration of the overlying skin 
was observed. 
observation 
period 
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dead/ number 
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! : l i i ! I ! i ! 
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Figure 2: Long-term surviving monkeys in the control group. 
After microscopic examination, the following diagnosis could be made: renal cortical car-
cinoma, diameter 1.3 cm, right kidney; pheochromocytoma 0.5 cm, right adrenal; pancreas, 
multiple small insulinomas; schwannoma of left ischiadic nerve; thyroid: cystic follicles, 
interstitial fibrosis and multifocal folicular hyperplasia; pituitary: multifocal hyperplasia in distal 
part. No glomus tumour metastases were observed. 
In addition to these-proliferative lesions and of more relevance to the clinical condition were the 
histological signs of a long-standing process of increased intravascular coagulation with 
sometimes extreme narrowing of the lumen of small and large arteries due to myointimal 
fibrosis. Ischemic necrosis and fibrosis secondary to impaired vascular sypply were found in 
the kidneys, lungs and liver. 
It can not be excluded that this vascular disease process already existed for many years as 
severe myointimal fibrosis and organizing thrombi were observed already in 1979 in the 
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peritesticular tissue in the vicinity of the glomus tumour and in the cavernous hemangioma of 
the left thigh. The grossly observed hemorrhagic areas in various tissues at necropsy appeared 
to be teleangiectatic veins and capillaries and multifocal cavernous hemangiomas. The rupture 
of such a hemangioma could explain the large hemorrhage in the inguinal region after 
stretching of the hind legs during anesthesia in November 1984 (which event started the 
clinical deterioration). Bacteriological examination of heartblood and inguinal ulcer revealed the 
presence of Staphylococcus aureus. 
It can be concluded that the rhesus monkey no. 646 died from diffuse intravascular coagulation 
and terminal septicemia with extensive endarterial myofibroblastic proliferation resulting in 
severe ischemic necrosis and fibrosis in kidneys, liver and lung. Other findings not directly 
related to the death of the animal and probably caused by the irradiation were: renal adenocar-
cinoma, adrenal pheochromocytoma, multiple panchreatic insulinomas, multiple hemangiomas 
and perineural sheath tumours. 
The rhesus monkeys no. 2658, irradiated with 8.5 Gy X rays in 1973, suffered from intrac-
table diarrhea during the last month of its life. Fecal examinations for protozoa or bacteria 
remained negative. During the last week serum uerum and creatinin values increased. The 
animal died on March 6, 1985. Necropsy revealed a stricture in the distal colon and several 
adhesions between intestinal loops in that area. The colon proximal of the stricture was severe-
ly dilated and the lumen was filled with fluid and gas. At microscopical examination, adhesions 
and a stricture of the distal colon appeared to be caused by endometriosis of the colonic serosal 
surface and associated inflammation and fibrosis. No other significant lesions were observed. 
Bacteriological examination of heartblood revealed the presence of Staphylococcus aureus. 
The non-irradiated female monkey, no. 926, born in 1963, developed a diarrhea with severe 
mucus production in the middle of December 1985. Examination of the faeces revealed the 
presence of flagellates. Treatment with Flagyl had no effect. The general condition graduallly 
deteriorated, blood urea and serum creatinin levels increased and she was euthanized on 
January 23, 1986. At gross morphology, the tissues were dry. No significant lesions were 
observed except a multifocal yellow discoloration of the liver. 
Microscopic examination revealed the presence of a mild chronic colitis with goblet cell 
hyperplasia, a moderate chronic gastritis, mild to moderate fatty changes in the liver, mild 
multifocal renal tubular atrophy and mild interstitial renal cortical fibrosis. The larger renal 
arteries shown the presence of a mild to moderate intimal fibrosis. As an incidental finding, a 
small anaplastic carcinoma of the uterine cervix was observed. Metastases have not been 
detected. This animal died of intractable diarrhea due to chronic colitis and subsequent fluid 
loss. 
The non-irradiated male monkey, no. 1747, born in 1966, died in March 1987 of acute right 
cardiac failure. At necropsy and histology, an extreme hyperplasia of the muscular wall of the 
large pulmonary arteries was observed compatible with a diagnosis of pulmonary hyperten-
sion. The right cardiac centricle was dilated and the liver showed signs of acute congestion. 
Tumours were not observed. 
The non-irradiated male monkey (Balthazar), born in 1961, died in February 1987, due to 
respiratory failure. This monkey had an excessive thoracic kyphosis at Th 5-6 for years. At 
necropsy, severe lung lesions were present. There was extensive lung mite infection with 
bronchiectasis, lung fibrosis and emphysema. The large systemic arteries showed focal intimal 
fibrosis and a variable narrowing of the lumen. Left and right cardiac ventricles were 
hypertrophic. Other lesions observed were multifocal, fibrotic thickening of the liver capsule 
with periportal and perisinusoidal fibrosis in the subcapsular area and chronic gastritis. 
Tumours were not observed. 
The X-irradiated female monkey, no. 2490, born in 1971, was euthanized in April 1987, 
because of technically inoperable uterus myomatosus. Necropsy and histological examination 
revealed, in addition to the presence of multiple benign leiomyomas of uterine body and cervix, 
also a cavernous hemangioma of the left adrenal, a benign splenic stromal tumour, a severe 
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chronic gastritis and fibrosis and mineralization of the pancreatic islets. 
The X-irradiated female monkey, no. 2489, born in 1971, was euthanized in October 1987 
because of increasing weight loss and intractable diabetes. Necropsy and histological examina-
tions revealed fibrosis and mineralization of pancreatic islets but no other histological lesions 
compatible with longstanding diabetes were observed. The liver showed multifocal areas of 
fatty change. In the lungs, focal mild interstitial fibrosis was found. No neoplastic lesions were 
observed. 
The male rhesus monkey, no. 2652,, TBI X-irradiated in January 1974, died unexpectedly at 
24 July 1988 after a few days of clinical illness at the age of 17 years. His body weight had 
decreased during the last year from 4500 to 3500 g. At necropsy and histological examination 
it appeared that he died from severe acute bronchopneumonia, secondary to severe 
pneumonyssus infection of the bronchial tree with fibrosis, bronchiectasis and emphysema. 
Septic abcesses with cocci were observed in the liver. In the right and left kidney papillary 
cortical carcinomas were observed (with diameters of 1.5 cm and 0.4 cm). Additional non-
neoplastic findings were: right sided cataract, severe testicular atrophy, mild glossitis and 
oesophagitis due to candida infection; severe nodular hyperplasia and fibrosis in the right lobe 
of the liver; localized venectasies in the meninges with recent and organised thrombi, moderate 
to severe renal interstitial fibrosis and multiple smaller and larger cysts at the cortico medullary 
junction. 
The female rhesus monkey, no. 2498, treated with TBI X rays in November 1972, was 
euthanized December 12, 1988 at the age of 18 years, because of extreme emaciation (2100 g) 
and decline of general condition. At gross morphology only minor lesions, apart from the 
general wasting, were observed. Microscopically a small papillary cortical carcinoma was 
observed in the left kidney and a tubular adenoma in the right kidney. Uterine abnormalities 
were: multiple small leiomyomas, an endometrial polyp and multiple foci of endometriosis at 
the serosa. The most important non-neoplastic lesions were: severe septal fibrosis of the heart, 
severe fibrosis and atrophy of the exocrine pancreas with vacuolar degeneration of islet cells 
and moderately severe chronic superficial gastritis. These lesions could explain the clinically 
severe wasting disease. Additional non-neoplastic fmdings were: chronic liver-congestion and 
liver cell atrophy, glossitis and oesophagitis due to candida, severe lymphoid tissue atrophy, 
renal cortical cysts and moderate interstitial fibrosis. 
During the last year only one of the control rhesus monkeys, no. 1752, died. This animal was 
clinically healthy and died accidentally due to asphyxia after ketamine anesthesia necessary for 
scheduled Mantoux testing and blood sampling. Histological examination revealed diffuse 
myocardial fibrosis and myocardial cell hypertrophy and moderate multifocal emphysema and 
diffuse interstitial fibrosis of the lungs. In addition, there were histological signs of mild 
chronic colitis and superficial gastritis. 
Conclusions 
In the groups of rhesus monkeys irradiated with high doses of X rays (average dose 6.7 Gy) 
and fission neutrons (average dose 3.4 Gy) an appreciable number of malignancies have been 
observed. In a number of cases the animals died with multiple tumours of mutually different 
types. The tumours observed include glomus tumours, osteosarcomas, renal adenocarcinomas, 
thyroid follicular carcinomas and central nervous system tumours (astrocytoma and glioblas-
toma). In the group of 21 control monkeys, two monkeys died with malignant tumours. The 
latency periods for induction of neoplastic diseases varied between 7.5 and 16 years for X-
irradiated animals and between 4 and 18 years after neutron irradiation. As a consequence of 
this study, it is recognized that there is a strong need to screen regularly for secondary 
tumours, which may arise in patients who have previously received high-dose whole-body 
irradiation. 
The results can be analysed in terms of the number of animals developing tumours per group 
as a function of the total observation period for the entire group. In the total observation period 
of 90 monkey-years, seven neutron-irradiated monkeys developed malignant tumours. 
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For the X-irradiated monkeys, ten have died with malignant neoplasms during the observation 
period of 237 monkey-years, while two animals died with malignant neoplasms in the control 
group during 460 monkey-years. The simplest way to obtain a quantitative assessment of the 
risk for tumour induction is to divide the number of observed tumours by the years at risk and 
the average absorbed dose. In this way, risk factors of 10 x 237-1 x 6.7-1 = 63 x 10-4 Gy-1 
year-1 for X rays and 7 x 90-1 x 3.4-1 = 229 x 10-4 Gy-1 year-1 for fission neutrons and an 
RBE of approximately 4 can be derived. It should be realized that these risk factors are derived 
from tumour incidence data obtained at relatively high doses and that they pertain to risk factors 
per monkey-year. Furthermore, this appraoch does not take into account the time-dependence 
of the tumour appearance. If one applies the concept of cumulative tumour rate the cumulative 
hazards are 0.64 and 0.18 for the neutron and X-ray experiment at 10 years past irradiation. 
On the basis of such a calculation the RBE for tumour induction in rhesus monkeys would be 
equal to 0.64 x 3.4-1/(0.18 x 6.7-1) = 7. It is clear that the different approaches can produce 
some ambiguities in the assessment of risks resulting from different types of radiation. 
For a comparison of the risk factors for induction of fatal malignancies in subhuman primates, 
it should be realized that the life span of monkeys is approximately one third of that in man. On 
the basis of recent epidemiological studies risk coefficients have been derived for occurrence of 
fatal malignancies after exposure of man to high doses of low-LET radiation (Broerse and 
Dennis, 1990).With the additive risk projection model the lifetime risks of mortality vary 
between 4 and 5 x 10-2 Gy-1, whereas the multiplicative model results in a lifetime risk be-
tween 7 and 11 x 10-2 Gy-1 for the whole population. These risk estimates apply to a dose 
range of 0.5-6 Gy and they are strongly influenced by the finding that children are considera-
bly more sensitive to radiation effects than are adults. Assuming a mean latency period of 20 
years for the manifestation of malignancies the yearly risks would vary between 20 and 55 x 
10-4 year-1. It is interesting that the risk factor of 63 x 10-4 Gy-1 derived from the monkey ex-
periments is resembling the human experience. 
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I. Objectives of the project: 
Quantitative estimates of the risk for breast cancer induction are 
essential for risk-benefit-cost analysis of mammography procedures. Large 
scale programmes on radiation- induced mammary neoplasms have been performed 
at relatively few laboratories in Europe and the United States. The results 
obtained at these institutes are analyzed by mutually different statistical 
models and associated computer programmes. A collaboration has been 
established between the institutes in the Netherlands and in the Federal 
Republic of Germany, to investigate the implications of the different 
approaches. Special emphasis will be placed on the extrapolation of the 
animal data, to radiogenic risks of ionizing radiation for the human 
situation. 
11. Objectives for the reporting period: 
Experimental results on induction of mammary tumours in the rat for 
different exposure conditions (single and fractionated irradiation, 
sometimes combined with hormone administration) were available from earlier 
experiments. Different methods and models were applied on the experimental 
data from these large scale animal programmes with the aim of assessing the 
dependence on dose and exposure conditions with radiation carcinogenesis 
as the biological endpoint. The statistical methods were incorporated in 
an analysis program developed for a personal computer. 
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Ill. Progress achieved: 
RISK ASSESSMENT OF RADIATION CARCINOGENESIS IN EXPERIMENTAL ANIMALS 
Davelaar1 , J. , Broerse1 •2 •3 , J. J. , Weeda3 , J. , 
1 Dept. Clinical Oncology, Academic Hospital, Leiden, 
2 Radiobiological Institute TNO, Rijswijk, 
3 Institute of Radiopathology and Radiation Protection, Leiden. 
Abstract 
Appropiate statistical analyses have been applied to estimate the 
carcinogenic effect of radiation on rats. These methods consisted of a 
maximum likelihood or fit procedure to an analytical Weibull function as 
well as the use of the proportional hazards model. A comparison between the 
methods show the results to be independent of the applied analysis 
technique within the errors. The derived methods are used to assess carcin-
ogenesic risks in animal experiments as a function of dose, radiation 
schedule, such as single dose and fractionated irradiation, and radiation 
quality. An RBE of around 0.5 is found for carcinogenesis due to Cs-137 
gamma rays as compared to 300 kV X-rays. 
Introduction 
The carcinogenic effect of ionizing radiation for low dose levels has 
been investigated in a number of studies in the laboratory, mainly due to 
the lack of human epidemiological data. In these animal cohorts endpoints 
are taken as the occurrence of a malignant (or benign) turner or a general 
lifetime shortening. Different analysis techniques were proposed for these 
carcinogenesis data with the aim to evaluate the dependence on dose, 
radiation schedule and radiation type (Kellerer and Chmelevsky, 1982; 
Broerse et al 1985). A systematic comparison of these various analysis 
techniques on the same set of animal data has up to now not been 
undertaken. However it is important to elucidate the above mentioned 
dependences, particularly in data sets with limited statistics. Different 
analysis techniques have been applied to animal data from the 
Radiobiological Institute TNO, which were performed with the specific aim 
to investigate the risk of mammography procedures. These analyses will test 
previous findings in an attempt to compare the results from the various 
models and will provide new information on the RBE for carcinogenesis of 
gamma rays, which will also be discussed in the context of radiation 
protection applications. 
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Methods 
The type of animal data for radiation carcinogenesis discussed in this 
paper, consists of the observation of a tumor (benign or malignant) at a 
certain time. The distribution of these time periods up to the occurrence 
of a tumor, also denoted as 'failure' times, can be expressed as a survivor 
function S(t) or the cumulative hazard function H(t) (Kalbfleisch and 
Prentice 1980). These two functions are related as follows: 
H(t)-- log(S(t)). 
S(t) will be influenced by concurrent deaths of animals through causes 
not related to the endpoint, i.e. without the occurrence of a tumor. This 
right-censoring can be corrected for by actuarial analysis by the sum or 
product limit estimate (Kaplan and Meier 1958). An experimental assumption 
is made for microtumours observed upon obduction, which are taken to 
represent failures at a time of 10 weeks thereafter (Broerse et al., 1986). 
The resultant survivor function can be analyzed by parametric models such 
as the Weibull distibution. Alternative distributions have also been 
proposed: exponential, log-normal, gamma or log-logistic distributions 
(Kalbfleisch and Prentice 1980). The survivor function, represented as a 
Weibull distibution, has the following form: 
S(t) - exp[-{(t-g)/a(D)JPl, 
where g is the time offset, a is the time scale parameter as a function of 
dose D and fJ is the shape parameter. The optimization of this Weibull 
function to the survivor data can be achieved through a x2 fit (Broerse et 
al. 1985) or the maximum likelihood method (Kellerer and Chemelevsky 1982). 
The shape parameter fJ is assumed to be the same for the common £it to the 
survivor functions under study. The parameter g is taken to be zero for all 
analyses. A good assessment of the validity of the assumption, that the 
survival curve is represented by a Weibull function; is a log-log plot of 
the cumulative hazard, which should follow a straight line. The relative 
hazard of two cohorts is defined as: 
h(D)-{a(O)/a(D) JP· 
The survivor functions have also been analyzed by non-parametric models: 
(i) the log-rank test (Mantel 1966), giving a measure through the p-value 
of the equality of two (or more) survivor functions and (ii) the proportio-
nal hazards model (Cox 1972), giving a direct quantitative measure of the 
relative hazard h(D) in the animal cohorts under study without any 
assumption on the actual shape of the survivor function. 
Results 
For an assessment of the relative hazard a comparison needs to be made 
with a control cohort. Differences exist for control groups over the years, 
as shown in figure la for the WAG/Rij animal control cohorts from the TNO 
experiments since 1974 up to 1982. The vertical separation would represent 
a presumed difference in the relative hazard between the cohorts. A log-
rank test shows a statistical difference between the cohorts in 1974 and 
1978 (p-0.007), however no statistical difference exists for the other 
years. As a consequence of the variation over the years of experiment the 
analysis of the irradiated animals needs to taken against the control of 
the same year. The analysis with a common Weibull function to the control 
groups is shown in figure 1. The Weibull function as a straight line is a 
reasonably good representation of the cumulative hazard data. 
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analysis techniques are 
applied to animal cohorts 
from the experiments at 
TNO in the year 1982. 
These experiments were 
meant to investigate the 
carcinogenic action in the 
mammary gland of female 
WAG/Rij rats. A number of 
experimental factors were 
varied for the cohorts in 
these studies: (i) 
relatively low dose levels 
were employed notably 0.3 
Gy and 1. 2 Gy, both as a 
single dose as well as Figure 1: Control group versus year of 
fractionated over 120 experiment. 
fractions, which would 
simulate the procedure in mammographic screening; (ii) the single dose 
radiation was applied at two distinct times in the lifespan of the rats, 
i.e. at an age of 8 and 17 weeks to investigate a possible age dependence; 
(iii) the application of a natural hormone E-2 to simulate the carcinogenic 
risk of combined anticonceptiva and radiation. Further experiments were 
performed with the benign fibroadenomas, which will however not be 
discussed here (Broerse et al. 1989). The relative hazard, as defined 
above, for carcinomas versus the control group is shown in figure 2 for the 
various animal cohorts from the 1982 experiment with WAG/Rij rats, 
subjected to total body irradiation of gamma rays. The data are analyzed 
by three different methods, i.e. the chi-square fit, the maximum likelihood 
optimization and the proportional hazards model. From this figure it can 
be concluded, that within the errors the relative hazard is fully 
consistent for the three analysis methods and that the errors seem to vary 
slightly with respect to the applied method, being somewhat smaller in the 
case of the Weibull fitting procedure. 
The relative hazard for carcinogenesis can be seen to increase with dose 
from figure 2. The largest hazard is obtained at 1.2 Gy for the animals 
irradiated at an age of 8 weeks. The fractionated data show almost no 
difference from the control group with the relative hazard around 1 for 
both the 0.3 Gy and 1.2 Gy irradiated cohorts. These findings are 
consistent for all three analysis methods. An extensive discussion of the 
dose-response relationships in terms of linear and linear-quadratic models 
can be found in Broerse et al. (1989), where the data were analyzed with 
the chi-square fitting procedure. 
The relative hazard for the same experimental conditions with the 
additional administration of the E-2 hormone is shown in figure 3. Again 
the three analysis methods provide consistent values for the relative 
hazards within the errors with the smallest error bars for the chi-square 
fitting procedure. A marked increase in the relative hazard is found for 
the cohort of animals irradiated at 8 weeks of age, indicating a 
potentiating action of the E-2 hormone in combination with irradiation. The 
dose-effect relation can only be described in this case with a quadratic 
model (Broerse et al. 1989). For the cohort irradiated at 17 weeks of age 
the relative hazard is also increased with respect to the situation without 
administration of the E-2 hormone. The fractionated data still show almost 
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Figure 2: Relative hazard for cohorts without E2-drugs applied. 
no increased hazard as compared to the control group. 
The depen4ence of the carcinogenic risk on radiation quality has been 
investigated from data of total body irradiation by gamma-rays, as in the 
previously described experiments, in comparison with 300 kV X-rays. For 
this calculation of the relative biological effectiveness (RBE) both the 
malignant carcinomas and benign fibroadenomas have been used. The RBE as 
a function of dose is shown in figure 4 for similar cohorts as above 
irradiated at 8 and 17 weeks of age with a single dose, in addition to the 
fractionated experiments. As can be seen from this figure the RBE of gamma 
rays shows a relatively large value for the carcinomas in the cohort 
irradiated at 8 weeks, but consistently lower values for the other data, 
which in fact are compatible with a value around 0.5. 
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Conclusion 
The analysis methods employed show consistent results for the described 
experiments, but this may not be warranted for all types of carcinogenic 
experimental conditions. Such an implication probably means that additional 
tests will have to be performed on other data sets. 
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For the specific endpoint notably mammary carcinogenesis in the rat the 
following conclusions can be formulated: (i) the dose-effect curves for 
induction of carcinoma can be described by a quadratic relationship, (ii) 
a clear age dependence has been demonstrated with a larger susceptibility 
for mammary carcinogenesis in younger animals, (iii) the tumour incidence 
data are appreciably lower after the fractionated irradiations than for 
single irradiations at the same dose level. These findings imply that risk 
factors for induction of mammary carcinomas obtained at relatively high 
doses, can be reduced for the dose levels encountered in screening 
procedures such as mammography. 
The relative biological effectiveness (RBE) of gamma-rays with reference 
to X-rays varies between 0.8 and 0.9 for acute somatic effects such as cell 
survival and the occurrence of radiation syndromes in experimental animals. 
The quality factor (Q) introduced for low dose levels and mainly valid for 
the causation of stochastic effects, is also expressed with reference to 
X-rays. On the basis of the reported studies an RBE of 0.5 was derived for 
induction of mammary carcinoma after gamma irradiation. When the quality 
factor concept would be related to gamma irradiation at fractionated 
exposures, an appreciable raise in Q values could be anticipated. 
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Title of the project no.>• 
Etude du métabolisme de la toxicité réelle des composés d'uranium en 
situations industrielles en vue du réexamen d~s normes de la CIPR. 
Head(s) of project: 
Dr. J. Chalabreysse 
Scientific staff: 
E. Ansoborlo - M. Archimbaud - P. Bérard - M·.H. Hengé-Napoli - E. Pujol 
1. Objectives of the project: 
Evaluer les risques réels en déterminant les caractéristiques 
physico-chimiques et les comportements metaboliques des composés 
d'uranium produits ou traités dans l'industrie nucléaire : Développement 
d'une méthodologie. 
Il. Objectives for the reporting period: 
Cette méthodologie est la suivante : 
- Caractérisation physico-chimique d'un certain nombre 
composé~ industriels de l'uranium utilisés comme 
uo2. diuranates calcinés et uo3. 
- Etude et développement d'un test de solubilité in vitro chimique avec 
utilisation de différents solvants contribuant à la solubilisation des 
poussières. 
- Développement d'un test de solubilité in vitro cellulaire sur 
macrophages alvéolaires de rats. 
- Intoxication par voie intratrachéale de rats avec des composés 
industriels de l'uranium. 
- Etudes in vivo par inhalation sur rats et suivi des excrétions 
urinaires ainsi que sacrifice et analyse de:1 organes et tissus en fin 
d'expérimentation et tentative de bilan d'adsorption dans les organes 
et tissus. 
- Chez l'homme, essai de corrélation entre les études d'atmosphère de 
postes de travail et les résultats obtenus en radiotoxicologie. 
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Ill. Progress ach1eved: 
111.1 - Etude des caractéristiques physico-chimigues 
L'expérience acquise pendant plusieurs années sur les composés de 
l'uranium a permis de développer l'utilisation de différentes méthodes 
permettant l'étude des principales caractéristiques physico-chimiques. 
Methodology 
Les techniques de caractérisation principalement utilisées sont : les 
rayons X pour la forme cristalline, l'infra-rouge solide pour le type de 
liaison {uranyle par exemple), l'ESCAE pour déterminer les niveaux 
d'énergie des liaisons atomiques, la Microscopie Electronique à Balayage 
{MEB) pour visualiser les particules et déterminer leur forme, la 
fluorimétrie pour doser l'uranium présent dans un composé et enfin la 
spectrométrie de masse pour déterminer la composition isotopique. 
Results 
Cette méthodologie a 
étudiés pendant ces 
{QML et NUF) et uo
3
. 
été appliquée à chacun des 
5 années, soit : UF~, U02 , 
composés suivants 
uranates calcinés 
- pour uo2 la mise en évidence au MEB de particules intrinsèques 
très fines {< 1 ~m) mais sous forme d'aggregats. 
-pour les uranates calcinés QML et NUFCOR l'analyse RX a permis de 
différencier ces 2 composés l'un étant plutôt de l'U
3
o8 {QML) et l'autre u3o8 + UOx {NUFCOR). 
- enfin, pour UO industriel nous avons mis en évidence d'une part 3 
composés prés~nts {ADU {<5 %), u3o8 {<5 %) et principalement uo3) par RX et l'U03 séparé a été caractérisé en IR. Cette approche permet de mettre en évidence un vieillissement dans le temps dû à un 
phénomène d'hydratation de la poussière. 
Discussion 
Ces différentes techniques et ces quelques résultats marquants ont mis 
en évidence l'importance de la caractérisation préalable aux études in 
vitro et in vivo. Nous verrons que le problèille d'hydratation de l'UO 
par exemple influe beaucoup sur la transférabilité du composé. 3 
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III.2 - Etude de solubilité in vitro chimique 
Cette étude s'est déroulée en plusieurs étapes qui ont permis d'une part 
de comparer différents types de tests (dynamiques et statiques) et 
d'autre part divers solvants, ceci afin de se rapprocher le plus 
possible des tests in vitro cellulaires et des phénomènes observés in 
vivo (animal, homme). 
Methodology 
Le test retenu pour ce type d'étude a été le test statique plus simple 
d'utilisation (fig. 1). 
~ONPV.ST100E 
LIOUIOE DE SOLUSIUSAfiON 
,~ rel 
Figure 1 : Système de dissolution in vitro statique 
Les solvants les plus intéressants qui ont été étudiés sont : 
- solution de bicarbonates, 
- solution de phosphates, 
- solution de Gambie avec barbotage d'oxygène, 
- solution de Gambie avec addition de pyrogallol (p) et de Super-Oxyde 
Dismutase (SOD) sans barbotage d'oxygène (formation d'ions superoxyde 
0? ), 
- M1lieu de culture cellulaire (BME) sous 5 % de C02 • 
Ces tests sont réalisés en température à 37•c. Les cinétiques observées 
sont exprimées sous forme d'exponentielles ;ermettant de calculer des 
périodes de demi-dissolution. 
L'uranium est analysé par fluorimétrie. 
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Results 
Le test statique ainsi que les différents solvants cités ont été étudiés 
sur les composés suivants diuranates calcinés, UF4 et uo3
. 
Uranates calcinés QML et NUFCOR nous avons noté l'influence 
solution de carbonates. 
80 % W alors que NUF 
du barbotage d'02 , équivalent à la QML (u
3
o8 ) a un comportement 20 % D et (u
3
o8 + UOx) est plutôt 40 % D et 60 % w. 
UFg : la figure 2 montre les résultats obte1us avec 8 solvants et 
l'1mportance de 14~xygèng+seul et des ions superoxydes qui entrainent 
une oxydation de U en U , augmentant la solubilité de ce composé. 
Celui-ci peut être considéré comme un composé de type D. Notons aussi 
une solubilité importante en milieu carbonates. 
p 
SOD 
pyrogallol 
superoxyde Dismutase 
1 r·achon of llr'f1!1Jllm f'f'lliillllliHJ rmdl'i<Jnlvr~rt 
100 
90 
~~ \\' 
60 \\ 
50 \ 
40 
30 
20 
- ----- 2 
6 
3 
100 - ---~ 8 -7 - 1 
~--~--~--~--~--~ 
0 10 20 30 40 50 liO 
l1mr {tlays) 
na11cm 
2--- Gamble IG) 
3 G+02 
4-- G+H202 
5 PrGr~~oorn? 
6-- GtSOUt02 
7- - P+S00+02 
8- P~02 
Figure 2 : Solubilité in vitro de l'UF4 dans 8 solvants 
uo
3 
: La solubilité de ce composé a été étudiée dans du BME, milieu 
plus riche que Gamble en protéines ainsi que dans d'autres solvants 
on constate qu'il a un temps de demi-dissolution inférieur à 10 jours. 
Nous avons observé un vieillissement de l'U0
3 
séparé, dû à une 
hydratation dans le temps entrainant une solubilité différente 
(tableau 3) . 
ITEMPSI U03 (extrait) U03 (mélange) UO) (hydraté) U03 (four) 
1j 17 % - 35 % 40 % 25 % 55 % 
5j 28 % - 55 % 63 % 42 % 80 % 
Tableau 3 Résultats de solubilité dans le BME de 4 composés uo
3 
avec des degrés hygrométriques variant exprimés en 
pourcentage d'uranium solubilisé. 
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Discussion 
Les.principales observations tirées de cette étude sont : 
- l'insolubilisation de l'uranium quelque soit le composé en présence de 
phQgphates et de sa grande solubilité en milieu carbonates, 
- la solubilité augmentant avec le barbotage 
mécanisme d'oxydation des poussières. , 
d'02 et donc un 
- l'influence des ions superoxydes 02 surtout dans le cas d'UF4, · 
reproduisant ainsi un phénomène décrit au niveau du macrophage. 
- la solubilité décroissante de la poussière d'uo3 lorsque son degré d'hygrométrie augmente. 
Tous ces résultats nous conduirons 
base (comparable à Gamble mais 
supérieure) additionné d'oxydant. 
à essayer le BME comme solvant de 
dont la charge en protéines est 
111.3 - Test in vitro cellulaire 
Ce test a été développé essentiellement en 1989 et semble très important 
puisqu'il se situe entre le test in vitro chimique et le test in vivo. 
Methodology 
Il s'agit d'un test in 
maintenus en survie en 
culture ou BME (fig. 4). 
A 
vitro sur macrophages. alvéolaires de rats, 
phase gazeuse (5 % co2 ) dans un milieu de 
VUE EN COUPE 
- A = Bo1te de Pétri (60 x 15 mm) 
- B = Anneau en mat1êre plast1que 
- c =Réservoir contenant le milieu nutritif 
- D = l·lembrane poreuse 
- E = Zone de dépôt des macrophages alvéolaires (d'après 
VOISIN - 1976) 
Figure n· 4 Test in vitro ~ellulaire 
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Ce test est réalisé sur une période de 2 à 3 jours. L'activité des 
macrophages est suivie par un dosage d'Adénosine Triphosphate (ATP) 
intracellulaire. L'uranium aussi bien solu>ilisé que restant sur le 
filtre est analysé par fluorimétrie. 
Results 
Le composé principalement étudié a été l'UO~ extrait du mélange 
industriel dont a granulométrie a été sélectionnée avec un AMAD de 3 pm. 
Ce test a mis en évidence un effet d'insolubilisation de l'UO par les 
macrophages (fig. 5). Il a été réalisé sur les différentes fJrmes d'uo
3 plus ou moins hydraté (tableau 6) : uo3 industriel ou mélange de base, 
uoâ extrait du mélange, uo3 vieilli ou hydraté et uo3 passé au four à 
35 ·c donc déshydraté. 
CINETIQUE DE SOLUBILISATION 
D'U03 
Ï~ Ur .solubilise 
1 
»t\ 
1 \ 
1 \ 
1 \ l \\ 1+ .. ·-i *UD« 1 
\-. ____ _____ 
-------~ 
. 
1 
JOUrs 
Figure 5 uo3 extrait du mélange 
% DISSOUT LES 1 U03 1 U03 EXTRAIT UHH 
PREMIERES 24 H IDESHYDRATEI DU MELANGE 
SANS CELLULES 82,2 % 32.3 % 10,6 % 
IAVEC MACROPHAGES! 69,8 % 12,5 % 9.8 % 
1 MELANGE 1 
IINDUSTRIELI 
30 % 
25.5 % 
Tableau 6 Comparaison de la solubilité des différents composés uo3 en 
présence ou en l'absence de macrophages alvéolaires de rats 
Nous avons observé, comme pour les tests in vitro chimiques, la 
diminution de la solubilité avec l'augmentation de l'hydratation de la 
poussière. 
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Discussion 
Les principales remarques concernant ces essais 
- Les macrophages semblent exercer un effet d'insolubilisation de 
l'Uo3 quelque soit son degré d'hydratation. 
- L'augmentation du degré d'hydratation de 
diminution de la solubilité. 
l'UO 3 correspond à une 
- Ce test in vitro cellulaire développé avec 
poursuivi sur d'autres composés. 
l'UO devrait être 
3 
III.4 - Etudes in vivo 
2 types d'études in vivo sur rats OFA ont été réalisés 
chronologiquement : dans un premier temps des études avec intoxication 
intratrachéale par les diuranates calcinés QML et NUFCOR, et dans un 
deuxième temps des études par inhalation par voie sèche d'UF4 et d'U03. 
Methodology 
Intoxication intratrachéale : les instillations ont été réalisées après 
anesthésie de l'animal après mise en suspension des sels d'uranium dans 
du NaCl. L'animal est ensuite placé en cage à métabolisme. 
Intoxication par inhalation les rats sont placés dans une chambre 
d'inhalation sphérique de 8 1 où la génération par voie sèche était 
assurée par un tube !fitté la poussière est déposée et soufflée avec 
un débit de 50 1 mn . Le temps d'exposition est de 20 mn et l'AMAD 
des poussières comprises entre 7 et 10 ~m. (Il s'agit de poussières 
industrielles}. 
Quelques animaux sont sacrifiés juste après inhalation pour évaluer 
essentiellement la charge pulmonaire, et les autres sont placés dans des 
cages à métabolisme afin de suivre l'excrétion urinaire sur 15 à 20 
jours. En fin d'expérimentation l'uranium est dosé dans les organes ou 
tissus suivants poumons, reins, TOI, carcasse pour modéliser le 
transfert du composé. 
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Results 
Les résultats concernant l'intoxication intratrachéale ont montré des 
excrétions urinaires decroissantes avec pour NUFCOR un comportement de 
type D - W et pour QML, plutôt un comportement W confirmant les 
résultats observés in vitro. 
Les résultats concernant les inhalations sur UF et UO sont 
présentés pour UF4 sous forme d'un tableau récapituÏatif (ta~leau 7) 
et pour UO nous ne présentons que la c·Jurbe d'excrétion urinaire 
moyenne (?ig. 8) pour 11 rats. 
1 TISSUE DISTRIBUTION OF URANIUM IN RATS API'ER INHALATION OF UF4 
% INITIAL LUNG BURDEN (x ! SEM, N) 
DAYS N LUNGS KIDNEYS CARCASS URINE 
20 8 17.1! 0.610.4! 0.05113! 2.1 143.9! 2.91 
SEM = standard Error of Mean 
N = number of an1.mals per group 
. Im. t1al lung burden of uranium = 92 JJg ~ 9 
(t1 = 5.2 d) 
Tableau 7 Tissue distribution of uraniu.11 in rats after inhalation 
of UF4 
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Discussion 
L.Rft.I!LJ'1 EXCRETE LR!tfô 
4 
(f'9/Jour) 
0 L ....... _.__..__.__J_..::::====;:::::::::;:::::=:;;,...-J- L03 t'EL. 
0 5 ill ~ 
Figure 8 
TEr-PS (JOUrs) 
Inhalation uo3 mélange Malvesi Excrétion urinaire journalière 
Résultats moyens sur 11 rats 
Nous avons observé que les excrétions uri~aires étaient différentes 
entre l'intoxication intratrachéale et l'inhalation. Dans la première 
la décroissance de l'uranium est immédiate après une valeur forte à 
24 H, alors que pour l'inhalation nous observons une bosse sur les 72 
premières heures due à l'apport des poussières passant par le TGI. 
La granulométrie utilisée dans les inhalations est importante (AMAD de 
7 à 10 ~) et le compartiment principal es~ le naso-pharynx (NP). Ces 
conditions reproduisent le milieu industriel et correspondent à un cas 
peu étudié du modèle CIPR. 
L'UF4 a montré un comportement de type D confirmant les essais 
vitro chimiques avec une période d'environ 5 jours. 
in 
Pour les composés industriels QML et NUFCOR on observe une bonne 
corrélation avec les résultats obtenus dans les tests in vitro. 
Les résultats concernant l'UO~ sont en cours 
semblent correspondre à un composé de type :> - W. 
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d'exploitation et 
111.5 - Etudes sur l'homme 
Il s'agit de valider les méthodes et les stratégies de surveillance 
radiotoxicologiques de travailleurs exposés à des composé~ industriels 
d'uranium en France. 
Methodology 
-résultats radiotoxicologiques de persomels 
pulmonaire et excrétions urinaires et fécal,!S) • 
exposés {rétention 
-résultats des contrôles atmosphériques journaliers {APA). 
- Résultats des mesures des aérosols aux postes 
particulier, diamètres aérodynamiques moyens). 
de travail {en 
Sur la base du modèle défini par la C.I.P.R. 30 et des données calculées 
par le Docteur PIECHOWSKI {DPS/SEAPS), le SHI a conçu un programme, 
implanté sur un microordinateur, permettant le calcul des incorporations 
soit lors d'une exposition chronique soit 
en tenant compte des caractéristiques 
résultats radiotoxicologiques. 
ap~ès une exposition unique, 
du poste de travail èt des 
Resulta 
Evolution des examens après exclusion d'un agent sur poste uo2-
u3o8 {fig. 9). 
Aérosols de classe Y : ·- U02 -- U308 ..... 
Pastillap 
" . 
~ 
i·· 1 
·~ 
lj URINES 
11 -1 !,-, --:---:---:,--':', =:=:-, --;,:----;,.---;---r--: 
r:: 1 : 1 
,ours iprès uétusion -
Figure 9 : Evolution des examens après exclusion 
Exposition à un oxyde d'uranium type u3o8 e~ calcul de la dose interne après incident. 
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Les hypothèses du calcul sont : 
- exposition unique après incident, 
- u
3
o8, composé de classe Y, 
- d~amètre aérodynamique moyen = 1 pm, 
- composition isotopique = 234 U, 235 U, 238 U. 
Les calculs sont effectués à partir des résultats observés sur les 
selles. Les doses effectives sont :omprises entre 0.1 et 
0.32 msivert. 
Suivi de l'exposition chronique à l'UF4 
mesures des concentrations atmosphériques 
en parallèle présenté précédemment. 
Discussion 
entre 1977 et 1988 avec 
et de l'excrétion urinaire 
De nombreuses observations dans,l'entreprise et notamment dans le cas 
de l'UF4 ont permis de guider les expérimentations in vitro et in 
vivo. 
En effet pour ce composé la décroissance rapide des urines suite à des 
incidents montrait qu'il avait plutôt un co~portement D. 
Les résultats 
équivalents de 
d'incident. 
radio toxicologiques 
dose effective en 
permettent 
chronique et 
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de calculer les 
également en cas 
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Title of the project no.: 
Etude de la toxicité réelle des composés de l'Uranium en situation 
industrielle. 
Head(s) of project: 
Dr. J. CHALABREYSSE. 
Scientific staff: 
E. ANSOBORLO - M. ARCHIMBAUD - P. BERARD - M.H. HENGE-NAPOLI - E. PUJOL. 
1. Objectives of the project: 
Evaluer les risques réels, les ca~actéristi1ues physico-chimiques et les 
comportements métaboliques des composés d'ura1ium produits ou traités dans 
l'industrie nucléaire. 
Il. Objectives for the reporting period: 
Les résultats obtenus in vivo chez l'homme et l'animal ont mis en évidence 
pour l'UF4 une excrétion urinaire rapide cara:téristique d'un composé D. 
Dans ce cadre les essais in vitro chimiques ont été poursuivis en étudiant 
de nouveaux solvants entrainant des mécanisme; de dissolution équivalent à 
ceux constatés in vivo. De même nous· avons d·~veloppé des essais in vitro 
cellulaires sur macrophages alvéolaires de rets, et des études in vivo par 
inhalation sur rats avec suivi des excrétions urinaires ainsi que sacrifice 
et analyse des organes et tissus. 
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Ill. Progress achieved: 
III.l. Etudes in vitro 
Les études de solubilité in vitro ont pour but de déterminer l'appartenance 
des composés industriels d'uranium (plus particulièrement UF4 et U03) aux 
classes D, W et Y de la CIPR. 
Les tests utilisés sont de 2 types : 1 test ~n vitro chimique et 1 test in 
vitro cellulaire sur macrophages alvéolaires de rats. 
Méthodology 
a) Test in vitro chimique 
Nous avons poursuivi l'étude de liquides de solubilisation afin de se 
rapprocher le plus possible d'une part de~ résultats des test~ in vit~o 
cellulaires et d'autre part des phénomèned observés in vivo (animal, 
homme), en utilisant un test statique défini dans nos études précédentes. 
Les solvants retenus pour ce test ont été successivement : 
Solution de bicarbonate 
de Gamble avec barbotage d'oxygène Solution 
Solution 
dismutase 
02-) 
de Gamble avec addition de i'Jrogallol 
(SOD) sous barbotage d'oxygène (formation 
et de Super oxyde 
d'ions superoxydes 
Milieu de culture cellulaire (BME) sous 5 % de C02. 
Ces test sont réalisés en température à 37•c. Les cinétiques observées sont 
exprimées sous forme d'exponentielles permettant de calculer des périodes 
de demi dissolution. 
b) Test in vitro cellulaire 
Un test sur macrophages alvéolaires 
gazeuse (5% C02) a été appliqué 
poussières uranifères (U03). 
de rat maintenus en 
à' l'étude de la 
survie en phase 
solubilisation de 
En bref, la description du test est la suiva1te : une rondelle en matière 
plastique, évidée en son centre de façon à ~~éer un puits, est placée dans 
une boite de Pétri. Le puits est rempli de milieu nutritif BME. Une 
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membrane poreuse recouvre ce puits. Les cellules gt la poussière à tester 
sont déposées à la surface du puits à raison de 10 cellules par boite et 
d'environ 1 particule par cellùle. 
Pour les témoins, on ne dépose que la poussière, sans cellules. 
La quantité d'uranium solubilisée en 24 heures est dosée dans le milieu 
nutritif du puits. 
Le test est réalisé sur une période de 
macrophages est suivie par un dosage 
intracellullaire. 
2 à 3 jours. L'activité des 
d'Adenosine-triphosphate (ATP) 
Dans ces 2 tests l'Uranium solubilisé ou restant sur filtre est dosé par 
fluorimétrie. 
Results 
a) Test in vitro chimique 
C'est avec UF4 que l'on a comparé l'effet des différents solvants. 
Nous avons cherché à reproduire le phénomène d'oxydation auquel on assiste 
dans l'étude de solubilisation avec le macrophage. Avec la solution de 
Gamble + barbotage d'oxygène et la solution de Gamble + Pyrogallol et 
superoxyde Dismutase, on assiste à un phénomène d'oxydation de la 
poussière. 
Ces résultats sont présentés dans la courbe 1 et ont montré un passage de 
U4+ en U6+ sous forme ion uranyle entrainant une solubilité rapide de ce 
composé de type D avec une période de l'ordre de 2 à 3 jours. 
~·H •. 1 
Fraction of Uranium remaining undissolved 
100~------------------------------,.-------------~ 
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. ..~~-- -7 10 ~8 .... 1 8-P+02 
0~----+-----4-----~-----+------~--~~---------------
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Dans le cas d'U03 industriel nous avons dans un premier temps procédé à une 
caractérisation physico-chimique du composé et séparé celui-ci en 3 
constituants principaux le Diuranate d'Ammonium ·(ADU < 5 %), ·le 
sesquioxyde d'Uranium U308 (U308 < 5 %) et l'U03. 
Nous avons constaté un vieillissement à l'air de l'U03 séparé dans·le temps 
du à un phénomène d'hydratation de la poussière mis en évidence par des 
analyses en Infrarouge solide (Fig.2). Ce degré d'hydratation variable de 
l'U03 joue .un grand rOle.dans la solubilité de ce composé (Tableau 3) dans 
un milieu de culture cellulaire .(BME). 
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U03 industr 1.el mélange COmurhex 003 extrait du mélange 
~ ~ .......... , 
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_./ 
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1·· "' ..... ' 
-· :'""'\ 0 if. 'J r .J ·- •WT ... 
.. 
.,.. .. 
-· 
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-
... .. ,,. ... .. , .. ... .. .. .. .. 
"" 
.• ... ,. 
003 .passé au fon.r l50°C ldeshydratê) · 003 hydr.ttê soit UHH (UOl, 2H20) 
!." ig :; : SPECTRES l~:FRA ROUGE DE 4 TYPES 003. 
TEMPS U03 (extrait) U03 (mélange) U03 (hydraté) U03 (four) 
lj 17 % - 35 ~ 40 % 25 % 55 % 
5j 28 % - 55 % 63% 42 % 80 % 
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Le tableau 4, présente la solubilité de UO:I extrait et U03 industriel 
dans divers milieux. 
t U03 industriel U03 séparé du mélange 
IJOURSIGamble +021Gamble+P+SODI HC03 IGamble +021Gamble+P+SODI HC03-
1 81,5 % 84,8 % 154,8 % 1 65.3 % 78,2 % 144,9 % 1 
1 1 1 1 
5 57.8% 62,1 % 1 5.2 % 1 40,8 % 54.9 % 1 4.7% 1 
1 1 1 1 
10 41,5 % 50,1 % 1 0,5 % 1 30,9 % 43,1 % 1 0,6 % 1 
1 1 1 1 
30 17,9% 27,2% 1 1 1 5,2 % 14,9 % 1 1 1 
1 1 1 1 
p = Pyrogallol 
SOD = Super Oxyde Dismutase 
TABLEAU 4 = Solubilité in vitro chimique de U03 industriel et U03 extrait 
de ce mélange dans divers milieux. 
Résultats exprimés en pourcentage cumulé restant non solubilisé au 
temps t. 
b) Test in vitro cellulaire 
Le composé principalement étudié a été l'U03 extrait du mélange industriel 
dont la granulométrie a été sélectionnée avec un AMAD retenu de 3 ~· 
Ce test a mis en évidence un effet d'insolubilisation de l'U03 par les 
macrophages (Fig.5). Il a été réalisé sur les différentes formes d'U03 
(Tableau 6) à savoir : U03 industriel ou mél~ge de base, U03 séparé de ce 
mélange, U03 vieilli ou hydraté (UHH) et UOJ vieilli deshydraté au four à 
35o·c. 
CINETIQUE DE SOLUBILISATION 
D'U03 ...... 
1l Ir .solubilise 
i 
J 
i\ 
1 \\ 
a+ \ 
1 \ 
~ 
.~ \\._ __ _ 
1 "-~ 
1 -·-
jours 
Fiq 5 003 EXTRAIT DU MELANGB 
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% DISSOUT LES 1 U03 1 U03 EXTRAIT 
PREMIERES 24. H 1 DESHYDRATE 1 DU MELANGE 
SANS CELLULES 82,2 % 32,3 % 
IAVEC MACROPHAGES! 69,8 % 12,5 % 
UHH 
10,6 % 
9,8 % 
1 MELANGE 1 
IINDUSTRIELI 
30 % 
25,5 % 
Tableau 6 : Comparaison de la solubilité des différents composés en 
présence ou en l'absence de macrophages alvéolaires 
de rats 
Nous avons observé comme pour les tests chimiques l'influence du degré 
d'hydratation sur la solubilité. 
Discussion 
- La connaissance des caractéristiques physico-chimiques de la poussière 
étudiée est essentielle et a permis de mettre en évidence d'une part 3 
composés dans l'U03 industriel de base et un phénomène d'hydratation de 
l'U03 extrait. 
- Cette hydratation de l'U03 a une influence importante sur la solubilité 
aussi bien dans les tests chimiques que cellulaires. Plus la poussière 
est hydratée moins elle est soluble. 
-Les macrophages exercent un effet d'insolubilisation de l'U03 quelque 
soit son degré d'hydratation. 
Dans l'ensemble l'U03 sous ses différentes formes semble plutôt avoir 
une solubilité rapide avec un temps de demi-dissolution inférieur à 10 
jours avec des périodes différentes. 
Pour l'UF4 nous constatons que le solvant permettant de reproduire les 
mécanismes de dissolution équivalent à ceux constatés in vivo sont Gamble 
+ Pyrogallol + Superoxyde dismutase sous barbotage 02 ; Pour l'U03 c'est 
le BME. 
Ces 2 résultats nous conduirons à essayer le BME comme 
(comparable à Gamble mais dont la charge en protéine 
additionné d'oxydant. 
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solvant de base 
est supérieure) 
III.2. Etudes in vivo 
Objectif 
Etude in vivo par inhalation de l'U03 in~ustriel et comparaison des 
cinétiques de solubilisation in vivo et in vitro. 
Méthodology 
Expérimentation sur rats (OFA) avec génération de poussières sèches. Le 
diamètre aérodynamique moyen est de 8 ~m avec une déviation standard de 
2. 2 expérimentations on été réalisées: Dès la première nous avons suivi 
l'excrétion urinaire des rats {12 rats) et au bout de 14 jours nous avons 
sacrifié tous les animaux et procédé au dosage de l'uranium des 
différents organes : carcasse, ensemble trachee poumon, reins, TGI. 
Results 
Les résultats de la première expérimentati)n 
tableau 7 et l'excrétion urinaire moyenne 
représentée dans la fig. 8. 
14 j 4,4 ~g 
sont 
sur les 
regroupés 
12 rats 
dans le 
a été 
Tableau 7 : Résultats d'analyses d'organes en Uranium suite à une 
inhalation d'U03 industriel après 14 jours. 
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1N-flLAT!Ctl LJ03 MELANGE MALVES! 
EXCRETJ Ct! Œ 1 NA 1RE JC1»f'lll ERE 
RESULTATS MOYENS SlR 11 RATS 
~lltl EXCRETE Œli'E 
4 C....ViC1Jr) 
0 ..__.___.___._..__..1_ ====_._===L::::::.:::::L:=:::._J-- LJ03 MEL. 
0 5 10 15 
TENPS ( 1 C1Jrs) 
De même par la seconde inhalation sur 6 rats les résultats sont donnés 
dans le tableau'9. 
ORGANESjPOUMONSjREINSj TG! 1 CARCASSE 1 URINES 1 TETE PEAU ISANGI 
I<TB +P)I 1 1 1 1 TETE 1 1 
Sacrifice! 1 1 1 1 1 1 
immédiat 12.36 pgj 1 314 pgj 214 pg 1 1 1 52 pgl734 pgj 1 
t = 0 1 1 1 1 1 1 1 
1 1 1 1 ! 1 1 1 
t .. 1 j j0,85 pgl' 1 11157 pgl 56 pg 11,26 pgl2,7 pgj 50 pgj 1 
1 1 1 1 1 1 1 1 
Tableau 9 Résultats d'analyses d'organes en uranium suite à la seconde 
inhalation d'U03 industriel. Sacrifice immédiat et à 24 h exprimé en pg 
dans l'organe. 
Discussion 
La granulométrie de ces 2 expériences est importante : l'AMAD est de 8 
pm correspondant à un dépôt principal dans le Naso Pharynx (NP) (83 %), 
confirmé dans la deuxième expérimentation ou l'analyse de la tête 
comprenant à la fois la bouche et le NP donc •me valeur très supérieure à 
celle du poumon, ce qui correspond à la réalité industrielle. 
L'élimination urinaire principale se fait su•: les 3 premiers jours alors 
que dans le modèle CIPR, qu'il s'agisse d'un composé D ou W cette même 
élimination devrait se faire en 24 heures. 
Les résultats sont en cours d'exploitation et semblent correspondre à un 
composé de type D - W. 
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Title of the project no.~ 1 
Mechanisms governing particle ·translocatio·n and related aspects of lung 
function 
Head(s) of project: Dr G Patrick 
Scientific staff: Dr G Patrick 
I. Objectives of the project: 
The primary aim was to clarify those cellular and physiological 
processes which determine the movement of particles within the respiratory 
tract, especially to sites which are important in lung dosimetry. This is 
of value for the development of improved dosimetric models to pro¥ide a 
more realistic assessment of the risk of lung cancer from inhaled radio-
active particles. The approach was to be based mainly on methods for the 
selective deposition of particles in specific regions of the respiratory 
tract of experimental animals. 
11. Objectives for the reporting period: 
The above aims were to be pursued by three different methodologies: 
(a) tracheobronchial retention of particles deposited on the conduct-
ing airways, administered by the intratracheal instillation of 
test particles; 
(b) tracheobronchial retention of particles administered by 
inhalation; 
(c) alveolar clearance mechanisms of particles administered by micro-
injection. 
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Ill. Progress achieved: 
(a) Tracheobronchial retentjoo of particles: intratracheal jnstjllation 
Methodology 
133 Rats of the Fischer-344 strain were administered Ba$04 test part-
icles via an intratracheal cannula, using techniques developed previously 
in this laboratory. The volume of suspension instilled was only 2 pl, to 
achieve local deposition in the distal trachea. The particles had a count 
median diameter of 0.34 pm with a geometric standard deviation of 1.7. 
The instillation was made 10 min after recovery from anaesthesia so that 
muco-ciliary clearance was not impaired by the anaesthetic. Clearance was 
measured by whole-body gamma counting, including scans along the length of 
the animal, and by serial sacrifice at intervals up to 24 weeks after 
instillation (3). 
To ascertain the pattern of lymphatic drainage in the rats used, 
colloidal carbon was injected intraperitoneally, intratracheally (at a 
volume of 0.5 ml to ensure deposition throughout the lungs) and by micro-
injection (2-7 pl) into the interstitial tissue of the tracheal wall. 
Lymph nodes were assessed for carbon content by light microscope examin-
ation of histological sections (4). 
Results 
133 The amount of Ba remaining in the distal trachea after one week, 
where the particles had been deposited, was 0.41% of the initial dose. By 
24 weeks the amount had decreased to 0.10%, and the clearance curve from 1 
to 24 weeks could be satisfactorily fitted by a single exponential term 
with a half-time of 88 days. These figures were derived from serial 
killing and radioassay of the distal trachea (2,3). 
Similar clearance rates were calculated from whole-body gamma 
133 
counting. The scanning profile of Ba along the thorax did not change 
between 1 and 24 weeks (3). 
In a related study the pathways of lymphatic drainage in the thorax 
of the Fischer rat were defined, using colloidal carbon as a tracer 
material. It was shown that while the lung lobes were drained mainly to 
the posterior mediastinal lymph nodes, the tracheal wall was drained 
primarily to the internal jugular and posterior cervical nodes (4). 
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133 Following the instillation of BaS0 4 particles into the distal 133 
trachea, the amount of Ba found in the internal jugular and posterior 
cervical lymph nodes increased to a maximum of 0.022% of the inJected .dose 
by 8 weeks, and slowly decreased thereafter (3). 
Discussion 
The retention of 133 BaS0 4 particles in the distal trachea after 1 
week was similar to values reported earlier for a variety of types and 
sizes of particle. Measurement of the long-term clearance from this 
region had not been attempted before. It was clear that particles 
retained in the airway wall were removed only slowly, at a rate not very 
different from alveolar clearance during the same period. For this 
reason, when particles are inhaled and clearance is followed by external 
thorax counting, the slow clearance of particles from the walls of the 
conducting airways is obscured by the retention and clearance of the much 
larger amounts deposited in the alveolar region (7). 
Some of the particles cleared from the tracheal wall were removed to 
the lymph nodes which normally drain that region. However it is not clear 
what proportion of the deposit was cleared by that route. 
(b) Tracheobronchial retention of particles: inhaled particles 
Methodology 
A new approach has been investigated to see if it possible to analyse 
retention in the rat trachea following the administration of particles by 
inhalation. For this purpose it is necessary to undertake a metabolic 
study of excretion of cleared particles, and to use highly· insoluble test 
particles. 
In an exploratory study Fischer rats have inhaled (nose-only) 4 pm 
(median aerodynamic diameter) monodisperse fused aluminosilicate particles 
(FAP) labelled with 57Co. The large diameter ensured a relatively high 
deposition in the large airways. The rats were whole-body counted at 
intervals up to 28 days, and were housed in metabolism cages during the 
periods 4-7 and 21-28 days. At sacrifice after 0, 7 and 28.days the 
trachea was dissected free and its lumen washed repeatedly with saline. 
A measured length of washed trachea was assayed for 57Co, as were the 
tracheal washes. 
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Results 
The washing procedure removed 99% of the particles from the trachea 
in rats killed immediately after inhalation. After 28 days only 85% could 
be removed by washing in the same way. The tracheal wall contained 0.016% 
of the total body burden at that time. 
By measuring the rate of urinary and faecal excretion of 57Co, it was 
possible to calculate the rate at which 57Co-FAP was being removed from 
the lung by "mechanical" clearance- i.e. clearance as particles- to the 
gastro-intestinal tract, and by dissolution and translocation to blood. By 
assuming that the velocity of muco-ciliary clearance up the trachea of the 
rat is 5 mm/min, in accordance with an earlier estimate in this laborat-
ory, and from the measured length of the washed segment of trachea, it was 
possible to calculate the amount of 57Co-FAP which was being cleared 
through t.h is segment by muco-ci l i ary clearance. Results so far indicate 
that this amount comprised no more than 5% of the 57Co that was washed 
from the trachea at 28 days. 
Discussion 
This study has suggested that it is possible to analyse the particle 
content of the trachea of the rat into three compartments: particles being 
rapidly cleared (by muco-ciliary action), particles on the surface of the 
trachea but not being rapidly cleared, and particles incorporated into the 
airway wall. This has been achieved following administration by inhalat-
ion, and may therefore be more readily compared with studies on delayed 
clearance reported elsewhere, including human volunteer studies. 
(c) Alveolar clearance mechanisms 
Methodology 
Particles of colloidal gold have been injected into subpleural 
alveoli of rat lung, using a glass micropipette with a bevelled tip of 
outside diameter 10-14 ~m (1). The colloid was prepared by reduct1on of 
Hl95AuCl 4 with ascorbic acid. to produce polydisperse I95Au-labelled gold 
particles with a count median diameter of 15-30 nm. It was confirmed by 
gel chromatography that the colloidal preparation contained no soluble 
(ionic) gold. 
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The micropipette was passed into the left lung through the parietal 
pleura, from a small area of which the overlying muscle had been removed. 
This technique ensured the deposition of particles within 1-2 mm laterally 
and most of the particles were found on immediate sacrifice to be in the 
alveoli adjacent to the pulmonary pleura (1). The alveoli were not 
flooded, since the volume of colloidal suspension injected was typically 
0.05 pl; the mass of particles injected was not greater than 1 pg. Removal 
of the micropipette did not collapse the lung. After injection the 
animals were allowed to recover from the anaesthetic. 
20 rats were injected for short-term studies on the fate of the gold 
particles. Later a long-term study using 38 rats was commenced, using the 
same techniques. After injection ~nd periodically throughout the study 
the rats were whole-body counted, and at certain intervals the excretion 
of 195Au was assessed using metabolism cages. Rats were sacrificed immed-
iately and after intervals of 1 day, 1 week and 1, 4, 9 and 15 months, for 
dissection and radioassay. The left lung was divided along its length 
into 2-mm slices, and those containing most 195Au into 2-mm cubes, for 
assay and for autoradiography and electron microscopy. 
Results 
The short-term studies up to 24 h after injection showed that there 
was no rapid clearance of particles from the alveoli. Very little gold 
was removed by muco-ciliary clearance to the extrapulmonary airways and 
gastro-intestinal tract. Also, the tiny amounts found in the liver and 
spleen up to 24 h indicated that very little of the 195Au had reached the 
blood; the kidney content and overall excretion level also confirmed that 
there had been no significant dissolution of the particles. 
By 4 min after injection a small proportion of the gold particles had 
already been taken up by a'lveolar macrophages (AM) in the deposition 
region. Phagocytosis by AM was well under way by 1 h, when particles were 
seen on the cell surface, in phagolysosomes and in the cytoplasm. After 
5 h nearly all the particles were within AM: by this time many of them 
were no longer confined to the deposition region, but had spread more 
evenly throughout the alveolar tissue up to a few hundred pm b~neatW the 
pleural surface. There were still a few particles free on the alveolar 
septa. By 5 h a few macrophages containing gold particles were seen at the 
terminal bronchioles, both on the ciliated epithelium and close to the 
peribronchiolar tissue adjoining the neighbouring alveoli. Other AM 
- 1622-
containing gold were seen around blood vessels. No particles were seen 
within lung cells other than AM, and none had penetrated to the inter-
stitium (5,6). 
Most of the work on the long-term study has been completed. All of 
the animals have been killed, the last group at 15 months after injection. 
In this group the whole-body retention data for 6 rats has been obtained 
for the full period. It was confirmed, as noted above, that there was no 
rapid early clearance phase of gold particles from the alveoli. The mean 
lung burden, relative to the initial value, was 94% at 1 week after inj-
ection, 87% after 2 weeks, but was still 48% at the end of the experiment. 
Interestingly, the range of values among the 6 rats was large, correspond-
ing to 27-69% after 15 months. 
On dissection it was found that, of the 195Au retained in the body, 
more than 90% remained in the left lung at all times after injection. By 
9 months 2.6% of the remaining body burden was in the thoracic lymph 
nodes, as compared with 2.2% in the liver, 0.02% in the spleen and 0.50% 
in the kidneys. 
The pattern of excretion at different times was analysed, and showed 
for example that from the 4th to the 8th week after injection the percent-
age of total 195Au excretion found in the urine fell from 5.3 to 1.1%. 
Supplementary experiments have also been conducted to define the excretion 
pattern of soluble 19 5Au injected i.v. into rats: the results will be used 
to analyse the overall metabolism of the injected gold colloid and thereby 
to def1ne the true rate of "mechanical" clearance of particles from the 
al veal i. 
Radioassay of the slices of left lung showed that, as before (1), the 
initial deposit was confined to within 1-2 mm of the deposit1on site. This 
relative pattern did not change appreciably over the whole period of the 
study. The pattern of 195Au distribution among the 2-mm cubes of fixed 
tissue taken from the slices with most activ1ty in them changed to some 
extent, but the greater part of the particles remained close to the 
original site of injection; only a small fraction was seen at locations 
between there and the main axial bronchus, and around the hilum. 
The autoradiographic and electron m1croscopic exam1nat1on of the 
large number of sections of lung taken at the different time points is 
still being completed. Preliminary results from this part of the work 
present some interesting findings. The large proportion of gold particles 
retained close to the injection site is within AM, which often form 
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aggregates of cells near the pleura. From 1 day after injection through 
to 15 months, 1 9 5Au has been seen on the surface of the ciliated airways; 
from 1 week onwards this was observed right up to the hilum. After 1 week 
gold was also observed in the tissue around the airways and from 1 month 
around airway bifurcations. At 4 months after injection particles were 
noted in lymphoid tissue near the hilum. The cellular location of these 
deposits remains to be clarified by electron microscopy. 
Discussion 
The data from the short-term studies confirm that the microinjection 
technique results in a pattern of deposition where nearly all of the 
particles are in sub-pleural alveoli, with a small proportion in alveoli a 
few hundred ~m deeper into the lung, but with no deposition on any of the 
ciliated airways. Hence it is possible by this technique to study 
clearance specifically from the alveolar region of the lung and to study 
the movement of particles resolved over quite small distances within the 
lung. 
While there is no rapid component to the kinetics of alveolar clear-
ance, the lung retention curves do not fit a single exponential curve. 
Most of the clearance process is well described, however, by an exponent-
ial term with a mean half-time of some 500-600 days. This average value 
should be interpreted with caution, in view of the wide variation between 
animals in this study. Since they were all injected at about the same 
time, with the same preparation of gold colloid and otherwise under very 
similar conditions, this variation may reflect differences in the location 
of the injection site in relation to the micro-architecture of the lung. 
The effect of such differences could have been detected because of the 
very small volume of lung into which most of the particles had been 
injected. 
Even at long times after injection there was clearly no widespread 
redistribution of particles throughout the lung. In principle, AM are 
capable of bringing about such a redistribution, for example by lateral 
movement between alveoli through the pores of Kahn. Instead there is only 
a small degree of redistribution to the tissue surrounding the conducting 
airways, which may represent the lymphatic dra1nage pathway, reaching to 
the hilum and including lymphoid aggregates in that region. Other than 
that, the injected particles seem either to leave the lung altogether by 
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AM movement and muco-clliary clearance, or else to remain in AM close to 
the original site of deposition. 
When the final analyses are completed, these findings, together with 
those described in the second project, will have important consequences 
for the future development of dosimetric lung models (7). It is necessary 
for these purposes to understand how, and to what extent, particles 
deposited in alveolar lung or on the conducting airways can be retained 
long-term at sites near to cells at risk of lung cancer induct1on. 
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Title of the project no.: 2 
Spatial distribution of particles in the lung in relation to cells at 
risk. 
Head(s) of project: 
Scientific staff: 
Or G Patrick 
Or A L Batchelor 
Or K J Morris 
I. Objectives of the project: 
The aim was to make a quantitative assessment of the spatial distrib-
ution of particles retained in the lung at long times after inhalation. 
Using human lung, measurements were to be made of the distances of occupa-
tionally inhaled particles from defined target cells, e.g. in the airway 
epithelium. This would permit an assessment to be made of the dose to the 
target cells in the lung from alpha-emitting particulates. Parallel 
studies were also to be made in the rat to study the spatial distribution 
of particles with respect to the airways up to two years after inhalation. 
11. Objectives for the reporting period: 
The above aims were followed by four main lines of enquiry: 
(a) particle distribution in human lung; 
(b) clearance from rat lung of inhaled tourmaline particles; 
(c) U0 2 distribution in rat lung; 
(d) cellular effects of inhaled U0 2 • 
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Ill. Progress achieved: 
1. Methodology 
(a) Particle distribution in human lung. Post mortem specimens of lung 
were obta1ned in the first instance from three Cornish tin miners. They 
had been exposed occupationally in the mines to dust from the local 
granite rock which was known to contain sufficient boron to allow its 
detection in histological lung sections. This was due to the presence in 
the rock of the mineral tourmaline, which is a crystalline complex 
silicate that occurs in many granites and contains approx. 3% boron. It 
can therefore be detected by neutron-induced autoradiography (NIAR) on 
CR-39 solid state track detector fashioned as microscope slides. 
5 pm sections were cut from different regions of the lung specimens, 
after resin-embedding, and mounted on CR-39 slides. The resin was removed 
from the sections with sodium ethoxide. Alternate sections were placed on 
standard glass slides for conventional histology. A second pre-etched 
CR-39 slide was placed tightly over each section mounted on CR-39, and the 
pairs of slides were exposed to thermal neutrons in a reactor to approx. 
12 -2 
10 cm (1). This produced 1.5 MeV alpha-particles from the tourmaline 
by the IDB(n,alpha) reaction, which were recorded in the CR-39 as short 
tracks. The top CR-39 slide was removed for etching in 40% KOH and track 
counting. The bottom slide with the section on it was re-exposed to a 
15 -2 
total of approx. 10 neutrons cm , to generate dense clusters of tracks. 
An image of the lung tissue itself was then produced on the bottom slide 
238 
of CR-39 by exposure to Pu alpha-particles attenuated in energy. The 
tracks from the tourmaline and the tissue image were rendered visible by 
etching the CR-39 with 40% KOH. At this stage the tissue section itself 
was lost. The dense clusters of tracks from boron in the tourmaline were 
clearly visible against the tissue image, so enabling them to be located 
in the lung tissue. The smaller numbers of tracks on the top slide, which 
were readily counted, could then be related to their corresponding 
position on the bottom slide (1). 
(b) Clearance from rat lung of inhaled tourmaline particles. To make 
some validation that tourmaline particles might be a suitable model for 
inhaled actinides in the lung, an experiment was conducted in which an 
aerosol of tourmaline was inhaled by rats and its clearance compared with 
that of Pu0 2 and other particles in the rat. 
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Cornish tourmaline was obtained and ground to a powder. The quartz 
content was reduced to approx. 5% by differential sedimentation. Further 
wet grinding in a micronizing mill (McCrone) reduced the particle size to 
the respirable range. The prepared tourmaline was then neutron-activated 
to give a radioactive gamma-emitting label suitable for measuring reten-
tion in the rat lung: the most useful label was 54Mn, produced from 
chemically-bound iron in the mineral. After irradiation the tourmaline 
was examined by X-ray diffraction (4). 
Fischer-344 rats were exposed nose-only to the activated tourmaline 
-3 
aerosol at a concentration of approx. 20 mg m The particle size was 
determined using a 7-stage cascade impactor. The rats were assayed for 
54Mn in a small animal whole-body counter after 3 days. They were sacrif-
iced in groups of four at intervals from 3 to 180 days after inhalation. 
The mass of tourmaline retained in the lungs was determined from the 54 Mn 
activity, also the liver content in order to estimate dissolution or 
leaching of the label from the tourmaline. 54 Mn was measured in these 
samples with a Ge(Li) detector (4}. 
(c) U0 2 distribution in rat lung. This study was undertaken to be compl-
ementary to the distribution work on human lung. 50 Fischer-344 rats were 
exposed nose-only to an aerosol of U0 2 at a concentration of 111-220 
-3 
mg m The particle size was measured as in {b). The U0 2 was obtained 235 234 
enriched to 93% U and thereby also to 0.8% U which provided most of 
the alpha dose to the lung. The rats were assayed for U0 2 in the whole-
body counter after 5 days. They were sacrificed in groups of five at 
intervals from 180 to 720 days after inhalation, with additional animals 
at times from 1 to 90 days. 
The lungs were fixed in inflation by intratracheal instillation of 
Os0 4 in fluorocarbon and each lobe was cut into 3-mm slices, further fixed 
in glutaraldehyde and resin-embedded for neutron-induced autoradiography 
(NIAR, see below). Other tissues were assayed for U0 2 in the same rats by 
delayed neutron analysis. Additional animals were sacrificed at intervals 
from 5 to 630 days for Similar U02 analySlS Of the lungs . 
The autoradiographs have been examined by light microscopy and image 
analysis (Seescan). Clusters of small numbers of tracks were counted 
manually, larger ones assessed by area on the image analyser. Each field 
of view scanned was also analysed for the area of each of the major tissue 
types in the lung, so that U0 2 concentrations per unit area could be 
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calculated as a measure of the volume particle concentration. 
In the course of developing the methodology of NIAR with CR-39 (see 
(a) above), it was found that at higher neutron fluxes an image of the 
tissue structure was formed on the top slide, which had been in close 
contact with the tissue section itself during irradiation in the reactor 
(1). Under the right conditions the image was adequate for determining the 
location of particles in the lung, e.g. whether on alveolar septa or 
associated with airways or blood vessels. The nature of this image was 
such that it was not possible to distinguish from it the small tracks due 
to boron-containing material, but it was certainly possible to distinguish 
235 
it from the much larger fission fragment tracks e.g. from U. The 
advantage of this procedure was that, unlike the former method using 
alpha-particles to produce a tissue image on the bottom slide (a), the 
tissue section itself on the bottom slide was not lost, and could be used 
for direct histological comparison, instead of using an adjacent section. 
It was considered that the image formed on the top slide might have 
been caused by the natural boron content of the tissue. Therefore the 
technique was further developed whereby the t1ssue section was soaked in 
10% NaB0 2 for 1 h. After a brief rinse and dehydration, a top slide of 
CR-39 was placed tightly over the section mounted on the bottom slide, and 
14 -2 
the pair was exposed to approx. 10 neutrons cm After etching in KOH 
as before, the top slide was used for microscopic examination both of 
fission fragment tracks from U02 particles in the lung and of the assoc-
iated tissue image (2). It was also observed that useful images could be 
readily obtained from other tissues, e.g. kidney and brain. 
(d) Cellular effects of inhaled U0 2 • As part of a study on the effects 
of neutrons and U0 2 on the lung, and of fission fragments induced by 
neutrons after inhalation of U0 2 • groups of four HMT rats were exposed to 235 
an aerosol of U-enrlched U0 2 similar to that in (c), with or without 
subsequent exposure to neutrons. The rats were sacrificed 8 days after 
inhalation and samples of lung tissue prepared for transm1ssion electron 
microscopy (TEM) by standard techniques. The morphometry of alveolar 
macrophages. type I and type II epithelial cells and blood leucocytes was 
studied using a Quantimet-720 image analyser (3). 
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2. Results 
(a) Particle distribution in human lung. For the amounts of boron found 
in the miners· lungs, the neutron fluences used here produced adequate 
numbers of tracks for locating particles in the lung sections. The tracks 
produced by the IOB(n,alpha) reaction were very short, appearing after 
etching with KOH as small pits. The dense clusters of these pits, 
15 -2 produced by 10 neutrons cm on the bottom CR-39 slide, overlapped and 
were readily visible as large pits contrasting well with the tissue image 
produced as described above. From this it was possible to identify the 
location of tourmaline particles, or aggregates of particles e.g. within 
macrophages, relative to the tissue structure. Confirmation of the 
structure was possible from the alternate sections prepared for convent-
ional histology (1). 
From the lung sections of the three available cases, a study of the 
location of the tourmaline in the lung showed deposits around the walls of 
small bronchioles; some of these appeared to be in the lamina propria, 
within 40 pm of the ciliated epithelium, but most would be described as 
peribronchiolar and were further away from the epithelium (5). 
A similar study of control lung tissue, obtained from subjects who 
had not been occupationally exposed to rock dust, showed no detectable 
boron by this technique. 
(b) Clearance from rat lung of inhaled tourmaline particles. Examination 
of the neutron-activated tourmaline by X-ray diffraction showed that it 
had retained its crystalline structure, although the diffraction peaks 
were slightly broadened. 
The mass median aerodynamic diameter (MMAD) of the aerosol was 3.3 
~m. and the geometric standard deviation (G$0) 2.0. The mean lung burden 
at 3 days was 24 pg (4). 
Over the period 3-90 days the lung retention data could be fitted by· 
-2 -1 
a single exponential term with a slope (A) = 1.50 x 10 days , which was 
useful for comparison purposes. For Pu0 2 , mixed Pu and U oxides, and 
Fe 203 , data obtained elsewhere over the same period could be fitted by 
-2 -1 
single exponentials with A = 1.22-1.65 x 10 days 
The 54Mn content of the rat liver measured at 7-90 days was used to 
estimate the rate of dissolution or leaching of the radionuclide from the 
-2 -1 
particles. An upper estimate for this was 0.36 x 10 days , indicating 
that tourmaline is indeed highly insoluble in the lung; the true rate of 
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"mechanical" clearance of tourmaline particles from the lung would then be 
-2 -1 
between 1.14 and 1.50 x 10 days In any case, this was not signific-
antly different from the values for the other aerosols quoted above (4). 
(c) U0 2 distribution in rat lung. The U0 2 aerosol generated for this 
study had a MMAD of 2.7-3.2 and a GSD of 1.7. The mean initial lung 
burden was 270 pg. The analysis of the mass of U0 2 in the different 
organs confirmed the highly insoluble nature of this aerosol: 81% of the 
body burden was in the lungs after 720 days. 10% was in the thoracic 
lymph nodes, 0.8% in the kidneys and 3.9% in the skeleton. The average 
tissue concentration in the lungs fell from 173 pg g-1 after 5-11 days to 
21 pg g-1 after 630 days, but the concentration in the lymph nodes reached 
less than 11 pg g- 1 (6). 
The lung content after 720 days represented 17% of the initial lung 
burden at 5 days. Interestingly the clearance curve over the whole period 
could be adequately described by a single exponential term, where the rate 
-2 -1 
constant A= 0.32 x 10 days (half-time= 219 days). By 720 days the 
accumulated mean lung alpha dose was estimated to be 5.7 Gy. By 540 days, 
when the dose was 5.2 Gy, very little fibrosis or other pathological 
effects were seen in the lung sections. After 720 days, however, 
fibrosis, metaplasia and some tumours were found (6). 
All the autoradiographs of the lung sections have been prepared, and 
the analysis of the U02 distribution is nearing completion. Each deposit 
of U0 2 identified under the microscope has been allocated to one of the 
following categories: alveoli, alveoli within 100 pm of an airway, 
pleural/subpleural, perivascular, airway, airway bifurcation, malignant 
diseased tissue, non-malignant diseased tissue. 
(d) Cellular effects of inhaled U0 2 . The mean lung burden 6 days after 
inhalation was 140 pg U0 2 , giving a mean lung alpha dose to sacrifice at 8 
days of 0.01 Gy. The U0 2 significantly increased the size of alveolar 
macrophages and also that of type II epithelial cells; the number of 
macrophages and of type I cells were increased. The lysosomal granules in 
the macrophages were also increased in size. Exposure to neutrons and to 
fission fragments had no significant effect on any of the cells studied 
beyond those observed in animals exposed to U0 2 alone (3). 
-1~1-
3. Discussion 
(a) Particle distribution in human lung. Work done on the limited number 
of specimens made available showed that it was possible to locate deposits 
of boron-containing mineral dust such as tourmaline. Their distribution 
in the lung could be ascertained with reference to the lung tissue image, 
and the mass of each deposit could be assessed by track counting. 
Thus tourmaline could be a useful material for assessing the long-
term spatial distribution of particles in man, since a population exists 
which inhales sufficient quantities to be detectable by the techniques 
described here. At the same time these lungs could be obtained free of 
overt lung disease, e.g. silicosis. Morever, tourmaline is a very 
insoluble material. It may therefore serve as model for describing the 
long-term spatial distribution of accidentally inhaled insoluble particles 
of actinide compounds such as Pu0 2 (see also (b) below). This would 
permit an assessment to be made of the accumulated alpha dose from inhaled 
actinides to cells at risk from lung cancer induction, e.g. cells in the 
epithelium of the conducting airways. It should be noted that examination 
of accident cases themselves, e.g. involving Pu0 2 inhalation, would be 
unlikely to give sufficient information because too few particles would be 
detectable in histological sections and determination of their spatial 
distribution would be impractical. 
No more specimens of tin miners' lung became available during this 
study. It was concluded that the data available did not permit a proper 
analysis of the spatial distribution of such particles, as more specimens 
would have been required. Nevertheless, it was shown that tourmaline 
particles can be retained in human lung such that a proportion of them are 
within 40 pm of the epithelium of the conducting airways (5). This means 
that, if tourmaline is a good model for inhaled alpha-emitting particul-
ates such as Pu0 2 , then alpha-irradiation of target cells in the epithel-
ium in human lung is possible from particles retained long-term. 
(b) Clearance from rat lung of inhaled tourmaline particles. Tourmaline 
clearance could not be measured by its boron content, since there was more 
boron in control rat lungs than the amount deposited as tourmaline. For 
this reason neutron-activated tourmaline was prepared as described above. 
The tourmaline particles were cleared from rat lung at a similar rate 
to Pu0 2 and mixed Pu and U oxides, where these actinides had been admin-
istered at low levels such that the alpha-irradiation of the lung would 
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not impair clearance. The rate was also similar to that for Fe 203 , which 
is non-toxic in the lung. Therefore it can be concluded that, as regards 
the rate of clearance from the lung, tourmaline is a good model for 
actinides of interest in practical radiological protection, and indeed for 
other less toxic aerosols. In so far as the period 3-90 days after the 
inhalation of rather insoluble particles represents a phase of clearance 
that is dominated by the action of alveolar macrophages, it can be assumed 
that tourmaline at the levels employed here does not impair macrophage 
function (4). 
This by itself does not prove that the spatial distribution of 
tourmaline in human lung will correspond exactly to that of the insoluble 
actinides retained long-term, but it does support the use of tourmaline in 
distribution studies. 
(c) U0 2 distribution in rat lung. This study was a continuation of 
previous work which described the uo2 distribution 2-30 days after 
inhalation. Analysis of the distribution of the same type of particle is 
now being completed up to 2 years after inhalation, which will indicate 
the relative doses from long-term retention to the different regions of 
lung, e.g. the conducting airways, vascular tissue, the pleura, etc. 
This study has been made possible by the associated development of 
techniques for NIAR and image analysis of the autoradiographs. The use of 
boronated t1ssue to provide an image on the CR-39 top slide proved to be 
better than could be achieved with non-boronated sections, and at lower 
neutron fluxes. The chief advantage over the previous method of imaging 
the lung onto the bottom CR-39 slide is that the section itself is not 
lost by the etching procedure, and so is available for histological 
examination. 
(d) Cellular effects of inhaled U0 2 . The U0 2 particles used in these 
studies clearly produced early as well as late effects on the lung. The 
effects on alveolar macrophages seen at 8 days after inhalation may have 
been associated with the slower rate of clearance of these particles. as 
compared with e.g. low levels of inhaled Pu0 2 . The inhibition of clear-
ance may have been due to a combination of chemical toxicity, alpha dose, 
and the moderately high initial lung burden of the aerosol (3). 
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I. Objectives of the project: 
The genome of some B-ecotropic recombinant retrovirus 
which emerge during the process of radiation-induced 
leukemogenesis of the C57BL/6 mouse may be suspected to act 
as the causative factor or as a cofactor in this process. 
To test for this hypothesis we looked for new retroviral 
integration sites in the DNA of primary and transplanted 
turners. Thirty per cent such turners were found to harbor a 
limited number of new retrovirus insertions. The role of 
these viruses was evaluated by analyzing the cell 
populations present in primary and corresponding in vivo 
propagated turners and by investigating their pathologic 
potential. 
11. Objectives for the reporting period: 
To investigate the leukemogenic potential of new 
ecotropic recombinant proviruses encountered in radio-
induced thymic lymphomas of the C57BL/6 mice. To correlate 
biological properties of such viruses with their genomic 
organization. 
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Ill. Progress ach1eved: 
1.- Methodology 
The new ecotropic provirus encountered in a radio-
induced thymic lymphoma of the C57BL/6 mouse was 
molecularly cloned. The env and LTR regions were sequenced 
and compared to other prototype retroviruses. The viral DNA 
was used to transfect murine cells in order to evaluated 
its ability to replicate and to assess its leukemogenic 
potential. 
2.- Results and discussion 
We previously reported that new ecotropic recombinant 
proviral sequences were found to be clonally integrated in 
a significant number ( 30 %) of primary or transplanted 
radio-induced turners of the C57BL/6 mouse. Such proviral 
sequences were already detected in in vivo or in vitro 
propagated radio-induced thymoma cells ( Jolicoeur et al., 
1983) but none of the viral isolates derived from these 
cells was found to be highly leukemogenic. We wondered 
whether in our turners one could detect ecotropic proviral 
sequences markedly different of the endogenous ecotropic 
one and eventually associated with the outgrowth of the 
turner. For this we screened 31 primary or transplanted (few 
passaged) radio-induced lymphomas for the presence of new 
ecotropic proviruses with either an anormally long LTR or 
with a specific integration site. Noteworthingly, such a 
proviral sequence was found but in only one turner. The 
provirus with an anormally long LTR was inserted in the 
chromosomal DNA within the PVT-1/MLVi-1/Mis-1 region which 
is a common integration site for MCF virus in mice and for 
Mo-MuLV in rats. This new ecotropic provirus was then 
molecularly cloned and found to be infectious and competent 
for replication after transfection of murine cells. The 
recovered virus termed T3651/B was shown to be B-ecotropic 
and of xc+ phenotype. T3651/B virus is T-lymphotropic (in 
vivo) and highly leukemogenic for newborn C57BL/6 mice. It 
is also highly leukemogenic for adult animals provided they 
are submitted to a subleukemogenic dose of irradiation. Our 
results indicate that although all CD4/CD8 cell populations 
of the newborn are potential targets for the neoplastic 
transformation by T3651/B virus, such cell populations in 
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the unirradiated adult animals are resistant. In contrast, 
the co4+;co8+ populations of the irradiated adult mice are 
the preferential target for neoplastic transformation. 
These observations are in accordance with the hypothesis 
proposed several times, of a radioresistant T-cell 
subpopulation( s) raised by irradiation and becoming the 
target(s) for radio-induced retroviruses. Although we 
cannot say that T3651/B virus emergence was the primary 
event leading to tumorigenesis because it was isolated at 
the 4th in vivo passage of 3651 turner cells, it remains 
that it is a new thymotropic highly leukemogenic virus with 
the ability to induce thymic lymphomas as irradiation does. 
Rassart et al. (1986) investigated the molecular 
events leading to the emergence of RadLVs starting from the 
parental endogenous ecotropic non leukemogenic C57BL 
provirus and ending to the passaged highly leukemogenic 
RadLV-VL3. In their model, they proposed that after 
irradiation, the first variants which appear are 
fibrotropic non leukemogenic B tropic MuLVs which arise via 
a gag-pol recombination between endogenous ecotropic and 
xenotropic proviruses. In a second step, few modifications 
(base substitutions) arising in the LTR and the appearance 
of a C rich sequence just in front of the "TATA" box confer 
to the B-tropic fibrotropic virus a weak leukemogenic 
potential. Next, the thymotropism and a higher leukemogenic 
potential are acquired by additional base changes within 
env and U3 LTR and more importantly by a 43 bp direct 
repeat within U3. 
The two viruses 
investigation (T1223/B 
elements which could be 
cloned and sequenced in our 
and T3651/B) are interesting 
situated · in the upper model. The 
weakly leukemogenic B-ecotropic T1223/B isolated from the 
RadLV/Rs complex was shown to have a xenotropic-like gag-
pal region and to have base changes within env and U3. In 
contrast to the B-tropic weakly leukemogenic primary RadLVs 
isolated by Rassart et al., T1223/B virus LTR does not 
harbor any C rich sequence upstream of the "TATA" box ; 
however, this virus has a base substitution in U3 enhancer 
inducing the appearance of a consensus sequence for the 
nuclear factor SEF1, a protein highly expressed in T 
lymphocytes which binds to the SL3-3 virus enhancer. 
Therefore the T1223/B virus enters in the same class as the 
primary weakly leukemogenic RadLVs Ti. 8 and Ti. 9 of the 
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model. Although, the nature of the env and LTR 
modifications which may be associated to a weak 
leukemogenic potential is unclear, it is interesting to 
remark that two different LTR alterations may lead to such 
a property. 
With respect to its leukemogenic potential, the 
T3651/B virus compares well with the cloned RadLVs isolated 
by Jolicoeur et al. ( 1986) and Merregaert et al. ( 1987) 
from the Kaplan' s strain of RadLV, BL/VL3. Both types of 
viruses have important modifications in the U3 region of 
their LTRs consisting in long tandem direct repeats of 
enhancer sequences. However, these repeats differ between 
T3651/B and the clones isolated from the RadLV/VL3 by the 
lenght and the number of repeats as well as by the nature 
and number of sequence motifs specifically recognized by 
nuclear factors. Indeed T3651/B LTR displays 5 tandem 
repeats. The 3 formers are perfect repeats of a 64 bp 
strecht of an endogenous U3 proviral sequence (from 
nucleotide 136 to nucleotide 199) while the fourth has only 
the last forty bases (159-199) and the fifth has one 
substitution (G ---> A position 426) and a deletion of the 
last base pair (position 430). Besides, if one considers 
the inference of substitutions and/or repetitions on the 
appearance of consensus sequences for nuclear factors, the 
T3651/B virus LTR has 4 LVb, 4 SEFl, 5 NFl-like and 4 LVa 
consensus sequences. 
It seemed important to compare this LTR structure of 
T3651/B virus to those of other thymotropic highly 
leukemogenic MuLV. The figure is a schematic representation 
of the respective configurations of U3 sequences including 
the direct repeats of T3651/B, C57BL/Ka endogenous 
provirus, RadLV/VL3, Mo-MuLV and SL3-3. Interestingly the 4 
leukemogenic viruses have common features. Indeed, in 
contrast to the C57BL endogenous ecotropic provirus, they 
harbor direct repeats of the same U3 region containing 
enhancer sequences with specific binding motifs for nuclear 
factors. The presence of several consensus sequences for 
nuclear binding factors and their repetitions in the LTR of 
these viruses allow to speculate that they are the major 
regulatory elements which lead to T-cell specific 
expression and leukemogenicity. This is supported in 
particular by the data brought by Thornell et al. ( 1988) 
who showed that the nuclear factor SEFl is predominantly 
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expressed in T-cell lineages and could be an essential 
factor for the T-cell tropism of SL3-3 MuLV and the ability 
of this virus to cause T-cell lymphomas. This could also 
apply to T3651/B virus which displays repetitions of the 
same consensus sequence for the SEFl factor. Although 
RadLV/VL3 has a less complex U3 general organization, it is 
noteworthy that it has numerous mutations along the LTR and 
particularly a C-rich sequence containing a 6 bp direct 
repeat located in U3 .just in front of the promotor "TATA" 
box. Such modifications can also be implicated in the 
thymoma induction ability of this virus. 
Finally, two thymotropic highly leukemogenic 
retroviruses, namely RadLV/VL3 and T3651/B, have been 
isolated after the irradiation of C57BL mice. Both induce 
thymic lymphomas, originate from endogenous retroviral 
sequences and have LTRs with repeats of enhancer sequences. 
However, these LTRs differ by the number and nature of the 
specific nuclear factors which can bind to them. It is thus 
possible that the mechanism implied in cell neoplastic 
transformation are not strictly identical for the two 
viruses. 
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Title of the project no.: 1 
Radiation-induced oncogenesis under different exposure conditions 
Head(s) of project: 
W. Gossner 
Scientific staff: 
W. A. Muller, U. Unzner, A. Luz, A. B. Murray, E. Schaffer 
I. Objectives of the project: 
The aim of this project is to study the modification of dose dependence in 
radiation-induced oncogenesis paying particular attention to the effects of 
different qualities of radiation, radiation dose rates and time patterns, injection 
mode, and age dependence. In addition the combined application of two 
different a-emitting radionuclides has been studied. 
11. Objectives for the reporting period: 
a) The influence of an irradiation free interval during internal irradiation of bone 
by short-lived bone-seeking radionuclides. 
b) The effect of dose protraction with a very low 224Ra activity in mice. 
c) Conditions of local osteosarcoma induction and distribution and dosimetric 
studies with the local applied radiothoriumcolloids 227Th, 228Th. 
d) The influence of age at incorporation of short-lived bone-seeking 
radionuclides. 
e) Combination eltperiments with simultaneous incorporation of two different 
radionuclides. 
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Ill. Progress achieved: 
1. Methodology 
In experiments investigating systemic effects the radionuclides were injected 
intraperitoneally as isotonic solutions. 
Female NMRI/Nhg mice from the GSF breeding colony were used. 
During the long-term experiment mice were checked on 5 days of the week. 
A complete autopsy was performed on all animals found dead or killed with 
obvious neoplasia or in moribund state. Macroscopic diagnoses were 
confirmed by histology. 
Osteosarcoma incidence was corrected for competing risks according to 
Miescher et al. (Schweiz. Med. Wschr. 71:1002-1007, 1941). 
2. Results 
a) The influence of an irradiation free interval. Comparison of short-lived 
q- and 6-emjtters. 
In order to study special time patterns 37 kBq/kg of the short-lived (half-life 
18.7 days) a-emitter 227Thorium were incorporated twice: At age of 3 and 12 
months or 12 and 14 months (Fig. 1 a). The earlier incorporation of one half of 
the activity in the first group induced a shortening of the latency time as com-
pared to the second experimental group. This means that the activity incor-
porated at 3 months of age was additive to the activity incorporated at 
12 months despite the irradiation free interval. 
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2x37 kBQ (1 fJCl) /kg Thorwm (<~-) 
at age of BO 
. 3 and 12 months ~: 
60 •12 and 14 months 
. 
40 : 
. 
20 . 
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1000 
1000 
Fig. 1 a+ b 
Corrected osteosarcoma 
incidence after fractionated 
internal irradiation . 
Female NMRI-mice. 
Incorporation schedule 
indicated within diagrams. 
a) internal a-irradiation by 
incorporation of 227Thorium 
b) internal ~-irradiation by 
incorporation of 177Lutetium 
A corresponding experiment with the short-lived (half-life 6.7 days) p-·emitter 
1nLutetium showed a contrasting result (Fig. 1b). 12 weekly incorporations of 
8 MBqlkg were applied continuously during 40 to 51 weeks of age or in 
portions (of 6 injections) at age 12-17 weeks and 40-45 weeks. In both groups 
cases with osteosarcoma occurred at the same age. This means that the first 
injection series during weeks 12-171ost some part of its effectiveness during the 
irradiation free interval. 
b) Dose protraction with a very low 224Ba actjyjty 
Two groups of approximately 300 4-week-old female NMBI-mice were used in 
the experiment. One gro~o~p received a singl~ injection pf 18.5 kBq/kg.224Ba~. 
body weight, corresponding to a mean skeletal a-dose of 0.15 Gy. The other 
group received the same total amount of 224Ba in the form of 72 fractions of'· 
257 Bqlkg each, app~ed twice weekly over a· period of 36 weeks. This scheme 
resulted in a mean skeletal dose rate of about 1 mGy/day, and the same final 
mean total skeletal dose of 0.15 Gy (s. also Table I). The unexpected result 
observed in this experiment was the early induction of malignant lymphoma in 
the protracted group. Figure 2 shows the situation up to the end of the ex-
periment, corrected for competing risks. The final number (percentage) of 
lymphomas was nearly equal for all experimental groups, but the time-course 
was different: In the protracted group a relatively greater number of lymphomas 
occurred very early, starting during the injection period and stopping shortly 
after the injections ceased. In contrast, in the second half of life lymphoma 
incidence showed a comparable slope to that in the other groups. Only the 
protracted irradiation group showed a considerable number of lymphomas in 
the first year of life. 
The single injection group showed a later onset of lymphomas than the controls 
in spite of the fact that there were three times more animals in this group than in 
controls. 
~ 100r-----------------------------------~ 
m 
ID 
u 
:!! 80 
0 
.s:::: 
~ 
>- 60 
.... 
c: 
~ 40 
c.. 
IU 
a. 
20 
A = One single injection of 18.5 k8Q/kg 
8 = 72 X 257 8Q/kg 
C = Untreated controls 
Days after start of treatment 
Fig. 2 Incidence of lymphomas after single and protracted injections 
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.IIbli..1 Dosimetry data and induction of osteosarcomas 
after i.p. injection of 224Ra 
Group Treatment Total Skeletal Osteosarcomas 
whole Ilia 
A S~ngle 
mjection 
18.5 kBqlkg 
skeletal dose dose rate 
Gy mGy/d 
0 15 60.00 a) 
% (casasltotal 
number of animals 
58% (17/295) 
B Protracted 
c 
IOJ&CtiORS 
72x257 Bq/kg 
Untreated 
controls 
015 1 13 b) 70% (211299) 
30% (3/99) 
a) mmumum dose rate shortly after mJect•on b) mean dose rate dunng enj8Ct1on span 
The histopathology showed that in the first period up to about day 300 all 
lymphomas were of the lymphoblastic type, whereas after this period mixed 
types of lymphomas were also observed in all three experimental groups 
(Muller, Linzner & Luz, 1988). 
After day 600 all three groups showed a very similar induction of lymphomas 
reaching an absolute percentage between 40 and 50 % (see Fig. 2). 
The cumulative incidence of osteosarcoma induction is shown in Fig. 3. 
There was a similar increase in the single and protracted group up to day 800. 
After this period osteosarcomas were observed only in the protracted group with 
seven cases out of 21 animals surviving beyond day 800. The percentages in 
Fig. 3 are corrected for competings risks as in Fig. 2, and were stopped when 
the number of surviving animals was less than ten in order to avoid an exagger-
ated evaluation of the last osteosarcoma cases. The total numbers of osteo-
sarcomas and absolute percentages are given in Table I together with the 
dosimetric data. There was no statistically significant difference in the unadjusted 
total percentages of osteosarcomas in the two treated groups. 
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Fig. 3 Incidence of osteosarcomas after single and protracted injections 
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c) Local osteosarcomas 
Former experiments have shown that 144Cerium radiocolloid can induce a 
high yield of local osteosarcomas in Sprague-Dawley rats after parosteal 
administration. Experiments with NMRI-mice with one fifth of the 144Ce activity of 
the rat experiment showed analogous results with high local osteosarcoma rates. 
Experiments with shorter-lived p-emitting radiocolloids did not induce local 
osteosarcoma, not even with multiple injections. 
In experiments with radiothoriumcolloids it could be shown that 95 % of the 
thorium isotopes stayed at the injection site whereas the radium daughters were 
distributed throughout the skeleton in a similar way as after i.p. injected radium 
(s. Fig. 4). 
The first results of the pilot studies showed a high systemic (anywhere in the 
skeleton outside of the injection site) incidence of osteosarcomas, i.e. ea. 50% 
for 9 kBq 227Th per mouse or 3 kBq 228Th per mouse, and a few local osteo-
sarcomas in the low dose groups (3 kBq 227Th per mouse and 1 kBq 228Th per 
mouse). 
Bq/g organ per Bq/animal 
10 1+-----~------~----~~-----L------t 
Th 2.28 at the InJectiOn site 
10°j+ __ ._ ____ -4~---------.----------~ 
-1 
10 
-2 
10 
Ra 224 in the skeleton 
................. ----------·--------------------------.. --------------------
' 10-3+--------r--------,--------,,-------r------:!" 
0 50 100 150 200 250 
1ncorporat ion period [days] 
Fig. 4 Specific activity after paratibial injection of 3.1 kBq/kg 228Th 
in colloidal form into NMRI-mice. 
d) lncor:poration of 227Jhorium at different age 
37 kBqlkg 227Th (corresponding to 200 cGy mean skeletal dose) were incor-
porated at age of 1 month or 12 months or 18 months (Fig. 5). Mice with osteo-
sarcomas appeared in the same age range and during the age range of 
spontaneous osteosarcomas observed in many control experiments. This means 
that the latency time of the radiation-induced osteosarcoma becomes shorter with 
incorporation at older age. The corrected osteosarcoma incidence (calculated as 
long as a minimum of 1 0 animals were surviving) was similar for the three age 
groups: 32% (1 month), 43% (12 months), 36 % (18 months). 
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After incorporation of 185 kBq/kg the corrected osteosarcoma incidence 
was lower in the older age groups: The values were 61 % (1 month), 
10 % (12 months), 15% (18 months). Only in the group with incorporation 
at 12 months was an earlier occurrence of all non-bone tumours observed 
(data not shown). 
:1: corr 
99.9+-~~--~~--~~~--~~~~~~ 
99 
95 
90 
Incorporation of 37 kBq (I pC1l /kg Th 227 
at age of 
• IB months 
I 
• 12 months <-- N<IO 
70 • 1 month \ I •• <-
50 +-'--' ---------"-----..!.--------:- ~~-----+ 
30 I I I --> •• I'.· . 
. :,· : 
~---------'----c---'-----,-1--'"'-" ~:c.__ ___ -+ 1 ~ 1 l • • 1 ! • . spontaneous 
,._.~· --------+ 
...• 
·' 0.1~-----~~~~~~-~~--r-.-~ 
0 200 400 600 BOO 1000 1200 
Age (days) 
Fig. 5 Corrected osteosarcoma incidence after incorporation of 227Thorium 
(corresponding to a mean skeletal dose of 200 cGy) at different age. 
Comparison with the occurrence of spontaneous osteosarcoma in 
1710 untreated controls (female NMRI-mice). 
e) Combination experiments 
The aim was, to find possible additive or synergistic effects. In this connection 
the effect of injection of 1.85 kBq/kg of the long-lived radionuctide 227 Ac on the 
induction of osteosarcomas in female NMRI-mice by different dose levels 
(18.5, 7 4, and 185 kBqlkg) of the short-lived radio nuclide 227Th was investigated. 
Table 11 shows data and results from the experiment with young animals. 
Tabl~ n Activities, doses, and final tumour incidences 
in the young (4-week-old) animal groups 
Bone Sarcous 
Groups ..,c:Hdes k:thtty No. of ste 1 eta 1 Dose Bone Sarccnas 'I corrected 
(kBq/kg) aniMls (Ill) 'I unadjusted for c011pettng rfslcs• 
Controls 50 
Z27k: 1.85 50 1.2 12 18.1 
227111 185 50 10.0 54 60.8 
AT 227k.+227'RI 1.85 + 185 50 11.2 68 64.8 
* value for ten sui"Vhing antuls 
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The percentage of osteosarcoma.t>earing animals after combined treatment -
was approximately additive, i.e., about the same as the sum of the values. in 
the groups with 227Th or 227 Ac alone. The P ·Values of log-rank· tests indicated 
significant or highly significant differences in times of tumour appearance 
between all four experimental groups. 
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Fig. 6 Incidence of osteosarcomas in 4-week-old mice 
(single and combined treatments) 
The cumulative incidence of osteosarcomas in the three groups is shown in 
Figure 6. Addition of 227Ac resulted in an earlier occurrence of tumours marked 
by a surprisingly steep increase in osteosarcoma incidence in the period 
300-400 days. This was much earlier than the occurrence of osteosarcomas in 
the 227 Ac alone group which was more than 600 days after injection 
(ContrOls= 0). Osteosarcoma incidence did not start to increase in the 227Th 
group until after 400 days after injection, so that for the first 600 days addition of 
227 Ac resulted in a marked increase in osteosarcoma incidence, although the 
final cumulative incidence in the combined and 227Th alone groups was about 
the same. A second series of combination experiments was performed using 
different levels of the radionuclides as shown in detail in Table Ill and Fig. 7. 
Table 111 Activities, doses, and final tumour incidences in the adult animal groups 
Age of mice: 10 weeks at 227 Ac-injection; 12 weeks at 227Th-injection 
--
~a~. of 
-
IU:11dn :~~ SU1tt11DDM 
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"'" 
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m,. 100 ..• 
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In the group administered 1.85 kBq/kg 227Ac and 18.5 kBq/kg 227Th, the time 
to appearance of osteosarcomas was significantly shorter (P < 0.0260 using 
the log-rank test) than in the thorium-alone group (Fig. 7). There was a higher 
rate of tumour appearance between 700 and 800 days in the combined group 
than in the other two groups added together (Fig. 7). Interestingly, the time of 
appearances in the thorium-alone group showed a bimodal distribution: before 
650 days and after 750 days. The addition of 1.85 kBq/kg 227 Ac, which adds a 
dose of about 1.2 Gy, to the dose of 4 Gy from 74 kBq/kg 227Th had no effect 
on either the corrected cumulative tumour incidence, the unadjusted incidence 
(Table Ill), or the tumour appearance time. In the group administered 185 kBq/kg 
227Th, the addition of 1.85 kBq/kg 227 Ac resulted in a slightly steeper but not 
significant increase in osteosarcoma incidence in the second half of the ex-
posure period, but there was no effect on the final corrected cumulative osteo-
sarcoma incidence or the unadjusted incidence (Table Ill). 
Ul 100 
"' e 
• C=Controls 0 
u 
. A=1.85 kBq/kg Ac227 c... 
"' 
80 . Ul . T1=18.5 Th227 0 
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Fig. 7 Incidence of osteosarcomas in 10-12-week-old mice 
(single and combined treatments) 
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Discussion 
a) The long-term experiments with fractionated internal irradiation demonstrate 
that the bone tumour inducing effect of the ~-emitter 177Lutetium can be partly 
abolished during an irradiation free interval. This kind of repair was not ob-
served with the short-lived a-emitter 227Thorium. 
b) The most surprising result in the dose protraction experiment was the obser-
vation that protracted a-radiation at low dose levels apparently activates a 
different target tissue for radiation oncogenesis. Both the results reported here 
and those from Humphreys, Loutit, Papworth, Stones quoted in Muller et al. 1988 
and 1989 show that the extrapolation of radiogenic effects towards very low 
doses is not only complicated with respect to the mathematical form of the dose 
response of a special effect (such as linear, supralinear, linear-quadratic, 
threshold, etc.) it also seems impossible to predict with certainty the spectrum of 
tumours induced. 
c) The most probable explanation for the osteosarcomogenic effect of 144Cerium by 
local application is that the high jl-energy (Emax = 3 MeV) of 144Praseodym, the 
decay product of 144Ce, might be responsible for the local osteosarcoma induc-
tion. The local injection method of radiocolloids of thorium applied seems to be 
suited for radium protraction experiments, in place of repeated injection with 
short-lived 224Radium, in long-term experiments with very low doses. 
d) At a mean skeletal a-irradiation dose of 200 cGy, mice of older age (12 months, 
18 months) are more susceptible to radiation-induced osteosarcoma than 
weanlings. At a higher level of internal irradiation dose older mice are less 
sensitive for radiation-induced osteosarcoma but may sometimes develop 
non-bone tumours earlier. 
e) The results of the combination experiments show that the combined incor-
poration of two a-emitting radionuclides at the levels of radioactivity studied 
has a lower biological effect than the sum of the effects of the components 
administered singly. However, the effect of adding a low level of a long-lived 
component to a higher level of a short-lived component is variable and de-
pends on the level of the short-lived component. Analogous results were also 
obtained in another combination experiment using two different doses of 
224Ra (18.5 kBq/kg and 185 kBqlkg) together with 1.85 kBqlkg 227 Ac, whereby 
only the combination with the lower 224Ra-dose showed a significant effect of 
the 227 Ac admixture. The less-than-additive effect observed is in good agree-
ment with experiments dealing with incorporation of a mixture of jl-emitters, in 
which the effects are also less-than-additive (Monakhov, Shvedov quoted in 
Muller et al. 1990). Thus our results show that the recommendation of the ICRP, 
which is known to be conservative for jl-emitters, is also conservative in the 
case of a-emitters, at least at the levels of radioactivity studied. 
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Pathogenesis of radiation-induced cancer 
Head(s) of project: 
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Scientific staff: 
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I. Objectives of the project: 
The evaluation of the molecular mechanisms responsible for radiation 
carcinogenesis. 
Investigations of exogenous factors which might modify the development 
and progression of radiation-induced tumours. 
11. Objectives for the reporting period: 
The activation of provial genes and their interaction with cellular oncogenes in 
radiation carcinogenesis was studied by two approaches. 
First, the activation of endogenous retroviruses during the early latent period of 
radiation-induced osteosarcomagenesis as well as in the induced tumours, and 
the pathogenicity of various virus isolates was studied in different mouse strains. 
Radiation-induced osteosarcomas were investigated for retrovirus and 
protooncogene rearrangement and amplification. 
Second, cell and tissue culture models were applied to establish the molecular 
and morphological events during normal osteogenic differentiation and to 
characterize retrovirus- and oncogen-induced effects on skeletal cells in vitro. 
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Ill. Progress achieved: 
Radiation activation of endogenous retroviruses 
Female C57BI/6 and BALB/c mice were injected with 0.06 1J.Ci/kg or 0.5 1J.Ci/kg of 
the short-lived alpha-emitting radionuclide 224Radium at 3-day intervals for two to 
four weeks. The continuation of this irradiation schedule results in 10% and 95% 
osteosarcomas, respectively. Infectious N-ecotropic XC+, and xenotropic C-type 
retroviruses were activated in bone marrow, spleen and bone tissue in both 
strains. Between 2 and 4 weeks after start of irradiation the number of C57BU6 
mice expressing infectious virus particles increased to 100%. Also the level of 
activated virus was up to 1 00-fold higher in high-dose irradiated than in low-dose 
irradiated mice. In BALB/c mice the levels of activated virus were within a smaller 
range and fewer animals responded to irradiation by virus expression. 
Virus antigen concentration in the sera of irradiated and control mice were around 
background levels indicating the absence of viraemia at the time of investigation. 
In contrast, all animals showed antiviral antibodies whereby the titers in irradiated 
mice were higher than in controls. Taken together, these data indicate a dose-
dependent activation of infectious endogenous retroviruses (OL MuLV) in the early 
latent period of radiation-induced osteosarcomas. High antivirus antibody titers 
were associated with the presence of retrovirus-specific immune complexes in the 
irradiated mice, which would explain the lack of free antigen in the sera of 
irradiated mice. 
Retroviruses in neoplastic and normal bone tissue 
Infectious C-type retroviruses were readily isolated from 227Th or 224Ra-induced 
osteosarcomas and from cell lines established from these tumours (OS MuLV). In 
the osteosarcomas of NMRI mice we found elevated concentrations of retroviral 
proteins with up to 1 000-fold higher levels than in normal bone tissue. In parallel 
with these experiments we isolated C-type retroviruses from spontaneously 
developing benign bone tumours (OA MuLV) as well as from bone tissue of non-
irradiated young adult mice (OL MuLV). From these findings we conclude, that 
spontaneous activation and expression of endogenous retroviruses is a common 
event in bone and hematopoietic tissues of different mouse strains. The process of 
virus activation is significantly enhanced in a dose-dependent manner by internal 
alpha irradiation and maintained until tumour development. Particularly high 
levels of viral antigens and infectious retrovirus particles were found in the 
irradiation-induced osteosarcomas. 
Amplification and rearrangements of endogenous retroviruses and proto-
oncogenes in radiation-induced osteosarcomas 
BALB/c mice harbour a single copy of an endogenous ecotropic retrovirus in their 
genome. We have investigated the fate of this provirus in radiation-induced 
osteosarcomas by molecular studies of the genome of the tumours. 
Extraction of DNA from small-sized primary tumours does not yield sufficient 
amounts for molecular analysis. We have therefore expanded primary tumour 
material by transplantation into syngeneic mice. DNA was extracted from these 
first generation transplants for further analysis. In 17 out of 29 osteosarcomas, we 
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found one or more newly acquired ecotropic proviruses in the genome of the 
tumours, and expression of viral RNA. This was in contrast to the lack of integration 
events in 19 clonal cell lines which were established from bone marrow cells of an 
irradiated, tumour-bearing mouse. Therefore, reintegration of ecotropic proviruses 
is a rare event in irradiated non-tumour cells, where 60% of the tumours had 
additional, newly acquired proviruses. New retroviral integrations with similar 
patterns were observed in several first generation transplants derived from the 
same primary tumours. From these observations we conclude, that radiation-
induced osteosarcomas develop by clonal expansion of subpopulations of distinct 
tumour cells, and that the integration events must have occurred before 
transplantation. 
Cellular regions flanking new proviral integration sites were molecularly cloned. 
Southern-blot analysis using these sequences did not detect rearrangements in 
any of the other tumours except in those from which they were derived. Although 
integration of proviruses into specific cellular regions could not be documented, 
the activation of ecotropic proviruses in the majority of the tumours suggest a role 
of these endogenous retroviruses in radiation-induced osteosarcomagenesis. 
Osteogenic tumours were analysed for structure and expression of cellular 
oncogenes. Whereas no alterations of the gene structure were found in the 
regions of the genes for c-fos, c-mos or n-myc, 9 out of 30 tumours of BALB/c mice, 
and 3 out of 23 tumours of NMRI mice showed amplification of c-myc sequences. 
A region of common proviral integration in virus-induced T-celllymphomas, Mlvi-1, 
localized on the same region on chromosome 15, was amplified concomittantly. In 
some tumours c-myc was amplified up to 40-fold. In one tumour the amplified c-
myc and Mlvi-1 sequences were localized on double minutes as shown by in situ 
hybridization. Three tumours with c-myc amplification also showed 
rearrangements of the c-myc gene region. One of these rearrangements included 
the 5' and 3' flanking sequences and the noncoding part of the third exon. We 
found repetitive sequences in the 5' region of the c-myc gene, and the 3' flanking 
region was substituted by sequences normally present in a more distant part of 
chromosome 15. Increased levels of c-myc transcripts of apparently normal size 
were found in tumours carrying amplified c-myc sequences. Expression of c-myc 
was highest in the tumours harbouring approx. 40 copies of this oncogene. In 
these tumours the abnormally high level of steady state c-myc RNA correlated with 
an early stage of osteogenic differentiation, suggesting that the c-myc gene may 
be involved in the control of the osteogenic differentiation of neoplastic skeletal 
cells. 
Molecular characterization of radiation-activated retroviruses 
Molecular cloning of osteosarcoma and osteoma-derived viruses and 
comparisons with the RFB virus and Akv, the germ line-derived retrovirus of AKA 
mice, revealed close similarities as shown by fingerprint analysis and restriction 
enzyme mapping, but also distinct differences, such as rearrangements and point 
mutations in the enhancer-consensus region of their 3' LTR sequences. The 
transcriptional activity of these sequences differed also considerably as shown by 
chloramphenicol-acetyl-transferase (CAT) assays in osteogenic cells and 
fibroblast cell lines. These alterations may account for differences in the specificity 
of the interactions of these sequences with binding proteins, in cell-specific 
transcriptional activity and protein expression, and finally in the induction of 
aberrant differentiation processes of skeletal cells. 
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Pathogenicity of bone tissue-derived retroviruses 
The retroviruses isolated from normal and neoplastic bone tissue represent 
replication competent murine leukemia viruses which do not transform 
mesenchymal cell in vitro. In vivo experiments, however, revealed distinct bone-
pathogenic properties in susceptible newborn mice which do not carry ecotropic 
retroviral sequences. Besides lymphomas they induced osteopetrosis and 
osteomas after mean latent periods of up to 9 months in NMRl mice, whereas CBA 
mice developed,predominantly bone lesions. All virus types t~sted, including the 
RFB osteoma virus, which was isolated by M.Finkel and coworkers from virus-
induced osteomas of CF-1 mice and which was used in a series of control 
experiments, induced the same pattern of diseases but with great variations in 
incidences and latent periods. 
Target cell in the skeleton and virus effects in bone cells 
Newborn female NMRI mice were infected intraperitoneally with OA MuLV. Femur 
metaphyses and lumb.ar vertebrae were investigated ultrastructurally 3d, .7d, and 
28d after infection. Budding, immature and mature virus was observed associated 
with osteoblasts and osteocytes, but never with osteoclasts or chondroclasts, 28d 
after infection. Skeletal tissue from infected old osteopetrotic mice showed virus 
particles associated w~th and budding from osteocytes and accumulated in 
devitalized osteocyte lacunae. 
Primary skeletoblast cell cultures were established from humeri and calvaria of 3-
day-old, 7-day-old, and 28-day-old animals in order to monitor the distribution of 
the virus following inoculation of newborn mice, and the degree of infection of the 
cells of the skeleton. Infectious ecotropic MuLV was found in all humerus cell 
cultures from infected mice and in 7d and 28d calvaria cell cultures. The levels of 
alkaline phosphatase, a marker enzyme indicative of the state of osteogenic 
differentiation· of bone cells, were markedly higher in cultures of calvaria and 
humeri from infected mice than in those of from controls. 
In contrast to the bone lesions found in several mutant mouse and rat strains 
which result from impaired osteoclasis due to dysfunctions of bone resorbing 
osteoclasts, the skeletal lesions induced by radiation~activated endogenous 
retroviruses and related virus types isolated from different bone tissues appear as 
a disease of the cells of the osteogenic lineage. 
Effects of retroviruses in bone cell and tissue cultures 
Primary cell cultures of periosteum and osteoblast-like cells were established from 
calvaria of newborn mice. In vitro infection. of undifferentiated periosteal cells with 
OA MuLV was followed by a decrease in cell growth and an increase in alkaline 
phosphatase activity. In contrast, differentiated osteoblast-like cells were barely 
susceptible to virus infection, and the virus did not influence growth or 
differentiation of this cell population. These data indicate towards a distinct 
increase· of osteogenic differentiation following virus infection in susceptible 
osteoblast precursor cells. 
This phenomenon was further investigated by use of a tissue culture model, the 
mandibular condyle of the neonatal mouse. At the time of dissection from the 
mandible, this tissue is composed of distinct zones containing cartilage cells at 
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different stages of differentiation. Namely, mesenchyme-like cells in the 
perichondrium, a zone of progenitor cells in the apical and lateral part, an area of 
young chondroblasts in the canter and mature chondrocytes in the basal part of 
the tissue. During in vitro cultivation over a period of 1 0 days, cells in the 
progenitor zone undergo osteogenic differentiation and form new bone. These 
processes are accompanied by the expression of characteristic genes typifying 
osteogenic differentiation including collagen type I, alkaline phosphatase, 
osteonectin, osteopontin and osteocalcin. 
Infection of mandibular condyles with OS-5 MuLV or OA MuLV resulted in reduced 
growth of osteoblast progenitor cells, which have been determined by 
immunohistochemical methods as the target cell population of the virus in this 
tissue. Thereafter, the tissue showed increasing cell condensation together with 
polymorphism and heavy mineralization of the osteoid matrix. 
Infection of mandibular condyles with the fos oncogene-bearing FBR 
osteosarcoma virus led to the development of an atypical proliferative osseous 
lesion resembling osteosarcoma, which was serially transplantable in syngeneic 
mice. 
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Title of the project no.: 1 
Late effects In 224Radlum treated ankyloslng spondylitis patients 
Head(s) of project: 
Prof. Dr. W. Gossner 
Scientific staff: 
Dr. R. R. Wick, Dr. W. A. Muller 
I. Objectives of the project: 
All three projects in this research programme are aimed at epidemiological studies 
of radiation effects in patients injected with 224Radium. 
Project 1 is concerned with more than 1500 ankylosing spondylitis patients treated 
between 1948 and 1975 with repeated intravenous injections of 224Radium. The 
a.-doses to the skeleton, on average 0.67 Gy, are considerably lower than the 
doses in the patients studied in Project 2. The causes of death, and occurrence of 
other lesions possibly related to the 224Radium treatment, are analysed and com-
pared with results in a control group of ankylosing spondylitis patients not treated 
with radioactive drugs or X-rays. 
11. Objectives for the reporting period: 
Contact and follow-up of patients of the exposure group and the control group. Re-
gistration of causes of death. Comparison of results in the exposure and control 
group and evaluation with respect to the risk of bone tumours, leukaemias, kidney 
and liver diseases, and other diseases known, or supposed from Project 2, to be 
related to the 224Radium treatment. 
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Ill. Progress achieved: 
As of December 1989, this study consists of more than 1500 ankylosing spondy-
litis patients (Table 1) from 9 hospitals. These patients have been collected from 
all orthopaedic hospitals in the FRG known to have treated notable numbers of 
ankylosing spondylitis patients with 224Ra. The majority of these patients, most of 
them treated in the years 1948-1975, received one series of 1 0 weekly injections 
of about 1 MBq of 224Ra each. This is the usual dosage for the present treatment 
of ankylosing spondylitis and leads to a cumulative a-dose of 0.56 Gy to the mar-
row-free skeleton of a 70 kg man. 
In addition there exists a control group of ankylosing spondylitis patients not 
treated with radioactive drugs or X-rays in order to provide comparative infor-
mation on causes of death and lesions possibly related to the basic disease itself 
or to chemotherapy. Patients for this control group have been drawn mainly from a 
hospital known to refuse 224Ra treatment on principle. 
Personal and treatment data for the patients of the exposure and the control group 
have been drawn from the hospital records. Information on the current status of 
patients is gained from re-examinations at different times after treatment and from 
questionnaires sent periodically to the patients. In course of the study or from 
questionnaires it has become evident that some of the patients have been treated 
with X-rays additionally. These patients have been deleted from the original study 
groups. Causes of death were determined preferably from hospital record and 
death certificates. For several patients also autopsy protocols were available. The 
underlying causes of death were classified and registered according to the 7th 
revision of the International Classification of Diseases (ICD). 
Up till now, 500 patients in the exposure group and 636 patients in the control 
group have died. Causes of death have been ascertained in 487 patients of the 
exposure group and of 576 patients of the control group. The remaining cases are 
still being investigated. 
Table 2 shows the skeletal and soft tissue diseases observed so far. In this table 
we restricted our interest to those diseases which are known or implied from Pro-
ject 2, the higher dose study, to be associated with a former administration of 
224Ra. In the exposure group, three cases of malignant tumours in the skeleton 
have been observed: one fibrosarcoma, one reticulum cell sarcoma of the bone 
marrow, and one generalized plasmocytoma originally observed in the bone mar-
row of sternum and pelvis. In the control group only one case of a skeletal tumour, 
·also a plasmocytoma, has been observed. 
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Diseases of the haematopoietic tissue among living and dead patients included: 
leukaemias (7 in the exposure group vs. 5 in the control group) and bone marrow 
failure (1 0 cases vs. 8). Also included in this table are cataracts and exostosis, two 
diseases which especially have been observed in the juveniles of Project 2. In the 
adults of this project who have been treated at considerably lower doses there is 
no indication of an increased incidence. 
Due to the fact that for administrative reasons we follow the patients of the expo-
sure and of the control group on different years the numbers in Table 2 are only 
informative. This is because we followed the control group last year, but it has 
been up to three years that we have followed the exposure group which will be 
contacted the next years. (Present follow-up time, exposure group: 16.5 yr, 
control group: 19.4 yr) 
More exact information is given in Table 3 which shows for different kinds of can-
cer a comparison between observed and expected cases. The expected cases 
shown here have been calculated from the annual incidences of cancer for the 
German Democratic Republic for the years 1973 - 1977. The results obtained from 
other calculations with the data of the smaller West German Cancer Registries of 
the Saarland and of Hamburg, however, do not differ very much from the results 
shown here. For the calculation we grouped the patients of our exposure and con-
trol group in five year classes of age according to their individual follow-up time, 
that means begin of treatment until last conta_ct or death. Table 3 shows that the 
number of observed, total cancers for both, the exposure and the control group, is 
within the range of expected cases. There is also no significant difference between 
observed and expected cases for cancers of stomach, liver, urinary system, .or the 
female breast. An increased incidence for stomach cancer might have been ex-
pected because of a higher intake of painkilling drugs in case of ankylosing spon-
dylitis patients compared to a standard population. For liver, urinary systems, and 
female breast there are some indications from Project 2 of an excess with higher 
doses, which cannot be observed in our patients. 
For cancers in the skeleton there might be a slight indication of an increased inci-
dence in the exposure group (3 cases observed vs. 0.6 - 1.2 expected; p = 
= 0.121) whereas in the control group the observed cases are within the limita-
tions of expected cases (1 case observed vs. 0.7- 1.6 cases expected). The 
types of bone tumours in our exposure group, however, are different from those 
observed in Project 2: two of the three cases observed in this project were tu-
mours of the bone marrow whereas in Project 2 mostly osteosarcomas were ob-
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served. This apparent difference is somewhat parallel to the observation that in 
this study the leukaemias seem to be increased. 
Table 4 shows a more detailed evaluation concerning the different types of leuk-
aemias. The expected numbers for the different subtypes of leukaemia given in 
this table are calculated from the mortality rates in Bavaria for the years 1976 -
1981*, because an evaluation of the four-digit categories of death causes is not 
available from the German Cancer Registries. The numbers for expected cases 
given in this table are percentages as found for the different types from the Bava-
rian mortality rates but calculated to the basis of the expected total leukaemias 
(2.2, or 3.0 cases, resp.). Table 4 shows an increased incidence of total leuk-
aemias for the exposure group, as well as for the control group (exposure group: 7 
observed vs. 2.2 expected, p = 0.0075; control group: 5 observed vs. 3.0 expected, 
p = 0.185). Subtyping of the leukaemias reveals that in the exposure group only 
the chronic myeloid leukaemias (3 cases vs. 0.7 expected, p = 0.034) are signifi-
cantly elevated whereas in the control group the acute lymphoblastic leukaemias 
(3 cases vs. 0.2 expected, p = 0.0011) are increased. 
For the control group this might be due to a higher intake of painkilling drugs com-
pared to the patients exposed to 224Ra. lt is well known that phenylbutazone, a 
drug which was widely used in the treatment of ankylosing spondylitis, can cause 
bone marrow depression. Acute leukaemias occurring in association with phenyl-
butazone treatment have repeatedly been reported in the literature. 
Whereas an increase of the rate of the tumours in the skeleton is uncertain, we ob-
served in the exposure group more chronic myeloid leukaemias than expected. As 
the average a-dose to the skeleton in the patients of our study group is lower by a 
factor of about 3 than in the adults and lower by a factor of about 17 than in the ju-
veniles of Project 2, effects on the bone marrow not observed there may be preva-
lent. Certain disorders of the haematopoietic system following treatment with 
224Ra were observed even at the same low dose level by other authors. 
Myeloproliferative diseases, mostly acute or chronic myeloid leukaemias, have 
been reported following Thorotrast applications too (see Table 5): 10 cases were 
observed among 432 deaths in a group of 878 well examined Thorotrast patients 
followed in the Federal Republic of Germany. Also included in this table are three 
cases of myeloid leukaemia in the adult group of Project 2. No case of myeloid 
• We would like to thank B. Grosche from the Bundesgesundheitsamt, lnstitut fOr Strahlenhygiene, 
Neuherberg for providing us with these data. 
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leukaemia is reported in Project 2 for the juveniles who received the highest 
doses. From Table 5 a correlation of the bone marrow dose with the· incidence of 
myeloproliferative diseases cannot be demonstrated, an effect of the dose-rate, 
however, may be taken into consideration (Fig. 1 ). The relatively high incidence of 
myeloid .leukaemias in· the Thorotrast patients seems very surprising because of 
the very low dose rate of only 1. 7 mGy per week of bone marrow dose. On the 
other hand, higher total doses, but also at higher dose rates produced no myeloid 
leukaemias in the juveniles of Project 2. The dose rates, as well as the incidences 
of myeloid leukaemia, for both, the patients of this project and for the adults of Pro-
ject 2, lie in between. 
Although the number of cases is low for the groups at the higher dose rates one 
should consider that not only the total dose but also the dose rate may play an im-
portant role in the induction of malignancies in man. In animals, bone seeking 
a-emitters given at very low dose rates, lower than those found to cause bone tu-
mours, have been demonstrated by different authors to induce leukaemias. Re-
sults from an experiment with varying amount of 224Ra performed by Humphreys 
et al. (1985) indicate that animals given amounts of 224Ra less than those found to 
cause osteosarcomas may be at risk instead from myeloid leukaemia. Also for 
239Piutonium, a bone surface seeker like 224Ra, the induction of myeloid leuk-
aemias has been demonstrated in mice down to dose rates of a.. few mGy/day or 
even less. In our institute- (CEC-Contract No. 816-D-080-D) a-doses to the ·marrow 
as much as one order of magnitude lower (30 - 200 mGy) .than·those reported up 
to now were found to be leukaemogenic when delivered over a long period at an 
extremely low dose rate. The types of these leukaemias, however, were different to 
those reported by other authors. . 
A hypothesis on cellular mechanisms for the induction of leukaemias at low dose 
rates has been set up by Thorne and Vennart in 1976. They postulated an inter-
mediate state of cells transformed by radiation which is radiation sensitive itself. 
This results in an equilibrum level of cells transformed or sterilized by radiation. At 
higher doses the sterilisation of transformed cells exceeds their production and 
less or no leukaemias are observed in the irradiated animals. Only at .low dose 
rates the radiation-induced leukaemias can be observed. -This hypothesis might fit 
for the induction of leukaemias not only for animals but. also for the observations 
made for humans in this project. 
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Table 1: ANKYLOSING SPONDYLITIS PATIENTS IN THE 
EXPOSURE AND CONTROL GROUPS (Dec. 1989) 
Exposure Control 
Group Group 
Total patients 1579 1461 
Treated with X-rays 
106 126 additionally 
Remaining patients 1473 1335 
Deceased patients 500 636 
Cause of death certified 487 576 
Cause of death not yet 
known, still in work 13 60 
Table 2: SKELETAL AND SOFT TISSUE DISEASES (Dec. 1989) 
Exposure Group Control Group 
Observed patients 1473 1335 
Deceased 487 576 
Total cancers 80 (+ 14*) 116 (+12) 
Skeleton 3 1 
Leukaemias 6 (+ 1) 5 
Acute leukaemia 1 4 
Chronic leukaemia 5 1 
Type unspecified 0 (+ 1) 0 
Bone marrow failure 4 (+ 6) 5 (+ 3) 
Cataracts 3 (+25) 1 ( + 16) 
Exostosis 0 (+ 1) 1 
• living 
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Table 3: CANCERS OF BONE AND SOFT TISSUE 
(Incidence obslexp as of Dec. 1989) 
Exposure Control 
Group Group 
obs exp obs exp 
Total cancers 94 97.7 128 139.8 
Stomach 14 11.1 15 17.0 
Liver 1 2.9 5 4.3 
Urinary System 6 6.4 8 9.6 
Female Breast 2.0 1 1.7 
Skeleton 3 0.6-1.2 1 0.7-1.6 
Leukaemia 7 2.2 5 3.0 
Table 4: LEUKAEMIAS IN 224Ra TREATED ANKYLOSING 
SPONDYLITIS PATIENTS (Dec. 198~) 
Exposure Control 
Group Group 
obs exp obs exp 
Total leukaemias 7 2.2 5 3.0 
Acute leukaemias (0.7) 4 (0.9) 
Acute lymphoblastic leukaemia 1 (0.2) 3 (0.2) 
Acute myeloid leukaemia 0 (0.5) 1 (0.7) 
Chronic leukaemias 5 (1.5) ' 1 (2.1) 
Chronic lymphatic leukaemia 2 (0.8) 0 (1.1) 
Chronic myeloid leukaemia 3 (0.7) 1 (1.0) 
(Type unspecified 0 
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) 
Table 5: MYELOPROLIFERATIVE DISEASES IN PATIENTS TREATED 
WITH 224Ra OR THOROTRAST (Dec. 1989) 
Total Deceased Marrow Burden Dose per Myeloproliferative Diseases 
pat. patients dose time week 
<GY> <week> <mGy> #cases I per cent 
Project 2 
Juveniles 218 90 5.3 51 104 0 0 
Project 2 
Adults 682 439 1.0 25 41 3 0.68 
Project 1 1473 487 0.34 10 34 3 0.62 
Thorotrast 
Study 878 432 3.0 1768 1.7 10 2.91 
(Examined (34 yr) 
[!atients~ 
Figure 1: DEATH CASES FROM MYELOPROLIFERATIVE DISEASES 
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IV. Other research group(s) collaborating'actively on this project [name(s) and 
address( es)]: 
10 Orthopaedic and Rheumatic Hospitals from the F.R. Germany and West Berlin. 
Close cooperation with the working groups In Projects 2 and 3 of this contract. 
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Title of the project no.: 2 
Late effects In 224Radlum treated juvenile and adults patients 
Head(s) of project: 
Prof. Dr. H. Spiess 
Scientific staff: 
Prof. Dr. M. Jensen, J. P. Scharff 
I. Objectives of the project: 
Follow-up initiated in 1948 of patients treated with 224Ra as juveniles or adults. 
Determination of stochastic and non-stochastic radiation effects and their dose, 
time, and age dependence. 
11. Objectives for the reporting period: 
Cooperation with Prof. F. H. Stefani (Eye Hospital of the University of Munich). 
Cooperation with Prof. C. W. Mays (National Cancer lnstitute/NIH, Radiation Epi-
demiology Branch, Bethesda/MD, USA) in the cataract and kidney study. 
Review of existing data. 
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Ill. Progress achieved: 
1. Methodology 
At 3 year intervals we are following the health of 900 Patients (509 men, 173 wo-
men, 111 boys, and 107 girls) who received repeated injections of 224Ra after 
World War 11, for treatment of ankylosing spondylitis or bone tuberculosis, but also 
for other non-cancerous diseases. 
On the average, the dosage in kBq/kg was about twice as high to the children as to 
the adults, and because of the growing skeleton, the average skeletal dose was 
much higher in the children than in the adults. Usually the patients received 1 or 2 
injections per week. The time spans were averaging 6 months for the adults and 
11 months for the juveniles. In our 1987-1988 survey the patients' follow-up times 
ranged from 0 to 43 years, averaging 24 years. At the time of last contact 529 of 
900 patients were deceased. 
The short, 3.62 days half-life of 224Ra causes some of its decay in the skeleton to 
take place on bone surfaces and some within bone volume, giving a local distri-
bution of a-particle dose similar to that from 239Pu. The calculated doses to the 
patients' skeletons (without marrow) ranged from 0.06 to 57.5 Gy, averaging 
4.16 Gy. Based on results in beagles (Lioyd et al., 1982) the average injection 
dosage of 666 kBq/kg body mass to these patients delivered an average a-par-
ticle dose of about 1.4 Gy to the liver and 2.3 Gy to the kidneys. We estimate very 
crudely the a-particle dose to the red marrow to average 2 Gy. However, this dose 
is non uniform, being highest near the bone surface and lowest in the central mar-
row. Unfortunately, no estimates of the dose to the glandular breast tissue are 
available: experimental evaluation of the breast dose from 224Ra and progeny in 
suitable experimental animals is urgently needed to interpret properly the ob-
served excess of breast cancers among the juvenile girls injected with 224Ra. 
2. Results 
Bone sarcomas 
These have occurred in 54 patients, with two developing a second primary sar-
coma, for a total of 56 bone sarcomas (compared to 0.2-0.3 cases expected na-
turally). Thus we conclude that virtually all of these bone sarcomas were radiation-
-induced-. The dose response has been fitted to a linear-quadratic-exponential 
equation and the wave-shaped distribution of tumour appearance times has been 
analysed. The earliest bone sarcoma appeared 3.5 years after the start of 224Ra 
injections. The incidence rate peaked at 8 years and then declined. The last of 
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such malignancies appeared in 1983, 33 years after injection. At low doses of 
224Ra, a cumulative lifetime risk from bone sarcoma of about 0.8 % per Gy of ske-
letal dose is inferred from our data that pertain mainly to high doses. The observa-
tion of only three tumours of the skeletal region among 1473 low-dose patients 
averaging 16.5 years follow-up and 0.65 Gy to the skeleton suggests that the risk 
coefficient at low doses may be even less. 
Soft-tissue malignancies 
There were 102 observed -soft tissue malignancies, and this number is close to the 
expectation for the age distribution and person-years of observation, with the age-
specific incidence rates from the Cancer Registry of Hamburg, West Germany, .or 
the Cancer Registry of the German Democratic Republic, respectively. The close 
agreement between the observed and expected rates suggests that, most of the 
soft-tissue malignancies were not induced by 224Ra but were due to other factors, 
but certain types of cancer were elevated in incidence, 
Breast cancer. 
The breast cancer excess came as a surprise with 15 cases observed versus 
4.1-6.1 cases expected. AU but one case occurred more than 1 0 years after i rra-
diation and all but' one occurred after the age of 35. In the patients given 224Ra as 
adults the six cases observed are statistically still consistent with the 3.5-5.2 ex-
pected cases. However, for those given 224Ra as juveniles, a tenfold increase oc-
curred (nine observed versus 0.6-0.9 expected, p « 0.001 ). Of especial interest 
are two cases that received 224Ra before the age of 10, which was prior to the pro-
liferation of breast tissue during puberty. In the A-bomb survivors, for comparison, 
the risk from radiation-induced breast cancers was higher in those irradiated at the 
age of 0-9 and .1 0-19 years, than in those irradiated as adults (Tokunaga et al., 
1987). External X-rays can increase the risk of breast cancer, but no evidence was 
found in the patients' records of any X-ray exposure before the diagnosis of breast 
cancer. The four living breast cancer patients were interviewed, and they reported 
no radiotherapy and no lung collapse therapy accompanied by fluoroscopy. In 
three of our dead patients with breast cancer who received 224Ra as juveniles, 
pneumothorax was unlikely because they were treated by Or: Paul Troch who did 
not use pneumothorax. He believed in 224Ra above any .alternative therapy. In the 
remaining "juvenile" case, pneumothorax was possible but not considered very 
likely, especially after receiving the antituberculosis drug isoniazid (INH) in 1953 
for pulmonary tuberculosis. Thus, even if a few of the nine juvenile cases received 
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pneumothorax it could not account for their observed relative risk of ten (9 cases 
observed vs. 0.9 expected). 
Women weighing over 70 kg had a relative risk of about 1.2 for breast cancer, 
compared to women of all adult weights in the study of Brinton et al. (1979). With 
known adult weights and heights for eight of nine juveniles with breast cancer and 
photographs including the remaining case, we classify two as obese, six as nor-
mal and one as thin. Thus, the effect of their weight on the risk from breast cancer 
seems minor. 
The nine juvenile breast cancer patients received the 224Ra injections during the 
years 1943-1950 when drugs against tuberculosis were not widely available in 
Germany. In general the tuberculosis patients took relatively few drugs, in contrast 
to the ankylosing spondylitis patients who took large amounts of drugs over pro-
longed times to suppress pain. Thus, we have no evidence that the nine cases of 
breast cancer might have been drug induced. Women with either a mother or a 
sister with breast cancer have a relative risk of about two for breast cancer com-
pared to other women (Brinton et al., 1982). In our interviews four patients with 
breast cancer reported cases of second degree relatives with breast cancer. Four 
cases who died before could not be interviewed. 
Whatever other factors may be responsible for an excess of the breast cancer rate, 
it seems unlikely to be drugs, obesity, delayed childbirth, external irradiation, or 
the original disease of tuberculosis. A possible role of the 224Ra and its decay pro-
ducts, can thus not be excluded and is in line with the extensive data that show 
that ionizing radiation can induce breast cancer (Shore, 1986; Tokunaga et al., 
1987; Hrubec et al., 1989). 
The average year of breast cancer diagnosis was 1977, and as of that time the 62 
surviving women who were treated as juveniles had an average dose of 740 kBq 
per kg, a value similar to the 800 kBq/kg among the seven patients of known do-
sage with breast cancer. If breast cancer had occurred predominantly at the higher 
dosages it would indicate more strongly the possibility of breast cancer induction 
by224Ra. 
Liver cancer 
These have ocurred in six 224Ra patients, i. e. in a significantly larger number 
than the 1.1-1.2 expected cases (p < 0.002). One "probable" liver cancer might 
possibly have been a metastasis, but the clinical and pathology reports indicate 
clearly that the remaining five were primary liver cancers, and not metastasis from 
the gallbladder or external bile duct. Even for the five confirmed cases versus 
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1.1-1.2 expected, the difference is still significant (p < 0.008). Three of the liver 
cancers were bile duct carcinomas, the most frequent form of liver cancer ob-
served following a-particle irradiation of the 2334 German Thorotrast patients in 
which 347 liver cancers had been recorded as of the year 1984 (Van Kaick et al., 
1986). A possible complication is that two patients had hepatitis of unspecified 
form and another one had hepatitis B. Hepatitis B increases the risk for hepatic cell 
carcinoma, but has not been associated with an increased risk for the bile duct 
carcinoma, and the latter occurred in the patient who had hepatitis B. None of the 
patients' records indicated an intake of drugs that might be liver carcinogens or an 
occupational exposure to solvents, arsenic or vinylchloride. Two of the patients 
with liver cancer told us that they rarely drank alcohol. Using the dosimetry of 
224Ra in the beagle liver (Lioyd et al., 1982) the calculated liver doses to the six 
patients with liver cancer average 1.9 Gy, compared to 1.4 Gy for all of the pa-
tients of known dosage in our series. Based on our results and the Thorotrast ex-
perience, we feel that most of the six liver cancers were radiation-induced and that 
more will come in the future. Perhaps a reason that more have not appei'!red al-
ready is that the span of injections in the patients with liver cancer ranged from 3 to 
27 months, averaging 11 months. Thus the period of irradiaton from the short-lived 
224Ra was brief and did not provide the continuous killing of liver cells and promo-
tion of cell division. 
Kidney cancers 
Land (1986) has reviewed the susceptibility of the kidney to radiogenic cancer. 
In our study, these have occurred in six patients versus 2.4-2.6 expected Cqses 
(p < 0.05). All of .these cancers were "hypernephromas". The tumour appearance 
times ranged from 12 to 35 years after the start. of 224Ra injections. 
The six cases with kidney cancers were not associated with use of drugs known to 
cause kidney damage, nor with occupational exposure to solvents, cadmium or 
mercury. Using the dosimetry of 224Ra in the beagle kidney (Lioyd et al., 1982), 
the calculated kidney dose to the five patients with kidney cancers averaged 
3.5 Gy, compared to 2.3 Gy for all the patients with known dosage in our series. 
Non-malignant diseases of the kidney were reported for 80 patients in our series 
of whom 60 have died, mainly from kidney disease. In contrast, only about four 
deaths from kidney disease should have been expected based on German mor-
tality statistics. We aim at a detailed analysis of the non-malignant kidney dis-
eases in the future. 
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Leukaemia 
Leukaemias occurred in six patients, compared to two cases expected according 
to German Cancer Statistics. However some of the ankylosing spondylitis patients 
took leukaemogenic drugs, such as phenylbutazone to suppress pain. The ele-
vated leukaemia rates observed in the control group of Project 1 predict five leuk-
aemia cases unrelated to radiation among the 224Ra spondylitis patients, while 
the German population rates predict 2.2 leukaemia cases among the 224Ra pa-
tients. 
Indeed, of the six leukaemias among the 224Ra patients of our study, four occurred 
among the 396 spondylitis patients, but only two among the 504 other patients 
who mostly had tuberculosis for which few drugs were available at that time in 
Germany. Only one of the juvenile patients has developed leukaemia and she, a 
tuberculosis patient, had chronic lymphatic leukaemia, a type not associated with 
radiation exposure. For all the patients in our series, the a-particle dose to red 
marrow is crudely estimated to average roughly 2 Gy. No excess of leukaemia 
has been observed in the US or British radium dial painters (Spiers et al., 1983; 
Baverstock & Papworth, 1986). 
Other cancers 
These have not yet shown a significant excess in the 224Ra patients, including 
stomach (11 versus eight to ten expected), lung (16 observed versus 18-20 ex-
pected), skin (four observed versus 2-11 expected), uterus (five observed versus 
3-5 expected), ovary (two observed versus one to two expected), prostate (six ob-
served versus five to seven expected), bladder (four observed versus three to four 
expected), brain (two observed versus one to two expected), and multiple myelo-
ma (two observed versus 0.5-0.6 expected). One of each of the following types oc-
curred: Hodgkin's lymphoma, cancer of parotid gland, pancreas, thyroid, oesopha-
gus, and fallopian tube. Six patients had cancers of unknown type. 
Two negative findings are of special interest. First, no melanomas were observed 
in the 224Ra patients, although melanomas have been induced in the eyes of 
beagles injected with radium isotopes (Taylor et al., 1972). However, it is possible 
that radium concentrates more in dog melanocytes (pigmented cells) than in hu-
man melanocytes. Second, no carcinomas of the head sinuses were observed in 
the 224Ra patients, although 37 head sinus carcinomas have occurred in US per-
sons internally contaminated with 226Ra (Gustafson & Stehney, 1985). The 226Ra 
decays to 3.8 day 222Rn gas which diffuses into the head sinuses and irradiates 
the squamous epithelium. In contrast, as 224Ra decays to 220Rn gas (thoron, 56s 
half-life), its short half-life limits its diffusion into the head sinuses. 
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Statistical and radiobiological evidence suggests that 224Ra and its decay pro-
ducts can induce bone sarcomas and may induce breast cancers, liver, and kid-
ney cancers in humans. In the continued follow-up, the possibility of increased 
rates of additional types of cancers will need to be monitored. 
Cataracts 
See radiation protection programme, progress report 1989. 
(Contract B16-D-221-D) 
T&~bll 1: SUMMARY OF THE 224Ra PATIENTS IN PROJECT 2 
(Dec. 1989) 
Patient No. Category Alive Dead Total ThX 
1 - 368 Men, Ankyl. spondyl. 122 246 368 114 
401- 516 Men, Tb 45 71 116 1 
601- 625 Men, other 5 20 25 3 
-----------------------------------------------------------------------------------------------------------
Total men 172 337 509 118 
701- 724 Women, Ankyl. spondyl. 10 14 24 8 
801- 924 Women, Tb 55 69 124 0 
951- 975 Women, other 6 19 25 8 
-----------------------------------------------------------------------------------------------------------
Total women 71 102 173 16 
Total adults 243 439 682 134 
1101 - 1117 Boys, 1- 5 y 11 6 17 0 
1201 - 1235 Boys, 6-10 y 21 14 35 0 
1301 - 1328 Boys, 11-15 y 19 9 28 0 
1401- 1431 Boys, 16-20 y 16 15 31 1 
------·---------------------------------------------------·----------------------------------------------· 
1501 - 1517 
1601 - 1635 
1701 - 1725 
1801- 1830 
Total boys 
. Girls, 1- 5 y 
Girls, 6-10 y 
Girls, 11-15 y 
Girls, 16-20 y 
Total girls 
Total juveniles 
Total patients 
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67 
7 
22 
17 
15 
61 
128 
371 
44 111 
10 17 0 
13 35 0 
8 25 0 
15 30 0 
46 107 0 
90 218 1 
529 900 135 
Table 2: SUMMARY OF DISEASES OF THE 224Ra PATIENTS 
IN PROJECT 2 (Dec. 1989) 
age at first injection 
1-20 yr adult total 
Skeletal diseases 
Bone sarcoma 38 18 56 
Exostosis 29 0 29 
Growth retardation 28 0 28 
Tooth breakage 40 20 60 
Soft tissue diseases 
Cataract 38 47 85 
Leukaemia 1 5 6 
Liver (non-cancer) 4 35 39 
Kidney (non-cancer) 11 69 80 
Diabetes 3 28 31 
Cancers of soft tissue 
Lung 1 13 14 
Female Breast 9 6 15 
Uro-genital region 1 17 18 
Stomach 2 17 19 
Skin 1 3 4 
Liver 1 5 6 
Kidney 1 5 6 
Brain 2 8 10 
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IV. Other research group(s} collaborating actively on this project [name(s} and 
address(es}]: 
-Prof. Dr. C. W. Mays, National Cancer lnstitute/NIH, Radiation Epidemiology 
Branch, Bethesda/MD, USA; deceased in 1989 
- Prof. Dr. F. H. Stefani, Eye Hospital, LM University of Munich 
- Prof. Dr. Gurland, Klinikum GroBhadern, LM University of Munich 
- Prof. Dr. E. Sonnabend, Dental Clinique, LM University of Munich 
- Dr. D. Chmelevsky, Gesellschaft fOr Strahlen- und Umweltforschung, 
lnstitut fOr Strahlenschutz, Neuherberg 
V. Publications: 
1. Mays, C. W., Rowland, R. E., Stehney, A. F.: 
Cancer risk from the lifetime intake of Ra and U isotopes. 
Health Phys. 48, 635-647 (1985) 
2. Mays, C. W., Spiess, H., Chmelevsky, D., Kellerer, A.: 
Bone sarcoma cumulative tumor rates in patients injected with 224Ra. 
Strahlenther. Suppl. 80, 27-31 (1986) 
3. Chmelevsky, D., Kellerer, A. M., Spiess, H., Mays, C. W: 
A proportional hazards analysis of bone sarcoma rates in German 224-Radium 
patients. 
Strahlenther. Suppl. 80, 32-37 (1986) 
4. Spiess, H., Mays, C. W., Spiess-Paulus, E.: 
Growth retardation in children injected with 224Ra. 
Strahlenther. Suppl. 80, 45-50 (1986) 
5. Stefani, F. H., Spiess, H., Mays, C. W.: 
Cataracts in patients injected with 224Ra. 
Strahlenther. Suppl. 80, 51-59 (1986) 
6. Sonnabend, E., Spiess, H., Mays, C. W.: 
Tooth breakage in patients injected with 224Ra. 
Strahlenther. Suppl. 80, 60-64 (1986) 
7. Mays, C. W.: 
Alpha-particle induced cancer in humans. 
Health Phys. 55, 637-652 (1988) 
8. Chmelevsky, D., Kellerer, A. M., Land, C. E., Mays, C. W., Spiess, H.: 
Time and dose dependency of bone-sarcomas in patients injected with 
Radium-224. 
Radiat. Environ. Biophys. 27, 103-114 (1988) 
- 1584-
9. Spiess, H., Mays, C. W., Chmelevsky, D.: 
Malignancies in patients injected with Radium-224. 
In: BIR Report No. 21, Risks from Radium and Thorotrast (Eds.: D. M. Taylor, 
C. W. Mays, G. B. Gerber, R. G. Thomas). London: British Institute of 
Radiology, 7-12 (1989) 
10. Mays, C. W., Spiess, H., Chmelevsky, D.: 
Cancers in patients injected with 224Ra· 
Health Phys. 56 (Suppl. 1 ), 45 (1989) 
11. Mays, C. W.: 
Wie gefahrlich ist Plutonium? 
In: Plutonium, GSF Magazin "Mensch und Umwelt", 6. Ausgabe, Neuherberg: 
Gesellschaft fOr Strahlen- und Umweltforschung, 45-50 (September 1989) 
- 1585-
Title of the project no.: 3 
Epidemiology of radiation carcinogenesis 
Head{s) of project: 
Prof. Dr. A. M. Kellerer 
Scientific staff: 
Dr. J. Breckow, M. Depner, H. Friede 
I. Objectives of the project: 
The project is aimed at the further development of mathematical methods for the 
analysis of the dose, age, and time dependences of radiation-induced neoplasms. 
lt is equally concerned with the application of these methods to animal studies and 
to epidemiological investigations. Risk estimates for low doses of ionizing radia-
tions need to be based on a synopsis of essential results obtained from animal 
studies and from the major human epidemiological investigations. Such a synop-
sis requires the utilization of comparable mathematical methods and models; the 
efforts in this project were focussed on this need. The joint analysis of dose, age, 
and time dependences is particularly important in view of the new risk estimates 
being obtained after the revision on the Japanese dosimetry and also in view of 
the increased interest, after the reactor accident in Chernobyl, in the problem of 
low dose of ionizing radiations. The great public concern about the risks even of 
small doses have given added urgency to this work. 
11. Objectives for the reporting period: 
This project was executed in close coordination and collaboration with Projects 1 
and 2 within this research program. lt had two major and equally important aims. 
The first aim has been the statistical and mathematical evaluation of the data from 
the 224Radium follow-up studies. This work has been mainly directed towards the 
analysis of the dose, time, and dose-rate dependences of the bone sarcomas in 
the 224Radium patients, and the analysis of analogous interrelations for the in-
creased occurrence of lens opacifications. 
The second major purpose of the project was methodological work aimed at the 
improvement of the mathematical methods that are equally applicable to animal 
studies and epidemiological investigations of radiation carcinogenesis. This work 
included also the analysis of the extended observations among the atomic bomb 
survivors after the revision of the atomic bomb dosimetry, joint work with Czecho-
slovakian colleagues on the evaluation of lung cancer data in uranium miners, 
and quantitative evaluation of lung cancer data obtained in animal studies by the 
group of Lafuma and colleagues in Fontenay-aux-Roses. 
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Ill. Progress achieved: 
Studies accompanying the follow-up of the 224Radlum patients 
Spiess, Mays, and Stefani had earlier in their follow-up of the 224Ra patients 
recognized an increased frequency of lens opacifications; in the few cases with 
detailed ophthalmological investigations they were able to see typical characte-
ristics of radiation-induced cataracts. A detailed retrospective investigation of the 
degree of cataracts among all patients is impossible, but it appeared more and 
more important to preserve and extract information on lenticular damage gained 
during the follow-up of the 224Ra patients. A thorough mathematical investigation 
of all diagnoses of cataracts and of their dependence on injected activity, age at 
treatment, age at diagnosis, and certain other factors was therefore performed. 
The data were restricted to information on loss of visual capacity, ascertained by 
the ophthalmologists' reports, which were obtained by slit-lamp investigations. 
The mathematical investigations were critically dependent on the possibility to 
establish reliable dependences on dosage of 224Ra, age at treatment, and time to 
the recognition of visual impairment. A mere correlation between the 224Ra injec-
tions and the enhanced frequency of cataracts would not have been sufficient to 
establish a causal relation between the a-ray exposure and the lenticular damage; 
the possibility of enhanced frequencies due to the original illness (specially bone 
tuberculoses) could not be excluded by such simple analysis. 
A stepwise procedure of non-parametric and parametric evaluation of the data 
was, therefore, utilized to obtain dependences on dosage for the different ages at 
treatment and diagnosis. The first level of the investigation was the construction of 
suitable scatter diagrams to permit a direct visual judgement of the data. The se-
cond step of the analysis was a non-parametric, i. e. model independent, maxi-
mum likelihood analysis. The final step was an evaluation in terms of suitable ana-
lytical functions in time and in dosage. 
The analysis has demonstrated that almost all of the "early cataracts", i. e. those 
appearing before an age of roughly 53 years, were due to the 224Ra injections. In 
line with the postulate of a non-stochastic radiation effect, i. e. radiation action on a 
multiplicity of cells, the dosage dependence was found to be consistent with a 
threshold of about 0.5 MBq 224Ra per kg bodyweight, or with a quadratic depen-
dence on dosage. A second notable finding was the virtual independence of the 
frequency of radiation-induced cataracts on age at treatment; the more evident 
induction of radiation-induced opacities in the younger patients was merely due to 
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the fact that the radiation-induced opacities were clearly separated from the later 
spontaneous age dependent cataracts. 
The result of these studies suggested the urgent need, to salvage the remaining 
information on subclinical lenticular damage and its evolution in this singular col-
lective of patients. A new research project was, therefore, initiated in which the sur-
viving patients are regularly called in for specific ophthalmological investigations. 
The most severe late effect of the 224Ra injections was the induction of more than 
50 bone sarcomas ainong the 900 224Ra patients of Project 2. This data set per-
mits, perhaps more than any other epidemiological observations, the precise de-
termination of dose and time dependences of radiation-induced cancers. The sta-
tistical studies were, therefore, extended to include additional aspects. The appli-
cation of a proportional hazards analysis that was non-parametric in time but li-
near-quadratic in mean skeletal dose led to risk estimates which were less by 
about a factor of two than earlier values. The non-parametric analysis was later 
followed by a parametric evaluation that utilized a log-normal model for the time 
dependence, establishing the connection to a formalism utilized in the radioepi-
demiological tables of NIH. This parametric analysis provided risk estimates which 
were consistent with those obtained in the non-parametric approach. 
A major effort in the project was aimed at the assessment of a possible dose-rate 
dependence for the 224Ra induced bone sarcomas. An increased probability for 
bone sarcomas at specified injected activities but longer protraction· times had 
earlier been surmised by Spiess and Mays, but there was a need to base the con-
clusions on a rigorous mathematical evaluation. To avoid bias by assumed mo-
dels, non-parametric test procedures were developed which permitted the assess-
ment of a dose-rate dependence with no assumptions on the shape of the dose 
dependence and with full account for the time at risk of each patient. The result 
confirmed the existence of the inverse dose-rate effect. A non-parametric maxi-
mum likelihood fit was then employed, to identify the underlying dose and dose-
-rate dependence quantitatively. This led to the remarkable finding that orie ob-
tains linear dose dependences for the 224Ra induced bone sarcomas, if different 
doses, i.e. different injected activities, are given within a constant time. In contrast 
one obtains linear-quadratic dependences, when the dose rate is constant, i. e. 
when higher doses are given within proportionally extended time periods. The de-
pendence on dose rate is not a small factor; when the same activity is adminis-
tered during a period of 1 year rather than in 2 months the osteosarcoma frequen-
cy is increased by a factor of 2. The result is in line with a growing number of 
findings of inverse dose-rate effects for densely ionizing radiations. In this study 
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there is no indication that the reversed dose-rate effect is more expressed at the 
higher than at smaller doses. However, it must be kept in mind that even the smal-
est doses of about 0.1 MBq per kg bodyweight are still large compared to doses 
directly relevant to radiation protection. 
The application of the results from the follow-up by Spiess et al. is, however, of im-
mediate interest with regard to the concurrent epidemiological investigation of the 
more recent low dose 224Ra patients which is the objective of Project 1. The re-
sults of both studies are at present consistent, however the low dose study is still 
incomplete. A sharper comparison of the results is expected in several years. The 
most recent findings in Project 2 concern an enhanced frequency of other neo-
plasms such as mammary carcinomas. Unlike the bone sarcomas these findings 
are subject to uncertainties with regard to the spontaneous incidence of the tu-
mours, and this has led to initial work in this project on the establishment of age 
specific cancer rates within the patients of the Spiess series. 
Methodological work and statistical evaluation of other studies 
The statistical evaluation of the 224Ra follow-up studies necessitated the further 
development of numerical techniques and of mathematical models for the determi-
nation of dose and time dependences. These mathematical aspects of the re-
search project were, however, treated in a broader context and were aimed at the 
development of general tools applicable to epidemiological studies of radiation 
cancerogenesis and animal studies. 
There were three main aspects. The first aspect concerned the improvement of 
maximum likelihood methods for model fits to data sets that are dependent on a 
variety of factors. For this purpose the flexible and highly efficient non-linear opti-
mization algorithm of J. Abadie was adapted to the use on small computers. Simp-
ler maximum likelihood algorithms, mostly based on the Newton-Raphson method, 
were sufficient for other purposes. The range of different algorithms will be used 
as a basis to develop a set of multipurpose programs for radiation studies. 
The numerical evaluation of complex data sets is of necessity abstract, and it is 
therefore difficult to judge the validity of the approach and the degree to which a 
model and its parameters are defined by the underlying data. To remove some of 
these difficulties and to permit a direct judgement of the data, broad use was made 
of graphic procedures and especially of scatter diagrams of the input data. From a 
mathematical standpoint such diagrams are simple, however, they have proved 
highly useful in a variety of applications, and they will be further extended. 
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A third component of the mathematical investigations. is the development of im-
proved non-parametric tests for right censored and double censored data. The 
need and the use of such tests is most clearly exemplified in the study on the re-
versed dose-rate effect for the induction of osteosarcomas. 
The mathematical methods have been employed in the 224Ra follow-up stu(.lies, 
but they have also been utilized for generating a synopsis of the cancer mortality 
data from Hiroshima and Nagasaki. The utilization of the numerical procedures in 
terms of the proportional hazards analysis will have to await the release of the 
most recent data based on the revised dosimetry. 
Extensive studies have been performed in the continued collaboration with the 
group of Lafuma and colleagues at Fontenay-aux-Roses on the induction of lung 
cancers in Sprague Dawley rats by radon daughter inhalations, neutron expo-
sures, and gamma-irradiations. The high .RBE values of radon daughter exposures 
and of neutron exposures in comparison to gamma rays were confirmed in this 
study. The analysis has furthermore provided evid1mce for a higher relative effi-
ciency of radon inhalations compared to a-rays than the one that would corres-
pond to quality factors which are currently employed. 
A recent effort in the project was directed towards a cooperation with Czecho-
slovakian colleagues on the evaluation of lung cancer incidence in uranium mi-
ners. Their important data sets have not been part of the joint analysis of occupa-
tional radon inhalation data in the BEIR IV report. During a guest visit of Dr. Ladis-
lav Tomasek from the Institute of Hygiene and Epidemiology in Prague procedures 
have been defined and algorithms have later been developed that are applicable 
to the Czechoslovakian data and are largely - but not entirely - analogous to 
procedures used in the BEIR IV report. This work will be continued, and in an ex-
tension the methods will be applied to the CzechosiClvakian data. 
The continued discusson of new risk estimates after the revision of the Japanese 
dosimetry has emphasized the need to coordinate the methods of analysis in dif-
ferent epidemiological studies, and this has been one of the main aims of the pro-
ject. The development of joint algorithms has also lbeen important and continues 
to be important with regard to the need to supplement the conclusions from epide-
miological studies with the data from animal experiments. The increasing difficul-
ties of performing animal experiments and the resulting need to combine the ef-
forts of different laboratories have made the use of consistent and comparable me-
thods particularly important. 
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Title of the project no.: · 1 
Epidemiological investigation on radiation cataract by the ophthalmological 
examination of patients who had received 224Ra 
Head(s) of project: 
Prof. Dr. H. Spiess 
Scientific staff: 
Prof. Dr. F. H. Stefani, J. P. Scharff 
I. Objectives of the project: 
A serial examination provides a possibility to detect cataracts at an early stage 
where they can be distinguished clinically from spontaneous cataracts or cata-
racts associated with the original disease that led to the radium treatment. An 
important feature of this ophthalmologically oriented follow-up will be the repea-
ted examination at regular time intervals of the same patients to assess the evolu-
tion of the radiation-induced cataracts. The aim is to gain further insight into the 
time and dose dependences. 
11. Objectives for the reporting period: 
Continuing the examinations of patients who were under 20 years of age at first 
injection with 224Ra. 
Some patients with subcapsular cataracts were examined by Prof. Dr. Hockwin 
(Eye Hospital Bonn) with a "Scheimpflugkamera". 
- 1594-
Ill. Progress achieved: 
Earlier in their follow-up of the 224Ra patients Spiess, Mays, and Stefani had re-
cognized an increased incidence of opacities. Since 1969 the questionnaires 
sent to the patients have included questions on their visual acuity, on visual prob-
lems, and on the address of their eye doctor. 
By detailed slit-lamp examination of 58 patients it was possible to document bi-
lateral disk shaped paracentral posterior cataracts with a narrow but optically 
clear subcapsular zone. This clear zone of about 0.5-0.6 mm corresponds to the 
lens fibres deposited during the period of about 40 years from treatment to exa-
mination. These findings established the radiation related origin of these cata-
racts. Such diagnoses are, however, only possible for non mature cataracts, i.e. 
cataracts at an early stage that do not yet interfere with vision. 
Most of the cataracts recorded among the patients were diagnosed at an ad-
vanced stage when the patients had problems with vision and consulted an eye 
doctor. The cataracts could therefore not be attributed, in the indivual cases, to 
the radium treatment; especially among the older patients, some were age re-
lated. A mathematical analysis of the mature cataracts was performed. The dose 
and time dependencies of the incidence of cataracts were derived. Critical to the 
analysis were reliable informations on the time after treatment of the cataract di-
agnoses. The analysis showed that most of the cataracts diagnosed before the 
age of 53 were radiation-induced. 
No difference in sensitivity with age at treatment could be detected. In agreement 
with other studies it was found that the data are consistent with either a linear 
dose relation with threshold or a quadratic relation. Another important conclusion 
was that a substantial part of the radiation-induced cataracts were diagnosed 
40 years after the radium injection or later. 
On the basis of these results it was decided to start a systematic ophthalmic in-
vestigation of the younger patients, i. e. the patients who were under 20 years of 
age at treatment. Most of these patients have not yet reached the age with high 
incidence of senile cataracts. The detailed investigations are therefore still teas-
able. lt is the aim of this complementary investigation to salvage a maximum of in-
formation on the incipient lens opacifications and on their evolution in the youn-
ger patients. 
Of the 128 living patients 54 were born in the 1940s and are now between 41 
and 50 years old, 65 were born in the 1930s, and nine were born in the 1920s. 
38 out of a total of 218 are known by 1989 to have opacification. This number in-
cludes four patients with confirmed cataract who have died and two who had had 
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surgical cataract extraction at the age of 14 and of 45. In one patient the lens had 
been studied at autopsy. 
58 patients have been examined in detail with a slit-lamp either in the eye hospi-
tal in Munich or by the patient's eye doctor. 34 patients were found to have some 
kind of lens opacity. In 14 out of the 34, the cataracts appeared to be morphologi-
cally similar to age-related cataracts. In 14 patients there was a bilateral posterior 
subcapsular cataract. In eight patients this was a bilateral dense round plaque 
with a clear subcapsular zone of about 0.5-0.6 mm. 
Detailed objective and reproducible documentation of cataract morphology is on-
ly possible with Scheimpflug photography including image analysis. A coopera-
tion has been started with the University hospital in Bonn: four patients have had 
an examination with the Scheimpflugkamera in Borm by Prof. Dr. Hockwin. The 
possibility to acquire a Scheimpflugkamera by an additional research grant that 
will include also heavy ions research is at present b1eing explored. 
Table 1: SUMMARY OF CATARACTS IN THE 224Ra 
PATIENTS IN PROJECT 2 (C1ec. 1989) 
Patient No. Category Total 
1- 975 Total Adults 47 
1101-1117 Boys, 1- 5 y 5 
1201-1235 Boys, 6-10 y 3 
1301-1328 Boys, 11-15 y 4 
1401-1431 Boys, 16-20 y 6 
Total Boys 18 
1501-1517 Girls, 1- 5 y 3 
1601-1635 Girfs, 6-10 y 6 
1701-1725 Girls, 11-15 y 5 
1801-1830 Girl$, 16-20 y 6 
Total girls 20 
Total juveniles 38 
Total patients 8 5 
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IV. Other research group(s) collaborating actively on this project [name(s) and 
address(es)]: 
- Prof. Dr. C. W. Mays, National Cancer lnstitute/NIH, Radiation Epidemiology 
Branch, Bethesda/MD, USA; deceased in 1989 
- Dr. D. Chmelevsky, Gesellschaft fur Strahlen- und Umweltforschung, lnstitut fOr 
Strahlenschutz, Neuherberg 
- Prof. Dr. Hockwin, Eye Hospital, University of Bonn 
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Title of the project no.: B I 6 - C£ 5 - D 
Molecular and cellular mechanisms of neoplastic cell 
transformation 
Head(s) of project: 
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Institut fUr Strahlenhiclogie der GSF 
!:' f'C'<l2 t 1euherl·erg 
Scientific staff: Dr. Cornel ia llorawetz 
Dr. ~·Jolfgang Vogel 
Prof.Dr. Ulrich Hagen 
Prof.Cr. Klaus-Rudiger Trott 
I. Objectives of the project: 
(lOO %) 
(!CC'%) 
( 25 %) 
( 15 %) 
Pmong other mechanisms for radiation induced cell transfor-
mation, the transposition (translocation) of cncogenes and 
the movement of viral enhancer elements have teen discus-
sed. As a model for the inducibility of transposition of 
molile gene elements the rehaviour of Ty-elements in yeast 
cells will be studied after treatment with mutagenic 
agents. In addition, cell transformation of mammalian cells 
(C3P./Tl/2) will he tested with respect to the dose effect 
relationships as modified ry fractionation and low dose 
rate, in order to learn mere about the mechanism of 
subtransformational repair. 
11. Objectives for the reporting period: (July 1SE5 - Dec.l9ES) 
a) Studies on the mechanisms of ~y-insertion into the 
prcmotor regions of the yeast ADH2- and JI.DE4-gene in 
chromoscmal and in episomal DrA. Effect of mutagenic 
agents as gamrnarays, ultraviolet light and ethylmethane-
sulfonate (n!S) on the frequency of transposition and 
its dependence on the metabolism of the cell. 
b) P.epair kinetics of the subtransformational damage of 
C3E/1CT1/2 cells. Experiments with fractionated irradia-
tion and with low dosr rates and in dependence of the 
state of proliferation. 
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Ill. Progress achieved: 
a) INDUCED TFANSPOSITION OF TY-ELEMENTS IN YEAST. 
1. Methodology: 
To study transposon-mediated mutations in eukaryotic orga-
nisms the yeast Saccharomyces cerevisiae was used. Haploid 
cells can be used, even recessive mutations are expressed 
phenotypically. S.cerevisiae is a facultative anaerobic 
organism, i.e. it can grow in the presence (oxidative path-
way) of oxygen as well as in its absence (fermentational 
pathway). These pathways are regulated very accurately, as 
for instance the isoenzymes of alcohol dehydrogenase (ADH 
I, II, III and IV). Strains of S. cerevisiae that carry a 
mutated ADRl gene (adh 1) are unable to grow fermentatively 
on media containing glucose. If in addition the respiratory 
chain is blocked by antimycin A, no growth at all is pos-
sible on glucose containing media. 
Ty-integration into the promotor regions of the ADH2- and 
ADH4 gene can lead to the expression of the glucose-re-
pressed ADH2 gene and to the expression of the normally 
silent ADE4 gne. Fermentation is possible again. Thus 
Ty-integrations are selectable by looking for mutants able 
to grow under these conditions (glucose and antimycin A). 
(Figure 1) However, besides the integration of Ty-elements 
tester strain under selected mutant with the 
selectiVe cond1tions retro virus like Ty-element 
normal cell with or tester strain under po1soned by Anti· transposed to the new locus 
Without Antimycin A normal conditions mycinA 
glucose glucose glucose glucose 
I I I I 
! ! ! ! 
pyru·vate pyruvate pyru·vate pyrJvate 
I I 
acetaldehyde I I acetaldehyde 
® respiratory m
10 ® ID chain ~ ~ - u -~ c <t 
ethanol production no ethanol production cell death ethanol productiOn 
and cell growth but cell growth and growth 
Figure 1. 
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other mutations lead to the same phenotype. Therefore fur-
ther analysis of the mutants (search for altered restric-
tion patterns at U.e JIDP2- and ADH4 gene) is done to eva-
luate the true num~er of transpositions events. 
2. Fesults anc Discussion. 
With this test system, various aspects of induced transpo-
sition were studied: 
i) Dose effect relations after exposure to IDUtagenic agents 
(Morawetz and Eagen, lSSO): 
The efficiency of agents to induce transposition can be 
evaluated by relating the transposition number to the 
lethal hits. (Yield cf transposition per treated cell). The 
alkylating agent rus is much more effective than UV-light 
or even gamma irradiation in this test system. 'I'he dose 
effect curves correspond to that of the yield of mutation, 
i.e. an increase with increasing doses and then a decrease 
at higher cytotoxic doses (Morawetz 1SB7). It could be 
shown, that transpositions to the JI~H4-locus are more 
frequent than transpositions to the ADH2 locus, depending 
on the type of agens and of the strain used. 
ii) Effect of inhi~itors on Ty-transposition: 
Incubating gamma-irradiated cells for eeveral hours leads 
to an fourfold increase in transposition yield up to a pla-
teau at 8 hours after irradiation. Inhibiting DNA synthesis 
l::·y hydroxyurea prevents this increase; inhibiting protein 
synthesis by cycloheximide abolishes spontaneous and indu-
ceCI transposition completely. However, inhibition of RNP.-
synthesis by actinomycin D is much less effective, the 
increase of the transposition yield will only be delayed 
(Morawetz und Iagen, lSSO) (Figure 2). 
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Fig. 2: Transposition to the 
JI.DF loci in strain l1C31 
after treatment with metabo-
lic inhibitors. Gamma-irra-
3 T 
diation with 100 Gy, Four 2 
hours incubation without 
(Control) or with actinomy-
cin D, cycloheximioe or 
hydroxyurea. 
long barred areas: ADH4 
locus; cross hatched: ADH2 
locus 
cpen areas: mutation with no 
detectable insertion. contr. act cycl HU 
iii) Expression of Ty-coded mRNA after mutagenesis 
(unpublished results). 
After treatment of the yeast cells, mRNA was isolated and 
hybridized with a labelled Ty-epsilon fragment. Ty-specific 
RNA was quantified in relation to the actine-RNA. In addi-
tion to the wild type also a variety of radiosensitive 
mutants (rad 1, 2, 5, 6 and 12) were studied in this way 
(unpublished results). Under certain conditions, there is an 
increase of Ty-specific mRNA-synthesis in gamma-irradiated 
or UV-irradiated cells. This effect was especially strong in 
the rad-mutants, whereas ll1S inhibited new Ty-mRNA-synthe-
sis. Because of the long halflife of Ty-mRNA (2,S hours), it 
was net possible to proof, that induced transposition of 
Ty-elereents after mutagenic treatment is mediated by an 
induced synthesis of Ty-mRNA. 
iv) Transposition in diploid cells. (unpublished results) 
The previous experiments were performed with haploid cells; 
it was of interest, whether induced transposition will occur 
also in diploid cells. Special strains had to be constructed 
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by selective pairing to follow transposition of ~y-elements 
into either allele of JI.DH2 or ADH4. The results did show, 
that the transposition yield in diploid cells is much lower 
than in haploid cells, although both alleles are affected. 
As in haploid cells insertion into the ADH4-locus is more 
frequent than into the ADH2-locus. The highest yields were 
observed at about 30 - 50 percent survival of the cells: 
higher doses apparently damage the transposition mechanism. 
v) Transposition of "Iy-elements into plasmids ( Vogel, 1 SE9). 
The results reported dealed with induced transposition into 
loci of chromosoJI:al DNA. Such experiments, however, don't 
allow an analysis of the integration positions in detail. 
For such a study "Iy-insertions into recoverable plasmid DNA 
have to be analysed. Several strains wen~ constructed with 
destroyed copies of the chromosomal ADH2·- and ADH4-gene. In 
addition, plasmids were constructed carrying the ADH2- and 
er ADR4-gene and introduced into the cells described. 
Mutants selected for antimycin A resistance after treatment, 
would indicate a Ty-insertion in the plasmid DNA. Such 
insertions were found in the 5'-position of the ADH2- or 
ADH4-gene. The exact position of "Iy-insertion was determined 
by restriction analysis and DNA sequencing (Figure 3). 
=::::3 (Ty.dfl, ·357111)) 
=:3 CT!"Z2·,o,.z. ·201 bpl 
CT!"10o-Z. ·1•111)1 
=:::3 CT!"10e4, ·17•111)1 
=:::3 CT!"3o41Z. ·111llll)l 
CT!"AI-11, ... sbpl 
CT!"AI-3. •81tlll)l 
Figure 3: Positions of Ty-insertions at the JI.DH2- and ADH4 
locus. 
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Comparing these data derived from plasmids with data in the 
literature on integration sites in chromosomal DNA, no dif-
ferences were observed. Integrated Ty elements on plasmids 
showed the the same orientation of the Tyelement relative to 
the structural gene, the same distribution of integration 
sites and corresponding cis-activation. Comparing the DNA 
sequence in the neighbourhood of 16 integration sites in the 
ADH2 and F~H4-gene no sequence specifitiy for the integra-
tions could be observed. However, all of the integrations 5' 
to the ADH2 gene are located within 86 bp, indicating a bia-
sed selection of mutants by antimycin A resistance. Possibly 
the "upstream activation sequence" of the ADH2 promotor is 
preventing cis activation of the ADH2 gene by Ty-elements 
situated beyond this position. Furthermore, also six mutants 
were selected where a solo-delta-element in the 5'position 
of the ADH4-gene leads to gene expression - a hitherto 
unknown phenomenon. 
2. General discussion about transposition of Ty-elements. 
The results described in this chapter clearly show the 
inducibility of Ty-transpositicn in yeast by mutagenenic 
respectively carcinogenic agents. Details of the mechanism 
of induced transposition of gene elements were studied. If -
as pointed out repeately - malignant cell transformation is 
due also to transposition of mobile gene elements, espe-
cially retroviruses, it is necessary to develop a corres-
ponding system in mammalian cells as in yeast in order to 
study the relation between transposition and carcinogene-
sis, induced by radiation and chemicals. 
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b) RJl.CIJI.TICN INDUCED TRANSFORHA'IION IN rlJl.MMALIAN CELlS. 
1. r1etPodology: 
The influence of protracting lo~: LET irradiation from acute 
exposures of less than lC minutes duration to those lasting 
hcurs and days (up one week at 1 Gy/d) on the transforma-
tion frec;uency was studiec in C:?HlCT 1/~' cells. Cells were 
plated in 'I-2C flasks at a density of less than :oc clone-
genic cells (i.e. 2,CCO cells, mean plating efficiency 22%) 
or less than ~CC colony forming survivors per flask. Ir-
radiation from a Co6C source (Eldorado) was startec 16 
hours after plating. The dose rate for acute irradiation 
was 1 Gy/min. Low dose rate irradiation was performec by 
putting an incubator into the irradiation room, the requi-
red dose rate was achieved by adjusting the distance to the 
source and by adding lead filters close to the source. Dose 
rate and dose distribution in the incubator were measured 
by an ionisation chamber in each position prior to the res-
pective experiment. The longest exposure time was E days at 
a dose rate of 1 Gy per day. lC days after irradiation cell 
survival was determined by counting colonies which had 
developed from the plated cells in E flasks. The other 
flasks remained in the incubator for a further six weeks 
with medium changes every 10 days. The number of transfor-
med foci (type II and III together) per surviving, clone-
genic cell was determined in the experiments for doses of 
2, 4, 6 and in some experiments e cy. 
2. Fesults anc Ciscussion. 
The spontaneous transformation frequency was very low in 
our experiments, it varied over the years but was always 
below lC-5• Acute irradiation with a dose rate of 1 Gy/ 
min increased the mean transformation frequency to 
:. 1c-s at 2 cy 
12. lC -5 at 4 Cy 
-" 25. 10 - at E Gy 
and 40. lC -5 at f' Gy. 
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The 4 Gy value is based on more than lCC transformations 
and over a period of 3 years transformation frequency ran-
ged between different series of experiments from e. lC-5 
to 20. 10-5• There was a decrease in transformation fre-
quency by a factor of between 2 and 3 as the dose rate was 
decreased to 1 Cy/h at dose between 4 Gy and 8 Gy. Further 
protraction lead to even greater reduction in transforma-
tion frequency. Recent experiments using a dose rate of 
1 Cy/d yielded a dose rate reduction factor of 2 compared 
to 1 Gy/h or a dose rate reduction factor of 5 compared to 
1 Gy/min. There was no significant difference in trans-
formation frequency between 1 Gy/d and 4 Gy/d. 
In order to rule out the possibility that the further re-
duction in transformation frequency by protracting irradia-
tion over several days was due to a decrease in transforma-
tion sensitivity as cells divide after plating, experiments 
were performed with high dose rate irradiation given either 
Eh, lEh, 24h or 48h after plating but no significant dif-
ference in transformation frequency ~~as found ('I'hese time 
span the duration of all exposures at 4 Cy/d which gave 
similar results as 1 Cy/d). 
T.herefcre, we conclude that there is a significant sparing 
effect on cell transformation at very low dose rates, i.e. 
those dose rates at which no furter sparing effect with 
regard to cell survival can ~e found. 
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I. Objectives of the project: 
To mxiertake a wi.de-nugirg study of the bioloqic:al effect:; of intennediate-
energy neut:ra1s an::l assess inplications for radic•loqical prat:ect.ian an::l 
radiobiology. 
11. Objectives for the reporting period: 
To establish the relative biological effectiveness of 24 keV neutrons for: 
(i) cell transfonnatian in vitro in C:3H lOI'!s JOOUSia fibroblasts; an::l 
(ii) micronucleus irductian in ht.nnan periJDeral blood l}'Diilocytes. 
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Ill. Progress achieved: 
1. Introduction 
Little biological data exist for exposure to intennediate-energy neu-
trons, yet a kno!.rledge of the relative effects of these neutrons is inp::>rtant. 
'Ibis is because they contribute a significant proportion of the oocupational 
dose equivalent arourxi rruclear reactors ani other neutron-prcxlucirg facilities 
such as medical aCDel.erators ani high energy synchrotrons (Harvey ani Beynon, 
1972; Mill, 1982). However, the neutron dose equivalent includes a factor, the 
quality factor (Q) , to aoocxmt for the increased effectiveness of neutrons 
c::x:mpared with low-IEI' _ radiations in prcxlucirg late biological effects such as 
cancer ani recently, national bodies such as the National Council on Radiation 
Protection an:i Measurements (N<E>) (in the USA) an:i the National Radiological 
Protection Board (NRPB) (in the UK) have suggested an upward revision of Q 
values. '1he case for these revisions is based al.Joost exclusively on evidence 
from experimental data since no significant epidemiological data for neutron 
exposures are available. However, these data are for fission-energy or fast 
neutrons - high energies not often encountered in oocupational exposure. 
Infonnation on the relative effects of intermediate-energy neutrons would be 
mre relevant an:i shoold fonn a major inp.rt into decisions concernin:] possible 
revisions in Q values. 
Also of interest is that the ionisirg products of intezmediate-energy 
neutrons have ran;JeS in tissue which are oatparable to the dimensions of 
cellular cayp:nents thought to be key taJ::gets in the expression of radiation 
damage. 'lhus data on the effects of these neutrons will aid :fun:Jamental 
studies aimed at urDerstanli.rg the mechanisms of radiation-irx:luced injw:y. 
SUch studies OCIIplement the work carried out with soft X-rays (COX et 
al., 1977). 
Finally, a knc:Jiiledge of the biological effects of intennediate-energy 
neutrons is crucial for their awlication to neutron capture therapy (Ncr) • 
Followirg the recent successes reported from Japan on the treatment of high-
-grade gliaoas with thermal neutrons (Hatanaka, 1983), there is 1'lOW renewed 
interest world-wide in this technique (Mill, 1989). However, thermal neutrons 
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have little penetratin;J pa..;er an:l for adequate irradiatioo of deeply-sited 
'b.molrs part of the patient's skull llllSt be reDDITed. Intermediate-energy 
neutrons, however, offer a superior treatment JOOdality aver thermal neutrons 
(Mill an:l HarrisCBl, 1988; Perks et al., 1988). ~Y" sha.tl.d permit the uniform 
irradiatioo of all 'b.molrs usirg lllll.tifractioo treatments without recourse to 
surgery. For their ultimate awlicatioo to NCl' the biolCXJical effects of 
i.ntenDediate-energy neutrons needs to be ascertained. 
'Ibis report details experiments carried out durirg the past :fwr years to 
det:emine the· relative biolCXJical effectiveness of i.ntenDediate-energy neu-
trons. Two cell lines (Hei.a S3 human camer cells ,aJ'd C:3H 10l'!i muse fi.bro-
blasts) an:l fresh human blood were used in the i.rnadiations. 'lbe biolCXJical 
empoints investigated were smvival (Heia an:l ¥ 10l'!i cells), cell:. trans-
forma.tioo (C:3H 10l'!i cells) and micronucleus imuct.ioo (human periJileral blood 
lyqhx:ytes) • 
2. '1he neutral beams at the Harwell I..aboratory 
One method of producirg beams of intermediate-energy neutrons is to 
filter the broad spectrum of neutrons present in a nuclear reactor. For 
exanple, a filter ca!pOSed of iron, aluminium an:l :sulpmr can be used to 
produce relatively p.u:e beams of 24 keV neutrons aJrd this technique has been 
used oo a J1UIIiJer of research reactors (Mill an:l Ha:rvey, 1980) • unfortunately, 
many beams are unsuitable for radici>iolCXJical expe:['iments because of their low 
intensity or because of their high oontri.butioo fl:1::111 fast neutrons. '!he 
flueraH:o-dcse cawersioo factor c:han}es quite rapidly with neutral energy in 
the regioo fl:'aa 10 to 100 keV an:l it is inpor.tant to keep fast neutron con-
taminatioo to a mi.nim.Im. 
In 1985, an intense an:l p.u:e beam of 24 keV neutrons, suitable for 
radici>iol(Xjical studies was made available on the PIIJro high-flux research 
reactor at the Haniel.l laboratory. '!he dos.imetry aJrd spa:LLooetry of the beam 
are described by Perks et al. {1988) • '!he free-in-air kenna rate fl:1::lll neutrons 
is 0.35 Gy h-1 with 79% of the kenna due to neutrons at 24 keV (the remaining 
21% is fl:1::lll neutrons with higher energies, althcAlgltl these represent only 7% of 
the total fluence). '!he contribution fran gamna radiatioo is 0.03 Gy h-1• 
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Fortunately, the beam is a vertical one, enabli..n} the irradiation of cell 
cultures in petri dishes. 
Most of the irradiations descr:il:led in this report were carried out usi..n} 
the 24 keV neutron beam. HolrleVer, a small llUIIiler of exposures usi..n} a beam 
with a mean energy of 10 keV were also carried out. 'Ihi.s beam is produced by 
usi..n} a filter of aluminimn, argon am sulprur. Unlike the 24 keV beam this 
beam is not truly lOOI'lOel'lergetic. 
3. Experimental Procedure 
'1\lo cell lines (Heia S3 hmnan cancer cells am C:3H 10'I'l5 IOOUSe fibro-
blasts) am fresh hmnan blood were used in the irradiations. 'nle procedures 
for both Heia am lOT's cells were similar. Approximately six days prior to 
irradiation sufficient llUIIilers of cells were inoculated into 35 nun diameter 
petri dishes containi..rg 1. 5 an3 of growth medimn am allowed to grow to 
oonfluenoe (in the case of Heia) or near confluence (for lOT's) • At this stage 
the growth rates of the cultures are greatly reduced. 'Ihi.s was necessary to 
SUJ:Press proliferation duri..n} the lon;J irradiation times which were up to 18 
hours. 'Dle irradiations were carried out at 37 °c, maintained by blowi..n} air 
aver the specimen. In order to prevent evaporation of the medimn duri..n} 
exposure the dishes were sealed with thin plastic film. 
Followl.rv;J renDVa1 fran the neutron beam the medimn was sucked off am 
trypsin added to detach the cells frcan the surface of the dish. 'Dle cells were 
then resuspen:ied in about 5 an3 of growth medimn am the cell concentration 
evaluated. 'Dle suspensions were diluted am replated onto fresh 10 an diameter 
petri dishes (Heia cells) or into prewarmad am pregassed 150 an2 flasks 
containi..n} 50 an3 of growth medimn (lOT's cells). 'Dle sanples were transported 
to Berkeley NUclear laboratories (BNL) in a battery--pc::lVIel:'Ed portable in-
cubator. Here they were transferred to a wann roan kept at 37 °c. 
Heia cells were cultured in Eagle's Minilii.Im Essential Medimn (EMEM) 
SUJ:Plemented with 16% foetal calf serum (FCS), 1% non-essential amino acids 
am 2 li'M HEPES. For lOT's cells the culture medimn was Eagle's Basal Medimn 
- 1613 -
st.Wlemented with 10% heat-inactivated ro; ani uaintained .in· an a"boosJilere 
oantaini.rg 5% carlxn dioxide. 
For the sw:vival assay, sanples were fixed ani stained with methylene 
blue twelve or thirteen days after eJqXJSUre. Survivin;J fractioos for both cell 
lines were assessed on the usual criterion of fifty or more non-giant cells 
per oolany. 
For cell transfomation sanples were incubated for a further four weeks 
with weekly medilnD c::harges. After the first medil.nD c:barge the serum con-
centration was reduced to 5%. After two to three weeks incubation lOT~ cells 
have fODDed a confluent contact-inhibited 11D110layer on the base of the flasks. 
TransfODDed cells grow into dense piles (known as foci) ani are tunrAlrogenic. 
Foci were scored by eye on the basis of J!Drlilological c:ilarges. !Die spontaneous· 
transfomatiat frequency .in unirradiated cells .in our laboratoey is about 
10-5• 
cells were either irradiated free-in-air (both 1~ ani Heia, usin;J· · 
24 keV neut:rcms) or at various depths with.in a polyethylene pmnt:an (Heia 
only, usin;J 10 keV ani 24 keV neutrons) • For the pmnt:an i.rradiatioos up to 
four dishes were placed at various depths with.in a 60 mn diameter :phantan am 
exposed to total .incident neutron fluen::leS .in the rarge 0.8 to 
2. 4 x 1012 an - 2 • For saoe pmnt:an irradiatioos boric acid (enriched .in 10a) 
was added to the medil.nD to give 10a ClCI'X:lel'1tra .in the rarge fran 30 to 
80 pq ml.-1 • cells so irradiated are ad:litionally exposed to 1.5 MeV a-par-
ticles (rarge in tissue about 9 ~) produced by the reactiat: 
lOa + In => 1Li. + a + 2. 79 MeV. 
In the case of the blood cultures, these ·were irradiated as whole blood 
with.in a few hours of bein;J obtained fran a healthy donor. After trans-
portation to ItiL, growth medil.nD (Eagles Minilll..nn Essential Medil.nD plus heat-
-.inactivated R:S) ani PtYtohaemagglutinin were added to the blood which was 
then cultured for forty-four hours. At this time cyt.odlal.asin B was added am 
the incubation peri<Xl oontinued for a further twenty-eight hours when the 
cultures were fixed am stained. '!his procedure results .in the fonnation of a 
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number of birrucleated lyqilocytes, sane of which will also contain small 
fragments of nuclear material (micronuclei). 'Dle cytoc::halasin B suppresses 
daughter cell separation but allows nonnal nuclear division. 'Ibis provides an 
aacurate tally of lyqilocytes which have mxiergone one division am which can 
potentially express micronucleus fonnation. FUrther details of this novel 
tedmique are described by Hall am Wells (1988) • 
For the detennination of the relative biological effectiveness (me) of 
the neutron beam, X-ray irradiations were also carried out. For these a 
Rlilips 420k.V x-ray set ~ at 250 k.V am 15 mA with 1. 6 mn altnninil.Dn am 
1. 6 mn copper filtration was used. At a distance of 78 cm fran the focus the 
absomed dose-rate in tissue is o. 4 Gy min - 1. 
4. Results am discussion 
4.1 Smvival data 
'!he free-in-air sw:vival cmves ootained after irradiation with 24 keV 
neutrons are exponential with no evidence of a shoulder. 'Ibis k:im of sw:vival 
1 curve is typically fOI..U'rl for irradiation with densely-ionising radiation. 
Until these experiments were carried out it was not certain whether the low 
energy recoil protons produced by 24 keV neutrons 'WOUld act like sparsely- or 
densely-ionising radiation. 'Ihese recoil protons have a maximum range of about 
500 nm am the .inplication is that interactions between events greater than 
this do not contribute to cell death. '!he interpretation of data obtained with 
24 keV neutrons using V79 cells is discussed in detail by Holt (1988). 
'!he sw:vival curves have been fitted to the data by a non-linear least 
squares regression analysis using the equation: 
s = exp (-aD -{3Ti2) 
where S is the sw:viving fraction am D is the absomed dose. For the 24 keV 
neutron curves, the value of /3 was taken as zero. '!he calculated values of a 
am {3 are given in table I, alorq with the low-dose me, calculated as the 
ratio of a values. 
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Table I. Parameters of the best-fit lines calculated by 1~-squares 
:regression for the relationship: s = exp(-aD -/ID ) for Heia am 
c 3H 1or~ cells. 
Cell line £iO kVp x-rays _2 
ajGy 13/Gy 
24 keV~ rile 
ajGy (ratio of a values) 
Heia S3 0.410 ± 0.059 0.045 ± 0.014 
C3H 1or~ 0.337 ± 0.035 0.007 ± 0.005 
1.35 ± 0.04 
1.13 ± 0.04 
3.3 ± 0.5 
3.4 ± 0.6 
Cells irradiated in the IiJantan are exposed to a wider quality of rad-
iations. 'Ihese are (i) a-particles am lithium recoil nuclei (boronated cells 
only); (ii) protons fran elastic scatterirg events with hydrogen am capture 
events in nitrogen; am (iii) ganma rays, both incident in the beam am frcan 
capture events in hydrogen. '!he contribution of each of these canponents am 
their variation with depth in the IiJantan have been calculated usirg Monte-
-carlo carp.Iter code techniques (Mill am Harrison, 1988). '!he data set 
oont:ainin;J 79 dose-survival points were then analysed by liR.lltiple linear 
:regression on the assunption that (i) the damage incurred frcan the three 
canponents was i.n:iepeOOent am (ii) the dose-response relationship for each 
CCI'l'p>lleilt was exponential. ie the data were fitted to the equation: 
log(sw:vival) = ~11> + kJ'a + krJlr 
where the subscripts p, a am r refer respectively to proton recoil, a-par-
ticle am ganma ray canponents. ~7 values (=-k-1 ) of 0.84 ± 0.04 Gy, 
o. 78 ± o.o4 Gy am 10.3 ± 5.4 Gy were ootained. 
'!he value ~ of 1.28 Gy-1 is in excellent agreement with the value of a 
for the free-in-air 24 keV neutron exposures of 1.35 Gy-1 as given in Table I. 
Clearly there is essentially no difference in the biological effectiveness 
between 24 keV neutrons am i.nternally-emitted 1.5 MeV a-particles. '!he linear 
energy transfer (IEI') of a-particles with this energy is approxllna.tely 
200 keV IJIII-1 (M::>rgan et al., 1988; Mill et al., 1989). 
4. 2 Micronucleus data 
'!he frequency of micronucleus induction as a function of radiation dose 
can be fitted to the :relationship (Wells et al., 1989): 
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N=a+bD+~ 
where N is the number of micronucleui per binucleate cell arx:l D is the ab-
somed dose. A Sllllil1al:Y of the results OOtained for 24 keV neutrons, a-parti-
cles of IEl' 23 keV J.'lll-1 arx:l 250 kVp x-rays is shotm in Table II. 
Table II. Parameters of the best-fit lines calculated by lF-squares 
regression for the relationship: N = a + bD + cD for micronucleus 
i.rxiuction in human l}'lllilocytes. 
Radiation Type 
250 kVp x:rays 29 ± 6 
23 keV J.'lll a-particles 20 ± 13 
24 keV neutrons 16 ± 6 
44 ± 23 
330 ± 54 
930 ± 55 
55 ± 6 
me 
(ratio of b values) 
1 
7.5 ± 4.1 
21 ± 11 
'!he me obtained for 24 keV neutrons is in broad agreement with the value 
reported by I.J.oyd et al., (1988) for dlrcxoosane aberrations, also in human 
blood. 
4.3 Transformation data 
Only a preliininary analysis of the transformation data has so far been 
carried out due to the large number of sanples to be scored arx:l analysed. '!he 
figure sharJs the results for irradiation with 24 keV neutrons, 20 arx:l 
23 keV J.'lll-1 a-particles arx:l protons arx:l 250 kVp X-rays. Clearly 24 keV neu-
trons are very effective in produci.rg transformants. At a transformation 
frequency equivalent to that produced by 2 Gy of X-rays, the me is about 12. 
For doses above about 0.5 Gy of neutrons it awears that the transformation 
frequency is higher than any level observed with X-rays, thus it is i.np:>ssible 
to define a value for the me at these neutron doses. 
5. SUimnary 
'!he relative biological effectiveness of 24 keV neutrons in a range of 
biological systems has been shown to be high arx:l carparable to the effective-
ness of high-IEI' a-particles. However, this response is well predicted by the 
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IEI'-di.strililtion of 24 keV neutrons am is in broad agreement with the cur-
rently-used values of the quality factor for i.ntennediate-energy neutrons. 
we are indebted to staff at the Hanlell laboratory for their SUR;IOrt am 
the use of their facilities; also to Dr L. Hei.ber for suwlyirg our stocks of 
<;H 10'1% cells a.M advice on their culture. 
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I. Objectives of the project: 
For three decades, retroviruses have been suspected -although not 
demonstrated unequivocally- to play a role in radiation-induced thymic 
lymphomagenesis in mice. Our proposal consisted in determining the 
molecular mechanisms by which radiation leukeMia virus (RadLV) exerts its 
leukemogenic effect, and in searching if similar mechanisms take place in 
radiation-induced thymic lymphomagenesis. Moreover, we proposed to 
investigate if the latter involves the participation of oncogenes, 
activated either by falling under the control of retroviral _genomes or 
other genomic elements, or by other mechanis~s such as somatic mutational 
events. 
11. Objectives for the reporting period: 
1. Molecular cloning and sequencing of the RadLV proviral genome and 
identification of the sequences that determine its leukemogenic 
potential, to disclose the mechanisms by which this potential comes to 
expression. 
2. Search for experimental evidence in favour of the idea that RadLV 
might activate oncoqenes by mutational insertion. 
3. Search for acquired Radi.V-like proviral genomes and for retrovirus-
activated oncogenes in the radiation-induced thymic lymphomas. 
4.Identification of factors ether than retroviruses or retrovirus-
controlled cellular genes, that might contribute to the malignant 
transformation (i.e. mitogenic growth factors or mutated oncogenes). 
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Ill. Progress achieved: 
1. Methodology 
1.1. Animals and viruses. Inoculations of RadLV were done in rats of the 
R strain or in mice of the C57BL strain (initially C57BL/Cnb, later 
C57BL/Ka). In the initial experiments we used the retroviral complex 
released by the cultivated BL/VL3 cells, and later the molecularly cloned 
RadLV/VL3 (T+L+) virus. Radiation-induced thymic lymphomas were obtained 
by treating C57BL/Ka mice with 4 weekly doses of 1. 75 Gy of X-rays 
(direct induction protocol). An indirect induction protocol consisted in 
irradiating, according the same schedule, thymectomised mice bearing the 
Thy-1. 2 surface antigen. Immediately therafter, they received a 
subcutaneous graft with thymuses from Thy-1.1 bearing congenic newborn 
mice. 
1.2. Molecular cloning of the RadLV genome. Retroviruses released by an 
in vitro cultivated RadLV-induced thymic lymphoma (RadLV/VL3) were used 
to infect a permissive cell line (BL-RL12-NP) . Newly synthesized proviral 
DNA was isolated before its integration into the cellular DNA, and cloned 
into the Psti restriction site of the bacterial plasmid pBR322. The 
biological integrity of the clone was tested by assessing the release of 
thymotropic and lymphomagenic virus upon transfection of cultivated cells 
(SC-1). 
1. 3. Nucleotide sequencing. Sequencing of the cloned RadLV genome was 
performed by the chemical method of Maxam and Gilbert. Later, sequencing 
of oncogenes was performed using the enzymatic dideoxy method. The 
primers for the Klenow fragment of DNA polymerase I were synthesized 
chemically using a Cyclone DNA Synthesizer (New Brunswick) . 
1.4. Molecular hybridizations. Provirus acquisitions and gene 
rearrangements were investigated using restriction enzyme digestions, 
agarose gel electrophoresis of the restriction fragments, transfer to 
filter membranes (Southern technique) and molecular hybridization with 
adequate probes. Gene expression was investigated by agarose gel 
electrophoresis of polyadenylated RNA followed by transfer to filter 
membranes (Northern method) and molecular hybridization with adequate 
probes received from various sources. Specific detection of RadLV-like 
proviruses was done with a probe (pEc-B4) that we hade been made able to 
choose upon examination of the nucleotide sequence of RadLV. 
1.5. Polymerase chain reaction (PCR). Whole chromosomal DNA was used as a 
substrate for the amplification of specific gene fragments. The reaction 
was primed with chemically synthesized oligodeoxyribonucleotides 
(Cyclone DNA Synthesizer, New Brunswick) , and performed with Taq DNA 
polymerase in a home-made, computer-driven automated PCR instrument. 
1.6. Involvement of growth factors in radiation leukemogenesis. The 
possible involvement of interleukin 1 (IL-l) and interleukin 6 (IL-6) was 
studied by inhibiting their synthesis with indomethacin, present at 20 
ug/ml in the drinking water from the 8th day before the first 
irradiation. The possible role of interleukin 2 (IL-2) was investigated 
by injecting three times a week the immunosuppressive peptide cyclosporin 
A (25 to 100 mg/kg) from the day before the first irradiation. In situ 
molecular hybridization was used to detect the expression of specific 
RNAs. Cytokine levels in blood and culture medium were measured by 
bioassays. 
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2. Results. 
2.1. Investigations on the viral etiology of radiation-induced lymphomas. 
2.1.1. Molecular cloning of the RadLV genome. 
Twenty hour cocultures of RadLV-producing BL/VL3 cells with BL/RL12-NP 
cells displayed, as expected, the appearance of a very homogeneous 
population of 8. 9 k~lobase pair (kbp) long extrachromosomal retroviral 
DNA molecules. Its homogeneity was demonstrated by the fact that 
digestions with a series of restriction enzymes yielded homogeneous 
patterns. The molecules were shown not to contain other Psti restriction 
sites than that present in each of the two identical long terminal repeat 
(LTR) sequences. Therefore, Psti digestion yielded a 8. 3 kbp fragment 
that was representative of the whole retroviral genome, including one 
~plit LTR of which part of the sequence was present at the 5' end and the 
other part at the 3' end. This fragment was ligated to the bacterial 
plasmid pBR322, yielding a recombinant plasmid that could be replicated 
to ponderal amounts after transformation and cultivation of competent 
bacterial cells. 
After its recovery from the plasmid by Psti digestion, the purified 
insert was used to transfect SC-1 cells which, as soon as a few hours 
thereafter, showed a massive production of retroviral particles. When 
inoculated into C57BL/Ka mice, they were shown to be thymotropic (early 
appearance of retroviral antigens on the surface of the thymic cells, as 
shown .bY immunofluorescence) and lymphomagenic (appearance of thymic 
lymphomas, with the same incidence (100 %) and latency period (3 to 6 
months) as the in vitro propagated RadLV/VL3. 
Because of the homogeneity of the uncloned extrachromosomal DNA, and 
because of the thymotropicity and leukemogenicity of the virus released 
upon transfection, we concluded that we had succeeded in cloning 
molecularly the major thymotropic and leukemogenic componant of the RadLV 
complex produced by the BL/VL3 thymic lymphoma cell line. Hence, we 
called it RadLV/VL3(T+L+). 
2.1.2. The nucleotide sequence of RadLV/VL3(T+L+). 
The RadLV/VL3(T+L+) genome is 8,318 nucleotides long. It is typically 
that of a chronic murine leukemia virus in that it contains the LTR, the 
~ gene (encoding the internal proteins plS, pl2, p30 and plO), the pol 
gene (encoding a protease, the reverse transcriptase and an endonuclease) 
and the env gene (encoding the membrane glycoprotein gp70 and protein 
NplS, and~e so-called R peptide of which the function is unknown). In 
contrast with acute mur~ne leukemia viruses, it does not contain 
sequences derived from a cellular gene. 
The bulk of the sequence is very similar to that of the endogenous, 
ecotropic Akv retrovirus of the AKR mouse. Its recombinant nature is 
however attested to by the obvious xenotropic features of the LTR and of 
the R peptide sequences. Outside the LTR, the sequence did not show 
characteristics that could be tentatively related to the oncogenic 
potential of the virus. 
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The LTR is 583 nucleotides long, and contains the typical TATA and CAT 
box sequences that are the promoters for RNA synthesis. In the 5' LTR, 
these promoters are responsible for the synthesis of the viral RNAs. 
The template RNA for the gag and E£! gene products is 8,318 nucleotides 
long. Due to the presence of two potential splicing sites, the template 
RNA for the env gene products may be either 3,019 or 3,322 nucleotides 
long. The analysis of the viral RNAs from virus-induced thymic lymphomas 
indicates that both sites may be used. In the 3' LTR, the promoters for 
RNA synthesis may play an important role in leukemogenesis. Indeed, they 
should be capable of promoting the synthesis of RNA from cellular genes 
adjacent to the 3' end of the integrated provirus. Proviral insertion 
adjacent to an oncogene might in this way lead to the appearance of a 
clonal tumor due to overexpression of this oncogene. This had been shmm 
to be the case in a few retrovirus-induced avian or murine leukemias, and 
there was no reason to believe that RadLV might be capable of acting in 
the same way. 
Another interesting feature of the LTR is the presence of a 43 bp long 
dupl~cated sequence, containing a consensus sequence which has the 
characteristics of enhancer of RNA synthesis. Such sequences can exert a 
remote action on genes that are located thousands of bases away, and in 
either orientation. Proviral integration in a more or less large domain 
encompassing an oncogene may thus lead to tumor formation, as it has been 
shown not only in some avian or murine retrovirus-induced leukemias, but 
also in mammary tumor virus-induced cancers. Tumorigenesis due to 
retroviral insertion adjacent to or in the vicinity of a cellular gene 
has been called "insertional mutation oncogenesis". 
2.1.3. A search for insertional mutagenesis by RadLV/VL3(T+L+). 
For such studies, RadLV/VL3(T+L+) was used to induce thymic lymphomas in 
the rat rather than in the mouse, which allowed us to avoid any 
interference between the phenomena to be studied and those that could be 
attributable to the numerous endogenous mouse proviruses. Indeed, there 
is but a low sequence homology between mouse and rat retroviruses. 
Since retroviral insertion had been described in a domain encompassing the 
~ oncogene of retrovirus-induced chick, mouse or rat tumors, this gene 
seemed to be a good candidate to initiate these studies. Out of 30 
RadLV/VL3(T+L+) tumors investigated, 4 presented a modified~ domain as 
shown by restriction enzyme analysis. We could show that the 
modifications resulted from the insertion of retroviral sequences (either 
a complete or a partial genome) in this domain. We did not find evidence 
for this in the 26 other tumors, which could be supposed to have been 
induced by proviral insertion in the vicinity of another oncogene or by 
another, yet undefined mechanism. 
In a next step, we designed experiments in order to investigate if the 
observed insertional mutagenesis could be considered as causative of cell 
proliferation rather than as an iniating step. Rat embryo fibroblasts 
were infected with RadLV and their DNA was then submitted to restriction 
enzyme analysis in order to examine the integration pattern of the 
acquired proviruses. As could be expected, the integration proved to have 
occurred completely at random. However, further cultivation of the 
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infected cultures resulted in the selective growth of cell clones, of 
which most displayed provirus at a given, although yet unidentified 
location. The same phenomenon was observed in the case of RadLV-induced 
mouse thymic lymphomas, which also underwent clonal growth in association 
with provirus in a given, though also unknoWn domain. From those results, 
we concluded that insertional mutation might not be a prerequisite for 
RadLV-induced lymphomagenesis. However, it may confer the cells a growth 
advantage in vitro and occasionally in vivo, constituting perhaps in this 
case a facilitating factor for the growth of some tumors. 
2.1.4. A search for novel proviruses in radiation-induced thymic 
lymphomas. 
Knowing the nucleotide sequence of RadLV/VL3(T+L+), we could easily chose 
the combination ~f a restriction enzyme and of an adequate probe to test 
for the acquisition of RadLV-like proviruses in radiation-induced mouse 
thymic lymphomas. The enzyme used was Kpni or Asp718, and the probe 
pEc-B4, which is homologous to ecotropic-specific sequences in the gp70 
region of the RadLV-like proviral genomes. 
RadLV-like proviruses were shown to have been acquired clonally in one 
third of the investigated lymphomas. The integration domain has yet not 
been identified, except in a single tumor were it turned out to be mlvi-1. 
Mlvi-1 is a presumed oncogene -which had been reported as being activated 
by insertional mutation in a number of retrovirus-induced mouse or rat 
tumors. This was ~he first evidence that radiation th}~ic lymphomagenesis 
may proceed by this mechanism, albeit only occasionally. We thus wondered 
about the significance of the apparent absence of novel provirus in the 
majority of the tumors. It had been previously reported in the literature 
that RadLV-like retroviral particles, although most often not detectable 
in primary tumors, could frequently be observed in cultivated lymphoma 
cells. Therefore, radiation-induced tumors were submitted to in vitro 
cultivation or to in vivo transplantation and subsequently analysed for 
the presence of novel proviruses. These were found in the majority of the 
cases but, as in the case of most provirus-positive radiation tumors, we 
could not yet demonstrate their presence in a specific domain of the DNA. 
This situation was similar to that observed in the case of RadLV-induced 
lymphomas or in that of in vitro RadLV-infected fibroblasts, with respect 
to the existence in most of the tumors of a minor cell population that 
could undergo preferential growth in association with the presence of 
novel provirus. So, we concluded that RadLV could hardly still be 
regarded as an initiating factor for radiation-induced lymphomagenesis 
but that it cquld however be considered as a facilitating, although 
dispensable agent for tumor growth. 
2.1.5. Discussion. 
The leukemogenic component of the RadLV complex is a recombinant 
retrovirus, generated from host endogenous retroviruses that had been 
presumably driven to expression by radiation. Whether induced 
straightforwards by irradiation or indirectly in non-irradiated thymuses 
implanted in irradiated hosts, one third of the radiation-induced mouse 
thymic lymphomas display the presence, in a large proportion or in the 
majority of their cells, of an acquired RadLV-related provirus. They 
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could not be shown to be inserted in a common domain of the tumour cell 
DNA. In one single case, the integration had occurred in the mlvi-1 
domain, a common proviral integration site in many of the the Moloney 
leukemia provirus induced rat thymic lymphomas. The apparently 
provirus-negative tumours contained a minor cell population that has en 
in vivo or in vitro growth advantage in relation with the presence of a 
novel provirus. We thus consider that, although it might play a 
facilitating role in the growth of a certain proportion (one third) of 
the radiation-induced thymic lymphomas, RadLV might not be the 
etiological agent. 
2.2. Ras gene mutations in radiation-induced mouse thymic lymphomas. 
2.2.1. Introduction. 
Since the hypothesis of a viral etiology of radiation-induced thymic 
lymphomagenesis was no longer tenable, we reoriented our experimental 
work towards a search for other possible causes. It had been known for 
several years that mutationally activated ras genes are often associated 
with a variety of human or animal malignancies. Activated ras genes are 
presently considered as the primary cause of the developme~of many of 
those malignancies. A high proportion of radiation-induced mouse thymic 
lymphomas had been shown to contain an activated K-ras or less 
frequently N-ras, mutated at codon 12. However, these studies involved 
only a very limited number of tumors, and the report that no other 
mutation than a GGT to GAT transition was found in our eyes quite 
intriguing. Indeed, we would not expect radiation to induce exclusively 
this unique nucleotide substitution. Moreover, nucleotide substitutions 
were searched for exclusively in ras genes that had been selected by 
transfection of cultured fibroblast5. Such in vitro transforming genes 
might actually not represent at all the bulk of the ras gene population 
in the tumor itself. 
Therefore, we used the polymerase chain reaction (PCR) to amplify 
selectively from total thymic lymphoma DNA a ras gene segment (exon 1 + 
intron 1.2 + most of exon 2) encompassing codo~12, 13 and 61, reported 
as those that are critically mutated in relation with the acquisition of 
in vitro transforming activity. Thus, no bias was introduced by modifying 
experimentally the original proportion of the various ras alleles 
possibly present in the tumor. Subsequently, we also avoided the 
classical bias consisting in searching exclusively for predetermined 
mutations by molecular hybridization with a corresponding oligonucleotide 
probe, by determining the entire nucleotide sequence of the amplified ras 
gene segment. In such a way, any DNA alteration must be made visible. 
Straightforward sequencing of PCR products, even from individual tumor 
DNA, cannot yield readable results due to the simultaneous presence of 
normal and of somatically mutated DNA and, as found later, to the 
coexistence of H-ras genes bearing different mutations. Sequencing was 
thus performed on ~eries of molecular clones from each PCR reaction. 
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2.2.2. Results. 
The results of the sequencing experiments performed on the PeR-amplified 
H-~ segment are summarised in Table I. 
1) Every investigated tumour was characterised by the coexistence of 
H-ras genes that could be distinguished from each other by one or several 
point mutations. 
2) The observed mutations were not introduced by a PCR artefact. Among 7 
H-ras clones derived from the PCR products of 2 control tissues (thymus 
andliver), only 2 were found to display a single -and identical-
mutation involving the third base of a codon. This might represent an 
actual in vivo situation and not necessarily an artefact, since the 
degeneracy of the genetic code is compatible ~Tith the occurrence of such 
mutations. 
3) Individual tumours are constituted by an heterogeneous cell 
population with respect as attested to a variety of mutated H-ras genes. 
This apparent lack of clonality is however limited. Two of the 
investigated tumours (48/1/1 and 48/1/11) yielded 2 indistinguishable 
mutated H-~ genes. 
4) A same H-ras molecule often displays several mutations, which may be 
located in t~exons, in the intron, or in both. Mutations in the exons 
often, but not always result in an amino-acid substitution. 
5) Transforming mutations, considered as involved in carcinogenic 
processes (substitution of amino-acid 12, 13 or 61) were not observed. 
6) Among 29 observed mutations, 25 were transitions (purine-purine or 
pyrimidine-pyrimidine substitutions) and 4 were tranversions (purine-
pyrimidine substitution or vice-versa). 
2.2.3. Discussion. 
The large diversity of H-ras point mutations in the radiation-induced 
mouse thymic lymphomas, th~ack of clonality of these tumours in this 
respect, the absence of transforming mutations in this investigated 
proto-oncogene, and the occasional absence of amino-acid substitutions 
resulting from the observed mutations, lead us to conclude that H-ras 
mutations are very probably not involved in the leukemogenic process.-we 
rather postulate that the leukemic cells are hyper-mutable. Moreover, the 
fact that a nonnegligible proportion of the tumour cells may contain 
identical multiple mutations on the H-ras gene suggests that the 
hyper-mutability is an early event in the carcinogenic process. It seems 
plausible that N-ras and/or K-ras will be found to undergo similar 
alterations, but m-addition totransforming mutations such as those 
described formerly in the literature. Experiments are being performed to 
test this prediction, as well as to investigate the possible 
hyper-mutability of other, non ~-related genes in the leukemic cells. 
An alternative interpretation of our findings is that the variety of 
H-ras mutations in the radiation-induced thymic lymphomas reflects 
permanent DNA alterations that were caused during the irradiation. In 
such case, one might expect to find similar alteration in 
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non-tumorous tissues of the leukemic mice. Experiments are being 
performed to test this hypothesis. If this proved to be correct, the 
implications would be that measuring the number of such alterations in 
circulating blood lymphocytes might allow to assess radiation damage. 
TABLE I. Mutations in molecular clones from PCR-amplified H-ras (exonl -
intronl.2 - exon2) of radiation-induced thymic lymphomas and of 
control tissues. 
Tissue 
or tumour 
Clone N° 
48/1/1 1 
48/1/8 
48/1/10 
48/1/11 
48/2/4 
thymus 
liver 
2 
3 
4,5 
6 
1 
2 
1 
2 
3 
1 
2 
3,4 
1,4 
2 
5,6 
3 
7 
8 
4 clones 
1 clone 
2 clones 
Exons 1 and 2 
codon mutation substitut. 
68 
60 
16 
CGG-CTG Arg-Leu 
GGT-GTT Gly-Cys 
AAG-AGG Lys-Ser 
50 ACA-ACG 
18 
23 
47 
39 
44 
GCC-ACC 
CTG-CCG 
GAT-GGT 
TCC-TCT 
GTG-GTA 
50 ACA-ACG 
52 CTA-TTA 
59 
71 
56 
57 
38 
73 
41 
35 
81 
18 
18 
51 
GCA-ACA 
TAC-CAC 
TTA-TTG 
GAC-GTC 
GAC-GGC 
CGC-CGT 
CGG-CAG 
ACT-ACC 
GTA-GTG 
GCC-GCT 
GCC-GTC 
TGT-TGC 
Ala-Thr 
Leu-Pro 
Asp-Gly 
Ala-Thr 
Tyr-His 
Asp-Val 
Asp-Gly 
Arg-Gln 
Ala-Val 
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Intron 1.2 
position mutation 
92 
58 
94 
36 
200 
190 
185 
114 
116 
G-A 
A-T 
T-C 
C-T 
T-C 
T-C 
C-T 
G-A 
A-0 
2.3. Cellular studies. 
In vivo 
involved 
indirect 
graft in 
and in vitro studies were aimed to understanding mechanisms 
in leukemogenic transformation. They should also apply to 
leukemogenesis, i.e. transformation of a nonirradiated thymic 
an irradiated host. 
Thymic lymphomas were induced with the classical irradiation protocol (4 
x 1.75 Gy) in C57BL mice. The yield was close to lOO %and the latency 
approximately 120 days after the last irradiation. The contribution of 
growth factors IL-2, IL-l and IL-6 was evaluated by giving cyclosporin A 
(i.p.), or indomethacin (per os). Neither drug altered the course of the 
disease, suggesting that these factors were not critical for 
lymphomagenesis. 
Tumors were also induced in NFS mice, which do not harbour ecotropic 
provirus susceptible to yield leukemogenic retroviruses upon 
recombination with a xenotropic provirus. Indirect lymphomas were 
obtained in thymus grafted to irradiated thymectomised C57BL or NFS 
recipients. Moreover, we obtained one lymphoma in an irradiated nude 
mouse given a thymic graft after the irradiation. 
Phenotype studies were not contributory. However, we recently obtained 
several cell lines from indirect tomors and in four such cases, they were 
negative for Thy-1, Lyt-2, L3T4 and Ig. 
In situ hybridisation revealed low level expression of IL-l, IL-6 and 
IGF-1 and this was not higher in lymphomas than in control thymus. The 
expression of IGF-2 was in contrast increased in 11 out of 11 primary 
lymphomas as ~ompared to control thymus. 
Activation mechanisms in tumor cells were investigated by looking at 
receptors for neurotransmitters and hormones coupled to adenylate 
cyclase. Lymphomas· (induced by radiation or by RadLV) expressed at least 
one such receptor, beta-adrenergic or VIP-ergic. Receptors for VIP are 
remarkable since they are of the "helodermin-prefering" type. 
In conclusion, our cellular and biochemical studies have documented the 
production of IGF-2 by radiation-induced lymphomas. IL-l, IL-6 or IL-2 do 
not play a critical role in lymphomagenesis. Lymphoma cells express 
receptors for hormones or neurotransm~tters coupled to adenylate cyclase. 
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Searching for reorganisation of proto-oncogenes. 
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Ill. Progress achieved: 
1. Methodology 
Classical restriction enzyme analysis of DNA with specific probes for 
molecular hybridization. 
2. Results 
In the frame of project n° 1, we obtained indications that the 
presumed proto-oncogene Mlvi-1 seems sometimes to be involved in 
radiation leukemia virus-induced leukemogenesis of rats. On the other 
hand, our colleagues of the INSERM Unit n° 117 (BordeaWj:, France) 
performed the molecular cloning of a gene that could be rearranged in 
radiation-induced leukemogenesis of C57BL mice. Our colleagues of the GSF 
(Neuherberg, FRG) provided us with a series of DNAs from radiation-
induced osteosarcomas of Balb/c mice. We tested these DNAs for 
rearrangements of the gene that was cloned in Bordeaux, and found that it 
was frequently and considerably amplified. It turned out , that this 
amplifications occurred in the tumors that already had been shown to 
display concommitant amplification of the proto-oncogene c-myc and of the 
presumed oncogene Mlvi-1. This result contributed to the identification 
of the gene studied in Bordeaux as Mlvi-1, and simultaneously confirmed 
the observations made in Neuherberg. 
3. Discussion. 
Radiation-induced osteosarcomas of the Balb/c mouse frequently display 
concommitant amplification of the proto-oncogene c-myc and of the 
presumed proto-oncogene Mlvi-1. It has been presently known that this 
phenomenon is due to the appearance of multiple minute chromosomes 
containing both c-myc and Mlvi-1. However, the contribution of these 
minute chromosomes to the osteosarcomagenetic process is still unknown. 
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EUROPEAN CHILDHOOD LBUKABKLVLDIPBOKA INCIDBNCB STUDY 
Progress Report 
A meeting of collaborators vas held, following the annual meeting of the 
International Association of Cancer Registries, in Haastricht, Netherlands, on 
21 September, vith Or Chadvick, Radiation Protection Programme of the CEC in 
attendance. A report of the meeting is attached. 
Several modifications to the.system of data collection vere proposed, in 
the light of experience of the submission of leukaemia case information from the 
baseline period, 1980-86. The results from most of the centres for !he baseline 
(pre-accident) period vere available, and presented to the meeting. There vas a 
discussion on the most appropriate methods for analysing the data for underlying 
time trends. Registries vill be expected to furnish their 1987 data (updating 
the entire period 1980-87 at the same time) by the end of 1989. A more formal 
presentation of the leukaemia incidence data vas scheduled for the first half of 
1990. 
The recommendations from the committee of experts convened earlier in the 
year by the CEC Radiation Protection Programme vere discussed. It vas not felt 
feasibl~ to extend the study to all childhood cancers. However, it vas agreed 
that dat~ on childhood lymphomas should also be collected and analysed, 
prima~ily because of the difficulties in distinguishing certain leukaemias from 
non-Hodgkin lymphomas, rathe-r: cnan :lilY likely change in incidence as a result of 
radiation exposure. 
A revised protocol of the study vas prepared, taking account of these 
modifications, and has been circulated to all participants in Noyember (!ARC 
Internal Report 89/002 Rev. 1 attached). 
Several contacts have been made in the past vith UNSCEAR. It is proposed to 
use the computer programme developed by UNSCEAR to refine the Chernobyl exposure 
estimation dovn from the rather large geographical areas used in the 1988 
UNSCEAR report to areas of an appropriate population size for epidemiological 
- 1638 -
analyses of childhood leukaemia (1-2 millions). These exposure estimates will be 
calculated over the next 6 months, and before any analysis takes place of 
leukaemia incidence data from after 1986. 
Continuation of study 
As described above, the first formal statistical analyses of childhood 
leukaemia risk in relation to estimated radiation exposure will take place in 
1990, when data from 1980-1987 will have been received. It is proposed that a 
report will be prepared for possible publication during 1990. A publications 
policy has been agreed amongst the collaborators, and incorporated into the 
protocol. The study should continue for at least 4 additional years, so that 
data for a minimum of S years post-Chernobyl are available. Detailed data 
analyses will take place each year. Meetings of participants are anticipated at 
approximately two-yearly intervals, in general to coincide with the annual 
meeting of the International Association of Cancer Registries. 
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TABLE 1 
Participating centres Approx. 1985 Childhood 
population (mill.) 
Austria (National data on childhood leukaemia) 1.3 
Czechoslovakia (Registries of Slovakia, Horavia, Bohemia) 3.8 
Denmark 1.0 
Finland 0.9 
France (2 Paediatric registries: Lorraine, PACA-Corse) 
(1 Haematology registry: Cote d'Or) approx. 1.6 
(2 General registries: Bas-Rhin, Isere) 
German Democratic Republic 
Federal Republic of Germany 
·Hungary 
Italy (Paediatric registry - Torino) 
(General registries: Varese, Genoa, Tuscany, Latina, 
Ragusa, Piemonte) 
Netherlands (Childhood Leukaemia Study Group) 
Norvay 
Poland 
Sveden 
Svitzerland (Regis,-ies of Basel, Geneva, Neufchatel, 
St. Gallen, Vaud and Zurich) 
UK: England & Vales 
Scotland 
USSR: Estonia 
Lithuania 
Yugoslavia: Slovenia 
3.1 
9.6 
2.4 
1.3 
2.5 
0.8 
9.41 
1.5 
0.5 
11.1 
1.3 
0.3 
o.8 
0.5 
1 Quality of registration varies by province, and data from a selected number 
vill be retained. 
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I. Objectives of the project: 
1) To identify genetic changes in proviral genes and 
other cellular genes associated with integrated 
proviruses occuring during the development of bone 
tumours. 
2) To determine the functional role of these mutations 
and to evaluate their role in osteosarcomagenesis. 
11. Objectives for the reporting period: 
1) To isolate and characterise additional viruses from 
bone tumours. 
2) To perform detailled transcriptional analyses of the 
isolated viruses. 
3) To analyse the cellular genes surrounding integrated 
proviruses in bone tumours. 
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Ill. Progress achieved: 
Methodology 
All our work during the period 1985 through 1989 has employed 
murine retroviruses as tools for the study of radiation 
induced carcinogenesis. All viruses are available as 
molecular clones, and standard techniques of molecular 
biology are used throughout the work. 
Results and discussion 
Isolation and characterisation of viruses. One section of the 
research concerns the structure and function of murine 
leukemia viruses associated with bone tumours and with lym-
phoid tumours. This part aims at identifying genetic changes 
specifically associated with the development of bone tumours. 
As well viruses from radiation-induced as from non-radiation 
induced tumours are included in the analysis. The viruses are 
characterized with respect to their pathogenic properties in 
laboratory mouse strains and their genomic structures have 
been analyzed by partial or complete nucleotide sequence 
analysis. A hypervariable region has been identified in the 
part of U3 associated with transcriptional enhancement. The 
structure of this region is important for the activation and 
expression of the viruses in different tissues. The 
biological properties of the viruses and the structures of 
their repeat modules are summarised in Table 1 and Figure 1. 
Virus strain Malignant lymEhoma OsteoEetrosis Osteoma 
p7D 9/10 (365 d) 5/10 (320 d) 1/10 
pN20-7 8/9 (333 d) 8/9 (376 d) 3/9 
lambda OTS-25 12/19 (4 75 d) 2/19 (601 d) 0/19 
lambda OTS-72 4/8 (417 d) 2/8 (396 d) 0/9 
Mock 3/9 (258 d) 0/9 0/9 
Table 1. Pathogenicity in NMRI mice of murine leukemia 
viruses derived from BALB/c mice. Molecular clones: p7D 
(Horowitz and Risser, J. Virol. 56:798-806, 1985) harbours 
the endogenous ecotropic proviru;-of the BALB/c mouse, and 
pN20-7 (Rassart et al., J. Virol, 39:162-171, 1981) harbours 
an exogenous derivative of the endogenous virus. The clones 
lambdaOTS-25 (Strauss et al., 1988) and lambdaOTS-72 (L. 
Pedersen, Thesis, Aa. u., 1987, manuscript in preparation) 
represent somatically acquired proviruses isolated from two 
independent radiation-induced osteosarcomas of the BALB/c 
mouse strain. Mean latency periods (days) are given. 
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Figure 1. Modular arrays of the repeat structures of 
selected MuLV 03 regions. Akv is the endogenous 
ecotropic virus of the AKR strain. SL3-3 and SL3-2 
(Dai et al. 1990) are lymphoma derived AKR viruses. FBJ, 
OA-I (Leib-Mosch et al. 1986), and RFB (manuscript in 
preparation) are bone tumour derived viruses. OTS-3 
represents a non-infectious somatically acquired 
provirus from a radiation-induced osteosarcoma of a 
BALB/c mouse (manuscript in preparation). The two LTRs 
of this virus differ; the downstream 03 region is 
shown. The remaining viruses are described in Table 1. 
The sequences of the modules and the point mutations 
relative to the Akv sequence are given in Pedersen et 
al. (1987). Modules indicated by lowercase letters 
contain only part of the normal module sequence. The 
03 sequences outside the modules are identical or nearly 
identical to the Akv sequences-
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Retrovirus derived vectors. Our studies of provirus 
activation and expression are carried out with defective 
proviruses to avoid uncontrolled spread of viruses during the 
experiment and to avoid the mutations that may accompany 
virus replication. To allow easy measurement of virus 
expression levels we use retroviral vectors with a pro-
karyotic reporter gene, either the gene encoding chlor-
amphenicol acetyltransferase (CAT) or the neo gene encoding 
neomycin phosphotransferase II (NPTII). We have constructed a 
number of such vectors that allow amplification of the DNA in 
prokaryotic vectors before introduction into mammalian cells 
in culture. The vectors are of two types. The structure of 
the expression vectors that exploit signals in the viral DNA 
for control of transcription is summarised in Figure 2. 
Vectors of this type are used for measurement of the strength 
of the transcriptional signals in variant and mutated U3 
regions in different cells in culture. This type of assay 
measures gene expression driven by unintegrated DNA. The 
transmission-expression vectors (Figure 3) are designed to 
allow one cycle of replication of the virus vector after 
introduction into a helper cell-line that provides all 
necessary proteins. This type of vectors allows determination 
of gene expression driven by a vector provirus integrated 
into chromosomal DNA of the host. Both types of vectors are 
based on the same prototype murine leukemia virus, Akv, and 
allow easy exchange of Akv U3 sequences with U3 sequences 
from other viruses (Figure 2 and Figure 3). 
Identification of transcription signals in uninteqrated 
vectors. This part of our work is directed towards the 
identification of nucleotide sequence elements in the U3 
region that regulate transcription by binding of specific 
host-proteins. Such proteins may be general or differentia-
tion-specific transcription factors or may be factors that 
are activated in cells in response to environmental agents. 
Our strategy for this analysis has been to perform a detailed 
genetic analysis of a prototype U3 region (from Akv) in one 
cell line (NIH 3T3) and subsequently to use the results from 
this analysis as the basis for studies of other U3 regions 
and other cell lines. A large number of U3 deletions has been 
introduced into the pAkv6-vector and their effect on 
expression analyzed. The effect of upstream deletions 
extending into U3 is summarised in Fig. 4. The results show a 
successive reduction in expression activity as a result of 
successive deletions and point to critical functions of 
specific sequences in the repeat module region. Additional 
studies using site-specific mutagenesis and purified protein 
fractions (data not shown, H. s. Olsen et al., manuscript 
submitted) have determined that the critical sequences 
mediate their transcriptional function by serving as a target 
for the binding of Nuclear Factor I proteins, a group of 
sequence specific DNA binding proteins in the host cell. 
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Figure 2. Genomic structure of the expression vector pAkv6-
cat and derived vectors (Lovmand et al., manuscript 
submitted, Pedersen et al., 1987, Kjeldgaard et al., 1989, 
Paludan et al., -1989a, Dai et al., 1990). The vectors contain 
an intron and the polyA signal from SV40. The numbers 
indicate the length of the f~agments in base pairs. The 
unique restriction sites Psti (P) and Kpni (K) allow 
insertion of appropriate variant U3 regions as shown (pVar6-
cat). The pAkv8.3-cat vector and the related pAkv8.2-cat and 
pAkv8.1~cat vectors (not shown) allow insertion of various 
fragments in a deleted U3 region or in a position downstream 
of the transcription unit. 
AkvLTR TnS AkvLTR 
1468 480 626 
neo 
SL3-3 LTR TnS SL3-3 LTR 
627 255 1468 480 627 
4 oeo 
• 
Fiqure 3. Structure of transmission-expression vectors 
(Jensen et al., 1986, Paludan et al., 1989a, 1989b). The 
vectors are ,shown as integrated vector proviruses in a 
mammalian host cell. The arrows denote host cell DNA. A 
simple construction scheme allows U3 replacement; A vector 
with the OA-I LTR has also been generated (not shown). 
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CAT 
activity 
-482 
-==->=> c T I 
-1 
Downstream border of deletions 
in U3 
Figure 4. Effect of upstream 
deletions in U3 of Akv upon 
transient expression activity. 
Plasmid DNAs of derivatives of 
pAkv6-cat (Figure 1) with 
upstream deletions in U3 were 
introduced into NIH 3T3 cells 
and the level of vector gene 
expression was determined by 
enzymatic measurements of the 
reporter gene product, CAT. 
The activity of undeleted 
pAKV6-cat is arbitrarily set 
to 100 and relative activity 
levels of the deleted pasmids 
marked on a logarithmic scale. 
The extent of the deletions is 
mapped on the complete U3 
region from base pair -1 to 
base pair -482. The arrows 
mark the two tandem repeats 
(modules B, C, D, E in Fig. 1) 
and C and T the CCAAT and TATA 
boxes, respectively. 
In a separate series of experiments we have analysed the role 
of tandem repeat sequences in gene expression of murine 
retroviruses. As shown in Figure 1, tandem repeats are widely 
occuring in the group of viruses under study, and both the 
mechanisms behind repeat formation and the role of the 
repetitions for provirus activation and expression are 
central in our work. For these studies our model system has 
again been the Akv U3 in NIH 3T3 cells. The vectors pAkv8.1-
cat, pAkv8.2-cat, and pAkv8.3-cat have been used for 
insertion of fragments of tbe Akv U3 region either in an 
upstream position or in a downstream position. Figure 5 shows 
a comparison of the activities of pairwise homologous 
constructs, differing only in their having one or two copies 
of the tandem repeat sequence. The results indicate a complex 
pattern of cooperativity between repeat sequences and U3 
sequences outside the repeats. Plasmids with two repeat 
copies show high activities in all cases, whereas the precise 
sequence environment seems to have a marked effect upon the 
homologous constructs with only one repeat copy. Thus, the 
repetitions do not only seem to increase the expression 
level, but may also serve to make the repeat units function 
more independently of flanking DNA. 
Less detailed expression studies (data not shown, Dai et al. 
(1990), Kjeldgaard et al., (1989), L. Pedersen et al., 
manuscripts in preparation) have been carried out in a number 
of cell lines for Akv and the variant LTRs from OA-I, RFB, 
SL3-2, SL3-3 and other viruses. In our recent work, an effect 
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Figure 5: Expression activities in presence of one 
or two tandem repeat units (S. Lovmand et. al., 
manuscript submitted). Deletion derivatives of pAkv6-
cat (left panel) and derivatives of pAkv8.1-cat, 
pAkv8.2-cat, and pAkv8.3-cat were used for transfection 
of NIH 3T3 cells and the gene expression activities 
determined as in Fig. 4. The boxes represent conti-
guous Akv U3 sequences and the lines non-U3 sequences. 
of the oncoprotein and stress-protein, Fos, on the expression 
from the Akv and OA-I U3 regions in osteogenic cells has been 
detected by co-transfection of fos-expression vectors 
(unpublished, data not shown). Such mechanisms may also play 
a role in induction of retroviruses in bone tissues by 
radiation. Another part of our present work studies the 
function of E modules of slightly different structure (Figure 
1) in U3 of OA-I, FBJ, and Akv viruses. A protein binding to 
these sequences has been purified from NIH 3T3 cells and its 
function in transcriptional regulation is being elucidated .. 
Regulation of transcription of integrated proviral vectors. 
In this part of our work we use the transmission-expression 
vectors described in Figure 3 to study the expression from 
individual vector proviruses integrated at different sites in 
the host chromosomes (Paludan et al. 1989a, 1989b, Jensen et 
al., 1986) using cell clones with only one provirus of 
apparently intact structure as detected by sequence analysis 
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after amplification by the polymerase chain reaction. The 
cell clones were obtained without selection for expression of 
the introduced neo gene. Three regulatory principles may be 
analysed by this approach: the regulatory DNA elements of the 
U3 region, the regulatory factors in the host cell that may 
interact with the DNA elements, and the regulatory role of 
chromosomal region of integration. The level of provirus-
expression may be measured under steady-state conditions as 
in Paludan et al. 1989a, 1989b, or their response to 
environmental agents may be studied. Figure 6 shows the 
results of steady-state measurements of provirus expression 
during continuous growth of the host cell, in this case the 
lymphoma cell line L691. Two different U3 regions (from Akv 
and SL3-3, Figure 3) with different transcriptional strength 
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Figure 6. Expression 
activities of integrated Akv 
and SL3-3 proviruses (Paludan 
et al., 1989a, 1989b). The 
expression activities were 
determined from single vector 
proviruses in individual un-
selected L691 cell clones 
(unsel.) as the enzymatic NPT 
II activity. The values are 
given relative to the acti-
vity of an arbitrary standard 
extract. The columns marked 
with sel. represent the NPT 
II activity in cell clones 
derived from infected popula-
tions selected for resistance 
to the antibiotic G418. 
in the host cell were employed. Integrated proviruses of 
identical structures show wide differences in expression 
levels (unselected L691/Akv and L691/SL3-3 values, Figure 6), 
to some extent offsetting the inherent differences in U3 
strengths, as detected in unintegrated DNA. According to our 
interpretation, the inherent U3 strengths may also determine 
the lowest expression values for each type of vector, and the 
higher values may represent positive chromosomal influence. 
Figure 6 also shows the effect upon expression levels of 
selection for the neo reporter gene expression by growth in 
the antibiotic G4l~The effects of NPT II expression levels 
upon cell growth and survival in the presence of G418 are 
further documented by the results of a growth-rate analysis 
presented in Figure 7. These results demonstrate that the 
full range of variation in expression levels among individual 
transferred genes may not be observed when antibiotics-
selected cell material is used, as is commonly the case in 
this type of gene transfer experiments. 
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Figure 7. Re1ative growth 
rates as functions· of NPT II 
activity in the presence of 
various G418 concentrations 
{Paludan et al., 1989b). The 
exponential growth rates were 
determined for 13 cell clones 
and for uninfected L691 
cells, without G418 and with 
five different G418 concen-
trations. G418 determined 
growth rates relative to the 
growth rates without G418 are 
shown as functions of NPT II 
activity. The G418 concen-
trations were {curves from 
top to bottom), o.~ mgjml. 
0.9 mgjml, 1.4 mgjml, 1.8 
mgjml, and 2.2 mgjml. 
In summary, the material described in this section represents 
a number of cell·clones, each with one vector transcription 
unit of identical structure inserted at different sites in 
the host DNA. The expression-level from the transcription 
unit varies about 25-fold among cell clones (for the Akv-neo 
proviruses), but completely inactive clones of apparently 
intact structure have also been isolated. The material has 
unique potentials for the study of the effect of environmen-
tal agents such as radiation on as well mutation rates as 
expression levels under various types of chromosomal 
influence. 
Identification of oncogenic target genes of the host. 
Replication competent retrovirUses may exert their oncogenic 
effect as proviruses integraned·at specific sites of the host 
chromosome by acting as mutagens that.disturb genes involved 
in growth control.·Retroviral e1ements activated during 
radiation· carcinogenesis may play a role in this manner. The 
group of host genes that can be oncogenetically activated by 
provirus insertion may also be sensitive to other kinds of 
mutations. To facilitate the analysis of proviral integration 
sites we have employed provirus tagging techniques. This 
approach may be particularly relevant for tumours of the 
bone, where only small quantities of DNA can be extracted. 
The tagged viruses are replication competent, but carry, in 
addition to the complete virus genome, a short nucleotide 
sequence that allow easy reisolation of integrated proviruses 
and their flanking host DNA in prokaryotic vectors. The supF 
tagging system is described in P. J~rgensen et al., (1988) 
and in Figure 8. A similar tagging system employing the laco 
region has also been developed (data not shown). The tagged 
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viruses have retained their pathogenicity, although the 
latency period may be somewhat prolonged as shown in Figure 9 
for the lymphomagenic SL3-3 virus. Using this approach, the 
proviral integration sites in a number of tumour DNAs have 
been analysed by their nucleotide sequence. 
Prokaryotic vector carrying a \tiral genome wtth supF Inserted 
In the 3 LTR 
5UR 3UR 
Provirus inserted in host DNA after repltcauon in the eukaryouc cell 
Figure 8. Tagging of the 
provirus with the prokaryo-
tic supF_gene (P. J~rgensen 
et al., 1988). A short DNA 
segment encoding the pro-
karyotic selectable marker 
gene, supF, was inserted at 
the Pstl site in the down-
stream U3 of the provirus in 
an E. coli plasmid vector. 
supF ..... 
~,--~~~~&~~tir-~w,__,~~m~~) 
An infectious virus stock was 
generated by transfection 
of mouse cells. In agreement 
with the retroviral life-
cycle both U3 copies of 
progeny proviruses were found 
to contain the supF gene 
(lower panel). 
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Figure 9. Pathogenicity of 
SL3-3, SL3-3supF, and Akv 
Mulvs in NMRI mice. Newborn 
mice were injected with 
medium from virus producing 
NIH 3T3 cultures, obtained 
after transfection of mole-
cular clones. The number of 
mice with malignant lymphomas 
at death was recorded as per 
cent of mice inoculated at 
the days indicated in the 
graph. The total number of 
600 mice was 35 for SL3-3, 75 for 
SL3-3supF, 28 for Akv, and 18 
for the controls. 
The integration sites of somatically acquired proviruses in 
radiation-induced osteosarcomas of BALB/c mice have been 
analysed (Strauss et al. 1988, unpublished). No common 
integration sites have been detected. The integration sites 
are being further investigated to analyse for homology to 
known sequences and to test for expression of the sequences 
of the pre-integration site. 
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I. Objectives of the project: 
This project aims to further define the events in malignant transform-
ation of cultured cells. l~hese events are immortalization, transformation 
and promotion. The searc:h will be for genetic mechanisms and genes 
involved. 
11. Objectives for the reportin~J period: 
1. Kinetics of induction of' immortalization. 
2. Two-step probabilistic phenomenon in immortalization. 
3. Characterization of newly immortalized cell lines. 
4. Effect of tumor promotor on immortalization. 
5. Effect of tumor promotor on genetic stability. 
6. Expression of proto-oncogenes in successive stages of 
transformation of SHE cells. 
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Ill. Progress achieved: 
1. Kinetics of induction of immortalization. 
Methodology. 
Tertiary cultures of SHE (Syrian hamster embryo) cells have been treated 
with either B(a)P (20 ~g/ml), X-rays (300 rad) or ENU (3mM). The treated 
cells were split into a large number of subpopulations and cultured for 6 
days in complete medium for expression of induced mutations. Subsequently 
each population was cultured in medium with low serum in order to select 
for immortalized cells, The cultures were propagated until senescence or 
escape from senescence was observed. This immortalization assay allows the 
monitoring of the growth rate and cloning efficiency (CE) of each 
population in the successive passages. Immortalization frequencies were 
determined with the P-zero method on the proportion of cultures which were 
mortal. 
Results. 
Contrary to expectation immortalization did not occur in a single step but 
required at least three steps: all populations which escaped normal 
senescence (step 1) invariably still had a low CE of about 0.1-1%. 
Increase of the cloning efficiency to 30 a 70% (step 2) occurred sooner or 
later via the sudden appearance of variant cells which replaced the 
original cell population. Many of these cell populations were slow growing 
during these two changes. In the majority of these slow growing cultures a 
second sudden change was observed in which fast growing cells took over 
(step 3) • An example of the occurrence of the three steps in 
immortalization is shown in figure 1 (line BP-11). 
It appears that all three steps are required for full immortalization as 
senescence still has been observed in cell lines which underwent only the 
first or the first and second step: six lines only underwent the first 
step and displayed an extended lifespan when compared with the controls 
but all six became ultimately senescent. Another six cell lines only 
underwent the first and the second step and two of them became senescent 
within the course of the experiment (150 days). After the third step the 
cell lines are remarkably similar in growth rates and behave like true 
established cell lines. 
The frequencies of the three steps have been calculated (table 1). The 
frequencies of the first step have been calculated on the number of seeded 
cells. These frequencies are in the order of 10"5 a 10"" which is in the 
order of magnitude of induced mutation frequencies at the HPRT locus in 
mammalian cells by these agents. 
The frequencies of the second and third step have been calculated per cell 
per generation The overall frequency is 6.3Xl0~ for the second step 
(increase in CE) and 4.3X10~ for the third step (increase in growth rate). 
These frequencies are in the order of magnitude of spontaneous mutation 
frequencies. 
Spontaneous immortalization has not been observed. This means that the 
spontaneous frequency of immortalization must be below 2.4X10"9 per cell 
per generation. 
Discussion. 
Steps in immortalization. 
The findings suggest that immortalization in 
process. At least three steps are required: 
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itself is 
1) escape 
a multistep 
from normal 
senescence, 2) increase in CE and 3) increase in growth rate. Newly 
immortalized cells have been reported to be non-malignant. Malignancy has 
been shown to correlate with growth in agar. Crawford et al ( 1983) 
demonstrated that immortal SHE cells required the ability to grow in agar 
with a frequency of 5.2Xl0-a per cell per generation. This means that at 
least four steps are required for neoplastic conversion of -primary SHE 
cells. 
The results indicate that these steps are sequential and dependent on each 
other: as sudden increases in the CB (step 2) are never observed in normal 
cells the first step must be considered as a prerequisite for the 
occurrence of the second step. It is indicated that the second step is a 
prerequisite for the third step as in all the cell lines in which these 
three steps can be recognized (12 lines) the increase in CB precedes the 
increase in growth rates. The same appears to hold for step 3 and step 4 
(grow in agar) because none of the .newly immortalized cell lines was able 
to grow in agar (see section 3). 
The importance of these findings are discussed in the •general dis-
cussion•. 
Spontaneous immortalization. 
In none of the experiments spontaneous immortalization was observed which 
means that the rate must be below 2.4Xl0_, per cell per generation. This 
seems in contrast to many publications which report spontaneous immortal-
ization of SHE cells. Some of these published data are such that the 
frequency of spontaneous immortalization can be calculated (Barrett and 
Ts'o, 1978; Tsutsuyi and Ts'o, 1986; Newbold et al, 1982). The weighted 
mean of these calculations is 6.1X10-10 • This indicates that the rate of 
spontaneous immortalization is indeed extremely low in SHE cells. This 
rate appears too low for a spontaneous mutation frequency. Therefore the 
question arises whether our data on induced immortalization should be 
explained by induced mutations. An alternative would be that 
immortalization, like some cases of malignant transformation, is the 
result of a two-step probabilistic process. Experiments directed at this 
problem are described in the next section. 
2. Two-step probabtlistic process in immortalization. 
Methodology. 
In a first experiment SHE cells have been treated with B(~)P (20 !Lg/ml) 
and 96 cultures have been initiated. each with 2000 cells. These cultures 
~ave been expanded and grown until senescence or immortalization occurred. 
In a second experiment treated cells have been .seeded for cloning and 
individual clones have been isolated and grown until the end of their 
lifespan, 62 control clones, 48 clones with a· normal morphology from 
treated cells and 48 clones with a transformed morphology also from 
treated cells. 
Results. 
If the mutagenic treatment would lead to the direct induction of immortal 
variants in the population it can be calculated that only 0.4 of the 96 
cultures would become immortalized. If, on the other hand, immortalization 
is due to a two-step probabilistic process in which treated cells have a 
fixed chance to become immortalized about 7.2 immortalized cultures can be 
expected. This expectation, is based on a chance for immortalization of 
5.2X10-a per cell per generation, based on our previous experiments. 
The number of observed immortalized cultures was 9 while 87 cultures were 
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Figure 1. Kinetics of line BP-11 demonstrating three separate steps in 
immortalization: escape from senescence, increase in cloning efficiency 
and increase in growth rate. 
exp. treat no of step 1 step 2 step 3 
no ment cultures 
1 B(a)P 18 2.2Xl0-4 7.9Xl0-a 2.5Xl0-a 
2 B(a)P 19 l.OXl0-4 l.lXlO-a 3.6Xl0-a 
3 X- ray 38 1.3Xlo-5 6.6Xl0-a 
-------
4 X-ray 40 2.0Xl0-5 2. 3Xl0-a 13.5Xl0-8 
5 ENU 18 l.lXl0-4 1. OXlO-a 2.6Xl0-a 
controls 64 <2.4XlO..g 
weighted mean: 6.3Xl0-a 4.3Xl0-a 
Table 1. Frequencies of steps in immortalization. Frequencies of step 1 
are per viable cell; frequencies of steps 2, step 3 and controls are per 
cell per generation. 
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mortal. In the control cultures no immortalization was observed. 
In the second experiment also no immortalization was observed in the cell 
populations derived from control cells while 3 populations derived from 
treated cells became immortal. All three were derived form clones with a 
transformed morphology. The expected frequency of immortal cultures was 
0.002 for the hypothesis for direct induction and 4.2 for the hypothesis 
of induction via a two-step probabilistic process. 
Discussion. 
The results show that carcinogenic treatment does not lead to the direct 
induction of immortal variants but that the immortal variants arise via a 
two-step probabilistic process. Therefore it is indicated that the 
carcinogenic treatment leads to a kind of activation in the cells which is 
transmitted to the successive generations and which generates a chance of 
about 5.2Xl0~ per cell per generation for immortalization. Similar 
phenomena have been described for the malignant transformation of 
C3Hl0Tl/2 cells and appear present in the malignant conversion in the 
progeny of treated clonogenic cells from rat thyroid and mamma. 
The implications of this finding are discussed in the •general 
discussion•. 
3. Characterization of newly imnortalized cell lines. 
Results and discussion. 
a) Complementation analysis. 
A TOR-mutant (resistant to thioguanine and ouabain) of an immortal cell 
line was fused with itself, with wild type cells or with eight different 
immortal cell lines. From each cross 25-40 proliferating hybrids were 
isolated and tested for lifespan. The fusion of the immortal line with 
itself led for 90% to immortal hybrids; fusion of the immortal line with 
mortal cells produced 75% mortal hybrids and fusion of the immortal line 
with the eight immortal lines produced a range from 25% to 100% of 
immortal hybrids. 
Although in this way some evidence was obtained for complementation by 
wild type cells and lack of complementation by fusion with itself and for 
heterogeneity within the set of eight cell lines the results are not 
satisfactory because clearcut data on complementation groups are not 
obtained. The reason for this problem is sought in the long procedure for 
obtaining TOR-mutants which may alter the characteristics of the cell 
line. To solve this problem, experiments are being carried out in which 
the genes for neomycin-resistance and hygromycine-resistance are 
introduced into the cells by retroviral vectors and by using subsequently 
these dominant markers for the isolation of hybrids. 
b) Chromosome analysis. 
From nineteen immortalized cell lines the karyotype has been analyzed. 
Abnormal chromosome numbers were observed in all cell lines. Chromosome 
breaks were not observed except in one cell line in which double minutes 
were found in only two of the cells. In ten of the cell lines substantial 
numbers of diploid cells were still observed. Some cell lines had only 
chromosome numbers in the diploid range. There were no significant 
differences between cell lines which had only undergone two steps in 
immortalization when compared with the cell lines which had undergone the 
three steps. 
From these observations it is indicated that aneuploidization is not the 
causal step in immortalization, nor tetraploidization but that 
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immortalization leads to genetic instability in the form of 
aneuploidization in the absence of chromosome breakage. 
c) Growth in soft agar. 
Thirteen lines have been tested for growth in agar by seeding the cells in 
a top layer of 0.33% agar over a bottom layer of 0.6% agar. Most lines did 
not grow at all and a few gave rise to only a few small colonies, the 
largest measuring 0.3mm in diameter. After cultivation of three lines over 
16 more passages clonal growth in agar was observed. 
From this it is concluded that newly immortalized cell lines do not grow 
in agar, which confirms published data. 
4. Effect of tumor promotor on immortalization. 
Methodology. 
Parallel cultures of SHE cells have been started. Repeatedly half of the 
cultures received TPA (20 ng/ml) two days before they reached confluence 
and had to be passaged. The cultures were kept until senescence or 
immortalization occurred. 
Results and discussion. 
Four experiments have been performed with heterogeneous results: in two 
experiments no effect of TPA was observed and most of the cultures 
demonstrated senescence together with the control cells; the two other 
experiments demonstrated an extensive prolongation of the lifespan of the 
TPA treated cultures. The prolongation of the lifespan was about 2-4 fold 
for the TPA treated cultures. 
The heterogeneity between experiments is not understood; it could not be 
correlated with differences in cell batch, serum source, population size 
or passage number. Still the results show that there must be conditions 
under which a tumor promotor can extensively enhance the lifespan of 
normal cells. As no immortalization was observed it could be calculated 
that in the presence of TPA the spontaneous rate of immortalization must 
be below 5.4Xl0-10 per cell per generation. As the spontaneous 
immortalization frequency is about 6.1Xl0-10 (see section 1) TPA does not 
enhance the spontaneous frequency of immortalization. 
5. Effect of tumor promotor on genetic stability. 
Methodology. 
A population of mouse lymphoma cells with a low number of pre-existing 
mutants is generated by seeding lOO cells and growing them to about 4Xl06 
cells. Half of the cells are treated with the tumor promotor TPA (20 
ng/ml) and subsequently a fluctuation analysis is started with both 
control and TPA-treated cells by seeding the cells in a large number of 
subpopulations of lOO cells each. From the fluctuation tests mutation 
frequencies per cell per generation are calculated which serve as 
indicators for genetic stability. 
RNA was isolated from the TPA-treated cells and northern blots were 
prepared using probes to study the induction of fos A, fos B and 
collagenase. 
Results and discussion. 
Nine experiments have been performed. The pooled experiments lead to a 
mutation rate of 2 .lXlo-7 in control cells and 3. 6Xlo-7 in TPA-treated 
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cells. Further analysis of the data indicates that the mutation rate could 
be up to 4-fold enhanced shortly after treatment, after which the mutation 
rate decreases to subnormal levels. These differences are however not 
significant (O.OS<P<O.lO). Experiments will be continued. 
In the same cells TPA enhanced the expression of fos B and of collagenase 
3-fold but no enhancement of expression of fos A was found. 
These results show that TPA induces some of the genes of the signal 
transducing pathway in mouse lymphoma cells; genetic instability, if 
present, is mild and of short duration. 
6. Expression of proto-oncogenes in successive stages of transformation of 
SHE cells. 
Methodology. 
Normal, immortal (BP-A) , EMU-transformed BP-A cells and BP-A cells 
transformed by the pEJ-cHa·-ras oncogen were compared in growth in agar, in 
response to growth factors (PDGF and EGF), in tumorigenicity in nude mice 
and in the expression of five cellular proto-oncogenes (myc, p53, c-H-ras, 
erb-B and c-sis) to investigate whether the sequential steps in malignant 
transformation are characterized by a pattern of oncogene activation. 
Results. 
A high cloning efficiency in agar was observed for the transformed cells 
while the normal and immortal cells early after isolation did not grow in 
agar. Immortal BP-A cells gave rise to some colonies in agar after 
prolonged cultivation. Growth in agar correlated with tumorigenicity in 
nude mice: transformed cells gave rise to tumors, early immortal cells did 
not, whlle late immortal cells gave rise to tumors only after a long 
latency period. Further it was found that normal and immortal cells 
responded to the addition of external growth factors while an ~ 
transformed line did not. 
The level of c-myc transcripts was similar in normal, senescent, immortal 
or transformed cells and did not decrease in cells incubated in serum-free 
medium. The expression of p53 did increase in transformed cells, but this 
expression correlated with the expression of histon genes. The level of c-
Ha-ras transcripts was similar in all stages of neoplastic conversion, 
except in the pEJ-induced transformant in which it was significantly 
enhanced. No erbB transcripts were detected and expression of c-sis was 
not observed in normal, immortal and pEJ-induced transformants. In 1 out 
of the 9 EMU-induced transformants expression of c-sis was detected. 
Finally, southern analysis revealed no rearrangement a in the five genes 
studied. 
Discussion 
C-myc and p53 were examined as it has been shown that they can play a role 
in immortalization; c-Ha-ras is known to be involved in transformation and 
c-sis and c-erbB were chosen because they code for a growth factor and 
growth factor receptor respectively and thus could be involved in the 
observed loss of growth factor requirement of the transformed cells. 
The results indicate that c-myc is not involved in the immortalization or 
transformation of SHE cells. As the increase in p53 transcription 
correlates with transcription of histon genes it is most likely that this 
increase is largely due to the increase in number of cycling cells. It is 
also concluded that c-Ha-ras, c-erbB and c-sis do not play a predominant 
role in immortalization or transformation of SHE cells. 
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General discussion. 
The results obtained in this project taken together with some scattered 
data from the literature lead to some rather important considerations on 
tumorigenesis: 
Origin of tumor cells. 
Malignant transformation is known to be a multiple step process. The 
number of steps involved, as indicated by population studies on the age 
related incidence of tumors, is thought to be 4-6 for most types of 
tumors. The nature of the steps is largely unknown nor the frequency with 
which they occur but there are strong indications that genetic events are 
involved. This follows from the changes found in familial cancer in which 
two well known types of genetic events appear causally related to the 
origin of the cancers, one type leads to the inactivation of a gene and a 
second leads to the loss of heterozygosity for the affected allele. As the 
same types of genetic alterations are observed in similar non-familial 
cancers similar types of origin are ascribed to those tumors. Moreover the 
presence of activated oncogenes in most tumors, which have arisen by a 
wide scala of genetic alterations also suggest genetic alterations as a 
cause for the origin of tumors. This notion is further supported by the 
fact that DNA-damage is the principal cause in the origin of tumors. 
Therefore the predominant model for the origin of tumors is that the 
mutations of genes are the causal events and that the multiple steps 
consist out of accumulated genetic alterations. This model on the origin 
of tumor cells can be adequately described as the stochastic genetic 
model. 
The findings of this project are not consistent with this model. Malignant 
conversion of primary SHE cells is also here a multistep process. We found 
that immortalization itself requires at least three steps, data in the 
literature indicate that conversion to growth in agar is a fourth step and 
there are some indications that a fifth alteration is needed to evoke 
tumorigenicity in cells which are able to grow in agar. The necessity of 
4-5 alterations in order to obtain tumorigenicity is in agreement with the 
stochastic genetic model. However the findings do not fit this model in 
two ways: 
Firstly all evidence suggests that the observed steps are sequential and 
that each step is a prerequisite for the next: escape from senescence is 
required for the increase in CE, increase in CE precedes increase in 
growth rate; iDUJiortality (the result of the three foregoing steps) is a 
prerequisite for growth in agar. A strict sequence of events has sofar not 
been observed in the gene alterations of tumorcells and there are several 
indications that activation of a certain oncogene or inactivation of a 
suppressor gene can be as well an early as a late step in the history of a 
tumor. 
Secondly there is evidence that the different steps are not directly 
induced by the carcinogen but that they arise by an indirect mechanism. 
This is shown in this project for the very first step, it is indicated by 
the data of Crawford et al for the fourth step, it is shown by Kennedy et 
al for the change of immortal C3Hl0Tl/2 cells into malignant cells and it 
is indicated for the malignant conversion of progeny from thyroid and 
maDUJI8 clonogenic cells in rats. 
Therefore it cannot be excluded that all the sequential steps are indirect 
and that often, instead of mutations leading to carcinogenesis, a 
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carcinogenic process is initiated which leads to the 
events although not mutations still might be 
amplification or somatic recombination. Our results 
data on euploidy of immortal cells seem to rule out 
one of the steps is aneuploidization. 
stepwise events. The 
genetic e.g. gene 
and many literature 
the possibility that 
It is conceivable that the observed events in the multistep process of 
malignant conversion of primary SHE cells are epigenetic in nature. A 
model on the origin of cancer cells based on epigenetic changes aould be 
adequately described as the sequential epigenetic model. 
A sequential epigenetic model of malignant conversion is still compatible 
with the stochastic genetic model: tumorigenicity can be considered as a 
perturbation of the signal transduction systems in the cell and both 
genetic and epigenetic changes will be able to affect these systems. As 
DNA damage is known to induce a cascade of gene activations and gene 
inactivations the whole signal transduction system can be involved. From 
studies with x-irradiated C3Hl0Tl/2 cells it is known that some changes 
persist over more than 25 generations after treatment; thus it is 
conceivable that stable epigenetic changes might occur with a neoplastic 
implication. 
As postulated by Herrlich it is also possible that the switching on of a 
signal transduction pathway leads to genetic instability and that in turn 
to the ( in)activation of oncogenes. In this view the stochastic genetic 
model still predominates. Sofar our studies on the induction of genetic 
instability by the tumor promotor TPA indicated that the switching on of a 
signal transducing pathway leads to only a mild genetic instability if at 
all; this point of course needs further exploration. 
Cellular lifespan as rate limiting factor in carcinogenesis. 
Until now there is no evidence for gross species specific differences 
between cell lines from different mammalian species in sensitivity to 
mutagens and in induction of genetic alterations. If tumors arise solely 
by the accumulation of genetic alterations there would be for somatic 
cells from different species no gross species specific differences in 
frequencies of malignant transformation. However· such differences are 
likely to exist between mouse and man: based on the difference in cellular 
mass (25g versus 60000g) and the difference in lifespan (2.5y versus 75y) 
between mice and men it can be estimated that the rodent somatic cells 
have a 70,000 higher chance to give rise to a tumor cell than human 
somatic cells. This figure is based on the supposition that a mouse 
population generates the same amount of tumors per individual as a human 
population. Although such a supposition is not necessarily exactly true 
the argument of the species specificity probably cannot be invalidated. 
Sofar the stochastic genetic model has no implicit explanation for 
species-specific frequencies in tumor cell formation. On the other hand 
epigenetic phenomena have almost by definition species specificity (e.g. 
differentiation). 
As carcinogenesis is a multistep process, for each step a rare progenitor 
cell has to grow to a large population in order to generate again a rare 
variant cell for the next step. As the frequencies of four successive 
steps in malignant conversion of primary SHE cells are known from our 
experiments and from data of Crawford et al it can be calculated how many 
cellgenerations are minimally necessary to generate a tumor cell. This 
calculation leads to about 97 population doublings. This figure exceeds by 
far the normal lifespan of normal cells, both from rodent and human 
origin. From this it can be concluded that increase in lifespan of cells 
is a prerequisite in the process of formation of a tumorcell. We found 
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that treatment with carcinogens in general reduced the lifespan of cells 
and that probably all the first three steps of the multistep process 
increased the lifespan. Moreover it was observed that there are conditions 
in which the lifespan of SHE cells can be strongly increased by the tumor 
promotor TPA. 
If immortalization is a prerequisite for tumor formation and if epigenetic 
mechanisms play an important role in immortalization it is understandable 
that wide species-specific differences exist in tumor cell formation: 
normal human fibroblasts and epithelial cells do not immortalize 
spontaneously and are very hard to immortalize by carcinogens; only a few 
cases have been described. Rodent cells on the other hand are easy to 
immortalize and mouse fibroblasts even immortalize spontaneously at a high 
frequency. If immortalization of mouse cells would be also a mul tistep 
process the frequencies of the steps have to be orders of magnitude lower 
than mutation frequencies. Therefore the immortalization frequencies 
correlate with species specific differences in malignant transformation 
and therefore immortalization should be considered as the rate limiting 
step in carcinogenesis. Apparently there is a gap in our knowledge at this 
point. 
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Title of the project no.: 1 
Studies of Radiation Induced Effects on Thyroid Cell SUrvival and Function, 
and of the dosimetry of radioiodine in cell cultures. 
Note: A canbined rep:Jrt on the achievements in Projects 1 and 2 (over the 
last four years) is presented below, as the material in both is 
intimately related. 
Head(s) of project: J. F. Malone. 
Scientific staff: A. Murphy, J. F. Malone, C. MJthersill, 
N. Sheahan, K. Maher, M. Lewis, B • Tuohy. 
I. Objectives of the project: 
When established in 1985 this project had two objectives. First to study 
the biological resp:Jnses (other than neoplastic developnent) to 
irradiation, and secon:ily to atten:i to the necessary developnents in 
dosimetry. The first study concentrated on the survival, recovery and 
function of thyroid cell cultures after irradiation. These studies 
contributed to the understanding of non-roalignant radiation in:iuced 
thyroid diseases, as well as providing correlative infonnation for the 
carcinogenic studies in Project 2, as both sets of gross endp:Jints are 
strongly interrelated. They also in:iicate if the status of the thyroid 
in vivo might be manipulated to prevent undesirable radiation sequelae. 
The dosimetric studies involve detailed micro dosimetric rronitoring of the 
structure of thyroid cell cultures using a sophisticated canputer roodel 
and image al'lalysis computer, as well as microscopic and macroscopic 
experimental investigations to confirm these results. 
During the Project additional investigations in dosimetry, in roodelling 
the thyroid radiation res_pJnse, in the res_pJnse of human cells in culture, 
and on the r.b.e. of 131-I were undertaken. 
11. Objectives for the reporting period: 
(a) Study of the survival and recovery of sheep thyroid cells after garrma 
rays administered in single or multiple doses with a view to 
preparing the way for 131-I irradiation studies. 
(b) Study and interpretation of the resp:Jnse of sheep thyroid to 131-I. 
(c) MJdelling res_pJnse of thyroid to irradiation in clinical, in vivo and 
cell culture systems. 
(d) Study of radiation resp:Jnse of human thyroid cells in culture. 
(e) IX>simetric and microdosimetry studies of 131-I in various sizes of 
thyroid fran experimental animals and the foetus to the adult human 
gland. 
(f) Microdosimetric calculations for cell cultures. 
(g) Methodological developnents for cell cultures. 
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Title of the project no.: 2 
carcinogenic Aspects of Thyroid Irradiation. 
Note: A combined report on the achievements in Projects 1 and 2 (over the 
last four years) is presented below, as the naterial in both is 
intinately related. 
Head(s) of project: J. F. Malone. 
Scientific staff: A • .Murphy, J.F. Malone, C. l\bthersill, 
N. Sheahan, M.K. O'Connor, M. Lewis, 
B. Tuohy, P. Gilligan. 
I. Objectives of the project: 
When established in 1985 it was hoped to determine and quantify the 
carcinogenic effect of acute and radioicx:line irradiation to the thyroid 
using differentiated cell culture transfornation rrodels, and if possible 
human naterial. It was also hoped to quantify the dose response 
relationship with respect to the induction of specific features of 
transfornation in thyroid cells and to determine if 131-I icx:line taken up 
by follicles contributed to transfornation. 
In addition it was hoped to explore the low dose and low dose rate effects 
and where possible, determine a reliable 'r.b.e.' value for 131-I. 
Finally it was intended to continue to support epidemiological studies 
of radiation carcinogenesis and related initiatives, being co-ordinated 
through this prograrrme. 
11. Objectives for the reporting period: 
(a) To identify indices associated with cell transfornation and develop 
and apply them to thyroid cell cultures. 
(b) To quantify the dose response for indice(s) of transfornation after 
high dose rate gamma and low dose rate 131-I irradiation. 
(c) To identify and highlight important changes relevant to dosimetry 
calculations. 
(d) To calculate the dose to foetal neurological tissue fran 131-I in the 
foetal thyroid. 
(e) To develop rnethcx:lology for assay of human cells and of snall volumes 
of tissue in culture. 
(f) To arrive at a figure for the r.b.e. of 131-I and identify the 
mechanisms underlying the figure identified. 
(g) To continue collaboration in epidemological studies. 
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Ill. Progress achieved: 
As already I!Bltioned the final reports for Project 1 am Project 2 have 
been grouped together as the material in them is closely interrelated. 
This permits the presentation of a rrore coherent report in which each 
topic is fully developed once, rather than being divided somewhat 
arbitrarily am being presented twice, which would otheiwise be necessary. 
The headings under which the report is presented are: 
1. Introduction. 
2. Methodology. 
3. Results/Discussion: 
3 .1. Survival am Recovery Studies in Sheep Cells. 
3. 2. Survival am Recovery Studies in Human Cells. 
3.3. The r.b.e. for 131-I in Survival Investigations. 
3. 4. General Developnents in Methodology. 
3.5. Unified ~el of Proliferative Aspects of Thyroid Radiaticn 
Respcnse. 
3. 6. General Developnents in Dosimetry. 
3. 7. Foetal - Neurological Dosimetry. 
3.8. Absorbed Dose as an Index of Ham. 
3. 9. Microdosimetric Methodology. 
3.10. Assays for Indices of Cell Transfoiination. 
3. ll. Dose Response Relationship for Indices of Cell Transfoiination. 
3.12. 131-I and l:Iunen Investigations. 
4. Conclusions. 
5. References. 
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1. INTRODUCI'IOO. 
Interest in the radiation response of the thyroid arises from the fact 
that it is likely to be exposed in mmy situations. These frequently 
involve its avidity for radionuclides of iodine, such as 131-I. This 
is particularly i.nportant in the aftermath of nuclear accidents which 
release abundant quantities of radioiodine, in medical diagnostic and 
therapeutic applications, and in health physics aspects of survillance 
of mmy rredical and laboratory workers. The consequences of thyroid 
irradiation include induction of benign and malignant neoplasia which may 
be fatal but rrore frequently are not. In addition hypothyroidism may be 
induced, which is consequential on disruption of cell division. Much 
of the study of thyroid radiobiology has been restricted by the absence 
of good exper:illental rrodels, a suitable theoretical franework, and 
inadequate dosirretry. This report presents detailed studies of cell 
survival which are dosirretrically sound and within the mainstream of 
radiobiological studies of other tissues. These studies are linked in a 
well developed conceptual approach that integrates them with previous 
apparently anomolous results and well established clinical data. In 
addition reports on new developments on the biological effectiveness of 
131-I, dosirretry, including S<:m:! special foetal concerns, and studies of 
cell tran~formation in cell cultures. 
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2. MErr'HCDOLOGY: 
2.1. In general the methods used for the investigations described here 
have been set out in detail elsewhere and are only referred to here in 
Sl.lll1l'larY fonn. Where necessary for clarity reference to a particular 
feature of the method used is made in the Results/Discussion Section. 
2 .2. Cell Cultures: 
The methods used have been described in detail in O'Connor et al (1980), 
and in sane of the publications listed for this report (Seynour et al. , 
1987). The methods for human cells were si.rrple adaptations of those 
developed for the sheep systan.EXperiments were generally initiated on 
well differentiated confluent cell cultures 10 to 15 days after 
explantation. 
2.3. Radiation and Subculture: 
External radiation was generally administer~1 using 60co garrma radiation 
at a dose rate of the order of 1 to 2 Gy min • This necessarily varied 
over the duration of the "WOrkprogranme. Irradiation with 131-I generally 
took place on cultures of similar age to those used in 60-Co experiments. 
Appropriate amounts of 131-I were added in the fonn of Na.I to the cultu-r:= 
medium-and left in place for a period of one week. After the final 
irradiation or ranoval of 131-I,the confluent cells were subcu).tured and 
assayed for cell survival, index of transfonnation,or other endpoint as 
appropriate. 
2.4. Survival Assay: 
Cell survival was assayed using the clonogenic method first described by 
Puck and Marcus (1956) and adapted for use with thyroid cultures by 
O'Connor et al (1980a, b). Briefly flasks were plated with known numbers 
of cells after irrad.B tion. They were incubated for 10-12 days which 
allowed develorxrent of macroscopic colonies fran single cells. The 
number of macroscopic colonies growing were scored and ocmpared with 
controls. It was particular i.rrportant to control for the variability in 
plating efficiency with innoculated cell number. 
2.5. In:lices of Transfonnation: 
These required serial subcultures of cells which were achieved W detaching 
the cells and replating than at a concentration of about 1 x 10 cells in 
5ml. of growth medium. The cultures were then grown to confluence or until 
growth ceased. Senescence was judged to have taken place in sane 
investigations when subcultures stopped growing and in others by assessing 
the plating efficiency of the cells at each subculture. The latter 
approach had the advantage of allowing quantitative detennination of the 
number (if any) of cells giving rise to inm::lrtal clones and of allowing 
microscopic exclusion of material fibroblast in origin. 
I.Dss of contact inhibited growth was detennined by counting any foci 
developing on the confluent nonolayer prior to subculture. After 
senescence of controls the cells for assay (irradiated or otherwise) were 
tested for soft agar growth using a method based on that of Kruse and 
Patterson (1973). In sane experiments foci and or soft agar clones were 
subcultured to check for characteristic thyroid function and/or epithelial 
norphology. Thyroid function in primary cultures and subcultures was 
detennined using the methodology described in detail in 0' Connor et al., 
(l980a). Ability to trap iodine,and T4 production,were accepted as 
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criteria of thyroid origin. 
LDH isozyme concentrations of the five isozyrres of lactate dehydrogenase 
were determined using gel electrophoresis according to the method of 
M:rrket and lobller (1959) . 
2.6. Do~imetry: 
Dosimetry of external 6Q-Cobalt irradiation used the standard techniques 
applied for radiotherapy. Dosimetry of 131-I in cultures was based on the 
assumption of unifonn distribution of the 131-I in the medium. The cells 
were assumed to be irradiated on the flat plane through the centre of an 
infinite hemisphere of material throughout which the concentration of 
131-I was equal to that in the medium. 
Microdosimetric rrodelling of the thyroid was perfonned using methods 
previously described. To facilitate calculations, should they becare 
necessary for short range radiations a method using a nuclear meiicine image 
analysis system was adapted for acquisition of data on follicle dimensions. 
Calculation of doses to the neurological system of the foetus fran 131-I 
in the foetal thyroid w:~s perfonned using standard physical data and foetal 
anatomy derived fran England, 1983. 
General aspects of dosimetry were approached fran standard accepted 
physical and biokinetic methods (Malone, 1980). 
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3. RESULTS AND DISCUSSION. 
3 .1. Survival and Recovery Studies in 5heep Cells: 
3.1.1. O'Connor et al. (1980) ~lished an extemed account of the 
properties of differentiated sheep thyroid cells in culture and a 
methodology that could be srployed to use the cultures for radiobiological 
investigations. In contrast to the in""'Vivo systans previously studied it 
was possible to obtain sufficient proliferation to develop a clonogenic 
assay, although the plating efficiency was relatively lCTN'. Growth curves 
daronstrating 10 cell divisions were reproducibly obtained and plating 
efficiencies were generally in the range 0.1 - 0.4 per cent, though 
higher values occured. 
3 .1. 2. The first reported survival curve for this system (0' Connor et al. , 
1980) gave a Do value of 4.1 Gy, and thereby appeared to support the large 
value seen in the gland weight assay (see belCTN') • In retrospect this value 
has been daronstrated to be untrue, due in part to the fact that survival 
was foll<Med for one decade only. Obtaining a reliable value was difficult 
due to the lC1N' plating efficiencies and other technical proble!IIS, 
particularly those associated with disaggregation of cll.lllpS of cells. 
Resolution of these problems led to the establisbnent of an unambiguous 
value of the Do for sheep thyroid cells in the range 1.5 - 2.0 Gy (Fig. 1) 
and an extrapolation number in the range 5-20. Split dose exper:lments in 
which the bole doses were separated by o-6 hours datonstrated significant 
recovery with a plateau value approaching 5. These values are supported 
by data fran the transplantation assy for thyroid cells of De M:>tt et al., 
(1979). 
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Fig. l(a) illustrates typical eo60 survival curve using the clonogenic 
survival assay. 
(b) curve illustrating recovery between doses of radiation. 
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3.1.3. Considering colonies of fibroblast origin in the total surviving 
fraction of single dose survival curves, after 6~ irradiation, had 
little or no effect on the Do values obtained, but did result in a notable 
alteration of shoulder size, with extrapolation m.unbers range narrc:Ming to 
17-21. However during split dose experiments no significant effect on 
either Do values or extrapolation numbers was observed on inclusion/ 
exclusion of fibroblast colonies in the total survival level. Table 1 
shows the mean level of fibroblast colonies obtained during single dose 
survival experiments, for 60-Co irradiated sheep thyroid cells, expressed 
as a percentage of the total colonies counted. 
Table 1: Percentage of fibroblast colonies obtained on irradiation of 
sheep thyroid cells with acute doses of 6crco. 
P::,se (Gy) 0 1.5 2.5 5 7.5 10 12.5 15 
Fibroblast 
Colonies (%) 11.45 12.9 10.9 13.9 14.7 19.3 19.1 19.9 
3.1.4. In an exper.i.ment involving multifractionation of a 14Gy dose of 
6~ the expected increase in survival with increasing number of fractions 
was observed, with little increased recovery between 7 and 14 fractions 
per week. (See Fig. 2). 
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(a) Average of cell survival for 5 sheep thyroids after I-131 
irradiation for .-1 week, and 
(b) Surviving fraction of sheep thyroid cells versus number of fractions 
of a 14 Gy dose of 60-Co. 
3.1.5. Similar methods were errployed to produce survival curves for sheep 
thyroid cells after 131-I irradiation distributed over one week. The Do 
obtained was of 7-10 Gy. (Fig. 2). In these studies the uncertainties 
inherent in 131-I dosimetry in vivo were eliminated and hence the dose 
cxnparisions may be taken as reliable. A canparison of this data with the 
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nultifraction experiment shows that with larger nl.mlbers of fractions the 
survival values were greater than those for 131-I. These results agree 
with previous catparisons and indicate that dose rate alone could account 
for the 131-I effect. 
3.2. Survival and Recovery Studies in Human Cells. 
-3 .2 .1. Survival curves for thyroid cells of human origin were much rrore 
varied than those fran sheep. For 6Q-Co garrma rays the Do was in the 
range 0.5 - 2 Gy and the extrapolation nl.mlber was close to unity. In Fig. 
3 survival curves fran four human thyroids are presented. While all four 
have a different survival pattern they are s1roilar in that each is rnuch 
rrore radiosensitive than sheep thyroid. This confinns a prior, but 
unexplained, observation of Clifton et al.(l9'78). In Fiq·. 3 two survival 
curves for human cells after 131-I irradiation are presented. The Do 
values are 6 and 9 Gv. 
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Fig. 3 (a) Cell Survival for two different Human 'Ihyroid Cultures after 
l week of 131-I irradiation, and 
(b) Survival curve for Human Thyroid Cells from 4 different patients. '!he 
dotted line is the survival curve for sheep cells. 
3.3. The r.b.e. for 131-I in Survival Investigations. 
3.3.1. Fran the above it is clear that the r.b.e. of 131-I as assessed in 
the sheep thyroid assay is 0.2 when the ratio of Do values is taken, i.e. 
lOGy for 131-I catpared to 2 Gy for high dose rate garrma rays. The value 
for human cells s1roilarly assessed is 0.16 - 0.20 which, for practical 
purposes is the same. It is of interest that the 13l-I/6o-co ratio remains 
constant despite the significant increase in radiosensitivity of human 
cells. The above values canpare with a value of 0.1 detennined using the 
goitrogen induced gland weight increase assay for cell survival in rat 
thyroids (see 3. 5. belCM) • However this value is subject to substantial 
dosimetry errors due to the methods used to assess the dose to the thyroids. 
Values ranging from 0 to 1 are cited for the r.b.e. for 131-I for cell 
transfonnation/carcinogenesis in Section 3.12 below. 
3. 4. General Developnents in Methodology. 
3 . 4 .1. A study was undertaken to detennine if small llQillbers of thyroid 
cells can be cultured. The results were interesting and indicated that 
when "well culture" metlxxis were applied, the relatively small nl.mlbers of 
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cells fran a needle biopsy can be cultured successfully. However the 
yield, in terms of cell number, fran such cultures is small, when the 
needs of radiobiological experiments are taken into account. 
3.4.2. Because of the above an alternative approach to culture of small 
anounts of tissue was also developed. This involved growth of intact 
explants and rronitoring the out:growth of cells fran them. This technique 
has been successfully erployed by other groups. The explant technique 
gives rise to growth inhibition curves for thyroids which are highly 
resistant and have Do values similar to those previously found by Malone 
et al. using the gland weight assay (see Section 3.5. below). The 
difference between these results and the results of the clonogenic assay 
suggests that only a small fraction of cells which grow out from the 
explant are involved in significant proliferation. 
3.5. Unified MJdel of Proliferative ~ts of Thyroid Radiation Response. 
3 . 5 .1. Numerous studies have been perfonned. on different aspects of the 
radiation response of the thyroid (Malone, 1975; Dumont and Malone 1980). 
These results have used different methods of assessing thyroid cell 
function and response, e.g. clinical hypothyroidism (Malone and CUllen, 
1976, 1977); transplantation assay (Clifton et al. 1978; De J'.1ott et al, 
1979); weight assay (Greig et al, 1969, 1970; Malone 1975); and clonogenic 
survival assays (O'Connor et al, 1980a,b,c). Using this literature it is 
extremely difficult to correlate the infonnation presented, into a single 
coherent self consistent picture. In fact it appears from that 
the various responses of the thyroid contradict each other. These 
apparent contradications need to be addressed to allow a rrodel for the 
thyroid at the cellular and macroscopic levels be developed and correlated. 
3. 5. 2. A rrodel has been developed for the cell population structure of the 
thyroid in line with those used for other tissues, such as the haanapoietic 
system, in which cell kinetics and radiation response are correlated. The 
rrodel is based on the "H-F Hybrid" type of Wheldon and Miehalowski 
(Wheldon, et al 1982). It proposes three population types in the thyroid, 
each of which can be correlated to a significant degree with a well defined 
and assessable feature of the radiation response. To present the rrodel 
coherently requires reviews of the background information with respect t9 
(a) the induction of Hypothyroidism after radioiodine therapy; (b) the 
assay of cell survival using the gland weight increase assay; (c) the 
clonogenic cell survival data presented above; and (d) the available cell 
kinetics data. This is undertaken in the following paragraphs. 
3. 5. 3. HyP?thyroidism after Radioiodine Therapy: 
Shortly after the introduction of 131-I therapy for hyperthyroidism it 
became evident that sane of those treated w:Juld becane hypothyroid. 
Thereafter it was deronstrated that the fraction of those treated who 
sul:lcumb to hypothyroidism increases with time (see Fig. 4) . 
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Fig. 4: Curves for the probability of hytX>thyroidism (a) after I -131 
therapy as a function of t.llre, and (b) as a function of dose 2 years after 
tlierapy. 
For nany years it was felt that incidence bore little relationship with 
radiation dose. Malone am CUllen (1976) daronstrated a direct linear 
dose-effect relationship for the early carp:ment of ~thyroidism, i.e,. 
that prior to the shJulder on the curve in Fig. 4 (a) • This relationship 
is dem:mstrated in Figure 4 (b) am is quite convincing. It was 
subsequently confinned by (Maxon et al. , 1977) for 131-I am by Malone et 
al. (1977) for'l25-I. 
3.5.4. The time scales involved are consistent with damage to the 
mechanisms of cellular proliferation (Table 2) which will evenblally 
express themselves as a reduction in organ function, due to a depletion in 
population. This mechanisn has been proposed, in conjunction with others 
over the years, but has not been fully accepted due (anong other reasons) 
to the absence of any apparent relationship between the doses involved 
am tmse involved in cell smvival or related studies. For ~e the 
dose required for in:luction of a certain. fraction of early hypothyroidism 
is evident in Fig. 4. For an incidence of 0.5 (i.e. 50% of the exposed 
pop.tlation) a dose of 250 Gy is required. This seems very large but is 
confinned in the u.s. Health Effects M:ldel Study for the Biological 
Consequences of a Nuclear Incident (Evans et al. 1985) • 
3.5.5. ~Survival us~ the Glam Weight Increase Assay: 
The thyroid -was a late starter with respect to the rreasuranent of cell 
SUJ:Vival am other aspects of mdiobiological assessments. This was in 
part due to the relatively small anount of cell proliferation that takes 
place in the glanl, am to the absence of suitable in-vitro nodels. 
Early attanpts at studies which mimicked cell smvival used a goitrogen 
stilnulated weight increase in the glani (Malone 1975), alnost all of 
which was due to cell proliferation and attributable to, at nost, 2 - 5 
cell division. The goitrogen stimulated weight increase is sensitive to 
radiation. It decreases with dose until a plateau value of approxirrately 
10% is reached at a dose of the order of 20 Gy. This correspords to the 
loss of all proliferative function in the cells, and the small canponent 
of weight increase seen was due to hyperthyroP1y alone (Malone 197 5, 
Dunont et al. 1980). Thus this would correspord with the tolerance limit 
for a single acute dose of radiation and is in keeping with the figures 
for thyroid cited in the radiotherapy literature (Rubin & Cassaret, 1968). 
This figure is therefore a key constant for the thyroid and hence nust be 
included in any nodel am is listed in Table 3 • 
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Fig. 5: (a) Weight increase using the fat pad assay. 
(b) InJ:Ubition of goitrogen - induced weight increase in the rat thyroid 
by a smgle dose of x-rays expressed as cell survival. 
3.5.6. "Cell Survival" was calculated by subtracting the non-proliferative 
carp:ment of weight increase fran the total and plating the renainder 
(nonnalized to 1.0 or lOO per cent for controls). This gave a classic 
exponential survival curve with a shouldered region (Fig. 5 ) , which was 
further attested to by the existence of a split dose recovery response. 
The Do of this survival curve was generally the order of 4-5 Gy which was 
attributed to same or all of the follcwing: (a) the unusual radioresistance 
of the gland; (b) the fact that the assay was based on the first few 
post irradiation cell divisions which are no:rnally rrore radioresistant 
than later divisions; (c) the fact that the assay was based on overall cell 
numbers rather than survival; (d) numerous other ingenoous explanations. 
In retrospect the explanations rrost likely to be true are (b) and (c) and 
there is now little reason to attribute unusual radioresistance to the 
gland. Hence (b) and (c) are here acceptEd as the main explanations for 
the 5 Gy Do value in Table 3 and Fig. 5 (b) . 
3. 5. 7. Further experiments with the weight assay daronstrated considerable 
recovery in nultifraction experiments (.Malone et al. 1974). Extrapolating, 
these results to the point at which no residual proliferative capacity 
'I.U\lld be left in the gla!rl, gives a value of about 50Gy for the point in 
question (.Malone et al. 1974, .Malone 1975). This corresponds to the 
endpoint, which in the case of a single dose of 20 Gy we equated with 
tissue tolerance. With regard to protracted distribution of dose over 
time "survival curves" using the weight assay also exist for 131-I in the 
rat thyroid with a Do of about 55 Gy (Durront et al. 1980) • lbwever great 
uncertaint<.1 attaches to the 131-I dos:imetry in these studies. 
3.5.8. Cell Kinetics Data: 
Cell Kinetics Data for the thyroid are rot widely available. Nevertheless 
sufficient infonnation is available fran in vivo and in vitro sources to 
be able to directly state or infer many features of the cellular heirarchy 
and kinetics structure in the gland. The available data necessary for the 
considerations to be taken up here are sunmarised in Table 2 which have 
been drawn fran various sources (.Malone et al. , 1983; .Malone 197 5; 
O'Conoor et al. 1980; Greig et al., 1970; Redmond et al., 1979, 1980), 
Under oormal conditions the rate of cell turnover is low. The mitotic and 
labelling indices are 3.5 and 7.8 cells per 10,000 respectively in rodents. 
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'fABU: 3: 
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Contains typical cell kinetics pa.rarreters, naFely in rodents. 
Surrnary of the different response of the 3 levels of the thyroid 
rrodel. 
TABLE 2. 
Mitotic Index 
DNA Labelling Index 
3.5/10,000 
78/10,000 
0.07-11.9 
15 - 180 
s Phase Duration (Labelled M) 7.5 - 10 hours. 
ill ) 
s Phase Duration (Ml X 0. 5) 11 hours 
Cell Cycle Time (Normal) > 9 - 16 weeks 
Cell Cycle Time (Stimulated Growth) 2 - 6.25 days 
Weight Doubling Time - 7 days 
Growth Fraction Stimulated 0.3 - 1.0 
Plating Efficiency 0.1 - 5% 
Doubling Time in Culture (Stimulation) - 2 days 
Cell Kinetics Parameters, mainly in Rodents. 
TABLE 3. 
Eii<fpouit ~~=~~;;a~~~~ ~~~e 
Hypothyroidism "Early Incidence in 
50% of Population" 
~ 250 
"Do" 
-
5 
Weight Assay D (Single Dose) 
-
20 
(Tol.) 
D (Fractionated) 
-
50 
(Tol.) 
D (Radioiodine) ,.., 55 
(Tol.) 
"Do 11 (Sheep Cultures) 
-
2 
Do (Fat Pad) 
"" 
2 
Clonogenic Do ( 131-I Sheep Cultures) ,.., 10 
Do (Human Cultures) .... (0.8 - 1.5) 
Do ( 131-I Human Cultures) 
"" 
6 - 9 
Early Incidence in 50% 
of Population but 
Hypothyroidism Corrected for Biological 
Efectiveness of 131-I "" 
25-50 
(i.e. 250Gy X 0.2) 
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On this basis the lower limit for cell turnover time is the order of 9 
weeks but it is probably longer, and 16 weeks or greater appears to be a 
reasonable estinate for small aninals. For larger species with a longer 
lifespan it is correspondingly longer, and for example, Durront estinates 
it is about 8-10 years in humans (Durront, 1989). The duration of the S 
phase from various considerations including labelled mitosis curves is 
about 7-ll hours. The resting phase of the gland can be interupted by 
goitrogenic stimulation which results in growth of the glarrl. During 
growth the DNA labelling index increases to about 5 per cent and the cell 
cycle time can be inferred to lie sc:rnewhere between the extremes of 2 and 
6.25 days. From these and related considerations it may be inferred that 
the growth fraction during goitrogenic stimulation lies between 25 and 
lOO per cent. The higher figure is unlikely because of the fact that all 
the cells eventually reach a stage where no further mitosis is possible, 
and hence it is quite likely that some of the cells are in this state even 
··in the beginning of stimulation. As the overall population increase is 
a factor of about 10, the number of divisions per mitotically active cell 
must be between 3-4 (for lOO% growth fraction) and 5-6 (for a 25% growth 
fraction) (Malone et al., 1983). This upper limit of 5 divisions appears 
to be the rraxirnum available during the adult lifespan of any species so 
far assessed. 
3. 5. 9. Thyroid cells rraintained in prirrary culture do not no:rmall y exhibit 
much proliferative activity when they are kept in a monolayer or near 
rnonolayer form. However if the cultures are diluted to encourage 
essentially clonogenic growth a small fraction of the cells between 0.1 and 
5 per cent will plate and grow to viable clones undertaking 10 or rnore cell 
divisions. This small fraction of cells with large, if not unlimited 
division potential, have a doubling time, the order of 1-2 days which also 
sets them apart from the no:rmal proliferative/goitrogenically stimulated 
proliferative response of the bulk of the cells in the gland referred to 
above and set out in Table 1, (O'Connor et al., 1980). 
3.5.10. Proposed M::xlel: From the above data it is evident that the 
radiation response of the thyroid has been evaluated at three levels i.e. 
clinical hypothyroidism; survival as assessed by the weight assay; and 
clonogenic cell survival. It is also clear that the doses required to 
produce the various responses seem to be,superficially at least,at odds 
with each other. The cell kinetic data suggest that the thyroid 
pop..llation may be broadly classified as an H-F type (Wheldon et al., 1982). 
As illustrated in Fig. 6 it is reasonable to regard it as consisting of 
three components consisting of (a) precursor/stem-cell types; (b) nature/ 
maturing cells with limited division capacity; and (c) nature rretabolically 
functional cells whose division capacity has been exhausted. The 
proportion of the pop.1lation in each of these categories has not been 
exactly determined, but from the info:rmation presented above limits on 
each cornparbnent nay be placed. Thus it is reasonable to postulate that 
the precursor/stem cell CC>IrqJartment will contain only the cells capable of 
proliferation to a level that renders them clogenic, i.e. 0.1 to 5 per cent. 
It is the behaviour of this carpartment that is seen in clogenic cell 
survival curves. 
3.5.11. The second compartment of mature/rraturing cells with sane 
division potential must consist of the growth fraction of the cells in the 
gland when it is goitrogenically stimulated (less the content of 
Carpartment 1). This is clearly between 25 and lOO per cent (Table 2) 
less something between 0.1 and 5 per cent. Thus CC>IrqJartment 2 consists of 
between 24.9 and 99.9 per cent of the cells, which have a limited division 
-1681-
capacity of sanething between zero and about 5 divisions per cell. It is 
1;he behaviour of this caipartment that is seen in the weight assay. The 
~t radioresistance in this assay is cooferred by the fact that it 
is based an the early post irradiation cell divisions. 
The third. and final caipartment consists of cells which are metabolically 
active, have no residual division capacity and hence will eventually die. 
Between 0 and 75 per cent of the cells must lie in this catpartment and 
its behaviour detennines the post irradiaticn appearance of hypothyroidism. 
Thus the rrodel proposes that the thyroid consists of three population 
types each associated with a specific feature of the known radiation 
response. 
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Fig. 6: M:Jdel for the response of the thyroid to irradiation. 
3. 6. GENERAL DEVEIDPMENI'S IN OOSIMm'RY. 
3. 6 .1. The ICRP values, and values calculated using the MIRD scheme of . 
thyroid dosimetry, both of which were widely used to estimate radiological 
detriment post Chemobyl, are no longer adequate, and fall down in a 
significant number of areas. The physical and physiological assumptions 
used regarding the thyroids netabolism, shape, mass and iodine uptake · 
distribution and·kinetics are poorly correlated with those of a non 
haoogenous population in the 1990's. They are in practice baSed an an 20 
year old reference nale whose statistics rely an data gathered between 
the nineteen fifties and seventies. To apply these assumptions to a 
non haoogenous population "'.UU.ld ignore many changes. L'l view 
of this a significant effort to collate and present data in this area has 
been made and is available in Malcne et al., (1990 a, b) ,WID, (1990). A 
surrmary of sat¥3 of the observations found include: 
(a) DietaJ:y Iodine Patterns - Gland mass, uptake and iodine kinetics are 
highly susceptible to influences of dietaJ:y iodine. Adult thyroid mass is 
routinely l<rl2g in iodine rich areas. '!his is about half the reference 
value. It increases to as high as 80g in areas where there is an iodine 
deficiency in the diet. Uptake and clearance times are also very 
susceptible to influences by dietaJ:y iodine and range fran 15 to 20 per 
cent up to alnost 100 per cent. 
(b) A;fe and Sex - Significant differences in thyroid characteristics are 
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noted with age. Mass varies fran rrq's in the foetal thyroid to lO's of 
grams in adult thyroids. Uptake also varies being as high as 70% in the 
case of premature or newborn and rapidly declines to the adult value. 
ReSidence time also increases with age with the effective half life in the 
foetus being approximately half that of the adult. Wonen have a sanewhat 
different pattern of thyroid metabolism fran men. 
(c) reiication - Sare fonns of medication will lead to variation in uptake, 
e.g. iodine contrast media, and drugs for cardiac and psychiatric uses. 
3. 7. FOETAL - NE.UROIDGICAL OOSIMEI'RY. 
3. 7 .1. Approximately 1-2% of any population at any time is pregnant. Thus 
because of the vunerability of this age group special attention needs to 
be paid to proper dose estimation. However the knowledge of iodine kinetics 
and thyroid lM.SS in the foetus is lacking. In view of this a systematic 
review was undertaken fran which dose est.imates to the foetus were derived 
(.Malone and Gilligan, 1990) • The assumption-' used vary fran author to 
author, and sare find the foetal thyroid dose is greater than that to the 
rrother per unit lM.temal ingestion. Others find that it is about half 
that to the rrother. Arising fran this the ICRP recarmend the use of the 
lM.ternal thyroid dose for that of the foetus (ICRP 53, 1988). 
3. 7. 2. As mental retardation is thought to be observed in children who have 
been exposed in utero to neurological doses as low as 0.04Gy in week eight 
to sixteen of pregnancy, the dose burden the foetal thyroid might present 
to the foetal brain upon injestion of 131-I by the rrother,was investigated. 
The necessary foetal anatanical data were derived fran the literature and 
the dose then calculated using standard physical techniques and the uptake/ 
kinetic data enployed in 3. 7.1. above. The results for 3 sets of biokinetic 
data are presented in Fig. 7 (b) , which derronstrates the mean neurological 
doses are 5 to 6 orders of lM.gnitude less than the thyroid doses. In view 
of this the lM.terial and foetal thyroid doses would need to be sufficiently 
large to cause ablation before direct neurological radiation damage might 
be anticipated (Gilligan and .Malone, 1990) . 
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Fig. 7: (a) Carparison of two est.imates of foetal thyroid dose to maternal 
thyroid dose per unit I-131 ingestion as a function of age. 
(b) Dose to foetal thyroid from foetal brain per unit I-131 ingestion as a 
function of age. 
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3. 8. ABSORBED DOSE AS AN IIDEX OF HARM. 
Absorbed dose estimates are frequently used in association with various 
Risk Coefficients to evaluate the overall hann that arises fran thyroid 
irradiation The question of whether this is the roost appropriate 
parameter to use, or not, must be reviewed. For exanple, it is not 
unreasonable to assume that there is an approximate relationship between 
cell number aJ'X1 nass in the thyroid. In the absence of data to the contrary 
it is also not unreasonable to assume that the rate of transfonnation per 
cell per unit dose is the same in small and large glands. The consequence 
of these 1SwO s:imple asSU!!ptions is that absorbed dose is not the appropriate 
parameter to use in derivation of risk estimates. For exanple 20g and 80g 
glands both receiving identical absorbed doses 'WOUld have risk estimates 
that are different by a factor of four. On the other hand if both glands 
took up identical anounts of activity this would give rise to identical 
risks even though the absorbed dose in each case is different. The latter 
conclusion relies on the traditionally assmned linearity of risk estimates 
with dose. 
The above considerations indicate that dose is not the appropriate physical 
parameter to associate with risk estimates. The total activity taken up 
or total energy deposited may be roore suitable, aJ'X1 indeed the latter has 
been suggested for similar purposes elsewhere (Malone et al., 1990 a,b) . 
3. 9. 'WCRODOS:JMETRIC MEI'HODOI.DGY. 
Dosimetric studies were undertaken both in tenns of developnent of 
autanated methods of analysis of the geanetrical properties of cells/ 
follicles in the cultures, and in tenns of refinanent of the roodels for 
calculation of dose to the cultures on a microscopic scale. A positive 
feasibility study of the fonner indicated that it 'WOUld be possible to use 
an image analysis systan to store the geanetriC infonnation required for 
detailed dose calculations at the cell/follicle level. The systan uses a 
microscope coupled to a video camera which in turn was interfaced to a 
nuclear medicine image anlaysis canputer using a frame grabber. In 
practice calculations at this level of detail have not been needed to date 
as only 131-I has been used, as no nuclides with very short range beta 
particles were employed. However microdosimetry of 131-I has been 
revitalized by new -work ttM appearing on the dosimetry labelled antibodies 
targeted at microfoci of t'llllOurs. 
3 .10. ASSAY FOR P.VICES CJI! CELL TAA.~SFORMATICI:T. 
3 .J.O.l. '!'he biological assessment systans available in this project all 
involved cell/tissue cultures. Apart fran practical or ethical 
considerations this was for two nain reasons. First it eliminated the 
uncertainties that had plagued interpretation of in vivo -work with 
radionuclides. Second with respect to cell transfonnation and related end 
points it pennitted design of experiments that had the potential (at the 
very least) of contributing to the insight available into the transfonnation/ 
dose relationship, without anbarking on the so called "rnegairoUSe" 
experiments. Optimism in this area was further enhanced by the fact 
that relative infonnation on the r.b.e. of 131-I viz a viz high dose rate 
garrma rays -would in itself be valuable even if absolute data on rates of 
transfonnation were not available. sane of the indices examined include_ 
(i) Senescence/I.rnoortality in Cell Cultures; (ii) Focus Fonnation in 
M:>nolayers; (iii) Grc:Mth on Soft Agar; and (iv) LDH Isoenzyme Analysis. 
Of these (iii) is possibly the roost denanding. However each is briefly 
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of cells to be examined for LDH profile. This has shown that the normal 
predaninance in human thyroid cells of LDH 1-3 with a peak at band 3 is 
changed and bands 4 and 5 appear in greater quantity as illustrated in 
Table 3, which is consistent with alteration towards transformation. 
3 .ll. DOSE RESPOt-SE RELATIONSHIP FOR INJICFS OF CELL TRANSFORMATION. 
3.ll.l. All of the endpoints discussed in 3.10 lend themselves to a certain 
level of quantitation. However the assay for growth on soft agar lends 
itself to, perhaps, a slightly nore rigorous form of quantitation. 
Examples of results for sheep thyroid cells are presented in terms of the 
number of soft agar clones per exposed cell in Table 6 and Fig. 8 below. 
3.11.2. A level of caution I!RlSt be applied to these results for a number 
of reasons. First while soft ilgar growth is a reliable and reproducible 
endpoint, all attempts to form ttlliDurs in nude mice by inoculating them 
with agar positive cells have proven negative. The validity of the nude 
mice assay as a definitive endpoint, which holds for fibroblast systems is, 
however, open to question in epithelial systems since epithelial ttlliDur 
cells tend to terminally differentiate in nude mice. 
z 
b 0 
)I 
-Uncorrected 
- - -Corrected 
-
Fig. 8: Number of soft agar clones detected in cultures of sheep thyroid 
versus dose, upper curve illustrates the effect of considering lethal 
!lRlta lions . 
.SOFT AGAR POSITIVE CIDNES DEI'ECTED IN CULTURES OF SHEEP THYROID ~N=10) 
IEXPOS'ED 'ID DOSES OF 60-Co RADIATION IN THE RANGE 0 - 12.5 Gy. 
DOSE 
0 
2.5 
5.0 
7.5 
10.0 
12.5 
TABLE 6. 
CIDNES/c::ELL EXPOSED 
-5 1.1 x 10 (Bgr. ) for 
unirradi~sed cells. 
9.9 X 10_4 4 X 10_4 2.7 X 10_5 4.0 X 10_5 2.5 X 10 
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PASSAGES ELAPSING 'ID 
SOFT AGAR DEl'OCl.'ION 
12 + 2 
ll + 1 
7"+ 2 
5 + 1 
4 ;- 1 
discussed, with examples, below. 
3.10.2. Senescence measurements/inriDrtality in cell lines: Subculture of 
sanples fran irradiatei sheep and human cultures was attanpted to assess 
the number of cell divisions which occur before senescence of the oontrols. 
Results are illustrated fran nine patients. (In sane other cases the 
epithelial cell plating efficiency was too !CM to allCM oonfluent 
epithelial cultures to develop and oontamination with fibroblasts which 
can undergo up to 22 passages made interpretation of results i.Irp:>ssible) . 
The results in Table 4 show the mean value over 3 patients of the cloning 
efficiency of human thyroid cells. 
TZ\BLE 4: cram~ EFFICIEOCIES. 
Dose (Gy) Passage No. 
1 2 3 4 
0 1.2 .. :!: 0.1 0.4 ± 0.06 0 0 
2.5 1.1 '+ o. 7 1.0 ± 0.08 1.2 + 0.1 1.0:!: 0.09 
-
5.0 0.016;!: 0.001 0.8 + 0.09 1.0 ± 0.08 1.2:!: 0.1 
7.5 o.oo2;t o .. ool 0.6 + 0.03 0.8 + 0.1 1.0:!: 0.08 
-
I 
I 
It can be seen that senescence occurs early in human thyroid cultures, but 
where high dose has taken place it was possible to maintain rate irradiation 
cultures for many passages. 
3.10.3. Focus foxmation on the nnnolayer is widely used as a marker for 
alteration of cell status. This occured in both sheep and human cells. 
A correlation was fol.D'ld between nl.lllber of foci developing on the nnnolayer 
of irradiated human cultures and the radiation dose. This is illustrated 
in Table s. 
TAB1 oE 5: Focus Fontati.-'"lll irl. Human Thyroid Cell Cultures. 
Original Radiation DOse (Gy) 
Patient 2.5 5.0 7.5 
1 6.3 + 0.4 10.0:!: 0.8 10.2 :!: 0.8 
2 1.1:!: 0.2 5.3 + 0.4 3.2 + 0.2 
-
3 7. 7 C+ 0. 7 
_, ll.2 + 0.9 15.0:!: 0.3 
4 3.4 + 0.4 10.2 + 0.8 12.2 + 1.3 
The pattern of focus foxmation appears to increase up to about 5 Gy and 
then plateau to 7. 5Gy. This is consitent with other indices though the 
data is subject to much uncertainty. 
I 
3.10.4. Soft Agar Gn:Mth: This was observed in a reproducible fonn in all 
high dose rate ganma ray irradiated sheep thyroid cultures. However it 
still has not been detected in any of the human thyroid cultures examined. 
It is possible that sane technical m:xlifications are necessacy, and in 
particular it may be necessacy to isolate and grow up the cells carp:>sing 
the foci referred to in 3.10.3 above. Further discussion of this area 
takes place in 3.10.ll and 3.10.12 below. 
3.10.5. IDH Is~ Analysis: A shift towards the anaerobic fonns in the 
IDH isoenzyme prole is characteristic of malignant cells in ~ivo. A 
microelectronphoresis technique was developed which pennited small numbers 
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'Survival here is ~residual survival calculated by taking the plating 
efficiency drop at each passage into accmmt as in MJthersill and Seyrrour 
(1987b). 
Second it has been established that late lethal mutations occur in both 
sheep and human thyroid cultures and these are manifest only after serial 
subculture. As an approach to the determination of the effect of this on 
survival, the C3H 101'~ transfonnation nodel was used as its relationship 
·..rith tuirorigenicity in vivo is known. Using the C3H system it is ap;,arent 
that the observed transfonration frerJUency is profO\IDdly affected by taking 
lethal mutations into consideration and the dose response curve does 
not plateau or invert in the range G-15 Gy. When a correction is applied 
to the 1 bell shaped 1 curve obtained for soft agar clones fran sheep 
thyroid, the decrease in number of transfonned clones at high radiation 
doses is renoved (Fig. 8) even though the validity of this correction 
remaining to be fully established. The correction is difficult to apply 
to thyroid culture data because of the problem of senescence of controls 
which prevents proper control plating efficiencies being established at 
the passages where cultures show agar positive clones. 
3.12. 131-I AND HUMAN INVESTI~IONS. 
3.12.1. The rrost demanding index of cell transfonnation used with the cell 
culture assays described above is the detection of soft agar growth. While 
this assay has been reliably applied to sheep thyroid cells irradiated 
with high dose rate irradiation, it has not been possible to produce soft 
agar positive cells using 131-I. This may indicate an absence of 131-I 
induced "transfonration" or technical failure in the system. Rigourous 
steps have been taken to exclude the latter in a large number of repeat 
experiments, but to date no transfonnation after 131-I has been observed 
in sheep cells. However it should be noted that there is a significant 
change in the senescence pattern after 131-I. 
3.12.2. Repeated attempts to apply the soft agar assay with human cultures 
have also produced negative results whether they were irradiated with 
6G-Co or 131-I. No clear reason for this has emerged over and above the 
general difficulty noted by rrost v.orkers in producing transfonnation with 
human material. However using alternative endpoints it is not.e<M::)rthy 
that Nakarmrra et al. (1989) have observed mitogenesis in thyroid cell 
cultures with frequencies not dissimilar to the soft agar growth noted in 
Table 6 and Fig. 8 above for sheep. 
TABLE 7 
End Point Source r.b.e. for 131 I Carment 
<lal<lcer ~~9~577 1 0.3 (0.1 1.0) Uncertain 
Laird, 1987 0.6 1.0 Dos:imetry 
UNSCEAR, 1988 0.3 (0.1 0.5) 
Holm, 1989 0 
Hamilton et al. 0 
1989 
Neoplasia Maxon, 1985 0.2 - 1.0 
Proliferative Malone,l975 et 
(Rat Thyroid) seq. 0.1 uncertain 
._I (Human eulture) 0.16 - 0.2 Dosirnetry (Sheep Culture) 0.2 
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3. 12 . 3. Fran the above the arrotmt of infonnation that can be added to the 
data on r.b.e. for 131-I is relatively little. This is sunmarized in 
Table 7 for both proliferative and non proliferative endpoints. However 
the findings do tend to support the lower rather than the higher values 
suggested for r.b.e. -
3.12.4. The epidemiological and related work in this project was oonducted 
in the main in association with the post Chernobyl initiative and is 
reported there. However two points are worthy of mention here. First 
calculation of the expected rate of incidence of neoplasia fran the 
above data in sheep and Nakarnura's (1989) human data <!Jives results within 
one or two orders of magnitude of those expected fran risk esti.rrate 
calculations. This is reasonably encouraging given the oonceptual and 
practical tmcertainty in the experimental systems and the significant 
tmcertainty (or indeed inaccuracy) in the ratio of death rate to incidence 
and the ratio of benign/malignant disease used in the risk esti.rrates. 
Second the inclusion of non fatalhann as a significant elenent in the 
total thyroid detriment was achieved in many projections of risk esti.rrate 
and in the post Chernobyl calculations, a feature which had been a 
longtenn objective of this project. 
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4. CDNCLUSIONS. 
This project has dem:mstrated that the proliferative radiobiology of the 
thyroid can be understood within the sane frarrework as that applying to 
other tissues. Survival, recovery and fractionation resr:onse in 
differentiated cell cultures are within the range observed for many 
mammalian cell systems. The Do for sheep cells is the order of 2 Gy and 
that for cells of human origin is in the range o.S - 2.0 Gy. The r.b.e. 
for 131-I is 0.16 - 0.2 and the response to it may be explained on the 
basis of dose rate. Furtherrrore the thyroid response has been 
characterized within the frarrework of a unified model that integrates cell 
survival data obtained in cultures; older cell survival data using the 
gland weight assay; the incidence of post irradiation hypothyroidism; and 
a postulated cell kinetics structure for the gland. 
The report also addressed the problem of population dosimetry given the 
differences in lifestyle emerging in the years since the adoption of many 
of the anatomic and physiological data for thyroid dosimetry. Special 
attention was paid to foetal dosimetry and in particular the possibility 
that the foetal thyroid might contribute a significant burden to developing 
foetal neurological tissue. This was regarded as particularly irrportant 
given the emphasis of radiation induced neurophysiological impairment 
arising in weeks 8-16 of gestation. The conclusion reached was that 
maternal and foetal doses due to 131-I ingestion would be similar and that 
the foetal brain dose would be much less than both by several orders of 
magnitude. The above investigations were conducted and reported within 
the frarrework of conventional thyroid dosimetry. However serious reasons 
emerged to undermine the appropriateness of absorbed dose as the unit to 
use in such studies and these are cited in the report. 
Studies of Indices of cell transformation yielded interesting results in 
cultured sheep thyroid cells in which a dose effect relationship was 
derronstrated for soft agar growth. However "transformation" of this type 
was not derronstrated after 131-I or with material of human origin. Hence 
the r.b.e. for 131-I must still remain in sorre doubt for this area, 
although it has been clarified for proliferative end points. In surrmary 
the projects ceported on have added notably to knowledge of thyroid 
radiat1on :~:·esponses and dosimetry during the last four years. 
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Synergistic effects of cigarette smoke in the induction of lung tumours by 
inhaled 239puo2 
Head(s) of project: 
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I. Objectives of the project: 
To demonstrate that exposure to cigarette s~oke enhances the incidence of 
lung tumours in mice previously exposed to 2 9puo2. 
11. Objectives for the reporting period: 
To complete the study started under a previous contract (816-D-100-UK) 
comparing the incidence of lung tumours in plutonium-exposed CBA/H mice 
which had received one year's exposure to cigarette smoke with that in 
animals which were either sham-exposed to smoke or were given no treatment 
other than their initial exposure to plutonium. To initiate further 
studies designed to determine the effects of tobacco smoke inhalation by 
mice on plutonium-induced lung tumours. 
- 1694-
Ill. Progress achieved: 
1. Introduction 
It is well known that both cigarette smoke and alpha-radiation are lung 
carcinogens and some studies have shown that when man and animals are 
exposed to both of these then the numbers of tumours found is larger than 
would be expected on the basis of a summation of the risk of exposure to 
each of these carginogens separately {1). This effect is commonly 
referred to as synergy. Synergy has been demonstrated in rats that were 
exposed to the products of cigarette smoke after they had been exposed to 
radon gas and its daughters, although the reverse order of these insults 
had no such effect (2). These results have been interpreted to indicate 
that radiation is an initiator of lung cancer and that cigarette smoke is 
a tumour promoter. However, other experiments have failed to demonstrate 
synergy and these include a study conducted on radon and cigarette smoke 
exposed dogs (3). In this experiment the effects of these was found to be 
antagonistic. it follows, that it is far from clear how these insults 
interact under different exposure conditions. The present experiments 
were conducted using plutonium-239 as the source of lung irradiation. 
Unlike radon and its daughters, plutonium irradiates the lung for a long 
period after its intake, so that when mice were subsequently exposed to 
cigarette smoke they received both insults simultaneously. This mimics the 
most likely exposure regimen for man where exposure to both carcinogens is 
1 i ke 1 y to be chronic and concurrent rather than acute and separated in 
time. The hypothesis tested was that at levels of exposure to 
plutonium-239 which have been demonstrated to cause lung tumours in mice, 
a subsequent chronic exposure to cigarette smoke would increase the tumour 
frequency. {That is that the effects of tobacco smoke and p 1 uton i urn in 
the mouse 1 ung are synergist i c) . The experiments were conducted on mice 
which have previously been shown to well tolerate exposure to cigarette 
smoke { 4, 5, 6 ) . 
2. Methods 
Three groups of female CBA/H mice were exposed (nose only) to an aerosol 
containing 239puo2 with an AHAD of 1.5 ~m and ag of 1.3. Each animal was 
approximately 10 weeks of age at the time of inhalation and received an 
initial alveolar deposit (IAD) of about 100 Bq of 239Pu. At 8 days after 
inhalation the animals were randomly allocated to one of three treatment 
groups. 
One group, designated PTS, was exposed to tobacco smoke for a period of 
one year. Each ani ma 1 received tobacco smoke - from a commercia 1 , UK, 
middle-tar brand of tipped cigarette - at a concentration of approximately 
1.3 mg 1-1 of tar particulate material for one hour per day, five days 
each week, for one year. Batte I! e Hark III smoking machines were used 
for these exposures and each one hour exposure consisted of two separate 
half-hour treatments separated by a rest period of 15 minutes. Tests made 
using cigarettes labelled with iodo(123I)hexadecane, a hydrocarbon with a 
boi 1 ing point equivalent to the mid-point of those of cigarette tars 
showed that this smoking procedure resulted in an average daily cigarette 
smoke tar deposit in the lungs of the smoking mice of 92.6±15 ~g. 
A second group of mice, designated PSS, was sham-exposed according to the 
protoco I described for PTS. The sham exposures were made on a Batte !I e 
Hark III smoking machine modified to deliver clean air rather than tobacco 
smoke. 
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The third group received no additional treatment and after exposure to 
plutonium were returned to the animal house as a designated cage control 
group - PCC. 
In addition to the above, two further groups of animals were included in 
the study. In contrast to the above, none of these animals were exposed 
to plutonium. One group (OTS) received tobacco smoke, as for the PTS 
mice, for one year. The other group (OCC) was used as a cage control and 
the mice in this group received no treatment. 
Following the cessation of either sham-smoking or smoking the PTS, OTS and 
PSS animals were returned to the animal maintenance facility for a further 
six month period during which time the animals received no further 
treatment. At the end of this period the mice in all five experimental 
groups were killed and necropsies performed. For examination, the lungs 
were inflated with 0.8 ml of formal acetic alcohol fixative. Subsequently, 
these were excised, dehydrated in alcohol and then cleared in methyl 
salicyclate. The cleared lungs were examined at low magnification by 
transmitted light microscopy and any lung lobes containing opacities 
(mostly tumours) were excised and embedded for histopathological 
examination. The pathological examination and classification of lung 
opacities was carried out under contract, in compliance with GLP 
standards. 
In addition to the above, the I ungs of some mice from each ex per i menta 1 
group were analysed to determine their radionuclide content at death. 
These were first ashed then scintillation counted using a cocktail 
comprising a plutonium extractant as well as a scintillant (7). 
All the animals were weighed at weekly intervals throughout the experiment 
and were allowed food and water ad libitum. 
3. Results 
The mice in the cage control group continued to gain weight during the 
first year of the experiment. In contrast, those animals which were 
sham-exposed to smoke gained much less weight - only 4 g compared with 
11 g for the caged control animals - and those exposed to cigarette smoke 
gained practically no weight (about 0.5 g) during this year. At the end 
of the smoking period the PTS and PSS mice rapidly gained weight, but at 
the end of the experiment, these remained about 4 g I ighter than those 
animals in the PCC group. 
Examination of the lungs of the animals that received plutonium revealed 
65 macroscopically defined lesions. Most of these lesions were very small 
and many would _probably have been missed using conventional 
histopathological techniques. For example, 57% of the lesions were less 
than 1. 5 mm in diameter and 2 2% were I ess than 1 mm. The I es ions were 
distributed throughout the lung parenchyma and no association with the 
major airways was found. The numbers of lesions found in animals exposed 
to plutonium are shown in Table 1. It can be seen that of the 61 lesions 
of nodular appearance, 30 were found in the cage-control animals (PCC), 21 
in the sham-smoked animals (PSS), but only 10 in the mice which received 
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tobacco smoke (PIS). A similar trend was found when the percentage of the 
affected animals in each group were calculated: PCC - 54%, PSS - 51%, PIS 
- 26%. 
The Table also shows the amount of 239pu remaining in the lungs of the 
mice in each group at the end of the experiment. The lungs used for the 
determinations were those of the 74 mice found to contain no 
macroscopically discernible lesion. It can be seen that the lung contents 
of the cage-control and sham-exposed mice were very similar, but that the 
lungs of animals exposed to cigarette smoke contained approximately four 
times as much plutonium, indicating that the cigarette smoke inhibited the 
clearance of the radionuclide. 
Experimental Number of Number of % with Alveolar Bq 
Group Mice Nodules Nodules at Sacrifice 
PCC 43 30 53.7% 3.3 Bq 
PSS 45 21 51.4% 3.8 Bq 
PIS 38 10 26.3% 14.2 Bq 
Table 1. Summary of the results of the macrosopic investigation of the 
numbers of lesions in the cage-control (PCCl sham-exposed (PSS) and 
tobacco smoke-exposed (PIS) mice. 
The results of the histopathological examination of the lungs is 
summarised in Figure 2. This shows that, excluding 5 metastasis of 
extra-pu 1 monary origin, 70 tumours were identified. Of these, 7 were 
judged to be malignant and 63 benign. Of the benign tumours 20 were solid 
tumours of a 1 veolar origin showing no tubular differentiation, 32 showed 
tubular differentiation and were judged to be of bronchiolar origin and 10 
were of mixed or uncertain origin. The Table also shows that more than 
twice as many primary tumours were found in the lungs of the mice ln the 
PCC group as in the equivalent group that were only given cigarette smoke 
(OTS) and that the number of tumours found in the sham-exposed group (PSS) 
was intermediate between those of the other groups that received 
plutonium. A closer examination of the results showed that there was no 
clear difference between the numbers of tubular-bronchiolar-benign tumours 
found in each of the experimental groups, but the other tumours types were 
generally much less prevalent in the lungs of the mice that were exposed 
to cigarette smoke. With the exception of a single tumour in the PSS group 
all the malignant tumours were found in the cage control mice (PCC). 
The ani ma 1 s wh i eh received no p l uton i urn contained fewer tumours. In both 
the OTS and OCC groups, the tumour incidence was approximately 20%, 
compared with the PCC ani ma 1 s, the OCC mice contained only } as many 
tumours. However, the difference between the OTS and PIS animal groups 
was much smaller indicating an inhibitory effect of cigarette smoke on 
tumour production. 
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4. Conclusions 
As expected, the results of this study show that an IAD of 100 Bq of 
plutonium-239 results in a significant enhancement of the incidence of 
lung tumours. However, when the results of the synergy study were 
examined, a much 1 ess expected resu 1 t was found in that the numbers of 
lesions in the mice exposed to both plutonium and cigarette smoke was 
1 ower than was found in either of the other groups of ani m a 1 s wh i eh 
received plutonium only. This result may be interpreted in two ways. 
Firstly, the result may be interpreted as indicating that the effects of· 
alpha-particles and cigarette smoke on the lung are antagonistic and that 
cigarette smoke had a protective rather than synergistic effect on the 
lungs of the mice. Alternatively, it may be that the promoting effect of 
cigarette smoke, together with the greater radiation dose to the lungs of 
the mice wh i eh received tobacco smoke - due to impaired c 1 earance of 
plutonium - may have had a lowering effect on the tumour incidence. This 
may have arisen if smoking had resulted in increased 
radiation-sterilisation of transformed cell$. Such an explanation is 
tenable because a dose response study for 239pu conducted in the same 
strain of mouse showed that at one year after exposure to plutonium the 
peak tumour incidence corresponded to an IAD of 160 Bq which is not very 
much greater than the 100 Bq used for the present studies. Further, more 
extensive studies are currently being undertaken using lower doses of 
plutonium and higher doses of tar. These will be completed in 1991. 
Cage Sham Tobacco Cage Tobacco 
control smoked smoked control smoked 
-----Plutonium exposed----
(PCC) (PSS) (PTS) (OCC) (OTS) 
Solid Alveolar Benign 6 4 3 6 1 
Mixed/uncertain Benign 1 3 0 3 3 
Mixed/uncertain Malignant 1 0 0 0 0 
Tubular Bronchiolar 7 8 7 5 5 
Benign 
Tubular Bronchiolar 6 1 0 0 0 
Malignant 
Metastases Extra- 4 1 0 0 0 
Pulmonary origin 
Total excluding 21 16 10 14 9 
Metastatic deposits 
Total Benign 15 15 10 14 9 
All types 
Number of mice 43 45 38 58 46 
in group 
% Mice with Tumours 46.5% 33.3% 26.3% 18.9% 19.6% 
Tumours per Mouse .58 .38 .26 .19 .20 
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Title of the project no.: 2 
Studies on the distribution and effects of alpha- and beta-emitting 
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Head(s) of project: 
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I. Objectives of the project: 
1. To determine the comparative distribution of p 1 uton i urn and amertcl urn 
in the bones and bone marrow of baboons, following their 
administration in different chemical forms by injection and 
inhalation. 
2. To study the effects of bone turnover and growth on the redistribution 
of plutonium and americium, and the influence of macrophages on their 
distribution in the red bone marrow. 
3. To use the data obtained to construct realistic models for the 
dosimetry of bone-seeking radionuclides in the human skeleton. 
11. Objectives for the reporting period: 
To continue to examine, by autoradiography, the bones of plutonium and 
americium contaminated baboons and man. 
To undertake a quantitative analysis of the distribution of plutonium 
in baboon bone at different times after its injection. 
To apply the dosimetric model developed for plutonium in man and to 
estimate the risks of leukaemia following plutonium intakes. 
To study the appropriateness of risk estimates based on Thorotrast 
toxicity data. 
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Ill. Progress achieved: 
During the current year, considerable progress has been made on the 
va 1 i dation and deve 1 opment of metabo 1 i c mode 1 s for bone seeking 
radionuclides. Particular attention has been given to two aspects of our 
current dosimetry programme. 
1. Dosjmetrjc Modelling 
The first of these was a comparison of the dosimetry models published by 
ourselves, by the ICRP and by Leggett at Oak Ridge, USA. The first stage 
was the conversion of each model to similar and compatible computer codes 
so that they might be compared. This stage was completed early in the 
financial year. Subsequently, the models were run for plutonium-239 
intakes by adults and by children of different ages. With respect to body 
retention and the retention half-time of plutonium in the skeleton, very 
good agreement was found between our model and that of the ICRP. However, 
the Oak Ridge model was found to be deficient to the point where it was 
obvious that it had never been run. Consultations with the NRPB revealed 
that the ICRP were to adopt a revised Leggett model for its age-related 
dosimetry and this model was also tested. In our opinion the revised 
model is also flawed, but the ICRP has apparently decided to continue with 
its use. 
The second study area is concerned with the problem of model accuracy. It 
is self-evident that any dosimetric model is only as good as the data and 
parameters incorporated within it and the uncertainties in these introduce 
uncertainties in the doses calculated by the model. In order to obtain an 
estimate of the accuracy of our model, a full sensitivity analysis has 
been undertaken. For this analysis the value of all the parameters used 
for the model are allowed to vary simultaneously according to our 
knowledge of their uncertainty. Multiple runs of the model were then 
undertaken in order to ascertain the distribution of its predictions. So 
far the results indicate that uncertainties in the modelling are likely to 
be less important for the prediction of consequences than uncertainties in 
risk estimates. This would seem to be true particularly for leukaemia 
induced by plutonium and related elements. 
2. Actinide Peposjtjon and Redistribution to· the Skeleton 
The effects of plutonium redistribution in baboon bone, supplied by the 
CEA, France, on its dos i me try in the ske 1 eton have been investigated. 
These studies were undertaken to provide information from a near human 
animal that can be used for the development of metabolically meaningful 
dosimetric models. The results have been produced by the examination and 
quantification of autoradiographs of bones from baboons killed at 
different times after the intravenous injection of a soluble plutonium TBP 
complex. The results obtained during the period of this project show 
that, despite substantial bone turnover amounting to more than 100% per 
year in both cortical and travecular bone, the radiation dose received by 
bone surfaces is affected to a much smaller extent than expected. For 
example, at 1 day after injection the fraction of the total alpha dose 
absorbed by the radiosensitive bone surfaces ranges from 15-20%, compared 
with an ICRP expectation of 25%: at 1 month bone turnover had reduced this 
to 10-11% and this level was then maintained so that it remained 7-12% at 
1 year post-injection. These results are consistent with the dosimetric 
assumptions made in our modelling. Similarly, no increase in radiation 
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dose received by the bone marrow as a consequence of its accumulation in 
marrow macrophages was found and the fraction of the radiation dose 
received by this organ remained at about 10%. 
Studies on human bone, contaminated with americium-241, have also been 
undertaken. These use bone removed by us at autopsy from an American male 
radiation work who died 11 years after a substantial radionuclide intake. 
The bones were donated by the United States Transuranium Registry and the 
current studies form part of the Registry's coordinated examination of the 
cadaver. Qualitatively, the results show that 1 i ttle radionucl ide 
redistribution had occurred during the 11 years in the patella and this 
bone also showed little radiation damage. Other bones exhibited more bone 
turnover and consequently greater amertctum redistribution. In the 
clavicles, limited americium redistribution was evident and in the ribs 
more was identified along with evidence of bone growth (drift). Both these 
bones showed some radiation damage including peritrabecular fibrosis and 
the initial surface pattern of radionuclide deposition was largely 
retained indicating the importance of secondary bone surface deposits. In 
the sternum, radiation damage was more evident and bone surface deposits 
of americium at many sites had become buried by reactive bone, but in this 
bone also, the relatively even surface pattern of deposition 
remained. However, in the lumbar vertebrae massive radionuclide 
redistribution was evident and many bone surfaces were depleted in 
americium. Only the surfaces of bone trabeculae towards the centre of the 
vertebral body seemed to retain their initial americium burden. In all 
bones, only a few percent or less of americium was present in the red bone 
marrow and none was present in the yellow bone marrow of the patella. 
Overall, the behaviour of actinide in the human bone was very 1 i ttle 
different from that seen in similarly contaminated dog and monkey bone 
emphasising the importance of the baboon studies. As yet, no quantitative 
assessment of the human bone has been made. 
3. Validity of Current Risk Estimates 
Volunteer studies on the metabolism of the radium-like alkaline earth 
element barium are continuing. These were initiated in order to check the 
validity of current estimates of the dosimetry of radium in man. This is 
important because our knowledge of the toxicity of radium-226 provides the 
basis for estimates of the risks associated with intakes of all 
alpha-emitting, bone-seeking radionuclides. The experiments were initiated 
over 20 years ago. To date, six male volunteers have been injected with 
the long-lived radioisotope barium-133. Of these, five have been injected 
for at least two years and the sixth was injected during 1989. The 
results show that, while the initial uptake of barium by the skeleton is 
variable, its clearance rate during the first few years post-injection is 
remarkably uniform. Clearance during this period is mostly by heterionic 
exchange. Substantial clearance data at later times is currently only 
ava i 1 ab 1 e for one vo 1 unteer. This man was injected at age 61 and then 
again at age 81. The data for this individual suggest that the long-term 
clearance is dominated by bone resorption and this appears to be 
significantly enhanced at the older age. This may be important as most of 
the human radium data is for women and they have a higher rate of bone 
loss in later life than men. In addition to the above, studies on the 
local rates of barium loss from different parts of the skeleton are 
continuing. These have demonstrated differences in the rate of bone 
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turnover in different bones. The data collected will be considered for 
use in advanced metabolic models for osteophilic radionuclides. 
It is known that following intakes of p l uton i urn and other bone-seeking 
radionuclides, the bone marrow is irradiated by plutonium present both on 
bone surfaces and in the bone marrow. It is also known that current risk 
estimates as recommended for use by the ICRP cannot be cohfirmed by 
reference to studies of human populations, all of which indicate very much 
lower risk estimates. Currently, we are examining experimentally the 
validity of the current human toxicity data bases to see if there are any 
contra-indications to their use for the prediction of leukaemia in human 
populations exposed to plutonium. Previous studies with pig bone have 
shown that rad i urn isotopes become deposited in the ske 1 eton in much the 
same way as the actinides and that the absence of substantial excess 
leukaemia in human populations exposed to radium-224 must therefore be 
taken to indicate that the risk of leukaemia in people exposed to 
actinides is also low. However, actinides, but not radium, are accumulated 
in the bone marrow. According 1 y, we are current I y studying the toxicity 
data for Thorotrast which is deposited in and irradiates the bone marrow 
with alpha-particles. Two aspects are being examined, firstly the 
uniformity of Thorotrast deposition in the bone marrow at different 
skeletal sites and secondly, how much Thorotrast is deposited in the red 
bone marrow as opposed to the fatty, yellow bone marrow. If it is found 
that Thorotrast is heavily concentrated in some parts of the red bone 
marrow but absent from others, then by invoking the concept of tissue 
sterilisation it may be possible to explain why so few leukaemias are seen 
in Thorotrast patients. Tissues from monkeys injected with Thorotrast and 
from a human who died from aleukaemic leukaemia as a consequence of her 
Thorotrast intake ( supp I i ed by the United States Transuran i urn Registry) 
have been used for the study. The human tissues were collected at 
autopsy. Techniques being employed initially included back-scattered 
electron imaging using the SEM and secondary ion mass spectroscopy (SIMS). 
These yielded excellent qualitative and locally quantitative results 
showing that some macrophages in the red bone marrow comprised 30% of 
thorium by mass, but the comparison of different sites proved problematic. 
It was therefore necessary to seek alternative methods for this task. As a 
result we were able to show that very good results could be obtained using 
X-ray fluorescence (XRF) in combination with limited image analysis. 
Results are now being collected from monkey bone removed one day after the 
injection of Thorotrast. Currently it would seem that the concentrations 
of thorium in the red bone marrow are in the order of 120 ~g g-1 and are 
about 10 times lower in the yellow marrow. Other monkeys which were 
injected with Thorotrast over 1 year ago remain a I i ve. Comp I ete tissue 
analyses are being undertaken. To data no results have been obtained which 
would suggest that there is any special feature of Thorotrast distribution 
which could explain its low toxicity. 
4. Effect of LET 
In addition to the above, the programme of experimental work designed to 
compare the effects of low and high LET radiations on the bone marrow has 
continued. This uses injected radiolabelled fused clay particles (FAP) as 
the vector for delivering the radiation dose to the bone marrow and other 
tissues comprising the reticulo-endothelial system. The system for the 
production of radiolabelled fused clay (FAP) is now fully installed and 
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particles labelled with cobalt-57 have been produced for use in 
preliminary studies. Curium-242 is currently being produced by the 
Chemistry Division, Harwell, and will be available for use by the end of 
March 1990. During the current year, studies have been carried out to 
determine the distribution and retention characteristics of FAP following 
its injection into mice and leaching experiments have been completed to 
measure the m vivo and m vztro dissolution rates of the material. In a 
preliminary study it was found that a large amount of the injected FAP was 
retained at the injection site. This was reduced to less than 5% in later 
mice which were injected by an improved technique. In these animals 80-90% 
of the clay was deposited in the liver with 2-3% in the bone marrow. No 
difference was found between the deposition patterns of 1 and 3 ~m 
diameter particles. Similarly, both sized particles were found to be 
essentially insoluble as determined by analysis of excreta. In addition to 
the above, cytochemical techniques required for the categorisation of 
myeloid leukaemia according to the FAB system of pathology have been 
developed in the laboratory and a protocol for the toxicity studies has 
been written. 
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Title of the project no.: 
Head(s) of project: 
Scientific staff: 
I. Objectives of the project: 
B16-D-092 IRL 
Or C Mothersill 
Dr C Seymour 
Or C Mothersill 
Or C Seymour 
Ms A Cusack 
Ms M McDonnell 
Ms P Nolan 
Mr V Rodilla 
Mr C Grimes 
1. To develop methods for culture of tissue of interest in 
the radiation protection field. 
2. To study the induction by radiation of features 
associated with carcinogenesis in these culture 
systems. 
3. To investigate mechanisms involved in the development 
of selected radiation transformation endpoints in the 
culture systems. 
4. To attempt to quantify radiation transformation 
frequencies in selected primary culture systems. 
5. To investigate the potentiating effect of known tumour 
promoters such as phorbol esters. 
11. Objectives for the reporting period: 
1. To integrate immunocytochemical and ultrastructural 
analysis of irradiated tissues in an attempt to 
quantify cellular changes. 
2. To develop a mathematical model for radiation induced 
transformation expression which incorporates a lethal 
mutation term. 
3. To continue to develop 3-D culture systems for 
available tissue. 
4. To quantify the biochemical changes detected in 
isoenzymes and intermediate filaments on a per Gray 
cell basis following irradiation. 
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Carcinomas account for 92% of tumours diagnosed yet 
research papers dealing with epithelial cell transformation 
only composed around 8% of the literature on the subject in 
the last five years. The situation regarding radiation 
transformation research is worse, with less than 0.05% of 
papers dealing with radiation transformation of epithelial 
cells. Tentative conclusions which may be drawn from this 
are that (a) we are looking at the wrong cells in the wrong 
way and (b) we cannot look at the right cells. 
The argument is often put forward that general information 
may be obtained from less than perfect models and 
extrapolated or used as a basis for the deduction of 
relevant answers. In the case of carcinogenesis this 
argument is hard to justify. Epithelial cells from which 
carcinomas arise are usually differentiated, highly 
specialised and functional with a polarity and precisely 
determined position in a tissue structure. In the human, 
tumours usually arise late in genetically dissimilar 
individuals after the tissue has functioned normally for 
maybe 60-70 years. While extrapolating from the simple to 
the complex may be a useful scientific method, there is a 
grave danger of the work becoming irrelevant when the real 
situation in which cancer arises is so far removed from the 
model used. The ideal model should be human, epithelial, 
three-dimensional, differentiated and with quantifiable and 
definitive endpoints. Many scientists have attempted to 
develop human epithelial systems have met with variable 
degrees of success. Among them are DiPaolo, who has used 
virus transfection to immortalise human skin and cervical 
epithelial cells. Mulcahy, who developed a fat pad assay 
where cells treated in vitro are injected into the fat pad 
of the rat, surviving clonogens of human cells are then 
tested for tumorgenicity in immunosuppressed mice; 
Grafstrom who has developed a system where clonal growth in 
culture of human bronchial and buccal cells can be achieved 
and changes monitored following exposure to chemical 
carcinogens; Seymour & Mothersill who developed a human 
thyroid system where a high degree of differentiation can 
be achieved and clonal growth after serial subculture 
detected in irradiated cells which have an extended 
lifespan. 
Reznikoff has developed a system for the study of long-term 
neoplastic change in urogenital cells following initiation 
by virus transfection. None of these systems has yet shown 
conclusive transformation by radiation. The question 
arises that, since we cannot detect transformation even 
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using the most carinogenic doses of radiation, are we 
looking at the right endpoints or at the problem in the 
right way? Possible reasons why radiation transformation 
has not been detected include the following: 
1. The event is extremely rare in human cells and the 
fragments of normal human tissue available do not 
supply enough cells to give a statistical chance of 
detecting a transformant; 
2. Cooperation of two or more cells or cell types is 
required - it is known that stromal elements are 
important, vascular elements probably are as well. 
3. Differentiated function may be required. This latter 
suggestion is attractive if the translocation theory of 
cancer induction is favoured since the activator gene 
sequence controlling some differentiated function in 
the normal cell and now lying next to the oncogene in 
the translocated chromosome would need to be switched 
on for the theory to work. 
Because of the complexity of the problem of epithelial cell 
carcinogenesis, this project approached the problem in the 
following manner: 
1. Only human tissues were used for development of the 
system. 
2. Cells were treated as soon as the tissue explants had 
attached in culture so that the structural integrity of 
t~e tissue was maintained during radiation exposure. 
3. After treatment the behaviour of epithelial cells 
within a mixed culture was monitored. 
4. Conditions which favoured differentiation rather than 
"growth of the cells were created. 
5. Endpoints were flexible and what does rather than what 
should happen was documented. 
METHODS 
1. Sources of tissue and Development of the culture 
system: 
Sources of normal human tissue in useful quantities are 
scarce and therefore the choice of tissue was limited by 
availability although efforts were made to choose radiation 
sensitive organs, or tissues of particular interest in 
radiation protection studies. Regular supplies of the 
following nQrmal tissues have been secured; Ureter from 
transplant donors, cervix, endometrium and ovary from 
hysterectomy patients, oesophagus from patients undergoing 
surgery for adenocarcinoma of the stomach, thyroid from 
patients undergoing pharyngolaryngooesophagectomy for 
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neoplasms of the upper oesophagus and skin from many 
different operations. Occasional samples of normal breast 
tissue have also been obtained. The tissues from tumour 
bearing patients were used with caution and only where no 
other source of normal human tissue was available. 
All tissues were set up as primary explant cultures. 
Thyroids were also digested and set up as primary cultures 
according to the methods developed by the group in earlier 
contracts. Relevant tumours were used as positive 
controls. 
2. Development of Assays for monitoring radiation induced 
changes: 
The small amounts of normal tissue available and the 
relatively low numbers of cell divisions undergone by 
normal cells prior to terminal differentiation, meant that 
methods for detecting early changes in irradiated cultures 
had to be developed for use with extremely low numbers of 
cells. Emphasis was therefore placed on developing in situ 
techniques (hybridisation, immunocytochemistry, and 
autoradiography). These methods had the added advantage 
that they did not require the structure of the culture to 
be destroyed and results could be interpreted in the 
context of the culture histology, ultrastructure and degree 
of differentiation. 
3. Irradiation: 
Cultures were usually irradiated using a standard cobalt 60 
teletherapy unit although some thyroid cultures were 
exposed to 131 Iodine and preliminary experiments with 
32 P were undertaken. Cultures were generally irradiated 
when the explants had attached (24-36 hrs after 
explantation) but before outgrowth had commenced so that 
the cells were irradiated under conditions where the tissue 
architecture was as close to the in vivo situation as 
possible. Post irradiation cultures were stored under 
conditions which did not especially favour normal cell 
growth but which would allow the build up of growth factors 
or angiogenesis factors should these processes be initiated 
by the treatment. 
Results: 
1. Culture system 
With all tissues tested the culture method used produces 
normal, epithelial cells which have been shown in the case 
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of the oesophagus and ureter at least to be similar in 
structure to cells in the parent tissue. The cultures 
proliferate for 2-4 weeks and then undergo terminal 
differentiation unless treated. Stromal elements, while 
present, do not dominate the culture. Endothelial cells 
organise over the epithelial monolayer and form 
capillary-like tubes. Stratification of squamous 
epithelium is detectable after 3-4 weeks of culture. 
2. Changes in proliferation following irradiation 
Following irradiation of the culture the overall outgrowth 
area is reduced in a dose-dependent manner and the numbers 
of proliferating cells detected by autoradiography is also 
reduced (to 10% at 5 Gy). However, certain areas of the 
culture show proliferative foci which are strongly positive 
when tested using the proliferating cell antibody Ki67. 
The numbers of foci increase with radiation dose up to 5-10 
Gy and then decline (Fig. l(a)). 
Fig 1 
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Numbers of proliferative foci detected at 
increasing radiation doses (la) over 1-3 weeks 
(lb) 
The dose causing peak numbers of proliferating foci in the 
culture varies from 5Gy after one week in culture to 10 Gy 
after three weeks in culture (Fig l(b)). The nature of the 
cells composing these foci is not known but their 
ultrastructure has features similar to those of highly 
differentiated squamous carcinoma cells, in particular the 
characteristic ring of tonofibrils around a nucleus pitted 
with nuclear pores. 
Estimates of the rate of "repopulation" or rate of growth 
of all survivors in the culture·after different doses of 
radiation may be obtained by determining the cell number or 
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number of proliferating cells at regular intervals. This 
type of data shows clearly (Fig.2) that after high doses of 
radiation the growth rate of survivors is faster than after 
low doses although the final total number of cells in the 
culture is almost the same. 
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Fig 2 Relative numbers of cells in the outgrowth with 
time after irradiation,controls normalised to 100% 
for each time point 
3. Cytokeratin profile 
The range of cytokeratins occurring in normal, normal 
irradiated and tumour oesophageal cells in culture is shown 
in Table 1. Differences between the normal and the other 
two groups, particularly in the occurrence of cytokeratins 
18 and 19, are apparent. 
TABLE 
Sample Dose 
control in vitro Normal 
Tumour -.r- ---.r--
control in vivo Normal 
Tumour -.r- --rr---
Normal in vitro 
11 -rr---.-,-
2.5 Gy 
5.0 Gy 
10.0 Gy 
15.0 Gy 
Nitrosamine + 5 Gy 
Nitrosamine only 
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Kerat1ns present 
4,5,6,8,14 
4,5,6,8,14,18,19 
4,5,6,8,14 
4,5,6,8, 14,18 
4,5,6,8,14,18,19 
4,5,6,8,14,18 
4,5,6,8,14,15,18,19 
4,5,6,8,14,15,18,19 
4,5,6,8,14,18,19 
4,5,6,8,14 
4. Lactate dehydrogenase isoenzyme profile 
A shift in the LHD isoenzyme profile towards the anaerobic 
forms of the enzyme has been detected in thyroid cells. 
This was also found in oesophageal cells but has not yet 
been quantified. 
5. Ultrastructure 
Various ultrastructural changes have been quantified. 
Fig.3(a) shows the pattern of occurrence of nuclear 
irregularities with radiation dose in human oesophageal 
epithelial cells and Fig. 3b shows how the numbers of 
intact mitochondria vary with dose. In both cases the 
damage reaches a peak at doses associated with expression 
of high absolute transformation frequencies and falls off 
or stays constant at higher doses. 
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Eia_1 Ultrastructural appearance of cultures exposed to 
increasing radiation doses. 3a Nuclear 
irregularities, 3b Mitochondrial damage 
6. Endothelial cell proliferation 
The relative frequency and absolute numbers of endothelial 
cells together with their degree of differentiation are 
shown with respect to radiation dose in Table 2. It can 
be seen that there is a marked increase in endothelial cell 
number, frequency and differentiation with increasing dose 
which peaks 7.5-10.0 Gy. 
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7. Oncogene Activation 
Antibodies to cMyc and nMyc were obtained from Dr G Evan, 
ICRF, and these revealed cMyc activation in positive tumour 
controls and in urothelial and oesophageal cultures exposed 
to 5 Gy gamma rays. This may, however, merely indicate 
that growth of cell is switched on post irradiation to 
enable repopulation of the tissue. 
a. 
TABLE 2 
RELATIVE FREQUENCY OF ENDOTHELIAL CELLS IN OUTGROWTHS. 
COUNTS ARE THE MEAN OF TWO TRANSECTS OF THE OUTGROWTH 
(EXCLUDING EXPLANT) 
DOSE TOTAL CELLS ENDOTHELIAL % ENDOTHELIAL DEGREE OF AREA 
(GY) IN TRANSECT CELLS CELLS DIFFERENTIATION (MM') 
0 510 8 0.2 None 352 
2.5 200 32 16.0 None - slight 80 
5.0 61 15 24.6 + 48 
7.5 49 36 73.5 +++ 40 
10.0 34 15 44.1 +++ 8 
12.5 26 16 61.5 ++ 3.2 
15.0 5 0 0 None 1.6 
Soft Agar G~owth 
This endpoint is of dubious use in epithelial cell 
transformation but as it is widely used for monitoring 
responses of possibly transformed normal cells and of 
tumours it was used in occasional experiments where the 
cell number in the culture made this possible. The test 
worked best with cultures of thyroid cells. These survived 
a range of doses where it was possible to quantify the 
frequency of soft agar colony formation in late passages of 
the radiation survivors with respect to radiation dose to 
the primary culture. The relationship was exponential with 
frequencies of 10-• transformants per surviving cell 
being obtained 17 passages after exposure to 7.5 Gy. No 
plateau was reached and extrapolation of the relationship 
gave a theoretical dose for 10 transformants per surviving 
cell. Using the explant system it proved too difficult to 
obtain sufficient cells to perform soft agar assays 
although cultures of focal cells have now been shown to 
have greatly extended lifespans and such experiments may be 
possible with these in the future. 
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9. Lethal Mutations and Quantification of Transformation 
Frequencies 
During the contract period the failure of survivors of 
irradiation to divide normally was noticed. Since 
transformation endpoints are traditionally expressed "per 
surviving cell" it became apparent that the criterion for 
judging a cell to have needed to be critically examined. 
The effect of taking lethal mutations into consideration 
using the C3H10T system and the thyroid soft agar assay 
was analysed. The frequency of transformation per 
surviving cell would seem to be underestimated at high 
doses using the conventional survival assay. 
This problem makes quantification of endpoints with respect 
of number of survivors in the explant system very difficult 
and it may be necessary to adopt a different approach to 
determining quantitative dose/response relationships, for 
example number or frequency of positive cells at a series 
of time points after irradiation. · 
DISCUSSION 
One of the major problems in the field of radiation 
protection is concern over induction of cancers in exposed 
humans. In order to study the carcinogenic effects of 
radiation in a systematic way it is clearly necessary to 
develop experimental systems which will allow the various 
stages of the carcinogenic process to be produced and 
quantified in a controlled manner. Ideally such systems 
should be based on human cells exposed to relevant doses of 
radiation which then undergo one or more definitive changes 
which can be quantified with respect to total dose, dose 
rate, radiation quality, etc. 
The results presented are an attempt to develop realistic 
and meaningful endpoints for human exposure to radiation. 
A useful endpoint must be reliable, relatively easy to 
study and given the problems of human tissue supply, should 
not require large numbers of cells. Because of the 
inability, to date, of any group to produce definitive, 
validated transformation of human epithelial cells using 
radiation, it is also necessary to consider alternative 
approaches to the qualitative and quantative demonstration 
of transformation or partial transformation in these cells. 
The endpoints found during this contract all show a dose 
response and are all associated in some way either with 
transformation to the neoplastic state in vivo or with· 
existing tumours. While none of them in itself is proof of 
transformation, taken together they provide evidence of 
alterations in several biochemical pathways or cellular 
substructures which change during in vivo carcinogenesis. 
The most promising approach to the problem from a radiation 
protection point of view would seem to be to assign a 
weighted value to each of the endpoints and determine a 
potential transforming factor (PTF) for the tissue for each 
radiation parameter of interest. This approach will be 
used in the future. 
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Title of the project no.: 
EXPERIMENTAL STUDIES AND MODELLING OF DEPOSmON AND RETENTION 
OF INHALED AEROSOLS IN MAN 
Head{s) of project: 
Docteur N. PARMENTIER 
Scientific staff: 
M. ROY, C.E.A. engineer,. with the collaboration of M.H. BECQ,UEMIN and 
A. BOUCHIKHI, medical doctors. Respiratory Function Exploration Department Pitie-
Salpetriere Hospital PARIS. 
I. Objectives of the project: 
The development of dosimetric modelling of the respiratory tract for radiation protection is 
under revision by the International Commission for Radiological Protection. The revised 
model will use recent knowledge in deposition and retention of inhaled aerosols, in humans 
and experimental animals. Modelling should apply to all members of the population and 
therefore consider the dependence of the parameters upon age anli the influence of 
diseases. The proposed work intended to contribute in assessing the important role of the 
dimensions and of the physiological state of the airways in airborne particle deposition. 
Such data exist for healthy adults but are missing for children, and rare for patients with 
impaired lung function. 
11. Objectives for the reporting period: 
Inhalation of inert insoluble particles was proposed to human volunteers, to measure either 
total or nasal airway deposition during controlled breathing. Healthy adults and children 
were to undertake the tests because the changing with age of the respiratory tract geometry 
and of the ventilation, is usually thought to result in changes of particle deposition values. 
An accurate estimate of particle deposition in the growing airways is of special interest not 
only for dosimetry in children, but also for a reliable assessment of accumulated doses 
during a whole Iifespan. Adult patients with impaired lung function were also to be studied 
for total airway deposition. 
The work arose from the international cooperation of aerosol physicists and medical 
research teams ; it was to be discussed with relevant specialists and the experimental data 
compared with their calculated airway deposition models. 
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Ill. Progress achieved: 
METHODOLOGY 
Deposition of monodisperse aerosols has been measured in the whole airways, or the nose 
only, by comparing inhaled and exhaled aerosol concentrations, measured by laser 
velocimetry. The ventilation was controlled, and the tidal volumes (VT) and frequencies 
(fR), selected according to age, body size, and sex, in order to standardize the physiological 
parameters at rest, and under light exercise. 
The children values were scaled to the adults' after GAUL TIER et al. (1981 ), 
GODFREY et al. (1971), and GODFREY (1973), (Table 1). 
The aerosol generation-exposure and measurement apparatus (Figure 1) consisted of the 
following elements : 
- a Tri-Jet aerosol generator T.S.I. provided dried aerosols from an aqueous suspension of 
monodispersed polystyrene beads from Prolabo-RhOne-Poulenc. Three different aerosol 
outlets could generate simultaneously different sizes of particles: 1, 2.05, 2.8 and 3.1 pm 
of mass median aerodynamic diameter, (M.M.A.D.); 
- a Krypton 85 source ionized the air in an adjoining chamber, where the aerosol was 
electrically discharged (Boltzmann equilibrium) ; 
- a diluting chamber mixed the aerosol with an appropriate volume of clean filtered air ; 
- an original inhalation device provided subject interface and was made up of ; a Fleisch 
pneumotachograph n• 2, with a membrane pressur•e-transducer (Enertec 
CH 51 +/- 2 mb), measuring inspiratory flow-rates and inspired volume when 
connected to a flow-rate integrator, to an oscilloscope, for visual monitoring, and to a 
recorder. 
Calibration with a sinusoidal pump per':nitted display .and recording of the inspired 
volume (Vi) and inhalation time (Ti) values .during the subjects' breathing, that was 
controlled also by auditive frequency signals. 
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VentJ.latlon Parameters Selected to SJ.mulate Two Levels of ActJ.vJ.tv and Scaled to_Age 
~ Light exercise 
Age fR VT, V E fR VT VE fR : fre 
( m1n - 1) ( l.min-1 -1 (1) ( l.m1n-l VT : tid y ( 1 ) ( min ) 
quency 
al volume 
VE : m1n ute ventlla t1on 
6 23 0.250 5.75 38 0.290 II.O 
8 23 0.280 6.0 37 0.460 17.0 
10 20 0.340 6.80 32 0.580 18.6 
M 18 0.430 7.75 27 0.760 20.5 
l2F 19 0.340 6.45 30 0.630 18.9 
M 15 0.540 8.1 25 0.930 23.2 
14 
F 18 0.370 6.7 26 0.770 20 
M 14 0.620 8.7 23 1.10 25.3 
16 
F 17 0.410 6.9 24 0.900 21.6 
M 13 0.770 10.0 21 1.25 26.2 
18 
F 15 0.470 7.05 22 1.0 22 
M 12 0.750 9.0 20 1.25 25 
30 I F 14 0.460 6.45 21 1.0 21 j I 
Metronome 
s.A>JOCI 
fiL...1 : Aerosol aeaeratioa-exposure system 
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Two original respiratory valves (EUGENE et al., 1987) resembling cardiac valvulae and 
adaptated to large airflows, separated inhaled from exhaled gases with good airtightness and 
low particle trapping : 
- a dessicator trapped exhaled air humidity ; 
- a dry spirometer accumulated up to 10 I. of expired gases. 
When saturated, the system was automatically disconnected and the contents of the 
spirometer were aspirated into the particle counter at a constant flow rate of 5 l.min-1 : 
- an aerodynamic particle sizer (A.P.S. 33, T.S.I.) measured the time taken by a particle 
between the two passages in two laser beams, after a constant acceleration in an airflow of 
15 m.s-1 (CHEN et al., 1985). Knowing the particle density, its aerodynamic diameter 
could be directly deduced as well as the particle concentration by unit volume. These data 
enabled calculation of mass and surface concentrations, the count median aerodynamic 
(M.M.A.D.), and the geometrical standard deviation ( a g) of particle distribution. 
All the preceding elements were made of brass or neoprene, and all angles, abrupt diameter 
changes and bifurcation were minimized in order to limit particle trapping. 
Subjects 
With the agreement of the Ethical Committee of the hospital Pitie-Salp~triere 41 children 
from 5 to 15 years old, boys and girls, and 29 adults, men and women, volunteered the 
tests : 
- all the children and a group of 10 adults (5 men and 5 women) were non-smokers and 
were healthy, as determined by both clinical examination and respiratory function 
explored by spirometry : vital capacity (VC), residual volume (RV), forced expired 
volume in sec ; (FEY 1 ), total lung capacity (TLC), and functional residual capacity 
(FRC); 
- a group of 9 adults (4 men and 5 women) suffered from interstitial lung disease (lLD) 
with restrictive lung function. A group of 10 adults (8 men and 2 women) suffered from 
chronic obstructive pulmonary disease (COPD) with obstructive lung function. 
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Methods 
After calibration of flow-rates, volumes, generated aerosol sizes and concentrations, 
particle deposition was measured in the subject's airways. 
I. Total airway deposition by mouth-breathing 
Measurements were made during mouth-breathing, with a noseclip : first, with the 
mouthpiece closed, the spirometer was filled automatically· with inhaled air, at a rate (V T 
and fR) equal to that of previously determined controlled breathing. The A.P.S. then 
aspir:ed air from the filled spirometer and measured. the distribution and concentration (Ci) 
of particles to be inhaled. The subject then inhaled an identical air-particle mixture. After 
5 washout cycles, the system was connected and the subject expired into the spirometer 
which was in turn emptied by the A.P.S., giving the distribution and concentration (Ce) of 
expired particles. 
The deposition (Dm) of inert particles in the airways by mouth-breathing, was measured by 
comparing their concentration in the inhaled (Ci) and expired (Cem) aerosols: 
Dm = I - Cem/Ci 
2. Nasal deoosition at inhalation 
Following total airways deposition, some of the same healthy subjects, adults and children 
performed the tests during nose-breathing, through a nose-mask with the mouth shut; 
using the same procedure, and identical ventilation rate. The deposition (Dn) by nose 
breathing in the airways, was calculated in the saw.e way as before, and , two values were 
obtained: 
-·deposition by mouth-breathing: Dm = I- Cem/Ci 
- deposition by nose breathing : Dn = I - Cen/Ci 
(usually Dn > Dm). 
It is usual to assume that the mouth has negligible air-flow resistance, and efficiency in 
removing airborne particles when breathing through a mouthpiece and wearing a nose-clip. 
So we may assume that Dm is equal to the sub-oral airway deposition, y, mainly the 
pharyngeal, tracheo-bronchial, and alveolar depositions, that stay the same during nose-
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breathing, provided the subject breathe at the same flow-rate for the mouth and nose 
breathing, 1-Dn, is then equal to : 
1-Dn = (1-x) (1-x') (1-y) (Figure 2) 
In order to calculate the particle fraction deposited in the nose during inspiration, x, that 
indicates the efficiency of the nasal filter toward the various particles, we have to make the 
assumption that the two nose deposited fractions x and x' are equal, we have then : 
1-Dn = (l-x)2 (1-y) 
1-Dn = (l-x)2 (1-Dm) 
Cen/Ci = (l-x)2 Cem/Ci 
and finally, the "nasal particle filtering efficiency" is given by : 
x = I- .rten/Cem 
In these subjects, anterior rhinomanometric determination of nasal resistances as a function 
of nasal flow-rates was made for each side of the nasal passages (GAHEM and 
MARTINEAUD, 1985) : the pressure and flow-rates variations were measured 
simultaneously in both nares during inspiration. The flow-rates, Q, were measured with a 
n• I Fleisch pneumotachograph fitted to one nostril by a rubber piece, and connected to a 
membrane pressure-transducer. The pressure drop, p, over the opposite passage was 
measured in the vestibular region by a pressure recording catheter, connected to a second 
pressure transducer. The flow-rate and pressure signals were recorded in the x/y mode, for 
both nasal passages in turns. The right and left resistances Rr and RI, could be calculated 
by the relationship : 
R = p/Q 
and the total resistance of the entire nose, Rr, by : 
For a given total nasal flow-rate during inspiration, the partitioning of the air-flow 
between the two nasal passages was given by the maximal flow-rate values obtained during 
a quiet breathing in each side at the same moment. 
- 1727 -
Heivht 
cm 
200 
180 
160 
140 
120 
lOO 
• Moles 
o Females 
5 
:-lose 
+ 
Bronchi v]..e:rfllrr 
Bronchioli (~ 
"'~' 
larynx 
flL..l : RealoaaJ deposltloa la the airways 
0 
8 
• ..oc. • 
• 
0 8 • 0 
• 
i 
0 
0 ... 
0. 0 i 
•ij 0 0 
i • 0 
fiL...l : Body-size versus aae la the healthy subjects 
- 1728 -
•••• 
0 
0 
• 
0 0 
0 
S
u
b
je
ct
s•
 b
io
m
et
ry
 a
n
d 
lu
n
g 
fu
n
ct
io
n
 
M
 
M
ea
n 
11
 c
h
il
d
re
n
 
10
 c
h
il
d
re
n
 
20
 c
h
il
d
re
n
 
10
 h
ea
lt
h
y
 a
d
u
lt
s 
9 
IL
D
 
r
e
s
tr
ic
ti
v
e
 
10
 C
OP
D 
o
b
st
ru
ct
iv
e 
St
-a
nr
1~
rd
 
8 
y 
tl
< 
a
ge
 <
 1
2 
12
( 
ag
e~
 1
5 
a
d
u
lt
s 
a
d
u
lt
s 
(]
 
a
g
e
~
 
y 
y 
dP
V
Ia
ti
on
 
M
 
F 
M
 
F 
M
 
F 
M
 
F 
-
-
M
 
7
.1
 
9
.8
 
1
2
.4
 
1
3.
3 
2
9.
4 
38
.4
 
4
3.
7 
35
.4
 
6
4
.5
 
7
1
.5
 
Ag
~ 
(y
) 
a
 
0
.9
 
1
.0
 
0
.4
 
1
.0
 
5
.3
 
1
2
.5
 
4
.6
 
1
0
.5
 
1
0
.0
 
I 
-
-
-
M
 
12
0.
3 
13
4.
3 
14
6.
0 
15
3.
1 
17
3.
4 
16
0.
0 
16
4.
7 
16
1.
2 
17
0.
3 
16
1 
li<
"i
gh
t 
(r
m
) 
a
 
6
.0
 
7
.9
 
6
.6
 
8
.7
 
4
.3
 
4
.5
 
4
.1
 
8
.9
 
6
.7
 
I 
M
 
21
.6
 
30
.0
 
38
.4
 
4
4
.0
 
65
.0
 
56
.2
 
55
.5
 
56
.8
 
57
.7
 
90
.5
 
W
ei
gh
t 
(k
g)
 
a
 
3
.8
 
3
.3
 
1
0.
1 
9.
1 
2
.9
 
1
.2
 
6
.2
 
1
3.
2 
4
.2
 
I 
M
 
1.
22
0 
2.
01
0 
2.
21
0 
2.
68
0 
5.
53
0 
3.
63
0 
3.
13
 
3.
01
 
3.
04
 
1
.7
1
 
VC
 
(I
.)
 
a
 
0.
26
4 
0.
34
1 
0.
44
0 
0.
40
0 
0.
60
0 
0.
40
0 
0
.4
3
 
0
.6
0
 
0
.6
9
 
I 
r., 
1.
11
4 
1.
76
0 
1.
91
0 
2.
30
0 
4
.5
10
 
3.
00
0 
2
.0
2 
2
.3
3 
1
.2
8
 
9
3
.5
 
FF
.V
1 
( 1
.)
 
a
 
0.
27
0 
0.
36
6 
0.
35
0 
0.
50
0 
0.
40
0 
0.
22
0 
0.
51
 
0
.6
5
 
0
.4
9
 
I 
-
-
M
 
0.
92
7 
1.
11
5 
1.
41
1 
1
. 7
00
 
3.
61
0 
2.
90
0 
3.
34
 
2
.0
7 
3.
91
 
2
.0
4
 
F n
r 
( 1
. 
) 
a
 
0.
21
9 
0.
21
2 
0.
19
0 
0
.5
 
0.
50
0 
0.
77
0 
1
.1
3 
0
.3
3
 
0
.6
3 
I 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Ta
bl
e 
Ja
 
X 
: 
MP
.~
n 
a
 
: 
S
ta
nd
ar
d 
T B M
 r 
d
ev
ia
ti
on
 
id
::t
l 
v
o
lu
m
e 
(I
.)
 
n
s
p
tr
al
or
y 
t.1
m
e 
(s
.)
 
r
e
a
lh
tn
g
 e
ye
! e
 
(s
.)
 
f':
ln
 
in
sp
ir
at
o!
:~
 
lo
w-
ra
t~
 
(I 
.
s
 
) 
-
-
-
X
 
a
 x
 
a
 x a X a 
V
en
ti
la
ti
o
n
 r
a
te
s
 
in
 t
h
e 
fo
u
r 
·
s
u
b
je
ct
 g
ro
up
s 
u
n
de
r 
c
o
n
tr
o
ll
ed
 r
e
s
ti
n
g
 v
e
n
ti
la
ti
o
n
 
11
 c
h
il
d
re
n
 
10
 c
h
il
d
re
n
 
20
 c
h
il
d
re
n
 
10
 h
ea
lt
h
y
 a
d
u
lt
s 
9 
IL
D
 r
e
s
tr
ic
ti
v
e
 
10
 C
OP
D 
o
b
st
ru
ct
iv
e 
a
ge
 ~
 8
 
y 
8 
o
g
e
 <
12
 y
 
1
~
 
15
 y
 
a
d
u
lt
s 
a
d
u
lt
s 
a
g
e
~
 
M
 
F 
M
 
F 
M
 
F 
M
 
F 
0.
33
8 
0.
37
1 
0.
48
8 
0.
51
4 
0.
90
7 
0.
53
0 
0.
90
8 
0.
81
6 
0.
59
4 
0.
50
1 
0.
07
9 
0.
06
4 
0.
06
3 
0.
12
5 
0.
21
2 
0.
07
5 
0.
18
2 
0.
44
9 
0.
11
2 
I 
1
.0
7 
1
.2
6 
1
.3
3 
1
.4
7
 
2.
21
 
1
.8
0
 
1.
31
 
1
.0
6
 
0
.9
9 
2
.2
5 
0
.3
6 
0
.3
5 
0.
44
 
0
.3
2
 
0
.6
0 
0.
26
 
0
.4
8
 
0
.4
4
 
0.
31
 
I 
2.
11
 
2.
58
 
2
.3
4 
3.
20
 
4
.0
5 
3.
68
 
2
.3
5 
2
.1
5 
2
.0
8 
4
.1
5 
0
.7
0
 
0.
53
 
0.
28
 
0
.6
2 
0
.9
3 
0
.7
9 
0
.3
3
 
0
.6
5 
0
.5
6 
I 
0.
37
1 
0.
30
8 
0.
40
4 
0.
36
0 
0.
42
5 
0.
30
2 
0.
76
4 
0.
79
7 
0.
64
0 
0.
22
0 
0.
19
5 
0.
06
4 
0.
15
2 
0.
09
1 
0.
08
7 
0.
08
2 
0.
23
9 
0.
37
2 
0.
17
3 
I 
1r
ab
le
 J
b 
V
en
ti
la
ti
o
n
 r
a
te
s
 
in
 t
h
e 
fo
u
r 
s
u
b
je
ct
 g
ro
up
s 
u
n
de
r 
c
o
n
tr
o
ll
ed
 m
o
de
ra
te
 e
x
e
r
c
is
in
g
 v
e
n
ti
la
ti
o
n
 
X
 
: 
M
ea
n 
11
 
c
h
il
d
re
n
 
10
 c
h
il
d
re
n
 
20
 c
h
il
d
re
n
 
10
 h
ea
lt
h
y
 a
d
u
lt
s 
9 
IL
D
 
r
e
s
tr
ic
ti
v
e 
10
 C
OP
D 
o
b
st
ru
ct
iv
e 
a
d
u
lt
s 
a
d
u
lt
s 
(J
 
: 
St
an
da
rd
 
ag
e~
 6
 y
 
6<
 a
ge
<
 1
2 
y 
12
< 
a
ge
-( 
15
 y
 
d
ev
ia
l1
on
 
M
 
F 
M
 
F 
M
 
F 
M
 
F 
- X
 
0.
34
2 
0.
53
2 
0.
54
7 
0.
64
0 
1.
16
6 
0.
93
4 
1.
29
9 
0.
97
2 
0.
97
1 
0.
81
6 
T
td
al
 
v
o
lu
m
e 
(I
.)
 
a
 
0.
07
9 
0.
10
7 
0.
11
6 
0.
11
5 
0.
11
9 
0.
13
4 
0.
33
4 
0.
25
9 
0.
14
6 
I 
X
 
0.
75
 
0.
96
 
0
.9
7 
0.
94
 
1
.4
7
 
1
.3
7 
0.
96
 
0
.7
6 
1
.0
1 
1
.6
7
 
In
sp
ir
at
or
y 
t1
m
e 
(s
.)
 
a
 
0.
22
 
0.
16
 
0
.1
5
 
0.
27
 
0
.5
5
 
0
.1
6
 
0
.1
0
 
0
.2
3
 
0.
14
 
I 
X
 
1
.4
9 
1
.9
2 
2
.4
2
 
2
.0
5 
3
.0
 
2
.7
2
 
2
.0
5 
1
.5
2 
2
.0
9 
3
.1
6 
B
re
at
ht
ng
 c
y.
cl
e 
(s
.)
 
a
 
0.
46
 
0.
30
 
0
.6
0 
0
.5
5 
0
.6
4 
0
.7
6 
0
.6
5
 
0
.5
0 
0
.4
6
 
I 
x
 
0.
46
4 
0.
57
2 
0.
59
5 
0.
72
4 
0.
69
4 
0.
69
7 
1
.3
55
 
1.
40
4 
0.
97
6 
0.
50
9 
M
ea
n 
in
sp
ir
at
or
y 
fl
o
w
-r
a
te
 
(l
.s
-1
) 
a
 
0.
14
5 
0.
14
7 
0.
24
6 
0.
21
6 
0.
22
3 
0.
15
0 
0.
32
6 
0.
63
1 
0.
20
2 
I 
Data treatment 
The mean values and standard deviation of the biometric and respiratory function data are 
given on~. for the subjects separated into six groups: 
11 children age ~ 8 years, 
10 children 8 < age < 12 years, 
20 children 12 ~age~ 15 years, 
10 healthy adults, 
9 lLD patients, 
10 COPD patients. 
The mean values and standard deviations of the ventilation parameters, at rest and at light 
exercise have been calculated for each of the 6 subject groups, tidal volume (1), inspiratory 
time and time of the total breathing cycle (s), and mean inspiratory flow-rate (l.s- 1). They 
are given on Ill1llil_1 
For the healthy subjects, adults and children, the body size is plotted against age 
(Figure 3) and also given as histograms for age-groups (Figure 4) and so is FRC 
(Figure 5). 
The deposition data have been treated differently for nose-breathing and mouth-breathing : 
I. Nasal deposition during inspiration 
Among the healthy subjects, 10 adults and 20 children performed the complete nasal and 
oral breathing : they were separated into three age-groups : 
10 adults 
8 children 12 ~age~ 15 
12 children 5 <age< 12 
The mean values and standard deviations of the ventilation parameters, at rest and at light 
exercise have been calculated for each of the subject groups : 
- Q (l.s-1) : mean inspiratory flow-rate ; 
- RT (kPa I-1s) : total nasal resistance at this flow-rate ; 
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Mean inapira~ry !low-rate la -l .455 .222 .3011 .084 .284 .130 
Total reaia1:aneea kPa L -l. .151 .05 .331 .151 .348 .252 
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MODEIIATI: EXCERCISING WNTILATION 
x a x X a 
Mean inspiratory fiow race la -l 1.057 .381 .522 .167 ,465 .155 
Tota.l resia't&nces kPa 1-1s .269 .078 .471 .11!8 .484 .435 
Pressure drop kPa .284 .245 .225 
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- p (kPa) : pressure gradient across the nose and nasopharynx during nose-breathing of the 
aerosol test (Table 4 ). 
For the same inspiratory flow-rate, Q choosen at 0.300 l.s-1, each individual nasal 
resistances have been calculated, for the left and right nasal passages and for the total nose. 
All total resistances, as well as the ones of the maximal and minimal air-flow sides were 
plotted against age (Figure 6). 
This presentation takes into account the nasal cycle with a predominant flow-rate in one of 
the nasal passages alternatively, that is observed in all of our subjects. 
For all the individual values of each particle size deposited fraction, at rest and at exercise, 
linear correlation coefficients, r, were calculated with the corresponding flow~rates, Q, and 
total nose resistances, R.r (Table 5). 
For every subject, and each deposition test, an impaction parameter, equal to: 
was calculated with : 
p =inhaled particle density (kgr1) 
d =inhaled particle dynamic diameter (um) 
p = pressure drop along the nasal passages (kPa) 
These values were plotted against the individual values fo the nasal deposited fractions, for 
the three groups (Figure 7). 
2. Total airway deposition by mouth-breathing 
2.1. For all the studied subiects 
A multivariate statistical analysis (PAGES et al., 1979) into principal components was 
computed upon all the individual subject's features : 
- age, (y), height, (cm); 
- ventilation represented by tidal volume V T (1), inspiratory time, ti (s) ; 
-respiratory function, VC, FRC, FEVI, (I); 
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- deposition of the three particle sizes, I, 2.05 and 2.8 pm : 
. REI, RE2, RE3 at rest; 
. Exl, Ex2, Ex3 at exercise. 
This calculation was computed on mM 3090-400, with the software APATDM from the 
mathematical library of the Compagnie Intemationale de Service en Informatique( CISI). 
This powerful method, resumed the 10 initial variables into 3 or more principal 
components, by which the 69 subjects were described with accuracy and simplicity. It 
provided linear correlations between those variables (Table 6), and a mutual comparison 
between the subjects : this was done on the graphs defined by the principal axes 
(Figures 8, 9) where were projected the subject points and the vectors of the variables. 
Data for total deposition of each of the three adult groups healthy, restrictive, and 
obstructive were compared by the Mann and Whitney non parametric rank test (Figure 10). 
2.2 For the healthv subjects onlv, adults and children, the breathing parameters actually 
measured during aerosol inhalation were plotted against age : tidal volume (Figure 11) and 
breathing frequency (Figure 12). Tidal volumes and respiratory times were also given as 
histograms for age-groups (Figures 13, 14). 
The experimental deposition data were compared by C.P. YU to the calculated model he 
has developed (YU and DIU, 1983). This model of deposition continuous along the airways, 
integrates the three main deposition processess : impaction, sedimentation and diffusion of 
particles ; the calculation includes the particle characteristics : 
-diameter, density, settling velocity, diffusion coefficient, etc ... ; 
as well as the morphological lung features : 
- length and diameter of the different airway generations, and average inclination angle, 
according to Weibel's lung model A ; 
and the breathing pattern : 
- tidal volume, air velocity, respiratory pauses. 
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An age-dependant model transformation (XU and YU, 1986) was later on based upon the 
growth processes in lung geometry described quantatively by REID (1977), from birth to 
adulthood. This growing pattern was applied to the thoracic airways : 
- tracheobronchial tree, fully developed at birth in number and growing only in sizes, and 
for which the ratio of length to diameter is constant except for the trachea and the main 
bronchi; 
- alveolar region, where the total number and size of alveoli is strongly dependent on age. 
For the comparison with our experimental data, Professor YU, integrated the growing 
pattern in body size versus age of our children subjects ; he calculated deposition at rest 
and under exercise, using the exact breathing parameters recorded during the experiments. 
He kindly provided several figures illustrating this comparison : 
- the experimental data of deposition are presented for each age-group as histograms, 
framing the calculated values, at rest and at exercise (Figure 15) ; 
- he plotted all the calculated fractions against the experimental data for the children 
separated into two-year age intervals : 5 to 7, 7.5 to 9.5, 10 to 12 and 12.5 to 15, 
(Figures 16 to 19) and for adults (Figure 20) ; on each graph is presented the regression 
equation obtained ; 
- finally, the ratio of model over experimental deposition was plotted against age for each 
particle size (Figures 21 to 24 ), both at rest and at exercise. 
The ratios of deposited fractions of each particle size over the corresponding inhaled tidal 
volume of aerosol were calculated for each subject. This deposition by unit inspired volume 
was plotted against body size at rest and at exercise (Figures 25, 26, 27). 
RESULTS 
I. Nasal deposition at insoiration : nasal filtering efficiency 
In children the nasal resistances at a flow-rate Q = 0.300 I.s-1 were decreasing sharply with 
increasing age (Figure 6). 
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The adult values were around 0.150 kPa l-1s for total resistances, and were scarcely reached 
at 14 years. The nasal cycle, with a predominant flow-rate in one of the nasal passages 
alternatively, existed in all of our subjects, and compared to the adults, the youngest 
children had a much more important desequilibrium between the two unilateral resistances. 
For each of the three age groups, the deposition data plotted against the impaction 
parameter p d2p2/ 3 (Figure 7) were very dispersed. However, the variability of nasal 
percent deposition among adults is greater than that in the two child groups in most cases, 
which suggests that the children were probably as successful in reproducing flow during 
oral and nasal breathing, a necessary condition to accurately calculate nasal percent 
deposition. For the studied particle sizes, the children in both groups had obviously less 
nasal particle filtering efficiency than the adults. Because the pressure drop, p, along the 
nasal passages, is dependent on the nasal resistance, RT, and on the inspiratory flow rate, 
Q, it was logical to try to delineate the respective influences of these two parameters upon 
deposition. For the data as a whole, adults and children, at rest and at exercise, the linear 
correlation of each particle size deposited fractions was higher with the flow-rates (as an 
example, for 2.05 11m, MMAD, r = 0.48) than whith the total nasal resistance (r = 0.15), 
(Table 5). From Table 4 : one can notice that the adults increased, more their flow..,rates 
from resting to exercising ventilations (57 %) than did the children in both groups (41 and 
39 %) ; this contributed a higher progress in pressure (73 % for the adults, 59 and 56 % 
for the children). 
2. Total airway deposition by mouth-breathing 
On the graphic representation of the multivariate analysis (ACP) (Figures 8 and 9) was 
indicated the percentage of the total information resumed by each of the two first principal 
axes (46.6 and 24 %at rest, and 55.5 and 18.8% at exercise). The relative position on the 
graphs of the groups of subjects indicated their mutual proximity regarding the listed 
variables. The general disposition of the subjects and variables was the same at rest and at 
exercise : Axis I was positevely correlated with all the variables, and Axis 2 separated the 
deposition variables from the functional ones. The age and tidal volume were almost 
confounded with Axis I, the best resuming factor, and therefore were excellent descriptive 
variables of our subjects. However the body size, better correlated with the lung function 
than age, was a good index for morphology and lung function : it could be a valuable 
substitute for age in a possible relationship with deposition. The correlation values 
(Table 6) confirmed the graph observations : as an example, height was better correlated 
with VC (r = 0.65), than was age (r = 0.34) ; at rest V T was significantly correlated with all 
the 9 other variables (r = 0.35 to 0.63), the correlations values were even higher for exercise 
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where depositio~ data presented high positive correlation coefficients with V T (0.69 to 
0.72) and good positive values with age (0.43 to 0.49), with height (0.45 to 0.49) and lung 
function : VC (0.35 to 0.46) and FRC (0.42 to 0.45) ; they were faintly correlated with 
FEY 1, and not at all with the inspiratory time. 
On the graphs, the subject group- were well individualized : the children were classified, 
regarding Axis 1, according to their age, and all the adults stayed at the same level. Along 
Axis 2, the younger children, like the restrictive and obstructive patients were higher than 
the healthy adults, especially at exercise, indicating that they increased their deposition 
independently from their lung function. 
In Mtho/ogjcql sub iects 
The non-parametric rank test of MANN and WHITNEY upon the individual deposited 
fractions in the three adult groups (Figure 10) showed that, at rest, the obstructive patients 
deposited more than the others, and that, at exercise, it was the restrictive ones, but the 
significance is nQt high (p < 0;05) probably because of the small numbers of subjects. This 
result, was observable on the ACP graphs, where the relative positions of the obstructive 
and restrictive groups have changed from rest to exercise. 
In the healthv sub iects the minute ventilations at rest and at exercise, resulted of changes in 
breathing rates : in the younger children, ventilation was increased at exercise more by 
frequency (Figures 12 and 14) than by tidal volume (Figures 11 and B) ; the adult like 
increasing pattern was reached around 15 years. Figure 15 shows that the observed 
deposition values were not very different in adults and children at rest, and rather higher 
in adults at exercise ; this could result from that higher increase in V T" · 
The experimental values were not constantly lower or higller thant the model ones. They 
~eemed to agree better for particles of 2.05 and 2.8 .um than for I um, depending on the 
age group_, The regressions for experiment in function of model was better for adults 
(slope = 0.81) on Figure 20 than for either of the children groupes (slope = 0.66) on 
Figures 16 to 18. Plotted against age, the children experimental data of 1 .um fitted better 
the model than the adult's (Figure 21), but this changed progressively with increasing 
particle sizes, and the fitting was better for adults with 2.8 and 3.1 .um (Figure 23, 24). As 
it was observed on the ACP, and from the correlation coefficients, there was a strong 
dependence of deposition upon tidal volume ; this might have outweighed an eventual 
effect of age and growth of the lung. Indeed such effect was suggested by Figures 25, 26 
and 27 where deposition by unit of inspired aerosol volume was plotted against body size, 
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the best index of lung growth in our calculations : this ratio decreased with increasing 
body size, and its values seemed higher at rest than at exercise, especially for 1 pm. 
DISCUSSION 
The conducting airways may be considered as a protective system which prevents large 
particles from penetrating into the alveolar region. This "filtration" is determined by the 
three mechanisms : diffusion, sedimentation and impaction. It depends on the size ()f the 
particles, on the airway dimensions and on the breathing pattern. 
Because of smaller airway dimensions, it is likely that the relative effects of impaction and 
diffusion for a given particle size are more effective in the child but that sedimentation 
onto the surface of the mucous layer due to gravity has about the same effect as in the 
adult. 
Several calculated models predicted a greater extra-thoracic and tracheobronchial efficiency 
in smaller (younger) than in larger (older) airways, assuming that conductive airways of the 
child therefore form a more efficient protective mechanism than in the adult, since they 
are so much smaller and should trap particles much more easily. However the effect of the 
change in lung size on the "filtration" of aerosols is surprisingly small. The child airways are 
certainly narrower but they are also shorter, and the time available for sedimentation or 
diffusion is reduced by the higher rate of breathing. It appears, therefore that the alveoli of 
the child are protected to about the same degree as those in the adult. 
1. Nasal denosition at insPiration 
In the nose, dep()sition by impaction is predominant : in attempting to correlate nasal 
deposition to an impaction parameters, YU et al. (1981) used the factor P d2Q, where: 
p = particle density 
d = particle diameter 
Q = inspiratory flow-rate 
The significant scatter when using such a parameter was noted by YU, as it was by 
HOUNAM et al. (1971) who obtained a better correlation with p d2p, (with p .. pressure 
drop in the nose) probably because pis a function of both flow-rate and a dimension. 
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HEYDER and RUDOLF (1977) found that data from their adult studies could better 
correlate by the parameter p d2p213, which was tested in the present study for adults and 
children. 
It was proposed by PHALEN et al. (1990) that pressure drop as a correlating factor for 
nasal deposition could be extended to children. This hypothesis was accompanied by 
experimental studies in scaled, idealized physical models of the nasal passage, following the 
design of SCOIT et al. (1978), of an adult and a newborn child. These studies demonstrated 
that deposition percent (for a range of flow rates) when correlated with p d2~ showed 
different curves for adult and child, but when correlated with pressure drop, a single curve 
for adult and child was obtained. It should be noted that a single idealized model was 
employed for each adult and newborn child, based on the date of SCOIT et al. (1978). The 
flow resistance of the idealized adult and child models were similar to values measured 
in vivo. 
The observations of the present study, in which nasal deposition was measured in adults 
and children in vivo, are not in agreement with the conclusions of PHALEN et al. (1990) in 
that deposition gives a much higher correlation in adults and children with flow rate than 
with nasal pressure drop. Neither parameter gives a high correlation coefficient, indicating 
that nasal passages shape differences within and between age groups are such as to make it 
difficult to predict nasal deposition accurately solely based on flow rate or resistance. 
This study indicates that the age effect of nasal deposition for normal breathing is not a 
monotonic function of age from 5 to adulthood : children of teenage show lower nasal 
deposition for two particle sizes. At moderate exercise flowrate, both teenage and younger 
children have lower nasal percent deposition of 1 micrometer particles on average than 
adults. For the other size, only the teenage children showed significantly lower percent 
deposition. It would be useful to have a more detailed measurement of nasal passage 
dimensions in future studies, such as the method of acoustic rhinometry described by 
HILLBERG et al. (1989). This technique measures the cross-section area of each nasal 
passage which plays an important role in inertial deposition, because it is related to the air 
velocity at each point in the nasal passage, and the region of highest deposition probability 
is that where maximum velocity undergoes a geometric situation optimal for deviation of 
particle paths from flow streamlines. Deposition in the anterior nasal passage, near the site 
of minimum cross-sectional area is consistent with the studies in nose models reported by 
ITOH et al. (1985). 
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2. Total airway deposition by mouth-breathing 
Our "total deposition" refers to tracheobronchial and alveolar ones, excluding nasal 
deposition. For these particle sizes, deposition occurs in the tracheobronchial tree by 
impaction and sedimentation, and in alveoli mostly by sedimentation. Undee these 
conditions, the evaluations of total particle deposition in adult airways from inhalation 
experiments, have pointed out its relationship with tidal volume and inspiratory time 
(HEYDER et al. 1980). If our data of deposition were strongly dependent on tidal volume, 
the inspiratory time, at least in the range of our experiments, did not influence them ; this 
could be explained by the ordinary cyclical pattern of ventilation, with peak-flows and 
very small inspiratory pauses, of our subjects, in contrast to the constant "academic" air-
flow adapted by HEYDER et al.. According to YU and DIU (1983) small values of ti, like 
in our study could not subtantially influence deposition in cyclic breathing pattern. 
Authors have pointed out the large intersubject variability of total airway deposition 
(HEYDER et al., 1982) ; the good correlations obtained in this study between deposition 
data and lung volumes, VC and FRC, as well as with age and body size, could at least 
explain part of this variability ; this is obvious for restrictive patients, who deposited more 
than the healtly subjects with similar tidal volumes. 
In the obstructive subjects, despite smaller tidal volumes, deposition was higher than in 
healthy subjects, at least for ventilation at rest. A similar observation was made by 
KIM et al. (1988) using an aerosol of 1 l!m particles. He related the data to the narrowing 
of conductive airways resulting in increased impaction "in situ" together with irregularities 
in flow-distribution and lung penetration of aerosol, increasing peripheral deposition in 
several zones, therefore enhancing overall aerosol lung deposition. 
In the healtly subjects, the fitting of our data to YU's model was better for adults than for 
children as shown on Figures 16 to 20. In children the fitting was better for the smaller 
particles (I and 2.05 Jlm), than for the larger ones (2.8 and 3.1 Jim) for which the 
experimental data are higher than the model ones this might result from a greater 
impaction under cyclic breathing in an experiments, than under the constant air-flow 
postulated in the model. 
In any event, the age factor child/adult effect upon deposition was not predicted to be 
large for these particle sizes (1.2 at 5 years old and 1.1 at 10 years, XU and YU, 1986) 
and this was behind our data dispersion. This is probably why the fittings of experimental 
data to the model were acceptable but not excellent. Particle deposition studied in adults 
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and children under physiological conditions close to spontaneoos ventilation were better 
correlated with ventilation (V T) than with lung dimensions (VC and FRC), probably 
because the latter included anatomical parameters that were not measured by lung function 
testing. However, when normalized by unit of tidal volume the deposition data obviously 
decrease with increasing body size ; this indicate that a meaningful relationship between 
aerosol deposition and lung dimensions, would have been possible only if the breathing 
pattern has been kept constant for all ages. 
CONCLUSION 
This study has dealt, in normal conditions of ventilation, with deposition of particles from 
1 to 3 um inhaled by healthy adults, patients with impaired lung function and children 
from 5 to 15 years of age. Compared with healthy adults, patients deposited more. In 
children, deposition did not differ much from that in the adults : children have airways 
which are structurally mature -afld therefore just miniaturized ones of an adult. The lower 
ventilation, on the one hand, prevents-more particles from entering the airways, but on the 
other hand, the smaller lung dimensions would increase deposition probabilities. However, 
this is probably a much too simplified representation of the effect of growth upon 
deposition. In order to precise the important role of lung dimensions, former studies should 
keep ventilation constant for all ages and body sizes, and include morphometric 
measurements at least of ·the nasal passages that are the easiest ·to reach. 
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I. Objectives of the project: 
Contrary to high doses of ionizing radiation, effects of very low doses, 
less than 0.1 Gy, are not well known. However, previous experiments 
have shown that very low dose rates of chronic irradiation can stimulate 
the proliferative activity of Paramecia and Cyanobacteria (PUl~EL et al. 
Health Physics, 1987). We intend to investigate, in this programme, the 
effects of very low doses of gamma rays on human cells cultivated in 
vitro. 
11. Oblectives for tl'le reporting period: 
In view to estimate the possible effects of the T.Jaxicum radiation 
dose to which people could be safely exposed (0.05 Gy/year), we intend 
to investigate the effects of a dose rate of 0.05 Gy/week on carbohydrate 
metabolism of h~~an dermal Tibroblasts. The rate of glucose utilisation 
will be investigated through the enz}~e activities of pathways of the 
pentose phosphate shunt (glucose 6 P dehydrogenase) and of the glycoly-
sis (glyceraldehyde 3 P phosphate dehydrogenase and pyruvate kinase). In 
another way, the transmembrane resting potential (Tt·:RP) will be measured. 
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III. - Progress achieved 
I. - METHODOLOGY 
Cell cultures : human diploid dermal fibroblasts were cultivated as a 
monolayer in 10 % calf serum-supplemented MEM. 
Irradiation facilities : cultures were exposed to a 60Co source giving 
a dose rate of 6.25 mGy/day at the culture level. 
Biochemical investigations:; After appropriate times of irradiation, 
cells were trypsinized, washed twice in PBSand disrupted by 30s of 
sonication. The homogenats were centrifuged to clarity at 5 000 g 
(0°C, 5 min.) and the supernatants used for assays. 
Protein content was determined acccording to Lowry's method (1951). 
The glucose 6 phosphate dehydrogenase (G6PDH) was assayed according to 
the method of Lohr and Waller (1974). Glyceraldehyde 3 phosphate 
dehydrogenase (G3PD~was measured using the method described by 
Scoper R.K. (1969) and the assay of pyruvate kinase was carried out as 
described by Gutmann and Bernt (1974). 
TMRPmeasurements were performed with glass microelectrodes under a mi-
croscope. About 2000 single cell measurements were done for each 
culture condition. 
2. - RESULTS 
The results of 4 experiments are exposed in table I. 
Irradiation did not induce significant change in G6PDH activity throu-
ghout the cell cultures. However, the G3PDH and pyruvate kinase activi-
ties appeared inhibited during the exponential growth phase (4th day 
of culture~ differences are significant i p <0.05 • Enzyme activities 
were recovered at the 7th day. In another way, cells did not show chan-
ges of their TI1PR values under irradiation as compared to controls. 
3. - DISCUSSION 
Our investigations show that, in our experimental conditions, gamma 
rays decrease the activity of enzymes involved in the glycolysis 
pathway. 
The G3PDH is a key enzyme catalyzing the single oxidative step in gly-
colysis. The oxidation, under irradiation, of the thiol group essential 
for its catalytic properties, could lead to the observed slight inacti-
vation of this SH-enzyme. This hypothesis is in good agreement with 
results of Palecz and Leyko (1983) showing that ionizing radiation 
doses of 5 Gy cause a slight decrease in SH groups of human erythrocyte 
membrane that may be responsible for the inactivatiort of membrane bound 
SH-enzymes. Bartoc et al. (1975) found a decrease of activities of seve-
ral other enzymes involved in glycolysis (hexokinase and phosphofructo-
kinase) which is linked to the oxidation of their SH group. We can sup-
pose that the decrease of pyruvate kinase activity could be ascribed 
to a general decrease of the glycolysis pathway activity. It should be 
observed that there is a recovery of all enzyme activities at the end 
of culture. 
Short-term control of the pentose phosphate cycle is determined by 
G6PDH activity which depends on GSH/GSSG ratio. We can assume that low 
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irradiation doses used do not cause significant change of the glutathione 
status in the cells as early expected, Indeed, we found no change of cata-
lase and glutathione reductase activities under irradiation (cf our last 
report), The lack of TMPR change is in favour of an undisturbed membrane 
permeability. 
4th day (25 mGy) 7th day (54 mGy) 
CONTROL IRRADIATED CONTROL IRRADIATED 
G6PDH (U.I) 52.2 + 1.2 53.2 + 3.1 80,5 + 3.4 78.8 + 7.6 
-
G3PDH (U,I) 219.0 + 18.2 178.1.:!:. 21.1 412.5 + 23.4 415.2.:!:. 37.7 
Pyr. Kinase 366.5 + 16.1- 282.6.:!:. 38.1 702.4 + 16.0 727.7.:!:. 20.9 
-
TMRP (eV) 10.5 + 1.8 9.9 .:!:. 2.3 10.2 + 2 9.4·.:!:. 4.9 
-
Table I 
In CONCLUSION 
Very low do~es (abDut 15 mGy) can bring changes in tbe metabolism of human 
cells. However, these responses are transient and disappear even when 
cultures are yet irradiated. On the other hand, it can be pointed out that 
the very low doses induce an enzyme inhibition : the radiation hormesis, 
already reported in single-cell organisms, did not occur under our experi-
mental conditions! 
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I. Obiectives of the oroiect: 
INTRODUCTION 
.The validity of different models for extrapolation of dose effect curves 
from high-level to low-level dose areas is questionable. The aim of the 
present investigation is therefore to give more detailed information 
about the reaction of cells in the low dose region using in vitro cul-
tures. 
The parameter of investigation chosen was the protein pattern of the 
cytosol and the membrane, which is dependent on the gene expression and 
thus can be changed by the influence of an external parameter like chro-
nic low level ionizing radiation. 
11. Obiectives for the reporting period: 
In this part of the project SDS-gel-electrophorese measurements of the 
cytosol and membrane protein patterns of human fibroblasts in culture 
at different ages and levels of development, irradiated with dose rates 
of 72 ~Gy/day and doses of 3.4 mGy, 6.6 mGy and 14 mGy, were carried 
out and compared to control measurements. 
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Ill. Progress achieved: 
I. - METHODS 
Material 
Human skin fibroblasts were cultivated as a monolayer in flasks. From 
the primary 9ell strain subcultures were prepared containing a hetero-
genous cell population with cells in different phases of the cell cycle. 
CUltivation method 
Skin fibroblasts were cultivated with Eagle's BME with Hepes Buffer (20 mM) 
+ 10 % foetal bovine serum, 1 % non-essential amino acids, 1 % glutamine, 
1 %penicillin+ streptomycin, at 37 degree C in an incubator. 
Irradiation facilities 
The cell cultures were exposed for 47, 92 and 195 days to a planar source 
containing thorium-nitrate by growing the cells in culture flasks 10 cm 
above the irradiation source (dose rate : 72 ~Gy/day). Unirradiated con-
trol cultures were kept under the same cultivation conditions. 
SDS-Polyacrylamid-Gel-Electrophorese Measurements 
Ih·order to measure the protein patterns of the cellular cytosol and 
membrane fraction after irradiation, the cells in the culture flasks 
were suspended and prepared forthe electrophoresis procedure. The same 
protocol was carried out with control cells. 
Evaluation 
To evaluate the molecular weight of the protein bands, a calibration 
standard was run in parallel with different samples. 
II. - RESULTS 
Three experiments have been performed. In two experiments, no changes 
have been noted. However, in a third one, using the same technics, 
changes in membrane proteins were observed, as shown in the following 
report.Three series have been carried out with about 8 x 107 skin cells 
each time. One control series was established at the beginning. The 
cells of- the second series for 92 days (total dose : 6.6 mGy) and of 
the third series for 195 days (total dose : 14 mGy). 
The protein pattern of the cytoplasm showed no change over the whole 
observation period and was comparable to the control cytoplasm (fig. 1). 
The protein pattern of the membrane fraction was changed in the first 
and the second series ; the protein concentration of the third series 
was too low for detection. Comparison with the unirradiated control pro-
teins showed that in the first series (3.4 mGy) two membrane proteins 
with the molecular weight of 45 and 50 kD are produced in higher amounts 
in contrast to a band of 24 kD, which was not detectable in this lane. 
In the second series (6.6 mGy), a band of 60 kD appeared together with 
a double-band instead of a single one at 45 kD. After irradiation with 
6.6 mGy, the 24 kD protein again can be demonstrated at a normal level. 
Additionally, the expression of a molecular weight range between 12 and 
18 kD increased in this group (fig. 2). 
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I. Objectives of the project: 
The overall objective of the composite programme was to improve the 
understanding of the behaviour of inhaled plutonium particulates in man 
thus increasing the realism of assessing body contents. This project 
concentrates on direct measurement of the distribution within the lungs. 
The unknown distribution of inhaled material and any changes with time are 
identified as major sources of uncertainty when interpreting direct 
measurements. Our approach was to determine the most probable 
distribution by using arrays of detectors and to derive a subject specific 
calibration factor from computer modelling, from the subjects chest 
structure and from studies on realistic chest phantoms. The technique is 
applicable at the limits of detection of the overall system. 
11. Obiectives for the reportina period: to 1989 • me &Kper1mentai phases of-t~ work were completed prior The 
objectives of the 1989 reporting period were; 
Minor modifications to the system and the interpretative techniques 
Preparation of the final report 
CEC funding in 1989 was minimal and this report covers the whole period 
1985 - 1989 together with a brief summary of work prior to that date where 
it is of direct relevance to the final report. 
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Ill. Progress achieved: 
Direct determination of plutonium 239 and associated radionuclides within 
the lung by means of external detectors rely on measuring the L-X-Rays 
which accompany most transuranic radioactive decays or by measuring 
associated low energy gamma rays. The specific emission rates of such 
radiations are low and the radiations themselves are easily absorbed 
within the chest structures. Such radiations must be detected above a 
background count composed of degraded low energy radiations which is also 
dependent on the subject's presence and on his chest structure. Detector 
development and application in this field, whilst still progressing, is 
not expected to produce a major breakthrough. Current limits of detection 
are such that there is insufficient sensitivity for assessing pure 
plutonium 239 in the human lung at levels around the annual limit of 
intake (ALI). However in much of the nuclear industry plutonium, often in 
the oxide form, consists of a mixture of the plutonium isotopes together 
with Amercium 241, the daughter of Pu 241. With such a mixture of 
radionuclides the specific X-ray emission is enhanced and this, together 
with the presence of 60 Kev radiations from Am 241, means that the 
sensitivities of current systems are just sufficient to monitor at the ALI 
level. The ALI, derived from ICRP 30, is recognised to be conservative 
and local ALis may be derived, based on observations of that specific 
material in man. Such a local ALI is used by ourselves (Ref 1 of Project 
2) and consequently direct monitoring of the lung is widely used in these 
laboratories. Detector responses have then to be interpreted in terms of 
the lung contents thus requiring system calibrations. The standard 
calibration is the response of the system to a realistic chest phantom, as 
developed by the Lawrence Livermore Laboratories. Corrections to this 
calibration are restricted to matching the sc•ft tissue depth overlying the 
rib cage. The major source of uncertainty is that arising from the 
inhomogeneous and unknown distribution of activity within the lung. The 
magnitude of this uncertainty, based on measurements on men accidently 
contaminated with low levels of plutonium, can approach a factor of 3. 
This uncertainty needs to be quantified and reduced prior to full 
application of direct monitoring laboratory techniques. 
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Methodology 
The methodology used in this project splits between hardware, software and 
the verification of the calibration factors. 
a) Hardware 
Hardware development was mainly done outside the current contract and is 
only briefly summarised here. The detectors consist of phoswich (dual 
phosphor) arrays above and below the chest. One array consists simply of· 
two 12.5 cm diameter circular phoswiches whilst the other consists of six, 
close packeq,-7.5 cm, square phoswiches. Each phoswich has its own pulse 
rise time 'vetoing' circuit to ensure that the only pulses analysed are 
those arising in the thin sodium iodide phosphor only. The arrays are 
then multiplexed into an ADC with in-built dead time correction, prior to 
analysis of all detectors by a computer based pulse height analyser. This 
analyser also receives pulses from an array of large sodium 
detectors, used to assess non plutonium activity within the subject. 
Module faults and the need for frequent retuning of the components in 
order to maintain peak operation of the system were fairly frequent and 
did adversely effect progress several times during the period of the 
contract. 
b) Software 
Two main computer programs were developed over the period of the project. 
The first, BODMOD, developed a model of a 'standard' man thorax which was 
then modified to ,match the specific subject. It is emphasised that the 
models are not anatomicaly realistic but are-developed as a matrix of 
attenuation coefficients. Thus the thorax is expressed as a three 
dimensional regular matrix of 2.5 cm cubes. Data for each cube are 
attenuation coefficients at different energies for a specified mixture of 
soft tissue, adipose tissue, bone, lung tissue and air. The modelling of 
tissue boundaries can be improved by a finer cell size. The original 
data, for the 'standard' man, was derived from anatomy atlases, the IRCP 
23 data and from the Lawrence Livermore phantom. This standard man model 
is them modified to match the individual subject. The modification is 
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basically one of identifying on the subejct certain physical 
characteristics eg the position of the sterrial notch and the xyphoid, the 
positioning and spacing of ribs from routine chest x-rays and the depths 
of overlying soft tissue and adipose tissue from ultrasonic scans. The 
standard man model is then compressed or extended to match these physical 
characteristics. 
The second program, PECAL takes the output of BODMOD and predicts the 
detector response for any distribution of activity within the lung spaces 
and any positioning of the detectors external to the skin surfaces as a 
series of 'cones'. Photon flux within a cone is calculated from the solid 
angles and attentuation of the radiation together with modifying factors 
for the effects of ribs and built up py in-scatter from adjacent cones. 
The integrated flux at each detector is scanned over all point sources and 
all cones. Different distributions of activity within the lung, expressed 
as a sum of point sources give a series of unique ratios between detector 
responses. 
c) Calibration factors 
The theoretical responses from the computer models are regarded as 
relative responses only. Normalised calibration factors are obtained from 
the Lawrence Livermore chest phantom for uniform distribution in the 
'standard' thorax. This phantom has a series of overlays to build up the 
chest wall thickness and a pair of 'lungs' were modified to hold point 
sources. A further series of studies done on simpler phantoms, were 
studies of tissue equivalent material with lung spaces and planar ribs. A 
combination of such studies was used to assess the realism of modified 
calibration factors generated by the computer models for inhomogeneous 
distribution of plutonium 239, amercium 241 and cobalt 57. The next step 
is the verification of the calibration factors by measurements on man. 
Project 2 describes studies on human volunteers who had enhanced known 
quantities Co 57 cobaltous oxide particles. Advantage was taken of the 
presence of these volunteers to validate the whole calibration approach 
for 120 KeV radiations. The ideal verification, measurements on man with 
known quantities of plutonium and amercium could not of course be done but 
the system was extensively tested both on a subject who had positive lung 
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counts from these radionuclides and on groups of plutonium workers with 
non-positive counts and on groups of non-exposed normals. 
Results 
Results for all the work on this project are detailed in the references. 
They are only briefly summarised here. The early work on the computer 
codes and on the detector systems are not summarised as their 
effectiveness on progress in those areas must be judged by the realism and 
detection capabilities of the whole system. However the 'areas of 
difficulty' highlighted by the computer codes are discussed briefly. 
Comments on Computer Codes 
The approach and code development worked well for 1-X-Rays in the region 
10-25 KeV where absorption losses were high. The judgement of success 
being the match of predicted x-ray photon flux with that observed from the 
phantom prior to normalisation. For higher energy radiations, 60 KeV from 
Am 241 and 120 KeV from Co 57 the initial predicted flux was considerably 
lower than that observed, demonstrating that the effect of build up 
factors were not being full accounted for, the effect being more 
pronounced at higher values of chest wall thickness and also more 
pronounced with material in the right lung than the left. The build-up 
parameters within the computer model were revised and based on 
experimental observation rather than theoretical values. The initial 
magnitude of this affect with earlier models was a factor of two, the 
refined model reduced the effect to a statistical one (±15%). 
Modifications to the computer codes aimed at further improving the 
determination of most probable distribution were necessary throughout the 
project. Gross artificial effects could occur eg positioqing the 
plutonium activity close to the lung surface behind a rib, but in general 
the modifications were applied from a successful starting position of the 
computer .codes agreeing with observations on man to within a factor of 
two. 
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The calibration factors 
Swmnaries of results are presented in tabular f,)rm expressed as a ratio of 
predictions to observed responses. Each ratio Ls subject to appreciate 
and variable statistical errors. The maximum v,ilue of the statistical 
error was 20%. For studies on point source dis:ribution each calibrations 
both observed and predicted, was the mean of at least ten point sources 
distributions. 
Comparisons with the Livermore Phantom 
a) Plutonium 239 homogeneous distributions - ratio of predicted to 
observed responses 
--
Chest wall thickness (cm) Left array Right array 
Left Right 
0.63 0.54 1.06 0.72 
0.89 0.78 0.96 0.82 
1.13 1.04 1.06 0.85 
1. 33 1. 34 1.00 0.78 
1. 61 1.49 0.87 0.83 
Note that underprediction for the 'right array' is common for all 
measurements on the Livermore phantom. This underprediction is not 
present in point source studies nor in measurements on man, see below, it 
would therefore appear to arise from some "artifact" in the phantom (RH 
side) which the modelling programmes do not reflect. It was considered 
not to be productive to modify the modelling to remove this effect as the 
immediate secondary effect would be overpredictions in man. 
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b) Plutonium 239 - point sources - ratio of predicted to observed 
response 
Left array Right array Full array 
Sources in left lung 1.5 0.5 1.4 
Sources in right lung 0.6 1.0 1.0 
Note that absolute responses vary by several orders of magnitude with 
changes in the relative positions of source and detector. The table 
summarises·an extensive series of studies in a very simplified form. 
c) Amercium 241 - homogeneous distributions - ratio of predicted 
to observed response 
Chest wall thickness (cm) Left array Right array 
Left Right 
0.63 0.54 0.6 0.5 
0.89 0.78 0.7 0.4 
1.13 1.04 0.6 0.5 
1.33 1.34 0.6 0.5 
1.61 1.45 0.6 0.5 
This illustrates the poor match of build up for modelling on this phantom. 
Relatively small changes in input parameters to the model can remove this 
effect but the current model parameters satisfactorily predict the 
responses from point sources and from man (see below). 
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d) Co 57 - point sources - ratio of predicted to observed responses 
2 Dimension Model /Buildup 3 Dimension Model 
Left array Right array Left array Right array 
Left lung 0.84 0.82 0.87 1.03 
Right lung 1.04 0.81 1. 07 0.84 
Note that build up factor modelling was not attempted for the full 3 
dimensional model. 
e) Co 57 - Response for man known lung content - unknown distribution 
Subject Left array Right array 
A 0.85 1.00 
B 0.97 0.98 
c 1.08 1.16 
Mean 0.97 1. 05 
These results summarise a whole series of measurements with time. In 
particular they cover a time period up to one year during which the 
distribution pattern changed. They also do not show any underprediction 
for the Right array as is seen in responses to phantom with a homogeneous 
distribution, neither to they show any evidence of underprediction because 
of build up effects - an effect which should be greater at 120 KeV than 60 
KeV. The table summarises the overall system's ability to respond to 
unknown distribution effects at 120 KeV. How does it respond to the 
lower energy radiations for plutonium and amercium? 
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f) Mixed transuranics radionuclides in man - unknown distribution -
unknown lung content 
Left Array Right Array 
Plutonium Amercium Plutonium Amercium 
1.6 1.31 1.22 0.80 
Presentation of predicted to observed response ratios when the lung 
contents are unknown is obviously not possible. However in one case there 
are sufficient well documented secondary indications to assess the lung 
contents, independently of lung counting, within the error bounds of this 
current work. Such secondary indications are a combination of personal 
air samples, nasal smears,early and late faecal samples and early and late 
urine samples. Naturally some modelling of overall lung clearance was 
necessary but as the measured lung clearance agreed with the faecal 
monitoring pattern and also agreed with the ICRP lung model, there is 
sufficient confidence in the data to present the information in the 
same style as the tables above. 
Choice of detectors 
Throughout the whole of this project the primary detector has been the 
phoswich. During the same period there has been a move by some major 
laboratories within this field of work towards using liquid nitrogen 
cooled, high intrinsic germanium detectors specifically developed for 
enhanced low energy responses. The advantages of the phoswich detector 
are large surface area, low background and operation at room temperature. 
The advantages of the solid state detectors are high resolution and simper 
electronic circuitry. The choice between the detectors is largely a 
matter of judgement and cost as both approaches have comparable 
performances. However, in order to achieve sufficient surfaces area, 
solid state systems as configurated in arrays. Such array configurations 
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could be directly amenable to the calibration approach pursued in this 
project. A study was therefore carried out comparing the theoretical and 
experimental responses of both types of primary detector in order to see 
whether the phoswich approach, summarised in this project, could be 
bettered if the detector arrays consisted of intrinsic germanium devices. 
The theoretical study consisted of deriving intrinsic efficiencies to 
distribute point sources with a lung matrix. The experimental studies 
used both detectors on distributed sources with the lung of realistic 
phantom and included measurements on man. 
The overall conclusion was that he phoswich was better in terms of limits 
of detection and in overall efficiency whilst the solid state detector was 
better at assessing discrete point sources especially if those sources, 
were near the lung surface. The relative responses of the two detectors, 
after corrections for surface area and intrinsic efficiencies, varied with 
source distribution. All observations could be explained by scattering 
outside the photopeaks and by build up effects. The phoswich detector, 
being of poor resolution contains an appreciable proportion of 
non-photopeak response whilst the solid state detector, with its high 
resolution can only achieve the required low background by concentrating 
on the photopeak region only. There was no indication that the use of 
solid state arrays would improve on the overall findings of this project 
using phoswich arrays. The converse applies in that laboratories using 
solid state arrays could improve their system by including inhomogeneous 
distribution within their calibration approach. 
The final aim of the project was that it should be applicable to man in a 
routine way, usable at the limits of detection of the overall system and 
demonstrate improvements in assessment of plutonium in man. In 1980, 
prior to the commencement of this project data was published - IRPA 
Jerusalem - showing the results of monitoring programmes of about 200 
measurements on plutonium workers who had no history of acute or chronic 
intakes. The distribution followed a normal pattern about zero with a 
values 133 Bq. A similar detection pattern was produced in 1988 using the 
technique developed under these projects. The new pattern was still 
distributed around zero but the a value has been reduced to 33 Bq. In 
both cases the material was taken as mixed oxide fuel with known contents 
of amercium 241. 
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Other Groups collaborating 
None directly but the project is also partially supported within the UKAEA 
RPR progress and as such the data discussed with other laboratories 
working within this field in the UK. 
Publications 
Assessment of Plutonium in the lung 
D Ramden, P P Foster 
ATOM (UKAEA) Nov 1986 
"BODMOD - A Computerised Chest Modelling System" 
K P Kingman 
AEEW RSD/TM 3 1985 
"Response modelling for distributing sources in lungs" 
F L Davies AEEW RSD/TM 12 1986 
"The predictions of detected efficiencies in lung monitoring" 
L F Alexander 
AEEW RSD/TM 8 1987 
"Tests on a LOAX detector' 
A Cooper 
AEEW RSD/TM. 1989 
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Title of the project no.: 2 
Lung Models 
Head(s) of project: 
D Ramsden 
P P Foster 
Scientific staff: 
I Pearman 
I. Objectives of the project: 
Within the overall objective of improving our understanding of the 
behaviour of plutonium particulates in man, this project covered two 
aspects. Firstly taking the lung Model, previously developed at Winfrith 
under CEC contract and expanding this model to include urinary excretion 
predictions. Such predictions are then compared with the data generated 
under project 3 of this programme. Secondly a study on the clearance of 
inhaled cobaltous oxide (Co57). This study, was part of a joint European 
interspecies intercomparison. The Winfrith involvement was studies on 
man, inhaling a 'standardised' aerosol. Measurements were continued so as 
to compare long term retention and excretion with current lung models. 
11. Objectives for the reporting period: 
The objectives of this reporting period were: 
a) the final intercomparisons of experimental data and theoretical 
models on lung retention and urinary clearance in man. 
b) Publication of results obtained. 
CEC funding was minimal in 1989. This report summarises progress over the 
period 1985 - 1989. 
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Ill. Progress achieved: 
Cobalt ST Studies 
The purpose of the joint EULEP study, which covered ten animal species and 
seven laboratories, was to test the hypothesis, central to the new ICRP 
lung model, that although the rates of mechanical clearance of 
particulates from the lung were largely independent of the inhaled 
material and markedly dependent on the animal species, the rates of 
translocation (solubilisation) of inhaled material to the blood were 
largely independent of the animal species. It is not the remit of this 
progress report to summarise the whole EULEP study and it restricts itself 
to measurements on man. The time-scales of the interspecies 
intercomparison was set by the life span of the small rodents and 
measurements on man, for that project, were completed at 200 days post 
inhalation. The measurements which then continued with for a further 2 
years are reported here. 
Methodology 
The methodology of the study was straight forward. Four healthy 
non-smoking male volunteers participated, two inhaling particles of 0.8 ~ 
(MGD) and two particles of 1.7 ~· The inhalations took place at the 
laboratories of AERE Harwell using proven equipment with the aerosols 
being generated from resuspension of the primary material generated at GSF 
Neuherburg FRG. Inhalation, by mouth, had an initial deposition target of 
100 KBq. After an initial measurement at Harwell the subjects returned to 
Winfrith and were routinely measured on a calibrate body monitor for lung 
and whole body, Co 57 contents and monitored for urinary and faecal 
clearance using standard analytical techniques. Measurements continued 
until the levels were below the limits of detection, at 600 days for 
bioassay and 1000 days for lung monitoring. 
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Results 
1 A standard protocol for expressing the results was common to all 
participating laboratories so that data could be compared for all 
species. This expressed urinary and faecal excretion rates (per day) 
as a fraction of the contemporary lung contents. A brief summary of 
this data is tabulated below. 
O.Bj.lm MGD 1. 7}JIII MGD 
Subject A B c D 
*Range of Urinary excretion 2.0 2.0 1.0 1.0 
Days 3 to 250 4.0 4.5 3.1 5.3 
*Range of Faecal excretion 3.3 5.8 17.3 9.1 
Days 3 to 250 0.2 0.4 0.3 0.7 
*Expressed as fraction of contemporary lung contents per day x 10- 3 
This data was then interpreted as translocation rates and mechanical 
clearance rates - excluding first 5 days. 
Subject A B c D 
*Translocation rate 0.35 0.45 0.21 0.39 
(Standard Deviation) 0.07 0.07 0.07 0.07 
*Mechanical clearance rate 0.04 0.20 0.07 0.10 
(Standard Deviation) 0.05 0.10 0.07 0.09 
*Expressed as % of day 
The activity balance was monitored throughout the study and varied 
between 91 and 100%. 
2 After the completion of the interspecies study measurements continued 
and are summarised in figures 1 to 3 presenting lung retention, urinary 
excretion and faecal excretion on all subjects up to 1000 days. 
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1 A short summary of the interspecies study is:-
The cobalt oxide retained in the lung of man for longer periods than 
other species. At day 200 the fraction of initially deposited material 
in the human lung was about 50% compared to 33% for the baboon, with 
other species varying between 1% and 15%. 
For translocation to blood the rates between species were still 
variable but the range was narrower than that observed for mechanical 
clearance. For man.the translocation rate was approximately 0.4% per 
day, independent of particle size. Other animal species gave values 
in the range 0.2 to 2.0% per day. The temporal pattern of clearance 
rate showed marked species variation with man being fairly constant and 
the nearest species match being obtained from the baboon. 
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2 The long term clearance and retention data were averaged over all four 
subjects and compared to ICRP behaviour as illustrated in Figs 4 to 6. 
Three of the four subjects lung retention data could be fitted to a two 
exponential pattern with short term clearances of about 1 day and long 
term retention of about 200 days. The other subject showed an 
intermediate component of about 44 days - a component which is commonly 
seen in measurements of accidentally inhaled particulate material in 
man. 
Although the faecal excretion pattern is not dissimilar to ICRP class 
W, this behaviour is not seen in either lung retention nor urinary 
excretion. In particular the patterns are different over the period 20 
to 500 days - periods in which routine monitoring after intakes are 
usually pursued to provide data on which dosimetry estimates are based. 
This urinary excretion pattern is also discussed below . 
.. AVERAIED SUB..ECT DATA 
e ICRP 30 CLASS Y 1 71Jm MGD 
• ICRP 30 CLASS Y O·B!Jm MGO 
•ICRP 30 CLASS W 1·71Jm MGO 
* ICRP 30 CLASS W 0·8 1Jm MGO 
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Lung and Urine Modelling 
Methodology 
The development of the Winfrith lung model was completed under CEC 
Contract. The model, currently in use for routine dosimetric purposes in 
these laboratories was not further developed until data from Project 3 was 
available. The model was then used and comparisons made in three areas. 
1 The in-vitro solubility of industrial plutonium oxide dusts gave an 
excretion pattern which could be 'convoluted' with the lung model to 
give predicted urinary excretion patterns which could be compared with 
those currently used by ourselves and by other laboratories. 
2 These curves were also compared with observations of Co57 in man. 
3 The Winfrith lung model and associated urinary excretion functions were 
used in a UK laboratory intercomparison of plutonium dosimetry 
methodologies. 
In addition the model was also 'formalised and used to derive the site 
specific ALis for these laboratories as required by UK legislation. 
Results 
1 The comparison of model predictions and experimental data is presented 
and discussed in Project 3. 
2 The current Winfrith urinary excretion model following inhalation is 
compared to data from Cs57 studies in Figure 7. 
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3 The UK intercomparison of plutonium dosimetry covered 4 data sets, each 
generated from measurements on man. For one of these data sets, 
intakes by inhalation with long term excretion, the model was used and 
the results compared to the answers from the other 6 participating 
laboratories. The percentage spread about the mean for all 
laboratories for this particular case was 43% with the predictions from 
this model being within 5% of the mean. 
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Discussion 
Models for lung retention, including that developed here, can now be 
encompassed by the, flexibility of the new ICRP lung model. They can be 
successfully used for dosimetry purposes when considering both direct 
monitoring and faecal excretion data. 
Models/predictions for urinary excretion are less securely based and 
still rely, to a large extent on the original Wright-Langham data. At 
present, beyond 1000 days post intake, this still remains the main source 
of data whilst, for class Y type behaviour, urinary excretion during the 
first few days is governed by particle size distribution, by particles 
shape and by traces of more soluble material. The important period for 
routine urine assessment for dosimetric purposes is that between 20 and 
200 days (see Figure 7) and it is in this period where the major 
differences occur between different models. This last statement will 
probably still be true when the new ICRP model is published. 
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IV. Other research group(s) collaborating actively on this project [name(s) and 
address( es)]: 
GSF Neuherberg FRG 
NRPB Chil ton UK 
CEA Brugeres-le-Chatel F 
MRC Harwell UK 
IGT/KFK Karlsruhe FRG 
AERE Harwell UK 
EEJIC Karlsruhe FRG 
V. Publications: 
1 Justification, calculation and use of,Site Specific ALis 
D Ramsden, P P Foster - CEC Workshop 
Radiation Protection Dosimetry 26 (1 to 4) 259 1989 
2 An interspecies comparison of the lung clearance of inhaled 
monodisperic cobalt oxide particles 
M R Bailey et al 
J Aerosol Se 20 (2) 169 1989 
3 Lung clearance of inhaled cobalt oxide in Man 
I Pearman et al 
SRP Int Symposium Malvern UK 1989 
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Title of the project no.: 3 
In-vitro Solubility Studies 
Head(s) of project: 
D Ramsden 
P P Foster 
Scientific staff: 
I Pearman 
M Bains 
I. Objectives of the project: 
The 'solubility' in man of dusts from mixed uranium/plutonium oxide fuels 
determines the validity of urine monitoring as a means of assessing 
systemic uptakes and intakes of such materials. In-vitro solubility 
studies have been used in these laboratories and by other workers to 
characterise the availability of material over time scales from a few days 
to a few months. This experiment was planned to extend the studies over a 
period comparable with the predicted main component in current lung models 
for class Y material ie up to three years. The in-vitro behaviour was 
then to be compared with the parameters in lung models and with observed 
behaviour in man. The final objective was to comment on the realism of 
the assessment of intakes from urine monitoring. 
11. Objectives for the reporting period: 
The experimental phase of the project was completed prior to 1988 and the 
current year was devoted to the analysis of the data and preparation for 
the final report. 
This report covers the period 1985-1989 together with a brief summary of 
work prior to that date. 
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Ill. Proo[ess achieved: The experLmental phases of this project started in 1983 and is described 
in the 1980-1984 Progress report of the CEC Euratom Radiation Protection 
programme. Briefly three parallel rigs were commissioned each containing 
a mock lung consisting of a characterised semi-permeable membrane. Each 
'lung' contained about one litre of 'lung fluid' maintained at 37°C under 
an inert atmosphere, the fluid being remotely agitated. The outsides of 
the membrane were swept by 'mock plasma' at 1.5 litres per day and the 
plasma was collected and analysed. A suspension of particulate industrial 
dusts of uranium/plutonium oxide was introduced into the lungs after 
characterisation for activity and particle sizing. The initial 
characterisations are given in table 1. 
Table 1 Input parameters to mock lungs 
a) Chemical composition of plasmas 
b) 
Sodium Chloride 
Ammonium Chloride 
Sodium bicarbonate 
Clycerine 
L-Cystine 
Sodium dihydrogen phosphate 
Tri sodium citrate 
Calcium chloride 
Sulphuric acid 
Thymol 
Radioactive components 
Count medium diameter (J..IIll) 
a g 
Mass medium diameter (J..IIll) 
Total initial alpha activity (MBq) 
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Rig 1 
0.4 
1.7 
1.21 
2.02 
g/litre 
68 
5.4 
22.8 
3.8 
1.2 
1.9 
0.6 
0.1 
0.3ml 
10 ppm 
Rig 2 
0.75 
2.26 
1.55 
2.02 
Rig 3 
1.18 
1.58 
2.13 
3.0 
Composition at March 1983 
(% by alpha activity) 
Pu238 
Pu239 
10.5 
32.6 
Pu240 30.0 
Am241 26.9 
Pu241 Total Alpha 15.0 
Uranium (natural) Plutonium (by weight) 2.0 
Prior to start up the membrane was characterised by electric microscopy 
and by a series of tests using colloidal gold-198 and indium 111. The 
effective pore size of the membrane lay in the region 1 to 20mm. 
Transferrin was added to rig 2. 
The experimental phase of the study, not described here lasted until 1986 
for all the rigs. The experiments were stopped just prior to the planned 
period of 3 years because all three rigs suddenly began to demonstrate 
increased transfer of activity across the membranes. This effect was 
coincidental with the appearance of 'bacterial growth clouding' within the 
plasma solutions. The bacterial growth was identified as Pseudomonas 
aeruginosa (pyocyarea) and tests were necessary to investigate whether the 
increases in membrane transfer were associated with the growth. No 
plutonium activity was associated with the bacteria and further tests on 
the membranes, repeating the initial Au-198 studies showed that the 
membranes were beginning to fail because of radiolytic effects. The 
experiment phases were therefore brought to orderly decommissioning during 
1986. 
Results 
Data was collected as the "solubilised" fraction of material. During the 
initial phases of the study daily analyses were performed. The analytical 
period then extended to weekly and finally monthly. Samples were analysed 
for uranium (initially), Amercium 241 and total plutonium. the effects of 
the occasional failure of circulation, via peristaltic pumps, were to 
introduce a step change in the observed material transfer which was 
quickly 'smoothed out' by restoring circulation. 
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The data was stored as cumulative solubilised fractions and a typical 
output graph is shown in the Figure. 
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Rig No 1 Cumulative Amercium solubilised fraction as percentage of 
initial contents 
After decommissioning the residual activities in the lung fluid and on the 
membrane were analysed in order to achieve a mass/activity balance. 
Analysis of results 
Initial analyses showed that all the outputs could be fitted to 
'solubilisation' expressions containing three exponents. 
3 
ie S ·= So + L Sne -xnt 
1 
with the values of Xn lying in the ranges: 
X1 half lifes of clearance 1 to 6 days 
Xz half lifes of clearance 20 to 80 days 
Xs half lifes of clearance 170 to 500 days 
Any longer lived components were not evident and are included in the 
permanent retained fraction So. 
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The presence of plutonium 241, at 1.1% by weight in the original 
radionuclide mix, meant that the analyses for Am241 solubilities had to be 
corrected for the grow-in of amercium for Pu241, This was done by 
standard methodology. The values of So, Sn, Xn were determined by best 
squares fitting techniques and are given in table 2 below. 
Rig 1 
Uranium Amercium 241 Total plutonium 
So (as fraction) 0.875 0.958 0.973 
X1 (d-1) 0.285 0.118 0.264 
s1 (as fraction) 0.122 0.013 0.012 
X2 (d-1) Not determined Not present 0.008 
s2 (as fraction) " " 0.0038 
X3 (d-1) Not determined 3,79 X 10-3 2.54 X 10-3 
s3 (as fraction) " 0.0329 0.0103 
Rig 2 This rig contained transferrin 
Uranium Amercium 241 Total plutonium I 
I 
l 
So (as fraction) 0. 71 0.958 0.959 
IX1 0.319 0.624 0.425 
:s1 0.29 0.0036 0.015 
ix2 0.0079 0.0144 
;s2 0.036 0.015 
I 
!Xl 1.25 X 10-3 3,38 X 10-3 
1s3 0.013 0.011 
, 
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Rig 3 
Uranium Amercium 241 Total plutonium 
So (as fraction) 0.924 0.964 0.986 
Al 0.251 Not determined 0.122 
s1 0.076 0.0037 
r.• 0.0318 Not determined 
s2 0.0282 
A3 2.73 X lQ-3 4.08 X lQ-3 
S3 0.0156 0.0107 
Discussion 
a) The effect of transferrin 
Rigs 1 and 2 were identifiable apart from the presence of transferrin in 
Rig 2. Although the presence of the complexing agent, citric acid, should 
have ensured that any solubilised material was held in a stable state, the 
protein complexing agent, was added to one rig to see whether this 
stability did in fact exist. 
There was no doubt that the amount of uranium, apparently solubilised, was 
markedly effected by the presence of transferrin, increasing for about 10% 
to 30%. There is also no doubt that the presence of transferrin had no 
effect on the amercium solubilised. The effects on the plutonium 
solubilisation were ambiguous with the total amount being 'solubilised' 
being 2.7% and 1.4% in the rigs without transferrin and 4.1% in the rig 
with transferrin. All the increased solubility occurred in the shortest 
component. For the purpose of comparison this shortest component (rig 2) 
is not included in further analyses. 
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b) Amounts available for 'solubilisation'. 
The main test of 'realism' in the study is estimating the total amount of 
material which would be eventually 'transported' from the lung to the 
blood and hence to bone and liver. This study makes no attempt to 
describe the behaviour of the material once 'solubilised' - such 
information being available from various studies on the Wright-Longham 
patients, on a few well documented cases of accidental intakes and on 
studies on animals. The numbers generated by this study can be compared 
with the figures given for the ICRP lung model and for figures generated 
for the AEEW lung model, see Project 2. 
Total activity eventually 'solubilised' from lung - (as fraction) 
ICRP 19 Class y 0.039 
Class w 0.126 
AEEW Model (Project 2) 0.018 
This study Plutonium 0.020 2: .006 
Amercium 0.040 2: 0.002 
These figures support the overall realism of the study and tend to support 
the previous work on the Winfrith lung model where the 'reduced' 
solubility was based on observations of urinary clearance in man of the 
same material. 
c) Time scales of clearance 
Best fits to the experimental data were obtained using three components 
and although not all components were present in all the rigs. The 
following table compares the amplitudes and half lifes of the three 
components expressed as % of available material and also provides an 
'average' figure. The shorter component, Pu/Rig 2, is not included (see 
(a) above) in the averages. 
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Short Intermediate Long 
Amp Half life Amp Half life Amp Half life 
(as % of (days) (days) (days) 
available 
material) 
Rig 1 Pu 44 2.6 14 87 38 273 
Am 22 5.9 - not present - 78 183 
Rig 2 Pu 37 1.6 36 48 27 205 
Am 6 1.1 62 88 31 554 
Rig 3 Pu 26 5.7 - not present - 76 170 
Am - not present - 56 22 43 254 
'Average' 23 3.4 28 61 49 273 
c/f models 
ICRP Y 15 0.1 - - 85 500 
ICRP W 71 0.1 29 50 - -
AEEW 32 0.1 6 30 61 300 
The numbers, although supporting the Winfrith model do imply that the 
intermediate component is more available for solubilisation than the model 
would predict. All models, predict a shorter half life for the rapidly 
solubilised component than that observed. 
d) The final comparison made here is to reflect the useability of this 
data in assessing plutonium intake for urinary excretion. Urine excretion 
models commonly used on those of Jones, Durbin of ICRP 54, based'on the 
Wright-Langham data which are then combined with a lung model to derive 
urinary excretion per unit intake to the lung. The figure below, compares 
excretion patterns from the Jones function with the ICRP lung model to 
data from this study combined with ICRP class Y behaviour. The conclusion 
is that long term in-vitro studies can be used to predict urinary 
excretion and that the predicted excretion patterns agree with current 
models for class Y behaviour - plutonium 239. 
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IV. Other research group(s) collaborating actively on this project [name(s) and 
address( es)]: 
None 
V. Publications: 
Solubility studies on the Industrial Plutonium Dust 
P P Foster, I Pearman, ME Bains and D Ramsden 
Design and Interpretation of Inhalation Studies. Hanover - March 1987 
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RADIATION PROTECTION PROGRAMME 
Final Report 
Contractor: 
Universite Libre de Bruxelles 
avenue F.D. Roosevelt, 50 
B-1050 Bruxelles 
Contract no.: BI6-D-178-B 
Head(s) of research team(s) [name(s) and address(es)]: 
Prof. J. Rommelaere 
Dept. de Biologie Moleculaire 
Universite Libre de Bruxelles 
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Cooperati.on between rad1.ation and CP.cogenes in malignant 
cransformation of mammalian cells. 
List of projects: 
, • Cooperation between radiation and oncogenes in malignant 
transformation of mammalian cells. 
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Title of the project no.: 
1. Cooperation between radiation and oncogenes in malignant transforma-
tion of mammalian cells 
Head(s) of project: J. ROMMELAERE 
Scientific staff: M. TUYNDER, G. HILGERS, B. AVALOSSE, Y.Q. CHEN, S. BARRIJAL 
I. Objectives of the project: 
This project has four main objectives 
a. To characterize phenotypic alterations which are induced by radiation 
in human fibroblasts and epithelial cells and which commit them into 
malignant progression. 
b. To develop a quantitative assay for monitoring the transforming effects 
of ionizing radiation on human epithelial cells. 
c. To identify synergistic actions between radiation and oncogenes for 
malignant transformation of human and murine cells. 
d. To study cellular mechanisms underlying the cancer-proneness and 
radiohypersensitivity associated with the human syndrome ataxia telangiec-
tasia. 
11. Objectives for the reporting period: 
a. To obtain a quantitative in vitro cell transformation system using 
human keratinocytes which allows risk assessment from Pxposure of 
humans with ionising radiation. 
b. To determine whether radiation transformed human cells are a 
preferential target for replication of and killing by autonomous 
parvoviruses. 
c. We dealt with the molecular analysis of transient conditional 
response induced by radiation in normal human fibroblasts. 
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Ill. Progress achieved: 
COOPERATION BETWEEN RADIATION AND ONCOGENES IN MALIGNANT TRANSFORMATION 
OF MAMMALIAN CELLS. 
1. INTRODUCTION 
The incidence of malignant transformatinn following exposure to carcino-
gens depends on several cellular parameters which may vary among different 
cells and/or individuals. The idertification of these parameters conditio-
ning cell susceptibility to transformation is important not only from a 
fundamental point of view but also for risk assessment. Cell cultures are 
particularly useful to this end, since their phenotype can be modulated 
in vitro and their progression from normality to malignancy can be 
monitored. The general goal of this work was to set up human cell cultures 
as in vitro model systems for the detection of acquired or inherited 
cellular changes cooperating with ionizing radiation for the induction of 
malignant transformation. 
Human cell determinants of proneness to radiation-induced transformation 
are poorly understood. This is due, in part, to difficulties in quanti-
fying in vitro transformation with cultures of human fibroblasts. We de-
ve1oped an alternative assay for transformation after ionizing irradiation, 
using cultures of human epithelial cells (see 2.1). Furthermore we have 
searched for cellular determinants of transformation according to a two-
point strategy. Firstly, candidate human cells for an enhanced suscepti-
bility to radiation-induced transformation include those from some cancer-
prone and radiation-sensitive syndromes such as ataxia telangiectasia (AT). 
Cultures of cells representative of this class as well as normal human cell 
lines were prepared and tested for their responses to irradiation (see 
2.2). Secondly, a negative determinant of malignant transformation by 
several carcinogens is the hypersensitivity of transformed cells to the 
lytic action of parvoviruses, a family cf oncosuppressing viruses. On 
one hand, it was determined whether parvoviral replication also inhibits 
in vitro transformation of human cells by ionizing radiation and could 
provide an additional marker for the analysis of the latter process (see 
2.3). On the other hand, parvovirus was used to isolate candidate. 
transformation-modulated cellular proteins by means of their binding to 
the parvoviral genome (see 2.4). 
2. RESULTS AND DISCUSSION 
2.1. Radiation-induced transformation of human keratinocvtes. 
Quantitative studies on transformation following irradiation were 
undertaken with primary cultures of human keratinocytes. Since epithelial 
cells constitute a most sensitive target for radiation carcinogenesis in 
humans, cultures of keratinocytes may provide a valuable model system to 
assess the transforming risk from ionizing radiation. 
As several parameters of cell transformation valuable for fibroblasts do 
not apply to epithelial cells, such as growth in a semi-solid medium or 
focus formation, a selective medium was developed permitting the identi-
fication of cell transformants. The rationale was based on the fact that 
cell lines established from skin carcinomas as well as keratinocyte strains 
transformed by SV40, human papilloma viruses (HPV) or oncogene-bearing 
retroviruses have been shown to express altered properties of growth and 
differentiation compared with normal keratinocytes (19, 20, 23, 28). 
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Most of these in vivo and in vitro transformed cells can be grown under 
restrictive conditions such as lowered serum or growth factor concentra-
tions and have been shown to be more resistant than their normal counter-
parts to terminal differentiation stimuli (18). One of the techniques 
allowing the growth of normal human keratinocytes in culture consists of 
their incubation in serum-free medium with a low (0.1 mM) calcium (ea++) 
concentration but supplemented with 10 ng/ml epidermal growth factor 
(EGF), insulin, hydrocortisone and some other growth stimulating consti-
tuents (6, 27). Under these conditions, the single cells form colonies 
and do not undergo terminal differentiation. However, these keratinocyt~l 
differentiate and cease proliferating in medium with a high (1-2 mM) Ca 
concentration in combination with a low EGF supplement {27). These proper-
ties were used to explore the transformability of human keratinocytes after 
X-ray irradiation by determining their ability to proliferate in such a 
selective medium. 
An immortalized and transformed human fibroblast line has been obtained 
after multiple treatments of a normal fibroblast strain with gamma-rays 
{17). A very similar protocol was used to obtain transformed keratinocytes. 
After X-irradiation (50 KV, 20 mA, 0.04 Gy/sec) the cells were incubated 
in proliferative medium (containing 0.1 mM ea++ and 10 ng/ml EGF). 2 or 
4 Gy X-rays were given to the cultures resulting in 40 and 15% cell 
survival, respectively. When irradiated or sham-irradiated cultures had 
reached 80% confluency they were split in 3 from which one dish was 
counted, another incubated in proliferative, and the last in selective 
medium (containing 1.2 mM ea++ and 0.1 ng/ml EGF). Cultures in prolifera-
tive medium were irradiated again with the same dose whent they reached 
50% confluency, and so on. Almost no resistant clones were obtained after 
single X-ray doses, but more and more emerged after multiple irradiations. 
Several cultures resistant to terminal differentiation were obtained after 
total injury of 14 Gy (7 times 2 Gy), 16 Gy (4 x 4 Gy) or (8 x 2 Gy) and 
24 Gy (6 times 4 Gy). These cultures were proliferating when parallel 
sham-irradiated cultures had reached senescence. Thus the transformants 
exhibit a prolonged life-span. Two resistant cultures designated TR7201 
(total dose 14 Gy) and TR8201 (total dose 16 Gy) were selected for 
further characterization. Both transformed cultures proliferate in the 
selective medium which causes normal keratinocytes to differentiate. 
Surprisingly, the X-ray transformed cultures did not grow well in the 
medium that allowed normal keratinocytes to proliferate without terminal 
differentiation (low ea++ and high EGF concentrations). Interestingly, 
many squamous carcinoma-derived cells die in medium containing concentra-
tions of EGF which are optimal for normal keratinocytes (5). Further 
analysis revealed that the two transformants were aneuploid and exhibited 
low and high expression of markers characteristic of differentiating and 
proliferating basal keratinocytes, respectively. In summary, X-ray 
irradiation of normal human keratinocytes cultures induces the dose-
dependent emergence of cell clones with longer life span than normal 
keratinocytes. These transformants exhibit properties of cells established 
from carcinomas and virally transformed keratinocytes (manuscript in 
preparation). 
2.2. Response to radiation in normal and cancer-prone human cells. 
a) Recovery and mutagenesis processes in AT cells. 
Conditions of abnormal sensitivity,to radiation and proneness to cancer 
are characteristic of some hereditary syndromes in humans. Cells from 
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patients with ataxia telangiectasia (AT) characterized by an hypersensiti-
vity to the lethal effect of ionising radiation and a radioresistant DNA 
synthesis (22) were analyzed for radiation-responses which can be monitored 
in vitro and might contribute to a propensity for the induction of mali-
gnant transformation. 
As a first step, we have extended and substantiated our previous finding, 
obtained in the framework of the previous Radioprotection Program, that an 
AT cell line, AT5BIVA, is deficient for the expression of the enhanced 
reactivation (ER) response. ER takes place when the survival of a damaged 
virus is higher in host cells pretreated with radiation or chemical carci-
nogens than in untreated cells. The ER response in mammalian cells is ana-
logous to Weigle Reactivation in bacteria, one of the SOS manifestations. 
Parvovirus H-1, a single-stranded DNA and nuclear-replicating virus, was 
used to probe ER in irradiated human fibroblasts. It has been shown that a 
transient and dose-dependent ER response occurs in irradiated normal human 
fibroblasts. In contrast, neither time-course nor dose-effect experiments 
revealed a significant ER of gamma-ray or UV-damaged parvovirus H-1 in X-
ray or UV-irradiated AT cells (12). It was also determined whether the 
expression of ER is similarly deficient when monitored with the double-
stranded DNA virus HSV-1 (in collaboration with Dr. A.J. van der Eb 
(Leiden). Time course experiments revealed a normal ER expression in X-ray 
or UV-pretreated AT cells, using UV-irradiated HSV-1 as a probe (13,14). 
Another conditional response identified in irradiated normal human cells 
was denoted Enhanced Mutagenesis (EM). EM is defined as an increased muta-
ger.esis of damaged virus in pretreated, as compared with untreated host 
cells. EM accompanies ER expression in so~e systems studied (10,15). It 
was therefore of interest to determine whether irradiated AT cells are able 
to express E~. A forward mutation assay was used to measure the fraction 
of mutants among the progeny of intact or damaged HSV-1 produced by mock 
or X-ray treated cells of normal and AT origin. In contrast with normal 
human cells, the AT5BTVA cells failed to achieve a dPtectable EM of HSV-1 
upon irradiation (13}. An essentially similar difference between normal 
and AT cells was found when the damaged temperature-sensitive single-stran-
ded DNA virus H1TS6 was used as a probe to measure mutagenesis (14). 
Altogether, the data suggest that AT cells are deficient for a component 
of ER which is of little importance for the rescue of damaged double-
stranded DNA but which contributes to the survival of a single-stranded 
DNA virus as well as to the mutagenesis of both types of damaged viruses. 
It is tempting to speculate that these phenotypic alterations may all be 
traced back to a common defect related to DNA replication across damaged 
templates. The latter process i~ indeed expected to be of prime importance 
not only for mutagenesis but also for the survival of damaged single-
stranded DNA that cannot rely on excision repair unless first converted to 
a double-stranded replicative form. Alternatively, irradiated AT cells 
may fail to produce signals that activate the latter process. 
However, AT cells are proficient in ER of double-stranded DNA viruses, an 
error-free process which might be due to stimulated excision of lesions 
from duplex viral DNA. 
The relevance of the reported defect of certain conditioned processes to 
the AT status seems double. On one hand, the aberrant conditioned response 
in AT cells seems to be associated with the radioresistant DNA synthesis 
typical of AT cells. Indeed, cell clone 67, a partial revertant of the 
AT5BIVA cell line, although corrected with respect to its sensitivity to 
X-rays induced killing, consistently retained both radioresistance of DNA 
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synthesis and the impairement of the conditioned response (14). On the 
other hand, the failure of irradiated AT cells to undergo the induction 
of a mutator operating on damaged virus may be correlated with the 
reduced number of mutations in cellular genes induced by X-ray observed 
by Arlett and Harcourt (1) in the same deficient cell line. 
b) Biochemical relevance of cellular responses to radiation. 
The present study was undertaken to investigate mechanisms controlling 
the expression of genes involved in radiation recovery processes. Several 
studies provided evidence that interferon alpha treatment of cells promo-
tes their recovery after irradiation (24, 29). We obtained corrborating 
results since we observed a synergistic effect of radiation and IFN-alpha 
treatment on ER of UV-damaged H-1 virus in normal human cells. 
An attempt was made at investigating the latter phenomenon at the molecular 
level by determining the expression of four IFN-inducible genes (i.e., 
2-5 A synthetase, IFI-15K, 6-16 and 1-8) in .cells exposed to IFN and/or 
radiation. These genes may possibly be involved in cellular recovery 
processes or be eo-regulated with the latter. Our results show·that the 
steady-state levels of specific IFN-induced mRNAs were higher in irradia-
ted cells compared with cells treated with IFN alone. Run-on and pulse-
chase experiments provided further evidence for this posttranscriptional 
mode of regulation of the IFN-induced genes by radiation. 
How radiation affects mRNA decay is still elusive. 
However, our data suggest that the accumulation of mRNAs in irradiated 
cells seems primarily due to a direct control of radiation at the level 
of stability rather than a consequence of the inhibition of RNA 
processing or protein synthesis. 
This effect appears to concern, in particular, transiently expressed mRNAs, 
raising the possibility that part of the inductive action of radiation 
muy be ascribed to the stabilization of short-lived cellular mRNAs. 
The posttranscriptional regulatory effect of radiation could have important 
biological implications. Control of the expression of essential inducible 
genes at the level of MRNA stabilization may provide opportunities for 
compensatory mechanisms to operate, permitting vital cellular processes 
to proceed during DNA repair (manuscript in preparation). 
2.3. Sensitivity of radiation-transformed human cells to oncosuppressive 
vi ruses 
With the object to identify other markers for monitori•ng the transforming 
effects of ionizing radiation on human cells, we determined whether the 
permissiveness of human fibroblasts to autonomous parvoviruses could be 
modulated by radiation. Parvoviruses are known to be strongly dependent 
on the physiological state of host cells for their replication, a property 
which may account for their oncosuppressive activity in vivo and their 
ability to destroy selectively SV40-transformed mouse cells in vitro (21). 
Normal human fibroblasts in culture are remarkably resistant to transfor-
mation by physi£o-chemical agents (11). Exposure of human fibroblasts to 
ionizing radiation usually results in infinite, anchorage-independent 
and non-tumorigenic cell strains (4, 16). It is generally accepted now that 
cell immortalization constitutes a l'lajor restraint to the use of normal 
human cells for quantitative studies on malignant transformation by 
radiation and chemical carcinogens (16). Therefore, we analyzed th·~ 
susceptibility to the autonomous parvoviruses H-1 and MV~ of the gamma-ray 
induced human fibroblast cell line KMST-6 in comparison with SV40- and 
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chemically immortalized fibroblast cell lines. Besides their immortal state, 
these cell lines exhibit a series of transformation characteristics such 
as reduced serum requirements for growth and aneuploidy {17). 
The normal parental strains and their transformed derivatives took up 
parvovirus with similar efficiencies. Yet, the transformed cell lines 
expressed 10-30 times more viral transcripts and viral 
proteins than their untransformed progenitors. The stimulation by trans-
formation of viral DNA synthesis was of the same amplitude, i.e., therP 
was a parallel increase in gene expression and DNA amplification. Thus, 
a generalized up-modulation of viral gene expression and DNA replication 
was observed in the transformed versus the normal fibroblasts {2, 8, 9). 
As parvoviruses are lytic viruses, it was not surprising that the greater 
virus replication ability in the transformed cells was associated with an 
enhanced killing of the latter. 
Similarly, whereas normal human fibroblasts do not appear to suffer from 
virus infection unless high virus inputs are inoculated, gamma-ray 
transformed fibroblasts were highly susceptibl~ to virus-induced killing 
{7' 8). 
As none of the in vitro transformed and immortalized cell lines was tumo-
rigenic, the latter property is not required for cell susceptibility to 
parvoviruses. The fibrosarcoma-derived human cell line HT1080 ranged among 
the ir. vitro transformants with respect to susceptibility to parvovirus 
H-1 and MV~ replication and killing (8). 
This suggests that the acquisition of the malignant state does not add to 
the cell susceptibility of the SV40 and physicochemically immortalized 
and transformed fibroblasts. The question whether the acquisition of 
immortality is associated with susceptibility to parvoviruses could be 
answered negatively, at least for immortalization caused by SV40 {7). 
Altogether, the result show that cell sensitivity to parvoviruses may 
constitute a marker of a preneoplastic transformed state which does not 
necessarily include immortality. The gamma-ray induced human fibroblast 
cell line KMST-6 behaves like viral and oncogene-transformed infinite or 
immortal fibroblasts with respect to their increased susceptibility to 
the replication of the autonomous parvoviruses H-1 and MVM compared with 
parental untransformed fibroblasts. 
2.4. Detection of transformation-sensitive cellular proteins by their 
bindinq to DNA of oncosuppressive parvoviruses. 
As the replication of the parvoviruses is associated with the transformed 
state (see above) cellular markers of transformation were sought with their 
help. Cellular proteins specific for the normal or transformed state may 
exist and exhibit specific affinity to parvoviral nucleic acids. Cellular 
proteins with specific affinity for parvoviral DNA were searched using the 
south-western blotting technique. In short, cellular proteins were fractio-
nated by SDS-polyacrylamide gels, blotted into nitrocellulose filters which 
were incubated in the presence of radiolabelled parvoviral DNA fragments. 
By this technique a nuclear parvoviral DNA-binding protein of approximately 
105 KDa molecular weight was detected that was more abundant (or more acti-
ve) in the normal human fibroblast strains K~S-6 and MRC-5 than in their 
gamma-ray and SV40-transformed derivatives KMST-6 and MRC5VI (3). 
The greater availability of the 105 KDa protein in parvovirus- resistant 
fibroblasts was confirmed in a series of hybrid clones between normal 
human- and transformed mouse fibroblasts,exhibiting varying susceptibili-
ties to the killing effect of parvovirus MVM {3). It is tempting to 
speculate that the 105 KDa species is a DNA-binding suppressor protein 
which is inactivated, lost or repressed in transformed and parvovirus-
susceptible cells. A parallel may 
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be drawn between such properties and those of the products of anti-
oncogenes (25}. 
3. CONCLUSIONS 
a. After repeated treatments of human foreskin keratinocytes with X-rays, 
cell clones emerged which resisted to a greater extent to terminal diffe-
rentiation stimuli than normal keratinocytes. These X-ray transformed 
cultures are induced in a dose-dependent fashion, exhibit a prolonged 
life-span, are aneuploid, and stain positively and negatively for 
markers of proliferating basal and differentiating keratinocytes, 
respectively. 
b. Cells from patients with the cancer-prone ataxia telangiectasia 
syndrome are altered for a radiation-induced process which plays a minor 
role in the reactivation (ER} of a double-stranded DNA virus but which 
contribute5 to the survival of a single-stranded DNA virus as well as to 
the mutagenesis of both types of damaged viruses. The data may be explainaf 
by an impaired capacity of AT cells for replication damaged viral DNA or 
by their failure to produce signals that activate the latter process. 
This deficiency seems to be associated with the radioresistant DNA 
synthesis and the hypomutability typical of AT cells. Our data suggest 
that part of the inductive action of radiation may be ascribed to the 
stabilization of short-lived cellular messenger RNAs. 
c. Human fibroblasts immortalized and transformed by gamma-radiation were 
more susceptible to parvovirus replication and killing than the normal 
parental cells. As the radiation- transformed cells were not tumorigenic, 
cell susceptibility to parvoviruses may constitute a preneoplastic marker 
of cell transformation. A 105 KDa cellular protein was identified by its 
specific binding to parvoviral DNA. This protein is more abundant (or 
more active} in normal than in transformed human cells. 
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I. Objectives of the project: 
Stud1es over the last few years have provided ev1dence 
that several cellular genes may exhib1t potent1al transforming 
activity (proto-oncogenes) (1). Activated proto-oncogenes have 
been detected 1nto spontaneous or induced animal tumors as 
well as into human neoplasias (1,2,3). 
Spontaneous, x-ray-1nduced and v1rus-1nduced murine 
tumors have been chosen as working models to invest1gate the 
molecular mechanisms involved in the acqu1sition of the 
malignant tumor cell phenotype. Our maJor purpose cons1sted 1n 
determining the role(s) of activated proto-oncogenes 1n the 
onset and progress1on of the neoplast1c process. 
11. Objectives for the reporting period: 
1) Search for and role(s) of oncogenes in spontaneus and 
X-ray- induced mouse tumors. By DNA-medlated gene transfer 
protocols we searched for trasforming genes in spontaneous 
reticulum cell sarcoma (RCS) of SJL/J mice (4,5), as well as 
in x-ray 1nduced lymphomas 1n (C57/Bl/CnexC3H/Cne) F1 m1ce(6). 
2) Stud1es on the mechanisms involved in the tumorigen1c 
behaviour of Friend leukemia cells (FLC): effects of X-ray 
ra~~~QD~ We analyzed the expression of histocompat1bil1ty 
antigens and the role of activated oncogenes in the metastatic 
process in the FLC system (7,8,9,10). Moreover we analyzed the 
effects of sublethal doses of x-rays on the FLC in__vivo 
behav1our. 
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Ill. Progress achieved: 
t1_t~TERI~I,~_}.ND __ ME_THODS 
~Jce. Male and female DBA/2 m1ce were obtained from Charles 
Rivers s.p.a.[M1lan, Italy). S~L/J female m1ce were purchased 
from The Jackscn Laboratory (Bar Harbor, ME). 
Turner cells. Spontaneous RCS were obtained 1n SJL/J m1ce at 
ages of 9-12 months. The RCS transplantable turners were 
mainta;ned 1n v1vc by ser;al passage of 101 viable cells 1.p. 
1nto 6-12 week old SJL/J mice. RCS cell suspens1ons were 
obta1ned by exc1sing turners, spleens and mesenter1c lymph 
nodes 8-10 days after 1noculation and gently teas1ng the 
tissue through nylon wool f1lters, as prev1ously described 
( 1 1 ) • 
Interferon a/G resistant 3Cl8-FLC (7) were cult1vated in 
RPMI med1um supplemented w1th 10 per cent fetal calf serum 
(FCS) (in v1tro passaged FLC) or passaged by weekly 
1ntraper1toneal (i.p.) 1noculation of 5-6-week-old DBA/2 m1ce 
(1n vivo passaged FLC). WGA-resistant (WR) 3Cl-8 FLC were 
isolated from 1n v1vo passaged 3Cl8-FLC, as descr1bed 
elsewhere (8). A cloned WR FLC population (i.e., w2 clone) (8) 
was used in the experiments described in this report. The 
orig1n of IFN-sensltive in vitro or in v1vo passaged 745 FLC 
have been previously described elsewhere (9). 
RNA extraction and analysis. Total cellular RNA was extracted 
accord1ng to the quick phenol guanid1n method (12). 20~g of 
RNA were fractionated by electrophores1s on 1.3% agarose gel 
and blotted onto nylon membrane (High-Bond, Amersham) 
overnight. Northern blots were hybridized at 42'C 1n 1M Nacl, 
10% dextran sulphate, 1% SOS and 50% formamide, or 40% 
formam1de. Following hybrid1zat1on with e1ther nick translated 
or random pr1med probes, all the blots were first soaked for 5 
minutes 1n 2x ssc (1xssc 0.15M NaCl, 0.015M sodium citrate) 
and success1vely washed 30mln in 2x ssc, 0.5% SOS at 65"C. The 
filters were exposed with x-ray films at -80'C using kodak 
cassettes provided with lanex intensifying screens. 
Molecular probes. The DNA probes used in the hybrid1zat1on 
experiments were: 1.5-kb Cla 1, Eco RI fragment from human 
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c-myc; 0.6-kb H1nd III, Barn HI fragment cloned from BALB 
murine sarcoma virus and representative of mouse c-h-ras, and 
a 1.0 kb Eco RI fragment excised from clone phihl 3 
representative of mur1ne c-k-ras (10). 
Evaluation of the number of hemoglobin-producing cells. 
Percentages of hemoglobin-producing (B+) cells were 
determined by the wet benzidine sta1ning method of Orkin et 
al., (1975) (13). 
Isolation of high molecular weight DNA. Cells were lysed by 
addit1on of 10 mM Tris-HCl, 150 mM EDTA (pH 7.8), and 0,5% 
sod1um dodecyl sulfate and the lysates were incubated 
overnight at 37'C in the presence of Proteinase K (200 ~g/ml). 
Partially deproteinized nucleic acids were extracted once 
with one volume of phenol, one volume of phenol/ chloroform/ 
isoamylalcohol (25/24/1), and one volume chloroform I 
isoamylalcohol (24/1). The DNA was precipitated with 2.5 
volumes of cold ethanol (-20'C), dried and stored at 4'C 1n 
sterile 10 mM Tris-HCl, 1 mM EDTA (pH 7.4) (3). 
DNA Blotting Analysis. Twenty micrograms of high molecular 
weight DNA were digested with appropr1ate restrict1on 
endonucleases and applied to horizontal 0.6% (w/v) agarose 
gels. Samples were electrophoresed at 30 V for 20 h, blotten 
onto nitrocellulose sheets, and hybridized for 48 h to 2x101 
cpm of the corresponding nick-translated-(32p)-labeled DNA as 
described by Southern (1975) {14). 
FACS analysis. Cellular UNA content was assayed by propid1um 
iodide staining method. Briefly, cells were fixed in 70% 
ethanol, 15 min at 4°C, washed and resuspended {108 cells/ml) 
in 1 ml of PBS, containing 0.1% NP40, addit1onated of 100 
Kunitz units of pancreatic RNAse (Sigma, St. Louis, MO) and 
incubated for 10 min at RT. 5 ~gr of propidium iodide (Sigma) 
were then added to each sample (stock solution 0.5 ~gr/ml 
propidium iodide in H20, 10 ~1/sample). Cytofluor1metric 
analysis was carried out in FACS can instrument 
(Becton-Dickinson, Mountain View, CA) (10). 
Tr~nsfection Assays. Transfection assays were·carried out by 
the calcium phosphate precipitation technique of Graham and 
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van der Eb (15) as modif1ed by Wigler et al. (16). Donor DNA 
(40 ~g) was resuspended 1n 1 ml of 0.25 M CaCl2 and gently 
mixed with an equal volume of 250 mM 4-(2-hydroxyethyl) 
-1-piperazlne-ethanesulfonic acid (pH 7.1) and 1.5 mM sodium 
phosphate. The DNA was allowed to precip1tate for at least 
h at room temperature and then added to 10 cm Petri dishes. 
where 1.5 x 105 recip1ent cells (NIH-3T3 or F2408) had been 
seeded the day before (3). NIH-3T3 mouse fibroblasts (17) and 
F2408 rat fibroblasts were selected for the1r best morphology 
and ma1ntained 1n Dulbecco's modified Eagle's medium 
supplemented with 10% calf serum. 
DNA cloning and seguencing. DNA cloning has been performed in 
ZAP vector follow1ng manufactury.protocols (Stratagene). DNA 
sequenc1ng has been performed following the chain-terminatlon 
DNA protocol described by Sanger (18). 
X-ray treatment of FLC. The exper1ments on X-ray-induced 
effects on survival and mutation 1ndex have been carr1ed out 
using the microtiter plate test method (19). 105 cells/ml 
were irradiated as described below and a su1table FLC 
dilution was 1mmed1ately plated for testing cell survival. 
The rema1ning cell suspension was subcultured every 48 hrs 
for 8 days. After 10 days of incubat1on, FLC were counted and 
the correspond1ng survival was calculated. FLC samples 
showing a surviving fract1on of 0.5 were used for the in vivo 
experiments. The cells were suspended in med1um at the 
concentration of 2x1os cells/ml and 0.2 ml were injected 1.v. 
in DBA/2 mice. The irradiation was performed by means of an 
X-ray apparatus operating at 200 KV 15 mA, with a 0.2 mm 
copper filter with a dose-rate of 1.2 Gy/min. The dose was 
delivered as single or fractionated, w1th different times (1 
to 3 hours) between the two doses. 
RESULTS and DISCUSSION 
We selected three dlfferent model systems to 1nvestigate 
at molecular level the mechanisms of proto-oncogenes 
activations and their roles in the onset and development of 
neoplas1as and dur1ng turner progression: a) X-ray-induced 
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lymphomas in (C57 81/Cne x C3H/Cne) F1 hybrid m1ce (6); b) 
Spontaneous mouse reticulum cell sarcomas (RCS) (4,5); c) Non 
metastatic and h1ghly metastatic Friend Leukemia cells (FLC) 
(7-10). 
1) Studies on x-rays-induced lymphomas (C57 81/Cne x C3H/Cnel 
F1 hybrid mice have been irrad1ated with 6 Gy of x-rays, 
according to Covelli et al (6). DNAs from the physically 
1nduced lymphomas have been isolated and utilized to 
transform NIH/3T3 mouse cells in transfection experiments. 13 
lymphomas have been tested and none of them has been scored 
positive for foci formation. These results ind1cate that no 
oncogenes, (at least detectable by means·of our experimental 
approaches) were activated in these lymphomas. 
2) Studies on spontaneous RCS in SJL/J mice. High molecular 
DNA was extracted from three transplantable cell lines 
established from spontaneous RCS of SJL/J mice. Such DNA was 
tested in transfection experiments. Round foci with an 
distinguishable morphology could be scored after 20 days in 
NIH/3T3 transfected cells. Several foci were selected and the 
established clones were further characterized (20). Filtered 
culture media from different clones of NIH-3T3 cells, 
transformed by the RCS tumor DNAs, have been tested 1n 
infection assays on normal NIH-3T3 cells. In these 
experiments, multiple foci of transformed cells were found. 
These foci showed the same growth character1stics as those 
obtained in the transfection experiments. These results 
demonstrated that the transforming activity of the ~CS tumor 
DNAs was associated w1th the presence of a transforming virus. 
DNAs from selected clones of NIH-3T3 transformed by the 
RCS virus were digested with several restriction enzymes and 
analyzed on agarose gels along with normal NIH-3T3 DNA. In 
the DNA extracted from the NIH-3T3 transformed clone, V2-6-1 
specific sequences were found to be present in a high copy 
number. Upon digestion of V2-6-1 DNA with Eco RI, followed by 
gel electrophoresis in buffer with ethidium bromide, a 
specific DNA band of 5.6 kb could be detected, whereas no 
band could be detected in control DNA. We postulated that 
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these genetic sequences represented the genome of RCS 
detected by the biological assays. Therefore, we cloned 
5.6 kb Eco RI fragment. Then we have performed the 
v1rus 
the 
DNA 
sequencing of the cloned virus by the chain-termination DNA 
protocol described by Sanger (18). These experiments showed 
that the cloned virus was h1ghly homologous to the mouse 
Polyoma viruse DNA (unpublished results). 
3) Studies on metastat1c and non metastatic FLC var1ants. 
Background. In previous studies we had showed that in vitro 
passaged Friend Leukem1a cells (FLC) were not tumorigenic 
when first inJected i.p. or 1.v. in syngene1c DBA/2 mice (9). 
By repeated i.p. passages of FLC in DBA/2 mice we selected 
FLC variants capable of forming hemorrhagic ascites with high 
eff1c1ency and of metastasizing to the spleen and to the 
liver, when injected either i.v. or s.c. (9). The acquisition 
of the FLC metastatic phenotype paralleled the appearance of 
a particular membrane glycoprotein pattern with respect to 
the non metastat1c FLC (8). Using such well character1zed 
experimental system, it was of interest to analyze some 
poss1ble changes 1n gene express1on between the metastatic 
and non metastatic FLC and the effects, 1f any, of X-ray-
treatment on the FLC phenotype. 
3-a. Analys1s of the histocompatibility antigen expression. 
An ensemble of experimental studies 1ndicates that the 
expression of histocompatibility antigens on the tumor cell 
membrane can play important roles in controlling the 
metastatic growth of several murine tumors (21). Therefore we 
measured the levels of expression of hystocompatibility 
antigens on the cell membrane and their gene expression 1n 
non-metastatic and in h1ghly metastatic FLC. H1ghly 
metastatic in v1vo passaged FLC (either interferon-sensitive 
745 or interferon alpha/beta -resistant 3Cl-8 cells) 
expressed h1gher levels of class I H-2K and H-2D antigens on 
the1r cell membrane w1th respect to the non-metastat1c in 
vitro passaged counterparts. The increased express1on of H-2 
class I ant1gens was associated with an 1ncreased 
accumulation of H-2D and H-2K m-RNAs (22). 
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3-b. Analyses of the oncogene expression. It has been w1dely 
demonstrated that oncogene act1vation is involved 1n at least 
some human spontaneus tumors (2,3). In tumor cell systems, a 
direct correlation has been shown between transformat1on and 
enhanced oncogene expression and/or mutat1on and rearrangment 
(23-25). Moreover in the FLC system, it has been shown 
correlations between oncogene expression a~d DMSO-lnduced 
differentiation (26). In the light of all these data, it 
seemed of interest to analyze the possible ·correlations 
between the expression of some oncogenes (i.e., c-myc, H-ras 
and K-ras) and the in vitro and in vivo behaviour of FLC. 
H1gh levels of c-myc oncogene mRNA were expressed in all the 
FLC variants; no major variations in the c-myc expression 
were observed in FLC cultivated in medium supplemented w1th 
different FCS concentrations and/or seeded at various cell 
densities. In addition, no changes in the express1on of H-ras 
or K-ras were observed between ~he different FLC types. We 
conclude, therefore, that other cellular genes, different 
from e-ras and c-myc, may be involved in the clear-cut 
differences in the FLC tumorigenic behav1our. 
3-c. Effects of x-ray treatment on the FLC phenotype. The aim 
of this study was to investigate the effects of x-ray 
sublethal doses on the FLC phenotype. For this purpose both 
highly metastatic and non-metastatic FLC variants have been 
employed. The. cells were grown and maintained in RPMI-1640 
medium supplemented with 10% FCS. The possibility that the 
irradiation procedures could result in some changes in the 
tumorigenic FLC phenotype has been investigated according to 
the following working hypothesis: 
Metastases to the liver and/or soleen (expected results) 
FLC non irradiated FLC 
type (control) 
in vivo p, + 
in.__y_1 tro p. 
WR FLC 
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irradiated FLC 
+ 
+ 
Prelim1nary experiments have been carried out 1n order to 
f1nd out the doses capable of determin1ng 50% survival w1th 
all clones, as described 1n the Mater1als and Methods. FLC 
samples, treated w1th 3 hour time 1nterval between the two 
semi-doses, were inJected 1.v. 1n DBA/2 mice (106 
cells/mouse). For the exper1ments concern1ng the 1n vivo 
passaged 3Cl-8 FLC, the m1ce were 1njected with the following 
cell samples: 1) non-irradlated FLC; 2) FLC 1rradiated w1th 
a 2.4 Gy single dose; 3) FLC irradiated w1th 1.2 + 1.2 Gy 
fract1onated dose. The m1ce were kept under control for 
surv1val and the dead mice were examined for metastases: no 
significative change in the tumorigenic behaviour between 
1rradiated and non irrad1ated FLC was detected. 
Similarly, in vitro passaged FLC were irrad1ated w1th a 
single dose (1.8 Gy), or w1th a fractionated protocol (0.9 + 
0.9 Gy) and subsequently inJected, as in the prev1ous 
experiment. 12 days after 1nject1on, three m1ce from each 
group were sacrif1ced and the liver and the spleen removed. 
The FLC recovered from these organs were cultured in vitro, 
cloned and tested for their growth capacity in agar (9). 
Other m1ce were observed for survival. The results d1d not 
show any significant change 1n the in vivo and 1n vitro 
behav1our of the treated cells vs untreated control FLC. 
Another set of exper1ments was performed with the 
WGA-res1stant non-metastatic FLC; 106 un1rrad1ated cells, or 
FLC irradiated with either a s1ngle 1.8 Gy dose or a 
fractioned 0.9 + 0.9 Gy dose were injected as previously 
described. 14 days after inject1on, 3 mice from each group 
were sacrificed and liver and spleen were removed. Neither 
liver nor spleen metastases were observed by gross 
examination. Cells obtained from these organs have been 
seeded 1n culture to detect the possible presence of small 
numbers of FLC. No FLC were recovered from the liver, whereas 
some FLC were detected from the spleen. These FLC have been 
grown 1n vitro and tested for WGA resistance, accord1ng to 
the procedure described elsewhere (8). The FLC 1solated from 
the spleen of the treated mice maintained the WGA-resistant 
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phenotype. These clones were then injected 1.v. into DBA/2 
mice; no s1gnif1cant differences in the surv1val time have 
been detected as compared to m1ce injected w1th unirrad1ated 
3Cl-8 WR FLC. 
Effect of X-ray radiation on the tumorigenity_ of WR __ FLC 
Treatment 
none 
acute dose 
fract.jose 
WGA 
phenotype 
res1 sta:1t 
resistant 
resistant 
Mean day of 
death 
35 
36 
37 
% of r-,1ce with 
FL...; recovered 
from the spleer> 
33% 
100% 
100% 
FLC derived from the spleen of mice 1njected w1th irradiated 
WR FLC were subsequently injected i .v. in DBA./2 mice, in 
order to check whether these FLC had acquired a more potent 
tumorigenic potential as compared to the control WR FLC. 
However, no s1gn1f1cant change 1n the tumorigenic tehav1our 
has been detected between the different WR FLC types (data 
not shown). Altogether these data demostrated that the in 
YJtro treatment of FLC W'th x-ray sublethal doses does not 
result 1n any clear-cut alteration of the 
phenotype of tumor cells in the FLC system. 
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I. Objectives of the project: 
RBE -values of electrons of defimte energies will be determined for cell transformation 
usmg the Immortalized mouse embryo fibroblast cell line C3H10T1/2. Monoenergetic 
electrons are produced within cells by 1rradiat1on with characteristic ultrasoft X-rays 
which are generated by bombarding su1table targets with accelerjlted protons. The 
radiat1ons used are 60co gamma-rays as reference radiation and AIK _<1.5 keVl 
and CK (0.278 keVl charactenst1c X-rays. 
11. Objec:tifts for the reporting period: 
Determination of the transformation frequency in C3H10T1/2 cells for 60co gamma-
rays as refenence radiation. 
Determination of the OER-value for transformation of C3H10T1/2 cells. 
Evaluation of the DNA lesion(sl 1nvolved 1n rad1ation-mduced cell transformation by 
comparing RBE- and OER-values for DNA les1ons and cell transformation. 
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Ill. Progress achieved: 
Introduction 
CytogenetiC and epidemiological stud1es suggest that DNA rearrangements are the 
mam cause for cancer mduct1on (1,2,3,4). Ev1dence derived from several sources 
1mphcates the DNA double-strand break !058) in DNA rearrangements (5,6,71. 
The companson of RBE- and OER-values for both the different radiation-induced 
DNA les1ons and cell transformation is a useful tool to elucidate the role of pr1mary 
DNA leslon(s) m cell transformation. RBE-values of densely 1omzing rad1ations for 
cell transformation have been determined by several authors. RBE-values of alpha 
particles are in the range of about 3 Ch1gh doses) up to about 12 (low doses) 
(8,9,10,11). S1milarly, neutrons (12,13) and ions of high LET (14) exhibit RBE-values 
higher than one. RBE-values of densely ioniz1ng radiations sigmficantly higher than 
one are also observed for the induction of DSB, suggestmg that DSB m1ght be a 
critical primary DNA lesion for cell transformation. A further support of this 
hypothesis may be obtained by comparing the OER-value of low LET radiat1ons for 
cell transformation and DNA lesions. 
Whereas the OER-values for most DNA lesions are known, the data on OER-values 
for cell transformation are scarce (15). 
Materials and Methods 
The C3H10T1/2 mouse-embryo f1broblast system developed by Reznikoff et al. (16) 
was used. Cells were kmdly donated to us by Dr.L.Hieber, Wiirzburg. Cells were 
maintained 1n Eagle"s basal med1um supplemented w1th 10% heat Inactivated fetal calf 
serum (Boehringer), 50 umts/ml penic1lhn and 50 t-tg,ml streptomycme. Cells of 
passage 12 were incubated in 75 cm2 flasks at 37° C in a humidified gas atmosphere 
(95% a1r, 5% C02). They were subcultered in 25 cm
2 flasks for 24 h and irradiated 
in exponential growth phase at a density of about 104 cells/cm2. After irrad1at1on 
cells were trypsimzed, pooled, and cell concentrations determined using a Coulter 
Counter. 
For exposure under anox1c conditions exponential cells were tryps1mzed and pooled 
prior to irradiation in suspension at a cell concentration of 105 to 106 cells/m! in 
glass vessels. Anoxia was achieved w1thm 5 mmutes by gassing the suspension with 
95% nitrogen ( < 10ppm o2l and 5% C02. 
Irradiations were performed with 60co gamma-rays at a dose rate of 0.7 Gy/min 
under aerobic and of 2.5 Gy/min under anoxic condition as determined with the 
Fricke dosemeter. 
For the survival assays appropriate dilutions were chosen to obtain about 80 v1able 
cells per 25 cm2 flask. After incubation for 14 days and staining with 10% giemsa, 
colonies w1th more than 50 cells were counted as surv1vors. For the transformation 
assays, about 300 viable cells were plated in 25 cm2 flasks. Cells were incubated 
for 6 weeks. After two weeks of incubation the med1um was changed every week. 
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For the determination of transformed cells, the cultures were washed with phosphate 
buffered saline, fixed with methanol and stained with lOX Giemsa. Foci of type 2 
and 3 were scored as transformed cells (16}. 
The plating efficiency of control cultures both under aerobic and anoxic irradiation 
conditions was 20 to 30 X . Control experiments showed that trypsinization 
of cells before irradiat1on has no effect on the radiation response. 
Results 
In figure 1 are shown the survival curves of C3H10T1/2 cells after y-irradiation 
under aerobic and anoxic conditions. The OER for cell inactivation is approximately 
constant in the dose range used and amounts to 2.8. 
s 
0 5 10 15 20 
D/Gy 
Fig. 1: Inactivation of C3H10T1/2 cells by 60co gamma-rays under aerob1c or 
anoxic conditions. 
In figure 2 the number of transformants per 104 survivors is plotted as a function 
of absorbed dose D. In addit1on, the mean numbt;tr of dsb per cell induced under 
aerobic and anoxic conditions is g1ven. The slopes of the three straight lines indicate 
the proportionalities to 0, 0 2, and o3 of the number of transformants. For high 
doses the number of transformants is proportional to approximately 0 3 . For doses 
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smaller than 2 Gy (aerobic conditions) or 7 Gy lanox1c conditions), corresponding to 
about 80 DSB per cell, a linear relationship between the number of transformants 
and dose becomes predominant. 
At high doses, the OER is 2.9 and decreases gradually to about 1.5 in the low dose 
region. 
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Fig. 2: Transformation frequencies after irradiation with 60co gamma-rays under 
aerobic or anoxic conditions. In addit1on to absorbed dose, the abszissa 
shows the mean number of DNA double-strand breaks induced either under 
aerob1c or under anoxic conditions ln058,02 ; nDSB,N 2 J. 
Discussion 
The .nactivat1on of C3H10T1/2 cells by 60co gamma-rays under aerob1c conditions is 
in excellent agreement With that found by H1eber et al. (10). The OER-value of 2.8 
determ.ned for the inactivation of C3H10T1/2 cells lies in the range of OER-values 
observed for most mammahan cell lines. 
The transformation frequenc1es under aerob1c irradiation conditions are 1n agreement 
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with the data obtained by Hall and Hei (9) and Hieber. et al. (10) at high dos" 
(5 Gy and 7 Gyl. However, at low doses (1 Gy and 3 Gyl our data show signifi-. 
cant discrepancies compared to the data of Hall and Hei (9) and Hieber et al. (10). 
This might be partially due to insufficient statistics of the experimental data. The 
OER-value for transformation of C3H10T1/2 cells is dose-dependent; at high doses 
( D> 5 Gy, aerobic condition) the OER is 2.9 and decreases gradually to about 1.5 
for doses smaller than 2 Gy (aerobic conditions). These results are in contrast to 
those reported by Borsa et al. (15) who found a dose-modifying OER-value of 3.0 
for the same cells irradiated in exponential growth phase with 250 kV X-rays. 
However, they found transformation frequencies which are by a factor of at least 
15 higher than those observed by Hall and Hei (9), Hieber et al. (10) and in this 
paper. 
Table 1: 
Comparison of RBE- and OER-values for transformation of C3H10T1/2 cells and 
for the different DNA lesions. 
Endpoint RBE of densely OER of sparsely 
ionizing r!~iations ionizing radiations 
Cell transformation ) 1 1.5 Uow dose reg1onl 
2.9 (high dose region) 
Single-strand breaks < 1 3 
Base damage < 1 
DNA-protem 
crosshnks 
Bulky lesions 
Induced 
double-strand breaks > 1 3 
Unrejoined or m1s-
reJoined double-strand >' 1.3 
breaks (yeast) 
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For the assessment of the critical DNA lesion(s) leading to rad1at1on-induced cellular 
transformation, the comparison of RBE- and OER-values for both endpoints may be 
useful. Table 1 shows that on the basis of their RBE- and OER-values, single-strand 
breaks, base damage and DNA~protein crosslinks are unlikely to play an Important 
role 10 cell transformation. RBE- and OER-values of bulky lesions (accumulation of 
base damage at the nm-scale} have not yet been determined. However, 1t is unlikely 
that the RBE of these lesions increases with LET, since high LET radiations produce 
such high yields of DNA radicals in a nm-scale that a DSB rather than a bulky 
lesion may be produced. 
The measurements of DSB were performed using the eukaryotic, unicellular yeast 
cell. The reason for this was that unrejoined or misrejoined DSB cannot yet be 
measured in mammalian cells at doses lower than 10 Gy (equivalent to about 400 
initial DSB/cell). Figure 3 shows the non-linear relationship between unrejomed or 
0 
0 
0 
110 
39 
1000 
220 
78 
2000 
330 nDSB,a2 
117 nt:SB,N2 
JXXJ 0/Gy 
Fig. 3: The mean number N of imt1al and unreJomed or m1srejomed DNA double-
strand breaks in yeast per relative molecular mass m , N m -l, as a function 
r r 
of absorbed dose D. The Irradiations were performed under aerobic or anox1c 
conditions. The hnes represent the best fits to the expenmental data as ob-
tained by regress1on analyses. 
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m1srejo.ned DSB and dose as well as the linear relationship between mitial DSB and 
dose after irradiation under aerobic and anoxic conditions. The OER is 2.8 for initial 
DSB. This result is in agreement with those obtained in mammalian cells (17,18,19). 
In contrast, a low OER of 1.3 for unrejoined or misrejoined DSB was found. 
DSB are the only DNA lesions exhibiting similar RBE and OER-dependencies (table 1) 
as cellular transformation. At high doses the OER of 2.9 observed for cell trans-
formation is comparable to the OER of 2.8 for induced DSB. At low doses the OER 
is 1.5 for cell transformation which may be related to the OER of 1.3 observed for 
unrejoined or misrejoined DSB. 
In conclusion, the comparison between RBE -values of densely ionizing radiations and 
of OER-values of sparsely ionizing radiations for the different DNA lesions and 
for cell transformation supports strongly the involvement of DSB in cell transformation. 
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I. Objectives of the project: 
To examine in rodents the behaviour of actinides that could be inhaled 
by humans as a result of occupational exposure or after their release into 
the environment. To undertake studies designed to understand the 
mechanisms involved in the translocation and clearance of radionuclides 
from the various regions of the respiratory system. To provide an 
experimental basis for assessing intakes of the actinides. To optimise 
treatment regimes for enhancing the removal of the actinides from the body 
after accidental intake. 
11. Objectives for the reporting period: 
1. To study the biokinetics of plutonium (Pu), amenc1um (Am) and 
associated radionuclides in rodents after the alveolar deposition of 
residues formed at nuclear facilities. 
2. To examine the biokinetics of uranium compounds formed in the 
fabrication of nuclear fuels. 
3. To investigate the efficacy of DTPA, LICAM(C) and other chelating 
agents on the decorporation of actinides present in different chemical 
forms. 
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Ill. Progress achieved: 
Inhalation facility 
For administering aerosols of high toxicity eg. alpha emitters to 
small laboratory animals, a new inhalation facility has been built and 
commissioned. It comprises a suite of interconnecting gloveboxes which 
accommodates all the operations involved in an inhalation exposure. The 
exposure chamber has been designed to accept animal holding tubes of 
various sizes so that any combination of 36 animals ranging in size from 
mice to guinea pigs can be exposed sirultaneously. In practice the main 
experimental animal is the rat and two of the exposure chambers are often 
connected in parallel. The operating characteristics of the exposure 
system were measured with monodisperse polystyrene and fused clay particles 
labelled with 99 mTc and 111 In respectively. For particles with a mass 
median diameter (MMD) of 1.6 pm (ag 1.14), the coefficient of variation in 
the aerosol concentration at the exposure points was 10% with no positional 
bias. With larger particles (3.3 pm, ag 1.09) the coefficient of variation 
was 5%. Typically the initial lung deposit in rats exposed to the aerosols 
was 0.05% to 0.07% of the amount dispensed into the aerosol generator and 
for monodisperse particles with an MMD of 2 pm, the coefficient of 
variation between the animals was about 20%. 
The new inhalation facility has been extensively used in the NRPB's 
expanding research programme on the biokinetics of actinide bearing dusts 
and the testing of chelating agents designed to enhance the elimination of 
transportable forms of actinides from the body. After the inhalation of 
plutonium dioxide, either alone or in combination with other metal oxides, 
other plutonium bearing residues and uranium oxides (MMD 1-2 pm), the 
coefficient of variation was in the range 10% to 22%. Lower values, about 
8% were observed for plutonium nitrate vapour. 
When information is required on the relationship between the systemic 
content of the actinides and their cumulative urinary excretion, or when 
insufficient material is available for inhalation experiments, the actinide 
bearing dusts are administered by intratracheal instillation. 
Inhalation studies 
Much of the published work on the biokinetics of the actinides after 
inhalation has involved studies with pure compounds eg. nitrates and 
oxides, often produced under laboratory conditions. Work conducted at the 
NRPB has demonstrated that it is not possible to use these data to assess 
the biokinetics of actinides present in complex mixtures of industrial 
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dusts. In the past five years studies have been undertaken with plutonium 
dioxide, either alone or in the presence of other oxides; residues formed 
in process lines or during the electrorefining of plutonium metal; actinide 
bearing dusts associated with the pond storage of spent nuclear fuel; dusts 
obtained from former nuclear weapons test sites and uranium compounds which 
are important intermediates in the nuclear fuel production cycle in the UK. 
The aims of this work were to provide an experimental basis for 
recommending site specific Annual Limits on Intake (ALis) and guidance for 
the interpretation of chest monitoring and urine analysis data. The 
biokinetics of the actinides in humans were predicted by combining the 
transfer rates to blood calculated from the animal experiments with 
mechanical clearance data obtained from human volunteers who had inhaled 
fused clay particles labelled with 8 5 Sr and 8 8 Y. This procedure is 
compatible with that likely to be adopted by an ICRP Task Group which is, in 
the process of developing a new dosimetric model for the respiratory tract. 
Plutonium-239 and americium-241 bearing materials 
Experimental data obtained on the biokinetics of the 2 3 9 Pu bearing 
materials in rats indicated that whilst the ALI 's ranged between those 
recommended by the International Commission on Radiological Protection 
(ICRP) for Class Wand Y compounds, the rates of transfer of 239 P!J ~ 
241 Am to blood (and hence the doses and risks to liver and skeleton) varied 
by more than two orders of magnitude (Table 1). 
In general, the transfer rates for 2 41 Am are about 50% greater than 
for 2 3 9 Pu. However, in these materials it should be stressed that 2 41 Am is 
' ' _. 
present as a daughter product of 2 41 Am and much greater discrepancies would 
be expected to occur if a mixture of both oxides were inhaled. The l~ge 
difference in the transfer rate of the actinides after the inhalation of 
the residues obtained from the electrorefining process can be attributed to 
different chemical forms of the actinides. In such residues 241 Am is known 
to be present as the chloride whilst 239 Pu can be present as finely divided 
metal or an insoluble platinum complex, the so called black salt. 
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Table 1. Transfer rates of 239 Pu and 241 Am from the lungs of rats to blood 
and the values for Class W and Y compounds derived from the ICRP model for 
man. 
Material Actinide Rates of transfer(% 01
1 ) 
0-28d 28-365d 
239Pu0 
2 Pu 0.007 0.007 
239Pu0 Pu 0.003 0.002 2 0.005 0.003 Am 
239Pu + 23su Pu 0.011 0.005 
+ Be oxides Am 0.012 0.008 
239Pu02 + BeO Pu 0.012 0.004 
Am 0.015 0.007 
Nitrate bearing Pu 0.33 0.050 
residues 
Residues from Pu 0.071 0.009 
refining process Am 1.46 0.041 
Nevada test Pu 0.31 0.13 
site material Am 0.41 0.18 
Cooling pond Pu 0.21 0.12 
residues Am 0.26 0.18 
238Pu + 241Am Pu 1.10 0.17. 
nitrates Am 1.42 0.22. 
Class w compound 1.5 0.45 
Class Y compound 0.067 0.016 
a: 28-252d 
'l'he assessment of intakes of 2 3 9 Pu from measurements of 2 41 Am in the 
chest will depend on the transportability of the actinides, the particle 
size of the aerosol, the ratio of the actinides in the aerosol, the ALI and 
the limit of detection of 241 Am. In general, the particle sizes of the 
aerosols produced at the workplace were about 5 fJID. AMAD. 'l'hus for class Y 
compounds eg. plutonium oxides and those with an appreciable class Y 
component, eg. nitrate bearing residues, the proposed ALl's are twice those 
reconunended by ICRP for aerosols of 1 fJID. AMAD. For the materials cited in 
Table 1, the predicted biokinetics of the actinides in humans suggest that 
acute intakes of the least transportable forms of 2 3 9 Pu equivalent to the 
ALI could be variously assessed by this method from several months up to a 
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few years after exposure. On the other hand intakes of 239 Pu as nitrate 
equivalent to the ALI could be ascertained for up to a few days. Aerosols 
formed in the vicinity of cooling ponds contain a mixture of actinides and 
fission products. The experimental data suggested that measurements of 
144 Ce or 13 7 cs in the body is likely to be more advantageous than those of 
2 41 Am for assessing intakes of 2 3 9 Pu. 
The animal experiments showed that, for all the dusts investigated, 
the relationship between the systemic content (predominantly the liver and 
skeleton) and the cumulative excretion of 239 Pu was similar to that 
obtained after administration of the citrate. This indicated that the 
behaviour of 239 Pu in the body after its entry into the blood was 
independent of the chemical form of intake and that the interpretation of 
urinary excretion data based on models derived from human data after 239 Pu 
citrate administration would be valid. 
The biokinetics of two of the materials cited in Table 1, namely 
239 Pu02 and the Nevada test site material, are also being investigated in 
guinea pigs over a 4 yr period. After two years, the 2 3 9 Pu to 2 41 Am ratio 
in the lungs for the first material remained essentially unchanged, whilst 
for the second, it had increased by about 1.5 fold. This study will be 
used to provide guidance on the interpretation of chest monitoring data in 
the long term. 
Uranium compounds 
Urani~ ore concentrates (UOC), trioxide (U03 ) dioxide (U02 ) and 
tetrafluoride (UF4 ) are important intermediates in the production of 
nuclear fuels~ UOC can consist of U03 or U3 08 or a mixture of both 
compounds. 
The calculated transfer rates of uranium to blood after inhalation of 
these materials are shown in Table 2. 
After the inhalation of U03 , the rates of transfer of uranium to 
blood indicate that it should be assigned to inhalation Class D and not W 
as recommended by ICRP. Intakes should be restricted on the basis of 
chemical toxicity to a maximum of 2.5 mg d- 1 and not on an annual limit of 
5 x 104 Bq (2g of natural uranium) derived from dosimetric considerations. 
After the inhalation of UF4 , the long term transfer rate of uranium 
to the blood suggests that the compound should be assigned to inhalation 
Class w for which the recommended ALI is 3 x 104 Bq. However since about 
40% of the initial lung deposit of uranium translocates to the blood by 7d 
after exposure, then a limit on intake based on chemical toxicity would 
appear to be more appropriate. 
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Table 2. Transfer rates of uranium from the lungs of rats to blood, and 
the values for Class W and Y compounds derived from the lCRP model for man. 
Material Rates of transfer (% a 
1 ) 
0-7d 7-84d 
uo3 32 2.3 
UF4 9.9 0.628 
U308 0.58 0.17 
uo2 0.25 0.061 
uob 
2 0.18 0.033 
Class W compound 4.7 0.51 
Class Y compound 0.24 0.016 
a: 7-350d b: ceramic form 
After the inhalation of U308 and U02 the transfer rates to blood lie 
between those predicted for Class W and Y compounds. The long-term 
retention half-times of uranium in human lung calculated for U3 08 , 
non-ceramic U02 and ceramic U02 using the procedure described previously 
are respectively about 230d, 430d and 520d. These values are compatible 
with those obtained from chest measurements of workers accidentally exposed 
to the same materials and lend support to the procedure used by NRPB for 
extrapolating the results of animal experiments to humans. The proposed 
ALl's for exposure to U3 08 and U02 , respectively 10
4 Bq and 5 x 103 Bq, based 
on the particle size of the aerosol at the workplace (AMAD 6 Jllll) and the 
biokinetics of the uranium are about 6 times and 3 times the values 
rec01lllllended by lCRP for a 1 Jl1ll aerosol. The predicted behaviour of U3 08 
and U02 in workers suggests that acute intakes corresponding to the ALl 
could be ascertained by chest monitoring up to more than ly after acute 
exposure and that chronic intakes equivalent to 1/365 ALl per day could be 
detected with a 6-monthly monitoring interval or less. 
Experiments have been undertaken to investigate the clearance of 
soluble forms of uranium from the three anatomical regions of the respira-
tory tract defined in the lCRP Lung Model. Small volumes, 2-3 pl, of 
uranyl nitrate and bicarbonate solutions were instilled into the nasal 
passage (N-P), trachea and bronchial tree (T-B) and pulmonary region (P) of 
the lungs of rats. The amounts of uranium which translocated to the blood 
by 10 days were, for both compounds, about 8%, 40% and 70% respectively of 
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the initial deposits. Otherwise 1110st of the uranium was excreted in the 
faeces~ only about 3%, 1% and 7% respectively was retained at the injection 
sites. The values obtained· for the translocation of uranium to blood from 
the N-P and T-B regions are at variance with those postulated for the IIIOdel 
for class D compounds, namely 50% and 95%, whilst the value postulated for 
the P region (100%) is in reasonable agreement with the experimental data. 
The results of this study suggest that for workers exposed to uranyl 
nitrate aerosols, the amounts of uranium that will translocate to the blood 
will be less than predicted by the IIIOdel, 23% v 42% for particles of AMAD 
1 Jlln· The likelihood of chemical damage to the kidneys will also be less 
than would be predicted for the IIIOdel. In some industrial situations, 
class D uranium compounds such as uranium trioxide, are likely to be 
present as a dust with an AMAD of about 5 Jlln· Under these conditions even 
less uranium would be expected to be translocated to the blood because 
deposition will occur predominantly in the N-P region. 
Thorium compounds 
Occupational exposure to thorium is becoming of increasing concern due 
to the low values recommended by ICRP for the ALI. CUrrently, experiments 
are in progress to evaluate the effect of mass on the biokinetics of 
thorium inhaled as the nitrate. When the mass concentration of thorium in 
the lungs of rats is equivalent to about twice the value calculated to be 
in human lungs after an intake of 232 Th, about 10% of the initial deposit 
transfers to blood within the first few days after exposure. Thereafter, 
the transfer rate to blood is similar to that predicted for a class Y 
compound. When the mass concentration of thorium is reduced "106 fold, the 
amount transferred to the blood increases by only about a· factor 2. Future 
work will examine the transportability of other industrial thorium 
compounds, eg. tetrafluoride, thoriated tungsten and dusts formed from 
mineral sands, and the relative biokinetic behaviour of thorium and its 
decay products since 228 Ac, 212 Pb and 208 Tl are used to assess the body 
content of 2 32 Th by whole body monitoring. 
Enhanced excretion 
In the event of accidental intakes of transportable forms of 2 3 9 Pu and 
2 41 Am by workers, the only widely accepted method of treatment is the 
administration of the chelating agent diethylenetriaminepenta-acetic acid 
(DTPA). The calcium salt is recommended for prompt treatment and the zinc 
salt for protracted treatment due to its lower toxicity. Experiments 
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conducted at NRPB are concerned mainly with intakes of plutonium in which 
the mass concentrations in the lungs of rats are equivalent to those in 
human lungs after acute exposure to about twenty times the ALI. Under 
these conditions the repeated injection of DTPA ( 30 pmol kg- 1 administered 
ip at 0.02, 0.25, 1.2 and 3d and then twice weekly from 6d to 24d) 
commencing 30 minutes after inhalation of plutonium as nitrate reduced the 
lung and total body contents by 28 days after exposure to about 1% and 2% 
respectively of those present in untreated animals. Similar results were 
obtained for americium inhaled as the nitrate. These data contrast 
strongly with those obtained in other laboratories in which DTPA had little 
effect on the decorporation of plutonium from the lungs when administered 
in concentrations equivalent to about 105 times the ALI for humans. 
Since in mammals, Pu( IV) becomes associated with the Fe( III) transport 
and storage systems future developments in decorporation are likely to 
involve the use of synthetic analogues of siderophores; the latter are 
sequestering agents produced by micro-organisms in order to obtain Fe(III) 
from their enviroment. one such compound, a linear catechoyl amide code 
named LICAM(C), was reported in the literature as being at least as 
effective as DTPA for removing 2 3 8 Pu from animals after the intravenous 
injection as the citrate. This observation was subsequently confirmed in 
European laboratories which collaborated under the auspices of the European 
Late Effects Project (EULEP). However a likely route of accidental intake 
of the actinides under industrial conditions is by inhalation. Experiments 
conducted at NRPB showed that LICAM(C) was found to be substantially 
inferior to DTPA when administered after the inhalation of plutonium 
nitrate irrespective of whether it was administered as a polymeric, 
esterified or pure form. Using the same treatment regimen as above, pure 
LICAM(C) reduced the 238 Pu content of the lungs and total body by 28d to 
61% and 58% of those in untreated animals. The other preparations of LICAM 
were even less effective. 
The efficacy of two of the most promising synthetic analogues of 
siderophores, namely a hydroxypyridonate derivative of desferrioxamine 
(DFO-HOPO) and a dihydroxamic acid derivative of DTPA (ZnNa-DTPA-DX), have 
also been compared with DTPA. In these studies, CaNa3 DTPA was used for the 
initial injection and ZnNa3 DTPA at all other times. After intravenous 
injection of 238 Pu as citrate and the repeated intraperitoneal injection of 
the compounds (30 pmol kg- 1 body wt at 0.02, 0.25, 1, 2 and 3d), the body 
contents of 238 Pu by 7d after exposure were reduced to respectively 8%, 29% 
and 15% of those in untreated animals. When the compounds were 
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administered at 0.02d only, the body contents were all about 50% greater 
than with repeated treatment. After the inhalation of 2 3 8 Pu as nitrate, 
the body contents of 238 Pu were reduced to 31%, 15% and 10% respectively of 
control values after repeated treatment when using the protocol above. As 
expected, DFO-HOPO was ineffective for enhancing the elimination of 241 Am 
after both methods of administration. However, after inhalation of 2 41 Am 
as nitrate, ZnNa-DTP~DX was as effective as DTPA, the body content by 7d 
with repeated treatment being about 7% of control values. The reSults of 
these studies confirm the potential usefulness of synthetic analogues of 
siderophores for treatment of overexposure to the actinides. However at 
present, DTPA remains the chelating agent of choice. 
The inhalation of thorium nitrate under industrial conditions is 
becoming of increasing concern due to the low values recommended for the 
Annual Limit on Intake (ALI) by ICRP. Yet, there is a paucity of data on 
the efficacy of treatment after this mode of intake. The efficacy of 
caDTPA and ZnDTPA, the compounds of choice for other actinide elements, 
have been evaluated after the pulmonary deposition of thorium in widely 
different amounts. In the first experiment, the amount of thorium 
deposited (6.5 pg as 230 + 232 Th) was-similar to the mass concentration 
calculated to be in human lungs after acute exposure to twice the ALI for 
232 Th. The prompt (300 or 1000 pmol kg- 1 body wt at 0.02d) or repeated (30 
or 300 pmol kg- 1 at 0.02, 0.25, 1, 2, 3d) administration of CaDTPA were at 
best only moderately successful for enhancing the elimination of thorium by 
7d after exposure. The body contents of 230 + 232 Th at this time were 
respectively about 74%, 65%, 90% and 74% of those present in untreated 
animals. Under similar conditions of treatment ZnDTPA was less effective 
than caDTPA. In the second experiment, thorium was administered as a 
carrier free form, 234 Th. However the substantial reduction in mass, about 
107 fold, did not appreciably increase the efficacy of treatment. After 
the repeated administration of CaDTPA at doses of 30 and 300 pmol kg- 1 
using the protocol above, the body contents of 2 34 Th by 7d were 
respectively 69% and 51% of those in untreated animals. ZnDTPA was again 
less effective than CaDTPA. 
These results differ markedly from those achieved for 238 Pu in which 
the body content was reduced to 10% of control values with caDTPA by 7d 
with repeated doses of 30 pmol kg- 1 • The development of more effective 
chelating agents for the decorporation of thorium are considered to be an 
important consideration for radiological protection of workers. 
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There appears to be no effective treatment for substantially enhancing 
the elimination of soluble uranium compounds from the body. Recently, it 
has been suggested that the administration of the sodium salt of 4,5-
dihydroxy-1,3 benzene-disulphonic acid (Tiron) could be used as an antidote 
for uranium poisoning. We have investigated the efficacy of this substance 
(30, 300 or 1000 pmol kg- 1 injected intraperitoneally at 20, 60 and 180 
min) after the intratracheal instillation of uranyl nitrate in amounts 
which correspond to about 20 times the permissible daily intake of uranium 
by workers (2.5 mg). The body contents of uranium by 5d after exposure 
were respectively 107 ± 6, 78 ± 4 and 65 ± 5% of those in untreated 
animals. These results indicate that the development of more effective 
chelating agents is an important consideration for workers potentially 
exposed to transportable uranium compounds. 
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I. Objectives of the project: 
To improve our understanding of the behaviour of bone-seeking 
radionuclides in the skeleton. 
To provide information that can be used to improve assessments of 
doses to radiation sensitive cells in the skeleton following intakes of 
bone-seeking radionuclides. 
11. Objectives for the reporting period: 
To continue with studies of the distribution of 239 Pu, 241 Am and 233 U 
in mice, their retention in individual bones of the skeleton, and micro-
distribution within bone. To continue with studies of the induction of 
osteosarcoma by these radionuclides. 
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Ill. Progress achieved: 
Studies have been undertaken of the skeletal uptake and distribution 
within bone of raditun, thoritun, uranitun, plutonitun and americitun, mainly in 
rodents. The results have shown that while each element is initially 
deposited on bone surfaces, they differ considerably in their distribution 
on different bone surfaces and may therefore deliver substantially 
different doses to sensitive cells on bone surfaces and in the marrow. For 
plutonitun, comparisons have been made between rats, mice and baboons, 
indicating that the behaviour of the actinide in rodent bone can be used to 
predict behaviour in primate bone. The distribution of raditun in bone was 
studied using pigs because of the close similarity between pigs and htunans 
in alkaline earth metabolism. The results confirmed the initial deposition 
of raditun on bone surfaces rather than throughout wne mineral. A r}udy is 
currently in progress to compare the toxicity of 2 Pu, 2 41 Am and 2 u in 
mice. The objective is to relate the differences in the distribution of 
dose within the skeleton, and the extent of irradiation of different cell 
types, with the observed incidence and distribution of osteosarcoma. A low 
incidence of leukaemias is also expected. 
The initial gross distribution of the actinides and raditun between 
individual bones of the skeleton has been measured at one day after 
admdnistration in young adult rats. The skeletons were stripped of their 
surrounding soft tissues by Dermestid beetles (Dermestes maculatus). They 
were then disarticulated and analysed for their radionuclide content. The 
relative concentration (RC) in individual bone was calculated as: 
RC = % initial activity in bone per g ash weight 
% initial activity in skeleton per g skeleton ash weight 
In general, each element deposited preferentially in the main body of 
the spine, limb girdles and ribs, with lowest RC values for the paw bones, 
head bones and caudal vertebrae. This is consistent with published 
information and is considered to reflect differences in the blood supply to 
different parts of the skeleton. In addition, in the case of the head 
bones, low RC values for each element may be attributed, at least in part, 
to the presence of teeth which add greatly to ash weight but little to bone 
mineral surface to which the elements bind. 
The variations between bones in the radionuclide concentrations was 
greatest for plutonitun. For example, the concentration of plutonitun in the 
lumbar and sacral vertebrae (RC of 2) was about six times greater than in 
the paw bones and mandibles (RC of 0.3). In contrast, the degree of 
variability exhibited by raditun, uranium and americium was much lower; the 
maximum variation being about a factor of two from an RC of 1.4 to 0.6. 
Thoritun gave intermediate results. 
Previous studies of the initial distribution of 239 Pu in rat bone have 
demonstrated the predominant deposition of this element on endosteal bone 
surfaces. Little plutonium was deposited on periosteal surfaces and on the 
surfaces of the cortical vascular canals or on the walls of the vascular 
cavities adjacent to the epiphyseal plate cartilages. The surfaces of the 
trabeculae which form a band across the deeper regions of the primary 
spongiosa of the metaphysis also concentrate little plutonitun. In 
contrast, the surfaces of other bone trabeculae and of the calcified 
cartilage remnants immediatel¥ underlying the epiphyseal plate cartilage 
were heavily labelled with 23 Pu. Thoritun, which is chemically similar to 
plutonium in the stability of the tetravalent form, has been shown to have 
a very similar distribution. 
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Baboon bones containing either 2 3 9 Pu or 2 41 Am have been analysed as 
part of a collaborative study with the CEA, Bruyeres-le-Chatel, France. 
The autoradiographs obtained show that the actinides become deposited with 
a similar pattern to that observed in rodents. This confirms the general 
validity of experiments using rodents for examining the factors influencing 
the deposition of radionuclides in the skeleton. However, while plutonium 
in rat bone appears to be uniformly deposited on growing, resting and 
resorbing surfaces, enhanced levels of plutonium deposition in regions of 
bone resorption were observed in baboon bones. The reason for this 
difference is unknown. It is considered, however, that since resorption 
sites are relatively rare in adult human bone, the pattern of distribution 
in humans is likely to be characterised by even endosteal deposition as in 
rats. 
Both plutonium and americium, initially deposited on bone surfaces, 
showed evidence of subsequent redistribution by bone growth and turnover. 
There was a tendency for surface deposited radionuclides to become 
relocated to foDn a more unifoDn volume deposit throughout the mineralised 
bone matrix. However, in the vertebrae, bone turnover seemed to be greater 
in the peripheral regions of the bone. Consequently, deposits of plutonium 
on more central bone surfaces persisted longer and this observation may go 
some way towards explaining why the spinal column is a preferred site for 
bone cancer induction. At all skeletal sites, some of the plutonium 
removed from bone surfaces by bone resorbing cells was found to be present 
in bone marrow macrophages. More plutonium was found in the macrophages of 
young animals than in those of adults which may be related to their higher 
rate of bone turnover. 
Data obtained on the distribution and retention of plutonium in the 
baboon and rodent skeleton have been used in conjunction with physiological 
data on the human skeleton to construct an age-dependent dosimetric ~el 
and make estimates of doses to rrnsitive cells in the human skeleton' ) • 
Calculations of the doses from 9 Pu to the red bone marrow and cells on 
bone surfaces using this model suggest that the current ICRP Publication 30 
model gives a reasonable estimate of the doses at all ages, provided growth 
of the skeleton is taken into account. For 239 Pu reaching the bloodstream, 
the calculated integrated dose to the bone marrow to age 70 years, derived 
using the age-dependent model, varied from 40 to 110 Gy Bq- 1 whereas the 
ICRP model gave values in the range 100-120 Gy. The corresponding values 
for the integrated dose to cells on bone surfaces were also lower than 
those calculated using the ICRP model but differed by less than a factor of 
three. 
For adult man, the dosimetric model predicts that the fraction of a 
plutonium intake that transfers to marrow macrophages increases gradually 
to reach about 2 - 3% of the total body content after about five years 
after the intake. Thereafter, the model predicts that the level of 
plutonium in the bone marrow will fall to about 1% after 50 years. Of the 
total marrow activity, about two-thirds is predicted to be present in 
haemopoietic marrow rather than fatty marrow. These predictions are 
consistent with limited available data from measurements on ex-radiation 
workers. 
The distribution of radi~226 in pig bone at 4 days after 
adminirtration has been studied in collaboration with the MRC Radiobiolgy 
Unit11 • This period was chosen because of the uncertainties which exist 
concerning the distribution of radi~224 (half-life 3.64 days). ICRP 
assume that 224 Ra is deposited on bone surfaces while it has also been 
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suggested that it should be regarded as entirely or partially distributed 
throughout bone mineral. This distinction is }~rtant because extensive 
toxicity data are available for the effect of 2 Ra in man and its correct 
interpretation requires a precise knowledge of its distribution relative to 
sensitive cells. Autoradiographs of pig bone showed that the majority of 
the arHvity was present on bone surfaces. All bone surface were labelled 
with Ra including the endosteal and periosteal surfaces and the surfaces 
of the vascular canals within the cortical bone. Further studies using 
tetracycline as a marker for bone growth also showed that growing bone 
surfaces concentrated more radium. than resting and resorbing surfaces. The 
thickness of the bone surface deposits of radium were measured in 
collaboration with the u.s. Argonne National Laboratory. The results 
showed that radium was present as a very thin deposit on many bone surfaces 
but with some burial at other sites. This observation was taken to suggest 
that radium deposits as a thin layer on quiescent bone surfaces and as a 
broader layer on growing bone surfaces. 
The avail~le data on the relative toxicity in rodents of the long-
lived isotope 26 Ra and the short-lived 24 Ra indicate that the latter is 
about six times more effective in causing osteosarcoma. This difference in 
toxicity has been attributed to differences in the distribution ?f these 
isotopes. It has been suggested that 2 2 4 Ra is more toxic than 2 Ra 
because it decays on bone surfaces rather than within the volume of the 
bone mineral. However, in rodents many bone structures are small compared 
with the track length of the « particles and this explanation may be 
inadequate to expla-in the magnitude of the observed effect. Consequently, 
Monte carlo calculations have been ~de to test the validity of the 
distribution-difference hypothesis< 2 • The results indicate that, for bone 
structures the size of those in mice, less than half of the observed 
difference in toxicity can be explained by consideration of the 
distribution of these radionuclides with respect to bone surfaces. 
Instead, it is suggested that the greater irradiation of trabecular than of 
cortical bone that is a characteristic of 224 Ra is responsible for its 
enhanced toxicity. 
The study of the comparative toxicity of 239 Pu, 241 Am and 233 U in mice 
can be considered as consisting of four parts: radiochemical measurements 
of the distribution of the nuclides between the skeleton and soft tissues 
at times up to 448 days after intraperitoneal injection as their citrate 
complexes; radiochemical measurements of the retention of the nuclides in 
individual bones of the skeleton over the same period; autoradiographic 
studies of the distribution of the nuclides within bone; and comparisons of 
osteo~rc~ inducti?n in groups of mice given intraperitoneal injections 
of 23 Pu, 2 1 Am and 33 u activity to deliver equivalent average skeletal 
doses. The first part of the study is complete; the other three parts are 
continuing (Contract support extended). 
The measurements of the tissue retention of 239 Pu, 241 Am and 233 u up 
to 448 days after a single intraperitoneal injection of 40kBq of each 
nuclide showed the expected rapid excretion of uranium compared with that 
of plutonium and americium. Thus1 whole-body retfntion after one rrek was 
68% of the injected activity for 39 Pu, 62% for 2 1 Am and 7% for 2 u. By 
the end of the 448 days of the study, whole-body retention had fallen to 
20%, 21% and 2.5%, respectively, of the injected activity. At this time, 
the proportion retained in the skeleton accounted for 86%, 94% and 99% of 
the total whole-body activity, respectively. Similar results were obtained 
for male and female mice. The greatest skeletal accumulation occurred at 
28 days after injection of Pu and Am and 7 days after injection of u. The 
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results obtained were used to calculate average bone doses over the 448 day 
period. The vflues obtained were 0.52 Gy for 239 Pu, 0.45 Gy for 241 Am and 
0.10 Gy for 23 U. These dose estimates were used to determine the 
administered amounts for the main toxicity study as outlined below14 l 
Measurements are in progress to determine the retention of 239 Pu, 241 Am and 233 U in the individual bones of the mouse skeleton with time 
after injection. The results for 239 Pu are complete and show that, as 
observed previously for rats, the greatest concentrations were generally in 
the main body of the spine, limb girdles and ribs, and lowest concen-
trations in paw bones and caudal vertebrae. Thus, the RC values obtained 
one day after administration were 2.0, 2.2 and 2.0 for the thoracic 
vertebrae, lumbar vertebrae and sternum, respectively, and 0.46 and 0.31 
for the caudal vertebrae and paws, respectively. There was a trend towards 
a more homogenous concentration distribution with time. 
Studies of the distribution of 239 Pu, 241 Am and 233 u within mouse bone 
at different times after injection have been carried out by CR39 auto-
radiography of femora and lumbar vertebrae. These studies have shown that 
Pu is predominantly deposited on endosteal bone surfaces. During 
remodelling and redistribution, some burial of Pu occurs at the epiphyseal 
plates and in cortical bone, but activity appears to remain largely on 
endosteal surfaces. With time, increasing amounts accumulate in the 
macrophages of the bone marrow. Americium deposits evenly on all bone 
surfaces and also on the internal bone surfaces of vascular canals in the 
cortical bone. With time, some burial can be seen at the growth plate and 
small amounts of activity are accumulated in the marrow macrophages. 
Uranium deposits on endosteal and periosteal surfaces but distribution is 
uneven with concentrations of activity in some areas. Small amounts of 
diffuse activity are seen throughout the bone marrow and bone mineral. 
Fission track autoradiogr~phs of femora have also been prepared for 
sections containing 2 3 9 Pu and 3 U. These have the advantage of having a 
bone image and will be used to make quantitative estimates of the 
distribution of activity on different bone surfaces, in ~ne volume and in 
the marrow. Similar measurements of the distribution of 41 Am will be made 
by superimposing CR39 autoradiographs and bone images produced by neutron 
bombardment. Photographic emulsion autoradiographs of mandibular condyle 
and rib are also being prepared for each nuclide to facilitate the 
identification of differences between the elements in their distribution on 
growing, resting and resorbing surfaces and their proximity to different 
cell types. 
To compare osteosarcoma induction by 239 Pu, 241 Am and 233 u, each 
nuclide has been administered to thrre groups of 50 - 100 animals at 
different levels of activity. For 2 9 Pu, the three groups were given 5, 15 
and 25 kBq kg- 1 • The corresponding amounts of 241 Am to give e~ivalent 
average skeletal doses were 5.8, 17.2 and 28.9 kBq kg-1 and of 33 U were 
39.5, 117.6 and 197.3 kBq kg-1. In each case the nuclides were adminis-
tered by intraperitoneal injection as the citrate complexes in nine equal 
aliquots over a three week period. Control animals (100) were given 
injections of inactive solution. The average skeletal doses to 600 days in 
the low, medium and high groups are estimated as 0.13 Gy, 0.37 Gy and 0.63 
Gy, respectively. The expected osteosarcoma incidences for 239 Pu are 7.5%, 
25% and 40% in the three groups. The available published information on 241 Am suggests that the incidence may be about a factor of three lower than 
for 239 f¥l there are no data available to allow the prediction of incidence 
in the 2 u groups. 
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All mice in the osteosarcoma study are examined daily. Moribund 
animals and those with developed tumours or paralysis are killed. All 
animals are being x-rayed at death to determine the presence of osteo-
sarcomas. Tumour classification is being carried 9¥t by histological 
examination. Animals in an additional high level 9 Pu group are being 
x-rayed periodically to follow tumour progression. TO date about 20% of 
the animals have died. Most of the deaths (about 80%) have been due to 
liver tumours which are endemic in ~e CBA/H strain mice. Five bone 
tumours have been observed to date( , • 
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I. Objectives of the project: 
The overall objective of the project is to improve the scientific 
basis of models used to relate intakes of radionuclides by inhalation to 
tissue doses and to environmental and bioassay measurements, by: 
(i) Measuring the rate at which discrete particles are cleared from 
different regions of the human respiratory tract: nasal passage, bronchial 
tree and pulmonary region. 
(ii) Testing the hypothesis that the rates at which discrete particles are 
cleared from the lungs to the gastro-intestinal tract are independent of 
particle composition. 
(iii) Investigating mechanisms of particle clearance from the lungs, and 
factors affecting clearance, including inter-species differences. 
11. Objectives for the reporting period: 
Development of techniques for studying particle clearance from the 
human respiratory tract, especially the nasal passage, and commencement of 
the experiments. Study of the biokinetics in man of intravenously 
administered yttrium-88. 
Investigation in rodents of factors affecting mechanical transport 
rates from the alveolar region: alpha-irradiation, broncho-alveolar lavage, 
exercise, gender, age, route of administration, and particle composition. 
Investigation of lobar distribution of particles. 
Development of models to describe mechanical transport of particles 
from the respiratory tract of humans and laboratory animals. 
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Ill. Progress achieved: 
1. Methodology 
The general approach used was to administer by inhalation, inert, 
monodisperse, radiolabelled particles. Respiratory tract retention and 
clearance were followed by external gamma-ray counting and excretion 
measurements, complimented in animal studies by serial sacrifices to 
determine tissue distribution. To obtain clearance rates due to mechanical 
transport of particles, correction must be made for particle dissolution, 
which may in turn require experiments to determine the biokinetics of the 
label. Considerable effort was put into developing techniques for 
producing test particles, and for administering them to human volunteers 
under controlled conditions. 
Approval was obtained for a human volunteer study to determine the 
clearance kinetics of particles deposited in the nasal passagec 21 • 
Subjects will inhale monodisperse polystyrene or fused alumdnosilicate 
particles (FAP) labelled with 97 Ru (\ 2.8 d), or: in pilot experiments, 
9 9aTc (\ 6 hours). Equipment is being set up for separating 97 Ru from 
cyclotron-irradiated molybdenum powder by steam distillation. Following 
examination of the relevant polymer chemistry, HPLC procedures were 
developed for purifying a ruthenium-binding lipophilic chelate to label 
polystyrene with 97 Ru. Techniques were developed to produce monodisperse 
polystyrene particles in the wide size-range (0.5 - 50 pm) needed for the 
nasal clearance studyc 5 ' 13 ' 191 • A commercial spinning-disc aerosol 
generator was modified to increase its maximum speed, enabling particles as 
small as 1 pm to be produced at 20% efficiency. Although particles up to 
50 pm could be produced, the technique was found to be inconvenient beyond 
15 pm, because the droplets are dispersed into a ring of -1 m diameter, 
resulting in problems of enclosure, shielding and recovery of the 
particles. A Vibrating Orifice Aerosol Generator (VOAG) was subsequently 
obtained, since the droplets emerge as a jet, and so are dispersed over a 
much smaller volume. Initial trials confirmed that the VOAG can also 
achieve greater uniformity, and higher output efficiency. 
A laser aerosol photometer/spirometer, designed specifically for 
measurements of particle deposition in the respiratory tract, was obtained 
from GSF Frankfurt. This instrument, with other components of the aerosol 
administration apparatus, is operated under computer control. Software was 
written to enable rapid, simultaneous measurements to be made of the flow 
rate and aerosol concentration in inhaled and exhaled air. A bicycle 
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ergometer was installed to permit inhalations to be carried out at 
breathing patterns determined by set rates of working. Considerable inter-
and intra-subject variation in nasal deposition and clearance is expected, 
partly due to morphological differences. Equipment to measure the cross-
sectional area of the nasal passage as a function of distance into the nose 
by deconvoluting a reflected sound pulse was obtained from Aarhus 
university. Calibration tests and pilot studies were conducted, including 
measurements on casts of human nasal passages (adult, 6-year old and 1-year 
old). A detector system was set up to enable measurements of activity in 
the head, lungs and stomach to be made during and immediately after 
administration of labelled aerosols. Detector support stands were 
constructed and five 120 x 100 mm Nai(Tl) detectors installed. A micro-
computer based multi-channel analyser (MCA) was obtained to record spectra. 
Approval was obtained to study the biokinetics of 88 Y in man< 17 ' 181 • 
88 Y (~ 107 d) is used as a label for FAP in long-term lung clearance 
studies, and the contribution to clearance made by particle dissolution is 
determined from measurements of its urinary excretion< 3 l. However, no 
information on the retention and excretion of tracer level yttrium in man 
following systemic uptake was known. 88 Y was administered by intravenous 
injection of 0.5 ml of 0.9% sodium chloride solution to which 88 Y citrate 
at pH 7 had been added. Following a pilot study in which one subject 
received 0.4 kBq, two subjects each received 4.0 kBq 88 Y. Total body and 
organ retention were measured at selected times up to one year. Quanti-
tative faecal and urinary collections were made for 5 and 14 days 
respectively for one subject and for 14 and 24 days for the second. 
Subsequently, 72-hour urine samples were obtained at approximately monthly 
intervals. For comparison, groups of 4 rats were intravenously injected 
with the same 8 8 Y solutions. 
In collaboration with Dr. Stahlhofen (GSF Frankfurt), FAP was prepared 
in which gold colloid labelled with 198Au (~ 3 days) was incorporated, to 
obtain an exceptionally inert material (Au-FAP). It was also established 
that FAP is easily labelled with 111 In (t~ 3 days), which is readily 
available and gives a lower dose per unit intake than 198 Au< 131 • Assist-
ance was provided in setting up a system at Frankfurt to generate mono-
disperse FAP. Dr. Stahlhofen's group have investigated human bronchial 
clearance by following retention of activity administered as a bolus of 
particles injected into the inspired air. When the particles were 
administered at the end of the breath, in order to deposit them primarily 
in the conducting airways, the fraction (F
5
) which was not cleared rapidly 
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by mucociliary action was surprisingly large (NSO%). Assistance was 
provided in one -study, in which 6 subjects inhaled 3 pm aerodynamic 
diameter (AD) 19 8 Au-FAP( 7 • 8 ' • One subject inhaled the particles under the 
same conditions as those under which he had previously inhaled 3 pm AD iron 
oxide particles. The others inhaled the bolus in a horizontal position, 
which was expected to result in more proximal deposition than when sitting 
upright. 
Several animal studies on factors affecting particle clearance from 
the alveolar region to the gastro-intestinal (GI) tract (begun under the 
previous contract, BID-D-489-UK) were completed. Particle retention and 
clearance were followed from 7 days to at least 6 months after in,take. 
Retention of FAP was compared with that of a mixed actinide oxide, and the 
effects of alpha-irradiation, exercise, gender and route of administration 
were studied in ratsl 10 ' 11 '. The effect of broncho-alveolar lavage (BAL) 
on alveolar retention of FAP was studied in hamsters. Alveolar particle 
clearance rates were also estimated in the studies of the lung clearance of 
cobalt oxide particles described in detail under Project 4( 6 • 9 • 14 - 16 • 20 '. 
This enabled comparisons to be made of mechanical clearance rates of 
materials with different dissolution rates, and determdnation of the effect 
of age on mechanical transport. 
A model to describe mechanical transport of particles from the human 
respiratory tract, suitable for predicting clearance kinetics and hence 
doses from inhaled radionuclides, is being developed in collaboration with 
other members of the ICRP Task Group on respiratory tract modelsl 21 '. 
Complimentary mechanical transport models for laboratory animals are being 
developed to determdne translocation rates of materials from experimental 
data. 
2. Results 
(i) Particle clearance from the human respiratory tract. 
The results of the pilot study on the biokinetics of 88 Y were consis-
tent with the more accurate results obtained using the full activity, and 
good agreement was found between the results for the two subjectsl 17 ' 18 '. 
Total body retention (R(t) at t days after injection) in both cases was 
well characterised by a two-component exponential function: 
R(t)/R(O) - 0.22 exp (-ln(2)t/0.65) + 0.78 exp (-ln(l)t/920) 
The fraction of the total 88 Y excreted which appeared in urine (Fu) during 
the fi~st .5 days was 0.94 and 0.93 for subjects A and B respectively. 
Measurements of the distribution of activity in the body were consistent. 
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with 1110st being deposited on bone surfaces. About 10% of the injected 
activity went to liver, of which half cleared rapidly (~ 25 d and 6 d in A 
and B respectively), and the rest with a half-life long compared to the 
time scale of the experiment. Results for rats were broadly similar to 
those for humans: -25% of the injected activity was excreted in urine, 
mainly on the first day, and most of the retained activity was in the 
skeleton. However, faecal excretion was higher (Fu • 0.75), and liver 
retention lower than in man. The results for humans were generally in 
agreement with the ICRP 30 IIIOdel for yttrium, which is based on animal 
data. Similarly there was no need to re-assess the contribution to 
clearance made by dissolution in the previous human lung retention study 
which used 88 Y-FAP! 3 l. 
The results of the study in which lung retention of 1 pm 85 Sr-FAP and 
4 pm 8 8 Y-FAP were followed in humans for up to a year( 3 l were, however, 
re-analysed! 12 l. Since it was considered possible that using two-component 
exponential functions to represent lung retention might have influenced the 
estimated clearance rates, in particular resulting in relatively constant 
rates beyond 150 d, polynomial functions were fitted to the original data. 
The new analysis confirmed that the clearance rate from the lungs to the GI 
tract decreases from -0.3% of the remaining lung content per day at 25 d 
after inhalation, to -o.l% per day at 150 d, but indicated that it 
continues to decrease, to 0.05% per day at 350 d. Intersubject variation 
was also characterised. At 200 d after inhalation, most of the results 
conformed to a log-normal distribution with a median of 0.08% per day, and 
geometric standard deviation of 1.6. 
In the investigation of bronchial clearance conducted in collaboration 
with Dr. Stahlhofen at Frankfurt( 7 ' 8 l it was found that for the seated 
subject the slow--clearing fraction of the lung deposit F
8
, was -so%, as 
found before with iron oxide particles, confirming that the result is 
independent of the test material. F. was even higher, about 75%, for the 
subjects who inhaled the bolus in a horizontal position. 
(ii) Animal experiments. 
Lung retention was followed for up to 640 d in rats that inhaled a 
mixed actinide oxide containing 239 Pu and/or 57 Co-FAP(lOl. Lung retention 
of 239 Pu in rats exposed at the lowest level (initial lung deposit 0.1 kBq 
a-activity) was greater than that of 57 Co, the difference being attributed 
to slower dissolution of the FAP. At the higher levels of actinide (2 and 
9 kBq), greater retention of 239 Pu occurred, and at the highest level, 
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greater retention of FAP also, these effects being attributed to impaired 
clearance resulting from e-radiation induced lung damage. Exercise 
produced no significant effect on alveolar clearance of 57 Co-FAP, nor was 
there a difference between males and femalest 111 • The clearance of intra-
tracheally instilled 57 Co-FAP was significantly faster than that of inhaled 
particles up to about 30 d after intake, but not thereaftert 111 • Broncho-
alveolar lavage (BAL) at 7, 30 or 200 d after inhalation of 57 Co-FAP by 
hamsters removed 66%, 59% and 68% of the lung content at the start of 
treatment. The fractional clearance rate of the material remaining in the 
lung after BAL was similar to that in the control animals. The results 
suggest that BAL can be an effective treatment even if delayed and that it 
does not selectively remove material which would clear relatively rapidly. 
Alveolar mechanical clearance rates, M(t), were estimated for 57 eo-
labelled cobalt oxide particles (57 Co3 04 ) in the studies described in 
Project 4. For rats and hamsters that inhaled 0.8 pm and 1. 7 pm "porous" 
57 Co3 04 , values of M(t) for the two particle sizes were similar in each 
species, even though their dissolution rates were differentt 6 • 9 • 14 • 151 • 
They were also similar to values of M(t) in rats and hamsters respectively, 
obtained from previous experiments with FAPt 41 , which dissolves in the lung 
much more slowly than 57 Co3 04 • No significant difference was found between 
values of M(t) for rats which inhaled "dense" 57 Co3 04 , at the ages of 3, 
13, 21 and 46 weekst 16 ' 201 • In all groups the clearance rate decreased 
from -3% of the remaining lung content per day at a week after inhalation, 
to -o.S% per day at 9 months. Values of M{t) were similar to those 
57 observed in rats in the study using "porous" Co3 04 , and in studies using 
FAP. 
Progress was made on developing a model to describe mechanical 
transport of particles from the human respiratory tract. In the current 
version, time-dependent clearance rates are represented by combinations of 
first-order compartments to avoid problems with chronic exposures and 
radioactive decay productst 211 • Interim estimates of representative values 
and ranges have been made. A model for rats has also been developed, using 
the same compartmental structure, but with appropriate values. The 
exercise has, however, highlighted the difficulties involved in estimating 
many of the parameters needed from available data. 
3. Discussion 
Since administrative problems delayed the planned measurements of 
particle clearance rates from the human respiratory tract, greater effort 
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was placed on animal studies, on which European collaboration opened up 
unexpected opportunities. 
The facilities for preparing test particles and administering them to 
human volunteers were extensively upgraded. Although initially required to 
study particle clearance from the nasal passage, they will be applicable to 
other projected human inhalation studies, especially those requiring 
particle administration to a selected part of the respiratory tract. There 
remain major uncertainties about the kinetics of clearance of particles 
from each part of the human respiratory tract, even for healthy adult 
males 11 ' 12 l. Of particular current concern is the possibility, suggested 
by the Frankfurt experiments, that a significant fraction of material 
deposited in the TB region may not be cleared rapidly by mucociliary 
action, since the TB epithelium is regarded as being of relatively high 
radiosensitivity. These uncertainties were highlighted by work on the 
development of a model to represent mechanical clearance kinetics. It is 
planned to commence the nasal clearance study shortly, and further studies 
of human lung clearance in due course. Closer collaboration on human 
inhalation studies is foreseen with GSF Frankfurt and also with CEA 
Fontenay-aux-Roses, with whom a joint proposal to the CEC Radiation 
Protection Programme 1990-91 was submitted and selected for funding. 
Studies in rodents provided further support for the assumption that 
mechanical transport rates from the respiratory tract are independent of 
particle composition. This is important for applying the results of human 
studies using non-toxic materials to the prediction of clearance of toxic 
materials. Similar rates of mechanical clearance from the alveolar re~ion 
to the GI tract were found for FAP, an actinide oxide, and three different 
forms of 57 Co3 04 • The alveolar mechanical clearance rate was generally 
found to be remarkably constant in a given species. It is largely 
independent of age and gender, and unaffected by voluntary exercise, or 
even BAL. High levels of a-irradiation were found to impair it, and the 
rate was found to be higher (but only initially) for particles administered 
by instillation than by inhalation. 
- 1857 -
IV. Other research group(s) collaborating actively on this project [name(s) and 
address(es)]: 
Dr. w. Stahlhofen 
Abteilung fUr Biophysikalische Strahlenforschung, GSF Frankfurt, FRG. 
Dr. H. Toivonen 
Finnish Centre for Radiation and Nuclear Safety, Helsinki, Finland. 
V. Publications: 
1. M.R. Bailey (1985). Human data on clearance. IN Lung Modelling for 
Inhalation of Radioactive Materials. Proceedings of a Meeting Jointly 
Organized by the CEC and NRPB, OXford 26-28 March 1984 (Eds. H.Smith 
and G.B.Gerber) CEC pp.93-110. 
2. M.R. Bailey (1985). Assessment of the dose to the nasopharyngeal 
region from inhaled radioactive particles. ibid pp. 273-279. 
3. M.R. Bailey, F.A. Fry and A.C. James (1985). Long-term retention of 
particles in the human respiratory tract. J.Aerosol Sci. 16:295-305. 
4. M.R. Bailey, A. Hodgson and H. Smith (1985). Respiratory tract 
retention of relatively insoluble particles in rodents. J.Aerosol Sci. 
16:279-293. 
5. H. Toivonen and M.R. Bailey (1986). Developments of the spinning-disc 
to produce.monodisperse aerosols in a wide range of sizes. Aerosols: 
Formation and Reactivity. Proc. 2nd International Aerosol Conference, 
west Berlin, 22-26 September 1986 Pergamon, pp. 1045-1048. · 
6. M.R. Bailey, W.G. Kreyling, S. Andre, A. Batchelor, A. Black, C.G. 
Collier, E. Drosselmeyer, G.A. Ferron, P. Foster, B. Haider, 
A. Hodgson, H. Metivier, S.R. Moores, A. Morgan, H-L. MUller, 
G. Patrick, I. Pearman, s. Pickering, D. Ramsden, c. Stirling and 
R.J. Talbot (1987). An interspecies comparison of the lung clearance 
of inhaled monodisperse cobalt oxide particles. Proceedings of the 
Second International Symposium on Deposition and Clearance of Aerosols 
in the Human Respiratory Tract, Salzburg 18-20 September, 1986 (Edited 
by W.Hofmann) Facultas Universitatsverlag pp. 118-122. 
7. W. Stahlhofen, J. Gebhart, G. Rudolf, G. Scheuch and M.R. Bailey 
(1987). Investigation of human lung clearance kinetics with inhaled 
pulses of radioactively labelled particles. In Aerosols: Their 
Generation, Behaviour and Applications. Proc. First Conference of The 
Aerosol Society, Loughborough University of Technology, 31 March-
1 April 1987 pp. 101-104. The Aerosol Society. 
8. w. Stahlhofen, J. Gebhart, G. Rudolf, G. Scheuch and M.R. Bailey 
(1987). Human lung clearance of inhaled radioactively labelled 
particles in vertical and horizontal position of the inhaling person. 
J. Aerosol Sci. 18:741-744. 
- 1858 -
9 M.R. Bailey, W.G. Kreyling, s. Andre, A. Batchelor, A. Black, 
C.G. Collier, E. Drosselmeyer, G.A. Ferron, P. Foster, B. Haider, 
A. Hodgson, H. Metivier, S.R. Moores, A. Morgan, H-L. MUller, 
G. Patrick, S. Pickering, D. Ramsden, c. Stirling and R.J. Talbot 
(1988). An interspecies comparison of the translocation of material 
from lung to blood. Ann. Occup. Hyg. 32, Supplement 1: 975-985. 
10. e.G. Collier, A.C. James and M. Ellender (1988). The effect of alpha 
irradiation on retention of particles in the rat lung. ibid pp. 1007-
1015. 
11. C.G. Collier, A. Hodgson, M.R. Bailey and S.F. Barry (1988). Factors 
affecting the clearance of fused aluminosilicate particles from the 
rat lung. J.Aerosol Sci. 19:689-702. 
12. M.R. Bailey (1989). Application of human volunteer experiments in 
setting exposure limits. Proc. Workshop on Biological Assessment of 
Occupational Exposure to Actinides. Versailles, May 30 - June 2, 
1988. Radiat. Prot. Dosim. 26: 249-257. 
13. M.R. Bailey (1989). Generation and administration of labelled 
aerosols for clearance studies. Presented at the Seventh 
International Congress on Aerosols in Medicine, Rochester NY 26-29 
September, 1988. J.Aerosol Medicine 2: 99-110. 
14. M.R. Bailey, W.G. Kreyling, S. Andre, A. Batchelor, C.G. Collier, 
E. Drosselmeyer, G.A. Ferron, P. Foster, B. Haider, A. Hodgson, 
R. Masse, H. Metivier, A. Morgan, H-L. MUller, G. Patrick, I. Pearman, 
s. Pickering, D. Ramsden, c. Stirling and R.J. Talbot (1989). An 
interspecies comparison of the lung clearance of inhaled monodisperse 
cobalt oxide particles. Part I. Objectives and summary of results. 
J.Aerosol Sci. 20:169-188. 
15. C.G. Collier, M.R. Bailey and A. Hodgson (1989). An interspecies 
comparison of the lung clearance of inhaled monodisperse cobalt oxide 
particles. Part v. Lung clearance of inhaled cobalt oxide particles 
in hamsters rats and guinea-pigs. ibid 233-247. 
16. C.G. Collier, A. Hodgson, S. Gray, J. Moody and A. Ball (1989). Study 
of the effect of age on lung clearance. Proc. 4th Int. Symp. of the 
Society for Radiological Protection, Malvern, 4-9 June 1989, (IOP, 
Bristol) 459-462. 
17. G. Etherington, M.R. Bailey, M-D. Dorrian and A. Hodgson (1989). A 
study of the biokinetics of intravenously administered yttrium-88 in 
man. ibid 445-448. 
18. G. Etherington, M.R. Bailey, M-D. Dorrian and A. Hodgson (1989). The 
biokinetics of intravenously administered yttrium-88 in man. Radio-
logical Protection Bulletin No 105 September 1989 pp. 16-19. 
19. H. Toivonen and M.R. Bailey (1989). Development of the spinning-disc 
to produce monodisperse aerosols in a wide range of sizes. Aerosol 
Sci. Technol. 11:196-205. 
- 1859 -
20. W.G. Kreyling, S. Andre, C.G. Collier, G.A. Ferron, H. Metivier, and 
G. Schumann (1989). Interspecies comparison of lung clearance after 
inhalation of monodisperse solid cobalt oxide particles. Proc. 
European Aerosol Conference, Vienna, 18-22 September, 1989. J. Aerosol 
Sci. (in press). 
21. A. Birchall (1989). Uncertainty in bioassay determdnation of 
plutonium intakes. NRPB Memorandum M-207 (in press). 
- 1860 -
Title of the project no.: 4 
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tract. 
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I. Objectives of the project: 
To improve the scientific basis of models used to relate intakes of 
radionuclides by inhalation to tissue doses and to environmental and 
bioassay measurements, by: 
(i) Interspecies comparison of translocation of materials from particles 
in the lung to the blood. 
(ii) Measurement of absorption to blood of materials deposited in the 
anterior or posterior nasal passage of human subjects. 
(iii) Measurement of absorption to blood and retention in the epithelium of 
materials deposited in the nasal passage of rodents. 
11. 
( i) 
(ii) 
(iii) 
Objectives for the reporting period: 
Design, construct and test new facilities for administration of 
radioactive aerosols to rodents. 
Compare the rate of translocation to blood of 57 Co following 
inhalation of 57 Co3 04 by rats, hamsters and guinea-pigs and by rats 
of different ages. 
Investigate factors affecting translocation to blood of 57 Co from 57 Co304 in the lungs, to account for interspecies differences: effect 
of med1um on 57 Co3 04 dissolution; meas~rement of intraphagolysosomal pH; comparison of transfer of soluble 7 eo from lungs to blood in 
different species. 
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Ill. Progress achieved: 
Methodology 
(i) Experimental studies on translocation to blood of material deposited 
in the lungs frequently require exposure of animals by inhalation. A new 
facility for administering radioactive aerosols to small animals was 
designed and constructed! 3 ' 81 • A suite of interconnecting gloveboxes was 
designed to accaamodate all of the operations involved. A new exposure 
chamber was designed to reduce the variation between individual animals and 
permit exposure of animals ranging in size from mice to guinea-pigs. With 
two chambers in parallel, simultaneous exposure of up to 72 animals is 
possible. The new system was tested extensively using radio-labelled fused 
aluminosilicate and polystyrene particles (1-3.5 pm AMAD). Variation in 
lung deposit between individual rats was found to be 15-20% (compared to 
40% with the previous system) and the efficiency ·(activity deposited in 
each animal's lungs/activity nebulised) was around 7 x 10- 2 %. The system 
has been fully operational since 1987, and more than 12 exposures have been 
conducted, using materials such as thorium nitrate, plutonium nitrate, 
plutonium oxide and cobalt oxide. 
(ii) An inter-laboratory collaborative study! 1 ' 2 ' 4 ' 5 ' 71 was conducted 
primarily to test the hypothesis that translocation of materials from the 
lungs to the bloodstream is independent of the animal species. 'Porous' 
cobaltosic oxide labelled with 57 Co (~ 271 d) (57 Co3 04 ) was chosen as the 
test material as it is moderately soluble and most systemic cobalt is 
rapidly excreted in the urine. Thus translocation rates could be estimated 
from urinary excretion rates and a simple biokinetic model. Monodisperse 
57 Co3 04 particles (0.8 and 1.7 pm mean geometric diameter MGD) were 
prepared at GSF Neuherberg and distributed to the participating 
laboratories to be administered to a wide range of species: GSF (dogs) , CEA 
Bruyeres-le-Chatel (baboons), KFK Karlsruhe (rats), MRC Chilton (SPF rats), 
Harwell laboratory (mice), AEE Winfrith (Man) and NRPB (rats, hamsters and 
guinea-pigs). 
Particles were administered to all experimental ani~ls early in 
1985. The human exposure however, did not take place until February 1986 
and so a second group of rats were exposed at NRPB to establish whether 
storage had altered the characteristics of the material. Animals at NRPB 
were exposed by nose-only inhalation. Total retention, organ distribution 
and excretion of activity were measured for 400 days after exposure. 
Groups of animals were killed at specific times after exposure and the 
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activity in the lungs measured. This allowed the lung retention to be 
determined from the measurements of whole body activity made on living 
animals. 
Translocation rates were calculated from urinary excretion. 
Allowance was made for 57 eo cleared by translocation which was excreted in 
the faeces, and also for the systemic uptake of 57 eo from particles cleared 
to the GI tract. This was done using a simple biokinetic model, the 
parameters for which were determined in supplementary experiments. The 
whole body retention and excretion of 57 eo was measured in animals of each 
species injected intravenously with 57 eo-nitrate, and in animals which had 
been fed 57 eo3 04 particles. Measurements continued for up to 3 weeks after 
exposure. Translocation rates were estimated in a similar way for all 
species in the interlaboratory collaboration and the results for different 
species were compared. 
(iii) For the study on the effect of animal age on lung clearance<&) 
kinetics a different batch of 57 eo3 04 was used. This had a MGD of 1 pm and 
was denser than that used in the previous study. It was again supplied by 
or W.G. Kreyling. Groups of rats ranging in age from 3 weeks to 1 year 
were exposed simultaneously to an aerosol of the particles in the new 
inhalation facility. Following the same experimental procedure as for the 
interspecies comparison (above), the lung retention, translocation and 
mechanical clearance of 57 eo were followed for 9 months after exposure. 
Estimation of clearance rates from excretion rates required supplementary 
experiments on the retention and excretion of 57 eo following systemic 
uptake and the uptake of 57 eo from particles passing through the GI tract 
for animals of different ages. The translocation rates obtained for adult 
rats for this 'dense' 57 eo3 04 were compared with those obtained previously 
for the 'porous' material and with translocation rates of the same 'dense' 
material measured in dogs and baboons which had been exposed to the same 
material. The results for these three species for the 'dense' 57 eo3 04 
formed a second interspecies comparison of translocation rates< 9 l. 
(iv) Results from the two interspecies comparisons< 5 ' 9 , suggested species 
differences for translocation rates of the same material. Possible reasons 
for these differences were investigated. The effects of the composition of 
the medium on the in vitro dissolution of 57 eo3 04 were investigated in a 
simple system. 57 eo304 particles were suspended in solutions of selected 
concentrations of citrate, bicarbonate and pH. The suspensions, contained 
in dialysis tubing, were immersed in similar solutions from which samples 
were removed for analysis. Measurements continued for 3 months. 
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(v) Since the initial stage of translocation (dissolution of the 
particles) takes place mainly within macrophages, species differences in pH 
within the lysosomes were investigated. Cells were recovered by lavage 
from guinea-pigs and transported to the Karolinska Institute, Stockholm, 
Sweden. Cells from dogs, baboons and rabbits were provided by other 
laboratories. The cells were incubated with fluorescein-labelled silica 
particles. The pH within the phagolysosomal vacuole was determined by UV 
fluorescence spectrophotometry. Results were compared for the different 
species. 
(vi) Another possible reason for the species differences in translocation 
rates was investigated. Following dissolution of 57 Co from the particles, 
material is transferred to the blood. Species differences in this pathway 
could result in differences in translocation rates even if dissolution of 
the particles occurred at the same rate. This possibility was investigated 
by comparing the retention of 57 Co following instillation of 57 CoC12 
solution into the lungs of rats and guinea-pigs. Information was already 
available for dogs and further studies are planned using baboons and mice. 
Whole body retention, excretion and tissue distribution of 57 Co was 
followed for 3 months after instillation of about 150 kBq of 57 CoC12 • In 
addition samples of trachea were taken for autoradiographic studies to 
determine the distribution of the activity within it. 
Results and Discussion 
(i) Interspecies comparison of translocation rates< 1 ' 2 ' 4 ' 5 ' 7 ,. 
Lung retention and clearance were followed for 400 days after 
inhalation of 57 Co3 04 particles by rats, hamsters and guinea-pigs. Lung 
retention and excretion of 57 Co was similar in rats exposed in 1985 and in 
1986, indicating that storage of the material had not affected its lung 
clearance characteristics. 
By 400 days after exposure to 0.8 pm 57 Co3 04 , 0.08, 0.37 and 0.1% of 
the initial lung content remained in the lungs of rats, hamsters and 
guinea-pigs respectively. For animals exposed to 1.7 pm 57 Co3 04 , 1.6, 1.65 
and 1.27% respectively remained in the lungs. 
The rate of translocation of 57 Co from the lungs to the blood (S(t) 
at time t after inhalation) was calculated as a fraction of the activity 
remaining in the lungs. In all three species studied at NRPB, S(t) could 
be determined from about 10 to 350 days after exposure. For the 1. 7 pm 
particles initial values of S(t) were similar (0.3% dr 1 in guinea-pigs to 
0.6% d- 1 in rats). In all three species it increased slowly with time to 
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about 1% d- 1 , reaching this value at about 150, 250 and 300 days 
respectively for the guinea-pigs, rats and hamsters. For the 0.8 pm 
particles S(t) was generally higher than for the 1.7 pm particles, showed 
more pronounced changes with time and greater differences between species. 
Initial values of 0.7, 1.6 and 0.6% d- 1 for guinea-pigs, rats and hamsters 
respectively, increased to a peak of about 3% dl 1 at 350, 50 and 250 days 
respectively. In rats the value of S(t) fell markedly again to about 0.5% 
d- 1 by the end of the experiment. 
A simple model of translocation of 57 Co associated with particles in 
the lungs to blood was developed, which was well able to account for the 
different forms of S(t) observed, including those for the other species 
used in the interlaboratory collaboration. The form of the predicted 
translocation rate as a function of time depended upon two variables: the 
initial dissolution rate and the fraction of material dissolved from the 
particles which was retained in the lung with a long half-time. 
(ii) Effect of animal age on lung clearance kinetics! 6 l. 
Deposition of 57 Co3 04 in the lungs increased with age. Lung 
retention, expressed as a percentage of the lung content on day 7 after 
exposure, was significantly lower in the youngest animals (3 weeks at 
exposure) than in adults. Aged animals (46 weeks at exposure) showed 
significantly higher lung retention than did young adults. Translocation 
rates (S(t)) were estimated from the urinary and faecal excretion rates, 
corrected by the transfer coefficients determined in the supplementary 
metabolic experiments. 
In all age groups S(t) tended to increase with time from about 1% d- 1 
to 1.5-4% d- 1 • Analysis of variance showed that between groups of 
different ages there were no significant differences in the mechanical 
clearance rates, but there were significant differences in S(t) (p<O.Ol), 
with the youngest animals having the highest translocation rates (1.5-2 
times higher). The results suggest that provided mature animals are used, 
the effect of age on translocation rates to blood is minimal. In 
extrapolation of translocation rates in animals to those in humans, the 
differences in the rates between the species (see above) are likely to be 
much larger than between animals of different ages. However, the influence 
of age should be considered when extrapolating from data obtained using 
very young animals or when attempting to predict the translocation rates in 
children. 
57 Exposure of rats to 'dense' Co3 04 formed part of a second inter-
laboratory collaborative study19 ,. The lung retention and clearance of 
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this material was compared in rats, baboons and dogs and with the results 
for the 'porous' 57 Co3 04 used previously. S(t) was about 3 times lower for 
the 'dense' particles than the 'porous' ones in all three species, 
supporting the assumption that S(t) is proportional to specific surface 
area, which was calculated to be about 3 times higher for the 'porous' than 
for the 'dense' 57 Co3 04 particles of the same size. In all cases, the time 
dependence of the translocation rate could be predicted by the simple model 
described above. 
(iii) Factors affecting in vitro dissolution of 57 Co3 04 • 
Of the factors studied, pH had the most significant (p<0.001) effect 
on dissolution of 57 Co3 04 in vitro. The highest dissolution of 
57 Co3 04 
occurred at pH 4.5 (generally 2-6 times higher than at pH 7.2). Citrate 
concentration-also had a-significant effect on dissolution rates (p<0.02), 
with particles in 0.2 mM citrate dissolving slightly faster than in 0.067 
mM citrate. Bicarbonate concentration had no effect on dissolution and 
there was no evidence of synergism between the factors. These results 
suggested that pH in the dissolving environment (alveolar macrophage 
lysosome) is likely to be a major factor in determdning particle 
dissolution rates. 
(iv) Measurement of intraphagolysosomal pH. 
Measurements were conducted on alveolar macrophages from guinea-pig, 
rabbit, dog and baboon. For all four species the pH was found to be 
4.5-4.6, with little variation between individuals. These species showed· 
wide variation in translocation rates of 57 eo from 57 Co3 04 , and yet the pH 
in the lysosomes was very similar, indicating that another factor must be 
responsible for the differences. 
(v) Comparison of retention of soluble cobalt in the lungs. 
Retention of 57 Co was followed for 100 days after instillation, by 
which time total body retention was 0.93 and 1.4% of the administered 
activity in rats and guinea-pigs respectively. A two component exponential 
function fitted to the whole body retention data showed that for both 
species around 95% of the activity was cleared within the first day, and· 
the remaining 3.5-5% was cleared with a 45 day half-time. Animals were 
killed at 7, 30 and 100 days and·the tissue distribution of activity 
determined. At all times the lungs contained >25% of the whole body 
activity and the highest activity of any organ. For both species through-
out the experiment the highest concentration of activity was in the trachea 
(100-600 times the average throughout the body). The lungs also showed 
high concentrations (45-150 times the average concentration). 
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OVerall, the results for excretion and retention were similar for the 
rats and guinea-pigs and also similar to those reported previously for 
hamsters and beagles. All four species retained a similar fraction of 
dissolved activity (3-5%) in the lungs, and the range of values could not 
account for the differences observed between species in translocation 
rates. 
Interestingly both rats and guinea-pigs showed preferential 
accumulation of 57 Co in the trachea. This activity was not associated with 
the administration site. Tissue samples from the experimental animals have 
been taken for autoradiographic examination. Initial results suggest that 
cobalt accumulates in the cartilage rings of the trachea. 
Much of the work has been of a collaborative nature. This has 
required considerable effort in the co-ordination of the work and the 
presentation of the results for publication. 
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I. Objectives of the project: 
Dr. 
Dr. 
Dr. 
CDr. 
F. Pall tt l 
D. Carottl 
S. Scarpa 
A. Tomassettl > 
Unde[' the gene['al biochemical assumption that hypomethylatlon of 
eukaryotlc genes Is CO['['elated to thel[' exp['esslon, and taking Into 
account that gene demethylatlon 
soma tl ea 11 y I nhe£'1 tab I e event 
can be expected to behave as a 
with mutation-like effects but 
occU['['Ing with a hlghe[' f['equency than t['ue mutation, lt was p['oposed 
to Investigate, using an In yltro cellular system capable of cell 
dlffe['entlatlon under controlled conditions, how the DNA methylation 
patte['n correlates to the cultural and/or dlffe['entlatlon 
cha['acterlstlcs of the cells, and In particular to the phenotyplc 
changes Induced by sublethal exposure to Ionizing radiation. 
11. Objectives for the reporting period: 
I> Effects of sublethal exposure to X-lr['adlatlon on specific gene 
expression by cultu['ed cells endowed with a DNA-methylatlon-sensltlve 
tendency to undergo terminal differentiation. 
2> Effects of Dill\ methylation Inhibitors on the susceptibility to 
radiation damage of cultured mammalian cells. 
3l Evaluation of single-strand breaks occurring In nuclear Dill\ during 
cell differentiation and/or exposure to X-rays. 
4l Identification of factors which regulate, within chromatin structure 
and at the single gene level, the susceptibility to ln_Yl!rQ 
methylation of particular CpO sequences In 0111\. 
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Ill. P•og•ees achieved; 
1. Methodology. 
The main cellular system used was the L5 rat myoblast line <or, rather, 
subclones derived from lt>. These cells can either be maintained In a 
prollfE'rating, undifferentiated state, or can be Induced to differentiate and 
fuse Into multinucleated myoflbers simply by decreasing the foetal calf serum 
<FCS> concentration In the cell culture medium <Scar·pa !!.L..AL.., Cell Dlff. 11, 
105, 1985>. Three clones were chosen -- M6, M9 and M12 -- which differ In their 
tendency to undergo spontaneous fusion or In their susceptibility <In terms of 
acceleration and/or facilitation of the differentiation process) to the presence, 
In the culture medium, of the adenosine analog 3-deazaadenoslne <DZA> --the 
effect of this drug being potentlated by the simultaneous presence of 
homocysteine <Scarpa ~. Proc.Natl .Acad.Sci.USA 81, 3064, 1984>. 
All myoblast clones were grown In F14 medium addltloned with 10\ FCS 
('growing medium'>, and eventually transferred to F14 medium with only 1\ FCS 
("fusion medium') in order to induce differentiation and fusion into myofibers. 
The extent of differentiation was evaluated by computing the number of nuclei 
found in flbers vs the total number of nuclei. The effects caused on the three 
clones by the addition of 3 1uM DZA and 50 1uM HCY can be described as follows: 
clone M6, normally fusing to a level of 50% when transferred to the 'fusion 
medium', was stimulated to 75\ fusion by addition of DZAtHCY; clone M12 failed to 
differentiate spontaneously but reached up to 50\ fusion upon addition of the two 
drugs; clone M9 had the most abnormal behaviour, since at early passages <less 
than 5 transfers after cloning> Its fusion was partially Inhibited by the 
presence of the drugs, while after several passages (over 15 transfers after 
cloning) lt exhibited a 'typical' fusion pattern, very similar to that of M6. 
Every one of the three clones possessed a normal karyotype (42 chromosomes, as In 
normal rat tissues> and exhibited, upon X-lrradlatlon, survival curves with a 
typical 'shoulder' In the 0-5 Gy region, similar to those of other rodents cell 
lines such as CHO and V79. 
In our experiments, the cells from a given clone were subJected to 
X-lrradlatlon <the radiation dose being usually In the 0-5 Gy range) either In 
the 'growing medium• or In the 'fusion medium"; methylation Inhibitors were, If 
the case, added .u.ill Irradiation, and the effects on cell differentiation and 
survival were Investigated. The occurrence of radiation-Induced single-strand 
breaks of DNA was monitored, In cells which had been pre-Jabeled for 48 hours 
wl th radioactive thymidine, by the DNA alkaline elution technique <Kohn .tLAL_, 
Biochemistry lJi, 4629, 1976> -- this procedure being also capable of detecting 
more complex structural differences In chromatin between dlfferentlatled and 
undifferentiated cells. The 5-methylcytoslne levels were measured by high 
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performance liquid chromatography In two dl fferent systems or, after suI table 
derlvatizatlon, by a gas chromatographic procedure coupled to mass spectrometry. 
An Independent study of the possible effects of methylation Inhibitors on 
the susceptibility of cultured mammalian cells to radiation damage was also 
performed by Invest! gat ing, In human Jymphocytes and in chlnese hamster ovary 
<CHO> cells, sister chromatid exchange, which was then correlated to the levels 
of cytosine methylation in the Isolated DNA from these cells. 
Standard chromatin fractionation procedures, previously developed in our 
laboratory, were used to investigate how chromatin structure -- in particular 
through its tightly-bound protein constituents can Influence the 
susceptibility of its DNA to undergo in yltro methylation, and how the enzyme 
which catalyzes this process I.e. DNA-methyltransferase is distributed 
within the structural levels of eukaryotlc chromatin. The possibility of an 
intrinsic resistance of some well-defined polydeoxyrlbonucleotide sequences to 
the action of the enzyme was also investigated, using as substrates either 
synthetic polydeoxyribonucleotides of known composition, or genomic clones 
obtained by inserting, In plasmid vectors, some naturally occurring 'CpG-rlch 
Islands' <which are reportedly, in ylvo, in a non-methylated state> or 
non-Island-associated genes. A new assay for DNA-methyltransferase was also 
developed. 
2. Results and Discussion 
The extent of cell fusion occurring In cultures of the M9 myoblast clone 
upon transfer from the 'growing medium' to the so-called 'fusion medium' with 
only 1% FCS, was found to be more markedly Inhibited by eposure to X-rays If 
I rradl at I on had been performed at day 1 rather than at day 4 after transfer 
<Fig. 1, upper panel, open .Y.II· full triangles>. The same difference was found 
also when, In cultures of the same M9 clone, the extent of cell fusion was 
modified by addition of DZA+HCY <Fig. 1, lowest panel, same symbols>. An 
analogous pattern was also found <Fig. 1, lowest panel, open .Y.Ii· full squares> In 
cultures of clone M12 In the presence of DZAtHCY <this clone undergoing 
practically no fusion In the absence of these drugs>. Cultures of clone M6, which 
fused to a high extent either spontaneously or upon addition of the drugs, were 
instead almost unaffected, as far as fusion was concerned, by X-irradiatlon. 
These findings are consistent with the overall hypothesis that cell commitment to 
differentiation is Inversely related to the susceptibility of the cells to agents 
Interfering with differentiation Itself. Cells which had completed commitment, 
even If they were not yet fused <this event becoming evident only at day 6>, were 
practically Insensitive to Irradiation, up to 5 Grays. 
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Figure 
Effects of X-lrradlatlon on cell fusion In differentiating myoblasts. 
GrOIJing myoblasts were transferred to the 'fusion medium' <FI4 medium • 1\ fCSl 
addltloned with 3 1uH DZA and 50 1uH HCY <lowest panel>, with only 50 1uH IICY <middle 
panel> or without any addition (upper panel>, and Irradiated either at day I <solid 
I I ne> or at day 4 (dotted line> after transfer. The extent of fusion wn always 
recorded at day 6 after transfer. The results obtained with clones H6, H9 and Hl2 are 
Indicated respectively by circles, triangles and squares. 
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5.0 
The same system of differentiating myoblasts was also Investigated by the 
DNA alkaline elution technique, both to monitor radiation-Induced single-strand 
breaks of DNA and to detect more complex structural differences In chromatin 
between undifferentiated and differentiated cells. Operationally, cell cultures 
were pre-labeled for 48 hours with 14c-thymldlne, then transferred to the 
appropriate medium for the desired time and, If required, subJected to 
X-lrradlatlon, after which they were Immediately poured on Nuclepore filters <2 
1u porosity>. The cells retained on the filters were then lysed with a detergent-
and proteinase-containing buffer at pH 9.6, to which a more alkaline (pH 12.2> 
buffer was progressively added, thus allowing a quantltatlon of the extent to 
which a given radiation dose had brought about DNA strand breaks which could be 
revealed upon alkaline denaturation. The rates of elution of 14c-labeled DNA 
fragments from the various filters could be converted Into l4c;3H ratios, thus 
normalizing the results of different experiments and Increasing their overall 
reproducibility <Sapora et al., In 'Radiation carcinogenesis and DNA 
alterations', F.J.Burns ~ eds., Plenum Press, New York, 1986>, by adding to 
each experimental sample, after Irradiation and before the transfer to the 
corresponding Nuclepore filter, a comparable amount of 3H-Iabeled 
undifferentiated cells which had been Irradiated at 4.5 Gy <and which served as 
an Internal control>. In these experiments, the dose-response curves of the 
Interpolating lines can be assumed to reflect the susceptibility of chromatin DNA 
to radiation damage, while the Y-lntercept Indicates to which extent, even 
without Irradiation, chromatin DNA Is, In that particular cell system, prone to 
alkaline denaturation. 
In fig. 2 are compared the results obtained with undifferentiated myoblasts 
collected from a 'growing' culture -- with those obtained with cells at the 
4th or 7th day after transfer to the 'fusion medium'. In cells collected at day 4 
after transfer, the value of the dose-response slope was practically the same as 
for undl fferent I ated cells -- their sensl t1 vi ty to radiation-Induced DNA breaks 
being therefore the same·-- but the Interpolating line had undergone a 
significant upward shift, consistent with some 'loosening up• of the chromatin 
architecture. At a later stage of differentiation <day 7 after transfer to the 
'fusion medium"·>, the cell DNA was Instead more resistant to radiation damage, as 
Indicated by a lower value of the slope of the dose-response curve (flg.2, lowest 
line>, while the Y-lntercept had returned to Its original value. 
The occurrence of Intrinsic (radiation-Independent> chromatin rearrangements 
occurring In the course of the differentiation process can also be evaluated --
apart from the above-mentioned variations of the Y-lntercept of fig. 2 -- also by 
measuring the radioactivity emerging In the unretalned fraction which, In these 
experiments, precedes the actual alkaline elution. The amount of this 
'unretalned' labeled material was negligible In undifferentiated cells, but added 
up to almost 30% of the whole genomic DNA In the case of differentiating cells 
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(both at day 4 and at day 7 after transfer), where it consists o~ acid-
precipitable DNA fragments with an average molecular mass of 10 Da. Since 
DNA labeling had been performed before the induction of the differentiation 
process, it seems reasonable to ascribe the persence of these fragments to the 
reported occurrence, in rather similar differentiating systems, of enzymati-
cally-lnduced single-strand breaks correlated to the onset of differentiation 
(McMahon et al;, Proc. Nati • Acad. Sci. USA 81, 7461, 1984). 
Figure 2 
X-ray dependence of the DNA elution rate induced by alkaline denaturation. 
Growing myoblasts, pre-labeled for 48 hours with 14C-thymidine, were subjected 
to different doses of X-rays either before (closed circles) or after transfer 
(4 days: open squares; 7 days: open triangles) to the "fusion medium" 
(F14 medium+ 1% FCS). Comparable amounts of cells were then immediately poured 
on Nuclepore filters, lysed and subjected to progressive alkaline denaturation 
of their DNA. The rate at which labeled DNA fragments were collected in the 
eluate is plotted -- after normalization to an internal standard of 3H-
thymidine-labeled cells irradiated with 4.5 Gy -- vs the X-ray dose. 
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The possible effects of variations of DNA methylation on the probability of 
damage-Induced rearrangements In chromatin DNA was also Investigated In CHO 
ce 11 s, by studyIng how the Increased frequency of sister chromatId exchange, 
caused by the two hypomethylatlng drugs L-ethlonlne and 5-azacytldlne, was 
actually correlated, through subsequent cell cycles, to the 5-methylcytoslne 
content of nuclear DNA. It was found that, while there was an excellent 
correlation In the first cycles after addition and removal of the drug, overall 
DNA methylation levels returned to •normal" values between the 10th and the 16th 
cycle after removal of the hypomethylatlng drug, despite the persistence of a 
high frequency of sister chromatid exchange. 
Other experiments were performed with the aim of Identifying, In the 
myoblast system, the existence of an actual correlation between cellular 
differentiation and variations In site-specific or genome-wide DNA methylation. 
Two members of this group <D. Carottl and S. Scarpa> have collaborated In 1986 to 
experiments Indicating that, In Friend erythroleukemla cells, a transient 
hypomethylatlon <probably due to active removal of methyl groups), followed by 
remethylatlon, takes place In the very early stages of differentiation (preceding 
the first DNA replication> • In order to Investigate If active demethylation can 
Indeed be considered as a general phenomenon linked to cell differentiation, and 
to verify whether lt modified the sensitivity to Ionizing radlatlons of the 
differentiating cells, the levels of DNA methylation were measured throughout the 
dlfferentlatlve process of cultured myoblasts. To this purpose, L5 myoblasts In 
the repllcatlve status (I.e. with 10% foetal calf serum In the culture medium> 
were labeled for 48h with 14c-urldlne. At various times after Induction of 
differentiation by cell transfer to the 'fusion medium•, chromatin DNA was 
Isolated and hydrolyzed to bases, and the extent of cytosine methylation was 
measured by HPLC. No significant variation of the methylcytoslne-to-cytoslne 
ratio could however be evidenced under these experimental conditions. Even 
addition of 3-deazaadenoslne, known to perturbate s-adenosylmethlonlne 
metabolism, was unable to produce appreciable changes In the pre-existing overall 
DNA methylation levels. A 10% decrease of methyl groups Incorporation occurred 
Instead when DNA was labelled after shifting the culture to a 'fusion medium• In 
which 3-deazaadenoslne was also present -- this slight hypomethylatlon remaining 
constant throughout the entire dlfferentlatlve process. This moderate Inhibitory 
effect on the methylation of newly-synthesized DNA was however strictly dependent 
on the presence of the drug, and was apparently unrelated to the differentiation 
process Itself: it did not occur when differentiation was Induced by the simple 
shift to the 'fusion medium• In the absence of 3-deazadenoslne, nor was it 
related to the different ability of the drug to accelerate and facilitate the 
differentiation process In the M6 and Ml2 myoblast clones. DZA had no effect on 
the extent of DNA methylation In actively growing cells. 
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Far all e I Invest !gat Ions were performed wl th the aim of c I ar I fy I ng how. 1n 
y_Lts_o and ln__yl.J1.Q, the DNA methylation process, which Is achieved trough the 
action of a DNA methyltransferase which catalyzes the transfer of the methyl 
group from S-adenosyl-L-methlonlne to the 5 position of cytosine moieties present 
In the DNA, Is regulated In eukaryotes. Post-repllcatlve methylation concerns In 
fact only 3-6% of the cytoslnes, all of which are reportedly Included In the 
dinucleotide CpG. 
A methodological aspect of these Investigations concerned the development of 
a new assay for DNA methylase, based on the release of 3H from the 5 position of 
selectively labeled cytosine moieties In the DNA -- as an alternative to the 
standard assay procedure based on the measurement of labeled methyl groups from 
S-adenosylmethlonlne to acld-preclpltable DNA. In order to validate this new 
method, lt was verified whether DNA-methyltransferase-catalysed transfer of 
methyl groups from S-adenosylmethlonlne to the 5 position of cytosine moieties of 
DNA was In exact stoichiometry with the liberation of the hydrogen atom from this 
same position of the cytosine moieties. Since In early experiments tritium 
release was always found to be greater than apparent methyl transfer, the 
Interesting possibility arose, that the methylase was catalysing an exchange 
reaction at the 5-H position of DNA cytosine In addition to the methylation 
reaction Itself. A source of experimental error found In the standard 
<traditional> assay was the Impurity of commercially available 
S-adenosylmethlonlne, as well as, occasionally <when ~occus luteus DNA was 
tested for ~ methylation>, Inefficient trichloroacetic acid precipitation 
of the DNA. After correction for these errors, good agreement was found between 
the two methods, using either 3H-dCTP nick-translated mammalian DNA, as a 
hemlmethylated substrate, or Micrococcus luteus DNA for de novo methylation. 
Various types of DNA were also compared as substrates. The best for efficiency 
and for other practical reasons was nick-translated <and therefore partially 
heml-methylated> mammalian DNA. The amount of 3H which was released <measured on 
the basis of original label present In the DNA> was found to be Independent of 
the extent of nick translation both In hemlmethylatlon and ~ methylation. 
By adding, before or at various times during the reaction, unlabeled DNA which 
was otherwise chemically Identical with the labeled substrate, lt was also 
possible to Investigate the processlvlty of the reaction. The time of addition of 
the non-radioactive substrate was found to make no difference as far as the rate 
of 3H release was concerned, this result being evidence against a processlve 
mechanism. 
As a further approach to the problems of the regulation of DNA methylation, 
polydE'oxyrlbonucleotldes with known base composition were synthesized, In order 
to Investigate the enzyme requirements In terms of bases adJacent to the CpG 
target. As enzyme source human placenta was used. The presence of guanlne 
nucleotldes, and In particular of the dinucleotide CpG, seemed the only necessary 
- 1sn-
characteristics required by these synthetic polymers In order to be substrates In 
the methylation reaction. The presence of a methylcytoslne on the opposite strand 
greatly favoured the reaction. 
In the 'course of the reported Investigations an effect of DNA concentrations 
on methylase activity was observed. High concentrations (above 200 1uglml > of 
double-stranded Micrococcus luteus DNA were found to Induce a time-dependent 
Inhibition of the 'de novo' methylase activity, while single-stranded DNA did not 
show such an effect. The enzyme was apparently Irreversibly Inhibited because 
neither high salt dissociation of the DNA-enzyme complex nor extensive digestion 
of the Inhibitory aubstrate could restore the Initial rate of methylation. The 
Inhibitory effect seemed to be related to the base composition of the substrate, 
because it was not found with the synthetic polymer polyCdi-dC>.polyCdi-dC>, 
while it was present using either polyCdC-cG>.polyCdC-dG> or 
polyCdA-dT>.polyCdA-dT>. 
As a natural prosecution of these experiments we have also studied the 
Influence of the average distance between CpG's on the efficiency of catalysis. 
This choice was essentially motivated by a peculiar characterlst'lcs of vertebrate 
DNA: although the entire genome Is gener~lly CpG-depleted, peculiar areas exist, 
In which the CpG dlnucleotldes are present at a higher frequency (similar to that 
of the GpC dinucleotide), but In an unmethylated status. These so-called CpG-rlch 
Islands are always found at the 5' end of housekeeping genes and seem to have a 
role In controlling the expression of the associated genes. How these regions, 
which should theoretically behave as excellent substrates for the enzyme, can 
escape methylation In vivo Is sti 11 an open question. We have analyzed the 1.n 
~ methylation pattern of several plasmlds containing cloned genomic DNA 
sequences of widely different CpG frequencies, ranging from an average of I CpG 
every 8 nucleotldes, as found In CpG-rlch Islands, to CpG every 200 
nucleotldes, typical frequence In a random genomic DNA. Human placenta enzyme was 
used with cloned human and murine CpG-rlch Islands and with the human beta-globin 
gene. 
The extent of methylation for a single sequence was measured after 
restriction digestion of an In vitro methylated plasmid and subsequent Isolation 
of the fragments by means of agarose gel electrophoresis. The amount of 
radioactivity Incorporation was correlated to the number of CpG's present In each 
fragment. The correlation was very good for all fragments except for those 
containing an average CpG spacing lower than 11 nucleotldes. In this case the 
methylation efficiency was reduced of about 40%. In our analysis Isolated CpG's, 
generally considered as less favourable substrates, become methylated to the 
expected level. The system seems to reflect the physiological situation where 
Isolated CpG's are almost completely methylated and clustered ones are not. 
Eukaryotlc DNA methyltransferase shows, therefore, a peculiar sensitivity to CpG 
- 1878 -
frequency, and this characteristics can be expiected to play a regulatory role In 
maintaining CpG-rlch Islands In a hypomethylated condition. 
These results do not however totally account for the "physiological" l..o._y_J_y_Q 
situation, where practically no methyl groups are usually found In clustered 
CpG's. This discrepancy between the .l..n__yl_yQ situation and the In vitro results 
suggests that, In vivo, Interaction with other chromatin component<s> can also 
play a role In preventing methylation of clustered CpG's -- but no direct 
experimental evidence supporting this hypothesis has sofar been obtained. 
Experimental data concerning the Influence of chromatin structure <and of Its 
dl fferent components> on the actIvIty of eukaryot le DNA-methy I transferase have 
Instead shown that, at least In human placenta chromatin, there are some 
tightly-bound components which strongly stimulate, In vitro, the enzyme-catalysed 
transfer of methyl groups to DNA cytosine moieties. It was also found, as an 1n 
vivo counterpart of this phenomenon, that, In chromatin loops, there are some Dtlll 
segments characterized by a high methylation level and by a strong association 
with some 'tightly-bound proteins". 
Within the general framework of collaborations with other research groups, 
new kinetic methodology was developed, through which novel results were obtained 
about Interactions between allosteric effectors In deoxycytldylate 
amlnohydrolase, Including demonstration that occupation of activator sites by 
substrate gives rise to extremely high cooperatlvltles. Stoichiometry of 
substrate and modifier sites of dCMP amlnohydrolasre was established, and Its 
consequences for allosteric mechanisms were analysed. Half-site reactivity In the 
enzyme glutathlone-S-transferase was also studied. 
- 1879 -
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Title of the project no. 1: Radiation Carcinogenesis in vitro 
Head of Project and SCientific Staff: L. Tallone Lombardi, D. Bettega, P. Calzolari, A. 
Ghidoni, A. Ottolenghi. 
The general aims of this project were to obtain experimental data on the biological 
effectiveness and dose-responses of various types of radiation, and to use these quanti-
tative data to test models of radiation action and seek biologically relevant parameters 
of radiation quality. 
The experimental work was mainly centred on determining the dose-effect relation-
ship for induction of oncogenic transformation in cultured mammalian cells exposed 
to low doses of high LET ionizing radiations such as alpha particles from radioactive 
decay. In addition cell survival, growth kinetics and cell density effects after exposure 
to various type of radiations, were also determined. 
The system used was the C3H10T1/2 mouse embryo fibroblast cell line. The cells 
were cultured following standard protocols and transformation frequency was deter-
mined by the number of type 11 and Ill foci following the criteria already established 
in the literature. Radiations used were low LET protons from a Cyclotron, 220 KV p 
X-rays and a-particles from a 244 Cm source. 
Oncogenic transformation 
Our main activities centred on studying dose-effect relationship in transformation 
induced by 4.3 MeV a-particles,with an LET of 101 KeV/p,m. For this purpose, 
cells were cultured on a 3 cm diameter, 1.5 p, thick mylar foil sealed with araldite 
to a pyrex ring. Using this support no difference was found in growth rate, plating 
efficiency or spontaneous transformation frequency as compared with cells cultured on 
conventional Petri-dishes. The samples were irradiated in a purpose-built irradiation 
chamber. Survival and transformation were determined in parallel and were compared 
with analogous results obtained with low LET protons. The survival curve with alpha 
was an exponential function of the dose with a mean lethal dose of 0.61 ± 0.02 Gy. The 
corresponding RBE was a decreasing function of the dose varying from 15 to 4 when 
the alpha particle doses ranged from 0.1 to 2 Gy. The transformation curves showed 
complex shapes with an apparently constant region at low doses followed by a linear 
increase with dose. RBE values decrease from 20 to 4 in the dose region between 0.1 
and 2 Gy. There was a significant transformation incidence at doses that have very 
little effect on cell survival. No effect of the dose rate was found at total doses of 0.05 
or 0.1 Gy with dose rates of 0.11 and 0.005 Gy/min. 
The effect of the temporal distribution of the dose was also studied with low LET 
protons (1.82 ± 0.03 K e V/ p,m ). Total doses of 0.5,1 and 7 Gy were delivered as a single 
fraction and two equal fractions with various time intervals up to 10 h between doses. 
The frequency of transformation per surviving cell is lower with split doses than with 
single doses by factors of 3.1 ± 0.5, 3.1 ± 0.6 and 1.5 ± 0.3 at doses of 7, 1 and 0.5 Gy 
respectively. 
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Cell-den8ity effect 
Cell density dependence of transformation frequency was studied in C3H10Tl/2 
cells exposed to 0.5 and 7 Gy of 200 KV p X-rays in the cell density range between 
50 and 2500 cells/10 ern diameter Petri-dish. It was found that the initial cell density 
strongly influences transformation frequency with decreasing factors of about 4 and 
about 10 at 7 and 0.5 Gy respectively throughout the density interval studied. The 
data can be well fitted with two equations: an allometric function represented on a log-
log scale by a straight line and a sigmoidal function with two plateaux between 50 and 
250 cells/dish and above 600 . The region between 50 and 250 cells/dish turned out 
to be a region of low variation in transformation frequency values. Similar conclusions 
have been reached in three out of four cases from an analysis of data reported in the 
literature. 
Cell gi'Owfh kinetic8 
Growth curves and colony sizes were determined in C3H10T1/2 cells exposed to 
0, 1, 3, 5 and 7 Gy of low LET protons. The data were analyzed to determine the tem-
poral dependence of the growth properties of survivors and to investigate whether the 
surviving percentages are well represented by the conventionally calculated surviving 
fractions. 
The data showed that irradiated populations could be represented by a moiety 
of surviving cells which have the same growth rate as the unirradiated cells and a 
moiety of non-surviving cells which begin to divide at nearly the same growth rate 
but gradually lose their ability to divide. Growth curves were studied with a model 
represented by an exponential plus a Gompertz function which takes into account the 
behaviour of the surviving and non surviving subpopulations. It was found that the 
surviving cells grow at a constant rate a= 0.029 ± 0.002 h-1 ; non-surviving cells have 
a growth rate equal to a, but lose their ability to divide at a rate per unit of dose 
b = 0.0041 ± 0.0009 h- 1 Gy- 1 ; division delay was short,being equal to 1 ± 0.8 h Gy- 1 . 
Growth curves of the entire population are influenced by non-survivor progeny up to 
150, 200 and 250 h from irradiation at 3,5 and 7 Gy respectively; at longer times the 
population can be considered to consist of survivor progeny. 
The percentage of cells having the same growth rate as the control population is 
less by a factor of about 2 than that of survivors calculated from macrocolony counting 
at doses as high as 7 Gy. 
Survival model8 
Survival curves of C3H10T1/2 cells reported in the literature were analysed by 
using multitarget, multihit and linear quadratic models. The relative parameters were 
analyzed and the variation between the results obtained by different laboratories dis-
cussed. The inactivation probability density function for each curve was studied and 
the mean lethal dose, variance and mode of distribution calculated. A set of equations 
was also proposed , which greatly simplify the calculation of these quantities. 
- 1885-
The main conclusions of this study were : 
a) The best parameters to represent cell survival are the mean D and the standard 
deviation u of the inactivation probability-density function. The values of parameters, 
a, /3, D0 , n, k, and A are more variable from experiment to experiment and more 
dependent on the range of available data used for estimation. 
b) The quasi threshold dose Dq is the mode of inactivation probability density. It can 
be also interpreted as the dose around which the cell response .to a dose increment is 
at its maximum. 
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P.Unalkat 
1. To study the chemical forms in which plutonium and other actinides 
are present in blood plasma, in intracellular structures, such as 
lysosomes, and in the various compartments of the gastrointestinal 
tract. 
2. To elucidate the mechanisms of transfer across plasma and mucosal 
membranes and to identify factors which may influence the transfer. 
11. Objectives for the reporting period: 
a. To study the role of transferrin as the principal transport protein 
for actinide and lanthanide elements in blood plasma. 
b. To examine the cellular uptake of metal-transferrin complexes in 
relation to the transferrin receptor mechanism. 
c. To investigate the binding of actinide metals to intracellular ligands. 
d. To develop an experimental model of the human gastrointestinal tract 
for the purposes of examining the speciation of actinides and identi-
fying factors which may influence their absorption into the blood stream 
following ingestion. 
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Ill. Progress achieved: 
a. Binding of actinides to transferrin. 
Transferrin is the principal iron transport protein in mammalian blood 
plasma, but previous studies from this and other laboratories have shown 
that plutonium, thorium, americium and curium are also transported in the 
blood as transferrin complexes. During the course of this project the bind-
ing of the actinides neptunium-239, protactinium-233, and the lanthanides 
ytterbium-169 and europium-154 to serum proteins has been investigated in 
vivo, following intravenous injection of the metal citrates into rats, and 
in vitro in rat, horse or human serum. 
The binding of the radionuclides was examined by sequential gel permeation 
chromatography on Sephacryl S-300 followed by re-chromatography of the eo-
eluted albumin-transferrin fractions on DEAE-Sepharose, or DEAE Cellulose, 
eluting with a linear gradient of 0 to 0.5 M NaCl. The results from the 
studies with neptunium, protactinium, ytterbium and europium showed that 
transferrin was the principal binding protein in blood serum after both in 
vivo and in vitro labelling. The association of the actinide or lanthanide 
with transferrin was further verified by means of polyacrylamide gel elec-
trophoresis and by immunodiffusion methods. Saturation of the serum with 
iron led to the displacement of plutonium, neptunium and ytterbium from the 
transferrin complex, providing strong evidence that the metals bind to the 
two iron-binding sites in the transferrin molecule. Protactinium was not 
displaced by iron saturation of the serum suggesting that either the pro-
tactinium-transferrin complex has a greater stability than the iron-trans-
ferrin complex, or that this metal do~s not bind to the iron-binding sites. 
Ultra-violet difference spectroscopy of the plutonium- and ytterbium-trans-
ferrin complexes, formed from purified human ape-transferrin, indicated that 
the metal binding capacity of human transferrin was two metal atoms per 
protein molecule, the same as for iron. Attempts to demonstrate the forma-
tion of the Pu-Tf and Pu 2 -'ff complexes using iso-electric focussing electro-
phoresis were unsuccessful due to the dissociation of the metal protein 
complex during electrophoresis; this technique clearly demonstrates the Fe-
Tf and Fe 2 -Tf complexes, thus it seems likely that the plutonium-transferrin 
complex is less stable than that with iron. Ytterbium may be regarded as an 
analogue for a trivalent actinide, and americium and curium have been shown 
previously to form relatively weak complexes with transferrin. In collabo-
ration with the School of Chemistry and Applied Chemistry of the University 
of Wales College of Cardiff, computer simulation methods for the calcula-
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tion of metal speciation in biological systems such as blood plasma, the 
gastrointestinal tract and in actinide-contaminated wounds have been intro-
duced into this Institute and applied to various problems. One example was 
the use of computer simulation methods to calculate a minimum value for the 
formation constant, log B, of the-ytterbium-transferrin complex; this cal-
culation yielded a value of about 12, some 10 to 15 orders of magnitude 
less than that of the iron-transferrin or plutonium-transferrin complexes. 
In summary this phase of the work confirmed the importance of trans-
ferrin as the principal transport protein for actinides, and for at least 
two lanthanides, in mammalian blood plasma in vivo. The studies further 
suggest that the two iron-binding sites on the transferrin molecule are 
important for the binding of the actinide and lanthanide metals. This was 
confirmed in other studies which have demonstrated that, as for iron, bi-
carbonate is required as a synergistic ion for metal binding to take place. 
Studies still in progress are concerned with the estimation of the thermo-
dynamic stability constants for the formation of the plutonium-transferrin 
complex. 
In collaboration with the Institute of Experimental Nuclear Physics of the 
University of Karlsruhe, attempts are being made to elucidate the mecha-
nisms of binding of foreign metals to transferrin using hafriium as a plu-
tonium analogue and europium as an americium analogue and various spectro-
scopic methods including UV-spectroscopy and time-dependent perturbed an-
gular correlation of gamma rays. These investigations confirm the impor-
tance of the iron-binding sites and have indicated that phosphate ions, as 
well as bicarbonate ions, may be involved in the metal binding. In further 
collaboration with the Daresbury Laboratory in the UK, attempts are being 
made to apply x-ray small angle scattering to the analysis of complexes in 
solution, with the aim of obtaining detailed information of the binding of 
the metals to the N- and C- terminal binding sites in the transferrin 
molecule. 
b. The cellular uptake of the iron- and plutonium-transferrin complexes. 
There is considerable experimental evidence to indicate that iron is taken 
up into at least some mammalian cell types via a receptor mediated mecha-
nism involving a transferrin-specific'receptor. In view of the observations 
discussed above which show that actinide and lanthanide metals bind to 
transferrin after entry into the systemic circulation of animals, it was of 
interest to investigate whether plutonium was taken up into cells via this 
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transferrin-receptor mechanism. In a large series of experiments using a 
range of human or animal cells in culture the uptake of iron-59 or pluto-
nium-239 from either the citrate or transferrin complexes was compared 
following incubation of the cells with the metal complexes in vitro. 
Studies of the total uptake of iron-59 by four cell lines, primary cultures 
of rat hepatocytes, and the human cell lines Hep G-2 Hepatoma, HeLa, and 
WI-12 Lymphoblasts, showed that the uptake of iron from the citrate complex 
was greater by factors ranging,according to cell type, from 8 to 100 than 
that from the transferrin complex. Essentially similar results were obtai-
ned in the studies with plutonium-239, except that the differential between 
the uptake from citrate and from transferrin was smaller, ranging from 
about 1 with Hep G-2 cells to about 10 in primary rat hepatocytes. More 
detailed studies were made to distinguish between membrane-bound and truly 
intracellular metal, these showed that both iron-59 and plutonium-239 were 
bound to the cell membrane in a form which could be released by a brief 
treatment with trypsin. This suggested the involvement of a metal binding 
protein or receptor in the cell membrane. The amount of the iron-59 bound 
to the cell membrane was always smaller than the amount transferred to the 
interior of the cell, however, for plutonium membrane binding exceeded 
cellular uptake by factors ranging from about 3 for the citrate to about 40 
for the transferrin complex. Studies in rat hepatocytes using a number of 
different types of metabolic inhibitor suggested that neither the intra-
cellular accumulation nor the membrane binding of either iron or plutonium 
were influenced by clustering of membrane proteins, intactness of microtu-
buli or of microfilament assembly; further endocytosis did not appear to 
play an important role in the uptake of these metals by hepatocytes. 
As part of a search for in vitro models for human or animal organs for 
studies of the mechanisms of metal uptake and loss liver spheroids, clusters 
of 200 to 300 cells, were prepared from pure, freshly isolated, rat nepato-
cytes and from mixtures of hepatocytes, endothelial cells and Kupffer cells 
and compared in relation to the uptake of plutonium and iron and to the re-
tention of biochemical parameters, such as the enzymes GOT, GPT and Cyto-
chrome P450 and protein synthesis, with monolayer or single cell suspensions 
of liver cells. The results suggested that while the liver cell spheroid is 
an excellent system for the study of the metabolism of organic substances 
its applicability to inorganic biochemical studies, especially to metal 
speciation analysis, is limited. 
These comparative investigations of the role of the metal-transferrin 
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complex-transferrin-receptor system in the uptake of iron and plutonium 
suggest that for primary rat hepatocytes, rat liver cell spheroids and for 
other cell lines such as HeLa, iron does appear to be incorporated into the 
cell via this mechanism, although it may not be the major uptake mechanism 
in all circumstances. With plutonium although large amounts are bound to 
the cell membrane transfer to the cell interior is very small when trans-
ferrin is present in the medium, thus the transferrin-receptor mechanism 
does not appear to be important in facilitating the transfer of plutonium 
into the cell, indeed, the presence of transferrin·may be a form of detoxi-
cation mechanism hindering the uptake of this foreign metal into the cell. 
It has not yet been established unequivocally whether the plutonium-trans-
ferrin complex binds irreversibly to the transferrin receptor on the cell 
surface, or whether the membrane binding of plutonium involves a site other 
than the transferrin receptor. If irreversible binding of the plutonium-
transferrin complex to the transferrin receptor does occur this would indi-
cate strongly that the binding of plutonium to transferrin results in some 
conformational change which inhibits dissociation of the metal-transferrin-
receptor complex. The aim of the studies discussed under (a) above is to 
attempt to establish if such conformational changes do occur, no~ only with 
plutonium but also with other "foreign" metals which form stable complexes 
with transferrin in vivo. 
c. The subcellular distribution of actinides in liver. 
Previous studies have shown that following entry into the syst'emic circula-
tion plutonium, americium, curium and actinium deposit predominantly in ly-
sosomal structures in liver and that the iron-storage protein ferritin ap-
pears to be a final storage form. The subcellular distribution studies car-
ried out during this contract were concerned with three topics: the uptake 
of plutonium into liver cell nuclei; the subcellular distribution of nep-
tunium and protactinium; and the mechanism of transfer of plutonium and 
protactinium from the liver cell membrane to the lysosomes. Autoradiographic 
studies in liver specimens obtained from rats and hamsters following intra-
venous injection of plutonium-239 indicated the deposition of a small but 
significant fraction of the total cellular plut~nium in the cell nucleus. 
Since slich nuclear deposition could be important in relation to the induction 
of radiotoxicity a comparative investigation of the cellular uptake and 
distribution of plutonium-238 and plutonium-239 in 2-day old cultures pre-
pared from freshly isolated rat hepatocytes was carried out. The cells were 
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incubated for periods of up to 5 hours in serum-free Waymouth's MB752/1 
medium containing plutonium citrate, 670 nM Pu-239 or 2.5 nM Pu-238; after 
incubation the cells were washed thoroughly in Hank's balanced salt solution 
suspended in 0.25 M sucrose-SmM Tris.HCl pH 7.4 and homogenised by passage 
through a 10 micrometre pore-size polycarbonate membrane filter. Standard 
centrifugal methods were then used to obtain the lysosomes, other subcel-
lular organelles and purified nuclei. The results showed that more than 70% 
of the cellular plutonium-238 and 55% of the plutonium-239 was deposited in 
the lysosomes. Nuclear deposition of plutonium-239 ranged from 10% after 1 
hour to 30% after 5 hours of incubation, in contrast plutonium-238, which 
has a 270-fold greater specific activity showed no significant association 
with the cell nuclei. These results suggest that nuclear uptake of plutonium 
is mass dependent; it appears unlikely to be of real significance for the 
radiological protection of workers in the nuclear industry, except in the 
case of a very severe internal contamination incident. 
Since data on the subcellular distribution of neptunium and protactinium 
were not available in the literature, limited studies of the subcellular 
distribution of these elements in rat liver following intravenous injection 
of either neptunium-237, neptunium-239 or protactinium-239 as their citra-
tes were made. The results obtained using standard differential centrifuga-
tion methods or free-flow electrophoresis for subcellular fractionation 
showed that, like the other actinides studied, both elements were deposited 
predominantly in lysosomes. 
In order to try to learn something about the mechanisms of transfer of plu-
tonium and protactinium from the cell membrane to the lysosomal structures 
in liver cells the time dependent distribution of the actinide-binding com-
ponents was studied in liver cytosol, prepared from either in vivo or in 
vitro labelled cells, using gel chromatography on Sephadex and Sephacryl 
gels. The results for both plutonium and protactinium indicate that very 
rapidly after entry through the cell membrane the metals become bound to 
proteins and to low molecular weight ligands in the cytosol, one protein of 
molecular weight about 200 kD appears to be specially important in that over 
the course of about 12 hours protactinium and plutonium appear to be trans-
ferred almost quantitatively from this protein to ferritin, the predominant 
storage protein for actinides in the cell. This 200 kD protein appears to 
play no role in the transfer of iron from cell membrane to ferritin, the 
protein itself, which appears to be present in only very small amounts, 
has not yet been characterised. Some studies have been carried out to at-
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tempt to elucidate the way in which plutonium becomes incorporated into 
ferritin, the preliminary results have led to the proposal of the hypothesis 
that the plutonium atoms become lodged in the channels in the apoferritin 
core, considerable further work will be required to substantiate this hypo-
thesis. 
d. The speciation of actinides in the gastrointestinal tract. 
Studies in experimental animals, plus very limited studies in man, suggest 
that the absorption of plutonium and other actinide elements from the human 
gastrointestinal tract is very small, probably much less than 0.1% of the 
ingested amount. However, the animal studies indicate clearly that absorp-
tion can be influenced by physiological factors such as fasting as well as 
by dietary-components and by some drugs. The study of absorption at these 
very low levels in experimental animals is difficult, requires many animals 
and often yields results with large experimental errors, further a very 
large and expensive experimental programme would be required to investigate 
all the physiological, pathological and food factors which could lead to 
enhanced absorption of actinides in man. In order to attempt to elucidate 
the chemical speciation of actinide elements in the various compartments of 
the human gastrointestinal tract a simple in vitro model has been developed 
and used to study the fractionation of plutonium, neptunium and protactinium 
and the ways in which the fractionation is influenced by various types of 
foodstuff. 
The model consists of a "mouth" in which reactions with human saliva may be 
studied, after the required reaction time a sample is removed for analysis 
and to the remainder a simulated gastric juice, with a similar enzyme and 
salt composition to human gastric juice, is added and allowed to react·, 
after sample removal simulated duodenal juice is· added to the reminder"of 
the gastric system and after an appropriate reaction time a further sample 
is removed. In the initial studies'the samples were analysed by centrifuga-
tion to separate insoluble and soluble material, the soluble fraction was 
then analysed by chromatography on Sephadex G-50 to yield "protein-bound", 
"low-molecular weight soluble" and "hydrolysed" fractions. 
Figure 1 illustrates the results obtained with two important dietary com-
ponents, tea and orange juice, for plutonium-239, neptunium-239 and pro-
tactinium-233; the data show clearly that for all three actinides the pro-
portions of insoluble, hydrolysed, low molecular weight and protein bound 
nuclide change markedly during the transition from mouth to stomach to d 
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denum. This suggests that the components of the diet ingested with the acti-
nide are likely to play a greater role in determining its chemical specia-
tion in the gastrointestinal tract than the actual chemical form in which 
the actinide was ingested. Thus tea results in predominantly insoluble, and 
presumably non-absorbable, material while the citrate in orange juice leads 
to a high proportion of soluble low-molecular weight complexes, which may 
Pu-239 
Pa-233 
"Mouth" "StotOOch" "Duodenum" "Mouth" 
Pu-239 
Pa-233 
"Stomach" 
ORANGE JUICE 
"Duodenum" 
Figure 1. The percentage distribution of the chemical fractions of plutonium, 
neptunium and protactinium in the simulated human gastrointestinal 
tract. S - Sedimentable (insoluble) material; V - Protein-bound 
material; L - Low molecular weight soluble species; H - "Hydro-
lysed" species. 
Following these simple initial studies attention has been concentrated on 
the "duodenum", the compartment from which absorption through the mucosal 
wall into the systemic circulation occurs. More refined methods for the ana-
lysis of the low molecular weight fraction from the simulated duodenum, 
using cation and anion exchangers and solvent extraction were developed. 
These studies suggested that following introduction of plutonium nitrate or 
plutonium citrate into the mouth in the absence of other dietary factors, 
the soluble low molecular weight fraction in the duodenum was about 17% and 
70-80% respectively of the total nuclide. However, for each compound only 
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about 0.1% was present in the form of electrically neutral species which 
might be expected to be adsorbable. Computer speciation analysis of pluto-
nium in a duodenal system containing ci trate also suggests that about 0.1% was 
present as uncharged complexes. It is important to note that the in vitro model 
and the computer simulation yield values for the potentially absorbable pluto-
nium fraction which lie close to those for the absorption of plutonium from ci-
trate observed in experimental animals. 
Most recent studies have involved the addition of a simulated bile to the 
duodenal system and the systematic examination of the influence of endo-
genous components of the duodenal fluids on the speciation; of particular 
interest has been the observation that lecithin may play an important role 
in controlling plutonium speciation. Lecithin vesicles formed in the duo-
denum under physiological conditions can trap appreciable amounts of plu-
tonium, or other heavy metal, in a form which appears likely to be non-
transportable through the cell membrane. The possibility of developing a 
lecithin vesicle therapy for the limitation of actinide absorption in the 
event of an oral contamination incident is being investigated. 
e. General Discussion 
The four topics discussed above have all been concerned with improving 
understanding of the chemical mechanisms involved in the transport of acti-
nides in blood, across cell membranes and within the cell itself from the 
site of entry to the ultimate deposition site. The elucidation of these me-
chanisms is of fundamental importance in relation to our understanding of 
actinide and general heavy metal biochemistry and of the reasons why the 
specific metals assume their particular distribution patterns in the body. 
Further such knowledge assists in the understanding and prediction of toxic 
effects in man. 
From the point of view of radiation protection, apart from their contribu-
tion of our fundamental understanding of the metabolic behaviour of the 
highly radiotoxic actinide elements, the data discussed above have two prac-
tical applications. 
The studies of actinide binding to transferrin and the subcellular ligands 
are important in relation to the development of improved methods of chela-
tion therapy for accelerating the removal of plutonium and other actinides 
from the human body following an internal contamination incident. These 
studies show that an essential requirement for any new chelator for the 
treatment of plutonium contamination in man is that it must mobilise 
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plutonium from its transferrin complex in the blood, and release the metal 
from ferritin in the cells. Thus in vitro studies of the ability of any 
proposed new chelator to mobilise the chosen actinide from its transferrin 
and ferritin complexes are now an essential pre-requisite for the testing 
of the substance in animals. During the period under review in vitro 
studies of the ability to release plutonium from transferrin and ferritin 
have been an essential part of our screening programme for new chelators 
and this has led to a considerable reduction in the number of animal ex-
periments carried out. 
The use of in vitro models and of computer simulation methods for the study 
of the chemical speciation of metals in the gastrointestinal tract has al-
ready been developed to the point where predictions about factors in the 
human diet which may either lead to enhanced actinide absorption from the 
gastrointestinal tract, or which can be recommended for limiting absorp-
tion, can be made with reasonable confidence. Further development of these 
methods, coupled with their validation by a few very carefully designed 
and executed studies in experimental animals or in human volunteers, can 
be expected to increase the confidence with which predictions can be made 
and eliminate the need for a very large programme of studies in experimen-
tal animals. 
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I. Objectives of the project: 
1. To use primary cultures of human tissues to study the 
interaction between radiation and known or suspected 
environmental carcinogens, promotor's, mutagens or 
toxins. 
2. To design model systems where a carcinogen's effect in 
its in vivo target organ can be studied in relevant 
systems in vitro. 
3. To screen treated cells for changes in ultrastructure 
or iocenzyme profile in addition to conventional 
transformation endopints which often have to be studied 
in specialised cell lines or rodent models. 
11. Objectives for the reporting period: 
1. To quantify increased proliferation of epithelial cells 
resulting from combined exposure to radiation and 
carcinogens. 
2. To quantify as far as possible the intermediate 
filament and biochemical changes. 
3. To investigate the problem of metabolic activation of 
carcinogens in culture and to see what role irradiation 
might have in this. 
4. To continue to study the effects of tumour promoters on 
the system. 
5. To continue epidemiological studies to identify risk 
factor combinations. 
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Ill. Progress achieved: 
INTRODUCTION 
It has become apparent in the last few years that in 
animals and cell culture systems some environmental 
carcinogens can have interactive affects with radiation and 
many of these are supra-additive. Many of the mechanisms 
involve a carcinogen which is activated by radiation or 
which yields high numbers of toxic free radicals when 
irradiated. Other carcinogens are thought to destabilise 
the DNA making radiation damage more prone to misrepair 
The implications of supra-additive effects of environmental 
carcinogens and radiation for radiation protection are that 
doses which on their own can be shown to be harmless may 
have adverse effects in a real situation where low levels 
of environmental carcinogens may be present. 
The contract sought to approach this problem on two levels, 
first by developing cultures of the human target organ for 
the particular carcinogen, e.g. oesophagus cultures for 
nitrosamine experiments, bladder cultures for 
nitrosoaniline experiments, which could be exposed to 
various chemical/radiation combinations and monitored for 
any cell alterations. The second approach was to survey 
cancer mortality statistics and to produce distribution 
maps showing areas of the country where particular cancers 
occurred at above average levels. Factors identified in 
culture as being interactive could then be studied in high 
and low incidence counties for the particular cancer. 
METHODS 
Explant cultures of human organs were set up as follows: 
Tissue ( 2cm• ) was obtained from theatre. A small 
sample of tissue was fixed for histopathological 
examination to confirm abscence of overt abnormalities and 
the remainder placed in complete growth medium and rushed 
to the tissue culture laboratory. The tissue was diced 
into 2-3 mm• pieces and digested for 30 min in 10 ml 
Earle's Balanced Salt Solution (ESBB) containing 0.1% W/V 
trypsin and 1 mg/ml Collagenase Type IV. The partially 
digested pieces were then plated in 25 cm• plastic flasks 
in 2 ml growth medium. Flasks were placed in a 5% eo. 
humidified incubator set at 37°C until required. Medium 
changes were never given during the culture period. 
For carcinogen experiments, appropriate concentrations of 
carcinogens were added to existing culture medium in a 
volume of 0.05 ml of growth medium. Where the carcinogen 
had to be dissolved in a solvent (DMSO, ethanol), a 
concentrated stock solution was prepared and a dilution of 
at least 1:100 was made with growth medium prior to 
addition to cells. Carcinogens were added one day after 
the explants were set up, allowing time for the explants to 
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adhere to the plastic, and 12 h prior to irradiation. 
Irradiation took place using a Cobalt 60 Teletherapy unit 
delivering 94 cGy/min at 60 (ems) SSD. 
For routine growth estimations cultures were fixed in 
formalin two weeks after carcinogen and radiation 
treatment. They were stained with Haematoxylin and Eosin 
and the area of outgrowth calculated and converted to cell 
number. Cell proliferation was studied in selected 
cultur~s using the monoclonal antibody Ki67 (DAKO) and an 
indirect peroxidase immunocytochemical development 
technique. 
The epithelial nature of the outgrowth was confirmed in 
representative samples of cultures using a low molecular 
weight general cytokeratin antibody with indirect 
peroxidase development. The presence of stromal or 
endothelial elements was monitored using anti vimentin and 
anti human endothelium. 
RESULTS 
Tissue Culture 
Figure 1 shows the effect of increasing levels of three 
different environmental carcinogens known to affect the 
oesophagus on the outgrowth of oesophageal explants, 
assessed at two we~ks after treatment. The figures also 
show the combined effect of the carcinogens and a single 
dose of radiation (5 Gy). 
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It is apparent that low levels of benzo(a)pyrene or 
-propiolactone alone or in combination with radiation 
stimulate growth. Higher levels of carcinogen inhibit 
growth. With n-nitrosoethanolamine the carcinogen 
inhibits growth when used alone, but there is a remarkable 
growth enhancement when a low level (0.05 g/ml) is used in 
combination with 5 Gy gamma rays. The percentage increase 
or decrease in growth for each concentration of carcinogen 
with and without radiation is shown in Table 1. 
Carcinogen No Jrradl~lllon +5 Gy 
conccn-
tr~1l1on Cell No. %t \Uf\'1\'.tl Cell No. %t SUr'viVaJ 
11g/ml 
{1-propwlactone 0 1 X 105 100 7 X 104 100 
0 0025 1 7 X 105 170 1 7 X 105 243 
0 025 4 X 104 40 56 X 104 75.7 
0.25 0 0 0 0 
2.5 0 0 0 0 
N-llitrtJS0£'1hanolamine 0 1 X 105 100 X 104 100 
0005 24 X 104 24 3 5 X 104 43.7 
0 05 5.2 X 104 52 I 55 x 10 5 194 
0.5 2.7 x to• 27 6.9 X 104 g6 2 
5.0 2.5 x to• 25 7.8 X 104 97 5 
Bcn:o( a)pytl'IIC 0 9.5 X 104 100 73 x to• tOO 
0 t J.}H X 10' 187 t 06x tO' 145 
1.0 11 X 10 5 1t5 t 4 X 105 t92 
10.0 4 x to• 42 3.1 x to• 42 
Table 1 
Actual Cell numbers and percentage survival for normal 
oesophageal mucosal cells exposed K carcinogens and 
radiation singly or in combination. 
Since the combination of radiation and nitrosamine seemed 
important, it was decided to vary the radiation dose with 
constant levels of the other two carcinogens and see if a 
combination leading to dramatic growth enhancement similar 
to that seen with nitrosamines could be detected for the 
other carcinogens. Results are shown in Fig 2 for 1 ug/ml 
benzo(a)pyrene (2a) and for 0.025 ug/ml B-propiolactone 
(2b). It is apparent that 0.025 g/ml B-propiolactone 
leads to enhancement of growth at a radiation dose of 2.5 
Gy while it had no effect at 5.0 or 7.5 Gy and reduced 
growth at 10 Gy. With 1 g/ml benzo(a)pyrene, considerable 
growth enhancement was also seen after a radiation dose of 
2.5 Gy but with higher doses, 5-12.5 Gy, a gradual 
reduction in growth was observed. 
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Where cultures treated with growth stimulating levels of 
nitrosoethanolamine +radiation and stained for 
proliferation using Ki 67 antibody, there was considerable 
proliferative activity around the edge of the explant and 
in small pockets throughout the cultures treated with 
nitrosamine and radiation. Similar results were observed 
for cultures treated with benzo(a)pyrene or 
B-propiolactone. The proliferative activity around the 
outgrowth edge was seen in control cultures although from 
the area and cell number measurements it was obviously 
greater in the carcinogen-treated group. The proliferating 
foci were only seen in cultures treated with carcinogen or 
carcinogen and radiation and were abundant in the latter 
group. Since the cells looked different to the epithelial 
cells and grew over the epithelial cell layer, they were 
tested for the presence of vimentin and for the endothelial 
antigen using in situ immunocytochemistry. The cells 
stained negative for vimentin, excluding the possibility 
that they were fibroblasts, but were positive for 
endothelial antigen. They also had characteristic 
ultrastructural appearance of squamous carcinoma cells. 
Their nature has therefore still to be resolved. 
Quantification of the numbers of foci with respect to dose 
was performed for both urothelial and oesphageal cultures, 
the results of urothelium are shown in Fig 3. 
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It is clear that there is a direct correlation between dose 
and focus number in the range 2.5 - 5.0 Gy. The 
combination of nitrosamine with radiation greatly increased 
both the number and size of the foci. On ultrastructural 
examination it can be seen that the damage carried by these 
proliferating focal cells is immense and involves almost 
total loss of normal mitochondria. Since this suggested 
that these cells might have defective respiration, 
experiments were performed where inhibitors of aerobic or 
anaerobic respiration were used. The results showed that 
the cells have defective aerobic respiration but quite 
adequate anaerobic glycolysis. Growth of other cells in 
the culture, which were not part of the focus, was 
inhibited by both aerobic and anaerobic inhibitors as were 
control cells. 
The results of experiments where explants were irradiated 
and numbers of endothelial cells present in the outgrowth 
after two weeks were counted show that both the absolute 
numbers of endothelial cells and their frequency relative 
to other cell types in the explant increased after 
irradiation. The degree of differentiation (organisation 
into capillary-like tubes) also showed a characteristic 
relationship with dose. Differentiation was maximal after 
explant doses in the region of 2.5-5.0 Gy. Nitrosamine 
(0.05 mg/ml) increased the numbers of endothelial cells and 
at radiation doses below 5 Gy had a dose multiplying effect 
of 1.9. The effect of nitrosamine and radiation 5 Gy on 
the organisation and differentiation of endothelial cells 
into capillary tubes was pronounced and appeared to be 
mediated by the epithelial cells in the culture. 
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EPIDEMIOLOGY 
Maps and tables have been produced showing cancer 
distributions and assessment of the significance of the 
patterns is at present underway. The Atlas of Cancer 
Mortality is in press with the Irish Department of Health. 
DISCUSS lOB 
The results presented indicate that low doses of 
carcinogens combined with low (<5 Gy) doses of radiation 
can stimulate the outgrowth of cells from oesophageal and 
urothelial tissue explants and cause proliferation of 
endothelial cells. All the chemicals are known or 
suspected carcinogens for oesophageal mucosa and for 
urothelium in vivo. It is, therefore, of considerable 
interest of find stimulation of cell proliferation in 
vitro. Each carcinogen shows a different pattern of dose 
response and growth peaks at a different combination of 
treatments. In the case were nitrosamine and radiation 
were used in combination it is difficult to say whether the 
nitrosamine is acting by protecting the cells against 
radiation damage or by enhancing the growth rate of 
survivors but the immunocytochemical evidence would suggest 
that proliferation of at least certain groups of cells is 
actively stimulated by the presence of nitrosamine during 
irradiation The possibility that radiation is in some way 
'metabolically activating' nitrosamine cannot be 
discounted. 
The interaction between chemical carcinogens and radiation 
in animals has been reviewed by Streffer and Muller, who 
found mainly additive or subadditive effects with 
alkylating agents such as nitrosamine&. Synergistic 
effects were sometimes seen but were generally confined.to 
radioresistant organs and to very specific combinations of 
doses and times of administration of agents. DiPaolo 
found using cell cultures that the cell killing effect of 
radiation and the chemical carcinogen tended to mask the 
transforming effect, but using benzo(a)pyrene treated cells 
was able to demonstrate considerable enhancement of 
transformation by exposing cells 48 h later to 1.5-2.5 Gy. 
Using an experimental lung tumour mouse model, other 
workers found synergistic effects if fractionated radiation 
and urethan were combined but not if acute radiation was 
used. 
The finding that proliferation of endothelial cells occurs 
only in carcinogen±radiation treated cultures is very 
interesting since angiogenesis is an key factor in 
epithelial tumour growth. It is interesting to speculate 
whether the carcinogens themselves stimulate growth of the 
endothelial cells or whether they stimulate the epithelial 
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cells to secrete an angiogenesis factor. Preliminary 
results suggest the latter is occuring. 
In all these studies it is apparent that the balance 
between cell proliferation and cell killing is fundamental 
to the observation of synergistic interactions. Situations 
or conditions which show reduced toxicity show synergistic 
effects, while toxic effects are associated with additive 
or subadditive effects. 
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I. Objectives of the project: 
in 
as 
dependence 
influenced 
of the level of 
by decorporation 
Research sponsored by the former CEC contract BIO-D-381B showed that a 50% 
decrease of the 226-Ra content due to chronic decorporation with 
Na-alginate did not alter significantly the bone tumour incidence in mice. 
The present project was developed to investigate whether the lack of 
long-term protection was linked to the characteristics of the radioisotope 
and whether a similar lack of protection was observed after decorporation 
of other high risk isotopes such as 241-Am (chosen for its predominant 
role in aged nuclear waste). The decorporative treatment schedules used 
(Na-alginate after 226-Ra injection and Zn-DTPA after 241-Am injection) 
were both efficient in reducing the skeletal burden. We investigated 
whether the radiation dose to sites at risk (bone surfaces) was modified. 
11. Objectives for the reporting period: 
(1) Evaluation of the efficacity of protracted Zn-DTPA injections to 
reduce long-term radiation effects. Zn-DTPA therapy started 4 days after 
241-Am injection to mimic time elapsing between an accident and start of 
the therapy. 944 C57BL mice were included in the study. 
(2) In addition to the comparison of the efficacity of the decorporative 
treatments, relative toxicity ratios from 241-Am versus 226-Ra could be 
calculated with respect to mortality rate and rate of death with bone 
tumor. This information is important since very few experiments allow in 
the same species direct comparison of the effects of an actinide with the 
effects of 226-Ra, the latter are assumed to be the link between animal 
experiments with bone-seekers and extrapolation of the effects to man. 
(3)A. The effect of Na-alginate treatment on 226-Ra distribution in femurs 
and vertebrae was evaluated via alpha-track autoradiography. 
(3)B. The ability of Zn-DTPA treatment to remove a skeletal 241-Am burden 
was studied via implantation of Am contaminated bones in non-radioactive 
recipient mice which were subsequently treated with Zn-DTPA. 
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Ill. Progress achieved: 
1. Methodology 
(1) C57BL mice were injected with either 22, 58, 190, 373 or 1197 kBq 
241-Am per kg mouse, or 940 kBq 226-Ra per kg mouse or remained 
uncontaminated. 4 days after injection of 58 and 373 kBq 241-Am/kg mouse, 
half of the group received intraperitoneal zn-DTPA injections (50 ~mole/kg 
mouse) once a week during 8 successive weeks. The other mice of these 
groups were sham-injected with 0.9% NaCl. Also the non-contaminated group 
was split, one third received Zn-DTPA injections, one third received sham 
injections and one third was not injected at all. At death, the carcasses 
were radiographed, suspect tissues were dissected and the tissues were 
processed for histopathology. Life table analyses was used to compare 
mortality rate among the groups, also mortality from specific diseases 
(bone-, liver- and lung tumors, thymic lymphosarcomas, non-thymic 
lymphoreticular sarcomas and non-neoplastic late-degenerative changes) was 
compared among the groups via Peto statistics and the non-parametric 
Breslow modified Wilcoxon test as developed by Hoel and Walburg. To 
evaluate the efficacity of the treatment schedule for the removal of 
241-Am, the 241-Am burden of femurs, vertebrae and livers was 
radiochemically measured in 8 mice of the Zn-DTPA and corresponding 
sham-treated 241-Am injected groups at the end of the decorporative 
Zn-DTPA treatment. 
(2) The toxicity ratio of 241-Am versus 226-Ra was calculated with respect 
to mortality rate and rate of death from bone tumour. The proportional 
hazards regression model was used and calculations were done in function 
of injected radioactivity, in function of the average skeletal dose and in 
function of the average dose rate to the skeleton. 
(3)A. C57BL mice were injected with 24 kBq 226-Ra, 4 days later half of 
the mice received daily 5% Na-alginate in their diet over a period of 6 
months. The mice were then killed, femora and vertebrae were removed for 
examination via alpha-track autoradiography. The tissues were fixed, 
embedded in Spurr' s resin, sections were collected onto CR-39 plastic 
slides and exposed in a cycled vacuum during 4 weeks. After exposure the 
slides were etched to develop the 226-Ra alpha-tracks originating from the 
bone section (NRPB, Chilton, Priest et al., Human Toxicology, 1983). 
(3) B. To test whether Zn-DTPA removes any 241-Am from bone surfaces, 
241-Am contaminated bones were implanted in not-radioactive recipient 
mice. The implanted bones had a 1 day old or a 28 day old 241-Am 
contamination. Previous to implantation in cell-tight diffusion chambers, 
bone and bone marrow cells were killed by repeated freeze-thawing, to 
prevent also recycling of Am due to active bone remodelling. Half of the 
recipient mice were chronically treated with Zn-DTPA injections 4 days 
after implantation. The Zn-DTPA injections were given once a week during 8 
successive weeks. 
The 241-Am content of the implanted cortical (femur diaphysis) and 
trabecular bones (femur epiphysis + metaphysis) was radiochemically 
measured at the end of the Zn-DTPA treatment period. 
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Results 
(1) Chronic injections with zn-DTPA, once a week, during 8 successive 
weeks, and starting 4 days after injection of 58 and 373 kBq 241-Am/kg 
C57BL mouse were an effective protection against long-term radiation 
damage. At both dose levels of 241-Am, Zn-DTPA treatment decreased 
significantly the mortality rate. Death from 241-Am induced bone tumours 
was significantly reduced at the lower dose level (58 kBq 241-Am/kg 
mouse) • A sparing effect due to Zn-DTPA treatment was also observed for 
cancers which occur spontaneously in the C57BL mice, but which were 
enhanced by 241-Am injection (liver tumours, lymphoreticular sarcomas and 
lymphosarcomas). No tumours did show up in sham-treated mice after 373 kBq 
241-Am/kg mouse due to the 241-Am induced shortened life-span. In the 
corresponding Zn-DTPA treated mice, bon~ tumors, and a few other malignant 
tumors were observed. This may be ;related to the increased life-span of 
the animals due to zn-DTPA treatment. 
The applied Zn-DTPA treatment was efficient for the reduction of .the 
241-Am burden with 45 + 8% in the vertebrae, 40 + 11% in the femurs and 97 
+ 7% in the liver aft;r injection of 58 kBq Am/kg. A similar fraction of 
the Am burden was removed due to Zn-DTPA treatment in the high dose group. 
The reduced 241-Am body burden obtained via Zn-DTPA therapy protected the 
cells at risk for long-term radiation damage. This was in contrast with 
the lack of protection against long-term radiation damage after a delayed 
Na-alginate treatment following 226-Ra injection. 
(2) The data on survival time and death with bone tumor could be compared 
between 241-Am injected mice and 226-Ra injected mice of the same C57BL 
strain (previous experiments). This enabled to compare directly in the 
same.strain the effects of the bone-surface seeker 241-Am to the effects 
of the bone volume seeker 226-Ra. The proportional hazards regression 
model was applied and the rate of death with bone tumor was 12.9 times 
higher after 241-Am injection than after 226-Ra injection if the 
regression covariate was the average dose to the skeleton. The relative 
risk was 3.5 if regressed to the injected radioactivity. The mortality 
rate after 241-Am injection was 20 times higher than after 226-Ra 
injection if regressed to average dose to the skeleton. 
(3)A. Daily treatment with Na-alginate of mice injected with 226-Ra 
resulted after 6 months in a significantly decreased 226-Ra ~oncentration 
per g bone ash in the lumbar vetebrae of treated mice (P < 0.05) • The 
alpha-tra~k autoradiographs showed no evidence of translocation or 
redistribution of 226-Ra due to chronic Na-alginate treatment. It is thus 
unlikely that due to mobilization of 226-Ra from the bones by alginate, a 
redistribution occurred so that more target cells close to bone surfaces 
are expose~ despite the overall reduced skeletal 226-Ra burden. 
(3)B. In an experiment in which translocation of 241-Am from liver to bone 
and active bone remodelling was prevented, chronic zn-DTPA treatment 
(injections once per week during 8 weeks) was not succesful in removing 
any 241-Am from trabecula;- or cortical bone surfaces. Zn-DTPA did not 
remove any significant amount of 241-Am from bones with a one day old 
241-Am contamination, or from bones with a 4 weeks old 241-Am 
contamination. 
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Conclusion 
A delayed chronic Zn-DTPA treatment of mice after 241-Am injection removed 
a substantial proportion of 241-Am from skeleton and from the liver. This 
resulted in a protection of the animals against long-term radiation damage 
(prolonged survival, decrease in tumor incidence). The reduced 241-Am 
burden obtained with a Zn-DTPA treatment which started only 4 days after 
241-Am injection and which lasted 8 weeks protected the cells at risk. 
Our transplantation experiment with Am contaminated bones suggested that 
Zn-DTPA reduced the dose to the cells at risk by preventing redeposition 
on bone surfaces of 241-Am in the circulation and not by removing the 
241-Am which was already bound to bone. We have shown that the additional 
radiation dose from 241-Am, translocated to bone from the liver and the 
remodelling bone surfaces, is important for development of late radiation 
effects. 
These results are in contrast with previous findings where a chronic 
administration of Na-alginate to 226-Ra injected mice in spite of a 
reduced 226-Ra burden, failed to protect the mice against 226-Ra induced 
life span shortening and bone tumor induction. 
Since alpha-track autoradiography showed no evidence after alginate 
therapy for redistribution of 226-Ra in the vertebrae e.g. closer to the 
cells at risk, we assume that the initial 226-Ra radiation dose to cells 
at risk determines the late radiation effects. Therefore the time lapse 
between decorporative treatment and 226-Ra radiocontamination should be as 
short as possible. 
The toxicity ratio of 241-Am versus 226-Ra related to average skeletal 
dose was 20.4 for reduction of life span, and 12.9 for rate of death from 
bone tumour. This latter value was more than 2 times higher than the risk 
ratio reported in the literature for beagles and mice. 241-Am did not only 
induce bone tumors but also increased in a dose dependent way death from 
other tumors which naturally occurred in the mice (liver tumors, 
lymphosarcomas, lymphoreticul sarcomas). 
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STUDIES ON THE MOLECULAR BASIS OF RADIATION-INDUCED CARCINOGENESIS 
1. Induction of Leukemia in vivo 
2. Induction of oncogenic~ransformation in vitro. 
Contract nr. BI6D-185-NL 
Prof.Dr. A.J. van der Eb 
Department of Medical Biochemistry 
Sylvius Laboratoria P.O.Box 9503 
2300 RA Leiden, The Netherlands 
Dr. A.G.Jochemsen 
B. KLein 
Project 1. Induction of leukemia in vivo 
Introduction 
The objective of the research proposal, which consisted of 2 pro-
jects, was to gain an understanding of the mechanism of radiation-induced 
carcinogenesis. As a model the induction of leukemia in vivo (project 1) 
or of oncogenic transformation in vitro (project 2) were chosen. It is 
generally accepted that induction of cancer is a multistep process, 
requiring activation of at least 2 complementing oncogenes in the same 
cell. This complicates studies on the role of physical or chemical agents 
in carcinogenesis since high doses of the agent are required to activate 
2 oncogenes in the same cell. In an attempt to circumvent this problem we 
have used as starting material normal diploid cells or established cell 
lines in which one activated oncogene had already been introduced arti-
ficially before the radiation treatment. Cells carrying such an activated 
oncogene would require one step less than the original cells, so that 
low, more "physiological", doses of radiation could be used to induce 
subsequent step(s), and the effects of radiation_ could be more easily 
studied. 
The originally planned approach was to introduce an activated 
oncogene (ras or ~) into bone marrow cells from an inbred mouse strain, 
with the use of a retroviral vector. The cells would then be exposed to 
ionizing- or UV-radiation and transplanted back into (lethally irra-
diated) syngeneic mice. If these two types of radiation activate dif-
ferent carcinogenic pathways this could result in complementation of 
different oncogenes. The endpoint is the induction of a form of leukemia. 
Results and Discussion 
Attempts to introduce genes with the use of retroviral vectors into 
bone marrow stem cells have met with considerable difficulties. Control 
experiments carried out in collaboration with the gene-therapy group in 
the lab (Drs. H. van Ormondt and R. Hoeben) and with Dr. D.Valerio 
(Radiobiological Institute, Rijswijk) have indicated that it is indeed 
possible to introduce genes with retroviral vectors into hemopoietic stem 
cells. However, most of the spleen colonies found after transplantation 
of the infected bone-marrow cells into lethally-irradiated mice soon lost 
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expression of the retroviral insert due to inactivation of the LTR-
enhancer. Therefore, it was decided to abandon this approach and to try 
and use bone marrow from transgenic mice carrying an activated oncogene 
in the germ line. Mouse strains transgenic for the ~-1 oncogene or the 
c-~ oncogene became available towards the end of 1988 in the laboratory 
of Dr. A. Berns (Netherlands Cancer Institute, Amsterdam). The oncogenes 
were regulated by the H-2 or the IgH promoter. Due to lack of sufficient 
numbers of animals expressing the oncogenes in blood cells it was not 
possible to carry out the experiments in 1989. In collaboration with Dr. 
Berns this work will be carried out as soon as sufficient animals can be 
set aside for the purpose. 
Project 2. Induction of transformation in vitro 
Introduction 
The aim of this study was to introduce an activated oncogene (ras, 
~) into primary rodent cell cultures or established rodent cell lines, 
and to treat the cells subsequently with ionizing- or UV-radiation. It 
could then be tested which type of radiation treatment can cause a second 
transformation event resulting in morphological transformation or altered 
growth behaviour. The method could possibly lead to the development of a 
suitable and relatively cheap assay of carcinogenic potential of chemical 
or physical agents. 
The results obtained with primary rat embryo or rat kidney cultures 
indicated that these primary cells are not suitable for the experiments 
mentioned above, for the following reasons: 
1) transfection efficiencies were relatively low, necessitating the 
isolation of colonies that had been co-transfected with an oncogene and a 
dominant marker gene conferring neomycin-resistance. This turned out to 
be a problem because the cells still appeared to have a limited life 
span and virtually stopped growing before a sufficient number of cells 
could be obtained to test expression of the cotransfected oncogene. (2) 
the primary embryo cultures showed high spontaneous "transformation" 
frequencies. 
The established rodent cell lines tested also proved to be unsuit-
able, because they were all found to be already weakly oncogenic even 
before transfection of the oncogene. It was decided, therefore, that the 
best approach would be to focuss on primary cultures derived from mice 
transgenic for an activated oncogene. Mice transgenic for the ~-1 
oncogene were available at the laboratory of Dr. Berns, as mentioned 
above. The c-~ transgenic mice were not suitable because they expressed 
the oncogene only in lymphocytes. 
Methodology 
To minimize the risk of spontaneous transformation, only primary 
cultures of baby mouse kidney cells were used. 7-8 days old transgenic 
mice expressing the ~-1 oncogene from the H2 promoter were sacrificed 
and the kidneys were trypsinized and brought in culture. 2 days after 
seeding, the cultures were 60-70~confluent and were then irradiated with 
UV-light or X-rays. (5-10 J .m and 300-600 rad, respectively). The 
cultures were maintained for 6 weeks by changing the medium twice weekly. 
Cultures from each category were also trypsinized 1 day after irradiation 
and reseeded at lower cell density or suspended in soft agar medium to 
score for anchorage-independent growth. The dishes were regularly checked 
for appearance of morphologically transformed foci or agar colonies. 
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Results and discussion 
Cultures of baby mouse kidney cells from mice transgenic for the 
~-1 oncogene were irradiated as indicated above. In none of the cul-
tures morphological transformation could clearly be observed, nor was any 
growth in soft agar detected. This negative result was later explained by 
the fact that the ~-1 gene was only expressed at very low levels in the 
kidneys of these mice, whereas ~-1 protein could not be detected. The 
experiments will be repeated with a transgenic mouse strain showing high 
expession of the ~-1 oncogene in the kidneys. Of this particular mouse 
strain only few individuals were available. Therefore, larger numbers of 
mice have to be bred before the experiments can be carried out. Attempts 
will also be made to obtain other strains of transgenic mice harboring 
appropriate oncogenes that are expressed in suitable tissues (preferably 
baby mouse kidney, alternatively whole embryo). 
References 
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Title of the project no.: Radiation Protection Programme 1985 1989 
~inal Report - · 516-D-097-UK 
STUDIES OF THE MECHANISM AND PREVENTION OF LOW DOSE RADIATION 
CARCINOGENESIS OF THE THYROID 
Head(s-) of project: 
Professor E D Williams 
Scientific staff: 
Dr V Wynford-Thomas 
Miss K Horler 
Dr N Williams 
Post-Doctorate Research Officer 
Research Offieer 
Clinical Lecturer 
I. Objeotiws of the project: 
To study the quantitiative relationship between low dose radiation 
and the development of thyroid tumours in the rat and to study the role 
of the growth stimulatory effect of TSH on tumour development and the 
value of TSH suppression in the prevention of radiation induced thyroid 
tumours. 
11. Objectives for the reporting period: 
To study the relationship between low dose radiation of the thyroid 
and the number of tumours induced in the goitrogen model, and to study 
the effect of temporary or permanent interruption of the growth stimulus 
on carcinogenesis. 
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Ill. Progress achieved: 
1. Methodology 
The study has used radiation to the thyroid from an external source 
and ·from 1 31 I followed by longterm goitrogen ·treatment to give rise to 
thyroid tumours.· The tumours ·induce~ were quantified by sub-serial 
section of the gland, counting th$ lesions in each section, classifying 
them as focal hyperplasias or adenomas and measuring the largest 
diameter of each-lesion. Studies carried out included: 
(a) studying the effect of very low dose external radiation; 
(b) giving 13-1r followed by antithyroi'<i treatment for ·varying 
periods, then killing the animals, 
(c) giving 131 r followed by antithyroid treatment for varying periods 
then maintaining animals off antithyroid treatment and killing all 
groups together, 
(d) giving- radiation to·mice followed by·longterm goitrogen treatmertt 
followed by a period of remission; and linking the changes to the 
clonality of the lesions and 
(e) giving radiation to one group of animals after they were given a 
limited course of antithyroid treatment and comparing the number 
and type of lesions with a group of equal age which had not had 
previous treatment. 
2. Results 
A. The results of the (1, tO, 100 rads) were inconclusive~ ·an 
initial study suggesting a clear dose ~ffect at the lowest rad dose rate 
could not be confirmed by a second larger study. 
B. The results of a study of the rate of onset of focal 
hyperplasias (FH) and of adenomas (A) after a single dose of radiation 
followed by prolonged goitrogen therapy were of considerable interest. 
This study showed that the FH numbers increased lineally with time after 
radiation but that A numbers initially increased more slowly and later 
increased more rapidly. The size of the lesion showed a difference 
between FH and A. The FH size profile remained almost unchanged with 
time, while the A profile showed a higher mode than FH and a much 
greater increase in higher diameter lesions with time. Both the changes 
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in the absolute numbers and in the diameter profile are consistent with 
a progression of FH to adenoma in the genesis of thyroid neoplasia. 
C. The result of a study of the regression of number and size of 
radiation induced lesions on withdrawal of goitrogen stimulation showed 
that virtually all lesions produced by 47 or 120 day goitrogen treatment 
were undetectable by the end of the experiment, while over half of the 
lesions produced by 200 day goitrogen treatment were present at the end 
of the experiment, although they were of much smaller size. These 
results suggest that later lesions are more permanent than the earlier 
lesions. 
D. 131 A study of mice given I followed by longterm goitrogen 
showed that by 46 weeks of treatment a high incidence of adenomas and a 
significant incidence of adenomas had been achieved. When goitrogen was 
withdrawn for a period of 4 weeks there was a small drop in the number 
of adenomas, and a significant drop in the number of carcinomas. Both 
showed histological evidence of regression. Parallel studies of the 
clonal origins of the lesions using G6PD histochemistry in mice 
heterozygous for a G6PD deficiency showed that the lesions were all 
monoclonal. This study shows that regression does not imply that the 
lesions were not monoclonal. It suggests that in the modal using 
radiation followed by longterm goitrogen therapy the tumours induced 
remained TSH dependent - and their frequency may result from the lack of 
the requirement to develop TSH autonomous growth. 
E. This study is still under evaluation. 
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Title of the project no.: 
Flow cytometric analysis, computer aided morphometry and 
histopathology of radiation-induced rat mammary neoplasma as 
parameters for their biological behaviour 
Head(s) of project: 
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I. Objectives of the project: 
Rat mammary tumor models are frequently used for research on 
the mechanism of human mammary carcinogenesis. However, the 
value of these models has been criticized as rat mammary 
carcinomas are clinically less malignant than the human counter 
parts. 
The present study was undertaken in order to study the nuclear 
DNA content in formalin fixed rat mammary tumors using flow 
cytometry and to compare these data with histological and 
cytological characteristics. The applicability of the rat as a 
model for human mammary gland carcinogenesis will be endorsed 
if in this respect a similarity between human and rat tumor 
characteristics can be established. 
11. Objectives for the reporting period: 
To assess cytological characteristics, such as nuclear area, 
perimeter and nuclear irregularity, of benign and malignant rat 
mammary tumors by applying morphometrical methods to archival 
formalin fixed tumor material as used for DNA flow cytometry 
and histology. 
To evaluate the data on DNA flow cytometry and nuclear 
characteristics as collected during the whole contractual 
period and to correlate them with histological signs of 
malignancy such as cellular pleomorphism, mitotic rate, 
invasiveness and metastatic capacity. 
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Ill. Progress achieved: 
1 . Methodology 
Animals. Paraffin blocks from rat mammary tissues used for 
FCM were derived from radiation carcinogenesis studies 
described by van zwieten (1). In these studies inbred female 
Wag/Rij rats and Sprague-Dawley rats in the 6th generation of 
inbreeding were obtained from the specified pathogen free 
stock colony. After bilateral or multilateral total body 
irradiation, as described earlier (1), at the age of 8 weeks, 
they were housed in experimental rooms under conventional 
conditions. The health of the experimental animals was followed 
closely by bacteriological and serological monotoring. The 
animals were kept for their entire lifespan, clinically 
examined weekly and a complete gross necropsy was performed on 
those found dead or killed moribund. Histological slides were 
prepared from all organs and tissues. 
Histology. The microscopic examination was performed 
independently by two pathologists on hematoxylin-phloxine-
saffron (HPS) stained sections according to the classification 
of van Zwieten (1). For our investigations representative 
samples of the following diagnostic categories were selected: 
tubular adenomas (n=8), papillary cystadenomas (n=8), 
fibroadenomas (n=10), noninvasive (n=9) and invasive (n=7), 
tubulopapillary carcinomas, noninvasive (n=9) and invasive 
(n=9), cribriform comedo carcinomas and metastasizing 
carcinomas (n=S). 
Flowcytometric analysis of DNA content. 
a. Cell preparation and staining. Fifty pm sections were 
prepared from paraffin blocks of the selected benign and 
malignant rat mammary turners, cleared of paraffin by two 
changes of xylene of 10 minutes each and stepwise rehydrated in 
a series of alcohol 100%, 96%, 70% and 50% to destilled water 
as described by Hedley (5). Each step took 10 minutes at room 
temperature and fluids were changed twice. The rehydrated 
tissue sections were washed twice with PBS and subsequently 
subjected to enzymatic digestion to prepare a suspension of 
free nuclei. The tissue sections were incubated for 30 minutes 
in 3 ml 0.05% protease XXIV (Sigma P8038) at pH 7.3 at 37°C. 
The digestion was stopped by adding 10 ml cold PBS. After 
vortexing the suspension was filtered through a 30 pm mesh 
nylon gauze, centrifuged, washed with PBS, resuspended and 
passed 2 times through g 27 gauge needle. The final volume was 
adjusted to about 10 nuclei/ml. To provide an internal 
standard for normal diploid cells, nuclei of formalin fixed 
renal tissue of the same mammary tumor bearing rat were 
isolated using the same procedure and overnight labeled with 
FITC (3 ~g/ml in 0.5 M sodium bicarbonate pH 8.0). The nuclei 
were subsequently rinsed once with distilled water to remove 
excess stain. Ten minutes before FCM 0. 5 ml labeled renal 
nuclei was mixed with 0. 5 ml of tumor nuclei and the ensuing 
suspension was labeled with PI in a final concentration of 4 
~g/ml. 
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b. P1ow cytometric ana1ysis of DNA content. Cellular DNA 
content was measured in at least 10. 000 cells on a modified 
fluorescence activated cell sorter, RELACS-3 (3-laser Rijswijk 
Experimental Light Activated Cell Sorter) using an argon laser 
operating at 488 nm (0.5 W). 
Forward light scatter and time-of-flight measurements were 
conducted to eliminate aggregates and debris from the analysis. 
Distilled water was used as sheath fluid. For measuring PI 
fluorescence, RG 620 and KV 550 filters (Schott Glaswerke, 
Mainz, FRG) were used in front of a s-20 type photomultiplier 
(PM). For FITC, a 520 - 550 nm band pass filter (Pomfrett, 
Stamford, CT) in combination with a 530 nm long pass filter 
(Schott) was used, also with a S-20 type PM. The filters were 
used in combination with dichroic beamsplitter FT 570 (Zeiss, 
Oberkochen, FRG). 
c. Ploidy assessment. By measuring simultaneously red (PI) and 
green (FITC) fluorescence a scatter plot resulted, which was 
used to provide two histograms: one representing renal nuclei 
(both green and red fluorescence) and one representing tumor 
nuclei (red fluorescence only) (See progress report 1988). From 
these histograms the peak channel number of the first major 
peak of the tumor cell suspension was derived and divided by 
the peak channel number of normal renal nuclei (DI). To check 
whether the presence of FITC influenced the fluorescence 
intensity of PI, peak channel numbers of nuclei of the same 
renal tissue stained with PI or PI + FITC were compared. It 
appeared that in the presence of FITC a higher red fluorescence 
was observed. This factor could vary from 1. 00 to 1.14. The 
amount of the contribution may vary with dye concentration and 
filter choices. Therefore, a correction factor was determined 
for each run using the same standard deparaffinized renal 
tissue. Histograms with a coefficient of variation of less than 
8% in the diploid peak were considered of sufficiently good 
quality for further analysis. Tumors with a GO-G1 population 
with a DI between 0.9 and 1.1 were defined as diploid. A cell 
population with a DI ~ 0.9 was considered to be DNA hypoploid 
and a cell population with a DI between 1.1 and 1.8 to be DNA 
hyperploid. 
Cytologica1 characteristics. 
a. Mitotic activity index. In 24 tumors we tried to relate the 
mitotic index to DNA aneuploidy and histological signs of 
malignancy. To this end we chose material from tubulopapillary 
tumors in various degrees of malignancy i.e. tubulopapillary 
adenomas, noninvasive and invasive tubulopapillary carcinomas. 
The number of mitoses was counted in 10 random fields at x400 
magnification in the histologically most malignant areas of the 
tumors. 
b. Computer aided morphometry. To this end 3 pm thick slides 
were prepared of the same 24 tumors selected for establishing 
the mitotic activity index. Morphometric analysis was performed 
in the most atypical areas as judged by hypercellularity, 
nuclear and cellular pleomorphism and relatively high mitotic 
rate. 
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Photomicrographs of these areas were made with a 63x 
objective and printed at a final magnification of 2500x, 
resulting in nuclear images of at least 20 mm diameter. At 
least 25 epithelial nuclei with intact nuclear outline were 
randomly selected for assessment of perimeter, area and 
formfactor PE (4rr area/quadrated perimeter). Nuclear outlines 
were directly measured by using a cursor and graphic tablet 
coupled with a MOP Videoplan (Kontron, Munich, FRG; software 
version 5.42) microcomputer. 
Statistics. Differences in frequency distribution in data 
groups were assessed with the Fisher's Exact Test or Students 
T test. The level of significance was set at a p of s 0.05. 
2. Results 
Out of 65 tumors, 43 were DNA-diploid (66%) and 22 aneuploid 
(34%). Twelve (18%) of the DNA aneuploid tumors were 
hypoploid. There were no animals with a tetraploid tumor 
according to the criteria formulated by Rutteman (6). The 
results of histological typing and of FCM examinations are 
summarized in Table 1. 
Benign tumors. Five 
aneuploid GO-G1 peaks. 
hypoploid. 
(18%) of the 26 benign tumors had 
Four of the 5 aneuploid tumors were 
Within the series of benign tumors 
between histological typing and ploidy 
there was 
status. 
no relation 
Malignant tumors. Seventeen (44%) of the 39 malignant 
tumors had aneuploid G0-G1 peaks. Eight ( 4 7%) of these 17 
aneuploid tumors were hypoploid. Nine (47%) rats of the 19 
with a tubulopapillary carcinoma had an aneuploid pattern 
while 8 (40%) of the 20 with a cribriform comedo carcinoma 
were aneuploid. Therefore, tubulopapillary carcinomas and 
cribriform comedo carcinomas did not differ in DNA ploidy 
status. 
Within the series of malignant tumors no correlation was 
observed between degree of malignancy (non-invasive s invasive 
s metastatic) and percentage of DNA aneuploid tumors (~ 
2.) • 
Within the group of benign tumors diploid cases were more 
frequent than in the group of malignant tumors (82% and 56% 
respectively) (ps0.05). 
Within the group of malignant tumors hyperploid cases were 
more frequent (9/39) than in the group of benign tumors (1/26) 
(ps0.05). There was no difference in hypoploidy between the 
malignant (8/39) and benign groups (4/26). 
DNA and mitotic activity index. In the series of 
tubulopapillary tumors, tubulopapillary carcinomas had a 
significantly higher mitotic activity than the tubulopapillary 
adenomas (psO. 05) (Table 3). Mitotic activity index varied 
considerably between tumors. No difference was observed 
between invasive and non-invasive carcinomas. There was no 
correlation between the mitotic activity index and the DI 
(data not shown) . 
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Table 1 DNA ploidy distribution in 65 rat mammary tumors 
Number of Diploid Aneuploid 
animals total hypopl. hyperpl. 
Benign 
tubular 
adenoma 8 7(88)a 1(12) 1 0 
papillary 
cystadenoma 8 6 (75) 2(25) 1 1 
fibroadenoma 10 8(80) 2 (20) 2 0 
21(82) 5 (18) 4 -1--
Malignant 
tubulopap.carc. 19 10(53) 9(47) 6 
noninvasive 9 4(44) 5(56) 2 
invasive 7 4(57) 3(43) 3 
metastatic 3 2 1 1 
cribriform-
comedocarc. 20 12(60) 8(40) 2 
noninvasive 9 3(33) 6(66) 2 
invasive 9 7 (78) 2(22) 0 
metastatic 2 2 0 
22(56) 17 (44) 8 
aNumber of animals, percentages in parentheses. 
Table 2 Relationship of histological malignancy grade and 
ploidy levels 
Aneuploid 
3 
3 
0 
0 
6 
4 
2 
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Number of Diploid 
animals total [hypopl. hyperpl.] 
Benign 26(100) 21(82)a 
Malignant 39(100) 22(56) 
noninvasive 18(100) 7(39) 
invasive 16(100) 11(69) 
metastatic 5 4 
5(18) 
17 (44) 
11(61) 
5 (31) 
1 
[4 (15) 
[8(21) 
[ 4(22) 
[ 3(19) 
[ 1 
aNumber of animals, percentages in parentheses. 
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1( 4) 
9(23) 
7 (39) 
2 (12) 
0 
Table 3 Relationship of mitotic activity index and 
tubular (papillary) turners 
tubulopap. 
adenoma 
tubulopap. care. 
noninvasive 
tubulopap. care. 
invasive 
aMean ± s.e. 
Number of 
animals 
8 
9 
7 
Mitotic activity index 
25,1 ± 16,0 
28,7 ± 18,3 
Table 4 Mean and standard error (s.e.) of various morphometrically 
established nuclear features in rat mammary turners 
feature 
(mean ± s. e.) 
perimeter 
s.e. 
area 
s.e. 
formfactor PE 
s.e. 
D MAX 
s.e. 
1 
tubulopapillary 
adenoma 
24.0 
± 0. 73 
42.3 
± 2.8 
0.911 
0. 07 8 
8.0 
± 0.23 
Number of animals 8 
2 
non-invasive 
tubulopapillary 
carcinoma 
27.6 
± 2.3 
58.0 
10.6 
0.909 
0.094 
9.2 
0.7 
9 
x Significantly different from value in column 1. 
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3 
invasive 
tubulopapillary 
carcinoma 
28.2 
± 1.6 
60.1 
6.7 
0.921 
0.004 
9.3 
0.5 
7 
X 
X 
X 
Morphometry. The results of the nuclear measurements 
performed on histological slides of the ·8 tubulopapillary 
adenomas, 9 non-invasive tubulopapillary carcinomas and 7 
invasive tubulopapillary carcinomas are summarized in Table 4. 
The mean values for area, perimeter and maximal diameter D.Max 
were greater in both carcinoma groups as compared to the 
adenomagroup, reaching the level of significance only for the 
invasive carcinomas as compared to the adenoma category. 
Overlap between the 3 groups was appreciable. 
3. Discussion 
The clinical behavior of rat mammary carcinomas is 
different from that of human breast cancer i.e. they are 
characterized by a noninvasive or microinvasive growth pattern 
and a low frequency of metastasis [about 5 % (1) 1. Their 
volume doubling time is lower and may even be less than that 
of benign rat mammary tumors (7). 
In the present study, DNA ploidy patterns were determined 
in spontaneous and radiation and/or estrogen treatment induced 
rat mammary tumors. The DNA content of the tumor cells was 
related to DNA content of diploid reference cells and 
expressed as the DI i.e. , the ratio of the mode of the 
relative DNA content of the G~0 cells of the sample divided by the mode of the relative F. content of the diploid a110 reference cells. 
According to the convention on nomenclature for DNA 
cytometry {8), the reference cells were mixed with the cells 
of the tumor sample before PI labeling. The reference cells 
were derived from paraffin blocks of renal tissue of the same 
rat to assure identical treatment of sample and reference 
cells before PI staining used for DI estimation. In order to 
recognize the added reference cells from those of the sample 
they w~re prepared and prestained with FITC separately. 
Subsequently, both sample and FITC labeled cells were mixed 
and stained with PI. The small shift of PI intensity of the 
reference cells due to double staining as measured in parallel 
control experiments using renal nuclei stained with PI only 
and PI + FITC was corrected for and was never greater than a 
factor 1.14. Using this method we could clearly·recognize the 
normal reference G110 peak and therefore distinguish DNA hypoploid and DNA hyperploid peaks. This is impossible when 
normal cells in the tumor are used as a reference. In the 
latter situation, the first peak is assumed to represent 
normal G cells. 
In th~1~resent study 5 (20%) of 26 benign tumors were DNA 
hypoploid and 1 (4%) hyperploid. These findings contrast with 
data obtained in man where benign mammary tumors are 
characterized by a DI of about 1. However this may be species 
related as comparable percentages of DNA aneuploidy have been 
reported in canine benign mammary tumors (6,9). Of the 39 
malignant rat tumors 17 (44%) were aneuploid and 9 (23%) of 
these were hyperploid. Thus DNA aneuploidy and especially DNA 
hyperploidy was more frequent in malignant than in benign rat 
mammary tumors. No differences in this respect were observed 
between invasive and non-invasive carcinomas. 
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In the present study we observed a lower incidence of 
aneuploidy (44%) in the rat mammary carcinomas than normally 
observed in human mammary carcinomas (4,10). Others, however, 
also observed a relatively low incidence (44%) of aneuploidy 
in human mammary carcinomas (11). 
In man DNA aneuploidy is associated with a poor prognosis 
(2, 12). However, rats with mammary carcinomas do not die 
because of generalized metastatic disease but in the majority 
are euthanized because of the large size of the tumors or 
ulceration of overlying skin. They, therefore, might have 
lived for a much longer time. In man prognosis is mostly 
determined as survival after time of diagnosis and treatment. 
Rats are left untreated and histological diagnosis is made 
after necropsy. 
In our study DNA hyperploidy was observed more often in 
malignant than in benign tumors. But within the carcinoma 
category hyperploidy or the degree of DNA hyperploidy was not 
more frequent in the histologically or clinically more 
malignant cases as has been reported in man (10). 
Baak et al. (2,3) noticed that, in addition to histological 
appearance, quantitative nuclear parameters and the mitotic 
rate are good predictors of prognosis in breast cancer. In our 
study, we indeed found a correlation between histological 
malignancy, nuclear features and mitotic activity index, 
however, no differences were observed between invasive and 
noninvasive malignant tumors. 
In conclusion, our study shows that the category of 
histologically malignant rat mammary tumors differ 
significantly from benign rat mammary tumors in the relative 
frequency of DNA hyperploidy, mitotic activity index and some 
quantitative nuclear characteristics. This lends support to 
the contention that the histologically malignant rat mammary 
tumors, although clinically less malignant, are in many 
aspects comparable to their human counter parts. 
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Scientific staff: 
I. Objectives of the project: 
The objective of the European Late Effects Project Group (EULEP) .is to 
plan, promote, execute and analyse co-operative research relevant to the 
understanding of the biological effects of exposure of living organisms 
to ionizing radiation. 
Objectives Jor the' reoortiog oeriod· . . . To co-ord1nate reSearch ~ct1v1t1es on spec1f1c aspects of the late 
effects of ionizing radiation by means of problem-oriented task 
groups; 
2. To maintain, develop and standardise relevant methodologies, to 
3. 
introduce new techniques, and to initiate appropriate training 
activities, by means of four committees: 
Committee of External Radiation Dosimetry and Techniques 
Committee of Internal Radiation Dosimetry and Techniques 
Committee of Pathology 
Committee of Cell and Molecular Biology; 
To plan regular symposia on aspects of late effects studies. 
- 1938-
Ill. Progress achieved: 
During the period covered by this report, EULEP carried out an 
internal reorganisation by which the co-ordination of research activities 
is achieved through a number of task groups. Each of these has been 
established to deal with a specific problem that has been studied by a 
co-ordinated effort in the member laboratories. 
The four standardisation committees referred to in section II have 
continued to play an important role in the activities of EULEP, and their 
work will be reported first. 
Committee of External Radiation Dosimetry and Techniques 
For the purposes of standardisation of experimental conditions, so 
that results of animal studies are directly comparable between member 
laboratories, the committee has organised periodic intercomparisons of 
the dosimetry of X-ray exposures. Mouse phantoms filled with thermo-
luminescent dosimeters have been mailed to each institute and irradiated 
under an agreed protocol. The read-out of the TLDs and derivation of the 
absorbed doses have been performed at the National Institute of Public 
Health and Environmental Protection (RIVM) at Bilthoven, The Netherlands. 
The results have been evaluated jointly by RIVM and TNO. 
The fifth dosimetry intercomparison was performed in 1983-1985 and 
the mean results for the different laboratories were within ~ 5% of the 
readings at the reference laboratory for all except one of the eleven 
participating institutes. That one case was followed up in 1986-87, when 
it was found that the discrepancy was not due to the dosimetry 
instrumentation itself, but probably resulted from a change in the 
position of the monitor chamber. Separate estimates were also made in 
this intercomparison of the degree of uniformity of dose distribution 
across the phantom. 
A sixth dosimetry intercomparison was planned during 1988 and 
carried out in 1989. Preparations included various refinemen·ts to the ' 
procedures at Bilthoven. Fifteen laboratories participated in the first 
session and the measurements were performed as before. Further 
estimations were made for those institutes with deviations close to or 
greater than ~ 5%. The evaluation of the results will be completed in 
early 1990, but preliminary data for the absorbed dose in the centre of 
the phantom reveal that the figures were in excess of ~ 5% of the value 
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at the reference laboratory for four participating institutes. 
Concerning the distribution of absorbed dose in the mouse phantom, four 
participants did not meet the criterion for a uniform dose distribution, 
viz. a ratio of maximum to minimum doses of less than 1.10. These 
discrepancies will be followed up by consultations in the first instance. 
The EULEP protocol for X-ray dosimetry and exposure arrangements was 
published in 1985, with an abbreviated version published as a journal 
paper. This has proved of immense value as a handbook and source of 
guidance on the subject. 
Other activities of the committee have included dosimetric aspects 
of total-body irradiation of patients for bone marrow transplantation in 
the treatment of acute leukaemia and other diseases. Symposia dealing 
with this topic were organised in 1986 and 1988, in conjunction with 
other bodies representing the clinicians involved. 
Committee of Internal Radiation Dosimetry and Technigues 
Since its formation in March 1986 the committee has pursued 
activities in three areas: 
(i) Task Groups. The committee has given support to the six task 
groups which lie within its sphere of responsibility: Lung, 
Decorporation, Stem Cells, Bone, Fetal Dosimetry and G-I Tract. Another 
task group, on Early Indicators of Pulmonary Damage, was set up during 
the reporting period but was later dissolved when two of the three member 
laboratories had to cease work in this field. Encouragement was given to 
the task groups on bone, stem cells and fetal dosimetry to hold joint 
meetings; two such meetings have been held to which eminent guest 
speakers were invited. These proved very successful with the larger 
audience leading to lively discussions and considerable cross-
fertilisation of ideas. 
(ii) Training and Standardisation. Recognising that several EULEP 
laboratories were working on various aspects of alveolar macrophage 
function the committee organised a one day workshop on macrophages in 
1987. This workshop was partly educational, with critical review papers 
from world-renowned experts in various aspects of macrophage function, 
and partly provided a forum for the detailed discussion of the work on 
macrophages being carried out in the various laboratories. This very 
successful venture initiated a number of new collaborative projects 
between member laboratories and led to an extensive programme of worker 
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exchange in order to standardise the experimental methods being used in 
the different laboratories. Scientific discussions were held during 
committee meetings on Some Problems of Beta Dosimetry (1987) and on 
Cell-Specific Dosimetry (1989). 
(iii) Committee Scientific Work. Following the accident at the 
Chernobyl nuclear power station many EULEP members received urgent 
requests for assessments of the committed radiation doses likely to be 
received by particular groups in the population following intake of 
radionuclides in foodstuffs or in water. Acting on a request from 
Council a working group of the committee developed a simple computer 
program for the calculation of the absorbed radiation dose to 21 tissues 
of adults, and 1 and 10 year-old children, resulting from ingestion of 
any of the 50 most important radionuclides. This program - DOSELIB -
contains dosimetric information from the database of the Federal German 
Health Office, upgraded to take account of the new metabolic models for 
the actinides proposed in ICRP Publication 48, and the co-operation of 
Professor Alexander Kaul and his colleagues is gratefully acknowledged. 
The program is suitable for any ISM-compatible computer and is available 
on floppy disc. Plans have been made to update this program to take 
account of any changes in dose limits in new Recommendations of the ICRP 
which are currently in preparation. 
Co-operation with other organisations - In 1988 a formal link was 
established with Committee 6 (Assessment of Internal Dose) of the 
EURADOS-CENDOS European Radiation Dosimetry Group, as a result of this 
link each committee is now represented by its chairman of meetings of the 
other. A joint EULEP-EURADOS application, involving five laboratories (4 
EURADOS + EULEP), on the Assessment of Internal Dose from Radionuclides 
using Stable Isotope Tracer Techniques in Man was selected for funding 
under the European Communities Radiation Protection Programme 1990-91. 
Committee of Pathology 
The main goals of this committee are (1) to further standardise and 
update diagnostic terminology as used by pathologists of the EULEP member 
laboratories and (2) to increase the expertise of members on various 
morphological aspects of late effect studies in laboratory animals, 
including the application of new techniques. 
The committee has organised yearly slide seminars each covering a 
different organ system. These are intended to give members an up-to-date 
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overview of specialist diagnostic procedures as well as providing a forum 
for discussion of problem areas and standardisation of terminology. 
Outside experts were invited to lecture on specialist topics in which 
expertise was lacking within the committee. Slide seminars were held on 
the respiratory tract, the urinary tract, the haemopoietic tissues, the 
bone marrow (with particular emphasis on myeloid lesions), and on the 
neuroendocrine and APUD system. 
The committee also organised symposia on more general topics in 
animal pathology, the subjects of which included Comparative Pathobiology 
of Experimental in vivo and in vitro Systems, Total-body Irradiation, and 
Quantitative Morphology. In addition members of the Committee 
contributed to other EULEP workshops and symposia, including the 
symposium on effects after combined exposure to ionizing radiation and 
chemical substances. 
The committee has maintained a consultation centre for problem 
cases. The majority of these were discussed during the annual slide 
seminars. 
Two further fascicles of the EULEP Atlas were published (E Kunze: 
Preneoplastic and neoplastic lesions of the urinary bladder of the rat; C 
Zurcher: Neoplastic and non-neoplastic lesions of male and female genital 
tract of the mouse and rat); two fascicles are in press (P Bannasch and 
H Zerban: Preneoplastic and neoplastic lesions of the kidney of the rat; 
P K Pattengale: Neoplastic lesions of the mouse lymphoid system) and a 
further fascicle (on skin) is in preparation. 
The activities of the committee greatly helped in maintaining and 
upgrading the expertise of individual pathologists in the member 
laboratories. The decision to invite outside experts to give "state of 
the art" lectures at the slide seminars has proven very valuable, 
providing members with an opportunity to discuss the most modern 
developments in pathology, and to use these to improve diagnostic 
precision in animal experiments. Maintaining this level of expertise in 
the committee is essential for the maintenance of the high quality 
pathology support given in many studies performed in EULEP laboratories. 
Committee of Cell and Molecular Biolo&v 
Following the establishment of this new committee in 1986, it was 
proposed that its major activities should consist of (a) individual and 
collective training courses for research workers with no previous 
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experience in molecular biology, and (b) workshops designed to introduce 
experts in the different laboratories to novel techniques which had been 
developed in one of them. 
At two meetings in December 1986 and January 1987 the committee 
determined the priority to be given to various aspects of training in 
molecular biology. It was agreed to provide on the one hand a general 
introduction to the techniques of molecular biology, and on the other 
hand training on molecular hybridization in situ. The committee also 
decided which form the training courses should be given in order to be 
the most profitable . 
. In May 1987 a training course took place on "The fundamentals of 
molecular biology"; this was held in the laboratories of CEN, Mol, 
Belgium, and was entirely funded by EULEP. It was attended by 12 young 
research workers from EULEP-associated laboratories, coming from 8 
different countries. The participants became acquainted with DNA and RNA 
purification from mammalian tissues, restriction enzyme analysis, 
transfer of RNA and DNA onto immobilising supports, radioactive labelling 
of molecular probes, and subsequent molecular hybridization. 
In 1987 the committee also supported a 2-month stay of a EULEP-
associated member at the University of Brussels, in order to introduce 
into the EULEP network the technique of in situ molecular hybridization 
which was much needed. 
On several occasions the committee has organised or co-ordinated 
workshops for the members of the various task groups involved in the use 
of cell and molecular biology techniques. There were two such workshops 
in 1987 and two in 1988. 
TASK GROUPS: Eleven task groups were established in 1986, some 
representing new lines of work within EULEP but others broadly continuing 
work which had been co-ordinated previously. Since that date other task 
groups have been established to meet changing demands and new 
opportunities for collaboration. Some of the more significant aspects of 
progress achieved are as follows: 
(a) Molecular Approach to the Study of Radiation-Induced Osteosarcoma 
The objective has been to study the pathogenesis of radiation-
induced osteosarcoma at the molecular level. A powerful feature of the 
programme has been the parallel development of studies with cell lines, 
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organ culture in vitro, and in vivo pathogenesis. The infection of 
osteoblast-like cell lines with viral sequences from radiation-induced 
murine osteosarcoma has resulted in neoplastic transformation and 
abrogation of osteogenic differentiation. Osteosarcoma-like lesions have 
been produced in organ culture of cartilage in vitro, which are 
transplantable in mice; this model has been used to study cell migration 
and invasion. 
The participation of retroviruses is the major focus of interest, 
together with the role of certain oncogenes. Newly integrated proviruses 
in radiation-induced osteosarcomas have been analysed and cloned. The 
viruses are highly homologous but the different clones exhibit different 
pathogenicity in bone, suggesting rather subtle differences among the 
proviral genomes. The RFB osteoma virus was cloned and its LTR sequence 
was compared to that of other bone tissue material. Studies on the 
proviral integration sites in RFB-induced osteomas have been co-
ordinated. The study on the localisation of the viral sequences which 
may confer pathogenicity on the RFB virus has called for a co-ordinated 
experimental strategy, including the generation of recombinants between 
RFB and a highly homologous non-pathogenic virus, and pathological 
studies on transgenic mice. 
(b) Molecular Approach to the Study of Radiation-Induced Haemopoietic 
Neoplasias 
Originally'this task group was established to study molecular 
aspects of the induction of thymic lymphoma (TL) in the C57Bl mouse. It 
had been found that there were new proviral inserts in some primary 
tumours and in all cell lines grown in vitro or serially transplanted. 
The possible expression of RNA synthesis from a cellular gene promoted by 
new integrated proviruses was studied; there was found to be unexpected 
activation by RadLV of endogenous rat proviral genomes. 
A direct test of the Kaplan hypothesis was made, to determine if the 
induction of TL by radiation might be directly mediated by a 
leukaemogenic retrovirus. In general, novel provirus representing a 
recombinant of endogenous proviruses was not found in the affected cells, 
thereby failing to confirm the hypothesis. 
The final conclusion of that collaborative work was that, even if 
RadLV-like proviruses might facilitate cell growth, they should be no 
longer considered as inducing agents or as essential factors in the 
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production of TL. Some work is continuing on TL induction, however, 
directed towards the interaction between radiation-induced preneoplastic 
cells and the thymic microenvironment. 
In the last year, the composition and aims of the group were 
changed, to concentrate more on myeloid leukaemia in the CBA mouse. 
Specific chromosomal lesions have been studied which are commonly found 
in leukaemic cells, also the possible activation of genes resulting from 
this which may be concerned with leukaemogenesis itself. Attention has 
focused chiefly on a region of chromosome 2, where structural 
rearrangements had suggested an association with enhanced activity of the 
gene for interleukin-1 beta. Further studies have suggested however that 
IL-1 beta deregulation is probably not an initiating event in myeloid 
leukaemia. Studies are continuing on the sites of chromosome 2 
rearrangement which show remarkable radiation fragility. 
(c) Cell Biology of Haemopoietic Tissues 
The task group was established initially to investigate the cell 
biology of thymic lymphoma, complementing the molecular biology described 
above (b). These studies used two models for investigating relevant 
cellular factors, a thymic graft to thymectomised irradiated animals, and 
the transfer of pre-leukaemic cells and/or factors to irradiated 
recipients. In situ hybridisation studies have been performed. 
The group has been actively looking for the role of lymphokines 
after irradiation, during leukaemogenesis in vivo and during the long 
period preceding the establishment of lymphoma lines in tissue culture. 
With the shift in emphasis towards myeloid leukaemia noted above, 
the group is now redirecting some of its efforts to include myeloid as 
well as lymphoid malignancies, but the overall aim remains to investigate 
the cellular basis of long-term consequences of irradiation in 
haemopoietic tissues. In the two cases growth factors seem to play 
critical but different roles. 
(d) Cellular Basis of Late Vascular Changes in the Irradiated Brain 
Over many years this project has elucidated important aspects of the 
pathogenesis of damage to certain regions of the irradiated brain, seen 
from 12 to 24 months after doses of 20 Gy X-rays. The group has 
integrated methodological and physiological studies with the aim of 
delineating and evaluating the areas at risk in the central nervous 
- 1945 -
system, evaluating the degree of risk and also factors that may modify 
the expression of the late effects. 
It was found that vasodilatation preceded demyelination. There was 
no early decrease in vascular density or vasodilatation in the deep 
cortex, but both were evident at 12 months post-irradiation. While the 
blood-brain barrier did not break down, the antipyrine distribution space 
increased after 14 - 18 months. There was a decrease in nutritional 
blood flow. · 
The white matter of the brain is the more sensitive part, and the 
fimbria hippocampi (FH) is the most sensitive region. The earliest 
manifestation of damage has been defined in terms of a "tissue injury 
unit", consisting of enlargement of endothelial cells and astrocytes, 
blood vessel dilatation, and blood vessel wall thickening. Electron 
microscopic studies also showed primordial telangiectatic lesions in the 
FH. The appearance of the tissue injury unit occurred before the 
development of damage to the nervous tissue itself, ie, demyelination; 
moreover, it represents the most sensitive response of the CNS to 
irradiation. 
(e) Non-Stochastic Effects on the Skin 
Two task groups have been active on different aspects of the late 
radiation response of the skin. One has been c~ncerned to evaluate the 
contributions of epidermal basal cell damage and dermal cell killing to 
the eventual desquamation and epidermal breakdown, as a function of 
depth-dose and.field size. This is of importance in defining the risk 
from local irradiation by energetic beta-emitters in contact with the 
skin. Mouse and pig skin were compared, using sources of 90sr and 170Tm 
(thulium) oft, 5 or 9 mm diameter. In the case of pig skin, the 
classical pattern of epithelial damage was not seen over the first few 
weeks: damage occurred rather by endothelial and fibroblast cell death in 
the dermis, leading to capillary loss from the papillary dermis and 
epidermal breakdown from 14 days after doses of 200-500 Gy. In the 
mouse, 300-1500 Gy again caused~amage in the dermal as well as epidermal 
layers, leading to epithelial and follicle breakdown by 6 days. 
More recently a second task group on skin began work on the effects 
of residual radiation injury from an initial exposure on dermal and 
subcutaneous vascular and connective tissue. The skin was to be re-
exposed to high energy beta particles from 90sr plaques. Two strains of 
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pig were compared, and different anaesthetic procedures which were in use 
in the different laboratories. The response to 90sr irradiation in terms 
of moist desquamation after 9 weeks was found to be very different for 
the two strains. Using either anaesthetic (azaperonjetomidat or 
halothane/N20/02), the large white pigs showed a lower EDso for moist 
desquamation than the Gottinger miniature pigs, by a factor of 1.3-1.4. 
With azaperon/etomidat there were variations in the EDso between 
different skin fields, but not with halothane/N20/02 unless the 
percentage of 02 in the mixture was reduced from 70% to 21%. 
(f) Radiation Effects on the Heart 
A collaborative project was established to examine morphological and 
functional changes in the irradiated rat· heart. 'Wistar and Sprague-
Dawley (S-D) rats were used, and doses selected for each (17.5 and 20.0 
Gy respectively) which resulted in a comparable latent period from 
irradiation to death from cardiac failure. Similar pathological lesions 
were seen in the two strains at 100 days. The first effect was a rapid 
decrease in capillary density and loss of alkaline phosphatase by 
capillary endothelial cells, both seen by 28 days and before any marked 
pathological changes. The correlation with functional changes was 
however complex. Cardiac output measured in S-D rats decreased by 28 
days, whereas in Wistar rats it increased over the same period of time. 
The percentage of cardiac output distributed to the ventricular muscle, 
assessed by 86Rb extraction, increased in S-D rats but did not change 
significantly in Wistar rats. In ftct the rate of blood perfusion per 
gram of venticular muscle calculated from these data did not change 
greatly in either strain of rat, compared with controls, over the period 
of observation. Thus the cardiovascular system compensated for the 
marked morphological changes, though not in the same way in the two 
strains of rat. 
(g) Effects of Radiation on Pre-Implantation Mouse Embryos 
The effects of X-rays, neutrons and tritiated arginine and thymidine 
have been studied on 1- and 2-cell embryos from different mouse strains. 
In one strain similar to the NMRI mouse, there was an increased 
teratogenic risk: in particular an increase in the number of 
gastroschises. The sensitivity was very pronounced at the 1-cell stage, 
but changed within hours. There was no detectable threshold at the 1-
-1~7-
cell stage, unlike multicellular embryos (32 to 64 cells) where 
abnormalities appear only above 0.5- 1.0 Gy. C57Bl mouse embryos did 
not show increased teratogenic risk at the pre-implantation stage. 
Chromosome aberrations have also been studied at this stage of 
development. Tritiated thymidine did not increase the frequency of 
aberrations at the first mitosis, but arginine did produce a rise in the 
second and third divisions, thymidine less so. Dose-effect curves were 
linear up to 1.88 Gy X-rays and 0.75 Gy neutrons. 
It has been shown that zygotes of certain mouse strains are very 
sensitive to radiation-induced block of the cell cycle at the G2 stage, 
e.g. after 1 Gy X-rays. This is dependent on the maternal, not the 
embryonic genotype. Protein synthesis in blocked embryos differed from 
unirradiated controls by the absence of phosphorylation of some 35 kD 
proteins at the time of the first cleavage. Caffeine can reverse the G2 
block, probably by restoring, directly or indirectly, the post-
translation modification of these proteins. Another current aspect of 
this work is to ascertain whether G2 block involves the nucleus of the 1-
cell embryo; the nucleus does not normally control development until the 
2-cell stage. 
(h) Effects of Radiation on the Development of the Central Nervous 
System 
The aim has been to assess radiation-induced damage to the fetal CNS 
by means of animal experimental models. A number of related endpoints 
have been studied, and some experiments have been extended down to low 
dose levels. 
Structural defects in the developing brain have been demonstrated in 
a number of models. The development of the cerebral cortex was found to 
be very sensitive ~o irradiation in the mouse, manifested as disturbed 
proliferation and migration of neurones and a disturbed branching pattern 
of neurones in the cortex. Image analysis showed that the degree of 
neuronal disturbance decreased with increasing age at time of exposure: 
as little as 0.1 Gy affected the alignment of neurones at 12 days post-
conception (p.c.), rising to 0.5 Gy as the minimum dose at 17-18 days 
p.c. 
A part of the corpus ca:losum has been found to be the most 
sensitive area to structural damage. Significant atrophy was found in 3-
month old rats exposed to only 0.15 Gy X-rays or 0.05 Gy neutrons at 15 
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days p.c. 
Other studies in the NMRI mouse showed that 0.9 Gy X-rays at day 12 
p.c. caused cell depletion especially in the proliferating ependymal 
zone. 1.9 Gy completely prevented the development of this area. 
Recent studies have investigated lectin-binding sites on neuroblasts 
of several regions of the embryonic brain (9-10 days p.c.). The binding 
of certain lectins has been shown to occur 6-12 hours after doses as low 
as 0.125 Gy, disappearing again 24-36 hours later; this binding was 
presumably either absent or masked in the unirradiated, normally 
developing brain. 
A new addition to this collaboration-is behavioural studies 
conducted on mice, using a maze to assess effects of radiation on spatial 
memory. Performance at 60 days of age is being studied after X-
irradiation at different stages of organogenesis. 
(i) Interspecies Comparison of Lung Clearance 
The purpose of the task group has been to quantitate the kinetics of 
various particle clearance and retention mechanisms in the lung in 
different animal species and in man. Special emphasis has been placed on 
the two main clearance mechanisms for long-term retained aerosol 
particles: the translocation of dissolved material from the lungs to 
blood, and "mechanical" particle clearance via the pharynx to the gastro-
intestinal tract. 
In the last five years the task group has carried out three 
collaborative interspecies comparisons of lung clearance, and a fourth is 
in progress: 
(i) Lung clearance of inhaled porous monodisperse cobalt oxide 
particles of 0.8 pm and 1.7 ~m diameter, in man, baboon, dog, guinea-pig, 
HMT rat, F-344 rat, Sprague-Dawley rat, hamster and mouse. 
(ii) Lung clearance of inhaled solid cobalt oxide particles of 
0.9 ~ diameter, in baboon, dog and HMT rat. 
(iii) Interspecies comparison of phagolysosomal pH in alveolar 
macrophages, using fluorescein-labelled silica particles, in baboon, dog, 
rabbit, guinea-pig and HMT rat. 
(iv) Lung clearance and retention of soluble cobalt after 
instillation of a Co2+ solution, in baboon, dog, guinea-pig, HMT rat and 
F-344 rat. 
In the first two of these studies, translocation of dissolved cobalt 
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and mechanical clearance of oxide particles were evaluated over at least 
six months. The particles used varied both in size and in specific 
surface area. It was concluded that for moderately soluble particles, 
translocation of the material from lungs to blood was the most prominent 
clearance mechanism, and was dependent on the species - in man and baboon 
the ra~e of translocation was about five times less than in the dog and 
small animals. Also, particle dissolution was more effective within the 
alveolar macrophage than in extracellular fluid in the lungs; the rate-
determining parameter for translocation was the specific surface area. 
The studies on pH in the macrophage phagolysosomes were undertaken 
to see if this was the determining factor in the difference in 
translocation rate between the species. However, similar pH values of 
4.8 ± 0.2 were found in alveolar macrophages obtained from four species, 
whose translocation rates in the earlier in vivo experiments had been 
very different. 
Of the dissolved cobalt which is transferred to blood, 5-10% was 
accumulated in the cartilage of the tracheobronchial airways. This is 
being compared in the different species to improve the model for 
translocation of dissolved material, and thereby the general dosimetric 
model for inhaled radionuclides. 
(j) Treatment after Incorporation of Actinides (Reduction of Risk) 
The main collaborative effort during the period was directed towards 
the testing of the catechoyl amide 3,4,3-LICAM(C) for enhancing the 
elimination of plutonium from the body. The compound had been reported 
in the literature as being more effective than the current agent of 
choice, DTPA. The studies involved its administration as either a 
methylated or pure form to several animal species (mouse, hamster, rat, 
baboon) after the intake of different chemical forms of plutonium by i.v. 
injection (citrate) or by inhalation (nitrate and· TBP complexes); in the 
latter case the mass concentrations of plutonium in the lungs were 
equivalent to those in humans after intakes which ranged between 10 and 
105 times the ALI. These studies were supported by in vitro experiments 
designed to investigate the stability of the Pu-LICAM(C) complex at 
physiological pH and the ability of the chelate to remove plutonium from 
its carrier protein in blood, transferrin. It was concluded that after 
the injection of plutonium citrate both forms of LICAM(C) were as 
effective as DTPA but its potential use in humans was contraindicated by 
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the excessive amounts deposited in the kidneys; after inhalation of the 
lower amounts of plutonium as TBP, LICAM(C) was marginally more effective 
than DTPA, though neither chelating agent under these conditions 
substantially reduced the body content of plutonium. The enhanced 
deposition of plutonium in the kidneys was due to the instability of the 
LICAM complex at about pH 6. The task group recommended that DTPA should 
remain the agent of choice. 
The most promising compounds for the decorporation of plutonium 
however still appear to be synthetic analogues of siderophores. 
Collaboration with the University of California and Lawrence Berkeley 
Laboratory has resulted in advice on the purity of LICAM(C), the supply 
of two promising compounds (DFO-HOPO and DTPA-DX) which were currently 
being examined, and detailed information for the EULEP synthesis of a 
third compound 3,4,3-LIHOPO. 
A number of diphosphonate complexes synthesised at the Pierre and 
Marie Curie University Paris were shown to be inferior to DTPA for 
enhancing the elimination of plutonium. 
During the period 1985-89, improvements were made to the efficacy of 
DTPA treatment for plutonium by oral administration, infusion and 
injection. The chelating agent was shown to be most effective for 
thorium injected intravenously as the citrate and nitrate when 
administered promptly (1.5 min); the body content was reduced by only 
about a factor 2 or less when treatment was delayed for more than 30 
minutes or when thorium nitrate was inhaled. Tiron, a compound suggested 
for the treatment of uranium poisoning, was only partially effective-for 
enhancing the elimination of uranium when inhaled in amounts equivalent 
to the ALI for humans. The development of more effective therapeutic 
regimes for thorium and uranium will be an area for future research. 
(k) Stem Cell Studies after Contamination with Alpha-Emitters 
Co-ordinated studies have been designed to investigate the effects 
of alpha-emitting bone-seeking radionuclides on target cells in mouse 
bone marrow. In order to interpret metabolic data for such radio-
nuclides, and to provide a rational basis for estimating risk factors for 
leukaemia and osteosarcoma, it is important to determine the type and 
location of cells in the bone marrow which would be sensitive to alpha 
irradiation, as well as their different radiation responses with time. 
The radial distribution of stem cells in the mouse femur marrow has 
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been found to be non-uniform, with the most primitive cells in the axial 
marrow receiving lower doses from radionuclides in the bone than more 
mature cells in the marginal marrow. The differential responses of these 
cells after irradiation with incorporated 239pu and 224Ra have been 
compared. Recovery of stem cells took place within three months of Pu 
administration, but there was a long-term loss in stem cell quality. 
Recovery was better after Ra treatment, but took place more slowly. The 
overall pattern of cell migration and radiation response is complex. 
Other studies have investigated haemopoietic stem cells in fetal 
liver and in neonatal spleen and bone marrow following 239pu 
administration to the mother at different times of gestation. 
It is recognised that the effects of alpha-emitters on the micro-
environment of stem cells are also of great importance. This has been 
studied using long-term bone marrow cultures, irradiated by incorporation 
of 241Am. Further work has shown that after leukaemogenic doses of 239Pu 
and 224Ra, different damage to the stem cells and the micro-environment 
can be seen. Plutonium administered to pregnant mice indicated different 
target cell populations in the offspring, depending on the time of 
administration during gestation. The regulation of haemopoiesis by 
stromal cells was found to be extremely radiosensitive in the offspring 
following 241Am injection into pregnant mice. 
The development of an in vitro assay for bone formation demonstrated 
the involvement of stromal marrow cells in osteogenic differentiation. 
This suggests that stromal cells may also be target cells for 
osteosarcoma development after alpha-irradiation. 
(1) Metabolism. Dosimetry and Effects of Bone-Seeking Radionuclides 
A major aim of this group is to co-ordinate long-term studies with 
alpha-emitting radionuclides, which are to determine the metabolism, 
spatial distribution and toxicity of these materials in bone of various 
species; the biological end points are leukaemia and osteosarcoma. Thus 
one collaborative study has investigated plutonium and americium 
distribution in baboon bones, another has studied 226Ra distribution in 
beagle dogs. A large life-time study in the CBA mouse has compared 
239Pu, 241Am and 233u metabolism in the skeleton. This study showed very 
different distributions on bone surfaces and in macrophages in the bone 
marrow at long times after injection. The mice have been given amounts 
of the three radionuclides which will give the same average dose to the 
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skeleton. Differences seen in the late effects therefore will be due to 
differences in the micro-distribution of the alpha-emitters. 
One study has highlighted the effect of dose protraction on the 
incidence of malignant lymphoma: an incidence of 13.5% was observed when 
224Ra was injected into the NMRI mouse twice weekly for 36 weeks, giving 
a final dose of 0.15 Gy. Lymphoma was not seen if the same dose was 
given from a single injection. More recent studies have shown that 
whether protraction affects the incidence of osteosarcoma depends on the 
total amount of activity injected. 
In a large-scale study on the effects of low doses of 224Ra in the 
CBA mouse, it has now been shown that single injections at levels below 
those which give the maximum incidence of osteosarcoma will induce 
myeloid leukaemia. In this range of injected activity the incidence of 
leukaemia is significantly greater than that of osteosarcoma. 
Relative risk ratios are also being measured for osteosarcoma in 
rats, following the administration of 238pu, 237Np and 226Ra. 
Preliminary results suggest a risk factor of 12% per Gy for 237Np average 
alpha dose to bone. 
Finally, consideration has been given to effects on man, firstly in 
a follow-up of patients given 224Ra in the treatment of ankylosing 
spondylitis. Secondly, recent calculations have shown that the dose to 
red bone marrow from naturally occurring alpha-emitters may be greater 
than was thought previously because of the possible concentration of 
radon in the fat of marrow tissue. The measurement of natural alpha-
radioactivity in children's teeth is being used as a method for 
monitoring environmental exposure in the general population. 
(m) Fetal Dosimetry and Effects of Incorporated Radionuclides 
This task group was established in 1988 because of an increasing 
concern regarding the risk to the developing embryo and fetus following 
the release of radionuclides into the environment. There are no 
generally accepted models for calculating tissue doses following intakes 
by the mother, either during or prior to pregnancy. Furthermore, there 
is only limited information on the radiosensitivity of tissues in the 
fetus and newborn. Studies are now being co-ordinated in three areas: 
(i) The distribution and retention of radionuclides in the fetus 
and newborn animal compared with that in the mother. A number of 
laboratories have obtained information on the extent to which 
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radionuclides are accumulated by the embryo and fetus following acute or 
chronic intake by the mother at various times before or during gestation. 
These studies have given information on relative concentrations of 
radionuclides in maternal and fetal tissues, and the extent to which 
radionuclides deposit heterogeneously in the embryo and fetus, as well as 
on the transfer of radionuclides to newborn animals during lactation. 
Studies have been carried out on a wide range of radionuclides including 
plutonium, americium, alkaline earths, 59Fe, 60co, 210po, 125I and 131I. 
(ii) The effects of incorporated radionuclides. A series of 
studies has been undertaken to assess the consequences of deposition of 
radionuclides in the developing embryo and fetus, to provide information 
on the sensitivity of tissues for early as well as late effects, and the 
extent to which tissue sensitivity varies throughout the period of 
gestation. In this area the task group has worked closely with the task 
group on stem cells. 
(iii) The development of dosimetric models from animal and human 
data. The problems in the development of suitable dosimetric models for 
the fetus include the rapidity of fetal growth, the varying progress of 
organ development in different species, and the presence of different 
types of placenta in different species: all of these provide a selective 
but potentially different barrier between maternal and fetal blood. 
Effort has been put into developing a dosimetric model for the actinides 
incorporating information from the different laboratories. This has to 
take account of the migration of stem cells during fetal life, e.g in the 
case of haemopoietic tissue. Effort is also going into developing 
dosimetric models for polonium and radon. 
(n) Retention and Absorption of Ingested Radionuclides and Irradiation 
of' the·Gastro-intestinal Tract 
Since it was formed in'1987, the task group has co-ordinated studies 
on the gastro-intestinal tract of the neonate, which was considered to be 
at risk from ingested radioactivity. 
Studies of the intestinal retention of plutonium in neonates have 
demonstrated clear species differences and lead to the conclusion that 
retention in human neonates is likely to be low. Retention was much 
greater in neonatal rats than in guinea-pigs: for example, 5 days after 
administration of 238Pu citrate to 6-day old animals, the small intestine 
retained about 20% of the administered activity in rats compared with 
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about 0.02% in guinea-pigs. The cellular distribution of the retained 
activity is also different, with act1v1ty concentrated in the epithelial 
cells in rats but largely confined to the central region of the villi in 
guinea-pigs. In the guinea-pigs given 239pu nitrate at 2 days of age and 
killed 10 days later, 96% of the dose was delivered to the top 2/3rds of 
the villi with only about 4% in the sensitive lower region near the 
crypts. In both species therefore, and particular in guinea-pigs, the 
retained activity was very largely at some distance from the crypt cells. 
The possibility of uptake of ingested particulates into the lymphoid 
tissue (Peyer's patches) has been studied in suckling guinea-pigs, using 
particles of plutonium dioxide less than 5 pm diameter. Autoradiographic 
examination showed very low levels of retention on the villus surface, 
and no significant retention in the lymphoid tissue. 
Limited studies with baboons showed a level and pattern of retention 
similar to that in the guinea-pig. This suggests that the guinea-pig can 
be taken as an appropriate model for retention in man. Previous work 
with neonatal baboons given plutonium nitrate had also shown no evidence 
of retention in lymphoid tissue. 
Work has also been undertaken on the absorption of ingested 
radionuclides 1n a human volunteer study to measure the absorption of 
neptunium and curium, as well as polonium in different chemical forms. 
Finally, speciation studies are being undertaken to identify the chemical 
forms of radionuclides in food materials in the gastric and intestinal 
fluids. The objective of these studies is to determine the availability 
of radionuclides in the food chain for intestinal absorption. 
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IV. Other research group(s) collaborating actively on this project [name(s) and 
address(es)]: 
EULEP co-ordinates research on late effects of radiation in 22 Voting 
Member institutes; it also has over 30 individual corresponding members 
in other universities and establishments. Through these it is linked to 
a wide range of academic and research foundations throughout the EC. 
EULEP has also developed links with three other bodies: 
1. European Radiation Dosimetry Group (EURADOS) 
2. United States Department of Energy (DOE) 
3. European Bone Marrow Transplantation Group (EBMT) 
V. Publications: 
(This list is limited to items published by or on behalf of EULEP 
itself.) 
EULEP Newsletter: during the period 1985-89, 14 issues have been 
published (nos. 39-54). 
EULEP Pathology Atlas - the following new chapters have been made 
available: 
Neoplastic and non-neoplastic lesions of the male and female genital 
tract of the mouse and the rat, 1987. 
Preneoplastic and neoplastic lesions of the urinary bladder of the 
rat, 1988. 
Neoplastic lesions of the mouse lymphoid system, 1989. 
Preneoplastic and neoplastic lesions of the kidney of the rat, 1989. 
EULEP Protocol for X-ray Dosimetry, eds. J Zoetelief, J J Broerse & 
R W Davies, Commission of the European Communities, EUR 9507 EN, 1985. 
EULEP Symposium on Metals in Bone, ed. N D Priest, MTP Press Ltd, 
Lancaster, UK, 1985. 
A H L Aalbers and F J M Bader, The fifth EULEP X-ray dosimetry 
intercomparison, RIVM report 248005001, National Institute of Public 
Health and Environmental Hygiene, Bilthoven, The Netherlands, 1986. 
Symposium on Radiation Carcinogenesis: Molecular and Biological Aspects 
(eo-sponsored by EULEP), eds. J Boniver & M Janowski, Leukaemia Research 
10 (7), 1986. 
EULEP Symposium on Effects after Combined Exposure to Ionizing Radiation 
and Chemical Substances, organised by C Streffer, International Journal 
of Radiation Biology 51 (6), 1987. 
DOSELIB: A computer program for the calculation of radiation dose to the 
population following inhalation or ingestion of radionuclides, D M Taylor 
and W-G Thies, 1988; floppy disks available on request from IGT, 
Kernforschungszentrum Karlsruhe. 
EULEP Symposium on Skin - its Relevance in Radiological Protection and 
Radiation Accidents, organised by J W Hopewell in 1989, International 
Journal of Radiation Biology, in press. 
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Europaische Gemeinschaften - Kommission 
European Communities - Commission 
Communautes europeennes - Commission 
EUR 13268- Tiitigkeitsbericht- Programm Strahlenschutz- 1985-1989 
Progress report- Radiation protection programme- 1985·89 
Rapport d'activite- Programme« radioprotection"- 1985·1989 
Volume 2 
Luxembourg: Office for Official Publications of the European Communities 
1991 - X, 839 pp. - 16.2 x 22.9 cm 
Radiation protection series 
ISBN 92·826·2170·7 
Kat./cat.: CD·N B·13268·3A-C 
Preis in Luxemburg (ohne MwSt.): 
Price (excluding VAT) in Luxembourg: ECU 62.50 
Prix au Luxembourg, TVA exclue: 
The final report of the 1985·89 radiation protection programme outlines 
the research work carried out during the whole contractual period under 
all contracts between the Commission of the European Communities 
and research groups in the Member States. More than 700 scientists 
collaborated on this programme. 
Results of more than 440 projects are reported. They are grouped into 
six sectors: radiation dosimetry and its interpretation; behaviour and 
control of radionuclides in the environment; non-stochastic effects of 
ionizing radiation; radiation carcinogenesis; genetic effects of ionizing 
radiation; evaluation of radiation risks and optimization of protection. 
Within the framework programme, the aim of this scientific research is 
to improve the conditions of life with respect to work and protection of 
man and his environment and to assure safe production of energy, i.e.: 
(i) to improve methods necessary to protect workers and the popula· 
tion by updating the scientific basis for appropriate standards; 
(ii) to prevent and counteract harmful effects of radiation; 
(iii) to assess radiation risks and provide methods to cope with the con· 
sequences of radiation accidents. 
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